Citrus Sinensis ID: 041720
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.559 | 0.674 | 0.594 | 1e-146 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.501 | 0.484 | 0.659 | 1e-142 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.473 | 0.637 | 0.484 | 3e-92 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.555 | 0.758 | 0.426 | 5e-90 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.473 | 0.630 | 0.469 | 7e-89 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.495 | 0.666 | 0.454 | 5e-88 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | no | no | 0.524 | 0.239 | 0.391 | 1e-73 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.526 | 0.240 | 0.385 | 3e-73 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.494 | 0.225 | 0.406 | 5e-73 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | no | no | 0.505 | 0.234 | 0.396 | 2e-71 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 520 bits (1340), Expect = e-146, Method: Compositional matrix adjust.
Identities = 230/387 (59%), Positives = 307/387 (79%), Gaps = 1/387 (0%)
Query: 92 RHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKM 151
+H EQ+AAGWP+WL+ A GEA+ G VP +A++FEK++KIGQGTYS+V++A+++ TGK+
Sbjct: 84 KHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKI 143
Query: 152 VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDL 211
VALKKVRFDN +PES++FMAREI++LRRLDHPN++KLEG++TSR+S ++YLVF+YM+HDL
Sbjct: 144 VALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDL 203
Query: 212 AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271
AGL+S +KFSE +VKC MRQL+ G+EHCH RG++HRDIK SN+L+++ G+LK+ DFGL
Sbjct: 204 AGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGL 263
Query: 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT 331
A I +K+ +TSRVVTLWYR PELL+G+T+Y V +DLWS GC+ AELL G+PI+ GRT
Sbjct: 264 ATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRT 323
Query: 332 EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCL 391
EVEQLHKI+KLCGSP E+YWKK K HG ++KP+ PY+ +RE KDF P+++ LID L
Sbjct: 324 EVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALL 383
Query: 392 SIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREP 451
SIEP R TAS+ L E+FT++PYAC+P+ LPKYPP KEIDAK+RDE RR+ RA +
Sbjct: 384 SIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQ-RAASKAQ 442
Query: 452 ASSKRQRRARQTLQLQEPNSYSSKELE 478
R+ R R P ++ EL+
Sbjct: 443 GDGARKNRHRDRSNRALPAPEANAELQ 469
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-142, Method: Compositional matrix adjust.
Identities = 229/347 (65%), Positives = 283/347 (81%), Gaps = 1/347 (0%)
Query: 98 QIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV 157
Q+ AGWP+WL + AGEA+ G +P +A+SFEKLEKIGQGTYSSV++AR++ T ++VALKKV
Sbjct: 135 QVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKV 194
Query: 158 RFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSC 217
RF N P+S+RFMAREI+ILRRLDHPN++KLEG+ITSR+S ++YL+FEYMEHDLAGL+S
Sbjct: 195 RFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLAST 254
Query: 218 HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277
I FSE Q+KCYM+QLLHG+EHCH RG++HRDIK SN+L+++ LK+GDFGLAN
Sbjct: 255 PGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQG 314
Query: 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337
KQ LTSRVVTLWYRPPELL+GST+Y V+VDLWS GC+ AEL GKPI+ GRTEVEQLH
Sbjct: 315 HQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLH 374
Query: 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397
KIFKLCGSP EEYWK SKLPH +FKPQ PY+ C+ E K +A+ L++ L++EP
Sbjct: 375 KIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDA 434
Query: 398 RGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK-QRDEARRRK 443
RGT +S L E+FTT P A DPSSLPKY P+KEID K Q +EA+R+K
Sbjct: 435 RGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKK 481
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (870), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 167/345 (48%), Positives = 231/345 (66%), Gaps = 18/345 (5%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ FEKLE+IG+GTY V+ A+E T ++VALKK+R DN + E A REI IL++L
Sbjct: 22 VDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDNER-EGFPITAIREIKILKKLH 80
Query: 182 HPNIIKLEGVITS---------------RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQ 226
H N+I+L+ ++TS + +IY+VFEYM+HDL GL+ ++F+ PQ
Sbjct: 81 HQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQ 140
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286
+KCYMRQLL G+ +CH+ ++HRDIK SN+L++NEG LKL DFGLA +S + LT+R
Sbjct: 141 IKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTNR 200
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
V+TLWYRPPELL+GST Y +VD+WSVGC+FAELL GKPIL G+ E EQL KIF+LCG+P
Sbjct: 201 VITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGTP 260
Query: 347 PEEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
E W +K+P + FKPQ P + ++E K F A+DL++ L+++P +R +A L
Sbjct: 261 DELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDAL 320
Query: 406 MCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMRE 450
EYF T P CDP SLPKY E K++ + +R+ A R+
Sbjct: 321 DAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAKRQ 365
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 174/408 (42%), Positives = 248/408 (60%), Gaps = 25/408 (6%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ FEKLE+IG+GTY V+ A+E+ TG++VALKK+R DN + E A REI IL++L
Sbjct: 23 VDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNER-EGFPITAIREIKILKKLH 81
Query: 182 HPNIIKLEGVITS--------------RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQV 227
H N+I+L+ ++TS + IY+VFEYM+HDL GL+ ++F+ PQ+
Sbjct: 82 HENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQI 141
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287
KCYM+QLL G+ +CH+ ++HRDIK SN+L++NEG LKL DFGLA + + LT+RV
Sbjct: 142 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRV 201
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
+TLWYRPPELL+G+T Y ++D+WSVGC+FAELL KPIL G+ E EQL+KIF+LCGSP
Sbjct: 202 ITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPD 261
Query: 348 EEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
E+ W SK+P + FKP P + +RE + F A++L++ L ++P +R +A L
Sbjct: 262 EKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALD 321
Query: 407 CEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQL 466
EYF T P CDP SLP Y E K++ + +R+ A +KRQ+ LQ
Sbjct: 322 AEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEA-------AKRQKLQHPPLQH 374
Query: 467 QE-PNSYSSKELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPRNP 513
P + H+ N+ +N + G +PR P
Sbjct: 375 SRLPPLQHGGQSHAAPHWPAGPNHPTNNAPPQVPAGPSHNFYGKPRGP 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (842), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 162/345 (46%), Positives = 227/345 (65%), Gaps = 18/345 (5%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ FEKLE+IG+GTY V+ ARE T ++VALKK+R DN + E A REI IL++L
Sbjct: 22 VDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDNER-EGFPITAIREIKILKKLH 80
Query: 182 HPNIIKLEGVITS---------------RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQ 226
H N+I+L+ ++TS + +IY+VFEYM+HDL GL+ ++F+ PQ
Sbjct: 81 HQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQ 140
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286
+KCYM+QLL G+ +CH+ ++HRDIK SN+L++NEG LKL DFGLA ++ + LT+R
Sbjct: 141 IKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNR 200
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
V+TLWYRPPELL+GST Y +VD+WSVGC+FAELL GKPIL G+ E EQL KIF +CG+P
Sbjct: 201 VITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCGTP 260
Query: 347 PEEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
E W +K+P + FKP + ++E K F A+DL++ L+++P +R +A L
Sbjct: 261 DESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQDAL 320
Query: 406 MCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMRE 450
EYF + P CDP SLPKY E K++ + R+ A R+
Sbjct: 321 DAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKRQ 365
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 163/359 (45%), Positives = 230/359 (64%), Gaps = 17/359 (4%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ FEKLE+IG+GTY V+ A+E+ TG++VALKK+R DN + E A REI IL++L
Sbjct: 23 VDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNER-EGFPITAIREIKILKKLH 81
Query: 182 HPNIIKLEGVITS--------------RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQV 227
H N+I L+ ++TS + IY+VFEYM+HDL GL+ ++F+ PQ+
Sbjct: 82 HENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQI 141
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287
KCYM+QLL G+ +CH+ ++HRDIK SN+L++NEG LKL DFGLA + + LT+RV
Sbjct: 142 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRV 201
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
+TLWYRPPELL+G+T Y ++D+WSVGC+FAELL GKPIL G+TE EQL+KI++LCGSP
Sbjct: 202 ITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPD 261
Query: 348 EEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
E W SK+P + K P + +RE + F A++L++ L ++P +R A L
Sbjct: 262 ESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALD 321
Query: 407 CEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQ 465
EYF T P CDP SLP Y E K++ + R A ++ +Q+ +R Q
Sbjct: 322 AEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQ 380
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 148/378 (39%), Positives = 219/378 (57%), Gaps = 16/378 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+ F+ + IG+GTY V++AR+ TG+MVALKKVR DN + E A REI ILR+L H
Sbjct: 703 DKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLTH 761
Query: 183 PNIIKLEGVITSRLS--------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
+II ++ ++T + YLVFEYM+HDL GL + F+E +K +MRQL
Sbjct: 762 QSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQL 821
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
+ G+++CH + +HRDIK SNIL+NN G +KL DFGLA + +S+ + T++V+TLWYRP
Sbjct: 822 MEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRP 881
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
PELL+G Y ++D+WS GC+ EL KPI + E+ QL I ++CGSP W
Sbjct: 882 PELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDV 941
Query: 355 -KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF-TT 412
KLP+ + KP+ Y LRE A+DL D L+++P KR TA L CE+
Sbjct: 942 IKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDV 1001
Query: 413 QPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSY 472
+P P LP + E+ +K+ RRR+ + M + S+ + R +L L + +
Sbjct: 1002 EPSKMPPPDLPLWQDCHELWSKK----RRRQKQMGMTDDLSTIKAPRKDLSLGLDDSRTN 1057
Query: 473 SSKELEDEAHFADRKNNN 490
+ + + A + N+N
Sbjct: 1058 TPQGVLPPAQLKSQSNSN 1075
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 146/379 (38%), Positives = 219/379 (57%), Gaps = 16/379 (4%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ F+ + IG+GTY V++AR+ TG+MVALKKVR DN + E A REI ILR+L
Sbjct: 703 VDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLT 761
Query: 182 HPNIIKLEGVITSRLS--------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
H +II ++ ++T + YLVFEYM+HDL GL + F+E +K +MRQ
Sbjct: 762 HQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQ 821
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
L+ G+++CH + +HRDIK SNIL+NN G +KL DFGLA + +S+ + T++V+TLWYR
Sbjct: 822 LMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYR 881
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PPELL+G Y ++D+WS GC+ EL KPI + E+ QL I ++CGSP W
Sbjct: 882 PPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPD 941
Query: 354 S-KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF-T 411
KLP+ + KP+ Y LRE A+DL D L+++P KR TA L CE+
Sbjct: 942 VIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRD 1001
Query: 412 TQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNS 471
+P P LP + E+ +K+ RRR+ + M + S+ + R +L + + +
Sbjct: 1002 VEPSKMPPPDLPLWQDCHELWSKK----RRRQKQMGMTDDVSTVKAPRKDLSLGMDDSRT 1057
Query: 472 YSSKELEDEAHFADRKNNN 490
+ + + + + N+N
Sbjct: 1058 STPQSVLPSSQLKPQGNSN 1076
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 145/357 (40%), Positives = 210/357 (58%), Gaps = 16/357 (4%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ F+ + IG+GTY V++AR+ TG+MVALKKVR DN + E A REI ILR+L
Sbjct: 702 VDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLT 760
Query: 182 HPNIIKLEGVITSRLS--------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
H +II ++ ++T + YLVFEYM+HDL GL + F+E +K +MRQ
Sbjct: 761 HQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQ 820
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
L+ G+++CH + +HRDIK SNIL+NN G +KL DFGLA + +S+ + T++V+TLWYR
Sbjct: 821 LMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYR 880
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PPELL+G Y ++D+WS GC+ EL KPI + E+ QL I ++CGSP W
Sbjct: 881 PPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPD 940
Query: 354 S-KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF-T 411
KLP+ + KP+ Y LRE A+DL D L+++P KR TA L CE+
Sbjct: 941 VIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRD 1000
Query: 412 TQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQE 468
+P P LP + E+ +K+ RRR+ + M + S+ + R +L L +
Sbjct: 1001 VEPSKMPPPDLPLWQDCHELWSKK----RRRQKQMGMTDDVSTIKAPRKDLSLGLDD 1053
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 144/363 (39%), Positives = 211/363 (58%), Gaps = 14/363 (3%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
+ F+ + IG+GTY V++A++ TG++VALKKVR DN + E A REI ILR+L
Sbjct: 725 VDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLI 783
Query: 182 HPNIIKLEGVITSRLS--------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
H +++ ++ ++T + YLVFEYM+HDL GL + FSE +K +M+Q
Sbjct: 784 HRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 843
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
L+ G+++CH + +HRDIK SNIL+NN G +KL DFGLA + S+ + T++V+TLWYR
Sbjct: 844 LMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYR 903
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PPELL+G Y ++D+WS GC+ EL KPI + E+ QL I +LCGSP W
Sbjct: 904 PPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPD 963
Query: 354 S-KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT- 411
KLP+ + KP+ Y LRE A+DL+D L+++P KR TA L ++
Sbjct: 964 VIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKD 1023
Query: 412 TQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNS 471
+ DP LP + E+ +K+R R+R+ + EP SK R+ + EP
Sbjct: 1024 VELSKMDPPDLPHWQDCHELWSKKR--RRQRQSGVVIEEPPPSKASRKETTSGTSAEPVK 1081
Query: 472 YSS 474
SS
Sbjct: 1082 NSS 1084
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | ||||||
| 449447394 | 691 | PREDICTED: probable serine/threonine-pro | 0.968 | 0.966 | 0.550 | 0.0 | |
| 449481356 | 691 | PREDICTED: probable serine/threonine-pro | 0.968 | 0.966 | 0.548 | 0.0 | |
| 449510951 | 875 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.978 | 0.771 | 0.526 | 0.0 | |
| 255578312 | 696 | ATP binding protein, putative [Ricinus c | 0.850 | 0.843 | 0.574 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.960 | 0.966 | 0.528 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.931 | 0.969 | 0.526 | 0.0 | |
| 225452911 | 712 | PREDICTED: probable serine/threonine-pro | 0.868 | 0.841 | 0.560 | 0.0 | |
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 0.878 | 0.916 | 0.534 | 0.0 | |
| 356511986 | 670 | PREDICTED: probable serine/threonine-pro | 0.914 | 0.941 | 0.506 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.934 | 0.952 | 0.506 | 0.0 |
| >gi|449447394|ref|XP_004141453.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/707 (55%), Positives = 502/707 (71%), Gaps = 39/707 (5%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRAS------------ENATLNLNYVFSSKNPSGAL 48
MGC+SSK AKAA SPV+ +T+ + EN ++ S + L
Sbjct: 1 MGCISSKNVAKAAASPVYNHHHHRTKPNKPTTTTTATVAAENGSVVTLPPSSKAHSVTTL 60
Query: 49 DFGSKEGERSEDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLT 108
D+ K + SED+ SR++ +K S +LG S R+V+AEQ+AAGWP+WL+
Sbjct: 61 DYEKKGEDISEDR---SRDI------KKSKGGKGGSFRLGFSQRYVEAEQVAAGWPSWLS 111
Query: 109 AAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR 168
+AAGEAV+G VP+RA+SFEKLEKIGQGTYSSVFRAREV +GKMVALKKVRFDNFQPESIR
Sbjct: 112 SAAGEAVHGWVPLRADSFEKLEKIGQGTYSSVFRAREVESGKMVALKKVRFDNFQPESIR 171
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVK 228
FMAREIMILRRL+HPNI++LEG+ITS++S++IYLVFEYM+HDLAGL S +IKFSE Q+K
Sbjct: 172 FMAREIMILRRLEHPNIMQLEGIITSKMSSSIYLVFEYMDHDLAGLVSSPNIKFSEAQIK 231
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288
CYMRQLL +EHCHLRGIMHRDIKASNILVNNEGILKL DFGLAN++ S+NKQ LTSRVV
Sbjct: 232 CYMRQLLSAIEHCHLRGIMHRDIKASNILVNNEGILKLADFGLANVINSRNKQALTSRVV 291
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348
TLWYRPPELLMGST+Y ++VDLWS+GCVFAEL +GKP+LKGRTEVEQLHKIFKLCGSPPE
Sbjct: 292 TLWYRPPELLMGSTDYGLTVDLWSIGCVFAELHLGKPLLKGRTEVEQLHKIFKLCGSPPE 351
Query: 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
E+WKK+KLPH MFKPQ+ YE L E+CK+F PTA+ L+++ L+IEPYKRGTASS LM E
Sbjct: 352 EFWKKTKLPHAAMFKPQHAYESSLSEKCKEFAPTALSLLESFLAIEPYKRGTASSALMSE 411
Query: 409 YFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQE 468
YF T+PYACDPS+LPKYPP KE+DAK R++ARR++ AR++E ++R RR R+ QE
Sbjct: 412 YFKTKPYACDPSTLPKYPPNKEMDAKNREDARRKRANARVKESGVTQRPRRVRRN--FQE 469
Query: 469 PNSYSSKELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTS 528
NS+ +++EA + + N ++T+ K +G R+P+ FDT SE+ AT+ +
Sbjct: 470 LNSHKVP-IKEEAEENIQPSRRNGSSTANLCKEQGDVFQRDPQKQLFDTTSESQAATAPN 528
Query: 529 HASHGDTVFTVPTQISASSGFAWAKNQQDEVAASLS--LRSHTSTFDTSGLGFEDNTSNL 586
GD+ FT P +SASSGFAW K +++E +++S L+S S+ D S F + T L
Sbjct: 529 Q--RGDSAFTAPIPVSASSGFAWVKKRKEEATSTVSDGLKSQISSLDPS---FANYTFEL 583
Query: 587 TKDD---TVMHVKS--KEKDLFEASMRSMRMPPNQAHSRAQSFNVQDYLTETCDKEEVGI 641
TK T + V S +E +L + R P ++ ++++ D E K
Sbjct: 584 TKKQNGHTHIPVSSGTQEYELRKNHRRKHNFP--ESFDASEAYPFLDMSNELYPKPPSNT 641
Query: 642 GRGNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSRF 688
N + ++FSGPLL++ +IDE+LQRN + IR R+SRF
Sbjct: 642 A-ANLENDDTESHIEFSGPLLTQPHRIDELLQRNESHIRRVARKSRF 687
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449481356|ref|XP_004156158.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/707 (54%), Positives = 502/707 (71%), Gaps = 39/707 (5%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRAS------------ENATLNLNYVFSSKNPSGAL 48
MGC+SSK AKAA SPV+ +T+ + EN ++ S + L
Sbjct: 1 MGCISSKNVAKAAASPVYNHHHHRTKPNKPTTTTTATVAAENGSVVTLPPSSKAHSVTTL 60
Query: 49 DFGSKEGERSEDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLT 108
D+ K + SED+ SR++ +K S +LG S R+V+AEQ+AAGWP+WL+
Sbjct: 61 DYEKKGEDISEDR---SRDI------KKSKGGKGGSFRLGFSQRYVEAEQVAAGWPSWLS 111
Query: 109 AAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR 168
+AAGEAV+G VP+RA+SFEKLEKIGQGTYSSVFRAREV +GKMVALKKVRFDNFQPESIR
Sbjct: 112 SAAGEAVHGWVPLRADSFEKLEKIGQGTYSSVFRAREVESGKMVALKKVRFDNFQPESIR 171
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVK 228
FMAREIMILRRL+HPNI++LEG+ITS++S++IYLVFEYM+HDLAGL S +IKFSE Q+K
Sbjct: 172 FMAREIMILRRLEHPNIMQLEGIITSKMSSSIYLVFEYMDHDLAGLVSSPNIKFSEAQIK 231
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288
CYMRQLL +EHCHLRGIMHRDIKASNILVNNEG+LKL DFGLAN++ S+NKQ LTSRVV
Sbjct: 232 CYMRQLLSAIEHCHLRGIMHRDIKASNILVNNEGVLKLADFGLANVINSRNKQALTSRVV 291
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348
TLWYRPPELLMGST+Y ++VDLWS+GCVFAEL +GKP+LKGRTEVEQLHKIFKLCGSPPE
Sbjct: 292 TLWYRPPELLMGSTDYGLTVDLWSIGCVFAELHLGKPLLKGRTEVEQLHKIFKLCGSPPE 351
Query: 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
E+WKK+KLPH MFKPQ+ YE L E+CK+F PTA+ L+++ L+IEPYKRGTASS LM E
Sbjct: 352 EFWKKTKLPHAAMFKPQHAYESSLSEKCKEFAPTALSLLESFLAIEPYKRGTASSALMSE 411
Query: 409 YFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQE 468
YF T+PYACDPS+LPKYPP KE+DAK R++ARR++ AR++E ++R RR R+ QE
Sbjct: 412 YFKTKPYACDPSTLPKYPPNKEMDAKNREDARRKRANARVKESGVTQRPRRVRRN--FQE 469
Query: 469 PNSYSSKELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTS 528
NS+ +++EA + + N ++T+ K +G R+P+ FDT SE+ AT+ +
Sbjct: 470 LNSHKVP-IKEEAEENIQPSRRNGSSTANLCKEQGDVFQRDPQKQLFDTTSESQAATAPN 528
Query: 529 HASHGDTVFTVPTQISASSGFAWAKNQQDEVAASLS--LRSHTSTFDTSGLGFEDNTSNL 586
GD+ FT P +SASSGFAW K +++E +++S L+S S+ D S F + T L
Sbjct: 529 Q--RGDSAFTAPIPVSASSGFAWVKKRKEEATSTVSDGLKSQISSLDPS---FANYTFEL 583
Query: 587 TKDD---TVMHVKS--KEKDLFEASMRSMRMPPNQAHSRAQSFNVQDYLTETCDKEEVGI 641
TK T + V S +E +L + R P ++ ++++ D E K
Sbjct: 584 TKKQNGHTHIPVSSGTQEYELRKHHRRKHNFP--ESFDTSEAYPFLDMSNELYPKPPSNT 641
Query: 642 GRGNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSRF 688
N + ++FSGPLL++ +IDE+LQRN + IR R+SRF
Sbjct: 642 A-ANLENDDTESHIEFSGPLLTQPHRIDELLQRNESHIRRVARKSRF 687
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449510951|ref|XP_004163820.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101228141 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/730 (52%), Positives = 491/730 (67%), Gaps = 55/730 (7%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSK------- 53
MGC+SSK AKA SP+ + + + L+ SK
Sbjct: 155 MGCISSKNVAKADASPLHKHHHYHHKTKPTTATTATVPIENNGSVVTLEPSSKAHSVTTL 214
Query: 54 ---EGERSEDKPKG-SRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTA 109
E ++ EDK + SR++K S S +LGLS R+++AEQ+AAGWP+WL++
Sbjct: 215 DHHEIKKGEDKSEDRSRDIK-----KSKGGGRGGSFRLGLSQRYIEAEQVAAGWPSWLSS 269
Query: 110 AAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF 169
AAGEAV+G VP+RA+SFEKLEKIGQGTYSSVFRAREV +G+MVALKKVRFDNFQPESIRF
Sbjct: 270 AAGEAVHGWVPLRADSFEKLEKIGQGTYSSVFRAREVDSGRMVALKKVRFDNFQPESIRF 329
Query: 170 MAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKC 229
MAREIMILRRL+HPNI++LEG+ITS++S++IYLVFEYMEHDLAGL SC D+ FSE QVKC
Sbjct: 330 MAREIMILRRLEHPNIMQLEGIITSKMSSSIYLVFEYMEHDLAGLVSCPDVMFSEAQVKC 389
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT 289
YMRQLL +EHCHLRGIMHRDIKASNILVNNEGILKL DFGLAN++ ++NKQ LTSRVVT
Sbjct: 390 YMRQLLSAIEHCHLRGIMHRDIKASNILVNNEGILKLADFGLANVINTRNKQALTSRVVT 449
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
LWYRPPELLMGST+Y ++VDLWS+GCVFAEL +GKP+LKGRTEVEQLHKIFKLCGSPPEE
Sbjct: 450 LWYRPPELLMGSTDYGLTVDLWSIGCVFAELHLGKPLLKGRTEVEQLHKIFKLCGSPPEE 509
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
+WKK KLPH MF+PQ+ YE L E+CK+F P AV L+++ L+IEPYKRGTASS LM EY
Sbjct: 510 FWKKXKLPHAAMFRPQHAYESSLDEKCKEFAPVAVRLLESFLAIEPYKRGTASSALMSEY 569
Query: 410 FTTQPYACDPSSLPKYPPKKEIDAKQRDEARR--RKVRARMREPASSKRQRRARQTLQLQ 467
F T+PYACDPS+LPKYPP KE+DAK R++ARR R AR +E +++R RR R+ Q
Sbjct: 570 FKTKPYACDPSTLPKYPPNKEMDAKNREDARRKNRVNNARAKETGATQRPRRVRRN--FQ 627
Query: 468 EPNSYSSKELEDEAHFADRKNNNND-----------NNTSRTYKGRGSAVGREP---RNP 513
E NS+ +++E D +N NN + + +G R+P +
Sbjct: 628 EFNSHKVA-IKEELSAEDVQNINNQPSRRNGSNNNNTTNNLSKDQQGDVFQRDPQKKQQQ 686
Query: 514 TFDTISETSRATSTSHASHGDTVFTVPTQISASSGFAWAKNQQDEVAASLS--LRSHTST 571
+DT SETS+A +T+ GD+ FT P +SASSGFAW K +++E +++S L+S S
Sbjct: 687 LYDTTSETSQAAATAPNQGGDSAFTAPMLVSASSGFAWVKRRKEEATSTISDGLKSQISA 746
Query: 572 FDTSGLGFEDNTSNLTKDD---TVMHVKSKEKDLFEASMRSMRMPPNQAHSRAQSFNVQD 628
D S F + T L K T + V + E +R + + + A+SF+ +
Sbjct: 747 LDPS---FANYTMELNKKQNGHTSIPVSTTSSGTQEYELRKQQR--TKHNLPAESFHASE 801
Query: 629 YLT----ETCDKEEV------GIGRGNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANT 678
+ ++EEV N + + FSG LL++ +IDE+LQRN +
Sbjct: 802 AYSRPFLNMSNEEEVYPKPPSSNITTNLDNDDTESNIDFSGQLLTQPHRIDELLQRNESH 861
Query: 679 IRHANRRSRF 688
IR R+SRF
Sbjct: 862 IRRVARKSRF 871
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578312|ref|XP_002530023.1| ATP binding protein, putative [Ricinus communis] gi|223530502|gb|EEF32385.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/649 (57%), Positives = 452/649 (69%), Gaps = 62/649 (9%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSKEGERSED 60
MGCV+SK++ A +S ++ +T SS+ PSG+ F K + +D
Sbjct: 1 MGCVTSKRSVSVAAGAAAASSSPSLGFNDRST-----AASSRQPSGSFHFDQKSKKDRKD 55
Query: 61 KPKGSR--------------------------ELKKLKKGSSNKKSNAFSIKLGLSLR-H 93
R E KK ++ SS+ +SN KLG S R +
Sbjct: 56 HSFSRRRKESCDLDNNNNNNEDENGFNQSSNHESKKYRRRSSSGQSN---FKLGFSNRQN 112
Query: 94 VDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVA 153
V AEQIAAGWP+WL++AA EA++G VP+RA+SFEKLEKIGQGTYSSVFRAREV TG+MVA
Sbjct: 113 VSAEQIAAGWPSWLSSAAAEAIHGWVPLRADSFEKLEKIGQGTYSSVFRAREVETGRMVA 172
Query: 154 LKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG 213
LKKVRFDNFQPESIRFMAREI+ILRRLDHPNIIKLEG+ITSRLS++IYLVFEYMEHDLAG
Sbjct: 173 LKKVRFDNFQPESIRFMAREILILRRLDHPNIIKLEGIITSRLSSSIYLVFEYMEHDLAG 232
Query: 214 LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273
LSS D+KFSE QVKCYM+QLLHG+EHCHLRG++HRDIK SNILVNNEGILK+GDFGLAN
Sbjct: 233 LSSSPDVKFSESQVKCYMKQLLHGIEHCHLRGVLHRDIKVSNILVNNEGILKIGDFGLAN 292
Query: 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV 333
+L KNK +LTSRVVTLWYRPPELLMGST+Y VSVDLWSVGCVFAELL+GKP+LKGRTEV
Sbjct: 293 VLNPKNKHQLTSRVVTLWYRPPELLMGSTSYGVSVDLWSVGCVFAELLVGKPLLKGRTEV 352
Query: 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393
EQLHKIFKLCGSPP+EYWK+ KLP+ MFKPQ+ YE LRERCKDF AVDLI+T LSI
Sbjct: 353 EQLHKIFKLCGSPPDEYWKQCKLPNVTMFKPQHIYESSLRERCKDFPTAAVDLIETFLSI 412
Query: 394 EPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPAS 453
+P KRGTASS L+ +YF T PYACDPSSLPKYPP KE+DAK RDE RRR R R+ +
Sbjct: 413 DPEKRGTASSALLSQYFNTTPYACDPSSLPKYPPNKEMDAKYRDETRRRMSGVRARDAGA 472
Query: 454 SKRQRRARQTLQ-LQEPNSYSSK-ELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPR 511
+R R+ +TLQ N Y+SK E++D+ + ND NT +GRG V RE
Sbjct: 473 PRRSRKVNRTLQECNILNKYASKEEMKDKTQVVCKL---NDGNTQMLNRGRG-GVSREV- 527
Query: 512 NPTFDTISETSRATSTSHASHGDTVFTVPTQISASSGFAWAKNQQDEVAASLSLRSHTST 571
+ + DT S+TS+AT GD +F P + ASSGFAWAK +Q++ +++LS S
Sbjct: 528 SSSIDTTSDTSQATK------GDCIFMGPAPVIASSGFAWAKRRQEDASSTLSYNQSMSM 581
Query: 572 FDTSGLGF--------------EDNTSNLTKDDTVMHVKSKEKDLFEAS 606
S L E+ +S + + HV K++ F++S
Sbjct: 582 TQISALDSSSFSFANSSFNLTKEEESSRGSHEAASNHVMQKKRSRFDSS 630
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/707 (52%), Positives = 475/707 (67%), Gaps = 44/707 (6%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSG---ALDFGSKEGER 57
MGCVSSK+A +P F+ SV+ +NA S ++ G A +F K+
Sbjct: 1 MGCVSSKQAVSV--TPAFDVSVA---FRDNAG-------SGRSRGGRVVAAEFEKKKKSG 48
Query: 58 SEDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYG 117
+ EL + + SSN ++ S +LG ++V+ EQ+AAGWPAWL+A AGEA+ G
Sbjct: 49 GGESGLSGSELGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAGEAIQG 108
Query: 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMIL 177
VP+RA+S++ LEKIGQGTYS+VFRARE+ TG++VALKKVRFDNF+PES+RFMAREI IL
Sbjct: 109 WVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAREITIL 168
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
RRLDHPNI+KL+G+ITSRLS +IYLVFEYMEHDL+GL SC DIKFSE QVKCY +QLL G
Sbjct: 169 RRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTKQLLSG 228
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+EHCH RG+MHRDIK +N+LVNNEGILK+ DFGLAN +S +Q LTSRVVTLWYRPPEL
Sbjct: 229 LEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWYRPPEL 288
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
L+GST+Y SVDLWSVGCVFAELL+G+PILKGRTEVEQLHKIFKLCGSPP+EYWKKSKLP
Sbjct: 289 LLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWKKSKLP 348
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417
H +FKPQ PYE CLRE KD +VDLI+T LS+EPYKRGTASS L EYF T+PYAC
Sbjct: 349 HATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKTKPYAC 408
Query: 418 DPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKEL 477
DPSSLPKY P KEIDAK R+E+RR+KV R+R S K R+ +L +++++
Sbjct: 409 DPSSLPKYSPNKEIDAKNREESRRKKVGGRVR--GSEKPTRKPNGINKLVPAENFTAQTQ 466
Query: 478 EDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGDTVF 537
K N N + + G+ +G EP P+ D ++E A+ +AS GD F
Sbjct: 467 ------GPHKLNGNGFHIFKEGDGK---LGGEPPKPSIDVLTE---ASHMKNASQGDIPF 514
Query: 538 TVPTQISASSGFAWAKNQQDEVAASLSLRSHTSTFDTSGLG-----FEDNTSNLTKDDTV 592
+ P Q+S SSGFAWAK ++D+ + RS + + L N SN ++ V
Sbjct: 515 SGPLQVSTSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNNSNRLENSDV 574
Query: 593 MH---VKSKEKDLFEASMRSMRMPPNQAHSRAQSFNVQD-YLTETCD-----KEEVGIGR 643
+ S+ D E + R M Q R SF+ D Y ++ +EE+ R
Sbjct: 575 SNGGRTDSRGYDSSEIAKRVMLKQWGQ-FERPDSFDASDMYHSQELSLPMYRREEMAAKR 633
Query: 644 GNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSRFYR 690
+ Q + V+FSGPLLS+S ++DE+L+R+ IR A RRS F R
Sbjct: 634 NHLSYQDQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQR 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/704 (52%), Positives = 468/704 (66%), Gaps = 61/704 (8%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSKEGERSED 60
MGCVSSK+A +P F+ SV+ F SG
Sbjct: 1 MGCVSSKQAVSV--TPAFDVSVA---------------FRDNAGSG-------------- 29
Query: 61 KPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVP 120
+ +G R L + + SSN ++ S +LG ++V+ EQ+AAGWPAWL+A AGEA+ G VP
Sbjct: 30 RSRGGR-LGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAGEAIQGWVP 88
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+RA+S++ LEKIGQGTYS+VFRARE+ TG++VALKKVRFDNF+PES+RFMAREI ILRRL
Sbjct: 89 LRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAREITILRRL 148
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
DHPNI+KL+G+ITSRLS +IYLVFEYMEHDL+GL SC DIKFSE QVKCY +QLL G+EH
Sbjct: 149 DHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTKQLLSGLEH 208
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH RG+MHRDIK +N+LVNNEGILK+ DFGLAN +S +Q LTSRVVTLWYRPPELL+G
Sbjct: 209 CHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWYRPPELLLG 268
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
ST+Y SVDLWSVGCVFAELL+G+PILKGRTEVEQLHKIFKLCGSPP+EYWKKSKLPH
Sbjct: 269 STDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWKKSKLPHAT 328
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+FKPQ PYE CLRE KD +VDLI+T LS+EPYKRGTASS L EYF T+PYACDPS
Sbjct: 329 LFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKTKPYACDPS 388
Query: 421 SLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDE 480
SLPKY P KEIDAK R+E+RR+KV R+R S K R+ +L +++++
Sbjct: 389 SLPKYSPNKEIDAKNREESRRKKVGGRVR--GSEKPTRKPNGINKLVPAENFTAQTQ--- 443
Query: 481 AHFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGDTVFTVP 540
K N N + + G+ +G EP P+ D ++E A+ +AS GD F+ P
Sbjct: 444 ---GPHKLNGNGFHIFKEGDGK---LGGEPPKPSIDVLTE---ASHMKNASQGDIPFSGP 494
Query: 541 TQISASSGFAWAKNQQDEVAASLSLRSHTSTFDTSGLG-----FEDNTSNLTKDDTVMH- 594
Q+S SSGFAWAK ++D+ + RS + + L N SN ++ V +
Sbjct: 495 LQVSTSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNNSNRLENSDVSNG 554
Query: 595 --VKSKEKDLFEASMRSMRMPPNQAHSRAQSFNVQD-YLTETCD-----KEEVGIGRGNG 646
S+ D E + R M Q R SF+ D Y ++ +EE+ R +
Sbjct: 555 GRTDSRGYDSSEIAKRVMLKQWGQ-FERPDSFDASDMYHSQELSLPMYRREEMAAKRNHL 613
Query: 647 PGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSRFYR 690
Q + V+FSGPLLS+S ++DE+L+R+ IR A RRS F R
Sbjct: 614 SYQDQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQR 657
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452911|ref|XP_002278818.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/633 (56%), Positives = 445/633 (70%), Gaps = 34/633 (5%)
Query: 67 ELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESF 126
EL++ KKGS N KS FS++ G +L V+AEQI AGWP+WL+AAAGEA++G +P+RA+SF
Sbjct: 89 ELQRSKKGSVNGKST-FSVRFG-NLHKVEAEQIIAGWPSWLSAAAGEAIHGWLPLRADSF 146
Query: 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
EKLEKIGQGTYS+V+RAR+V TG++VALKKVRFDNFQPES+ FM+REI ILRRLDH NI+
Sbjct: 147 EKLEKIGQGTYSTVYRARDVETGRIVALKKVRFDNFQPESVMFMSREITILRRLDHRNIM 206
Query: 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
KLEG+ITSRLS +IYLVFEYMEHDLAGL SC DIKFS QVKCYM+QLL +EHCHL G+
Sbjct: 207 KLEGIITSRLSCSIYLVFEYMEHDLAGLVSCPDIKFSVAQVKCYMQQLLSAIEHCHLLGV 266
Query: 247 MHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV 306
MHRDIKASNILVNNEG+LKL DFGLANIL K+KQ LTSRVVTLWYRPPEL++GST+Y V
Sbjct: 267 MHRDIKASNILVNNEGVLKLADFGLANILRPKHKQILTSRVVTLWYRPPELILGSTSYGV 326
Query: 307 SVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366
SVDLWSVGCVFAELLIGKP+ KGRTEVEQLHKIFKLCGSPP+EYWKKSK PH MFKP +
Sbjct: 327 SVDLWSVGCVFAELLIGKPLFKGRTEVEQLHKIFKLCGSPPDEYWKKSKFPHATMFKPHH 386
Query: 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426
YE LRER +++ TA++LI+T LS+EP KRGTASS L+ EYF T+PYAC+PSSLPKYP
Sbjct: 387 SYESTLRERFREYPTTALNLIETLLSVEPPKRGTASSALISEYFNTKPYACEPSSLPKYP 446
Query: 427 PKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDEAHFADR 486
P KEIDAK R+EARR+ +R + ++ RR+R + QEPNS S + + R
Sbjct: 447 PNKEIDAKCREEARRKTGGVGVRGSGALRKPRRSRTS--SQEPNSTSKFAVTESNTQYSR 504
Query: 487 KNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGDTVFTVPTQISAS 546
+N+ + + KGRG G + P+F+T S+ S+ S+ S GD +F VP QI+A
Sbjct: 505 RNSGSSSAHISKGKGRGFDYG-DSEKPSFETSSQISQ---VSNVSRGDFLFQVPKQITAP 560
Query: 547 SGFAWAKNQQDEVAASLSLRSHTS-------TFDT----SGLGFEDNTSNLTKDDTVMHV 595
FAWA ++ E A S S T D S L F+D S + + +
Sbjct: 561 CSFAWAAKRRKEHTAPPRTYSRCSSRYSAVETLDVVDENSALEFQDRVSG----EGLSGL 616
Query: 596 KSKEKDLFEASMRSMRMPPNQAHS----RAQSFNVQDYLTETCDKEEVGIGRGNGPGQQE 651
+S+ +D MR R+ + + +Q F + E + +G+ +
Sbjct: 617 RSQGRDEMAKPMRKQRIQFDSFDTSDLYHSQEFAAAVHQGELARRHNLGL-------KDH 669
Query: 652 QGTVKFSGPLLSESQKIDEILQRNANTIRHANR 684
V+FSGPLL E +++E LQR + IR A +
Sbjct: 670 PDRVEFSGPLLCEPHRVEEHLQRRESQIRQATQ 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/643 (53%), Positives = 450/643 (69%), Gaps = 37/643 (5%)
Query: 67 ELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESF 126
EL + + SSN +S +F ++ L ++++ E +AAGWPAWL+A AGEA+ G VP++A++F
Sbjct: 31 ELGESGRASSNGESVSFRLR-NLQ-KYIEGEHVAAGWPAWLSAVAGEAIQGWVPLKADAF 88
Query: 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
EKLEKIGQGTYSSVFRARE+ TG++VALKKVRFDNF+PES+RFMAREI+ILRRLDHPN++
Sbjct: 89 EKLEKIGQGTYSSVFRAREIETGRIVALKKVRFDNFEPESVRFMAREILILRRLDHPNVM 148
Query: 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
KL+G+ITSRLS +IYLVFEYMEHD+ GL SC D++FSE Q+KCYMRQLL G+EHCH +G+
Sbjct: 149 KLDGLITSRLSCSIYLVFEYMEHDITGLLSCPDVRFSESQIKCYMRQLLFGLEHCHSKGV 208
Query: 247 MHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV 306
MHRDIK SN+LVNNEG+LK+GDFGLAN + ++Q LTSRVVTLWYRPPELL+GST Y
Sbjct: 209 MHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVTLWYRPPELLLGSTEYGA 268
Query: 307 SVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366
SVDLWSVGCVFAELL+GKP+L+GRTEVEQLHKIFKLCGSPP+EYWKKS+LPH +FKPQ
Sbjct: 269 SVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDEYWKKSRLPHATLFKPQQ 328
Query: 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426
PY+ LRE KD TAV+LI+T LS+EPYKRGTASS L EYF T+PYACDPSSLPKYP
Sbjct: 329 PYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEYFMTKPYACDPSSLPKYP 388
Query: 427 PKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDEAHFADR 486
P KEIDAK R+EARR+K R R + K R+ P + ++A +
Sbjct: 389 PSKEIDAKNREEARRKKTSGRSRGAETRKPARK---------PGGINKLAPAEDATARIQ 439
Query: 487 KNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGDTVFTVPTQISAS 546
+ N+ KG + G E R + D + E +AS GD F+ P Q+S+S
Sbjct: 440 GSQNSITTNVCLPKGVDAKSGGEARKASLDKLEEI---FHVKNASQGDIPFSGPLQVSSS 496
Query: 547 SGFAWAKNQQDEVAASLSLRSHTSTFDTSGLGFEDNTSNLTKD-----------DTVMHV 595
SGFAWA+ ++D+ + RS + + +GL +N++ L + D + +
Sbjct: 497 SGFAWARRRKDDASVRSHSRSTSRSLINNGL---ENSTALQEKSNFDSRRRENGDAIYGI 553
Query: 596 K--SKEKDLFEASMRSMRMPPNQ-----AHSRAQSFNVQDYLTETCDKEEVGIGRGNGPG 648
+ S+ D E S R+++ +Q + ++ ++ Q+ +EE+ R N G
Sbjct: 554 RTNSRGHDSNEISKRALQKQWSQLERPDSFDASEGYHSQELSLALYQREEME-ARRNNLG 612
Query: 649 QQEQG-TVKFSGPLLSESQKIDEILQRNANTIRHANRRSRFYR 690
Q+QG V FSGPLLS+S ++DE+L+R+ IR A R+S F R
Sbjct: 613 FQDQGDKVDFSGPLLSQSHRVDELLERHERQIRQAVRKSWFQR 655
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511986|ref|XP_003524702.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/723 (50%), Positives = 457/723 (63%), Gaps = 92/723 (12%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSKEGERSED 60
MGCV +K+A +P E SV S KN +++E
Sbjct: 1 MGCVVAKQAVSV--TPAIEHSVE----------------SEKN----------RKKKTES 32
Query: 61 KPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVP 120
EL + + SSN S + S +LG ++V+ EQ AAGWPAWL+A A EA++G VP
Sbjct: 33 VGASRSELGESGRASSNGGSESLSFRLGNLSKYVEGEQAAAGWPAWLSAVACEAIHGWVP 92
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+RA++FEKL+KIGQGTYSSVFRA+E+ TGK+VALKKVRFDNF+PES+RFMAREIMILRRL
Sbjct: 93 LRADAFEKLDKIGQGTYSSVFRAKEIQTGKIVALKKVRFDNFEPESVRFMAREIMILRRL 152
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
DHPNIIKLEG+ITSRLS +IYLVFEYMEHD+ GL + +IKFSE Q+KCYM+QLL G+EH
Sbjct: 153 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKCYMKQLLSGIEH 212
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH RG+MHRDIK SN+LVNNEGILK+ DFGLAN S NKQ LTSRVVTLWYRPPELL+G
Sbjct: 213 CHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTLWYRPPELLLG 272
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
ST Y SVDLWSVGCVFAELLIGKPIL+GRTEVEQLHKIFKLCGSPPEEYWKK++LPH
Sbjct: 273 STAYGASVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEYWKKTRLPHAT 332
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+FKPQ PY+ CLRE KDF ++V+L+ T LS+EP KRGTASS L EYF T+PYACDPS
Sbjct: 333 LFKPQQPYDSCLRETFKDFHASSVNLLQTLLSVEPSKRGTASSALSLEYFKTKPYACDPS 392
Query: 421 SLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYS-----SK 475
SLP YPP KEIDAK +E+RR+K+ R S K R +L S S+
Sbjct: 393 SLPIYPPSKEIDAKNEEESRRKKIGGRACRAESRKPSRNPLALSKLAPAEDLSSQTQTSQ 452
Query: 476 ELEDEA-HFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGD 534
+++D + H +N N + G+ +N AS D
Sbjct: 453 KMDDRSVHIIKEENTNTCEEAPKQSSGKPEDASSYMKN-----------------ASQVD 495
Query: 535 TVFTVPTQISASSGFAWAKNQQDEVAASLSLRSHTSTF---------DTSGLGFEDNTSN 585
F P Q+S SSGFAWAK ++D+ S+RSH+ + +TS L +N+ +
Sbjct: 496 IPFPGPLQVSKSSGFAWAKRRRDDT----SVRSHSRSISRGYIFNSSETSTLNSRNNSES 551
Query: 586 LTKDDTVM---HVKSKEKDLFEASMRSMRMPPNQ--AHSRAQSFNVQDYLTETCDK---E 637
++ H S+ DL E S +M+ NQ R SF+ TCD+ +
Sbjct: 552 RNHENKKFFGAHANSRGHDLLEISKLAMQ---NQWSKFDRLDSFD-------TCDEYHSQ 601
Query: 638 EVGIG----------RGNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSR 687
E+ + R N Q + V+FSGPLLS+ +DE+L+R+ + IR RRS
Sbjct: 602 ELSVALYNRQDSLSKRSNLSYQDQAEKVEFSGPLLSQMHTVDELLERHESHIRRTVRRSW 661
Query: 688 FYR 690
F R
Sbjct: 662 FQR 664
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/716 (50%), Positives = 464/716 (64%), Gaps = 71/716 (9%)
Query: 1 MGCVSSKKAAKAAGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSKEGERSED 60
MGCVSSK+A VS T A +++ + ++ +G L K+ +
Sbjct: 1 MGCVSSKQA------------VSVTPA-------IDHSGAFRSNAGGLAEPEKKRSKKRT 41
Query: 61 KPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVP 120
+ G+ + + + G ++ ++ S +LG ++V E +AAGWPAWL+A AGEA++G VP
Sbjct: 42 ESGGASQSEVGESGRTSSNCDSLSFRLGNLHKYVQGEHVAAGWPAWLSAVAGEAIHGWVP 101
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+RA++FEKLEKIGQGTYSSVFRARE+ TGK+VALKKVRFDNF+PES+RFMAREI+ILRRL
Sbjct: 102 LRADAFEKLEKIGQGTYSSVFRARELETGKIVALKKVRFDNFEPESVRFMAREILILRRL 161
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
DHPNIIKLEG+ITSRLS +IYLVFEYMEHD+ GL S DIKF+EPQ+KCYM+QLL G+EH
Sbjct: 162 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQLLVGLEH 221
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CHLRG+MHRDIK SN+LVNNEG+LK+ DFGLAN + ++Q LTSRVVTLWYRPPELL+G
Sbjct: 222 CHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVTLWYRPPELLLG 281
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
ST+Y +VDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+EYWKKS+LPH
Sbjct: 282 STDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKSRLPHAT 341
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+FKPQ PY+ CLR+ KD T+V L+ T LSIEPYKRGTA+S L EYF T+PYACDPS
Sbjct: 342 LFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEYFKTKPYACDPS 401
Query: 421 SLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDE 480
SLP YPP KEIDAK R+E+ R+K+ R+R + K R+ P ++
Sbjct: 402 SLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRK---------PLGFNK------ 445
Query: 481 AHFADRKNNNNDNNTSRTYKGRGSAVGREPRNPTFDTISETSR-----ATSTSHASHGDT 535
A ++ + TS R V E R D + S A+ +AS GD
Sbjct: 446 --LAPAEDLASQTQTSHKVNARSFRVLEEERTKIGDKAQKPSSGKPEDASHVKNASQGDI 503
Query: 536 VFTVPTQISASSGFAWAKNQQDEVAASLSLRSHTSTFDTSGLGFE-------------DN 582
+ P Q+S SSGFAWAK+++D+ S RSH T + G F D
Sbjct: 504 PLSGPLQVSTSSGFAWAKSRKDDT----SFRSHCRTI-SRGHTFNPLEPCTLNSRNNLDT 558
Query: 583 TSNLTKDDTVMHVKSKEKDLFEASMRSMRMPPNQ--AHSRAQSFNVQD-YLTETCD---- 635
+ K+ + S+ DL E S SM+ NQ R SF+ D Y ++
Sbjct: 559 RNQENKEFSGGCTNSRGHDLLEISKLSMQ---NQWSKFDRPDSFDASDEYHSQELSIALY 615
Query: 636 -KEEVGIGRGNGPGQQEQGTVKFSGPLLSESQKIDEILQRNANTIRHANRRSRFYR 690
+E+ R N Q + V+FSGPLLS+ +DE+L+R+ IR RRS F R
Sbjct: 616 HREDSASKRSNLSFQDQGEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQR 671
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | ||||||
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.617 | 0.609 | 0.599 | 1.7e-152 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.560 | 0.545 | 0.638 | 3.5e-152 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.507 | 0.543 | 0.728 | 9.3e-152 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.508 | 0.558 | 0.698 | 1.3e-141 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.466 | 0.463 | 0.664 | 3.9e-125 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.466 | 0.450 | 0.667 | 2.7e-124 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.497 | 0.558 | 0.606 | 1.1e-120 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.618 | 0.745 | 0.517 | 1.5e-120 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.466 | 0.555 | 0.627 | 2e-118 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.501 | 0.467 | 0.583 | 1.7e-117 |
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1330 (473.2 bits), Expect = 1.7e-152, Sum P(2) = 1.7e-152
Identities = 263/439 (59%), Positives = 323/439 (73%)
Query: 1 MGCVSSXXXXXXXGSPVFEAS-VSKTRASENATLNLNYVFSSKNPS--GALDFGSKEGER 57
MGCVSS +P + S V K +E + V P+ + + S+ G+R
Sbjct: 1 MGCVSSKQTVSV--TPAIDHSGVFKDNENECSGSGRIVVEDPPRPTLKKLVSWRSRSGKR 58
Query: 58 SEDKPKGSREXXXXXXXXXXXXXXAFSIKLGLSLRHVDAEQIXXXXXXXXXXXXXEAVYG 117
K GS + S +LG R+++AEQ+ EA++G
Sbjct: 59 RSQK-SGSE-----LGSESGRASDSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHG 112
Query: 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMIL 177
VP+R+++FEKLEKIGQGTYS+VFRA E TG++VALKKVRFDNF+PES++FMAREI+IL
Sbjct: 113 WVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILIL 172
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
RRL+HPNIIKLEG+ITS+LS I LVFEYMEHDL GL S DIKF+ PQ+KCYM+QLL G
Sbjct: 173 RRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSG 232
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK--LTSRVVTLWYRPP 295
++HCH RG+MHRDIK SN+L++NEGILK+ DFGLAN S +K LTSRVVTLWYRPP
Sbjct: 233 LDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPP 292
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
ELL+G+T+Y SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPPE+YWKKSK
Sbjct: 293 ELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSK 352
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
LPH +FKPQ Y+ CLRE KD + T ++LI+T LSI+P+KRGTASS L+ +YFTT+P+
Sbjct: 353 LPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPF 412
Query: 416 ACDPSSLPKYPPKKEIDAK 434
ACDPSSLP YPP KEID K
Sbjct: 413 ACDPSSLPIYPPSKEIDTK 431
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1331 (473.6 bits), Expect = 3.5e-152, Sum P(2) = 3.5e-152
Identities = 253/396 (63%), Positives = 308/396 (77%)
Query: 48 LDFGSKEGERSEDKPKGSR------EXXXXXXXXXXXXXXAFSIKLGLSLRHVDAEQIXX 101
L + SK G++S K GS E + S +LG ++++AEQ+
Sbjct: 47 LSWWSKSGKKSSSKKSGSELGSDFGELSESGRASSNCRSESVSFRLGNLSKYLEAEQVAA 106
Query: 102 XXXXXXXXXXXEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN 161
EA++G VP R+++FEKLEKIGQGTYSSVFRARE TG++VALKKVRFDN
Sbjct: 107 GWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVALKKVRFDN 166
Query: 162 FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK 221
F+PES+RFMAREI+ILR+L+HPNIIKLEG++TS+LS +I+LVFEYMEHDL GL S DI
Sbjct: 167 FEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDID 226
Query: 222 FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNK 280
F+ PQ+KCYM+QLL G++HCH RG+MHRDIK SN+LVNNEGILK+ DFGLAN S NK
Sbjct: 227 FTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNK 286
Query: 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
Q LTSRVVTLWYRPPELL+G+T Y SVDLWSVGCVFAELLIGKP+L+GRTEVEQLHKIF
Sbjct: 287 QPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIF 346
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRE--RCKDFTPTAVDLIDTCLSIEPYKR 398
KLCGSPPE+YWKKSKLPH +FKPQ Y+GCLRE + K + ++LI+T LSI+P+KR
Sbjct: 347 KLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKR 406
Query: 399 GTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK 434
GTAS+ L+ +YFT++P+ACDPSSLP Y P KEIDAK
Sbjct: 407 GTASTALVSQYFTSKPFACDPSSLPVYSPSKEIDAK 442
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1382 (491.5 bits), Expect = 9.3e-152, Sum P(2) = 9.3e-152
Identities = 255/350 (72%), Positives = 302/350 (86%)
Query: 85 IKLGLSLRHVDAEQIXXXXXXXXXXXXXEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAR 144
+ LG S R+++AEQ EAV+G VP++AE+F+KLEKIGQGTYSSVFRAR
Sbjct: 64 VSLGSSHRNIEAEQAAAGWPAWLCSAAAEAVHGWVPLKAEAFQKLEKIGQGTYSSVFRAR 123
Query: 145 EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204
EV TGKMVALKKV+FDN QPESIRFMAREI+ILR+L+HPNI+KLEG++TSR S++IYLVF
Sbjct: 124 EVETGKMVALKKVKFDNLQPESIRFMAREILILRKLNHPNIMKLEGIVTSRASSSIYLVF 183
Query: 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGIL 264
EYMEHDLAGLSS DI+F+EPQ+KCYM+QLL G+EHCH+RG++HRDIKASNILVNN+G+L
Sbjct: 184 EYMEHDLAGLSSNPDIRFTEPQIKCYMKQLLWGLEHCHMRGVIHRDIKASNILVNNKGVL 243
Query: 265 KLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324
KLGDFGLAN++T NK +LTSRVVTLWYR PELLMGST+Y VSVDLWSVGCVFAE+L+GK
Sbjct: 244 KLGDFGLANVVTPSNKNQLTSRVVTLWYRAPELLMGSTSYGVSVDLWSVGCVFAEILMGK 303
Query: 325 PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV 384
PILKGRTE+EQLHKI+KLCGSP + +WK++KLPH FKPQ+ YE LRERCKD + T V
Sbjct: 304 PILKGRTEIEQLHKIYKLCGSPQDSFWKRTKLPHATSFKPQHTYEATLRERCKDLSATGV 363
Query: 385 DLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK 434
L++T LS+EP KRGTASS L EYF T+PYACDPSSLPKYPP KE+DAK
Sbjct: 364 YLLETLLSMEPDKRGTASSALNSEYFLTRPYACDPSSLPKYPPNKEMDAK 413
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1316 (468.3 bits), Expect = 1.3e-141, Sum P(3) = 1.3e-141
Identities = 246/352 (69%), Positives = 296/352 (84%)
Query: 84 SIKLGLSLRHVDAEQIXXXXXXXXXXXXXEAVYGLVPMRAESFEKLEKIGQGTYSSVFRA 143
S++ GL +V+AEQ+ EAV+G VP+RAE FEK EKIGQGTYS+VFRA
Sbjct: 73 SLRSGLPHSNVEAEQVAAGWPSWLSSAAPEAVHGWVPLRAEDFEKREKIGQGTYSNVFRA 132
Query: 144 REVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203
EV+TG+++ALKK+R NF+ E+IRF+AREIMILRRLDHPNI+KLEG+I SR SN++Y V
Sbjct: 133 CEVSTGRVMALKKIRIQNFETENIRFIAREIMILRRLDHPNIMKLEGIIASRNSNSMYFV 192
Query: 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263
F+YMEHDL GL S DIKF+E Q+KCYM+QLL GVEHCHLRGIMHRDIKA+NILVNN+G+
Sbjct: 193 FDYMEHDLEGLCSSPDIKFTEAQIKCYMKQLLWGVEHCHLRGIMHRDIKAANILVNNKGV 252
Query: 264 LKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG 323
LKL DFGLANI+T +NK +LTSRVVTLWYR PELLMGST+Y+VSVDLWSVGCVFAE+L G
Sbjct: 253 LKLADFGLANIVTPRNKNQLTSRVVTLWYRAPELLMGSTSYSVSVDLWSVGCVFAEILTG 312
Query: 324 KPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL-PHGDMFKPQNPYEGCLRERCKDFTPT 382
+P+LKGRTE+EQLHKI+KL GSP EE+W+K+KL P MF+PQ+ YEGCLRER +F T
Sbjct: 313 RPLLKGRTEIEQLHKIYKLSGSPDEEFWEKNKLHPQTKMFRPQHQYEGCLRERFDEFPKT 372
Query: 383 AVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK 434
A++L++ LSI+P KRGTASS LM EYF TQPYACDPS+LPKYPP KE+DAK
Sbjct: 373 AINLLENLLSIDPEKRGTASSALMSEYFNTQPYACDPSTLPKYPPNKEMDAK 424
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 3.9e-125, Sum P(2) = 3.9e-125
Identities = 214/322 (66%), Positives = 265/322 (82%)
Query: 113 EAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR 172
EA+ G VP RA+SFEKL+KIGQGTYS+V+RAR++ K+VALKKVRFDN +PES+RFMAR
Sbjct: 121 EAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 180
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
EI ILRRLDHPNIIKLEG++TSR+S ++YLVFEYMEHDLAGL+S IKFSE QVKCY++
Sbjct: 181 EIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKCYLQ 240
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
QLLHG++HCH RG++HRDIK SN+L++N G+LK+ DFGLA+ + Q LTSRVVTLWY
Sbjct: 241 QLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTLWY 300
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
RPPELL+G+T Y +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP E+YW
Sbjct: 301 RPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYWV 360
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
KS+LPH +FKP PY+ + E K+F A+ L++T LS+ P RGTA++ L E+F+T
Sbjct: 361 KSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSEFFST 420
Query: 413 QPYACDPSSLPKYPPKKEIDAK 434
+P CDPSSLPKYPP KE+DA+
Sbjct: 421 RPLPCDPSSLPKYPPSKELDAR 442
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 2.7e-124, Sum P(2) = 2.7e-124
Identities = 215/322 (66%), Positives = 263/322 (81%)
Query: 113 EAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR 172
EA+ G +P +A+SFEKLEKIGQGTYSSV++AR++ T ++VALKKVRF N P+S+RFMAR
Sbjct: 150 EAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAR 209
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
EI+ILRRLDHPN++KLEG+ITSR+S ++YL+FEYMEHDLAGL+S I FSE Q+KCYM+
Sbjct: 210 EIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMK 269
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
QLLHG+EHCH RG++HRDIK SN+L+++ LK+GDFGLAN KQ LTSRVVTLWY
Sbjct: 270 QLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWY 329
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
RPPELL+GST+Y V+VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP EEYWK
Sbjct: 330 RPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 389
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
SKLPH +FKPQ PY+ C+ E K +A+ L++ L++EP RGT +S L E+FTT
Sbjct: 390 ISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTT 449
Query: 413 QPYACDPSSLPKYPPKKEIDAK 434
P A DPSSLPKY P+KEID K
Sbjct: 450 SPLASDPSSLPKYQPRKEIDVK 471
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 208/343 (60%), Positives = 267/343 (77%)
Query: 92 RHVDAEQIXXXXXXXXXXXXXEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKM 151
R +AE I EA+ G VP RA+SFEKL+KIGQGTYS V++AR++ TGK+
Sbjct: 107 RSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKI 166
Query: 152 VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDL 211
VA+KKVRF N PES+RFMAREI ILR+LDHPN++KL+ ++TS+LS +++LVFEYMEHDL
Sbjct: 167 VAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDL 226
Query: 212 AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271
+GL+ +KF+EPQ+KC+M+QLL G+EHCH RGI+HRDIK SN+LVNN+G+LK+GDFGL
Sbjct: 227 SGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGL 286
Query: 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT 331
A+ Q LTSRVVTLWYR PELL+GST Y ++DLWSVGC+ AEL + KPI+ GRT
Sbjct: 287 ASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRT 346
Query: 332 EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCL 391
EVEQ+HKIFKLCGSP EE+W +K P +KPQ+PY+ L E K+ + +++DL+D L
Sbjct: 347 EVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLL 406
Query: 392 SIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK 434
S+EP KR +ASS L+ E+FTT+P C SSLPKYPP KE+DAK
Sbjct: 407 SVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAK 449
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1186 (422.6 bits), Expect = 1.5e-120, P = 1.5e-120
Identities = 225/435 (51%), Positives = 303/435 (69%)
Query: 1 MGCVSSXXXXXXXGSPVFEASVSKTRASENATLNLNYVFSSKNPSGALDFGSKEGERSED 60
MGCV + +A SK AS + + N A D K+ E +
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSK--ASSGVVVVGESSVTKSNGVIADDVEKKKNEEAN- 57
Query: 61 KPKGSREXXXXXXXXXXXXXXAFSIKLGLSLRHVDAEQIXXXXXXXXXXXXXEAVYGLVP 120
G +E + +L +H EQ+ EA+ G VP
Sbjct: 58 ---GDKERKSSKGDRRRSTKP--NPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVP 112
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+A++FEK++KIGQGTYS+V++A+++ TGK+VALKKVRFDN +PES++FMAREI++LRRL
Sbjct: 113 RKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRL 172
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
DHPN++KLEG++TSR+S ++YLVF+YM+HDLAGL+S +KFSE +VKC MRQL+ G+EH
Sbjct: 173 DHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEH 232
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH RG++HRDIK SN+L+++ G+LK+ DFGLA I +K+ +TSRVVTLWYR PELL+G
Sbjct: 233 CHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLG 292
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
+T+Y V +DLWS GC+ AELL G+PI+ GRTEVEQLHKI+KLCGSP E+YWKK K HG
Sbjct: 293 ATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGA 352
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
++KP+ PY+ +RE KDF P+++ LID LSIEP R TAS+ L E+FT++PYAC+P+
Sbjct: 353 IYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPA 412
Query: 421 SLPKYPPKKEIDAKQ 435
LPKYPP KEIDAK+
Sbjct: 413 DLPKYPPSKEIDAKR 427
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 2.0e-118, P = 2.0e-118
Identities = 202/322 (62%), Positives = 268/322 (83%)
Query: 113 EAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR 172
+++ L P RA ++EKLEKIGQGTYS+V++A+++ +GK+VALKKVRFDN + ES++FMAR
Sbjct: 101 DSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDNLEAESVKFMAR 160
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
EI++LRRL+HPN+IKL+G++TSR+S ++YLVFEYMEHDL+GL++ +KF PQVKC+M+
Sbjct: 161 EILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMK 220
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
QLL G+EHCH RG++HRDIK SN+L++N+GILK+ DFGLA K KQ +TSRVVTLWY
Sbjct: 221 QLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQTMTSRVVTLWY 280
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
RPPELL+G+T+Y VDLWS GC+ AELL GKP++ GRTEVEQLHKIFKLCGSP + YWK
Sbjct: 281 RPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWK 340
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
K +LP+ +FKPQ+PY+ C+ E FTP++V L++T L+I+P RGT++S L E+FTT
Sbjct: 341 KYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTT 400
Query: 413 QPYACDPSSLPKYPPKKEIDAK 434
+P CDPSSLPKYPP KE++ K
Sbjct: 401 EPLPCDPSSLPKYPPSKELNVK 422
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1095 (390.5 bits), Expect = 1.7e-117, Sum P(3) = 1.7e-117
Identities = 202/346 (58%), Positives = 257/346 (74%)
Query: 89 LSLRHVDAEQIXXXXXXXXXXXXXEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVAT 148
+S + + +Q+ E++ P RA +FEKLEKIGQGTYSSV+RAR++
Sbjct: 176 VSPKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLH 235
Query: 149 GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208
K+VALKKVRFD ES++FMAREI+++RRLDHPN++KLEG+IT+ +S+++YLVFEYM+
Sbjct: 236 NKIVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMD 295
Query: 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGD 268
HDL GLSS +KF+EPQVKCYMRQLL G+EHCH RG++HRDIK SN+L++++G+LK+ D
Sbjct: 296 HDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIAD 355
Query: 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328
FGLA LTS VVTLWYRPPELL+G+++Y V VDLWS GC+ EL GKPIL
Sbjct: 356 FGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILP 415
Query: 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLID 388
G+TEVEQLHKIFKLCGSP E YW+K KLP FK PY + E KDF + + L++
Sbjct: 416 GKTEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLE 475
Query: 389 TCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAK 434
T LSI+P R +A L EYF T+P+ACDPS+LPKYPP KEIDAK
Sbjct: 476 TLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAK 521
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 690 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-152 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-126 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-109 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-106 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-103 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-102 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-93 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-91 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-90 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-89 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-89 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-86 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-85 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-85 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-83 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-77 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-76 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-74 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-74 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-73 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-73 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-73 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-72 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-72 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-70 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-69 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-62 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-62 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-62 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-61 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-60 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-60 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-58 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-58 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-57 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-56 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-53 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-53 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-52 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-51 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-51 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-49 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-48 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-46 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-45 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-44 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-44 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-43 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-42 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-41 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-39 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-35 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-26 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-26 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-20 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-18 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 441 bits (1138), Expect = e-152
Identities = 151/287 (52%), Positives = 208/287 (72%), Gaps = 2/287 (0%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+EK+ +IG+GTY V++AR TG++VALKK+R +N + REI +L++L HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
++L+ ++TS+ +IY+VFEYM+HDL GL ++KF+E Q+KCYM+QLL G+++ H G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
I+HRDIK SNIL+NN+G+LKL DFGLA T +N T+RV+TLWYRPPELL+G+T Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 306 VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMFKP 364
VD+WSVGC+ AEL +GKPI +G TE+EQL KIF+LCGSP +E W SKLP + KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 365 QNPYEGCLRER-CKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ PY+ LRE P+A+DL+D L+++P KR +A L EYF
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 374 bits (963), Expect = e-126
Identities = 126/290 (43%), Positives = 175/290 (60%), Gaps = 13/290 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN----FQPESIRFMAREIMILRRLD 181
+EKLEK+G+GTY V++AR+ TG++VALKK+R DN ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
HPNI+KL VI + +YLVFEY + DL S +K M QLL G+ +C
Sbjct: 57 HPNIVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H I+HRD+K NIL+N +G+LKL DFGLA + T VVTLWYR PE+L+GS
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGD 360
+Y+ +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++ G+P EE W +KLP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
P+ P + L + P +DL+ L P KR +A L YF
Sbjct: 234 PTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 332 bits (853), Expect = e-109
Identities = 132/302 (43%), Positives = 187/302 (61%), Gaps = 9/302 (2%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIRFMA-REIMILRRLDH 182
+EK +K+G+GTY+ V++AR+ TG++VA+KK++ + + I F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PNII L V + SN I LVFE+ME DL + I + +K YM L G+E+ H
Sbjct: 62 PNIIGLLDVFGHK-SN-INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRD+K +N+L+ ++G+LKL DFGLA S N+ K+T +VVT WYR PELL G+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGAR 178
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
+Y V VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P EE W + LP
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSS 421
FKP P L++ + A+DL+ L++ P KR TA L YF+ P PS
Sbjct: 239 FKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
Query: 422 LP 423
LP
Sbjct: 297 LP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 325 bits (835), Expect = e-106
Identities = 132/305 (43%), Positives = 187/305 (61%), Gaps = 19/305 (6%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+E L K+G+GT+ V++AR++ TG++VALKK+ N + + A REI IL++L H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 183 PNIIKLEGVI------TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH 236
PN++ L + + R ++Y+V YM+HDL+GL +K +E Q+KCYM QLL
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK----------NKQKLTSR 286
G+ + H I+HRDIKA+NIL++N+GILK+ DFGLA +K T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
VVT WYRPPELL+G Y +VD+W +GCVFAE+ +PIL+G+++++QLH IFKLCG+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 347 PEEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
EE W LP + Y L ER P +DL+ LS++PYKR TAS L
Sbjct: 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 406 MCEYF 410
YF
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-103
Identities = 128/294 (43%), Positives = 180/294 (61%), Gaps = 12/294 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN----FQPESIRFMAREIMILRR 179
+ +EKL +I +GTY V+RAR+ TG++VALKK++ + F S+R EI IL +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLK 60
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
L HPNI+ ++ V+ + IY+V EY+EHDL L F + +VKC M QLL GV
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H H I+HRD+K SN+L+NN GILK+ DFGLA S + T VVTLWYR PELL+
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQLVVTLWYRAPELLL 179
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPH 358
G+ Y+ ++D+WSVGC+FAELL KP+ G++E++QL+KIFKL G+P E+ W S+LP
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239
Query: 359 GDMFKPQNPYEGCLRERCK--DFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
LR++ + DL++ L+ +P KR +A L YF
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 315 bits (810), Expect = e-102
Identities = 135/304 (44%), Positives = 191/304 (62%), Gaps = 6/304 (1%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
FEKL +IG+GTY V+RAR+ +G++VALKKVR DN + + I + REI +L L HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
I++L+ V+ + ++I+LV EY E DLA L FSE QVKC M QLL G+++ H
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
I+HRD+K SN+L+ ++G LK+ DFGLA + +T +VVTLWYR PELL+G T Y
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMFK 363
++D+W+VGC+ AELL KP+L G++E+EQL I +L G+P E W S LP F
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 364 -PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSL 422
P+ PY L+ + + + L++ L +P KR TA L YF +P C+P +
Sbjct: 247 LPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMM 305
Query: 423 PKYP 426
P +P
Sbjct: 306 PTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 291 bits (746), Expect = 3e-93
Identities = 131/294 (44%), Positives = 183/294 (62%), Gaps = 11/294 (3%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
F+ + +IG+GTY V++AR+ TG++VALKKVR DN + E A REI ILR+L+H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRN 67
Query: 185 IIKLEGVITSRLSNT--------IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH 236
I+ L+ ++T + YLVFEYM+HDL GL + FSE +K +M+QLL
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
G+ +CH + +HRDIK SNIL+NN+G +KL DFGLA + S+ + T++V+TLWYRPPE
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SK 355
LL+G Y ++D+WS GC+ EL KPI + E+ QL I +LCGSP W K
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK 247
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
LP+ + KP+ Y LRE A+DL+D L+++P KR TA L +
Sbjct: 248 LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 4e-91
Identities = 135/306 (44%), Positives = 186/306 (60%), Gaps = 30/306 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
+EKL KIGQGT+ VF+AR T ++VALKKV +N + E A REI IL+ L H N
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHEN 72
Query: 185 IIKL------EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
++ L + +R + YLVFE+ EHDLAGL S ++KF+ ++K M+ LL+G+
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN-ILTSKNKQ--KLTSRVVTLWYRPP 295
+ H I+HRD+KA+NIL+ +GILKL DFGLA SKN + + T+RVVTLWYRPP
Sbjct: 133 YYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS-PPE------ 348
ELL+G +Y +D+W GC+ AE+ PI++G TE QL I +LCGS PE
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252
Query: 349 --EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTASSL 404
E +KK +LP G K ++ER K + P A+DLID L ++P KR A +
Sbjct: 253 KLELFKKMELPQGQKRK--------VKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 405 LMCEYF 410
L ++F
Sbjct: 305 LNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 6e-90
Identities = 125/289 (43%), Positives = 174/289 (60%), Gaps = 10/289 (3%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
++KL KIG+GTY V++AR+ TG++VA+KK++ F+ E I A REI +L+ L+HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR-FESEGIPKTALREIKLLKELNHPN 59
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
IIKL V + +YLVFE+M+ DL L E +K Y+ QLL G+ CH
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
GI+HRD+K N+L+N EG+LKL DFGLA S + T VVT WYR PELL+G Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLGDKGY 176
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK---LPHGDM 361
+ VD+WSVGC+FAELL +P+ G++E++QL KIF+ G+P E W K +
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
F + L + + +P A+DL+ L +P+KR TA L YF
Sbjct: 237 FPKKAGMP--LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 279 bits (717), Expect = 1e-89
Identities = 106/286 (37%), Positives = 155/286 (54%), Gaps = 33/286 (11%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E LEK+G+G++ V+ AR+ TGK+VA+K ++ + + R + REI IL++L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
++L V + +YLV EY E DL L + SE + + Y+RQ+L +E+ H +
Sbjct: 60 VRLYDVFEDE--DKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
GI+HRD+K NIL++ +G +KL DFGLA L +KLT+ V T Y PE+L+G Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLG-KGY 173
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364
+VD+WS+G + ELL GKP G +QL ++FK G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPE---------- 220
Query: 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
D +P A DLI L +P KR TA L +F
Sbjct: 221 ------------WDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 8e-89
Identities = 120/297 (40%), Positives = 171/297 (57%), Gaps = 22/297 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ---PESIRFMAREIMILRRLD- 181
+E+L +IG+G Y +V++AR++ TG+ VALKKVR + P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 182 --HPNIIKLEGVI-TSRLSN--TIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLL 235
HPNI++L V R + LVFE+++ DLA LS C +K MRQLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 236 HGVE--HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
GV+ H H I+HRD+K NILV ++G +K+ DFGLA I + + LTS VVTLWYR
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYR 173
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE+L+ S+ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF + G P EE W +
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ F P + + +DL+ L+ P+KR +A L YF
Sbjct: 233 NVSLPRSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 3e-86
Identities = 116/295 (39%), Positives = 164/295 (55%), Gaps = 19/295 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKV----RFDNFQPESIRFMAREIMILRRLD 181
++ L +IG+G + VF+A++ TG+ VALKKV + REI L+
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ----ALREIKALQACQ 57
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
HP ++KL V LV EYM DL+ + + E QVK YMR LL GV +
Sbjct: 58 HPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H GIMHRD+K +N+L++ +G+LK+ DFGLA + + + + + +V T WYR PELL G+
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGD 360
Y+ VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P EE W + LP D
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP--D 233
Query: 361 ----MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
F P L E D +P A+DL+ L +P KR +A+ L YFT
Sbjct: 234 YNKITFPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 3e-85
Identities = 117/290 (40%), Positives = 178/290 (61%), Gaps = 12/290 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
++K+EKIG+GTY V++AR+ TG++VALKK+R + + E + A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I++L V+ S N +YLVFE+++ DL + S P +K Y+ QLL G+ +CH
Sbjct: 60 IVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
++HRD+K N+L++ EG LKL DFGLA + T VVTLWYR PE+L+GS
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQ 176
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMF 362
Y+ VD+WS+GC+FAE++ +P+ G +E++QL +IF+ G+P E+ W + LP +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---Y 233
Query: 363 KPQNP--YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
KP P L + + +DL+ L +P KR +A + L YF
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 270 bits (691), Expect = 9e-85
Identities = 125/330 (37%), Positives = 183/330 (55%), Gaps = 36/330 (10%)
Query: 123 AESFEKLEK-IGQGTYSSVFRAREVATGKMVALKKVR---FDNFQPES--------IRFM 170
+E + + +G+GTY V +A + TGK+VA+KKV+ N + I F
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 171 A-REIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKC 229
RE+ I+ + H NI+ L V + I LV + M DL + I+ +E QVKC
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVD-RKIRLTESQVKC 123
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-------------NILT 276
+ Q+L+G+ H MHRD+ +NI +N++GI K+ DFGLA T
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQL 336
+ ++++TS+VVTLWYR PELLMG+ Y+ +VD+WSVGC+FAELL GKP+ G E++QL
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 337 HKIFKLCGSPPEEYW-KKSKLPHGDMFKPQNP--YEGCLRERCKDFTPTAVDLIDTCLSI 393
+IF+L G+P E+ W + KLP F P+ P + D A+DL+ + L +
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD----AIDLLQSLLKL 299
Query: 394 EPYKRGTASSLLMCEYFTTQPYACDPSSLP 423
P +R +A L EYF + P CDPS LP
Sbjct: 300 NPLERISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 1e-83
Identities = 102/282 (36%), Positives = 147/282 (52%), Gaps = 29/282 (10%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E L K+G G++ +V++A+ TGK+VA+K ++ + + + + REI ILRRL HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
++L + +YLV EY E DL S SE + K Q+L G+E+ H
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
GI+HRD+K NIL++ G++K+ DFGLA L K+ LT+ V T WY PE+L+G Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK-LCGSPPEEYWKKSKLPHGDMFK 363
VD+WS+G + ELL GKP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS------ 230
Query: 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
A DLI CL+ +P KR TA +L
Sbjct: 231 -----------------EEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 3e-77
Identities = 120/341 (35%), Positives = 178/341 (52%), Gaps = 33/341 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
+E L+ IG G Y V A + TG+ VA+KK+ FD+ + + REI +LR L H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHE 59
Query: 184 NIIKLEGVITSRLS---NTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVE 239
NII L ++ N +Y+V E ME DL + S + ++ ++ ++ Q+L G++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL--TDDHIQYFLYQILRGLK 117
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK--LTSRVVTLWYRPPEL 297
+ H ++HRD+K SNILVN+ LK+ DFGLA + +K LT VVT WYR PEL
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK---- 353
L+ S+ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G+P EE K
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237
Query: 354 ------SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407
LP KP+ P L + +P A+DL++ L +P KR TA L
Sbjct: 238 KARNYLKSLPK----KPKKP----LSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 408 EYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARM 448
Y DP P P + D DE +++ +
Sbjct: 290 PYL--AQLH-DPEDEPVAKPPFDFDFFDDDELTEEELKELI 327
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 4e-76
Identities = 108/290 (37%), Positives = 155/290 (53%), Gaps = 5/290 (1%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+E L +G+G Y V + R ATG++VA+KK + + + RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
NI+ L+ R +YLVFEY+E L L V+ Y+ QLL + +CH
Sbjct: 61 NIVNLKEAF--RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
I+HRDIK NILV+ G+LKL DFG A L ++ LT V T WYR PELL+G TN
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE---EYWKKSKLPHGD 360
Y VD+W++GC+ AELL G+P+ G ++++QL+ I K G P E + + G
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
F + E R + A+D + CL ++P +R T LL YF
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 4e-74
Identities = 114/291 (39%), Positives = 179/291 (61%), Gaps = 13/291 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHPN 184
+ K+EKIG+GTY V++ R TG++VA+KK+R ++ + E + A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQ-VKCYMRQLLHGVEHCH 242
I+ L+ V+ + +YL+FE++ DL L S ++ + + VK Y+ Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R ++HRD+K N+L++N+G++KL DFGLA + T VVTLWYR PE+L+GS
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLGSP 177
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
Y+ VD+WS+G +FAE+ KP+ G +E++QL +IF++ G+P E+ W + LP
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD--- 234
Query: 362 FKPQNP--YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+K P +G LR K+ +DL++ L +P KR +A L YF
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 6e-74
Identities = 117/293 (39%), Positives = 173/293 (59%), Gaps = 16/293 (5%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F+K+EKIG+GTY V++AR TG++VALKK+R D + E + A REI +L+ L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+KL VI + N +YLVFE++ DL + + P +K Y+ QLL G+ CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
++HRD+K N+L+N EG +KL DFGLA + T VVTLWYR PE+L+G
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 176
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
Y+ +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P E W + LP
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD--- 233
Query: 362 FKPQNPYEGCLRERCKDFTPT----AVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+KP P R+ P DL+ L +P KR +A + L +F
Sbjct: 234 YKPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 1e-73
Identities = 126/301 (41%), Positives = 176/301 (58%), Gaps = 21/301 (6%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+++EKLEKIG+GTY V++AR+ TGK+VALKK R + E I A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 183 -PNIIKL---EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP----QVKCYMRQL 234
I++L E V ++YLVFEY++ DL + P +K +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
L GV HCH G+MHRD+K N+LV+ + G+LK+ D GL + K T +VTLWYR
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYR 178
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE+L+GST+Y+ VD+WSVGC+FAE+ +P+ G +E++QL IFKL G+P E+ W
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 354 -SKLPHGDMF---KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
SKL F KPQ+ L D +P +DL+ L +P KR +A + L Y
Sbjct: 239 VSKLRDWHEFPQWKPQD-----LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 410 F 410
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-73
Identities = 111/290 (38%), Positives = 169/290 (58%), Gaps = 10/290 (3%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F++LEK+G+GTY++V++ R TG++VALK++ D E A REI +++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHE 58
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP--QVKCYMRQLLHGVEHC 241
NI++L VI + N + LVFEYM+ DL H ++ + VK + QLL G+ C
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H ++HRD+K N+L+N G LKL DFGLA ++ VVTLWYR P++L+GS
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VNTFSNEVVTLWYRAPDVLLGS 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGD 360
Y+ S+D+WSVGC+ AE++ G+P+ G +QL KIF++ G+P E W S+LP
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
P+ P + L++ P +DL+ L + P R +A L +F
Sbjct: 236 PTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 4e-73
Identities = 114/299 (38%), Positives = 175/299 (58%), Gaps = 20/299 (6%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRL 180
+ E+++KL+K+G+G+Y++V++ R TG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L +I ++ + T LVFEY++ DL S V+ ++ QLL G+ +
Sbjct: 61 KHANIVTLHDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH R ++HRD+K N+L++ G LKL DFGLA S + ++ VVTLWYRPP++L+G
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKK-SKLPH 358
ST Y+ S+D+W VGC+F E+ G+P+ G T+V +QLHKIF++ G+P EE W S P
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 359 -----GDMFKPQNPYEGCLRERCK--DFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ P+ L D P +L L EP KR +A+ + YF
Sbjct: 238 FKPYSFPFYPPRP-----LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 5e-72
Identities = 112/294 (38%), Positives = 176/294 (59%), Gaps = 20/294 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKV--RFDNFQPESIRFMAREIMILRRL-DH 182
++ ++++G GT+ SV+ AR TG++VA+KK+ +F +++ E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQLLHGVEHC 241
PNI+KL+ V R ++ +Y VFEYME +L L K FSE ++ + Q+L G+ H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H G HRD+K N+LV+ ++K+ DFGLA +++ T V T WYR PE+L+ S
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-----SKL 356
T+Y+ VD+W++GC+ AEL +P+ G +E++QL+KI + G+P ++ W + SKL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
G F P L + + +P A+DLI L +P KR TAS L YF
Sbjct: 234 --GFRFPQFAPTS--LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 5e-72
Identities = 118/289 (40%), Positives = 161/289 (55%), Gaps = 8/289 (2%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
+EKLEKIG+GTY +VF+A+ T ++VALK+VR D+ REI +L+ L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I++L V+ S + LVFEY + DL SC+ VK +M QLL G+ CH
Sbjct: 61 IVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHS 117
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
++HRD+K N+L+N G LKL DFGLA + ++ VVTLWYRPP++L G+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL 176
Query: 304 YNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
Y+ S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P EE W SKLP
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD-YK 235
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
P P L T DL+ L P +R +A L YF
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-70
Identities = 117/298 (39%), Positives = 177/298 (59%), Gaps = 23/298 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+ +EK+EKIG+GTY V++AR+ T + +ALKK+R + + E + A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
NI++L+ V+ S +YLVFEY++ DL + S D + +K Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 242 HLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H ++HRD+K N+L++ LKL DFGLA + T VVTLWYR PE+L+G
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLG 177
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK-------- 352
S +Y+ VD+WSVGC+FAE++ KP+ G +E+++L KIF++ G+P EE W
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
KS P + P++ L P VDL+ L ++P KR TA + L EYF
Sbjct: 238 KSAFPK---WPPKD-----LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 113/316 (35%), Positives = 164/316 (51%), Gaps = 32/316 (10%)
Query: 126 FEKLEKIGQGTYSSVFRAR--EVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+E IG+GTY V++A+ GK A+KK + D Q I A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHD----IKFSEPQVKCYMRQLLHGV 238
N++ L V ++YL+F+Y EHDL + H + VK + Q+L+GV
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 239 EHCHLRGIMHRDIKASNILVNNE----GILKLGDFGLANILTSKNKQKLTSR--VVTLWY 292
+ H ++HRD+K +NILV E G++K+GD GLA + + K VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLHKIFKLC 343
R PELL+G+ +Y ++D+W++GC+FAELL +PI KGR +QL +IF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 344 GSPPEEYWKK-SKLPH----GDMFK----PQNPYEGCLRERCKDFTPTAVDLIDTCLSIE 394
G+P E+ W K+P FK P N + E+ K DL+ L +
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWM-EKHKKPDSQGFDLLRKLLEYD 300
Query: 395 PYKRGTASSLLMCEYF 410
P KR TA L YF
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-69
Identities = 118/292 (40%), Positives = 164/292 (56%), Gaps = 27/292 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIR-FMAREIMILRRL-D 181
+E L+K+G+G Y V++A + T ++VALKK+ FD F+ ++ R F REIM L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDL-----AGLSSCHDIKFSEPQVKCYMRQLLH 236
HPNI+KL VI + IYLVFEYME DL A + + + M QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-------LEDVHKRYIMYQLLK 118
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS----KNKQKLTSRVVTLWY 292
+++ H ++HRD+K SNIL+N++ +KL DFGLA L+ LT V T WY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+L+GST Y VD+WSVGC+ E+L+GKP+ G + + QL KI ++ G P E +
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 353 KSKLPHGD-MFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
K P M P P + L E + A+DL+ L P KR TA
Sbjct: 239 SIKSPFAATMLDSLPSRPRKP-LDELLPKASDDALDLLKKLLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 2e-67
Identities = 106/296 (35%), Positives = 157/296 (53%), Gaps = 19/296 (6%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +EKL KIG+G+Y VF+ R TG++VA+KK P + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
N++ L V R ++LVFEY +H + + E +K + Q L V CH
Sbjct: 61 NLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
+HRD+K NIL+ +G +KL DFG A ILT T V T WYR PELL+G T
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQ 177
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS---------PPEEYWKKS 354
Y VD+W++GCVFAELL G+P+ G+++V+QL+ I K G +++K
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+P + +P L + + + A+ + CL ++P +R + LL YF
Sbjct: 238 SIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 6e-64
Identities = 109/284 (38%), Positives = 153/284 (53%), Gaps = 7/284 (2%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIK 187
L KIG+GT+S V +A+ TGK A+K ++ +F+ REI LRRL HPNI++
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 188 LEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
L V+ R + + LVFE M+ +L L E +VK YM QLL ++H H GI
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
HRDIK NIL+ ++ ILKL DFG + SK T + T WYR PE L+ Y
Sbjct: 123 HRDIKPENILIKDD-ILKLADFGSCRGIYSK--PPYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 308 VDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY-WKKSKLPHGDMFKPQN 366
+D+W+VGCVF E+L P+ G E++Q+ KI + G+P E K K H + P
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239
Query: 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
G LR+ + + +DL+ L+ +P +R TA L YF
Sbjct: 240 KGTG-LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 77/191 (40%), Positives = 118/191 (61%), Gaps = 6/191 (3%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGV 191
+G+G + +V+ AR+ TGK VA+K ++ ++ + REI IL++L+HPNI+KL GV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 192 ITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250
N +YLV EY E L L ++ K SE ++ + Q+L G+E+ H GI+HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 251 IKASNILVNN-EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVD 309
+K NIL+++ G +KL DFGL+ +LTS +K L + V T Y PE+L+G Y+ D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 310 LWSVGCVFAEL 320
+WS+G + EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 6e-62
Identities = 111/296 (37%), Positives = 172/296 (58%), Gaps = 17/296 (5%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
+ E++ KL+K+G+GTY++VF+ R T +VALK++R ++ + + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L +I + T LVFEY++ DL L +C ++ S VK +M QLL G+ +
Sbjct: 62 HANIVTLHDIIHTERCLT--LVFEYLDSDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLSY 118
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH R I+HRD+K N+L+N +G LKL DFGLA + K ++ VVTLWYRPP++L+G
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLG 177
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW------KKS 354
ST Y+ +D+W VGC+ E+ G+P+ G T E+LH IF+L G+P EE W ++
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ ++ Q L +DL+ + L E R +A + L YF
Sbjct: 238 RSYLFPQYRAQP-----LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 8e-62
Identities = 112/293 (38%), Positives = 171/293 (58%), Gaps = 11/293 (3%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
+ E++ KL+K+G+GTY++V++ R T +VALK++R ++ + + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L +I + S T LVFEY++ DL L C + + VK ++ QLL G+ +
Sbjct: 63 HANIVTLHDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNY 119
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH R ++HRD+K N+L+N G LKL DFGLA + K ++ VVTLWYRPP++L+G
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLG 178
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
ST+Y+ +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P EE W + +
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW--PGILSNE 236
Query: 361 MFKPQN-P--YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
FK N P CL +L+ L E KR +A + YF
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 8e-62
Identities = 109/295 (36%), Positives = 171/295 (57%), Gaps = 17/295 (5%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
E +E L +G+G+Y V + + TG++VA+KK ++ + ++ +A REI +L++L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRH 59
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
N++ L V R +YLVFE+++H DL + + S +V+ Y+ Q+L G+
Sbjct: 60 ENLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLE--KYPNGLDES--RVRKYLFQILRGI 113
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
E CH I+HRDIK NILV+ G++KL DFG A L + + T V T WYR PELL
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELL 172
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG--SPP-EEYWKKSK 355
+G T Y +VD+W+VGC+ E+L G+P+ G ++++QL+ I K G P +E ++K+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
L G M P+ L +R + +DL CL I+P R ++S LL E+F
Sbjct: 233 LFAG-MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 3e-61
Identities = 113/293 (38%), Positives = 163/293 (55%), Gaps = 14/293 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL---DH 182
+E + +IG G Y +V++AR+ +G VALK VR + RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 183 PNIIKLEGVITSRLSN---TIYLVFEYMEHDL-AGLSSCHDIKFSEPQVKCYMRQLLHGV 238
PNI++L V + ++ + LVFE+++ DL L +K MRQ L G+
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H I+HRD+K NILV + G +KL DFGLA I + + LT VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVL 179
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-KLP 357
+ ST Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G PPE+ W + LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
G F P+ P ++ + + L+ L+ P+KR +A L +F
Sbjct: 239 RGA-FSPRGPRP--VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 4e-60
Identities = 116/295 (39%), Positives = 170/295 (57%), Gaps = 14/295 (4%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLD 181
A S+ LEK+G+G+Y++V++ G++VALK + E + F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
H NI+ L +I ++ T+ VFEYM DLA H V+ +M QLL G+ +
Sbjct: 62 HANIVLLHDIIHTK--ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H + I+HRD+K N+L++ G LKL DFGLA S Q +S VVTLWYRPP++L+G+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKK-SKLPH- 358
T+Y+ ++D+W GC+F E+L G+P G ++V EQL KI+ + G P E+ W SKLP+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 359 -GDMFKPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ F P P + LR K + P A DL L + P R +A L+ YF
Sbjct: 239 KPEWFLPCKPQQ--LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 4e-60
Identities = 106/331 (32%), Positives = 159/331 (48%), Gaps = 41/331 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV--RFDNFQPESIRFMAREIMILRRLD 181
++ +E IG G Y V A + +GK VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 182 HPNIIKLEGVITSR--LSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQL 234
H NII + ++ +Y+V + ME DL H I +E ++ ++ QL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDL------HHIIHSDQPLTEEHIRYFLYQL 116
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK---LTSRVVTLW 291
L G+++ H ++HRD+K SN+LVN + L++GDFG+A L+S + +T V T W
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351
YR PELL+ Y ++D+WSVGC+FAE+L + + G+ V QL I + GSP EE
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 352 KKS----------KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
+ LP K P+ +P A+DL+ L +P +R T
Sbjct: 237 NRIGSDRVRKYIQNLPR----KQPVPWSKIFP----KASPEALDLLSQMLQFDPEERITV 288
Query: 402 SSLLMCEYFTTQPYACDPSSLPKYPPKKEID 432
L + DP P PP + D
Sbjct: 289 EQALQHPFLAQYH---DPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 6e-60
Identities = 91/286 (31%), Positives = 139/286 (48%), Gaps = 36/286 (12%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
+ + E +G+G++ SV+ A + TG+++A+K V E + + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHGVEH 240
I++ G NT+ + EY+ +G S +K EP ++ Y RQ+L G+ +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYV----SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLM 299
H GI+HRDIK +NILV+++G++KL DFG A L + T V T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
G Y + D+WS+GC E+ GKP + G+P +K
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKP-------------PWSELGNPMAALYKIGSSGEP 222
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P+ L E KDF + CL +P KR TA LL
Sbjct: 223 PEI-PE-----HLSEEAKDF-------LRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 4e-58
Identities = 111/301 (36%), Positives = 172/301 (57%), Gaps = 23/301 (7%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
+ E++ KLEK+G+GTY++VF+ R T +VALK++R ++ + + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L ++ + S T LVFEY++ DL + C +I S VK ++ Q+L G+ +
Sbjct: 63 HANIVTLHDIVHTDKSLT--LVFEYLDKDLKQYMDDCGNI-MSMHNVKIFLYQILRGLAY 119
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH R ++HRD+K N+L+N G LKL DFGLA + K ++ VVTLWYRPP++L+G
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLG 178
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW--------- 351
S+ Y+ +D+W VGC+F E+ G+P+ G T ++LH IF+L G+P EE W
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
K P +KPQ L ++L+ L E KR +A + YF
Sbjct: 239 KNYNFPK---YKPQP-----LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
Query: 412 T 412
+
Sbjct: 291 S 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 7e-58
Identities = 113/320 (35%), Positives = 164/320 (51%), Gaps = 28/320 (8%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
VP R ++ L +G G Y V A + TG+ VA+KK+ + RE+ +L+
Sbjct: 13 VPDR---YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK 69
Query: 179 RLDHPNIIKLEGVIT--SRLSN--TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
+DH N+I L V T S L + +YLV M DL + C K S+ ++ + Q+
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQI 127
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
L G+++ H GI+HRD+K SNI VN + LK+ DFGLA ++T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 183
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
PE+++ +YN +VD+WSVGC+ AELL GK + G ++QL +I L G+P EE +K
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDF-------TPTAVDLIDTCLSIEPYKRGTASSLLMC 407
+ P + KDF P A+DL++ L ++P KR TA+ L
Sbjct: 244 SSESARNYIQSLPQ----MPK-KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298
Query: 408 EYFTTQPYACDPSSLPKYPP 427
Y Y DP P PP
Sbjct: 299 PYL--AEYH-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-57
Identities = 105/292 (35%), Positives = 154/292 (52%), Gaps = 21/292 (7%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
IG+G Y V A+ T + VA+KK+ FDN + ++ R + REI +LR LDH N+I ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTL-REIKLLRHLDHENVIAIK 70
Query: 190 GVIT---SRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHGVEHC 241
++ N +Y+V+E M+ DL H I S+ + ++ QLL G+++
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDL------HQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H ++HRD+K SN+L+N LK+ DFGLA TS+ +T VVT WYR PELL+
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
+ Y ++D+WSVGC+FAELL KP+ G+ V QL I +L GSP EE +
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243
Query: 362 FKPQNP-YEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+ P P A+DL++ L +P KR T L Y
Sbjct: 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 196 bits (498), Expect = 3e-57
Identities = 115/301 (38%), Positives = 171/301 (56%), Gaps = 16/301 (5%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRL 180
+A+S+EKLEK+G+G+Y++V++ + GK+VALK +R + E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L +I ++ T+ LVFEY+ DL H VK ++ QLL G+ +
Sbjct: 61 KHANIVLLHDIIHTK--ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H R I+HRD+K N+L+++ G LKL DFGLA S ++ VVTLWYRPP++L+G
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEYWKK-SKLPH 358
ST Y+ +D+W VGC+F E++ G G +++ QL +IF + G+P E+ W LPH
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 359 GDMFKPQN---PYEGCLRERCK--DFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
FKP+ LR+ + A DL L P R +A + L EYF+
Sbjct: 238 ---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294
Query: 414 P 414
P
Sbjct: 295 P 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 116/330 (35%), Positives = 177/330 (53%), Gaps = 33/330 (10%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ L +G G+ VF A + K VA+KK+ P+S++ REI I+RRLDH NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 186 IKLEGVI---TSRLS---------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
+K+ V+ S L+ N++Y+V EYME DLA + + SE + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQK--LTSRVVTL 290
LL G+++ H ++HRD+K +N+ +N E +LK+GDFGLA I+ K L+ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
WYR P LL+ NY ++D+W+ GC+FAE+L GKP+ G E+EQ+ I + EE
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 351 WKK--SKLPH---GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + +P D +P+ P LR+ P A+D ++ L+ P R TA L
Sbjct: 243 RNELLNVIPSFVRNDGGEPRRP----LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298
Query: 406 MCEYFTTQPYAC---DPSSLPKYPPKKEID 432
M Y Y+C +P SL + + E+D
Sbjct: 299 MHPYM--SCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 8e-54
Identities = 108/322 (33%), Positives = 158/322 (49%), Gaps = 41/322 (12%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
++ L IG+G Y V A TG VA+KK+ Q R + REI ILRR H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62
Query: 183 PNIIKLEGVITSR---LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
NII + +I N +Y+V E ME DL L + S ++ ++ Q+L G++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLK 120
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI--LTSKNKQKLTSRVVTLWYRPPEL 297
+ H ++HRD+K SN+L+N LK+ DFGLA I + LT V T WYR PE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE-------- 349
++ S Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+P +E
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 350 ----YWK----KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
Y K K K+P +F + P A+DL+D L+ P+KR T
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNAD--------------PKALDLLDKMLTFNPHKRITV 286
Query: 402 SSLLMCEYFTTQPYACDPSSLP 423
L Y + Y DPS P
Sbjct: 287 EEALAHPYL--EQYH-DPSDEP 305
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 2e-53
Identities = 91/288 (31%), Positives = 140/288 (48%), Gaps = 48/288 (16%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
FE LEKIG+G + V++AR TGK VA+K ++ ++ E + EI IL++ HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNI 59
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
+K G + + +++V E+ L L + +E Q+ ++LL G+E+ H
Sbjct: 60 VKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
GI+HRDIKA+NIL+ ++G +KL DFGL+ L+ + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMVGTPYWMAPEVING-KPY 174
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD---- 360
+ D+WS+G EL GKP P+ +
Sbjct: 175 DYKADIWSLGITAIELAEGKP-------------------------------PYSELPPM 203
Query: 361 --MFK-PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+FK N G LR K ++ D + CL P KR TA LL
Sbjct: 204 KALFKIATNGPPG-LRNPEK-WSDEFKDFLKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-53
Identities = 108/320 (33%), Positives = 166/320 (51%), Gaps = 30/320 (9%)
Query: 115 VYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREI 174
++G V + L+ +G G + V AR+ TG+ VA+KK+ P + RE+
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQ-VKCYMRQ 233
+L+ L H NII L + S L + IY V E + DL L + + E Q ++ ++ Q
Sbjct: 61 KLLKHLRHENIISLSDIFISPLED-IYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQ 116
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+L G+++ H G++HRD+K SNIL+N LK+ DFGLA I ++T V T +YR
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYR 172
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE+++ Y+V VD+WS GC+FAE+L GKP+ G+ V Q I L G+PP++
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232
Query: 354 ----------SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403
LP + P E+ K+ P+A+DL++ L +P KR +A+
Sbjct: 233 ICSENTLRFVQSLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
Query: 404 LLMCEYFTTQPYACDPSSLP 423
L Y PY DP+ P
Sbjct: 285 ALAHPYLA--PYH-DPTDEP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 8e-52
Identities = 114/299 (38%), Positives = 166/299 (55%), Gaps = 21/299 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRLD- 181
+ +E + +IG+G Y VF+AR++ G + VALK+VR + RE+ +LR L+
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 182 --HPNIIKLEGVIT-SRL--SNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLL 235
HPN+++L V T SR + LVFE+++ DL L + +K M QLL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G++ H ++HRD+K NILV + G +KL DFGLA I + + LTS VVTLWYR P
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 178
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E+L+ S+ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P EE W +
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR-- 235
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTP----TAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
D+ P+ + + + F DL+ CL+ P KR +A S L YF
Sbjct: 236 ----DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 94/304 (30%), Positives = 152/304 (50%), Gaps = 37/304 (12%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
E ++ LEKIG+G V++A + ATGK VA+KK+R E I EI+I++
Sbjct: 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCK 73
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
HPNI+ + + + +++V EYM+ L + + + ++ +EPQ+ R++L G+E+
Sbjct: 74 HPNIVDYYD--SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H + ++HRDIK+ NIL++ +G +KL DFG A LT K K K S V T ++ PE++
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVIKR 190
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
+Y VD+WS+G + E+ G+P + L I G PP L + +
Sbjct: 191 K-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------LKNPE 240
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+ P+ KDF ++ CL +P KR +A LL + AC
Sbjct: 241 KWSPE----------FKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKE 280
Query: 421 SLPK 424
Sbjct: 281 EFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-51
Identities = 101/320 (31%), Positives = 163/320 (50%), Gaps = 38/320 (11%)
Query: 126 FEKLEKIGQGTYSSVFRAR--EVATGKMVALKKVRFDNFQPE-SIRFMAREIMILRRL-D 181
+E ++++GQG Y V AR E + + VA+KK+ + F + + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRG 60
Query: 182 HPNIIKL--EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP----QVKCYMRQLL 235
H NI L ++ N +YL E ME DL + I+ +P + ++ Q+L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQI-----IRSGQPLTDAHFQSFIYQIL 115
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---NILTSKNKQKLTSRVVTLWY 292
G+++ H ++HRD+K N+LVN + LK+ DFGLA + +N +T V T WY
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+++ +Y ++D+WSVGC+ AELL KP+ KG+ V+QL++I ++ G+P EE
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 353 KSKLP------HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
+ P P+ P+E + P A+DL++ L+ +P KR +
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIF----PNANPLALDLLEKLLAFDPTKR------IS 285
Query: 407 CEYFTTQPYAC---DPSSLP 423
E PY DP P
Sbjct: 286 VEEALEHPYLAIWHDPDDEP 305
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-51
Identities = 83/284 (29%), Positives = 136/284 (47%), Gaps = 36/284 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E +++IG+G++ V+ R + GK+ LK++ N + E+ IL++L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGL--SSCHD-IKFSEPQVKCYMRQLLHGVEHC 241
IK + + +V EY + DL+ + F E Q+ + QL +++
Sbjct: 62 IKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H R I+HRDIK NI + + G++KLGDFG++ +L+S + V T +Y PEL
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYYLSPELCQNK 178
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
YN D+WS+GCV EL K +G +E KI K G P +P
Sbjct: 179 -PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYP-------PIP---- 224
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ Y LR +L+ + L +P +R + + +L
Sbjct: 225 ----SQYSSELR-----------NLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-51
Identities = 86/277 (31%), Positives = 142/277 (51%), Gaps = 34/277 (12%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
+ IG+G + V++ + TG VA+K++ + + E+++ + +EI +L+ L HPNI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
G I + S+++Y++ EY E+ L + F E V Y+ Q+L G+ + H +G++H
Sbjct: 66 GSIET--SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSV 308
RDIKA+NIL +G++KL DFG+A L + + S V T ++ PE++ S + +
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMS-GASTAS 180
Query: 309 DLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368
D+WS+GC ELL G P + L +I + PP LP + P+
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPP--------LP--EGISPE--- 226
Query: 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
KDF + C +P R TA LL
Sbjct: 227 -------LKDF-------LMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 8e-51
Identities = 113/314 (35%), Positives = 172/314 (54%), Gaps = 24/314 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+ + L+++G G Y +V A + TG VA+KK+ + FQ E A RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKH 73
Query: 183 PNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
N+I L V T LS + YLV +M DL L H+ K SE +++ + Q+L G+
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HE-KLSEDRIQFLVYQMLKGL 131
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
++ H GI+HRD+K N+ VN + LK+ DFGLA S+ +T VVT WYR PE++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVI 187
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ +Y +VD+WSVGC+ AE+L GKP+ KG ++QL +I K+ G+P +E+ KL
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF--VQKLQS 245
Query: 359 GDMFKPQNPYEGCLRERCKDF-------TPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
D +N + R R KDF P AV++++ L ++ R TA+ L YF
Sbjct: 246 ED---AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 412 TQPYACDPSSLPKY 425
D + P Y
Sbjct: 303 EFHDPEDETEAPPY 316
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 111/325 (34%), Positives = 170/325 (52%), Gaps = 19/325 (5%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
VP R ++ L +G G Y SV A + + VA+KK+ R RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 179 RLDHPNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
+ H N+I L V T S N +YLV M DL + C K S+ V+ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQL 127
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
L G+++ H GI+HRD+K SN+ VN + L++ DFGLA + ++T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRA 183
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
PE+++ +YN +VD+WSVGC+ AELL GK + G ++QL +I ++ G+P E KK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 355 KLPHGDMFKPQNPY--EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
H + P+ + L++ + P A+DL++ L ++ KR +AS L YF+
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 413 QPYACDPSSLPKYPPKKE-IDAKQR 436
DP P+ P E + K+R
Sbjct: 304 YH---DPEDEPEAEPYDESPENKER 325
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 106/338 (31%), Positives = 176/338 (52%), Gaps = 25/338 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
++ E IG+G+Y V A + TG+ VA+KK+ F++ ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 184 NIIKLEGVI---TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
+I++++ ++ + R IY+VFE ME DL + +D + + ++ QLL +++
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKY 118
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL--TSRVVTLWYRPPELL 298
H + HRD+K NIL N + LK+ DFGLA + + + T V T WYR PEL
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 299 MGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
GS + Y ++D+WS+GC+FAE+L GKP+ G+ V QL I L G+P E + +
Sbjct: 179 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 357 PHGDMF----KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
+ + + P ++ + P A+ L++ L+ +P R TA L
Sbjct: 238 EKARRYLSSMRKKQPVP--FSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL------A 289
Query: 413 QPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMRE 450
PY + + + P + I + + RRR + +RE
Sbjct: 290 DPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRE 327
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 3e-48
Identities = 110/316 (34%), Positives = 169/316 (53%), Gaps = 28/316 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
E + L+++G G Y SV A + TG+ VA+KK+ FQ E A RE+ +L+ + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 183 PNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
N+I L V TS +S YLV YM+ DL + SE +V+ + Q+L G+
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGL 130
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
++ H GI+HRD+K N+ VN + LK+ DFGLA ++T VVT WYR PE++
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVI 186
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ +YN +VD+WSVGC+ AE+L GK + KG+ ++QL +I K+ G P E+ +K
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL---- 242
Query: 359 GDMFKPQNPYEGCLRERCKDFT-------PTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+ ++ + + KDF+ P AVDL++ L ++ KR TA+ L YF
Sbjct: 243 -EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF- 300
Query: 412 TQPYACDPSSLPKYPP 427
+ D + P
Sbjct: 301 -DSFR-DADEETEQQP 314
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-46
Identities = 111/327 (33%), Positives = 161/327 (49%), Gaps = 42/327 (12%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESI---RFMAREI 174
VP R ++ L +G G Y SV A + TG VA+KK+ +P +SI + RE+
Sbjct: 15 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYREL 67
Query: 175 MILRRLDHPNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCY 230
+L+ + H N+I L V T S N +YLV M DL + C K ++ V+
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFL 125
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
+ Q+L G+++ H I+HRD+K SN+ VN + LK+ DFGLA ++T V T
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATR 181
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
WYR PE+++ +YN +VD+WSVGC+ AELL G+ + G ++QL I +L G+P E
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241
Query: 351 WKK----------SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
KK L N + G P AVDL++ L ++ KR T
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGA--------NPLAVDLLEKMLVLDSDKRIT 293
Query: 401 ASSLLMCEYFTTQPYACDPSSLPKYPP 427
A+ L YF DP P P
Sbjct: 294 AAQALAHAYFAQYH---DPDDEPVADP 317
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 5e-46
Identities = 96/276 (34%), Positives = 142/276 (51%), Gaps = 6/276 (2%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
FE L +G+G Y V + R T ++VA+KK + E RE+ +LR L NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
++L+ R +YLVFEY+E ++ L +V+ Y+ QL+ + CH
Sbjct: 63 VELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
I+HRDIK N+L+++ +LKL DFG A L+ + T V T WYR PELL+G+ Y
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YG 179
Query: 306 VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK---KSKLPHGDMF 362
+VD+WSVGC+ EL G+P+ G +E++QL I K+ G P E K + HG F
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
N + R + +DL+ L + P R
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 6e-46
Identities = 89/337 (26%), Positives = 139/337 (41%), Gaps = 40/337 (11%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-NFQPESIRFMAREIMILRRLDHP 183
S+ L K+G+G++ V+ AR+ K+VALK + + + + REI IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 184 -NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVE 239
NI+KL ++YLV EY++ SE + + Q+L +E
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 240 HCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANILT-----SKNKQKLTSRVVTLWYR 293
+ H +GI+HRDIK NIL++ + ++KL DFGLA +L S ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 294 PPELLMGSTN--YNVSVDLWSVGCVFAELLIGKP---ILKGRTEVEQLHKIFKLCGSPPE 348
PE+L+G + + S D+WS+G ELL G P K + Q KI +P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
P + A DL+ L+ +P R ++SS L +
Sbjct: 236 ASPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 409 YFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVR 445
S P + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 93/288 (32%), Positives = 142/288 (49%), Gaps = 38/288 (13%)
Query: 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
++ KIG GT+ V+ A + TG+++A+K++R + P++I+ +A E+ +L L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 187 KLEGVITSRLSNTIYLVFEY-MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
K GV R +Y+ EY L L H E ++ Y QLL G+ + H G
Sbjct: 63 KYYGVEVHR--EKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL----WYRPPELLMGS 301
I+HRDIK +NI +++ G++KLGDFG A L N + V +L Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 302 TN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI-FKLCGSPPEEYWKKSKLPH 358
+ + D+WS+GCV E+ GK +E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA-------------- 221
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
KP P L KDF +D CL +P KR TAS LL
Sbjct: 222 --GHKPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 9e-45
Identities = 102/314 (32%), Positives = 160/314 (50%), Gaps = 38/314 (12%)
Query: 131 KIGQGTYSSVFRAR--EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
K+G+GTY V++A+ + + ALK++ + REI +LR L HPN+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCH--------DIKFSEPQVKCYMRQLLHGVEH 240
+ V S ++L+F+Y EHDL + H ++ VK + Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 241 CHLRGIMHRDIKASNILVNNEGI----LKLGDFGLANILTSKNK--QKLTSRVVTLWYRP 294
H ++HRD+K +NILV EG +K+ D G A + S K L VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLHKIFKLCGS 345
PELL+G+ +Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 346 PPEEYWKK-SKLP-HGDMFKP--QNPYEGC-----LRERCKDFTPTAVDLIDTCLSIEPY 396
P ++ W+ K+P H + K +N Y C + + A L+ L+++P
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 397 KRGTASSLLMCEYF 410
KR T+ + YF
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 91/288 (31%), Positives = 138/288 (47%), Gaps = 40/288 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E+++ +GQG+ V++ R TGK+ ALKK+ D E + + RE+ LR + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHC 241
++K G I +V EYM D L+ K EP + RQ+L G+++
Sbjct: 60 YVVKCYGAFYK--EGEISIVLEYM--DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 242 HL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H R I+HRDIK SN+L+N++G +K+ DFG++ +L + Q T V T+ Y PE + G
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQG 174
Query: 301 STNYNVSVDLWSVGCVFAELLIGK-PILKGRTE--VEQLHKIFKLCGSPPEEYWKKSKLP 357
+Y+ + D+WS+G E +GK P L E + I C PP LP
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPPPS------LP 224
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+F+P D I CL +P KR +A+ LL
Sbjct: 225 AE------------------EFSPEFRDFISACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 89/301 (29%), Positives = 141/301 (46%), Gaps = 61/301 (20%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F+ LEK+G+G+Y SV++A TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI------KFSEPQVKCYMRQLLHG 237
I+K G + +++V EY G S DI +E ++ + Q L G
Sbjct: 59 YIVKYYGSY--FKNTDLWIVMEY-----CGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPE 296
+E+ H +HRDIKA NIL+N EG KL DFG++ LT ++ T V+ T ++ PE
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ YN D+WS+G E+ GKP
Sbjct: 170 VIQEI-GYNNKADIWSLGITAIEMAEGKP------------------------------- 197
Query: 357 PHGD------MFK-PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
P+ D +F P P L + + ++P D + CL +P +R +A LL +
Sbjct: 198 PYSDIHPMRAIFMIPNKPPPT-LSDP-EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 410 F 410
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 8e-44
Identities = 103/297 (34%), Positives = 153/297 (51%), Gaps = 33/297 (11%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHPNIIK-L 188
IG G + V+ + GK VALKK+ F N S + + RE+ +L H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 189 EGVITSRLS--NTIYLVFEYMEHDLAGLSSCHDIKFSEP-----QVKCYMRQLLHGVEHC 241
+ + + IY+V E M+ DL H I S VK ++ Q+L G+++
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDL------HKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H GI+HRDIK N+LVN+ +LK+ DFGLA + + +T VVT +YR PE+LMGS
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS------- 354
+Y +VD+WSVGC+FAELL + + + ++ ++QL I L G+P E + +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239
Query: 355 --KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
+ PH KP P L T AV L+ L +P KR +A+ L Y
Sbjct: 240 ILRGPH----KP--PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 87/289 (30%), Positives = 140/289 (48%), Gaps = 39/289 (13%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E LE IG+G++ +V + R + GK++ K++ + N + + + E+ ILR L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGL-SSCHDIK--FSEPQVKCYMRQLLHGVEHC 241
++ I R + T+Y+V EY E DLA L C + E + + QLL + C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 242 HLRG-----IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
H R ++HRD+K +NI ++ +KLGDFGLA IL + + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPE 180
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
L + Y+ D+WS+GC+ EL P R +++ KI + K ++
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI---------KEGKFRRI 230
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P+ Y L E +I + L+++P KR + LL
Sbjct: 231 PYR--------YSSELNE-----------VIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 83/289 (28%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN---FQPESIRFMAREIMILRRLD 181
+ K E +G G++ SV+ + G A+K+V + E+++ + +EI +L +L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLH 236
HPNI++ G T R + +Y+ E + S + F EP ++ Y RQ+L
Sbjct: 61 HPNIVQYLG--TEREEDNLYIFLELVPG-----GSLAKLLKKYGSFPEPVIRLYTRQILL 113
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
G+E+ H R +HRDIK +NILV+ G++KL DFG+A + + K S + ++ PE
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK--SFKGSPYWMAPE 171
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ Y ++ D+WS+GC E+ GKP V + KI + PP +
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP--------I 223
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P + A D I CL +P R TA+ LL
Sbjct: 224 P-------------------DHLSDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 91/287 (31%), Positives = 142/287 (49%), Gaps = 43/287 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F LE IG+G++ V++A + T ++VA+K + + + E I + +EI L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 184 NIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
I K G S L + ++++ EY G SC D+ K E + +R++L G+
Sbjct: 60 YITKYYG---SFLKGSKLWIIMEYC-----GGGSCLDLLKPGKLDETYIAFILREVLLGL 111
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
E+ H G +HRDIKA+NIL++ EG +KL DFG++ LTS K + V T ++ PE++
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFVGTPFWMAPEVI 170
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
S Y+ D+WS+G EL G+P L + L I K +PP L
Sbjct: 171 KQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPP-------SLE- 219
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G+ F KDF + CL+ +P +R +A LL
Sbjct: 220 GNKFSKP----------FKDF-------VSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 88/308 (28%), Positives = 133/308 (43%), Gaps = 81/308 (26%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMARE-----IMI---- 176
F+ + IG+G++S+V A+E T K A+K + R + +E + I
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--------DKRQLIKEKKVKYVKIEKEV 54
Query: 177 LRRLD-HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIK----FSEPQVKCY 230
L RL+ HP IIKL T + +Y V EY + +L I+ E + Y
Sbjct: 55 LTRLNGHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQY-----IRKYGSLDEKCTRFY 107
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS------------- 277
++L +E+ H +GI+HRD+K NIL++ + +K+ DFG A +L
Sbjct: 108 AAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 278 ------KNKQKLTSRVVTLWYRPPELLM-GSTNYNVSVDLWSVGCVFAELLIGKPILKGR 330
KN+++ S V T Y PELL S DLW++GC+ ++L GKP +G
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK--SSDLWALGCIIYQMLTGKPPFRGS 225
Query: 331 TEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTC 390
E KI KL S P +F P A DLI+
Sbjct: 226 NEYLTFQKILKLEYSFPP-----------------------------NFPPDAKDLIEKL 256
Query: 391 LSIEPYKR 398
L ++P R
Sbjct: 257 LVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 102/314 (32%), Positives = 159/314 (50%), Gaps = 38/314 (12%)
Query: 131 KIGQGTYSSVFRAR--EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
K+G+GTY V++A+ + K ALK++ + REI +LR L HPN+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCH--------DIKFSEPQVKCYMRQLLHGVEH 240
+ V S ++L+F+Y EHDL + H ++ VK + Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 241 CHLRGIMHRDIKASNILVNNEGI----LKLGDFGLANILTSKNK--QKLTSRVVTLWYRP 294
H ++HRD+K +NILV EG +K+ D G A + S K L VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLHKIFKLCGS 345
PELL+G+ +Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 346 PPEEYWKK-SKLP-----HGDMFKPQNPYEGCLR--ERCKDFTPTAVD-LIDTCLSIEPY 396
P ++ W+ K+P D + ++ E+ K + V L+ L+++P
Sbjct: 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 397 KRGTASSLLMCEYF 410
KR T+ L YF
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 38/270 (14%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDHPNIIKLEG 190
+G+G++ V R+ TGK+ A+K ++ + + + E IL R++HP I+KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 191 VITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
+ +YLV EY +L LS +FSE + + Y +++ +E+ H GI++
Sbjct: 61 AFQTEEK--LYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSV 308
RD+K NIL++ +G +KL DFGLA L S + + T Y PE+L+G Y +V
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAV 174
Query: 309 DLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368
D WS+G + E+L GKP E KI K + P
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------DPLRFP----------- 213
Query: 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ +P A DLI L +P KR
Sbjct: 214 --------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 103/342 (30%), Positives = 163/342 (47%), Gaps = 49/342 (14%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
++ L+ IG G V A + TG+ VA+KK+ F N + RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 184 NIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIK--FSEPQVKCYMRQLLHG 237
NII L V T + S +YLV E M+ +L C I+ ++ + Q+L G
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMDLDHERMSYLLYQMLCG 130
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
++H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VVT +YR PE+
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 188
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK---- 353
++G Y +VD+WSVGC+ E++ G + G ++Q +KI + G+P +E+ +
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247
Query: 354 ----------------SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397
+L +F P + L+ A DL+ L I+P K
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARDLLSKMLVIDPEK 301
Query: 398 RGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEA 439
R + L Y Y DPS + PP DE
Sbjct: 302 RISVDDALQHPYI-NVWY--DPSEVEAPPPA--PYDHSIDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 90/295 (30%), Positives = 143/295 (48%), Gaps = 50/295 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDH 182
+F+ +KIG+G +S V++A + G++VALKKV+ F+ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 183 PNIIK-LEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIK--------FSEPQVKCYMR 232
PN+IK L I + N + +V E + DL+ + IK E + Y
Sbjct: 62 PNVIKYLASFIEN---NELNIVLELADAGDLSRM-----IKHFKKQKRLIPERTIWKYFV 113
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
QL +EH H + IMHRDIK +N+ + G++KLGD GL +SK S V T +Y
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYY 172
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE + YN D+WS+GC+ E+ + G + L+ + K
Sbjct: 173 MSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCK----------- 218
Query: 353 KSKLPHGDMFKP--QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
K+ D + P + Y LR DL+ C++ +P KR S +L
Sbjct: 219 --KIEKCD-YPPLPADHYSEELR-----------DLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 90/292 (30%), Positives = 144/292 (49%), Gaps = 43/292 (14%)
Query: 128 KLEKIGQGTYSSVFRAREVATGKMVALKKV--------RFDNFQPESIRFMAREIMILRR 179
K E IG+GTY V+ A V TG+M+A+K+V R D+ Q + ++ + EI L+
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHG 237
LDH NI++ G T+ +I+L EY+ G SC +F E V+ + Q+L G
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIG--SCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL----ANILTSKNKQKLTSRVVTLWYR 293
+ + H +GI+HRD+KA N+LV+ +GI K+ DFG+ +I N Q ++ + W
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD--NDQNMSMQGSVFWMA 178
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
P + S Y+ VD+WS+GCV E+ G+ + + K+ +PP
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP------ 232
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+P + + +P A+D ++ C +I P R TA LL
Sbjct: 233 --IP---------------PDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 76/298 (25%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ +E +E IG G + V+ A + + VA+K++ + Q S+ + +E+ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-KFS-------EPQVKCYMRQLL 235
N++K + ++LV Y+ G S DI K S E + ++++L
Sbjct: 60 NVVKYYTSFVVG--DELWLVMPYLS---GG--SLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL-ANILTSKNKQKLTSRVV--TLWY 292
G+E+ H G +HRDIKA NIL+ +G +K+ DFG+ A++ ++ + + T +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE++ Y+ D+WS G EL G ++ L L PP
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQNDPP----- 225
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
L G +K ++ + +I CL +P KR TA LL ++F
Sbjct: 226 --SLETGADYKK--------------YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 109/332 (32%), Positives = 169/332 (50%), Gaps = 32/332 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
+++L+ IG G V A + G VA+KK+ F N Q + R RE+++L+ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKR-AYRELVLLKCVNHK 80
Query: 184 NIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
NII L V T + S +YLV E M+ A L ++ ++ + Q+L G++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VVT +YR PE+++
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVIL 195
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK--SKLP 357
G Y +VD+WSVGC+ EL+ G I +G ++Q +K+ + G+P E+ + +
Sbjct: 196 G-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 358 HGDMFKPQNP---YEGCL--------RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
+ +PQ P +E ER K T A DL+ L I+P KR + L
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 407 CEYFTTQPYACDPSSLPKYPPKKEIDAKQRDE 438
Y T DP+ PP +I Q +E
Sbjct: 315 HPYITVW---YDPAEAEAPPP--QIYDAQLEE 341
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 86/291 (29%), Positives = 142/291 (48%), Gaps = 42/291 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +E +++IG GTY V++AR++ATG++VA+K ++ + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI------KFSEPQVKCYMRQLLHG 237
NI+ G + + +++V EY G S DI SE Q+ R+ L G
Sbjct: 61 NIVAYFG--SYLRRDKLWIVMEY-----CGGGSLQDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+ + H G +HRDIK +NIL+ +G +KL DFG++ LT K S + T ++ PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWMAPEV 172
Query: 298 LMGSTN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
Y+ D+W++G EL +P + + L I K PP+
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------- 225
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
L+++ K ++P D I CL+ +P KR TA+ LL
Sbjct: 226 ----------------LKDKEK-WSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-36
Identities = 105/334 (31%), Positives = 167/334 (50%), Gaps = 32/334 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLD 181
+ ++ L+ IG G V A + + VA+KK+ F N Q + R RE+++++ ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKR-AYRELVLMKCVN 74
Query: 182 HPNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
H NII L V T + S +YLV E M+ A L ++ ++ + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
++H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VVT +YR PE+
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
++G Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P E+ KK +
Sbjct: 190 ILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 358 HGDMFKPQNPYEGCL-------------RERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
+ + + Y G E K A DL+ L I+P KR +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 405 LMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDE 438
L Y DP+ + PP +I KQ DE
Sbjct: 309 LQHPYINVW---YDPAEVEAPPP--QIYDKQLDE 337
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 44/278 (15%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI--RFMAREIMILRRLDHPNIIKLE 189
I +G Y VF A++ +TG + A+K ++ + ++ + + E IL + P ++KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAGLSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLRGIM 247
+ +YLV EY+ DLA L ++ E + Y+ +++ +E+ H GI+
Sbjct: 60 YSFQGK--KNLYLVMEYLPGGDLASL--LENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 248 HRDIKASNILVNNEGILKLGDFGLA------NILTSKNKQKLTSRVV-TLWYRPPELLMG 300
HRD+K NIL+++ G LKL DFGL+ + + +K R+V T Y PE+++G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
++ +VD WS+GC+ E L+G P G T E I PE
Sbjct: 176 Q-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE------------ 222
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ + A+DLI L +P KR
Sbjct: 223 ---------------DVEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 4e-35
Identities = 104/335 (31%), Positives = 167/335 (49%), Gaps = 40/335 (11%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL--- 188
IG G++ V+ A + T + VA+KKV D P+ + RE++I++ L+H NII L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 189 ---EGVITSRLSNTIYLVFEYME---HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
E + + + +V E++ H + ++ VK Y QL + + H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 243 LRGIMHRDIKASNILVN-NEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMG 300
+ I HRD+K N+L++ N LKL DFG A N+L Q+ S + + +YR PEL++G
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLG 244
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
+TNY +DLWS+GC+ AE+++G PI G++ V+QL +I ++ G+P E+ K+ + D
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304
Query: 361 M----FKPQNPYEGCLRERCKDFTP-TAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
+ KP++ L++ TP A++ I L EP KR L +F
Sbjct: 305 IKFPDVKPKD-----LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359
Query: 416 ACDPSSLPKYPPK--------KEIDAKQRDEARRR 442
C LPKY K + D RR+
Sbjct: 360 PC--IKLPKYIDKLPDLFNFCDAEIKEMSDACRRK 392
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 106/333 (31%), Positives = 164/333 (49%), Gaps = 34/333 (10%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
++ L+ IG G V A + + VA+KK+ F N Q + R RE+++++ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKR-AYRELVLMKCVNHK 83
Query: 184 NIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
NII L V T + S +Y+V E M+ A L ++ ++ + Q+L G++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VVT +YR PE+++
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
G Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P E+ KK + P
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTV 256
Query: 360 DMFKPQNP-YEGCLRERC-------------KDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ P Y G E+ K A DL+ L I+ KR + L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 406 MCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDE 438
Y DPS PPK I KQ DE
Sbjct: 317 QHPYINVW---YDPSEAEAPPPK--IPDKQLDE 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 47/288 (16%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES-------IRFMAREIMILRRLDHPN 184
IG G++ SV+ ++G+++A+K+V + S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I++ G I+L EY+ +A L + + F E V+ ++RQ+L G+ + H
Sbjct: 68 IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGL-----ANILTSKNKQKLTSRVVTLWYRPPELL 298
RGI+HRDIK +NILV+N+G +K+ DFG+ AN L++K S ++++ PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
T+Y D+WS+GC+ E+L GK P QL IFK+
Sbjct: 185 K-QTSYTRKADIWSLGCLVVEMLTGKHPFPD----CTQLQAIFKI--------------- 224
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G+ P+ P + + A+D ++ I+ KR TA+ LL
Sbjct: 225 -GENASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 84/296 (28%), Positives = 126/296 (42%), Gaps = 43/296 (14%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-D 181
FE +E IG+GTY V++AR TG++VA+K + + E I+ E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 182 HPNIIKLEGVITSRLSNT----IYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQ 233
HPNI G + ++LV E DL + E + +R+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
L G+ + H ++HRDIK NIL+ +KL DFG++ L S ++ T + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWM 180
Query: 294 PPELLMGSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
PE++ Y+ D+WS+G EL GKP L + L KI + +PP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPP-- 235
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
L P+N K F D I CL +R LL
Sbjct: 236 ----PTLKS-----PEN--------WSKKF----NDFISECLIKNYEQRPFMEELL 270
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/237 (31%), Positives = 127/237 (53%), Gaps = 22/237 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRF----DNFQPESIRFMAREIMILRRLD 181
+ K +++G G +SS ++AR+V TG ++A+K+V + + Q E + + +EI ++ RL+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHG 237
HP+II++ G +++ E+M AG S H + F E + Y QLL G
Sbjct: 62 HPHIIRMLGATCEDSHFNLFV--EWM----AGGSVSHLLSKYGAFKEAVIINYTEQLLRG 115
Query: 238 VEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSK--NKQKLTSRVV-TLWYR 293
+ + H I+HRD+K +N+L+++ G L++ DFG A L +K + +++ T+ +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC---GSPP 347
PE+L G Y S D+WSVGCV E+ KP L IFK+ +P
Sbjct: 176 APEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 8e-34
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLD 181
E +K+G+G + V++ G+ VA+K ++ + E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSC---HDIKFSEPQVKCYMRQLLHG 237
HPNI++L GV T +Y+V EYM G L H K + + Q+ G
Sbjct: 60 HPNIVRLLGVCTQ--GEPLYIVTEYMPG---GDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--KQKLTSRVVTLWYRPP 295
+E+ + +HRD+ A N LV ++K+ DFGL+ + + +++ ++ W P
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-AP 173
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELL 321
E L + D+WS G + E+
Sbjct: 174 ESLKDGK-FTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 16/205 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKK-VRFDNFQPESIRFMAREIMILRRLDHPN 184
FE L IG+G + V ++ T KM A+K + + S+R + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIKFSEPQVKCYMRQLLHGVE 239
++ L +YLV + + L G LS +KFSE QVK ++ +++ +E
Sbjct: 62 LVNLWYSFQDE--ENMYLVVDLL---LGGDLRYHLS--QKVKFSEEQVKFWICEIVLALE 114
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ H +GI+HRDIK NIL++ +G + + DF +A +T TS T Y PE+L
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMAPEVLC 172
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGK 324
Y+V+VD WS+G E L GK
Sbjct: 173 -RQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 49/279 (17%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRRLDHPN 184
L+ I +G + SV+ A++ +TG A+K ++ + Q +++ R IM+++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIK----FSEPQVKCYMRQLLHGVE 239
+ KL S+ + +YLV EY+ D A L IK E K Y+ +++ GVE
Sbjct: 59 VAKLYYSFQSK--DYLYLVMEYLNGGDCASL-----IKTLGGLPEDWAKQYIAEVVLGVE 111
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H RGI+HRDIK N+L++ G LKL DFGL+ K V T Y PE ++
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETIL 166
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
G + + D WS+GCV E L G P T P+ + +
Sbjct: 167 GVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFD--NILSR 208
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ P+ E C +P AVDLI+ L ++P KR
Sbjct: 209 RINWPEEVKEFC--------SPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 88/306 (28%), Positives = 143/306 (46%), Gaps = 45/306 (14%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD--NFQPESIRFMAREIMILRRLDH- 182
+++LE IG+G Y +V+R + V TG++VALK + D + I+ RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQS 59
Query: 183 --PNIIKLEGVITSRLSNT-IYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
PNI K G S L ++++ EY E + L I E + +R++L +
Sbjct: 60 QPPNITKYYG---SYLKGPRLWIIMEYAEGGSVRTLMKAGPIA--EKYISVIIREVLVAL 114
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
++ H G++HRDIKA+NILV N G +KL DFG+A +L N K ++ V T ++ PE++
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWMAPEVI 173
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y+ D+WS+G E+ G P + L KSK P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP--------KSKPP- 220
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
R ++ + + CL EP +R +A LL ++ ++
Sbjct: 221 --------------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA--HSKT 264
Query: 419 PSSLPK 424
P S+ K
Sbjct: 265 PVSILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 86/283 (30%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES---IRFMAREIMILRRLDHPNIIKL 188
+GQG + V+ +V TG+ +A+K+V FD PE+ + + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHGVEHCHLR 244
G + T+ + EYM G S +K +E + Y RQ+L GVE+ H
Sbjct: 70 YGCLRDDE--TLSIFMEYM----PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGST 302
I+HRDIK +NIL ++ G +KLGDFG + L + + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
Y D+WSVGC E+L KP E E + IFK+ P
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN-------------- 225
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
PQ P +P A + + KR +A LL
Sbjct: 226 -PQLP---------SHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 127 EKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+K+G+G + V++ VA+K ++ D + + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
PNI+KL GV T + +V EYM DL L + S + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL-WYRPPELLM 299
+ +HRD+ A N LV ++K+ DFGL+ L + K+ + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
+ D+WS G + L +IF L P
Sbjct: 178 EGK-FTSKSDVWSFGVL-------------------LWEIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 127 EKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+K+G+G + V++ + VA+K ++ D + + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
PN++KL GV T +Y+V EYME DL L K S + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEY 117
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL-WYRPPELLM 299
+ +HRD+ A N LV ++K+ DFGL+ L + + + + W PE L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLK 176
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
+ D+WS G + L +IF L P
Sbjct: 177 EGK-FTSKSDVWSFGVL-------------------LWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 81/300 (27%), Positives = 124/300 (41%), Gaps = 51/300 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ E L ++G G V + TGK++A+K +R + + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK------FSEPQVKCYMRQLLHG 237
I+ G + + I + EYM S I E + +L G
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYM-----DGGSLDKILKEVQGRIPERILGKIAVAVLKG 112
Query: 238 VEHCH-LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ + H I+HRD+K SNILVN+ G +KL DFG++ L N T V T Y PE
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTF-VGTSSYMAPE 169
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGK----PILKGRTEV-EQLHKIFKLCGSPPEEYW 351
+ G+ Y+V D+WS+G EL G+ P + E L I PP
Sbjct: 170 RIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPPP---- 222
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+LP G F+P D ++ CL +P +R + LL +
Sbjct: 223 ---RLPSG------------------KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 130 EKIGQGTYSSVFRAR---EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+K+G+G + V++ + + VA+K ++ ++ E + +E ++++L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DL--------AGLSSCHDIKFSEPQVKCYMRQLLHG 237
+L GV T +YLV EYME DL S S + + Q+ G
Sbjct: 60 RLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVVTL-WYRPP 295
+E+ + +HRD+ A N LV + ++K+ DFGL+ ++ +K T + + W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAEL 320
E L + D+WS G + E+
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 79/282 (28%), Positives = 117/282 (41%), Gaps = 34/282 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ + +G+G + R +V K+V + R EI+IL L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I NT+ + EY L + F E V Y+ Q++ V + H
Sbjct: 62 IAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
GI+HRDIK NI + G++KLGDFG++ IL S+ + V T +Y PEL G
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVVGTPYYMSPELCQG-VK 177
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363
YN D+W++GCV ELL L + F +P K + + +
Sbjct: 178 YNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYTPV-- 221
Query: 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ Y L L+ + L +P KR TA +L
Sbjct: 222 -VSVYSSELIS-----------LVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 67/220 (30%), Positives = 117/220 (53%), Gaps = 14/220 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPN 184
F+ L+K+G+G+Y SV++ + ++ + ALK+V + Q E + EI IL ++HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPN 60
Query: 185 IIKL-EGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIK---FSEPQVKCYMRQLLHGVE 239
II E + N + +V EY DL+ S K E ++ QLL G++
Sbjct: 61 IISYKEAFL---DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H + I+HRD+K++NIL+ ++K+GD G++ +L K +++ T Y PE+
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWK 174
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
G Y+ D+WS+GC+ E+ P + R+ + +K+
Sbjct: 175 G-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 88/281 (31%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDHP 183
+F +KIG+G +S V+RA + G VALKKV+ FD ++ +EI +L++L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIK----FSEPQVKCYMRQLLHGV 238
N+IK N + +V E + DL+ + H K E V Y QL +
Sbjct: 63 NVIKYYASFIE--DNELNIVLELADAGDLSRMIK-HFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
EH H R +MHRDIK +N+ + G++KLGD GL +SK S V T +Y PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPERI 178
Query: 299 MGSTNYNVSVDLWSVGCVFAEL-LIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
YN D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 179 H-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP---------- 227
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P + Y LR+ L++ C++ +P KR
Sbjct: 228 -----LPSDHYSEELRQ-----------LVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 67/222 (30%), Positives = 116/222 (52%), Gaps = 12/222 (5%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E ++KIG+G++ ++ A+ + + +K++ + +E+++L ++ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
+ + +++V EY + DL ++ + FSE Q+ + Q+ G++H H
Sbjct: 62 VTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 244 RGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R I+HRDIK+ NI ++ G + KLGDFG+A L + T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK-IFKLC 343
YN D+WS+GCV EL LK E LH+ + K+C
Sbjct: 179 -YNNKTDIWSLGCVLYELC----TLKHPFEGNNLHQLVLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 84/283 (29%), Positives = 132/283 (46%), Gaps = 48/283 (16%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPN 184
F+ L ++GQG Y VF A++ TG++VALK+++ F+ +R + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
++KL + + +YL EY+ D L + + SE + YM ++ V+ H
Sbjct: 63 LVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHE 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMGST 302
G +HRD+K N L++ G +KL DFGL+ I+T N S V + Y PE+L G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRG-K 173
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE------YWKKS-K 355
Y+ +VD WS+GC+ E L G P GS P E YWK++ +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPNETWENLKYWKETLQ 218
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P D + + + A DLI ++ +P +R
Sbjct: 219 RPVYD-------------DPRFNLSDEAWDLITKLIN-DPSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRRLDHPNIIK 187
+G G + V + + + ALK V+ + Q E I E IL +HP I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 188 LEGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLR 244
L T + IY++ EY L G + D F E + Y+ ++ E+ H R
Sbjct: 58 L--YRTFKDKKYIYMLMEYC---LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
GI++RD+K N+L+++ G +KL DFG A L K+ QK + T Y PE+++ Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNK-GY 169
Query: 305 NVSVDLWSVGCVFAELLIGKP 325
+ SVD WS+G + ELL G+P
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 84/287 (29%), Positives = 140/287 (48%), Gaps = 47/287 (16%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ + EKIGQG +V+ A +VATG+ VA+K++ QP+ + EI+++R HPNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKHPNI 78
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLS-------SCHDIKFSEPQVKCYMRQLLHGV 238
+ + + + + +++V EY LAG S +C D E Q+ R+ L +
Sbjct: 79 VNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMD----EGQIAAVCRECLQAL 128
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
E H ++HRDIK+ NIL+ +G +KL DFG +T + + K ++ V T ++ PE++
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVV 187
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y VD+WS+G + E++ G+P + L+ I G+P E KL
Sbjct: 188 T-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP--ELQNPEKL-- 241
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ D ++ CL ++ KRG+A LL
Sbjct: 242 ---------------------SAIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 38/248 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMA-REIMILRRL 180
+ FE ++ IG+G + V+ R+ TG++ A+K +R + + + A R+I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA--DA 58
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
D P I+KL + + +YLV EYM DL L D+ F E + Y+ +L+ ++
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALD 115
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-----------------NILTSKNKQK 282
H G +HRDIK NIL++ +G +KL DFGL N+L N
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 283 LT-----------SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT 331
S V T Y PE+L G T Y + D WS+G + E+L G P T
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 332 EVEQLHKI 339
E +KI
Sbjct: 235 LQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 81/304 (26%), Positives = 140/304 (46%), Gaps = 46/304 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ KIG+G+ V A + +TG+ VA+KK+ Q + F E++I+R HP
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHP 76
Query: 184 NIIKLEGVITSRL-SNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI+++ S L + +++V E++E + DI + +E Q+ +L +
Sbjct: 77 NIVEMYS---SYLVGDELWVVMEFLEG-----GALTDIVTHTRMNEEQIATVCLAVLKAL 128
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
H +G++HRDIK+ +IL+ ++G +KL DFG + SK + S V T ++ PE++
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVI 187
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y VD+WS+G + E++ G+P ++ + +I PP K K H
Sbjct: 188 -SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPP-----KLKNLH 239
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
+P +D L +P +R TA+ LL + A
Sbjct: 240 -------------------KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK---AGP 277
Query: 419 PSSL 422
PSS+
Sbjct: 278 PSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 87/285 (30%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKV--RFDNF-QPESIRFMAREIMILRRLDHPNIIKL 188
+G+GTY V+ AR+++T +A+K++ R + QP + EI + L H NI++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-----LHEEIALHSYLKHRNIVQY 70
Query: 189 EGVITSRLSNTIYLVFEYMEH----DLAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
G S N + +F ME L+ L S +K +E + Y +Q+L G+++ H
Sbjct: 71 LG---SDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 243 LRGIMHRDIKASNILVNN-EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL-MG 300
I+HRDIK N+LVN G++K+ DFG + L N T TL Y PE++ G
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAPEVIDKG 184
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
Y D+WS+GC E+ GKP F G P +K
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKP-------------PFIELGEPQAAMFKVG------ 225
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
MFK L K+F I C +P KR +A LL
Sbjct: 226 MFKIHPEIPESLSAEAKNF-------ILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPN 184
F L +IG G++ +V+ AR+V T ++VA+KK+ + Q E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
I+ +G +T +LV EY + + H E ++ L G+ + H
Sbjct: 77 TIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE--LLMGST 302
+HRDIKA NIL+ G +KL DFG A++++ N S V T ++ PE L M
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAMDEG 189
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
Y+ VD+WS+G EL KP L + L+ I + P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPT-------------- 233
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
N + R + +D+CL P R ++ LL +
Sbjct: 234 LSSNDWSDYFR-----------NFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 6/201 (2%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ K++KIG+G++ + GK +K++ P+ +E+ +L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DL-AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
++ + + +Y+V +Y E DL +++ + F E Q+ + Q+ ++H H
Sbjct: 62 VQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
R I+HRDIK+ NI + +G +KLGDFG+A +L S + T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 304 YNVSVDLWSVGCVFAELLIGK 324
YN D+W++GCV E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 83/243 (34%), Positives = 126/243 (51%), Gaps = 23/243 (9%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDHP 183
+F+ +KIG+G +S V+RA + K VALKKV+ F+ ++ + +EI +L++L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 184 NIIK-LEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKC--------YMRQL 234
N+IK L+ I N + +V E D LS IK+ + Q + Y QL
Sbjct: 63 NVIKYLDSFIED---NELNIVLELA--DAGDLSQM--IKYFKKQKRLIPERTVWKYFVQL 115
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
VEH H R +MHRDIK +N+ + G++KLGD GL +SK S V T +Y
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMS 174
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAEL-LIGKPILKGRTEVEQLHKIFKLCGSPP---EEY 350
PE + YN D+WS+GC+ E+ + P + + L + + C PP E Y
Sbjct: 175 PERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 351 WKK 353
+K
Sbjct: 234 SEK 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 84/289 (29%), Positives = 145/289 (50%), Gaps = 47/289 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + + EKIGQG +VF A +VATG+ VA+K++ QP+ + EI++++ L +P
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK-ELIINEILVMKELKNP 76
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS-------SCHDIKFSEPQVKCYMRQLLH 236
NI+ + + + + +++V EY LAG S +C D E Q+ R+ L
Sbjct: 77 NIVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMD----EAQIAAVCRECLQ 126
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+E H ++HRDIK+ N+L+ +G +KL DFG +T + + K ++ V T ++ PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPE 185
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ Y VD+WS+G + E++ G+P + L+ I G+P
Sbjct: 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP---------- 233
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ QNP + +P D ++ CL ++ KRG+A LL
Sbjct: 234 ------ELQNP---------EKLSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 3e-27
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPN 184
F L +IG G++ +V+ AR+V ++VA+KK+ + Q E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
I+ G +T +LV EY + L H E ++ L G+ + H
Sbjct: 77 TIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE--LLMGST 302
++HRD+KA NIL++ G++KLGDFG A+I+ N V T ++ PE L M
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMDEG 189
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y+ VD+WS+G EL KP L + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 75/224 (33%), Positives = 115/224 (51%), Gaps = 17/224 (7%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES---IRFMAREIMILRRLDHPNIIKL 188
+GQG + V+ +V TG+ +A K+V+FD PE+ + + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHGVEHCHLR 244
G + R T+ + EYM G S +K +E + Y RQ+L G+ + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYM----PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGST 302
I+HRDIK +NIL ++ G +KLGDFG + L + R V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE- 184
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
Y D+WS+GC E+L KP E E + IFK+ P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 17/224 (7%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES---IRFMAREIMILRRLDHPNIIKL 188
+GQG + V+ + TG+ +A+K+V+FD PE+ + + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHGVEHCHLR 244
G + + T+ + E+M G S +K +E + Y RQ+L GV + H
Sbjct: 70 YGCLRDPMERTLSIFMEHM----PGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTS--KNKQKLTSRVVTLWYRPPELLMGST 302
I+HRDIK +NIL ++ G +KLGDFG + L + + + S T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE- 184
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
Y D+WSVGC E+L KP E E + IFK+ P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 48/297 (16%)
Query: 128 KLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++++G+G + V R TG+ VA+K + + + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSC---HDIKFSEPQVKCYMRQLLHGVEH 240
NI+K +GV ++ L+ EY+ L H + + ++ + Q+ G+++
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLP--SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLWYR 293
+ +HRD+ A NILV +E ++K+ DFGLA +L K + WY
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WY- 179
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG---SPPEEY 350
PE L S + S D+WS G L+++F SPP E+
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVT-------------------LYELFTYGDPSQSPPAEF 219
Query: 351 WKKSKLPHGDM--FKPQNPYEGCLRERCKDFTPTAV-DLIDTCLSIEPYKRGTASSL 404
+ + G M + + R P V DL+ C EP R + + L
Sbjct: 220 LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 81/289 (28%), Positives = 136/289 (47%), Gaps = 41/289 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+E ++++G GTY V++AR + TG++ A+K ++ + + + +EI +++ H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHC 66
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHGV 238
NI+ G SR +++ EY G S DI SE Q+ R+ L G+
Sbjct: 67 NIVAYFGSYLSR--EKLWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H +G MHRDIK +NIL+ + G +KL DFG+A +T+ K S + T ++ PE+
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA-TIAKRKSFIGTPYWMAPEVA 178
Query: 299 MGSTN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
N YN D+W+VG EL +P + + L + K PP+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK-------- 230
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
L+++ K ++ T + + L+ P KR TA LL
Sbjct: 231 ---------------LKDKTK-WSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 73/233 (31%), Positives = 120/233 (51%), Gaps = 19/233 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E FE +++IG GTY V++AR V TG++ A+K ++ + E + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHS 66
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHGV 238
NI+ G R + +++ E+ G S DI SE Q+ R+ L G+
Sbjct: 67 NIVAYFGSYLRR--DKLWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGL-ANILTSKNKQKLTSRVVTLWYRPPEL 297
+ H +G MHRDIK +NIL+ + G +KL DFG+ A I + K+K S + T ++ PE+
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK--SFIGTPYWMAPEV 177
Query: 298 --LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348
+ YN D+W+VG EL +P + + L + K PP+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 2e-26
Identities = 85/270 (31%), Positives = 142/270 (52%), Gaps = 28/270 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F KLEKIG+G++ VF+ + T K+VA+K + + + E I + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 184 NIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
+ K G S L +T ++++ EY+ G S D+ E Q+ +R++L G+
Sbjct: 63 YVTKYYG---SYLKDTKLWIIMEYL-----GGGSALDLLEPGPLDETQIATILREILKGL 114
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
++ H +HRDIKA+N+L++ G +KL DFG+A LT + K + V T ++ PE++
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVI 173
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
S Y+ D+WS+G EL G+P +E+ + +F + + P
Sbjct: 174 KQSA-YDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPPTL-------E 222
Query: 359 GDMFKPQNPY-EGCLRERCKDFTPTAVDLI 387
G+ KP + E CL + F PTA +L+
Sbjct: 223 GNYSKPLKEFVEACLNKE-PSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 73/217 (33%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPN 184
F L +IG G++ +V+ AR+V T ++VA+KK+ + Q E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
I+ +G +T +LV EY + L H E ++ L G+ + H
Sbjct: 87 SIEYKGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE--LLMGST 302
++HRDIKA NIL+ G +KL DFG A+I + N S V T ++ PE L M
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVILAMDEG 199
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y+ VD+WS+G EL KP L + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 34/216 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD----NFQPESIRFMAREIMILRR 179
+ FE ++ +G G++ V R +GK ALK + Q E + E IL+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL---NEKRILQS 57
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG------LSSCHDIKFSEPQVKCYMRQ 233
+ HP ++ L G + + + +YLV EY + G L +F EP + Y Q
Sbjct: 58 IRHPFLVNLYG--SFQDDSNLYLVMEY----VPGGELFSHLRKSG--RFPEPVARFYAAQ 109
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW-- 291
++ +E+ H I++RD+K N+L++++G +K+ DFG A +++ R TL
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTLCGT 161
Query: 292 --YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
Y PE+++ S Y +VD W++G + E+L G P
Sbjct: 162 PEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 78/285 (27%), Positives = 118/285 (41%), Gaps = 40/285 (14%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
FE L KIG+G++ VF+ A ++ A+K++ E +L +LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 186 IK-LEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
I+ E + + +V EY E H L L E QV + Q+L G+ H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H + I+HRDIK+ N+ ++ +K+GD G+A +L+ T V T +Y PEL
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCED 175
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
YN D+W++G V E GK + + KI + G P P
Sbjct: 176 KP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--GVFP---------PVSQ 223
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
M+ Q LID CL+ + +R LL
Sbjct: 224 MYSQQ-----------------LAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 82/287 (28%), Positives = 143/287 (49%), Gaps = 44/287 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F KLE+IG+G++ VF+ + T ++VA+K + + + E I + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 184 NIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
+ K G S L T ++++ EY+ G S D+ F E Q+ ++++L G+
Sbjct: 63 YVTKYYG---SYLKGTKLWIIMEYL-----GGGSALDLLRAGPFDEFQIATMLKEILKGL 114
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
++ H +HRDIKA+N+L++ +G +KL DFG+A LT ++ T V T ++ PE++
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVI 173
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
S Y+ D+WS+G EL G+P +++ + +F + + P
Sbjct: 174 QQSA-YDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNPPTL-------- 221
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+F+ + ID CL+ +P R TA LL
Sbjct: 222 -----------------TGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 10/219 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDH 182
E F L +IG G++ +V+ A T ++VA+KK+ + Q E + + +E+ L++L H
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PN I+ +G +T +LV EY + L H E ++ L G+ + H
Sbjct: 81 PNTIEYKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE--LLMG 300
++HRDIKA NIL+ G +KL DFG A+ + N S V T ++ PE L M
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----SFVGTPYWMAPEVILAMD 193
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y+ VD+WS+G EL KP L + L+ I
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 82/294 (27%), Positives = 145/294 (49%), Gaps = 47/294 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + + EKIGQG +V+ A +VATG+ VA++++ QP+ + EI+++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNP 77
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS-------SCHDIKFSEPQVKCYMRQLLH 236
NI+ + + + + +++V EY LAG S +C D E Q+ R+ L
Sbjct: 78 NIVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMD----EGQIAAVCRECLQ 127
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+E H ++HRDIK+ NIL+ +G +KL DFG +T + + K ++ V T ++ PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPE 186
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ Y VD+WS+G + E++ G+P + L+ I G+P
Sbjct: 187 VVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP---------- 234
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ QNP + + D ++ CL ++ KRG+A LL ++
Sbjct: 235 ------ELQNP---------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 11/233 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPN 184
F+ +G+G + V RE ATG + A+K ++ E++ F E IL + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I +L+ + +YLV EY DL L + ++ +F E + Y+ +L+ + H
Sbjct: 63 IPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM---- 299
G +HRDIK N+L++ G +KL DFG A LT+ V T Y PE+L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 300 -GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI--FKLCGSPPEE 349
G Y V D WS+G + E++ G+ T + + I F+ PE+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKV---RFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
+G+G + V + ATGKM A KK+ R + E + ++I L ++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 189 EGVITSR--------LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
++ L N L + G F E + Y Q++ G+EH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEH 110
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H R I++RD+K N+L+++ G +++ D GLA + K +K+ R T Y PE+L G
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
Y+ SVD +++GC E++ G+ + R E + ++ + EY P
Sbjct: 169 EV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY------PD-- 219
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
F+P A DL + L +P KR
Sbjct: 220 -----------------KFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 89/310 (28%), Positives = 145/310 (46%), Gaps = 42/310 (13%)
Query: 104 PAWLTAAAGEAVYGLVPMRAESFEKLEK---IGQGTYSSVFRAREVATGKMVALKKVRFD 160
+ ++++ + G P A+S +LE+ IG G +V++ TG++ ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 161 NFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI 220
N + R + REI ILR ++HPN++K + + I ++ E+M D L H
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFM--DGGSLEGTH-- 163
Query: 221 KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280
E + RQ+L G+ + H R I+HRDIK SN+L+N+ +K+ DFG++ IL ++
Sbjct: 164 IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL-AQTM 222
Query: 281 QKLTSRVVTLWYRPPELLMGSTNYNV----SVDLWSVGCVFAELLIGK-PILKGRTEVEQ 335
S V T+ Y PE + N+ + D+WS+G E +G+ P GR + +
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDW 281
Query: 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEP 395
+ +C S P P+ P ++F I CL EP
Sbjct: 282 ASLMCAICMSQP----------------PEAP-----ATASREFR----HFISCCLQREP 316
Query: 396 YKRGTASSLL 405
KR +A LL
Sbjct: 317 AKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 40/291 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F KLE+IG+G++ V++ + T ++VA+K + + + E I + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK---FSEPQVKCYMRQLLHGVEH 240
I + G ++++ EY L G S+ +K E + +R++L G+++
Sbjct: 63 YITRYYGSYLK--GTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDY 116
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H +HRDIKA+N+L++ +G +KL DFG+A LT + K + V T ++ PE++
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQ 175
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
S Y+ D+WS+G EL G+P + L I K SPP + SK
Sbjct: 176 SA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTLEGQYSK----- 227
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
P++ + ++ CL+ +P R TA LL ++ T
Sbjct: 228 ------PFK---------------EFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 73/252 (28%), Positives = 122/252 (48%), Gaps = 23/252 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES---IRFMAREIMILRRLDH 182
+ L +G+G++ + V + + A+K++R P+S + +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK------FSEPQVKCYMRQLLH 236
PNI+ + + +Y+V EY + G IK F E + + Q+
Sbjct: 58 PNIVAFKESFEA--DGHLYIVMEYCD----GGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
GV+H H + ++HRDIK+ NI + G +KLGDFG A +LTS T V T +Y PPE
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPE 170
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP-PEEYWKKSK 355
+ + YN D+WS+GC+ EL K + + + K+ + P P Y + +
Sbjct: 171 -IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 356 LPHGDMFKPQNP 367
MFK +NP
Sbjct: 230 SLIKQMFK-RNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 82/289 (28%), Positives = 144/289 (49%), Gaps = 47/289 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + + EKIGQG +V+ A ++ATG+ VA+K++ QP+ + EI+++R +P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNP 76
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS-------SCHDIKFSEPQVKCYMRQLLH 236
NI+ + + + + +++V EY LAG S +C D E Q+ R+ L
Sbjct: 77 NIVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMD----EGQIAAVCRECLQ 126
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
++ H ++HRDIK+ NIL+ +G +KL DFG +T + + K ++ V T ++ PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPE 185
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ Y VD+WS+G + E++ G+P + L+ I G+P
Sbjct: 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP---------- 233
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ QNP ER + D ++ CL ++ +RG+A LL
Sbjct: 234 ------ELQNP------ER---LSAVFRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 36/231 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-----MAREIMILR 178
+ E+++ +G GT+ V R+ + ALK + PE IR + E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG------LSSCHDIKFSEPQVKCYMR 232
+ HP II+L T +Y++ EY + G L + +FS Y
Sbjct: 57 EVSHPFIIRLFW--TEHDQRFLYMLMEY----VPGGELFSYLRNSG--RFSNSTGLFYAS 108
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW- 291
+++ +E+ H + I++RD+K NIL++ EG +KL DFG A +KL R TL
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCG 160
Query: 292 ---YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y PE++ S +N +VD W++G + E+L+G P KI
Sbjct: 161 TPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 129 LEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
++++G+G + SV R + TG++VA+KK++ E +R REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I+K +GV S + LV EY+ + L H + ++ Y Q+ G+E+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR----VVTLWYRPPELLM 299
+ +HRD+ NILV +E +K+GDFGL +L ++K+ R WY P L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPESL-- 183
Query: 300 GSTNYNVSVDLWSVGCVFAEL 320
+ ++V+ D+WS G V EL
Sbjct: 184 TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+EK+ +G+G + V R A K+V +K++ + + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 186 IKLEGVITSRL-SNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I + L + +V EY LA C+ + E + + Q+L + H
Sbjct: 62 I---EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHV 117
Query: 242 HLRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLM 299
H + I+HRD+K NIL++ ++ ++K+GDFG++ IL+SK+K VV T Y PEL
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCE 174
Query: 300 GSTNYNVSVDLWSVGCVFAELL 321
G YN D+W++GCV EL
Sbjct: 175 GKP-YNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 73/237 (30%), Positives = 115/237 (48%), Gaps = 22/237 (9%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES---IRFMAREIMILRRLDHPNIIKL 188
+G+G + V+ + TG+ +A+K+V FD E+ + + EI +L+ L H I++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHGVEHCHLR 244
G + + + EYM G S +K +E + Y RQ+L GV + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTS--KNKQKLTSRVVTLWYRPPELLMGST 302
I+HRDIK +NIL ++ G +KLGDFG + + + + + S T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE- 184
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y D+WSV C E+L KP E E + IFK+ P K LP G
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQP-----TKPMLPDG 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 62/300 (20%)
Query: 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
E L+++G+G Y SV++ TG +A+K++R + + E+ IL + P I+
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIV 62
Query: 187 KLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGV---- 238
G + +Y+ EYM+ L + E ++ ++ G+
Sbjct: 63 DFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGI-PEDVLRRITYAVVKGLKFLK 119
Query: 239 -EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPE 296
EH I+HRD+K +N+LVN G +KL DFG++ N++ S K + + Y PE
Sbjct: 120 EEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS----YMAPE 171
Query: 297 LLMGST-----NYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEY 350
+ Y V D+WS+G E+ +G+ P PPE Y
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-------------------PPETY 212
Query: 351 ----WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
+ S + GD P P ++ A D + CL+ P +R T + LL
Sbjct: 213 ANIFAQLSAIVDGD--PPTLP---------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 85/303 (28%), Positives = 141/303 (46%), Gaps = 42/303 (13%)
Query: 115 VYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREI 174
++ P ++++E +E IG+GTY VF+ G A+K + + E I E
Sbjct: 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE---AEY 65
Query: 175 MILRRL-DHPNIIKLEGVITSR---LSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQ 226
IL+ L DHPN++K G+ + + ++LV E DL + EP
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286
+ + + L G++H H+ +HRD+K +NIL+ EG +KL DFG++ LTS ++ TS
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 287 VVTLWYRPPELLMGS----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKL 342
V T ++ PE++ + Y+ D+WS+G EL G P L ++ + +FK+
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKI 241
Query: 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402
+PP L +++ +F D I CL+ + KR T S
Sbjct: 242 PRNPP------PTLHQPELWS-------------NEFN----DFIRKCLTKDYEKRPTVS 278
Query: 403 SLL 405
LL
Sbjct: 279 DLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 76/281 (27%), Positives = 135/281 (48%), Gaps = 35/281 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
E KIG+G+ V ARE +G+ VA+K + Q + F E++I+R H N+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
+++ + + ++++ E+++ A + +E Q+ +L + + H +G
Sbjct: 81 VEMYK--SYLVGEELWVLMEFLQGG-ALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 246 IMHRDIKASNILVNNEGILKLGDFGL-ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
++HRDIK+ +IL+ +G +KL DFG A I SK+ K S V T ++ PE++ T Y
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVI-SRTPY 194
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364
VD+WS+G + E++ G+P + V+ + +L SPP + K+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPKLKNAHKI-------- 243
Query: 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+P D ++ L+ EP +R TA LL
Sbjct: 244 ---------------SPVLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+ +E + ++G G + V++A+ TG A K ++ ++ + E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 183 PNIIKLEGVITSRLSNTIYLVF-------EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLL 235
PNI+ L I + F M GL+ EPQ++ RQ+L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLT--------EPQIRYVCRQML 113
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ H ++HRD+KA NIL+ +G +KL DFG++ S QK + + T ++ P
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQKRDTFIGTPYWMAP 172
Query: 296 ELLMGSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
E++ T Y+ D+WS+G EL +P E+ + + K+ S P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +L ++G+G SV + R TG + ALK + D P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQL-------L 235
I+K G S++I + EY E G L S + K + + + L L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYK-KVKKRGGRIGEKVLGKIAESVL 115
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G+ + H R I+HRDIK SNIL+ +G +KL DFG++ L + T T +Y P
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAP 172
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAEL 320
E + G Y+++ D+WS+G E+
Sbjct: 173 ERIQGK-PYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI----RFMAREIMILRRLD 181
+ K E +G+G Y +V+ G+++A+K+V D + + E+ +L+ L
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK----FSEPQVKCYMRQLLHG 237
H NI++ G T NTI + E+ + G S + EP Y +Q+L G
Sbjct: 61 HVNIVQYLG--TCLDDNTISIFMEF----VPGGSISSILNRFGPLPEPVFCKYTKQILDG 114
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWY 292
V + H ++HRDIK +N+++ GI+KL DFG A L + L S T ++
Sbjct: 115 VAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE++ + Y D+WS+GC E+ GKP L +++L +F +
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYI---------- 220
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G L + F+ A+D + +CL+ + ++R +A LL
Sbjct: 221 ------GAHRGLMPR----LPDS---FSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 72/242 (29%), Positives = 121/242 (50%), Gaps = 29/242 (11%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIM----ILR 178
+++E +E IG+GTY V++ G + A+K + + I + EI IL+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQ 73
Query: 179 RL-DHPNIIKLEGVITSR---LSNTIYLVFEY-----MEHDLAGLSSCHDIKFSEPQVKC 229
L +HPN++K G+ + ++LV E + + GL C + E +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISY 132
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT 289
+ L G++H H I+HRD+K +NIL+ EG +KL DFG++ LTS ++ TS V T
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 191
Query: 290 LWYRPPELLMGSTNYNVS----VDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
++ PE++ Y+ S D+WS+G EL G P L ++ + +FK+ +
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPRN 248
Query: 346 PP 347
PP
Sbjct: 249 PP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-22
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREI---MILRRL-----DHP 183
+G+G++ VF A T + A+K ++ D + M ++ M+ +R+ +HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+ L T + ++ V EY+ DL + SCH KF P+ Y +++ G++
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFL 112
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPPELLM 299
H +GI++RD+K NIL++ +G +K+ DFG+ N+L K + T Y PE+L+
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---GDAKTCTFCGTPDYIAPEILL 169
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
G YN SVD WS G + E+LIG+ G E E I
Sbjct: 170 GQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 126 FEKLEKIGQGTYSSVFRAREVA---TGKMVA---LKKVRFDNFQPESIRFMAREIMILRR 179
FE L +G G Y VF R+V GK+ A LKK + ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
P ++ L + ++L+ +Y+ F+E +V+ Y+ +++ ++
Sbjct: 62 RRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H H GI++RDIK NIL+++EG + L DFGL+ ++ +++ S T+ Y PE++
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 300 -GSTNYNVSVDLWSVGCVFAELLIG 323
GS ++ +VD WS+G + ELL G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 126 FEKLEKIGQGTYSSV----FRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
+++ +G+G + V + TG+ VA+K ++ ++ I + +EI ILR L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY 64
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+K +G+ T N I L+ E++ L + K + Q Y Q+ G+++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLAN-ILTSKN----KQKLTSRVVTLWYRPP 295
R +HRD+ A N+LV +E +K+GDFGL I T K K L S V WY P
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-AP 181
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELL 321
E L+ S Y S D+WS G ELL
Sbjct: 182 ECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 81/306 (26%), Positives = 126/306 (41%), Gaps = 54/306 (17%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+R E E + +G G SV + + + TG ++A KKV + + + RE+ I+
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMR---QLLH 236
P I+ G + N I + E+M+ L + K V+ + ++
Sbjct: 61 RSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVE 114
Query: 237 GVEHCH-LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G+ + + + IMHRDIK SNILVN+ G +KL DFG++ L + V T Y P
Sbjct: 115 GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSP 171
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGK------PILKGRTE-----VEQLHKIFKLCG 344
E + G Y V D+WS+G EL +GK I + ++ L +I +
Sbjct: 172 ERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ--- 227
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
PP +LP DF D +D CL +P +R T L
Sbjct: 228 EPP------PRLPSS------------------DFPEDLRDFVDACLLKDPTERPTPQQL 263
Query: 405 LMCEYF 410
F
Sbjct: 264 CAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 36/287 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +E + ++G G + V++A+ TG + A K + + + E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCH 242
I+KL G ++++ E+ D +EPQ++ RQ+L +++ H
Sbjct: 70 YIVKLLGAFY--WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRD+KA N+L+ +G +KL DFG++ K Q+ S + T ++ PE++M T
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 303 ----NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y+ D+WS+G E+ +P E+ + + K+ S P + SK
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLSQPSK--- 240
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
++ D + T L P R +A+ LL
Sbjct: 241 --------------------WSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 130 EKIGQGTYSSVFRARE---VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+++G+G++ +V+ ++ VA ++ LK++ P +E +L +LDHP I+
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 187 KLEGVITSRLSNTIYLVFEYME-HDL-AGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCH 242
K R + I + EY E DL L SE QV + QLL GV + H
Sbjct: 66 KFHASFLERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R I+HRD+KA NI + N +LK+GDFG++ +L T+ T +Y PE L
Sbjct: 124 QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPEAL-KHQ 180
Query: 303 NYNVSVDLWSVGCVFAEL 320
Y+ D+WS+GC+ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
+ +G+G+Y V R GK +KK+ N + +E +L +L HPNI+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK------FSEPQVKCYMRQLLHGVEHCH 242
+Y+V + E G H +K E QV + Q+ +++ H
Sbjct: 65 RESWEGE-DGLLYIVMGFCE----GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+ I+HRD+K N+ + I+K+GD G+A +L ++ T + T +Y PEL +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELF-SNK 177
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
YN D+W++GC E+ K + +++I
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII---------------------- 215
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
EG L KD++P +LI T LS P KR + S+L QPY
Sbjct: 216 ------EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL------RQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 130 EKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+ IG G + V R R GK VA+K ++ + + + F+ E I+ + DHPNII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNII 68
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
+LEGV+T S + ++ EYME+ L +D KF+ Q+ +R + G+++
Sbjct: 69 RLEGVVTK--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPELLMGSTN 303
+HRD+ A NILVN+ + K+ DFGL+ L T ++ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-- 184
Query: 304 YNVSVDLWSVGCVFAELL 321
+ + D+WS G V E++
Sbjct: 185 FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 19/240 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +E + ++G G + V++A+ TG + A K + D E + EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCH 242
NI+KL N ++++ E+ + +EPQ++ +Q L + + H
Sbjct: 63 NIVKLLDAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR---VVTLWYRPPELLM 299
I+HRD+KA NIL +G +KL DFG +++KN + + R + T ++ PE++M
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 300 GSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
T+ Y+ D+WS+G E+ +P E+ + + K+ S P + S+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + KIG+G+ V A E TGK VA+KK+ Q + F E++I+R H
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHE 79
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
N++ + + + + +++V E++E H + +E Q+ +L + + H
Sbjct: 80 NVVDMYN--SYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN 136
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
+G++HRDIK+ +IL+ ++G +KL DFG SK K S V T ++ PE++
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFC-AQVSKEVPKRKSLVGTPYWMAPEVI-SRLP 194
Query: 304 YNVSVDLWSVGCVFAELLIGKP 325
Y VD+WS+G + E++ G+P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 11/201 (5%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKM---VALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
K+EK IG G + V R GK VA+K ++ + + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NII LEGV+T S + +V EYME+ L HD +F+ Q+ +R + G+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR--VVTLWYRPPELLMG 300
G +HRD+ A NILVN+ + K+ DFGL+ +L + T+R + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI-A 182
Query: 301 STNYNVSVDLWSVGCVFAELL 321
+ + D+WS G V E++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
EKIG+G + V++ + VA+K R +F+ +E IL++ DHPNI+KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH-------GVEHCH 242
GV + IY+V E + G S ++ + ++ +++LL G+E+
Sbjct: 59 GVCVQK--QPIYIVMELV----PGGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYLE 110
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLAN-------ILTSKNKQKLTSRVVTLWYRPP 295
+ +HRD+ A N LV +LK+ DFG++ ++ KQ + W P
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-----IPIKWTAPE 165
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAE 319
L G Y D+WS G + E
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 85/331 (25%), Positives = 144/331 (43%), Gaps = 41/331 (12%)
Query: 131 KIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
+IG+G +SV+ AR TG +V ++ +N E ++ + E+++ HPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
V T+ + ++++ +M + A L + SE + + L G+ + H G
Sbjct: 65 WTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 247 MHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLT--------SRVVTLWYRPPEL 297
+HR+IKAS+IL++ +G++ L GL+++ + +N QK S V W P L
Sbjct: 123 IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
YNV D++SVG EL G+ + + L + K PP + P
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITTFP 237
Query: 358 HGD--MFKPQNPYEGCLRERC-------------------KDFTPTAVDLIDTCLSIEPY 396
+ M Q+ + + E K F+P +L++ CL +P
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297
Query: 397 KRGTASSLLMCEYFTTQPYACDPSSLPKYPP 427
KR +ASSLL +F S L PP
Sbjct: 298 KRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 69/255 (27%), Positives = 115/255 (45%), Gaps = 43/255 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDH 182
+ FE ++ IG+G + V ++ TG + A+KK+R + + E + + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
P ++KL + + N +YL+ EY+ D+ L D F+E + + Y+ + + ++
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSI 117
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGL---------------------ANILTSKNK 280
H G +HRDIK N+L++ +G +KL DFGL +N L +K
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 281 QKLTSRVVTLW----------------YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324
+ R W Y PE+ + T YN D WS+G + E+L+G
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGY 236
Query: 325 PILKGRTEVEQLHKI 339
P E KI
Sbjct: 237 PPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRRLDHP 183
F+K++ +G+G VF R TGK+ ALK + + + + ++ + E IL LDHP
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEY-MEHDLAGL-----SSCHDIKFSEPQVKCYMRQLLHG 237
+ L + + LV +Y +L L C SE + Y ++L
Sbjct: 62 FLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKC----LSEEVARFYAAEVLLA 115
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---------------NILTSKNKQK 282
+E+ HL GI++RD+K NIL++ G + L DF L+ +
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 283 LTSRVV-------------TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG 329
+ S T Y PE++ G + +VD W++G + E+L G KG
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 330 RTEVEQLHKIFK 341
E I K
Sbjct: 235 SNRDETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES + K+G G + V+ T K VA+K ++ PE+ +E I+++L H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKKLRHD 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V + IY+V EYM L L S K PQ+ Q+ G+ +
Sbjct: 62 KLVQLYAVCSEE--EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
R +HRD+ A NILV + K+ DFGLA + T++ K + W P
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEA 175
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR------------TEVEQLHKIFKLCG 344
G + + D+WS G + E+ + GR +VE+ +++ +
Sbjct: 176 ANYG--RFTIKSDVWSFGILLTEI-----VTYGRVPYPGMTNREVLEQVERGYRMPRPPN 228
Query: 345 SPPEEY------WKKS 354
P E Y W K
Sbjct: 229 CPEELYDLMLQCWDKD 244
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 34/288 (11%)
Query: 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEG 190
KIG+G+ V A ++GK+VA+KK+ Q + F E++I+R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250
+ + + +++V E++E H + +E Q+ +L + H +G++HRD
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 251 IKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDL 310
IK+ +IL+ ++G +KL DFG + SK + S V T ++ PEL+ Y VD+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELI-SRLPYGPEVDI 199
Query: 311 WSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEG 370
WS+G + E++ G+P Y+ + L M + P +
Sbjct: 200 WSLGIMVIEMVDGEP-----------------------PYFNEPPLKAMKMIRDNLPPK- 235
Query: 371 CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ-PYAC 417
+ +P+ +D L +P +R TA+ LL + P +C
Sbjct: 236 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 52/296 (17%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PN 184
FE +E +G GTY V++ R V TG++ A+K + + E I+ EI +L++ H N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRN 74
Query: 185 IIKLEGVITSRL----SNTIYLVFEYMEHDLAGLSSCHDI-------KFSEPQVKCYMRQ 233
I G + + ++LV E+ G S D+ E + R+
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEF-----CGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+L G+ H H ++HRDIK N+L+ +KL DFG++ L + + + + T ++
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWM 188
Query: 294 PPELLMGSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
PE++ N Y+ D+WS+G E+ G P L ++ + +F + +PP
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPP- 244
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + K ++ +D I+ CL R + LL
Sbjct: 245 -----------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 85/303 (28%), Positives = 126/303 (41%), Gaps = 39/303 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ FEKL ++G G V + +G ++A K + + +P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
I+ G S I + E+M+ G S +K + +L + L
Sbjct: 60 YIVGFYGAFYS--DGEISICMEHMD----GGSLDQVLK----KAGRIPENILGKISIAVL 109
Query: 244 RG---------IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
RG IMHRD+K SNILVN+ G +KL DFG++ L S V T Y
Sbjct: 110 RGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 166
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGK-PI-LKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE L G T+Y V D+WS+G E+ IG+ PI E+E + G E +
Sbjct: 167 PERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 353 KSKLPHGDMFKPQNPYEGCL----------RERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402
S P D +P +E L + F+ D +D CL P +R
Sbjct: 226 VSGHPP-DSPRPMAIFE--LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK 282
Query: 403 SLL 405
L
Sbjct: 283 ELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PN 184
FE +E +G GTY V++ R V TG++ A+K + + E I+ +EI +L++ H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRN 64
Query: 185 IIKLEGVITSR----LSNTIYLVFEYMEHDLAGLSSCHDI-------KFSEPQVKCYMRQ 233
I G + + + ++LV E+ G S D+ E + R+
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEF-----CGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+L G+ H H ++HRDIK N+L+ +KL DFG++ L + + + + T ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWM 178
Query: 294 PPELLMGSTN----YNVSVDLWSVGCVFAELLIGKPIL 327
PE++ N Y+ DLWS+G E+ G P L
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-NFQPESIRFMAREIMILRRLDH 182
+ E +E++G+G Y V + R V TG ++A+K++R N Q + M +I +R +D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS-MRSVDC 59
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVE 239
P + G + +++ E M+ L + E + ++ +E
Sbjct: 60 PYTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 240 HCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H + ++HRD+K SN+L+N G +KL DFG++ L + T Y PE +
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTIDAGCKPYMAPERI 175
Query: 299 MGSTN---YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
N Y+V D+WS+G EL G+ P +T +QL ++ + P
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP------- 226
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+LP F+P D ++ CL +R LL +F
Sbjct: 227 QLPAE------------------KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 17/221 (7%)
Query: 129 LEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPESIRFMAREIM---ILRRLDH 182
L+ +GQG++ VF R++ G++ A+K ++ + +R R M IL ++H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNH 57
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DL-AGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
P I+KL + +YL+ +++ DL LS ++ F+E VK Y+ +L ++H
Sbjct: 58 PFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDH 113
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H GI++RD+K NIL++ EG +KL DFGL+ + +++K S T+ Y PE++
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV-N 171
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
+ S D WS G + E+L G +G+ E + I K
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 8/232 (3%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F +G+G + V + ATGKM A KK+ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++ L ++ + + LV M DL + + + F E + Y ++ G+E
Sbjct: 61 FVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H I++RD+K NIL+++ G +++ D GLA + + + RV T+ Y PE++ +
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
Y S D W +GC+ E++ GK + R E + ++ + EEY +K
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 64/250 (25%), Positives = 113/250 (45%), Gaps = 33/250 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES + ++K+G G + V+ K VA+K ++ PES E I+++L H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHD 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V++ IY+V EYM L L P + Q+ G+ +
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRPPE 296
+HRD++++NILV + + K+ DFGLA ++ T++ K + W P
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 174
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL----IGKPILKGRTEVEQLHKIFKL-C--GSPPEE 349
L G + + D+WS G + EL+ + P + R +EQ+ + +++ C P
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232
Query: 350 Y------WKK 353
+ WKK
Sbjct: 233 HELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 132 IGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRL-DHPNIIK 187
IG+G + V+ R+ TGKM A+K K R Q E++ R ++ L D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 188 LEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
+ + + + + + M DL S H + FSE +++ Y +++ G+EH H R +
Sbjct: 62 MSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 247 MHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV 306
++RD+K +NIL++ G +++ D GLA +K+K + V T Y PE+L Y+
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 175
Query: 307 SVDLWSVGCVFAELLIG 323
S D +S+GC+ +LL G
Sbjct: 176 SADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRR---LDHPNIIK 187
IG+GT+ V++ R+ T ++ A+K + + + + + E IL R + P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 188 LEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
L+ + + + +YLV +YM + +FSE + K Y+ +L+ +EH H I+
Sbjct: 61 LK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
+RD+K NIL++ G + L DFGL+ + NK T T Y PE+L+ Y
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF-CGTTEYLAPEVLLDEKGYTKH 177
Query: 308 VDLWSVGCVFAELLIG 323
VD WS+G + E+ G
Sbjct: 178 VDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 9/210 (4%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRR 179
M+AE F+ ++ IG+G + V R ++ ++ A+K + +F+ + F E I+
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ I++L +Y+V EYM DL L S +DI E + Y +++ +
Sbjct: 100 ANSEWIVQLHYAFQD--DKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAEVVLAL 155
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H G +HRD+K N+L++ G LKL DFG + + + + V T Y PE+L
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 299 M---GSTNYNVSVDLWSVGCVFAELLIGKP 325
G Y D WSVG E+L+G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 70/233 (30%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNF--QPESIRFMAREIMILRR 179
+FE L+ +G G Y VF R+V TGK+ A+K ++ + +++ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 180 L-DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ P ++ L + ++L+ +Y+ FSE +V+ Y +++ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK--LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
EH H GI++RDIK NIL+++EG + L DFGL+ S+ K++ S T+ Y PE++
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKP--ILKGR--TEVEQLHKIFKLCGSPP 347
G + +VD WS+G + ELL G L+G T+ E +I K PP
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRRLD 181
F L +G+G + V A TG++ A+K ++ + ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
HP ++ L + + + V EY DL + H FSEP+ Y ++ G+++
Sbjct: 61 HPFLVNLFACFQT--EDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP----PE 296
H I++RD+K N+L++ EG +K+ DFGL K R T P PE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-----KEGMGFGDRTSTFCGTPEFLAPE 171
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334
+L T+Y +VD W +G + E+L+G+ G E E
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 139 SVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198
V A+ T +VA+KK+ D+ E ++ + +EI+ R+L HPNI+ +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DS 72
Query: 199 TIYLVFEYMEHDLAGLSSCHD-IK------FSEPQVKCYMRQLLHGVEHCHLRGIMHRDI 251
+Y+V M + SC D +K E + ++ +L+ +++ H +G +HR +
Sbjct: 73 ELYVVSPLMAY-----GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 252 KASNILVNNEGILKLGDFGLANILTSKNKQKLT------SRVVTLWYRPPELLMGS-TNY 304
KAS+IL++ +G + L + + K++ S V L + PE+L + Y
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY 187
Query: 305 NVSVDLWSVGCVFAELLIG------KPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP- 357
N D++SVG EL G P + E K+ G+ P KS P
Sbjct: 188 NEKSDIYSVGITACELANGHVPFKDMPATQMLLE--------KVRGTVPC-LLDKSTYPL 238
Query: 358 -HGDMFKPQNPYE-GCLRER-----CKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
M + ++ E R+ + F+ ++ CL +P R +AS LL
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 126 FEKLEKIGQGTYSSV----FRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
+K+ +G+G + V + TG+MVA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHG 237
H NI+K +G + + + L+ EY+ L S D K + Q+ + +Q+ G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP-----LGSLRDYLPKHKLNLAQLLLFAQQICEG 119
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV------TLW 291
+ + H + +HRD+ A N+L++N+ ++K+GDFGLA + + RV W
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 176
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
Y E L + S D+WS G ELL
Sbjct: 177 Y-AVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + E +G G +V++A + T +++A+K + D E + + E+ IL + D P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSP 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
II G + N I + E+M+ G S K E + ++ G+ +
Sbjct: 60 YIIGFYGAFF--VENRISICTEFMD----GGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
I+HRD+K SN+LVN G +KL DFG++ L + + V T Y PE + G
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---KTYVGTNAYMAPERISGE-Q 169
Query: 304 YNVSVDLWSVGCVFAELLIGK 324
Y + D+WS+G F EL +G+
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 132 IGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRL-DHPNIIK 187
IG+G + V+ R+ TGKM A+K K R Q E++ R ++ L D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 188 LEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
+ + + + + + M DL S H + FSE +++ Y +++ G+EH H R +
Sbjct: 62 MTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFV 118
Query: 247 MHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV 306
++RD+K +NIL++ G +++ D GLA +K+K + V T Y PE+L T Y+
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGTAYDS 175
Query: 307 SVDLWSVGCVFAELLIG-KPILKGRTE 332
S D +S+GC+ +LL G P + +T+
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNF--QPESIRFMAREIMILRR 179
+FE L+ +G G Y VF R+V+ +GK+ A+K ++ + ++ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 180 LDH-PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ P ++ L + ++L+ +Y+ +F E +V+ Y +++ +
Sbjct: 61 IRQSPFLVTLHYAFQT--DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
EH H GI++RDIK NIL+++ G + L DFGL+ ++ S T+ Y P+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 299 M-GSTNYNVSVDLWSVGCVFAELLIG 323
G ++ +VD WS+G + ELL G
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 61/232 (26%), Positives = 111/232 (47%), Gaps = 8/232 (3%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F + +G+G + V + ATGKM A KK+ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHC 241
++ L ++ + + LV M H + F E + Y ++ G+E
Sbjct: 61 FVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H I++RD+K NIL+++ G +++ D GLA + Q + RV T+ Y PE++ +
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVK-N 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
Y S D W++GC+ E++ G+ + R + + ++ +L EEY +K
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-18
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRR 179
M+AE ++ ++ IG+G + V R ++ K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ P +++L +Y+V EYM DL L S +D+ E K Y +++ +
Sbjct: 100 ANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFYTAEVVLAL 155
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H G++HRD+K N+L++ G LKL DFG + + + V T Y PE+L
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 299 M---GSTNYNVSVDLWSVGCVFAELLIG 323
G Y D WSVG E+L+G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRL-DHPNIIKLE 189
+G+G++ V A T ++ A+K ++ D Q + + E +L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 190 GVITSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
++ + ++ V EY M H + +F EP+ + Y +++ G++ H
Sbjct: 63 SCFQTK--DRLFFVMEYVNGGDLMFH----IQRSG--RFDEPRARFYAAEIVLGLQFLHE 114
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPPELLMGS 301
RGI++RD+K N+L+++EG +K+ DFG+ IL ++ T Y PE+L
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---GGVTTSTFCGTPDYIAPEILSY- 170
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y +VD W++G + E+L G+ +G E E I
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-18
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRR 179
M+AE +E ++ IG+G + V R +T K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ P +++L + +Y+V EYM DL L S +D+ E + Y +++ +
Sbjct: 100 ANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFYTAEVVLAL 155
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H G +HRD+K N+L++ G LKL DFG + + + + V T Y PE+L
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 299 M---GSTNYNVSVDLWSVGCVFAELLIG 323
G Y D WSVG E+L+G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 37/232 (15%)
Query: 129 LEKIGQGTYSSVFRAREVA---TGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
L+ +G+G Y VF+ R+V TGK M LKK Q ++ A E IL + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKH 59
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY-------MEHDLAGLSSCHDIKFSEPQVKCYMRQLL 235
P I+ L + + +YL+ EY M + G+ F E Y+ ++
Sbjct: 60 PFIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-------FMEDTACFYLSEIS 110
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV------T 289
+EH H +GI++RD+K NIL++ +G +KL DFGL K+ + V T
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC-------KESIHEGTVTHTFCGT 163
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
+ Y PE+LM S + +VD WS+G + ++L G P + + KI K
Sbjct: 164 IEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 59/219 (26%), Positives = 111/219 (50%), Gaps = 26/219 (11%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNF--------QPESIRFMAREIM 175
+ LE +G G + V++ R+ G ++ALK++ N + +SI + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 176 ILR-RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDIK--FSEPQVKCY 230
I++ +L HPNI++ ++ +Y+V + +E G +S + K F+E ++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 231 MRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ---KLTSR 286
Q++ + + H + I+HRD+ +NI++ + + + DFGLA K KQ KLTS
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-----KQKQPESKLTSV 173
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
V T+ Y PE++ Y D+W+ GC+ ++ +P
Sbjct: 174 VGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 125 SFEKLEK-IGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRL 180
S K+E+ IG G + V R R GK VA+K ++ + + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHPNII LEGV+T S + ++ E+ME+ L +D +F+ Q+ +R + G++
Sbjct: 63 DHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-----QKLTSRVVTLWYRP 294
+ +HRD+ A NILVN+ + K+ DFGL+ L L ++ W P
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + + D+WS G V E++
Sbjct: 181 EAI--AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDHPN 184
F K++ IG G + V R+V T + A+K +R D + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
++KL + + + +Y V +Y+ D+ L I F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLA--------------------------NILTS 277
G +HRDIK NIL++ +G +KL DFGL +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 278 KNKQKLT----------------SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
++ +L S V T Y PE+L+ T Y D WSVG + E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 322 IGKPILKGRTEVEQLHKI 339
+G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 83/279 (29%), Positives = 125/279 (44%), Gaps = 53/279 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E L +IG GT V++ R TG ++A+K++R + E+ R + ++L+ D P
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHD-----IKFSEPQ----------VK 228
I+K G + VF ME +S+C D I+ P+ VK
Sbjct: 75 YIVKCYGYFITDSD-----VFICMEL----MSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRV 287
LH ++ H G++HRD+K SNIL++ G +KL DFG++ L SK K + S
Sbjct: 126 A-----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR--SAG 176
Query: 288 VTLWYRPPELLMGST---NYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLC 343
Y PE + Y++ D+WS+G EL G+ P +TE E L KI +
Sbjct: 177 CAA-YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE- 234
Query: 344 GSPPEEYWKKSKLPHGDMFKP--QNPYEGCLRERCKDFT 380
PP LP + F P + + CL KD
Sbjct: 235 -EPP-------SLPPNEGFSPDFCSFVDLCLT---KDHR 262
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 8/232 (3%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F + +G+G + V + ATGKM A K++ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++ L ++ + + LV M DL + + + F E + Y ++L G+E
Sbjct: 61 FVVNLAYAYETK--DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H ++RD+K NIL+++ G +++ D GLA + + + RV T+ Y PE+L +
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
Y +S D W +GC+ E++ G+ +GR E + ++ + E Y K
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES-IRFMAREIMILRRLDHPNIIKLEG 190
IG+G++ V + R+ T ++ ALK +R + S + E +L +++ P I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 191 VITSRLSNTIYLVFEYME-----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
S +YLV ++ H L + +F + + Y +LL +E+ H
Sbjct: 61 SFQSP--EKLYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLHKFN 113
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
+++RD+K NIL++ +G + L DFGL L K+ K + T Y PELL+G Y
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGH-GYT 171
Query: 306 VSVDLWSVGCVFAELLIGKP 325
+VD W++G + E+L G P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 63/244 (25%), Positives = 112/244 (45%), Gaps = 22/244 (9%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
S + L K+G G + V+ T VA+K ++ P+ F+ E I+++L HP
Sbjct: 7 SIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPK 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+I+L V T L IY+V E M++ L L PQ+ Q+ G+ +
Sbjct: 63 LIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+ +HRD+ A N+LV I K+ DFGLA ++ + + + PE +
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YN 179
Query: 303 NYNVSVDLWSVGCVFAELL----IGKPILKGRTEVEQLHKIFKL-C--GSPPEEY----- 350
+++ D+WS G + E++ + P + ++Q+ + +++ C G P E Y
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239
Query: 351 -WKK 353
WK+
Sbjct: 240 CWKE 243
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 51/285 (17%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRL 180
+ FE E +G G++ V A+ TG+ A+K ++ + + ++ +A+E IL L
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH---DIKFSEPQVKCYMRQLLHG 237
HP I+ + + + + N +Y + E++ + G H +F K Y +L+
Sbjct: 76 SHPFIVNM--MCSFQDENRVYFLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLA 130
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW----YR 293
E+ H + I++RD+K N+L++N+G +K+ DFG A +K+ R TL Y
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYL 182
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE++ S + +VD W++G + E + G P T KI L G +
Sbjct: 183 APEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAG--------R 231
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
K P F A DL+ L + KR
Sbjct: 232 LKFP-------------------NWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK------MVALKKVRFDNFQPESIRFMAREI 174
++ ++ ++G+G + VF E + +VA+K ++ + ++ + RE
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLG-ECYHLEPENDKELVAVKTLK-ETASNDARKDFEREA 59
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHD------IKFSEPQV 227
+L H NI+K GV T + +VFEYMEH DL H P
Sbjct: 60 ELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 228 KCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280
+ + QLL G+ + + +HRD+ N LV + ++K+GDFG++ + + +
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 281 QKLT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
++ ++ + + PPE +M + D+WS G V E+
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 46/301 (15%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
AE + L +IG+G + +V + +G ++A+K++R + E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHC 241
P I+K G + ++ E M+ L +++ ++L +
Sbjct: 63 PYIVKFYGALFRE--GDCWICMELMDISLDKFYKYVYEV-----LKSVIPEEILGKIAVA 115
Query: 242 HLRG---------IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
++ I+HRD+K SNIL++ G +KL DFG++ L + T Y
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPY 173
Query: 293 RPPELLMGSTN--YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEE 349
PE + S Y+V D+WS+G E+ GK P K + +QL ++ K G PP
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPP-- 229
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
L + + + F+P+ V+ I+ CL + KR LL +
Sbjct: 230 -----ILSNSEERE---------------FSPSFVNFINLCLIKDESKRPKYKELLEHPF 269
Query: 410 F 410
Sbjct: 270 I 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-17
Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 58/292 (19%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDH 182
+ FE L+ IG+G + V ++ TG + A+K +R D + E + + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++K+ + + +YL+ E++ D+ L D SE + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILT------------------------- 276
H G +HRDIK N+L++ +G +KL DFGL L
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 277 --------SKNKQKLT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPIL 327
KN+++L S V T Y PE+ M T YN D WS+G + E+LIG P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 328 KGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDF 379
T E K+ WK++ +F P+ P + E+ KD
Sbjct: 237 CSETPQETYRKVMN---------WKETL-----VFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 61/248 (24%), Positives = 104/248 (41%), Gaps = 35/248 (14%)
Query: 117 GLVPMRAES--------FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR 168
GL+P + ++ + ++ + G+ VF A + V LK + ++
Sbjct: 51 GLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTTLI 106
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVK 228
E M+L+ ++HP++I+++ + S + V + DL + Q
Sbjct: 107 ----EAMLLQNVNHPSVIRMKDTLVSGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQAL 160
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI-LTSKNKQKLTSRV 287
+Q+L G+ + H + I+HRD+K NI +N+ + +GD G A + + L V
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
T PE+L YN D+WS G V E+L P IF+ S P
Sbjct: 221 ET---NAPEVL-ARDKYNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTP 264
Query: 348 EEYWKKSK 355
EEY K
Sbjct: 265 EEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 75/257 (29%), Positives = 118/257 (45%), Gaps = 34/257 (13%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
++ + FEK+ ++G G VF+ +G ++A K + + +P + RE+ +L
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
+ P I+ G S I + E+M D L P+ Q+L V
Sbjct: 61 NSPYIVGFYGAFYS--DGEISICMEHM--DGGSLDQVLKKAGRIPE------QILGKVSI 110
Query: 241 CHLRG---------IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW 291
++G IMHRD+K SNILVN+ G +KL DFG++ L S V T
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRS 167
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEY 350
Y PE L G T+Y+V D+WS+G E+ IG+ PI + ++L +F G P E
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMF---GCPVEGD 221
Query: 351 WKKSKLPHGDMFKPQNP 367
+S+ +P+ P
Sbjct: 222 PAESETSP----RPRPP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 58/292 (19%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDH 182
E FE L+ IG+G + V ++ TG + A+K +R D + E + + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++K+ +L+ +YL+ E++ D+ L D +E + + Y+ + + ++
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI 117
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILT------------------------- 276
H G +HRDIK N+L++++G +KL DFGL L
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 277 --------SKNKQKLT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPIL 327
+N+++L S V T Y PE+ M T YN D WS+G + E+LIG P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 328 KGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDF 379
T E K+ WK++ + F P+ P + E+ KD
Sbjct: 237 CSETPQETYKKVMN---------WKETLI-----FPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 19/263 (7%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHP 183
F L +G+G++ V A T ++ A+K ++ D Q + + E +L D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 184 NII-KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
+ +L + + +Y V EY+ G + I KF EPQ Y ++ G+
Sbjct: 61 PFLTQLHSCFQT--VDRLYFVMEYVN----GGDLMYHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPE 296
H RGI++RD+K N+++++EG +K+ DFG+ +T+R T Y PE
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-K 355
++ Y SVD W+ G + E+L G+P G E E I + S P+ K++
Sbjct: 172 II-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230
Query: 356 LPHGDMFKPQNPYEGCLRERCKD 378
+ G M K + GC E +D
Sbjct: 231 ICKGLMTKHPSKRLGCGPEGERD 253
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 130 EKIGQGTYSSVFRAREVA-TGKM--VALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+K+G G++ V R GK+ VA+K ++ D F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-------KFSEPQVKCYMRQLLHGVE 239
+L GV+ L++ + +V E LA L S D F + Y Q+ +G+
Sbjct: 60 RLYGVV---LTHPLMMVTE-----LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS---RVVTLWYRPPE 296
+ + +HRD+ A NIL+ ++ +K+GDFGL L +N+ V + PE
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPE 170
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKI 339
L T + S D+W G E+ G+ G + + L KI
Sbjct: 171 SLRTRTFSHAS-DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 34/224 (15%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREI---MILRRL-----DHP 183
+G+G++ V A T + A+K ++ D + ++ M+ RR+ +HP
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKD------VVLEDDDVECTMVERRVLALAWEHP 56
Query: 184 NIIKLEGVITSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
+ L T + ++ V EY M H + S +F E + + Y +++ G
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH----IQSSG--RFDEARARFYAAEIICG 108
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPP 295
++ H +GI++RD+K N+L++ +G +K+ DFG+ N+ K ++ T Y P
Sbjct: 109 LQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---KASTFCGTPDYIAP 165
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
E+L G YN SVD WS G + E+LIG+ G E E I
Sbjct: 166 EILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 22/226 (9%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
E IG+G + +V + TG+ VA+K ++ D + F+ E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD---VTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
GVI L N +Y+V E M +L L + S Q+ + + G+E+ + ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
HRD+ A NILV+ +G+ K+ DFGLA + + S++ W P L ++
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKHK--KFSSK 177
Query: 308 VDLWSVGCVFAELL-IGK---PILKGRTEVEQLHKIFKLCGSPPEE 349
D+WS G + E+ G+ P + + E + K +++ PPE
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES K+GQG + V+ T + VA+K ++ PE+ +E ++++L H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHE 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V++ IY+V EYM L L PQ+ Q+ G+ +
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRVVTLWYRPPELLMG 300
+HRD++A+NILV + K+ DFGLA ++ ++ + ++ W P L G
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 301 STNYNVSVDLWSVGCVFAELL----IGKPILKGRTEVEQLHKIFKLCGSPPE 348
+ + D+WS G + EL + P + R ++Q+ + +++ PPE
Sbjct: 179 --RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 59/219 (26%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E+ + ++K+G G + V+ K VA+K ++ + PE+ F+A E ++++L HP
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMKQLQHP 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V+T IY++ EYME+ + L + IK + ++ Q+ G+
Sbjct: 62 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRPPE 296
+ +HRD++A+NILV+ K+ DFGLA ++ T++ K + W P
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEA 174
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334
+ G+ + + D+WS G + E++ G+ G T E
Sbjct: 175 INYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILR 178
+ LE++G+G + V++ + VA+K ++ +N +P+ + +E ++
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMS 63
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH--------------DLAGLSSCHDIK--F 222
L HPNI+ L GV T ++FEY+ H D+ S +K
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 223 SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282
Q+ G+E+ +HRD+ A N LV +K+ DFGL+ + S + +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 283 LTSR-VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
+ S+ ++ + + PPE ++ + D+WS G V E+
Sbjct: 182 VQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
++ + FE++ ++G G V + + +G ++A K + + +P + RE+ +L
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
+ P I+ G S I + E+M+ G S +K + K ++L V
Sbjct: 61 NSPYIVGFYGAFYS--DGEISICMEHMD----GGSLDQVLK----EAKRIPEEILGKVSI 110
Query: 241 CHLRG---------IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW 291
LRG IMHRD+K SNILVN+ G +KL DFG++ L S V T
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRS 167
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK-PI 326
Y PE L G T+Y+V D+WS+G EL IG+ PI
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-16
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP--- 225
+ EI+ L RL+H NI+K+E ++ R Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 226 -QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284
Q + M+QLL VE+ H + ++HRDIK NI +N +G + LGDFG A + +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
V T+ PE+L G Y D+WS G + ++L
Sbjct: 327 GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 37/247 (14%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
R +E ++KIG G + VF + T + K + + + + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDI--KFSEPQVKCYMRQLLHG 237
H NI++ ++ + +Y++ E+ + DL+ + C+ + K E + RQLLH
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 238 VEHCHL-------RGIMHRDIKASNIL-----------------VNNEGILKLGDFGLAN 273
+ +CH ++HRD+K NI +N I K+GDFGL
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL-- 188
Query: 274 ILTSKN---KQKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKG 329
SKN + S V T +Y PELL+ T +Y+ D+W++GC+ EL GK
Sbjct: 189 ---SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 330 RTEVEQL 336
QL
Sbjct: 246 ANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 132 IGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
IG G + VFR G+ VA+K ++ + + F++ E I+ + H NII+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 189 EGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
EGV+T ++ EYME+ L HD +FS Q+ +R + G+++ +
Sbjct: 72 EGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS---RVVTLWYRPPELLMGSTNY 304
HRD+ A NILVN+ K+ DFGL+ +L + T+ ++ W P + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI--AYRKF 187
Query: 305 NVSVDLWSVGCVFAELL 321
+ D+WS G V E++
Sbjct: 188 TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 55/176 (31%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 172 REIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP--QVKC 229
REI IL+ + H II L + R +T+ +V + DL + D P Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLF---TYVDRSGPLPLEQAIT 189
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRVV 288
R+LL + + H RGI+HRD+K NI ++ LGDFG A L + +
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR---TEVEQLHKIFK 341
TL PELL Y D+WS G V E+ + L G+ + QL I +
Sbjct: 250 TLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 10/219 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F K+G G + V+ + VA+K ++ D+ + +E+ L+RL H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLL--KQQDFQKEVQALKRLRHK 62
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++I L V + +Y++ E ME LA L S + Q+ G+ +
Sbjct: 63 HLISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
+ +HRD+ A NILV + + K+ DFGLA ++ ++ W P G+
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 302 TNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKI 339
++ D+WS G + E+ G+ G E +I
Sbjct: 181 --FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEG 190
K+G G Y V+ VA+K ++ D + E F+ +E +++ + HPN+++L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQLLG 69
Query: 191 VITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYM-RQLLHGVEHCHLRGIM 247
V T Y++ E+M + L L C + + V YM Q+ +E+ + +
Sbjct: 70 VCT--REPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
HRD+ A N LV ++K+ DFGL+ ++T + + PE L + +++
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIK 185
Query: 308 VDLWSVGCVFAEL 320
D+W+ G + E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 68/264 (25%), Positives = 110/264 (41%), Gaps = 52/264 (19%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDH 182
E F ++ IG+G + V ++ TGK+ A+K + + F+ + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
P ++ L + + + +YL+ E++ DL + +D FSE + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLAN---------------------------- 273
H G +HRDIK NIL++ G +KL DFGL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 274 -------ILTSKNKQKLT-----------SRVVTLWYRPPELLMGSTNYNVSVDLWSVGC 315
LT +K ++ S V T Y PE+ + Y D WS+G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA 236
Query: 316 VFAELLIGKPILKGRTEVEQLHKI 339
+ E LIG P E KI
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 51/148 (34%), Positives = 65/148 (43%), Gaps = 4/148 (2%)
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
E +LRRL HP ++ L V + LV DL QV R
Sbjct: 210 EARLLRRLSHPAVLALLDV--RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLW 291
QLL +++ H GI+HRDIK N+LVN + LGDFG A + T+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAE 319
PE+L G Y SVD+WS G V E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 64/293 (21%)
Query: 130 EKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
IG+G + V++ V VA+K + +F+ E I+R+ DHP+
Sbjct: 12 RCIGEGQFGDVYQG--VYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPH 68
Query: 185 IIKLEGVITSRLSNTIYLVFE---------YMEHDLAGLSSCHDIKFSEPQVKCYMRQLL 235
I+KL GVIT N +++V E Y++ + L I + Y QL
Sbjct: 69 IVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLS 117
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ + + +HRDI A N+LV++ +KLGDFGL+ L ++ K + + + + P
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 296 ELLMGSTNY---NVSVDLWSVG-CVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351
E S N+ + D+W G C++ L++G +G + + +I
Sbjct: 178 E----SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-----------E 222
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
+LP P N C PT L+ C + +P KR + L
Sbjct: 223 NGERLP-----MPPN----C--------PPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
E+IG+G + VF R A VA+K R + P+ +E IL++ HPNI++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH-------GVEHCH 242
GV T + IY+V E ++ G ++ P++K +++L+ G+E+
Sbjct: 60 GVCTQK--QPIYIVMELVQ----GGDFLTFLRTEGPRLK--VKELIQMVENAAAGMEYLE 111
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPEL 297
+ +HRD+ A N LV + +LK+ DFG++ + S K ++ W P L
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK---QIPVKWTAPEAL 168
Query: 298 LMGSTNYNVSVDLWSVGCVFAE 319
G Y+ D+WS G + E
Sbjct: 169 NYG--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLDHPNIIKLE 189
IG+G++ V A+ + G A+K ++ + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHR 249
+ + + +Y V +Y+ + F EP+ + Y ++ + + H I++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 250 DIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNVSV 308
D+K NIL++++G + L DFGL ++ TS T Y PE+L Y+ +V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTV 177
Query: 309 DLWSVGCVFAELLIGKPILKGRTEVEQ-----LHKIFKLCGS 345
D W +G V E+L G P R +V Q LHK +L G
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 132 IGQGTYSSVFRAREVATG-------KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
IGQG + VF+AR A G MVA+K ++ + F RE ++ DHPN
Sbjct: 13 IGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDHPN 69
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DL----------AGLSSCHD-----------IKF 222
I+KL GV + + L+FEYM + DL A S H +
Sbjct: 70 IVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 223 SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282
S + C +Q+ G+ + R +HRD+ N LV ++K+ DFGL+ + S + K
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 283 LT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
+ + + + + PPE + Y D+W+ G V E+
Sbjct: 188 ASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 60/187 (32%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 171 AREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCY 230
A E ILR ++HP+II+L+G T T ++ Y L++ +I + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPRYKTDLYCYLAAKRNIAICD--ILAI 187
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
R +L +++ H I+HRDIKA NI +N+ G + LGDFG A N K T+
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAEL------LIGKPILKGRTEVE-QLHKIFKLC 343
PELL Y +VD+WS G V E+ L K L G + + Q+ I +
Sbjct: 248 ATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306
Query: 344 GSPPEEY 350
G+ P E+
Sbjct: 307 GTHPNEF 313
|
Length = 391 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 148 TGKMVALKKVRFDNFQPESIRFMAR---EIMILRRLDHPNIIKL--EGVITSRLSNTIYL 202
TG VA+K +R D PE AR E + RL HPNI+ L G L ++
Sbjct: 2 TGHEVAIKLLRTD--APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFA 56
Query: 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG 262
VFEY+ D + M Q+L + H +GI+HRD+K NI+V+ G
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 263 I---LKLGDFGLANILT---SKNKQKLTSR---VVTLWYRPPELLMGSTNYNVSVDLWSV 313
+ K+ DFG+ +L + LT + T Y PE L G S DL++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAW 175
Query: 314 GCVFAELLIGKPILKGRTEVEQLHK 338
G +F E L G+ +++G + E L++
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + IG+G + V G+ VA+K ++ D+ ++ F+A E ++ L HP
Sbjct: 6 KELKLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHP 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
N+++L GV+ N +Y+V EYM D I + Q + + G+E
Sbjct: 61 NLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGME 116
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ + +HRD+ A N+LV+ + + K+ DFGLA + Q S + + + PE L
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALR 172
Query: 300 GSTNYNVSVDLWSVGCVFAEL 320
S D+WS G + E+
Sbjct: 173 EKKFSTKS-DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 34/234 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRR 179
E FE ++ I G Y +V+ R T + A+KK+ N Q + + F+ R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEP----QVKCYMRQL 234
++P ++ + ++ + +V EY+E D A L +K + Y +
Sbjct: 59 -ENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATL-----LKNIGALPVDMARMYFAET 110
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI----LTS--------KNKQK 282
+ +E+ H GI+HRD+K N+L+ + G +KL DFGL+ I LT+ K+ ++
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 283 LTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334
+ V T Y PE+++ Y VD W++G + E L+G G T E
Sbjct: 171 FLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 71/264 (26%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRF-DNFQPESIRFMAREIMILRRLDHPN 184
F K++ +G G + V AR+V T + A+K +R D + + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
+++L + + +Y V +Y+ D+ L I F E + Y+ +L VE H
Sbjct: 63 VVRLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGL-------------------------------- 271
G +HRDIK NIL++ +G +KL DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 272 -ANILTSKNKQKLTSR-------------VVTLWYRPPELLMGSTNYNVSVDLWSVGCVF 317
AN + L R V T Y PE+L+ T Y D WSVG +
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 318 AELLIGKPILKGRTEVEQLHKIFK 341
E+L+G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 16/226 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES K+GQG + V+ T K VA+K ++ PE+ +E I+++L H
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHD 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++ L V++ IY+V E+M L L PQ+ Q+ G+ +
Sbjct: 62 KLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN-KQKLTSRVVTLWYRPPELLMG 300
+HRD++A+NILV + + K+ DFGLA ++ + ++ W P L G
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 301 STNYNVSVDLWSVGCVFAELL----IGKPILKGRTEVEQLHKIFKL 342
+ + D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR-------FMAREIMILRRLDHPN 184
IG+G++ V A+ A GK A+K + Q ++I MA ++L+ + HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
++ L + + ++ +Y V +Y+ + F EP+ + Y ++ + + H
Sbjct: 58 LVGLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I++RD+K NIL++++G + L DFGL I SK T Y PE+L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG---TPEYLAPEVLR-KQ 171
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y+ +VD W +G V E+L G P R E I
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 132 IGQGTYSSVFRAREVATGKMVALK----KVRFDNFQPESIRFMAREIMILRRLDHPNIIK 187
IG+G++ V A+ GK A+K K+ + + + I MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 188 LEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
L + + + +Y V +++ + F EP+ + Y ++ + + H I+
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
+RD+K NIL++++G + L DFGL +++ T+ T Y PE++ Y+ +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT-TTFCGTPEYLAPEVIRKQP-YDNT 176
Query: 308 VDLWSVGCVFAELLIGKPILKGRTEVEQ----LHK 338
VD W +G V E+L G P R E LHK
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEG 190
+G+GT+ V RE ATG+ A+K +R + + + E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250
+ + + V EY + F+E + + Y +++ +E+ H R +++RD
Sbjct: 63 AFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 251 IKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDL 310
IK N++++ +G +K+ DFGL S + + + T Y PE+L +Y +VD
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLE-DNDYGRAVDW 178
Query: 311 WSVGCVFAELLIGK 324
W +G V E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPN 184
F L +G+G++ V A T ++ A+K ++ D Q + + E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 185 -IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVE 239
+ +L + + +Y V EY+ G + I KF EP Y ++ G+
Sbjct: 62 FLTQLHSCFQT--MDRLYFVMEYVN----GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVV--TLWYRPP 295
H +GI++RD+K N++++ EG +K+ DFG+ NI K T+R T Y P
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGTPDYIAP 170
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
E++ Y SVD W+ G + E+L G+P G E E I
Sbjct: 171 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 10/176 (5%)
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYM 231
E ++ +L HPN+++L GV T + I++V EYM + L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN-ILTSKNKQKLTSRVVTL 290
+ +E+ G +HRD+ A N LV + ++K+ DFGLA +L + ++
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTE---VEQLHKIFKL 342
W PPE+ + ++ D+WS G + E+ GK + + VE + ++L
Sbjct: 167 W-APPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPNIIKLEG 190
+G+G + V + ATGK+ A KK+ + + E IL ++ I+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCH-------DIKFSEPQVKCYMRQLLHGVEHCHL 243
++ + LV M G H + F EP+ Y Q++ G+EH H
Sbjct: 61 AFQTK--TDLCLVMTIMN---GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
R I++RD+K N+L++N+G +++ D GLA L + K T + PELL G
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKGYAGTPGFMAPELLQGE-E 173
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTE 332
Y+ SVD +++G E++ + + R E
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 6/211 (2%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLDHPNIIKLE 189
IG+G++ V AR A K A+K ++ + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHR 249
+ + ++ +Y V +Y+ + F EP+ + Y ++ + + H I++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 250 DIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVD 309
D+K NIL++++G + L DFGL N T T Y PE+L Y+ +VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF-CGTPEYLAPEVLHKQP-YDRTVD 178
Query: 310 LWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
W +G V E+L G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEG 190
+G+GT+ V RE ATGK A+K ++ + + + E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 191 VITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
L F ME+ G LS FSE + + Y +++ + + H
Sbjct: 62 ---YSFQTHDRLCF-VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD 115
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANI-LTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
+++RD+K N++++ +G +K+ DFGL ++ K + T Y PE+L + +Y
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN-DY 172
Query: 305 NVSVDLWSVGCVFAELLIGK 324
+VD W +G V E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
++IG G + V+ + K VA+K +R E E ++ +L HP +++L
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLY 65
Query: 190 GVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
GV T R + I LVFE+MEH L+ KFS+ + + G+ + ++H
Sbjct: 66 GVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSV 308
RD+ A N LV ++K+ DFG+ + T + + PE+ S Y+
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKS 182
Query: 309 DLWSVGC----VFAELLIGKPILKGRTE---VEQLHKIFKL 342
D+WS G VF+E GK + R+ VE ++ F+L
Sbjct: 183 DVWSFGVLMWEVFSE---GKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 8/232 (3%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDHP 183
+F +G+G + V + ATGKM A KK+ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++ L + + LV M DL + + + F E + Y +L G+E
Sbjct: 61 FVVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
I++RD+K NIL+++ G +++ D GLA + + + RV T+ Y PE++ +
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
Y S D W +GC+ E++ G+ + R E + ++ + EEY +K
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR-EIMILRRLDHPNIIKLEG 190
+G+G + V + TGKM A KK+ + +S MA E IL +++ P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCHDIKF----------SEPQVKCYMRQLLHGVEH 240
S+ + LV M + D+K+ +V Y Q+ G+ H
Sbjct: 61 AFESK--THLCLVMSLM--------NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H I++RD+K N+L++++G +L D GLA + K+ + +T R T Y PE+L
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKE 168
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTE 332
Y+ VD +++GC E++ G+ K E
Sbjct: 169 EP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRLDH 182
EK++ +G G + +V++ + G+ V + KV + P++ + + E ++ +DH
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
P++++L G+ LS+ + L+ + M L H + + Q+ G+ +
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPELLM 299
+ ++HRD+ A N+LV +K+ DFGLA +L K+ +V W +L
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 300 GSTNYNVSVDLWSVGCVFAELL 321
Y D+WS G EL+
Sbjct: 186 RI--YTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRL-DHPNIIKLE 189
IG+G+Y+ V R T ++ A+K V+ + E I ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHR 249
+ + ++ V EY+ K E + Y ++ + + H RGI++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 250 DIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNVSV 308
D+K N+L+++EG +KL D+G+ TS T Y PE+L G +Y SV
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSV 177
Query: 309 DLWSVGCVFAELLIGK 324
D W++G + E++ G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 22/235 (9%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
E +G+G + VF+ + VA+K + D Q I+F++ E IL++ DHPNI+KL
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLI 58
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
GV T R IY+V E + D + Q+ + G+ + + +H
Sbjct: 59 GVCTQR--QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 249 RDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
RD+ A N LV +LK+ DFG++ I +S +++ + W P L G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK----WTAPEALNYG--R 170
Query: 304 YNVSVDLWSVGCVFAEL----LIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWK 352
Y+ D+WS G + E + P + + EQ+ K +++ P++ +K
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES + +K+G G + V+ A K VA+K ++ + S+ E +++ L H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKTLQHD 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++KL V+T IY++ E+M L L S K P++ + Q+ G+
Sbjct: 62 KLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRVVTLWYRPPELLMG 300
R +HRD++A+NILV+ + K+ DFGLA ++ ++ + ++ W P + G
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 301 STNYNVSVDLWSVGCVFAELL 321
S + + D+WS G + E++
Sbjct: 179 S--FTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 56/219 (25%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES + ++K+G G + V+ + K VA+K ++ S++ E +++ L H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQHD 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V+T IY++ EYM L L S K P++ + Q+ G+ +
Sbjct: 62 KLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRPPE 296
+ +HRD++A+N+LV+ + K+ DFGLA ++ T++ K + W P
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEA 175
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334
+ GS + + D+WS G + E++ GK G + +
Sbjct: 176 INFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/186 (30%), Positives = 92/186 (49%), Gaps = 19/186 (10%)
Query: 151 MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH- 209
+VA+K +R D + F+ +EI I+ RL +PNII+L GV S + + ++ EYME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 210 DLAGLSSCHDI--KFSE----PQVK----CYMR-QLLHGVEHCHLRGIMHRDIKASNILV 258
DL S +I F+ P V YM Q+ G+++ +HRD+ N LV
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 259 NNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCV 316
N +K+ DFG++ L S + ++ R V W +L+G + + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 317 FAELLI 322
E+
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 8/223 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRRLDH 182
E FE L+ IG+G + V + K+ A+K + +++ + E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY-MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I L N +YLV +Y + DL L S + + E + Y+ +++ ++
Sbjct: 61 QWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM-- 299
H +HRDIK NIL++ G ++L DFG L + + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 300 --GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
G Y D WS+G E+L G+ + VE KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRL-DHPNIIKLE 189
IG+G+Y+ V T ++ A+K ++ + E I ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 190 GVI--TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
SRL + V E++ K E + Y ++ + H RGI+
Sbjct: 63 SCFQTESRL----FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNV 306
+RD+K N+L++ EG +KL D+G+ TS T Y PE+L G +Y
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGE-DYGF 175
Query: 307 SVDLWSVGCVFAELLIGK 324
SVD W++G + E++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 132 IGQGTYSSVFRAR-----EVATGKM-VALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+G G + V+ +G + VA+K +R E F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEP--------QVKCYMRQLL 235
+KL GV L+ Y++ E ME L+ L +F P + + +
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEG-----ILKLGDFGLA-NILTSKNKQKLTSRVVT 289
+E H +HRD+ A N LV+ +G ++K+GDFGLA +I S +K ++
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKI 339
+ + PE L+ + D+WS G + E+L +G+ E L +
Sbjct: 177 VRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 48/194 (24%), Positives = 97/194 (50%), Gaps = 5/194 (2%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEG 190
+G+GT+ V RE A+GK A+K ++ + + + E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250
++ + + V EY+ + FSE + + Y +++ +++ H I++RD
Sbjct: 63 SFQTK--DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 251 IKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDL 310
+K N++++ +G +K+ DFGL + + + + T Y PE+L +Y +VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTFCGTPEYLAPEVLE-DNDYGRAVDW 178
Query: 311 WSVGCVFAELLIGK 324
W +G V E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 69/262 (26%), Positives = 108/262 (41%), Gaps = 52/262 (19%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRF-DNFQPESIRFMAREIMILRRLDHPN 184
F K++ +G G + V A +V T + A+K +R D + + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
++KL + + +Y V +Y+ D+ L ++ F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANIL----TSKNKQKLT--------------- 284
G +HRDIK NIL++ +G +KL DFGL SK QK +
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 285 -------SRVVTLWYR--------------------PPELLMGSTNYNVSVDLWSVGCVF 317
R+ TL R PE+L+ Y D WSVG +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 318 AELLIGKPILKGRTEVEQLHKI 339
E+L+G+P T E K+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 128 KLEKI-GQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
K+E+I G G + + R K VA+ +R + F+A E + L + DH
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHS 66
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI++LEGVIT NT+ +V EYM + L H+ + Q+ + L G+++
Sbjct: 67 NIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFG------LANILTSKNKQKLTSRVVTLWYRPPE 296
G +H+ + A +LVN++ + K+ F I T+ ++ + LW P
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT-----MSGKSPVLWAAPEA 179
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
+ +++ + D+WS G V E++
Sbjct: 180 IQYH--HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++++G G + V + A K VA+K + E F+ E ++ +L HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 189 EGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
GV T + +Y+V E+ME+ L K S+ + + + G+E+ +
Sbjct: 65 YGVCTQQ--KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
HRD+ A N LV++ G++K+ DFG+ + + + + PPE+ S Y+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSK 181
Query: 308 VDLWSVGC----VFAE 319
D+WS G VF E
Sbjct: 182 SDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILR-RLDHPNIIKLE 189
+G+G++ V AR +G++ A+K ++ D Q + + E IL +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 190 GVITSRLSNTIYLVFEYMEH-DLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
+ + ++ V E++ DL + +F E + + Y ++ + H +GI+
Sbjct: 63 CCFQT--PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGII 118
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNV 306
+RD+K N+L+++EG KL DFG+ K TS T Y PE+L Y
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGP 175
Query: 307 SVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
SVD W++G + E+L G + E + I
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 37/212 (17%)
Query: 151 MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH- 209
+VA+K +R D F+ +E+ IL RL PNI +L GV T + ++ EYME+
Sbjct: 48 LVAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENG 104
Query: 210 DL---------AGLSSCHDIKFSEPQVKCYM-RQLLHGVEHCHLRGIMHRDIKASNILVN 259
DL + K YM Q+ G+ + +HRD+ N LV
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 260 NEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCVF 317
+K+ DFG++ L S + ++ R W +L+G + D+W+ G
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVT- 221
Query: 318 AELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
L +I LC P E
Sbjct: 222 ------------------LWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 77/317 (24%), Positives = 132/317 (41%), Gaps = 40/317 (12%)
Query: 127 EKLEKIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
E L IG+G +V AR TG+ V ++++ + E + F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK--FSEPQVKCYMRQLLHGVEHCH 242
I+ + N +++V +M + A C SE + ++ +L +++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---KQKLT------SRVVTLWYR 293
G +HR +KAS+IL++ +G + L GL + L+ N + ++ S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS-------- 345
P L Y+ D++SVG EL G K + L + KL G+
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT 234
Query: 346 --PPEEYWKKSKLPHGD----------MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393
P EE K + +P N E + F+P ++ CL
Sbjct: 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRTFSPHFHHFVEQCLQR 293
Query: 394 EPYKRGTASSLLMCEYF 410
P R +AS+LL +F
Sbjct: 294 NPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPES-IRFMAREIMI 176
++ ++++ +G G + +V++ V G+ V + K+ + P++ + FM E +I
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALI 62
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK--FSEPQVKCYMRQL 234
+ +DHP++++L GV LS TI LV + M H L H+ K + + Q+
Sbjct: 63 MASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCL-LDYVHEHKDNIGSQLLLNWCVQI 118
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ------KLTSRVV 288
G+ + R ++HRD+ A N+LV + +K+ DFGLA +L K+ K+ + +
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 289 TL---WYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--GKP 325
L YR + D+WS G EL+ GKP
Sbjct: 179 ALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 52/214 (24%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFR--AREVATGKM---VALKKVRFDNFQPESIRFMAREIMILR 178
E + ++GQG++ V+ A+ V G+ VA+K V + E I F+ E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMK 64
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSC-----HDIKFSEPQVKCYM 231
+ ++++L GV+ S T +V E M DL L S ++ P ++ ++
Sbjct: 65 EFNCHHVVRLLGVV-STGQPT-LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 232 R---QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRV 287
+ ++ G+ + + +HRD+ A N +V + +K+GDFG+ +I + +K +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + + PE L + D+WS G V E+
Sbjct: 183 LPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 80/303 (26%), Positives = 122/303 (40%), Gaps = 63/303 (20%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL-EG 190
+G G +V A+ V+ G+ A+K V + E+ L D +I+K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 191 VITSRLSN-----TIYLVFEYMEH-DLAGLSSCHDIK--------FSEPQVKCYMRQLLH 236
N I LV +Y DL +IK F E + Q+L
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLR-----QEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV------TL 290
V H H + ++HRDIK++NIL+ + G++KLGDFG SK S V T
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF-----SKMYAATVSDDVGRTFCGTP 209
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+Y PE+ Y+ D++S+G + ELL K G E +HK L G
Sbjct: 210 YYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK--TLAGR----- 261
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL---MC 407
+ P P +P +++ LS +P +R ++S LL +C
Sbjct: 262 -----------YDPLPP----------SISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300
Query: 408 EYF 410
+ F
Sbjct: 301 KLF 303
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREI---MILRRL-----DHP 183
+G+G++ V A G+ A+K ++ D + + ++ M+ +R+ ++P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD------VVLIDDDVECTMVEKRVLALAWENP 56
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
+ L T + ++ V E++ +F + Y +++ G++ H
Sbjct: 57 FLTHL--YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPPELLMGS 301
+GI++RD+K N++++ +G +K+ DFG+ N+ + ++ T Y PE+L G
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNRASTFCGTPDYIAPEILQG- 170
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y SVD WS G + E+LIG+ G E E I
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 8/222 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRRLDH 182
+ FE ++ IG+G + V + T ++ A+K + +++ + E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY-MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I L N +YLV +Y + DL L S + + E + Y+ +++ +
Sbjct: 61 QWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM-- 299
H +HRDIK N+L++ G ++L DFG + + + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 300 --GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
G Y D WS+G E+L G+ + VE KI
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 132 IGQGTYSSVFRAR---EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
+G+G + SV A+ E + + VA+K ++ D F I RE ++ DHPN+IKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 189 EGV-ITSRLSNTI---YLVFEYMEH-DLAG---LSSCHDIKFSEPQVKC--YMRQLLHGV 238
GV + SR + ++ +M+H DL +S + F+ P +M + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--KQKLTSRVVTLWYRPPE 296
E+ + +HRD+ A N ++N + + DFGL+ + S + +Q S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
L Y D+W+ G E++
Sbjct: 187 L--ADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 8/222 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV-RFDNFQPESIRFMAREIMILRRLDH 182
+ FE L+ IG+G + V + TG++ A+K + +++ + E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY-MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I L N +YLV +Y + DL L S + + E + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM-- 299
H G +HRDIK N+L++ G ++L DFG L + + V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 300 --GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
G Y D WS+G E+L G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 55/225 (24%), Positives = 110/225 (48%), Gaps = 28/225 (12%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREI 174
+P+ A F +E++G+ + +++ G ++VA+K ++ D P+ +E
Sbjct: 2 LPLSAVRF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEA 58
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCH-DIKFSEPQ--- 226
++ L HPNI+ L GV+T + ++FEY+ H+ + S H D+ S +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 227 VKCYMR---------QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277
VK + Q+ G+E+ +H+D+ A NIL+ + +K+ D GL+ + S
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 278 KNKQKLTSR-VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ ++ + ++ + + PPE +M ++ D+WS G V E+
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 135 GTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194
G + V + T K+ K ++ NF I M ++M D+PN IKL +T+
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM----KDNPNFIKLYYSVTT 80
Query: 195 RLSNTIYLVFEYM-EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKA 253
L+ +Y+ + DL L + K SE +VK +RQL+ + H I+H DIK
Sbjct: 81 --LKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 254 SNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWS 312
N+L + + + L D+GL I+ + + TL Y PE + G NY+VS D W+
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----GTLDYFSPEKIKGH-NYDVSFDWWA 191
Query: 313 VGCVFAELLIGK-PILKGRTE---VEQLHK 338
VG + ELL GK P + E +E L K
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 10/212 (4%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIR--FMAREIMILRRLDHPNIIKL 188
+G+G++ V A T ++ A+K ++ D Q + + + I+ L HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
+ + ++ V EY+ KF EP+ + Y ++ + H G+++
Sbjct: 62 HCCFQT--KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNVS 307
RD+K NIL++ EG KL DFG+ T+ T Y PE+L Y S
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ-ELEYGPS 176
Query: 308 VDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
VD W++G + E++ G+P + E + I
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 19/262 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPN 184
F L +G+G++ V A T ++ A+K ++ D Q + + E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 185 II-KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVE 239
+ +L + + +Y V EY+ G + I +F EP Y ++ G+
Sbjct: 62 FLTQLHSCFQTM--DRLYFVMEYVN----GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVTLWYRPPEL 297
H +GI++RD+K N+++++EG +K+ DFG+ N+ + T Y PE+
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIAPEI 172
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-KL 356
+ Y SVD W+ G + E+L G+ +G E E I + + P+ K++ +
Sbjct: 173 I-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 231
Query: 357 PHGDMFKPQNPYEGCLRERCKD 378
G M K GC E +D
Sbjct: 232 CKGLMTKHPGKRLGCGPEGERD 253
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 67/295 (22%)
Query: 130 EKIGQGTYSSVFR-------AREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+++G G + SV + +EV VA+K ++ ++ F+ RE ++ +LDH
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEHIAAGKKEFL-REASVMAQLDH 55
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHG 237
P I++L GV + LV E LA L + +K Q+ G
Sbjct: 56 PCIVRLIGVC---KGEPLMLVME-----LAPLGPLLKYLKKRREIPVSDLKELAHQVAMG 107
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---KQKLTSRVVTLWYRP 294
+ + + +HRD+ A N+L+ N K+ DFG++ L + + + R WY P
Sbjct: 108 MAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 295 PELLMGSTNY---NVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
NY + D+WS G E G E + +
Sbjct: 168 E-----CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML----------- 211
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV-DLIDTCLSIEPYKRGTASSL 404
E R + P + ++ +C P R T S L
Sbjct: 212 ------------------ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
E ++ +L H +++L GV T + IY+V EYM + C E +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTEYMS------NGCLLNYLREHGKRFQPS 100
Query: 233 QLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN-ILTSKNKQKLT 284
QLL G+ + + +HRD+ A N LV+++G +K+ DFGL+ +L + +
Sbjct: 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGK 324
S+ W PPE+L+ S ++ D+W+ G + E+ +GK
Sbjct: 161 SKFPVRW-SPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 81/301 (26%), Positives = 125/301 (41%), Gaps = 66/301 (21%)
Query: 132 IGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLE 189
IG+G + V +AR G +M A K + + R A E+ +L +L HPNII L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMR--------QLLH---- 236
G R +YL EY H +L + ++P QLLH
Sbjct: 75 GACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 237 ---GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---NILTSKNKQKLTSRVVTL 290
G+++ + +HRD+ A NILV + K+ DFGL+ + K +L R
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR---- 188
Query: 291 WYRPPELLMGSTNYNV---SVDLWSVGCVFAEL--LIGKPILKGRTEVEQLHKIFKLCGS 345
W + + S NY+V + D+WS G + E+ L G P CG
Sbjct: 189 W-----MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YCGM 227
Query: 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
E ++ KLP G ++ + P C D DL+ C +PY+R + + +L
Sbjct: 228 TCAELYE--KLPQG--YRLEKPLN------CDD---EVYDLMRQCWREKPYERPSFAQIL 274
Query: 406 M 406
+
Sbjct: 275 V 275
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 131 KIGQGTYSSVFRAR----EVATGKM-VALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
++G+G + VF A KM VA+K ++ + RE +L L H +I
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCH--------DIKFSEPQVKCYMRQLLH 236
+K GV + + +VFEYM+H DL H D + + + + + Q+LH
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 237 -------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR-VV 288
G+ + + +HRD+ N LV ++K+GDFG++ + S + ++ ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + PPE +M + D+WS G + E+
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 131 KIGQGTYSSVFRAR-----EVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
++G+G + VF A +VA+K ++ DN + + RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD----FHREAELLTNLQHE 67
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHD-----IKFSEPQVKCYMRQLLH- 236
+I+K GV + + +VFEYM+H DL H + + Q+LH
Sbjct: 68 HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 237 ------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR-VVT 289
G+ + + +HRD+ N LV ++K+GDFG++ + S + ++ ++
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + PPE +M + D+WS+G V E+
Sbjct: 186 IRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 69/270 (25%), Positives = 110/270 (40%), Gaps = 60/270 (22%)
Query: 129 LEKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
+ +G+G + V +A V VA+K ++ D + + ++ E+ +++ + H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKH 75
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH--------------DLAGLSSCHDIKFSEPQVK 228
NII L GV T +Y+V EY H + A E +
Sbjct: 76 KNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP---EETLT 130
Query: 229 CY-----MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283
Q+ G+E + +HRD+ A N+LV + ++K+ DFGLA + + +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 284 TS--RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
T+ R+ W P L Y D+WS G +L L +IF
Sbjct: 191 TTNGRLPVKWMAPEALF--DRVYTHQSDVWSFG-----------VL--------LWEIFT 229
Query: 342 LCGSP-P----EEYWKKSKLPHGDMFKPQN 366
L GSP P EE +K K + M KPQN
Sbjct: 230 LGGSPYPGIPVEELFKLLKEGY-RMEKPQN 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 45/270 (16%)
Query: 132 IGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNI 185
+G G + V A K VA+K ++ E M+ E+ I+ L +H NI
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENI 101
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
+ L G T + I ++ EY + DL L + + + + Q+ G+
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNK-QKLTSRVVTLWYRPPELLMGS 301
+ +HRD+ A N+L+ + I+K+ DFGLA +I+ N K +R+ W P +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP------PEEYWKKSK 355
Y D+WS G IL L +IF L +P +++K K
Sbjct: 220 --YTFESDVWSYG-----------IL--------LWEIFSLGSNPYPGMPVDSKFYKLIK 258
Query: 356 LPH---GDMFKPQNPYEGCLRERCKDFTPT 382
+ P Y+ + + C D P
Sbjct: 259 EGYRMAQPEHAPAEIYD--IMKTCWDADPL 286
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 131 KIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRF-MAREIMILRRLDHPN 184
++G+G + VF A +VA+K ++ + ES R RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQH 68
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCH--DIKFSE------------PQVKC 229
I++ GV T + +VFEYM H DL H D K Q+
Sbjct: 69 IVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR-VV 288
Q+ G+ + +HRD+ N LV ++K+GDFG++ + S + ++ R ++
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + PPE ++ + D+WS G V E+
Sbjct: 187 PIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 50/208 (24%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMI 176
++ F+K++ +G G + +V++ + G+ VA+K++R + P++ + + E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 62
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLL 235
+ +D+P++ +L G+ L++T+ L+ + M L H + + Q+
Sbjct: 63 MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK--QKLTSRVVTLWYR 293
G+ + R ++HRD+ A N+LV +K+ DFGLA +L + K +V W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELL 321
+L Y D+WS G EL+
Sbjct: 180 LESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 151 MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH- 209
+VA+K +R D + F+ +EI I+ RL PNII+L V + S+ + ++ EYME+
Sbjct: 48 LVAVKMLREDANKNARNDFL-KEIKIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENG 104
Query: 210 DLAGLSSCHDIKFSEPQVK---------CYM-RQLLHGVEHCHLRGIMHRDIKASNILVN 259
DL S H+ + + + +M Q+ G+++ +HRD+ N LV
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164
Query: 260 NEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCVF 317
+K+ DFG++ L S + ++ R V W +L+G + + D+W+ G
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTL 222
Query: 318 AELL 321
E+L
Sbjct: 223 WEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLD-HPNIIKLE 189
IG+G+Y+ V R ++ A+K V+ + E I ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 190 GVI--TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
TSRL +LV EY+ K E + Y ++ + H RGI+
Sbjct: 63 SCFQTTSRL----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNV 306
+RD+K N+L++ +G +KL D+G+ TS T Y PE+L G Y
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE-EYGF 175
Query: 307 SVDLWSVGCVFAELLIGK 324
SVD W++G + E++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 47/195 (24%), Positives = 97/195 (49%), Gaps = 6/195 (3%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEG 190
+G+GT+ V +E ATG+ A+K ++ + + + E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 191 VITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHR 249
+ + + + V EY + FSE + + Y +++ +++ H + +++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 250 DIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVD 309
D+K N++++ +G +K+ DFGL K+ + + T Y PE+L +Y +VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLE-DNDYGRAVD 178
Query: 310 LWSVGCVFAELLIGK 324
W +G V E++ G+
Sbjct: 179 WWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 2/122 (1%)
Query: 220 IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279
+ F E +V Q++ ++ H R +MHRD+K++NI + GI+KLGDFG + +
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 280 KQKLTSRVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK 338
+ S T +Y PE L Y+ D+WS+G + ELL KG ++ E + +
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
Query: 339 IF 340
+
Sbjct: 283 VL 284
|
Length = 478 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 128 KLEKI-GQGTYSSVFRAR---EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
KL KI G+G + SV + + + VA+K ++ D I E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 184 NIIKLEGV-ITSRLSNTI---YLVFEYMEH-DLAGL---SSCHDIKFSEPQVKC--YMRQ 233
N++KL GV + I ++ +M+H DL S + P +M
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--KQKLTSRVVTLW 291
+ G+E+ R +HRD+ A N ++ + + + DFGL+ + S + +Q +++ W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE--QLHKIFKLCGSPPEE 349
L Y D+W+ G E+ +G+T + H+I+
Sbjct: 182 IAIESL--ADRVYTSKSDVWAFGVTMWEIAT-----RGQTPYPGVENHEIYDY------- 227
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
L HG+ K P E CL E DL+ +C +P R T + L
Sbjct: 228 ------LRHGNRLK--QP-EDCLDE--------LYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 79/286 (27%), Positives = 116/286 (40%), Gaps = 62/286 (21%)
Query: 132 IGQGTYSSVFRAREVATGK-------MVALKKVRFDNFQPESIRFMAREIMILRRLD-HP 183
+G+G + V RA K VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 184 NIIKLEGVITSRLSNTIYLVFEYM------EHDLAGLSSCHDIKFSEPQ----------- 226
NII L GV T +Y++ EY E A D F +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS- 285
V C Q+ G+E+ R +HRD+ A N+LV + ++K+ DFGLA + + K TS
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 286 -RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG 344
R+ W P L Y D+WS G + E IF L G
Sbjct: 196 GRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWE-------------------IFTLGG 234
Query: 345 S-----PPEEYWKKSKLPHGDMFKPQN-PYE--GCLRERCKDFTPT 382
S P EE +K + H M KP N +E +RE C PT
Sbjct: 235 SPYPGIPVEELFKLLREGH-RMDKPSNCTHELYMLMRE-CWHAVPT 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAR-EVATGKMVALKKVRFDN---FQPESIRFMAREIMI 176
M+ E F + +G G++ V A + VA+K RF+ + + + + E I
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIK--RFEKSKIIKQKQVDHVFSERKI 84
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDIKFSEPQVKC-YMRQ 233
L ++HP + L G + + + +YLV E++ + G + K V C Y Q
Sbjct: 85 LNYINHPFCVNLYG--SFKDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
++ E+ I++RD+K N+L++ +G +K+ DFG A ++ ++ + T Y
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT----YTLCGTPEYI 195
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
PE+L+ + + + D W++G E+L+G P
Sbjct: 196 APEILL-NVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 31/244 (12%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+ + + L+ IG+G + V G VA+K ++ D + F+A E ++ +L
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLA-EASVMTQL 56
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH---- 236
H N+++L GVI +Y+V EYM S D S + LL
Sbjct: 57 RHSNLVQLLGVIVEE-KGGLYIVTEYMAK-----GSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 237 ---GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+E+ +HRD+ A N+LV+ + + K+ DFGL +S T ++ W
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTA 167
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELL-IGK------PILKGRTEVEQLHKIFKLCGSP 346
P L ++ D+WS G + E+ G+ P+ VE+ +K+ G P
Sbjct: 168 PEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225
Query: 347 PEEY 350
P Y
Sbjct: 226 PVVY 229
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 67/302 (22%)
Query: 132 IGQGTYSSV-----FRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+G+G + V FR + A VA+K ++ +N +R + E +L++++HP++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 187 KLEGVITSRLSNTIYLVFEYMEH--------------------DLAGLSSCHDIKFSEP- 225
KL G + + L+ EY ++ D SS D
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 226 ---QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-- 280
+ + Q+ G+++ ++HRD+ A N+LV +K+ DFGL+ + ++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL--LIGKPILKGRTEVEQLHK 338
++ R+ W L Y D+WS G + E+ L G P
Sbjct: 185 KRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP------------- 229
Query: 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
G PE + K + M +P+N E L+ TC EP KR
Sbjct: 230 ---YPGIAPERLFNLLKTGY-RMERPENCSEEMYN------------LMLTCWKQEPDKR 273
Query: 399 GT 400
T
Sbjct: 274 PT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRR 179
E F ++ I +G + V+ R+ K+ A+K V+ + ++ R+ + L +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ-AERDALALSK 62
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK--------FSEPQVKCYM 231
P I+ L + S +N +YLV EY+ + G D+K F E Y+
Sbjct: 63 --SPFIVHLYYSLQS--ANNVYLVMEYL---IGG-----DVKSLLHIYGYFDEEMAVKYI 110
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274
++ +++ H GI+HRD+K N+L++NEG +KL DFGL+ +
Sbjct: 111 SEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 124 ESFEKLEKIGQGTYSSVF----RAREVATGKM-VALKKVRFDNFQPESIRFMAREIMILR 178
+S L +G G + V+ R R+ ++ VA+K + + + F+ E +I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLH- 236
+ +H NI++L GV RL +++ E M DL + + P M+ LL
Sbjct: 65 KFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSS-LTMKDLLFC 121
Query: 237 ------GVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLA-NILTSKNKQKLTSR 286
G ++ +HRDI A N L+ +G + K+ DFG+A +I + +K
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
++ + + PPE + + D+WS G + E+
Sbjct: 182 MLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 67/253 (26%), Positives = 114/253 (45%), Gaps = 38/253 (15%)
Query: 120 PMRAESFEKL---EKIGQGTYSSVFRAREVATGK-------MVALKKVRFDNFQPESIRF 169
P S +KL + +G+G + V A + K VA+K ++ D+ + +
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 66
Query: 170 MAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM------EHDLA----GLSSCH 218
+ E+ +++ + H NII L G T +Y++ EY E+ A G+ +
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 219 DI-KFSEPQ------VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271
DI + + Q V C Q+ G+E+ + +HRD+ A N+LV ++K+ DFGL
Sbjct: 125 DIARVPDEQMTFKDLVSC-TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 183
Query: 272 ANILTSKNKQKLTS--RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILK 328
A + + + K T+ R+ W P L Y D+WS G + E+ +G
Sbjct: 184 ARDVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241
Query: 329 GRTEVEQLHKIFK 341
G VE+L K+ K
Sbjct: 242 G-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 26/193 (13%)
Query: 151 MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH- 209
+VA+K +R D + F+ +E+ IL RL PNII+L GV + + ++ EYME+
Sbjct: 48 LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENG 104
Query: 210 DLAGLSSCHDIKFSE-------PQVKCYM----RQLLH-------GVEHCHLRGIMHRDI 251
DL S H + E P C LLH G+++ +HRD+
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 252 KASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVD 309
N LV +K+ DFG++ L + + ++ R V W +LMG + + D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASD 222
Query: 310 LWSVGCVFAELLI 322
+W+ G E+L+
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI--RFMAREIMILRRLD 181
+ ++ + IG+G V+ A + + VALKK+R D + + RF+ RE I L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLI 60
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYME-----HDLAG------LSSCHDIKFSEPQVKCY 230
HP I+ + + + + +Y Y+E L LS K S
Sbjct: 61 HPGIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
++ +E+ H +G++HRD+K NIL+ G + + D+G A
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 82/305 (26%), Positives = 122/305 (40%), Gaps = 78/305 (25%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
FE + IG+G + V RA G KM A K+ + R A E+ +L +L H
Sbjct: 5 KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY---------------MEHDLA-----GLSSCHDIKF 222
PNII L G +R +Y+ EY +E D A G +S
Sbjct: 63 PNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS----TL 116
Query: 223 SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---NILTSKN 279
+ Q+ + + G+++ + +HRD+ A N+LV K+ DFGL+ + K
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSV---DLWSVGCVFAEL--LIGKPILKGRTEVE 334
+L R W + + S NY+V D+WS G + E+ L G P
Sbjct: 177 MGRLPVR----W-----MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--------- 218
Query: 335 QLHKIFKLCGSPPEEYWKKSKLPHG-DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393
CG E ++ KLP G M KP+N C D +L+ C
Sbjct: 219 -------YCGMTCAELYE--KLPQGYRMEKPRN---------CDD---EVYELMRQCWRD 257
Query: 394 EPYKR 398
PY+R
Sbjct: 258 RPYER 262
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMV---ALKKVRFDNFQPESIRFMAREIM 175
+ +++ +G+G + VF A+ E +V AL+K + +N Q E RE+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELD 60
Query: 176 ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME-HDL--------AGLSSCHDIKFSEPQ 226
+ R+L H N+++L G+ R + Y++ EY + DL + S Q
Sbjct: 61 MFRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286
Q+ G++H +HRD+ A N LV+++ +K+ L+ + + KL +
Sbjct: 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
++ L + PE + +++ D+WS G + E+
Sbjct: 179 LIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 129 LEKIGQGTYSSVFRAREVATG-----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+E++G+ + V++ T + VA+K ++ D + E M+ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL----------AGLSSCHDIK-----FSEPQV 227
NI+ L GV+T + ++F Y H DL + + S D K
Sbjct: 69 NIVCLLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL--TS 285
+ Q+ G+E ++H+D+ N+LV ++ +K+ D GL + + + KL S
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ W P ++ G +++ D+WS G V E+
Sbjct: 187 LLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 131 KIGQGTYSSVFRA--REVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + +V + + + K VA+K ++ DN P + RE ++++LD+P I+++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKF-------SEPQVKCYMRQLLHGVEHC 241
G+ + + LV E LA L + KF +E + + Q+ G+++
Sbjct: 62 IGICEAE---SWMLVME-----LAELGPLN--KFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---KQKLTSRVVTLWYRPPELL 298
+HRD+ A N+L+ + K+ DFGL+ L + K K + WY P
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 299 MGSTNYNVSVDLWSVGCVFAE 319
M ++ D+WS G + E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 31/236 (13%)
Query: 132 IGQGTYSSVFRAREVATGK-------MVALKKVRFDNFQPESIRFMAREIMILRRL-DHP 183
+G+G + V A + K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVSEMEMMKMIGKHK 78
Query: 184 NIIKLEGVITSRLSNTIYLVFEYM------EHDLA----GLSSCHDI-KFSEPQVKCY-- 230
NII L G T +Y++ EY E+ A G+ D K E Q+
Sbjct: 79 NIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 231 ---MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS-- 285
Q+ G+E+ + +HRD+ A N+LV + ++K+ DFGLA + + + K T+
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
R+ W P L Y D+WS G + E+ VE+L K+ K
Sbjct: 197 RLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKF---SEPQVKCYMRQLLHGVE 239
PN++ L I S ++++LV ++ E G H KF E VK + +++ ++
Sbjct: 45 PNMVCLHKYIVSE--DSVFLVLQHAE---GGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
H GI+ RD+ +NIL+++ G ++L F S+ + V Y PE +
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFS----RWSEVEDSCDGEAVENMYCAPE-VG 154
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILK 328
G + + D WS+G + ELL GK +++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 81/298 (27%), Positives = 119/298 (39%), Gaps = 76/298 (25%)
Query: 132 IGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLE 189
IG+G + V +AR G +M A K + + R A E+ +L +L HPNII L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 190 GVITSRLSNTIYLVFEY---------------MEHDLA-----GLSSCHDIKFSEPQVKC 229
G R +YL EY +E D A +S S Q+
Sbjct: 63 GACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS----TLSSQQLLH 116
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---NILTSKNKQKLTSR 286
+ + G+++ + +HRD+ A NILV + K+ DFGL+ + K +L R
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 287 VVTLWYRPPELLMGSTNYNVSV---DLWSVGCVFAEL--LIGKPILKGRTEVEQLHKIFK 341
W + + S NY+V D+WS G + E+ L G P
Sbjct: 177 ----W-----MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------- 211
Query: 342 LCGSPPEEYWKKSKLPHG-DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
CG E ++ KLP G + KP N C D DL+ C +PY+R
Sbjct: 212 YCGMTCAELYE--KLPQGYRLEKPLN---------CDD---EVYDLMRQCWREKPYER 255
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 46/208 (22%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMI 176
++ KL+ +G G + +V + + G VA+K ++ D ++ + + ++
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLA 62
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLL 235
+ LDH I++L G+ ++ LV + L H ++ + Q+
Sbjct: 63 MGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT--LWYR 293
G+ + ++HR++ A NIL+ ++ I+++ DFG+A++L +K+ S T W
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELL 321
+L G Y D+WS G E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 31/236 (13%)
Query: 132 IGQGTYSSVFRAREVATGK-------MVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
+G+G + V A + K VA+K ++ D + + ++ M+ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 185 IIKLEGVITSRLSNTIYLVFEYM------EHDLA----GLSSCH------DIKFSEPQVK 228
II L G T +Y++ EY E+ A G+ C+ + + S +
Sbjct: 86 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--R 286
Q+ G+E+ + +HRD+ A N+LV + ++K+ DFGLA + + K T+ R
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFK 341
+ W P L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 204 LPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 45/207 (21%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMIL 177
++ +K++ +G G + +V++ + G+ V + KV +N P++ + + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLH 236
+ P + +L G+ L++T+ LV + M + L + + + + Q+
Sbjct: 64 AGVGSPYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRP 294
G+ + ++HRD+ A N+LV + +K+ DFGLA +L + +V W
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELL 321
+L + D+WS G EL+
Sbjct: 181 ESIL--HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 170 MAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIKFSE 224
M RE I+ +LD+P I+++ GV + + LV ME G LS D + +
Sbjct: 42 MMREAEIMHQLDNPYIVRMIGVCEAE---ALMLV---MEMASGGPLNKFLSGKKD-EITV 94
Query: 225 PQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---KQ 281
V M Q+ G+++ + +HRD+ A N+L+ N+ K+ DFGL+ L + + K
Sbjct: 95 SNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154
Query: 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--GKPI--LKGRTEV---- 333
+ + WY P + ++ D+WS G E KP +KG EV
Sbjct: 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFI 211
Query: 334 EQLHKIFKLCGSPPEEY 350
EQ ++ PPE Y
Sbjct: 212 EQGKRLDCPAECPPEMY 228
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 134 QGTYSSVFRA--REVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
+GT+ +F + GK V +K V+ D+ + + +E +L L H NI+ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 190 GVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLH-------GVEH 240
V ++++ YM +L L C + + PQ +QL+H G+ +
Sbjct: 75 HVCIE-DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA-LSTQQLVHMAIQIACGMSY 132
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP-----P 295
H RG++H+DI A N +++ E +K+ D L+ L + L RP
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----NRPVKWMAL 188
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAEL 320
E L+ Y+ + D+WS G + EL
Sbjct: 189 ESLVNKE-YSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 31/212 (14%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVA---LKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
++IG G + V E G A +K++R E + F+ +E+ R L+HPN++
Sbjct: 1 DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVL 58
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMR---QLLHGVEHC 241
+ G S LV E+ DL L S + Q R ++ G+
Sbjct: 59 QCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA------NILTSKNKQKLTSRVVTLWYRPP 295
H +H D+ N + + +K+GD+GLA + +K+ V L + P
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC-----HAVPLRWLAP 171
Query: 296 ELLMGSTNYNVSV-------DLWSVGCVFAEL 320
E L+ ++ ++WS+G EL
Sbjct: 172 E-LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 132 IGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
+G+G + SV + + VA+K ++ + E + ++ DHPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 190 GVITSRLSNTIY----LVFEYMEH-DL------AGLSSCHDIKFSEPQVKCYMRQLLHGV 238
GV + + Y ++ +M+H DL + L C ++ VK +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--KQKLTSRVVTLWYRPPE 296
E+ + +HRD+ A N ++N + + DFGL+ + + + +Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 297 LLMGSTNYNVSVDLWSVGCVFAEL 320
L Y D+WS G E+
Sbjct: 186 L--ADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 1/74 (1%)
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTS 285
+K MRQ+L G+ H GI+HRDIK N+LV +G +K+ DFG A ++ T N L
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 286 RVVTLWYRPPELLM 299
+ + P EL+M
Sbjct: 371 MLDPRYSPPEELVM 384
|
Length = 507 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 130 EKIGQGTYSSVFRAREVATGKM---VALKKV-RFDNFQPESIRFMAREIMILRRLDHPNI 185
IG+G + V+ + + A+K + R + E + +E +I++ HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNV 58
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSE--PQVKCYMR---QLLHGVE 239
+ L G I + +V YM+H DL + I+ P VK + Q+ G+E
Sbjct: 59 LSLLG-ICLPSEGSPLVVLPYMKHGDLR-----NFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN----KQKLTSRVVTLWYRPP 295
+ + +HRD+ A N +++ +K+ DFGLA + K +++ W
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELL 321
L + + D+WS G + EL+
Sbjct: 173 SL--QTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 50/213 (23%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFR--AREVATGKM---VALKKVRFDNFQPESIRFMAREIMILR 178
E L ++GQG++ V+ AR++ G+ VA+K V E I F+ E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMK 64
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKC--YMRQLL 235
++++L GV++ +V E M H DL + + +++++
Sbjct: 65 GFTCHHVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 236 H-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRV 287
G+ + + + +HRD+ A N +V ++ +K+GDFG+ +I + +K +
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
+ + + PE L + S D+WS G V E+
Sbjct: 183 LPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK--QKLTSR 286
CY Q+ G+E R +HRD+ A NIL++ ++K+ DFGLA + +K +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ W P + Y + D+WS G + E+
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRV 287
CY Q+ G+E R +HRD+ A NIL++ ++K+ DFGLA +I + + S
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ L + PE + Y D+WS G + E+
Sbjct: 238 LPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 22/127 (17%)
Query: 240 HCHLRGIMHRDIKASNIL----------VNNEGI------LKLGDFGLANILTSKNKQKL 283
H L +MH D+K NIL V N + +++ D G +
Sbjct: 248 HTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC----CDERHSR 302
Query: 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC 343
T+ V T YR PE+++G + S D+WS+GC+ EL GK + +E LH + K
Sbjct: 303 TAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361
Query: 344 GSPPEEY 350
G P E+
Sbjct: 362 GRLPSEW 368
|
Length = 467 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 53/288 (18%), Positives = 107/288 (37%), Gaps = 59/288 (20%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-----PESIRFMA--REIMILRRLDH 182
E +GQGT++++++ + + + + + +A ++ +L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCY---MRQLLHGVE 239
+++KL GV R N + V EY++ L + + + +QL +
Sbjct: 61 KHLVKLYGV-CVRDENIM--VEEYVKF--GPLDVFLHREKNNVSLHWKLDVAKQLASALH 115
Query: 240 HCHLRGIMHRDIKASNILVNNEGI-------LKLGDFGLANILTSKNKQKLTSRVVTLWY 292
+ + ++H ++ NILV G+ +KL D G+ + S+ + RV + +
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-----RVERIPW 170
Query: 293 RPPELL-MGSTNYNVSVDLWSVGCVFAELLIGKPI-LKGRTEVEQLHKIFKLCGSPPEEY 350
PE + G + ++ D WS G E+ L + E+ Y
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-----------Y 219
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ +LP D +LI+ C + +P KR
Sbjct: 220 QDQHRLPMPD-------------------CAELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 63/262 (24%), Positives = 104/262 (39%), Gaps = 48/262 (18%)
Query: 130 EKIGQGTYSSVFRAREVATG---KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
++IG G + V EV +G V +K++R E ++F+ E R L H N++
Sbjct: 1 KEIGNGWFGKVILG-EVNSGYTPAQVVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLL 58
Query: 187 KLEGVITSRLSNTIYLVFEYME-HDLAG-LSSCHDIKFSEPQVKCYMR---QLLHGVEHC 241
+ G T LV E+ DL G L SC + P R ++ G+ H
Sbjct: 59 QCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPELLM 299
H +H D+ N L+ + +K+GD+GL++ K +T V L + PEL+
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 300 GSTNYNVSVD------LWSVGCVFAELL--------------------------IGKPIL 327
+ VD +WS+G EL + KP L
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 328 KGRTEVEQLHKIFKLCGSPPEE 349
K ++ +++ + C PE+
Sbjct: 236 K-LPLSDRWYEVMQFCWLQPEQ 256
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVA---LKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
++IG G + V + E+ T VA +K+++ + E F+ ++ R L HPNI+
Sbjct: 1 QEIGNGWFGKVLLS-EIYTDTGVARVVVKELKANASSKEQNEFL-QQGDPYRILQHPNIL 58
Query: 187 KLEGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMR---QLLHGVEHCH 242
+ G + LVFEY E DL S Q+ R ++ GV H H
Sbjct: 59 QCLGQCVEAIP--YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLA------NILTSKNKQKLTSRVVTLWYRPPE 296
+H D+ N + ++ +K+GD+G+ + + +++ + V L + PE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK-----CVPLRWLAPE 171
Query: 297 LL------MGSTNYNVSVDLWSVGCVFAELL 321
L+ + + ++W++G EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 130 EKIGQGTYSSVFRA--REVATG----KMVALKKV---RFDNFQPESIRFMAREIMILRRL 180
E +GQGT++ +F+ REV K L KV N+ ES F A +M +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYS-ESF-FEAASMM--SQL 56
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH---DLAGLSSCHDIKFS-EPQVKCYMRQLLH 236
H +++ GV + +V EY++ D + + I S + +V +QL
Sbjct: 57 SHKHLVLNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEV---AKQLAW 111
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEG--------ILKLGDFGLANILTSKNKQKLTSRVV 288
+ +G+ H ++ A N+L+ E +KL D G++ +T K+ L R+
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP 169
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG--KPI 326
W PPE + N +++ D WS G E+ G KP+
Sbjct: 170 --WV-PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 40/147 (27%), Positives = 60/147 (40%), Gaps = 34/147 (23%)
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK---QKLTS 285
Y Q+ G+E R +HRD+ A NIL++ ++K+ DFGLA + K+ +K +
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDA 235
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
R+ W P + Y D+WS G + E IF L S
Sbjct: 236 RLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWE-------------------IFSLGAS 274
Query: 346 P------PEEYWKKSKLPHGD-MFKPQ 365
P EE+ +L G M P+
Sbjct: 275 PYPGVQIDEEFC--RRLKEGTRMRAPE 299
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 49/175 (28%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNK-QKLTSRVVTL 290
Q+ G++ + +HRD+ A N+L+ + + K+ DFGLA +I+ N K +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
W P + Y V D+WS G IL L +IF L SP
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYG-----------IL--------LWEIFSLGKSPYPGI 318
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLI-DTCLSIEPYKRGTASSL 404
SK M K G + DF P + I C ++EP +R T S +
Sbjct: 319 LVNSKFY--KMVK-----RG-YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 10/119 (8%)
Query: 216 SCHDIKFSEPQVKCYMR------QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269
+ D +E YM Q+ +G+E + +HRD+ A N+L+ ++K+ DF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283
Query: 270 GLA-NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL--LIGKP 325
GLA +I+ N S + L + PE + + Y D+WS G + E+ L G P
Sbjct: 284 GLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/215 (22%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-------VALKKVRFDNFQPESIRFMAREIMI 176
E ++GQG++ V+ +A G + VA+K V E I F+ E +
Sbjct: 6 EKITMSRELGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASV 62
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCH-DIKFSEPQVKCYMRQ 233
++ + ++++L GV++ ++ E M DL L S +++ + Q +++
Sbjct: 63 MKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 234 LLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTS 285
++ G+ + + +HRD+ A N +V + +K+GDFG+ +I + +K
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
++ + + PE L + D+WS G V E+
Sbjct: 181 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVV 288
+ Q+ G+E + +HRD+ A N+L+ I+K+ DFGLA +I+ N S +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + PE + + Y D+WS G + E+
Sbjct: 302 PVKWMAPESIFDNL-YTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 167 IRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIK 221
I EI LRR+D NI+K+ G I + + L +E+ G L D+
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI-LEYCTRGYLREVLDKEKDLS 120
Query: 222 FSEPQVKCYMR-QLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279
F + K M G+ + + ++++ + + LV LK+ GL IL+S
Sbjct: 121 F---KTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177
Query: 280 KQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGK 324
+ V + Y ++L + Y + D++S+G V E+ GK
Sbjct: 178 FK----NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 51/205 (24%), Positives = 80/205 (39%), Gaps = 62/205 (30%)
Query: 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP------ESIRFMAREIMIL----RRLD 181
I Q V RA + +G+ VA+K V+ + + +R +AR I L RRLD
Sbjct: 138 IAQ-----VHRAV-LKSGEEVAVK-VQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLD 190
Query: 182 HPNIIK-------------LEGVITSRL------SNTIY-------------LVFEYME- 208
++ E R +Y L E+++
Sbjct: 191 LVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDG 250
Query: 209 ---HDLAGL-SSCHDIKF-SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263
D+A L S+ D K +E V+ ++RQLL G H D NILV ++G
Sbjct: 251 IKISDIAALKSAGIDRKELAELLVRAFLRQLLRD-------GFFHADPHPGNILVRSDGR 303
Query: 264 LKLGDFGLANILTSKNKQKLTSRVV 288
+ L DFG+ L K ++ L ++
Sbjct: 304 IVLLDFGIVGRLDPKFRRYLAELLL 328
|
Length = 517 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNK-QKLTSRVVTL 290
Q+ G+ + +HRD+ A NIL+ + I K+ DFGLA +I N K +R+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
W P + + Y D+WS G + E+
Sbjct: 282 WMAPESIF--NCVYTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 30/146 (20%), Positives = 61/146 (41%), Gaps = 14/146 (9%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++ + G + V+ V ++ + + + RE+ IL+ L + +
Sbjct: 3 IKLLKGGLTNRVYLLGT-KDEDYV----LKINPSREKGADR-EREVAILQLL-ARKGLPV 55
Query: 189 EGVI-TSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246
V+ + YL+ E++E L +S +E Q+ + +L H + L +
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAE-QLAELLAKL-HQLP---LLVL 110
Query: 247 MHRDIKASNILVNNEGILKLGDFGLA 272
H D+ NILV++ IL + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 49/185 (26%)
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGI-------LKLGDFGLANILTSKNKQKLT 284
+QL + + + ++H ++ A NIL+ G+ +KL D G++ S+ +
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE---- 179
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343
RV + + PE + G + + + D WS G E+ G+ LK RT
Sbjct: 180 -RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT------------ 226
Query: 344 GSPPEE---YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
P E+ Y KK +LP +P CK+ LI CL+ EP +R +
Sbjct: 227 --PSEKERFYEKKHRLP-----EPS----------CKELA----TLISQCLTYEPTQRPS 265
Query: 401 ASSLL 405
++L
Sbjct: 266 FRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 52/235 (22%)
Query: 176 ILRRLDHPNIIKLEGVITSRLSNTIYLVF-EYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
++R++ H +I+ L GV + N + F E+ DL + D+ + P +QL
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF-MHRKSDV-LTTPWKFKVAKQL 114
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGI-------LKLGDFGLANILTSKNKQKLTSRV 287
+ + + ++H ++ NIL+ EGI +KL D G+ +T ++Q+ R+
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI 172
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSP 346
W PE + S N +++ D WS G E+ G+ LK +T E+
Sbjct: 173 P--WI-APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----------- 218
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTA---VDLIDTCLSIEPYKR 398
E + YEG C TP+ DL+ C++ +P +R
Sbjct: 219 -ERF-----------------YEGQ----CMLVTPSCKELADLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLA 272
MRQ+L ++ H GI+HRD+K NI+ + G K+ D G A
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.54 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.37 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.28 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.15 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.08 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.57 | |
| PLN02236 | 344 | choline kinase | 96.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.24 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.96 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.1 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.97 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.65 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.47 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.94 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.68 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 92.67 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-75 Score=617.17 Aligned_cols=359 Identities=64% Similarity=1.102 Sum_probs=343.1
Q ss_pred hccCcccccChHHhhcccchhhhhhcccccccccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH
Q 041720 86 KLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE 165 (690)
Q Consensus 86 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~ 165 (690)
..+...+....++.+++||+|+....+++..+|++...+.|+.+++||+|+||.||+|++..+|+.||+|+++.+...+.
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 34444455667899999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 041720 166 SIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245 (690)
Q Consensus 166 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g 245 (690)
......+||.||++|+|||||+|.+++.+.....+|||||||+++|.+++......|++.++.+||+||+.||+|||.+|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 88889999999999999999999999998767899999999999999999998889999999999999999999999999
Q ss_pred eEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 041720 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325 (690)
Q Consensus 246 ivHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~ 325 (690)
|+|||||.+|||||++|.+||+|||||+++.......++..+.|.||+|||+|+|...|+.++|+||+||||.||++|+|
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99999999999999999999999999999988887889999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 326 ILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 326 PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
.|+|.++.+|+++|+++||.|.+++|...++|....+.+..+|...+.+.++.+++.+.+|+..||+.||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCCCCCCCCchhhhHHHHHHHHHHHH
Q 041720 406 MCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKV 444 (690)
Q Consensus 406 ~hp~f~~~p~~~~~~~lp~~~~~~~~~~~~~~~~~~~~~ 444 (690)
+|+||...|.+|++..||.|++.++.+.+.|.+.++...
T Consensus 399 ~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~ 437 (560)
T KOG0600|consen 399 QSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNK 437 (560)
T ss_pred cCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhccc
Confidence 999999999999999999999999999998888766554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=477.78 Aligned_cols=307 Identities=43% Similarity=0.725 Sum_probs=272.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+.+++|++|+||.||+|+++.|++.||+|+++.+......--.-++||.+|.+++|||||.+.++.....-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46799999999999999999999999999999999876422211123578999999999999999999998877789999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||++++..++.....+|.+.++..++.|++.||+|||.+.|+||||||+|+|+++.|.+||+|||||+.+.+. ...
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 9999999999888887789999999999999999999999999999999999999999999999999999998764 466
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC-CC-
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH-GD- 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~-~~- 360 (690)
++..+.|.||+|||+|+|...|+.++||||+|||+.||++++|.|.|.++.+|+.+|++.+|.|.+..|....... ..
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 7889999999999999999999999999999999999999999999999999999999999999999998755443 32
Q ss_pred CCCCCCCCccccccccCC--CChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCCCCCchhh
Q 041720 361 MFKPQNPYEGCLRERCKD--FTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEI 431 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~--is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~~~~~~~~ 431 (690)
.-.+..++.. ++..+.. ++....+|+..+|.+||.+|.||+++|.|+||.+.|.+++|..+|.+|.+.+.
T Consensus 314 ~~f~~~pyn~-lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~ 385 (419)
T KOG0663|consen 314 MTFSEHPYNN-LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQ 385 (419)
T ss_pred cccCCCCchh-hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccccc
Confidence 3344445443 4444444 55999999999999999999999999999999999999999999999876444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-59 Score=485.29 Aligned_cols=382 Identities=28% Similarity=0.343 Sum_probs=280.9
Q ss_pred CCcccccceecccccceeecccc-------cc-CcccccccccccccCCCCCCccCCCCCCccccCCCCcccccccccCC
Q 041720 3 CVSSKKAAKAAGSPVFEASVSKT-------RA-SENATLNLNYVFSSKNPSGALDFGSKEGERSEDKPKGSRELKKLKKG 74 (690)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 74 (690)
|+..+..++..|+..+..++++. |+ +.++.+|++-+......-.-+.+.++. ...++++..+..+......
T Consensus 40 ~~~~~~r~r~~~v~~~~~~~d~~nd~f~fGR~~~~d~~ln~~~~s~~~~~i~~~~~~~~~-~f~~dr~~~sn~~y~~DhS 118 (475)
T KOG0615|consen 40 CATVKPRARLVGVRRGIKSIDLANDEFTFGRGDSCDAPLNLNNVSNKHFKILLYNKISKI-HFRIDRDKNSNRVYLHDHS 118 (475)
T ss_pred cccccchhhhcceeeccccceeccceEEecCCCcccccccCccccccchheeeeeeeeee-eecccCCCccceEEEEecc
Confidence 77888889999999999998884 21 334444443211111111111111111 1122233333333333333
Q ss_pred CCCCCCcchhhhccCcccccChHHhhcccchhhhhhcc----cccccccccCcCCeeEEeEEeecCceEEEEEEEcCCCc
Q 041720 75 SSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAG----EAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGK 150 (690)
Q Consensus 75 ~~~~~s~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~ 150 (690)
+.....+...+..+.+.......++..+.|..-..... ...........+.|.+.+.||+|+||.|.+|.++.||+
T Consensus 119 ~nGT~VN~e~i~k~~~r~lkN~dei~is~p~~~~~v~~~~s~d~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk 198 (475)
T KOG0615|consen 119 RNGTFVNDEMIGKGLSRILKNGDEISISIPALKIFVFEDLSRDSSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGK 198 (475)
T ss_pred cCcccccHhHhhccccccccCCCEEEeccchhheeeeecccchhccCccchhcceeEeeeeecCCceeEEEEEEEcccCc
Confidence 33333343333333333322333333333322111111 11111112235668899999999999999999999999
Q ss_pred EEEEEEeecCCCCh-----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChh
Q 041720 151 MVALKKVRFDNFQP-----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEP 225 (690)
Q Consensus 151 ~vAvK~i~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~ 225 (690)
.||||++.+..... .....+.+|++||++|+|||||+++++|+. .+..||||||++||.+......++.+.|.
T Consensus 199 ~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed 276 (475)
T KOG0615|consen 199 QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--PDSSYMVLEYVEGGELFDKVVANKYLRED 276 (475)
T ss_pred EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--CCceEEEEEEecCccHHHHHHhccccccc
Confidence 99999998764322 123346899999999999999999999998 68889999999999998888888899999
Q ss_pred HHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC---CcEEEeecccceeccccCcccccccccccCCCCcccccCC-
Q 041720 226 QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS- 301 (690)
Q Consensus 226 ~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~- 301 (690)
..+.+++||+.||.|||++||+||||||+||||..+ ..+||+|||+|+... ....+.+.||||.|.|||++.+.
T Consensus 277 ~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 277 LGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred hhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc--cceehhhhcCCccccChhheecCC
Confidence 999999999999999999999999999999999876 689999999999875 34677889999999999999653
Q ss_pred -CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCC
Q 041720 302 -TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDF 379 (690)
Q Consensus 302 -~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~i 379 (690)
..|..++||||||||||.+|+|.+||.+..... ..++|.+.-+.+....|. .+
T Consensus 355 ~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~-------------------------~I 409 (475)
T KOG0615|consen 355 VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD-------------------------RI 409 (475)
T ss_pred eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh-------------------------hh
Confidence 335568999999999999999999999876555 888888888888777887 59
Q ss_pred ChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 380 TPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 380 s~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
+.++++||.+||.+||++|||++|+|+||||+..|
T Consensus 410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999999865
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=454.36 Aligned_cols=298 Identities=42% Similarity=0.721 Sum_probs=266.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.+|..+++||+|.||+||+|++..+|+.||||+++..+..........+||..|+.++|+||+.|+|+|.. ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 46889999999999999999999999999999999876655555668899999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
+|||+.++...+......|+..++..|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+...+ ...
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-RIQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-ccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999999987655 344
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc-cCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~-~~l~~~~~~ 362 (690)
+..+.|.||+|||.|.|...|+..+||||.|||+.||+.|.|.|.|.++.+|+..|++.+|.|.++.|.. ..++....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 4558999999999999999999999999999999999999999999999999999999999999999987 444544333
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~~~ 426 (690)
. +.|. ..+...+...++++.||+..||.+||.+|+|+.|+|.|+||+..|.++.+..+|...
T Consensus 239 ~-~~P~-~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 239 Q-QFPK-PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred h-cCCC-CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCc
Confidence 2 1111 122236778899999999999999999999999999999999999999998888644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-57 Score=456.15 Aligned_cols=285 Identities=36% Similarity=0.631 Sum_probs=257.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.|+.+.++|+|+||+||+|+++.||+.||||++.-...++...+-.++||.+|++|+|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 57999999999999999999999999999999998766667777778899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||||+...+..+......+++..+..|+.|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+.. ....+
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999999888888899999999999999999999999999999999999999999999999999998875 45778
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh---ccCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK---KSKLPHGD 360 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~---~~~l~~~~ 360 (690)
+.++.|.||+|||.+.|...|+.++||||+||++.||++|.|.|+|.++.+++..|...+|...+.... .+...++
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G- 237 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG- 237 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee-
Confidence 889999999999999998999999999999999999999999999999999999999999988765432 2222222
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...|.......+..++++++..+.||++.||..||.+|++.+++|.|+||.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 3344445556677788899999999999999999999999999999999955
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-57 Score=479.00 Aligned_cols=289 Identities=36% Similarity=0.647 Sum_probs=257.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|.++++||.|+||.||+|+.+.+|..||||.+++.-..-+.. .=+||+..|++|+ |||||+|.+++.+. ...
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~-~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDN-DRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhcc-Cce
Confidence 34678999999999999999999999999999999998765443322 2458999999998 99999999999984 339
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+|||||+.++..++..++..|++..++.||.||++||+|+|.+|+.|||||||||||..+..|||+|||||+.+.+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999988654
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc-CCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-KLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~-~l~~ 358 (690)
..+|.++.|.||+|||+|+....|+.++|||++|||++|+.+-+|.|.|.++.+++.+|...+|.|..+.|... .+-.
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 57788999999999999999999999999999999999999999999999999999999999999999999873 3333
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...|..+......+....+..++++.+||.+||.+||.+||||+|+|+||||+..
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 3334444444455566667899999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-55 Score=473.37 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=236.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..|+..+.||+|||+.||.+++..+|+.||+|++.+..+ .+...+.+.+||+|.+.|+|||||+++++|+| .+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 559999999999999999999999999999999987643 35667889999999999999999999999999 799999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|+|+|..+.+..+......++|.+++.+++||+.||.|||+++|||||||..||||+++.+|||+|||||..+..+. +.
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 99999999888888888899999999999999999999999999999999999999999999999999999887543 45
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
..+.||||.|.|||++.. ..++..+||||+|||||.||+|+|||...+-.+.+.+|....+..|.
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~-------------- 239 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS-------------- 239 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--------------
Confidence 567899999999999975 67899999999999999999999999999999999999887666553
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.++.++++||..||+.||.+|||+++||.|+||+.
T Consensus 240 ---------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 240 ---------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ---------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 58999999999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=439.13 Aligned_cols=263 Identities=29% Similarity=0.480 Sum_probs=236.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|+++++||+|+||+||+++.+.+++.+|+|++++...- ....+....|..||.+++||+||+++-.|++ ...
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCe
Confidence 4578899999999999999999999999999999999887543 3456788999999999999999999999998 799
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||+||+.||.|...+.+.+.|+|..++-|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++.....
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999864433
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.....++|||+.|||||++.+ ..|+.++|+|||||+||+||+|.+||.+.+..+..++|...-...+.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p----------- 246 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP----------- 246 (357)
T ss_pred CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-----------
Confidence 245566899999999999987 57999999999999999999999999999999999999764322221
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC----CHHHHHcCccccCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp----Ta~elL~hp~f~~~p~ 415 (690)
..++.++++||+++|..||.+|. ++.++-+||||....|
T Consensus 247 -----------------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 247 -----------------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred -----------------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 13788999999999999999995 7899999999998766
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-55 Score=426.51 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=241.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..+.|++.+.||+|.|+.||++.+..+|+.+|+|+++...+.....+.+.+|+.|.+.|+|||||+|++.+.. ....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeE
Confidence 3567999999999999999999999999999999998887777788899999999999999999999999987 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccceecccc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSK 278 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~~~~~~ 278 (690)
||||+|.|+.+..-+.....++|..+.++++||+++|.|||.+||||||+||+|+||.. ..-+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999877766666667999999999999999999999999999999999999954 3479999999998876
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
+......++|||.|||||++.. .+|+..+|||+.|||||.||.|++||.+.+...+++.|+...+..+..+|+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~------ 237 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD------ 237 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC------
Confidence 4456678999999999999964 689999999999999999999999999999999999999999999988887
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 238 -------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 238 -------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 699999999999999999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=433.40 Aligned_cols=298 Identities=34% Similarity=0.550 Sum_probs=251.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec---cCcc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS---RLSN 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---~~~~ 198 (690)
....|..++.||+|+||.|+.+.++.+|+.||||++...-......++..+|+.+|+.++|+||+.+++++.. ..-+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999999999999999997443345567788999999999999999999999875 2357
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+|+|+|+.++...+.. +..+++.++..++.||+.||.|+|+.+|+||||||.|+|++.+..+||+|||||+.....
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 8999999998777665544 335999999999999999999999999999999999999999999999999999987532
Q ss_pred -CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 -NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 -~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
....++.++.|.||+|||+++....|+.++||||+||||.|||+|++.|.|.+..+|+..|+..+|.|+++.+....-.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 2345688999999999999999899999999999999999999999999999999999999999999998877653311
Q ss_pred CCCCCC--CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCC
Q 041720 358 HGDMFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420 (690)
Q Consensus 358 ~~~~~~--~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~ 420 (690)
....+. ............+++.++.+.||+.+||..||.+|+|++|+|+||||...-.+.+..
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111110 111112334566789999999999999999999999999999999998765444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=434.09 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=228.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+...+++.++.||+|..|+||+++|+.|++.+|+|++. ...++...+++.+|++|++.++|||||.+|+.|..... .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eE
Confidence 44567889999999999999999999999999999994 45677888999999999999999999999999998422 69
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+||||++|.+..+....++++|..+..++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999998888877899999999999999999999995 99999999999999999999999999999887643
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHcCCCChhhhhcc
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR-----TEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~-----~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
...+++||..|||||.+.+ ..|+.++||||||++++||.+|+.||... ...+++..|.. .+|+..-.
T Consensus 233 --~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~lP~-- 304 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRLPE-- 304 (364)
T ss_pred --hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCCCc--
Confidence 5578999999999999986 57999999999999999999999999875 44555555533 23321100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+|+++++||..||++||.+|||+.|+|+|||++...
T Consensus 305 ----------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 305 ----------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ----------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 03899999999999999999999999999999999753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=429.99 Aligned_cols=292 Identities=40% Similarity=0.722 Sum_probs=250.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc-eeeeeceeeccC----c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN-IIKLEGVITSRL----S 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~----~ 197 (690)
...|+.+++||+|+||+||+|+++.+|+.||+|+++.....+..-....+|+.+|+.|+|+| ||.|++++.+.. .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 44588899999999999999999999999999999876443222234679999999999999 999999998731 1
Q ss_pred ceEEEEEeccchhcccccccCC---CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHD---IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
..++|||||++.++...+.... ..++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 2899999999998877665544 3577789999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+.-. ....+..++|.||+|||+|+|...|+..+||||+|||++||+++++.|.|.++.+++.+|++.+|.|.++.|...
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 6532 345778899999999999999989999999999999999999999999999999999999999999999999863
Q ss_pred -CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 355 -KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 355 -~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
.++......+.......+....+..++++.+|+..||+++|.+|.||..+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 3444443333333344555556677789999999999999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=424.57 Aligned_cols=262 Identities=28% Similarity=0.469 Sum_probs=235.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
...+|.+.+.||+|+|++||+|+++.++..||||.+.+..+.....+.+..||.||+.++|||||+|++++.+ ++.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEE
Confidence 3567999999999999999999999999999999999988888888999999999999999999999999998 78999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC------CcEEEeecccceec
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE------GILKLGDFGLANIL 275 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~------~~vKL~DFGla~~~ 275 (690)
||||||.||.+..++...+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999888888888899999999999999999999999999999999999999875 46899999999998
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.. .....+.||+|.|||||++. .+.|+.|+|+||+|+|||+|++|++||...+..+.+..|.......+.
T Consensus 166 ~~--~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~------- 235 (429)
T KOG0595|consen 166 QP--GSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV------- 235 (429)
T ss_pred Cc--hhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-------
Confidence 63 45667899999999999996 478999999999999999999999999999999998876554322221
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....+++...+|+..+|..+|..|.+..+-+.|+++...|
T Consensus 236 -------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 236 -------------------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------------hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 0114677788999999999999999999999999998765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=438.78 Aligned_cols=264 Identities=32% Similarity=0.493 Sum_probs=238.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
....+|...+.||+|+|++|++|+++.+++.||||++.+.-+ .+..++.+.+|-++|.+| .||.||+||-.|+| ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 346789999999999999999999999999999999977643 234456688899999999 89999999999998 78
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+|+||+++|.+..++.+-+.|+|.-++.|+.||+.||+|||++|||||||||||||||.++++||+|||.|+.+...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999887777777889999999999999999999999999999999999999999999999999999987643
Q ss_pred Ccc------------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 279 NKQ------------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 279 ~~~------------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
... ...+++||-.|.+||+|.. ...++.+|||+||||||.|+.|.|||.+.++.-.+++|+.+.+.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 221 1255899999999999864 678999999999999999999999999999999999999998877
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
++ ++++.+.|||+++|..||.+|+|+.+|-+||||.+..|.
T Consensus 307 p~-----------------------------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 307 PE-----------------------------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred CC-----------------------------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 75 688999999999999999999999999999999987664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=432.93 Aligned_cols=278 Identities=29% Similarity=0.487 Sum_probs=237.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|+++..||+|+||.||+|+.+.||+.+|+|++++..+ ...+++-+..|-.||...++|+||+||-.|++ ..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CC
Confidence 4568899999999999999999999999999999999988754 35667788999999999999999999999998 79
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||++||...-++...+.|+|..++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+||||+..+...
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999887777777779999999999999999999999999999999999999999999999999998543210
Q ss_pred -----------------------Cc-----------------------ccccccccccCCCCcccccCCCCCCcchhhHH
Q 041720 279 -----------------------NK-----------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWS 312 (690)
Q Consensus 279 -----------------------~~-----------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWS 312 (690)
.. ......+|||.|||||+|++ ..|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 00 01124689999999999997 55999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc-CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhh
Q 041720 313 VGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCL 391 (690)
Q Consensus 313 lGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~-~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L 391 (690)
|||||||||.|+|||.+.++.+...+|+. |+.. ..| ....++++++|||.+||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP-----------------~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFP-----------------EEVDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCC-----------------CcCcccHHHHHHHHHHh
Confidence 99999999999999999999999999976 3310 000 01257799999999999
Q ss_pred ccCCCCCCC---HHHHHcCccccCCCCCCCCCCCCCCCC
Q 041720 392 SIEPYKRGT---ASSLLMCEYFTTQPYACDPSSLPKYPP 427 (690)
Q Consensus 392 ~~DP~kRpT---a~elL~hp~f~~~p~~~~~~~lp~~~~ 427 (690)
. ||.+|.- ++||-.||||++..|-..-...|.+.|
T Consensus 428 ~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred c-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 9 9999975 999999999999888664444444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=406.07 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=237.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|+.++.||.|+||.|.+++++.+|..+|+|++.+... .-.+.+...+|..+|+.+.||+++++++.+.+ .+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCe
Confidence 456789999999999999999999999999999999987643 34556678899999999999999999999988 799
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||++||.++.++.+.++|++..++.|+.||+.||+|||+++|++|||||||||||.+|++||+|||+|+.+..
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999998888888999999999999999999999999999999999999999999999999999998753
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
...+.||||.|+|||++.. ++|+.++|+|||||++|||++|++||.+.+....+++|+.....+|.
T Consensus 197 --rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----------- 262 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----------- 262 (355)
T ss_pred --cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc-----------
Confidence 2467899999999999974 78999999999999999999999999999999999999987666653
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCC-----CCHHHHHcCccccCCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kR-----pTa~elL~hp~f~~~p~~ 416 (690)
.++++++|||+.+|++|-.+| .-..++.+||||.+..|.
T Consensus 263 ------------------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 263 ------------------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred ------------------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 589999999999999999999 357789999999987664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=433.22 Aligned_cols=260 Identities=32% Similarity=0.476 Sum_probs=230.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHhhcC-CCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ---PESIRFMAREIMILRRLD-HPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 196 (690)
.....|.+.+.||+|+||+|++|++..++..||||++.+.... ....+.+.+|+.+|+.+. ||||+++++++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-- 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-- 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence 3456799999999999999999999999999999988765221 134556779999999998 9999999999998
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~~ 275 (690)
...+|||||||.|+.+...+...+++.|.+++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 57799999999997666666668899999999999999999999999999999999999999999 99999999999887
Q ss_pred cccCcccccccccccCCCCcccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
. .......+.|||+.|+|||++.+.. +.+.++|||||||+||.|++|+.||...+...++.+|.......|.
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~------ 244 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS------ 244 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC------
Confidence 4 3345678899999999999998866 5568999999999999999999999999999999888765544442
Q ss_pred CCCCCCCCCCCCCCccccccccCCC-ChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDF-TPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~i-s~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.+ ++++++||.+||..||.+|+|+.++++||||+.
T Consensus 245 -----------------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 -----------------------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------------------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 34 999999999999999999999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=439.38 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=238.2
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-NFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
-|++.+.||.|+-|.|.+|++..||+.+|||++.+. .........+.+||.||+.|.||||+++|++|++ ...+|||
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEE
Confidence 389999999999999999999999999999999876 4444555678999999999999999999999998 7899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
+||+++|.+++++...++|+|.++.++++||+.|+.|||..+|+||||||+|+|||..++|||+|||+|.+-. ....+
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997643 33567
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
.+.||+|.|.|||+++|..+.+.++||||+|||||.||+|+.||.+.+-..++.++.++.+..|.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--------------- 233 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--------------- 233 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC---------------
Confidence 78899999999999999888899999999999999999999999999988999998877665553
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
.+++++++||.+||.+||.+|+|.+||+.|||+...+-..
T Consensus 234 --------------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 234 --------------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred --------------cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 6999999999999999999999999999999998765443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=414.43 Aligned_cols=281 Identities=36% Similarity=0.589 Sum_probs=238.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc---eEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN---TIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---~~~ 201 (690)
.|...+++|.|+||.||+|....+++.||||++..+.. .--+|++||+.++|||||+|.-+|....+. .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 48889999999999999999999999999999876542 124799999999999999999888765444 445
Q ss_pred EEEeccchhccccccc---CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccceeccc
Q 041720 202 LVFEYMEHDLAGLSSC---HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTS 277 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~---~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~~~~ 277 (690)
||||||+..+...+.. .+.+++.-.++-++.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999987765553 35679999999999999999999999999999999999999987 8999999999999864
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ....++..|..|+|||.+.|...|+.+.||||.|||+.||+-|+|.|.|.+..+|+..|++.+|.|..+........
T Consensus 179 ~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 G--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred C--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 3 44577889999999999999999999999999999999999999999999999999999999999998766543322
Q ss_pred CCCCCCCCCCCccccc-cccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLR-ERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~-~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.. .+..+......+. -..+..++++.+|+.++|.++|.+|.++.|+|.||||....
T Consensus 257 y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 257 YT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 22 2222222222222 24578899999999999999999999999999999998653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=397.94 Aligned_cols=261 Identities=33% Similarity=0.449 Sum_probs=236.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF------QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL 196 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 196 (690)
..|.-.+.||+|..++|.+|.++.+|..+|+|+|..... ..+..+.-.+|+.||+++ .||+|+++.|+|+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 347778899999999999999999999999999975421 123344567899999998 69999999999998
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+..+++|||+|..|.+++++.....++|.+.+.||+||++|++|||.++||||||||+|||+|++.++||+|||++..+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 78999999999999999988888889999999999999999999999999999999999999999999999999999876
Q ss_pred ccCcccccccccccCCCCcccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMG-----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
. ...+...||||+|+|||.+.. ...|+..+|+|++|||||.||.|.|||..+...-++..|+...+.+..+.|
T Consensus 175 ~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 P--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred C--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 4 466788999999999999843 456899999999999999999999999999999999999999999998888
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. +++.+.+|||.+||++||.+|.|++|+|.||||...
T Consensus 253 a-------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 253 A-------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred h-------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 7 699999999999999999999999999999999653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=407.76 Aligned_cols=283 Identities=38% Similarity=0.688 Sum_probs=235.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|+++++||.|+||.||+|++..++..||+|+++.... ......+.+|+.+|+.++||||+++++++.+ .+.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 4679999999999999999999999999999999975432 2223457789999999999999999999987 578999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999987666555555568999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC--CC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH--GD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~--~~ 360 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+.|....... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3456789999999998776778999999999999999999999999999999999999999999999887632211 11
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...+... ..........+++++++||.+||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111111 111122334678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=403.48 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=219.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|+++++||+|+||.||++++..+|..||.|.+..+.++....+.+..|+.+|++|+|||||++++.-..+....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45699999999999999999999999999999999998888888899999999999999999999998433333455999
Q ss_pred EEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHh--CC--eEeccCCcccEEEccCCcEEEeeccccee
Q 041720 203 VFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHL--RG--IMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 203 V~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~--~g--ivHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
|||||++|.+..++ .....++|..+|.++.|++.||.+||+ .. |+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999987665443 345569999999999999999999999 45 99999999999999999999999999999
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+.... ....+.+|||.||+||.+.+ .+|+.++||||+||++|||+.-++||.|.+-.++..+|.....+|-. +
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---~-- 250 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---D-- 250 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---H--
Confidence 87643 55677999999999999976 67999999999999999999999999999988888998776444321 0
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa 401 (690)
..+|.++..||..|+.+||..||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 1478899999999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=412.49 Aligned_cols=265 Identities=31% Similarity=0.502 Sum_probs=229.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh------------HHHHHHHHHHHHHhhcCCCceeeee
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP------------ESIRFMAREIMILRRLDHPNIIKLE 189 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~------------~~~~~~~~Ei~iL~~L~HpnIv~l~ 189 (690)
..++|++++.||+|.||+|.+|++..+++.||||++.+..... .-.+.+.+||.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4678999999999999999999999999999999997653211 1235789999999999999999999
Q ss_pred ceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 190 ~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
++..+...+.+|||+|||..|...........+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99999888999999999998877766655544999999999999999999999999999999999999999999999999
Q ss_pred ccceeccc----cCcccccccccccCCCCcccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 041720 270 GLANILTS----KNKQKLTSRVVTLWYRPPELLMG---STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKL 342 (690)
Q Consensus 270 Gla~~~~~----~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~ 342 (690)
|.+..... .....+...+|||.|+|||.+.+ ....+.+.|||||||+||.|+.|+.||.+....++..+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 99986522 12234456899999999999876 234577999999999999999999999999999999999775
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
--.+|+ .+.+.+.++|||.+||++||++|+++.++-.|||....
T Consensus 335 pL~fP~---------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PLEFPE---------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccCCC---------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 333332 12578899999999999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=402.42 Aligned_cols=284 Identities=34% Similarity=0.576 Sum_probs=233.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. .+.+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 36999999999999999999999999999999998665444455678899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999988776665556799999999999999999999999999999999999999999999999999987654333334
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC---CCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP---HGD 360 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~---~~~ 360 (690)
....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...|...... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 45678999999999976 45899999999999999999999999999988888888888887776655421110 000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.+................++.++.+||.+||++||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000111111224578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=421.60 Aligned_cols=261 Identities=31% Similarity=0.479 Sum_probs=235.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+........+.+.+|++|++.|+|||||.++++|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57899999999999999999999999999999999888778888899999999999999999999999998 7999999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
+|||.| .++.++..++.++|+.+..++.|++.||.|||+++|+|||+||.||||+..|++|+||||+|+.... +....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 999999 5555667778999999999999999999999999999999999999999999999999999998764 55677
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
+...|||.|||||++.+ ..|+..+|+||||||||||+.|+|||...+-.+....|...-..+|.
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--------------- 221 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--------------- 221 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc---------------
Confidence 88899999999999975 78999999999999999999999999998888888888653222221
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
.++..+++||..+|..||.+|.|-.++|.|||+++.-...+
T Consensus 222 --------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~ 262 (808)
T KOG0597|consen 222 --------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAE 262 (808)
T ss_pred --------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhc
Confidence 58899999999999999999999999999999987654433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=366.06 Aligned_cols=285 Identities=39% Similarity=0.706 Sum_probs=250.2
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|..+++||+|+||+||+|++..+++.||+|.++.+..++..-....+||.+|+.|+|.|||+++++... .+.+-||+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 4778899999999999999999999999999999876554444567899999999999999999999987 68999999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
|||..++...+..-++.+..+.++.+|.|++.||.|||++++.||||||.|+||+.+|++||+|||+++.+.-.- .-.+
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcys 159 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYS 159 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeee
Confidence 999999988888888899999999999999999999999999999999999999999999999999998875432 3345
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc-cCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMF 362 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~-~~l~~~~~~ 362 (690)
..+.|.||++|.++.|.+-|+...||||.|||+.|+.. |+|.|.|.+..+++.+|+..+|.+.++.|.. ..++....
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~- 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP- 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc-
Confidence 67889999999999999999999999999999999985 8999999999999999999999999999976 33333222
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.|..+....+.+..+.++...+||+..+|.-+|.+|++|+++|+||||...
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 222333334555667888899999999999999999999999999999863
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=422.61 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=235.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 197 (690)
++..++|.++++||+|+||+|+++..+.+++.+|||+++++. ++.+.++..+.|..|+.... ||.++.|+..|++ .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 567889999999999999999999999999999999999875 45677888999999998885 9999999999998 7
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.++|+||||+.||. .........|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+||||++....
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999999988 44455556899999999999999999999999999999999999999999999999999987543
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ....+++||||.|||||+|.+ ..|+.++|+|||||+|||||.|.+||.|.++.+....|+......|
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP---------- 588 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP---------- 588 (694)
T ss_pred C-CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----------
Confidence 2 246678999999999999976 6799999999999999999999999999999999999976433332
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPYA 416 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~~ 416 (690)
..+|.++.+++++||..||++|.- +++|..||||+...|.
T Consensus 589 -------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 589 -------------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred -------------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 258899999999999999999986 4789999999987763
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=412.62 Aligned_cols=264 Identities=33% Similarity=0.506 Sum_probs=237.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
.+.|++.+.||+|.||.||+|+++.+|+.+|+|++.+.... ......+.+|+.||++|. |||||.++++|++ ...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 45699999999999999999999999999999999876543 234568999999999998 9999999999999 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC----CcEEEeecccceecc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE----GILKLGDFGLANILT 276 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~----~~vKL~DFGla~~~~ 276 (690)
+||||+|.|+.+.+.+... .++|..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999998777666554 49999999999999999999999999999999999999643 479999999999876
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+..+...+|......++.++|+
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~---- 263 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD---- 263 (382)
T ss_pred C--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc----
Confidence 5 456788999999999999964 679999999999999999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
.++..+++||+.||..||.+|+|+.++|+|||++.....+
T Consensus 264 ---------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 264 ---------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred ---------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 6899999999999999999999999999999999864433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=401.29 Aligned_cols=286 Identities=38% Similarity=0.665 Sum_probs=231.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999999754322 223456789999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999988877766666679999999999999999999999999999999999999999999999999997643322 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.+....|....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--H 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc--c
Confidence 3456789999999998776678999999999999999999999998754 456777787777877777775422110 0
Q ss_pred CCCCC---CCccccccc--cCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 362 FKPQN---PYEGCLRER--CKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~---~~~~~l~~~--~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
+.+.. .....+... ...+++.+.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000 000011111 113567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=417.18 Aligned_cols=280 Identities=30% Similarity=0.533 Sum_probs=230.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-C-----CceeeeeceeeccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-H-----PNIIKLEGVITSRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~~~~~ 198 (690)
+|++++.||+|+||.|.+|.+..|++.||||+++.. .....+...|+.||..|+ | -|||+++|+|.. .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999854 345566778999999996 4 489999999998 69
Q ss_pred eEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC--cEEEeecccceec
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG--ILKLGDFGLANIL 275 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~--~vKL~DFGla~~~ 275 (690)
++|||+|+++.+|..++.... ..|+...++.++.||+.||.+||+.||||+|||||||||.+-+ .|||+|||.+...
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999999998887766543 3499999999999999999999999999999999999997654 7999999999875
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
. ....+++-+..|+|||+++| ..|+.+.||||||||++||++|.|.|.|.++.+|+..|+..+|.|+..+.+...
T Consensus 342 ~----q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 S----QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred C----Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 3 23337888999999999997 679999999999999999999999999999999999999999999987665422
Q ss_pred CCCC---C-CCCC--------------------------C--CC-CccccccccC-CCChhHHHHHHHhhccCCCCCCCH
Q 041720 356 LPHG---D-MFKP--------------------------Q--NP-YEGCLRERCK-DFTPTAVDLIDTCLSIEPYKRGTA 401 (690)
Q Consensus 356 l~~~---~-~~~~--------------------------~--~~-~~~~l~~~~~-~is~~l~dLI~~~L~~DP~kRpTa 401 (690)
..+. . ...+ . .| ....+...+. .-...+.|||++||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 1110 0 0000 0 00 0011111111 233468999999999999999999
Q ss_pred HHHHcCccccCCC
Q 041720 402 SSLLMCEYFTTQP 414 (690)
Q Consensus 402 ~elL~hp~f~~~p 414 (690)
.++|+||||+...
T Consensus 497 ~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 497 AQALNHPFLTGTS 509 (586)
T ss_pred HHHhcCccccccc
Confidence 9999999999654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=398.73 Aligned_cols=254 Identities=29% Similarity=0.477 Sum_probs=232.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
-+|++.+.||+|+||+|-+|.+...|+.||||.|+++.+. ...+-.+.+||+||..|+||||+.+|++|+. .+.++|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEEE
Confidence 3599999999999999999999999999999999988764 4456678999999999999999999999998 789999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||..+|.+.+++...+.|+|.+++++++||..|+.|||+++|+|||||.+|||||.++++||+||||+..+.. ...
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKF 208 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--ccH
Confidence 999999999998888888999999999999999999999999999999999999999999999999999988754 357
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
++++||+|-|.+||++.|..+-++.+|.|||||+||.|+.|..||.|.+...+..+|....+..|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--------------- 273 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--------------- 273 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---------------
Confidence 78999999999999999887779999999999999999999999999999999999877554333
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.-+.++.-||+.||.+||++|.|++++-.|=|++
T Consensus 274 ---------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 274 ---------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ---------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 3567889999999999999999999999997764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=413.56 Aligned_cols=257 Identities=29% Similarity=0.545 Sum_probs=228.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
...|....+||+|+.|.||.++...+++.||||.+....... .+.+.+|+.+|+.++|+|||.+++.|.. .+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence 455889999999999999999999999999999998776443 3578999999999999999999999887 589999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||+|+.+.++.... .++|.+++.|+++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.... ..
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-~K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-SK 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-Cc
Confidence 99999999877666543 59999999999999999999999999999999999999999999999999998876543 35
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
..+.+|||.|||||++.. ..|++++||||||++++||+-|.|||-.++....++.|.. .|.|.-..+
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~----------- 492 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNP----------- 492 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCc-----------
Confidence 678899999999999964 6799999999999999999999999999888888888755 344443322
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+|+.++|||.+||+.|+.+|++|.|||+||||+.
T Consensus 493 --------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 493 --------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred --------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 269999999999999999999999999999999954
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=395.45 Aligned_cols=303 Identities=43% Similarity=0.767 Sum_probs=250.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.++++++|+||+++++++.+...+.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35679999999999999999999999999999999976543332233466899999999999999999999764446789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.+++...+......+++.++..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+.... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 999999987666555545679999999999999999999999999999999999999999999999999998765332 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-CCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP-HGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~-~~~ 360 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...... ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2334456888999999877667899999999999999999999999999999999999999998888887653221 111
Q ss_pred CC-CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCCCC
Q 041720 361 MF-KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426 (690)
Q Consensus 361 ~~-~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~~~ 426 (690)
.+ .+..++ ..+......+++.+.+||.+||++||.+|||+.++|+||||...+.++.+..+|.+|
T Consensus 244 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 244 KFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred cccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11 111121 122333445789999999999999999999999999999999999999988888764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=400.62 Aligned_cols=291 Identities=32% Similarity=0.526 Sum_probs=231.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 201 (690)
+|++.++||+|+||.||+|++..++..||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 489999999999999999999999999999998754333334456889999999999999999999886421 23589
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK- 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~- 280 (690)
||||||.+++...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999876655443 445699999999999999999999999999999999999999999999999999976432221
Q ss_pred -ccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 281 -QKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 281 -~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122456789999999988642 568999999999999999999999999999988888888888888776554321110
Q ss_pred CCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 359 GDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 359 ~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
...+ .............++.+++.+.+||.+||+.||.+|||++|+|+||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 0000 000000111223345678899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=395.23 Aligned_cols=288 Identities=35% Similarity=0.664 Sum_probs=237.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|.++++||+|+||.||+|++..+++.||||.+...... .....+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 46799999999999999999999999999999999755322 223456789999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999987776665555568999999999999999999999999999999999999999999999999997653322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC-CC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG-DM 361 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~-~~ 361 (690)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.|........ ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 33457799999999987766789999999999999999999999999999999999999999999888865322110 00
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
+................+++++++||.+||+.||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000011112223456899999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=416.46 Aligned_cols=285 Identities=31% Similarity=0.497 Sum_probs=228.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc------C
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR------L 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 196 (690)
..+|++++.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 467999999999999999999999999999999986442 1245799999999999999999886431 1
Q ss_pred cceEEEEEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccc
Q 041720 197 SNTIYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLA 272 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla 272 (690)
...+++||||+++++...+. .....+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23577999999987654432 3455799999999999999999999999999999999999998665 7999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
+.+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++.++...++.+..+.+.
T Consensus 219 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 876432 233456789999999998876779999999999999999999999999999999999999999988877665
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...........+...............++++++||.+||.+||.+|||+.|+|+||||.....
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 422111111111111111111122357889999999999999999999999999999987543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=398.89 Aligned_cols=261 Identities=33% Similarity=0.503 Sum_probs=214.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
..+...+.||+|+||.||++.+..+|...|||.+...... ..+.+.+|+.+|.+|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3478889999999999999999999999999999866322 26779999999999999999999997555312379999
Q ss_pred EeccchhcccccccCCC-CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeecccceeccc--cC
Q 041720 204 FEYMEHDLAGLSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANILTS--KN 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~-~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~~~~--~~ 279 (690)
|||+.+|.+..+....+ .|+|..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999988877666554 7999999999999999999999999999999999999999 79999999999987763 22
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........||+.|||||++........++|||||||++.||+||.+||.. ....+.+..|......|
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P------------ 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP------------ 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC------------
Confidence 22345688999999999997522233599999999999999999999987 34444444443221111
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....+|+++++||.+||..||.+||||+++|.|||....
T Consensus 243 ---------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 ---------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1123689999999999999999999999999999999874
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=388.92 Aligned_cols=281 Identities=39% Similarity=0.665 Sum_probs=224.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc---CCCceeeeeceeec---cCc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDNFQPESIRFMAREIMILRRL---DHPNIIKLEGVITS---RLS 197 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---~~~ 197 (690)
+|++++.||+|+||.||+|++.. ++..||||++............+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999854 578899999876543333334456777777766 69999999998852 124
Q ss_pred ceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
..+++||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 578999999998766555432 3458999999999999999999999999999999999999999999999999998754
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|+...+.+....|.....
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred CC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 32 23345678999999999865 5689999999999999999999999999999999999999888877766654211
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....+.+.. ...+....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111110 111222335688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=391.37 Aligned_cols=274 Identities=27% Similarity=0.474 Sum_probs=232.2
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..++..++|++.+.||.|.-++||+|+.+.+++.||||+++.+..+.+ ++.+.+|+..|+.++||||++.+..|.. +
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--D 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--c
Confidence 346778999999999999999999999999999999999998876655 7889999999999999999999999988 7
Q ss_pred ceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+|+||.||.+|.+..++.. ...|.|..++.|+++++.||.|||++|-||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 899999999998876655442 334999999999999999999999999999999999999999999999999998655
Q ss_pred cccCcc---cccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 276 TSKNKQ---KLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 276 ~~~~~~---~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
...... .+.+++||++|||||+++. -..|+.|+||||||++..||.+|..||....+.+.+.. ++.+.||.-.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~- 253 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLL- 253 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCcc-
Confidence 432211 1256799999999999644 46799999999999999999999999999888877744 4445554211
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....-.+..+.++..++.+|..||..||.+||||+++|.|+||+..
T Consensus 254 ----------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 ----------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ----------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0111223345788899999999999999999999999999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=406.00 Aligned_cols=287 Identities=34% Similarity=0.510 Sum_probs=233.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 201 (690)
+|+++++||+|+||.||++.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998754334445567889999999999999999999987631 12789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 999999976655443 3457999999999999999999999999999999999999999999999999999876544434
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC----
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP---- 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~---- 357 (690)
.....++++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|...++.++.+.+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 4455678999999999987677899999999999999999999999999999999999999998876554321100
Q ss_pred -CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 -HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 -~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
......+ +....+.......++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKP--PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCC--CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0000000 111111122345688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=372.12 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=230.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|-||.||+|+.+.++..||+|++.+..+. .....++.+|++|-..|+||||+++|++|.+ ...+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--ccee
Confidence 467899999999999999999999999999999999876543 3344678999999999999999999999999 7899
Q ss_pred EEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
||++||...+.+...+. ...+|++..++.|+.|++.||.|||.++||||||||+|+|++.++.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999876654444 56679999999999999999999999999999999999999999999999999997643
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+.+++|.+....+|.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~---------- 243 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS---------- 243 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----------
Confidence 345577899999999999976 67899999999999999999999999999999999999887655542
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.++.++.|||.+||..+|.+|.+..|++.|||+...
T Consensus 244 -------------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 244 -------------------TISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -------------------ccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 689999999999999999999999999999998753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=390.70 Aligned_cols=277 Identities=27% Similarity=0.367 Sum_probs=237.8
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..+..+.|++++.||.|.-|+||+++...++..+|+|+|.+..+. .....+...|-+||..++||.++.||..|+. .
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--D 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--c
Confidence 456678899999999999999999999999999999999887554 4556778889999999999999999999998 7
Q ss_pred ceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+|||||||+||.+..+.++ ...|++..++.|+.+|+.||+|||-.|||+||||||||||-++|+|-|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 899999999999887765543 346999999999999999999999999999999999999999999999999997432
Q ss_pred cc---------------------------------c-C---------------------cccccccccccCCCCcccccC
Q 041720 276 TS---------------------------------K-N---------------------KQKLTSRVVTLWYRPPELLMG 300 (690)
Q Consensus 276 ~~---------------------------------~-~---------------------~~~~~~~~gt~~Y~APE~l~~ 300 (690)
.. . . ......++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 0 011235789999999999987
Q ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCC
Q 041720 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFT 380 (690)
Q Consensus 301 ~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is 380 (690)
...+.++|+|+|||+|||||.|..||.|.+..+.+.+|+...-.+|+. +.++
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~---------------------------~~vs 361 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE---------------------------PEVS 361 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------Ccch
Confidence 457999999999999999999999999999999999997654444432 2578
Q ss_pred hhHHHHHHHhhccCCCCCCC----HHHHHcCccccCCCCCCCCCCCCCC
Q 041720 381 PTAVDLIDTCLSIEPYKRGT----ASSLLMCEYFTTQPYACDPSSLPKY 425 (690)
Q Consensus 381 ~~l~dLI~~~L~~DP~kRpT----a~elL~hp~f~~~p~~~~~~~lp~~ 425 (690)
..++|||+++|.+||.+|.- |.||-+||||.+..|+--...-|.+
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 89999999999999999999 9999999999999998655444444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=391.53 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=220.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ .+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 369999999999999999999999999999999975432 22345668899999999999999999999887 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999998877666656668999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 217 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF---------------- 217 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC----------------
Confidence 234578999999999865 568999999999999999999999999988888777775432111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
...+++.+++||++||+.||.+||+ +++++.||||....|
T Consensus 218 -------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 218 -------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred -------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 1246889999999999999999995 999999999987554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=397.83 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=220.7
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 45789999999999999999999999999999999975432 22345678899999999999999999999987 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999998776666656668999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p------------- 235 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP------------- 235 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC-------------
Confidence 234678999999999975 5679999999999999999999999999888777777654211111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~ 413 (690)
..++..+.+||.+||+.||.+||+ ++++|.||||...
T Consensus 236 ----------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 236 ----------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 136788999999999999999997 7999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=396.55 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=214.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986432 23445667899999999999999999999987 689999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9877666666678999999999999999999999999999999999999999999999999999754322 223345689
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 214 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---------------------- 214 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----------------------
Confidence 999999999875 568999999999999999999999999887776666654321111
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
...+++++.+||.+||+.||.+|| ++.++|+||||....
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 125789999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=378.70 Aligned_cols=294 Identities=42% Similarity=0.721 Sum_probs=244.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec------cC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS------RL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~ 196 (690)
...|+.+.+||+|.||.||+|+...+|+.||+|++..++.....-....+|+.+|..|+|+|++.++++|.. +.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 456888999999999999999999999999999876543222222335789999999999999999998854 12
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...+||||.+|+.++.+++.....+|+..++..+|.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34699999999999999988888899999999999999999999999999999999999999999999999999998765
Q ss_pred ccCc---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNK---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...+ ...+..+.|.||++||.++|...|+++.|||..||||.||+++.|.|++.++..+++.|..+||....+.|.+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 4322 2356788899999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cC-CCCCCCC--CC-CCCCccccccccC--CCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 354 SK-LPHGDMF--KP-QNPYEGCLRERCK--DFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 354 ~~-l~~~~~~--~~-~~~~~~~l~~~~~--~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
.. ++..... .| ...-.+.+..+.+ .-.+++.||+..||..||.+|++++++|+|.||...|-+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 33 3322222 11 0111111222222 225689999999999999999999999999999987643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=397.22 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=235.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.-|.+.+.||+|.|.+|.+|++..+|+.||||++.+..++.-....+.+|+..|+.++|||||+||+++.. ...+|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEE
Confidence 34899999999999999999999999999999999988887777788999999999999999999999987 6899999
Q ss_pred Eeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE-ccCCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV-NNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl-d~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+|+-++| +.+++..+...+.|..+.+|+.||+.|+.|||+..||||||||+||.+ ..-|-|||.|||++..+.. ..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G~ 173 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--GK 173 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC--cc
Confidence 9999874 566677777789999999999999999999999999999999999876 5568999999999988764 46
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.+++.||+..|-|||+|+|..+..+++||||||||||.|+||++||+..++.+.+-+|+...+..|.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs------------- 240 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS------------- 240 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch-------------
Confidence 7788999999999999999887889999999999999999999999999999999999987666554
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.++.+.+|||..||..||.+|.|.+||..|+|++..
T Consensus 241 ----------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 241 ----------------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ----------------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 588999999999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=399.91 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=218.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..++||||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 469999999999999999999999999999999976432 23445678899999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc--
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-- 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-- 280 (690)
|||||+++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999887766666667899999999999999999999999999999999999999999999999999975432110
Q ss_pred --------------------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 281 --------------------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 281 --------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01134689999999999975 568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCC---CCCCHHHHH
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPY---KRGTASSLL 405 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~---kRpTa~elL 405 (690)
+.+..+.+.+|........ + +. ...+++++++||.+||. +|. .||+++|+|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~-p~----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETLI--------------F-PP----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCccc--------------C-CC----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9888888877764221110 0 00 01478899999999875 454 458999999
Q ss_pred cCccccCCCC
Q 041720 406 MCEYFTTQPY 415 (690)
Q Consensus 406 ~hp~f~~~p~ 415 (690)
+||||.+..|
T Consensus 292 ~hp~f~~~~~ 301 (363)
T cd05628 292 TNPFFEGVDW 301 (363)
T ss_pred CCCCCCCCCH
Confidence 9999998644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=385.70 Aligned_cols=288 Identities=36% Similarity=0.680 Sum_probs=236.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|+++++||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++.+ .+.++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 356799999999999999999999999999999998754322 223456789999999999999999999987 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 999999987766665555678999999999999999999999999999999999999999999999999997643322 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC-CC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH-GD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~-~~ 360 (690)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.+....|....... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 23345678999999998776678899999999999999999999999999999999999999988888886421110 00
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+........++......+++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111111222233345788999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=406.19 Aligned_cols=283 Identities=27% Similarity=0.356 Sum_probs=221.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+....|+++++||+|+||.||+|++..+++.||||.... ..+.+|+.+|+.|+|||||++++++.. ....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 158 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFT 158 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCee
Confidence 456679999999999999999999999999999997542 236789999999999999999999987 6789
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
++|||++.+++...+. ....+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 159 ~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999876655443 334689999999999999999999999999999999999999999999999999976443333
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHcCCCChhhhhc
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR-------TEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~-------~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||... ....++..++...+.++.+++..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 33445689999999999865 56899999999999999999999877543 23467777888777766543211
Q ss_pred cCCCCCCCC------CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 354 SKLPHGDMF------KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 354 ~~l~~~~~~------~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
........+ ....+...........++.++.+||.+||++||.+|||+.|+|+||||+..+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000000000 00000000011112246778999999999999999999999999999988653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=395.97 Aligned_cols=285 Identities=32% Similarity=0.532 Sum_probs=228.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|++++.||+|+||.||++++..+|..||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46799999999999999999999999999999999765444455667889999999999999999999986521 13
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 175 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT- 175 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc-
Confidence 579999999987665542 2488999999999999999999999999999999999999999999999999976432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC---
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK--- 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~--- 355 (690)
........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+++....
T Consensus 176 -~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 -NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred -CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 223345678999999999975 568999999999999999999999999999999999998888888766544311
Q ss_pred ------CCCCCCCCCCCCCc----cccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 356 ------LPHGDMFKPQNPYE----GCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 356 ------l~~~~~~~~~~~~~----~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+..........+. ..........++.+++||.+||..||.+|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 00000000000000 00011122457789999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=382.43 Aligned_cols=283 Identities=39% Similarity=0.658 Sum_probs=231.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||.|+||.||+|++..+|+.||+|.+............+.+|+.+++.++||||+++++++.+ .+.+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4889999999999999999999999999999997654333334567789999999999999999999987 67899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999988777665556679999999999999999999999999999999999999999999999999997654322 2234
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI-LKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~P-F~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.+....|............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987766689999999999999999998766 6777788888999988888877767542211111111
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+..+...........+++++.+||.+||+.||.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111122233345789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=400.52 Aligned_cols=263 Identities=28% Similarity=0.456 Sum_probs=219.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++||||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 469999999999999999999999999999999976432 23445668899999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ- 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~- 281 (690)
|||||.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998877666655667999999999999999999999999999999999999999999999999999764321100
Q ss_pred ------------------------------------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 041720 282 ------------------------------------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325 (690)
Q Consensus 282 ------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~ 325 (690)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 1113579999999999865 568999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC---HH
Q 041720 326 ILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT---AS 402 (690)
Q Consensus 326 PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT---a~ 402 (690)
||.+.+..+.+..+......... + ....+++++.+||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~---------------~----------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQF---------------P----------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCC---------------C----------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 99998888777776542111100 0 011478899999999996 9999998 99
Q ss_pred HHHcCccccCCCC
Q 041720 403 SLLMCEYFTTQPY 415 (690)
Q Consensus 403 elL~hp~f~~~p~ 415 (690)
++|.||||....|
T Consensus 292 ~ll~h~~~~~~~~ 304 (364)
T cd05599 292 EIKSHPFFKGVDW 304 (364)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999988644
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=380.63 Aligned_cols=283 Identities=37% Similarity=0.709 Sum_probs=230.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++++.||.|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.+ .+.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4899999999999999999999999999999987654333344567899999999999999999999987 68999999
Q ss_pred eccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.+++...+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999766554433 22568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 33456789999999987766688999999999999999999999999999888888888888887777754221100000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.........+......+++++.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000011112223345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=380.54 Aligned_cols=281 Identities=38% Similarity=0.656 Sum_probs=225.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc---CCCceeeeeceeecc---Ccc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL---DHPNIIKLEGVITSR---LSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~---~~~ 198 (690)
+|++++.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999976433322223455677777665 799999999988642 135
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+++||||+.+++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998766554432 33589999999999999999999999999999999999999999999999999987643
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22344678999999999875 56899999999999999999999999999999999999998888777766542111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....+.+. .........+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1112233345788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=383.83 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=215.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|+..+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|..++|+||+++++++.+ .+.+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 388999999999999999999999999999999765432 2333457889999999999999999999987 6789999
Q ss_pred Eeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 99999876643332 2346899999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+.......+..........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE------------ 223 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc------------
Confidence 3345678999999999975 578999999999999999999999999876544433333322111111
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
....+++++.+||++||+.||.+||+ ++++++||||....|
T Consensus 224 -------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 224 -------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 12357899999999999999999997 899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=394.17 Aligned_cols=265 Identities=27% Similarity=0.433 Sum_probs=223.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|..++||||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 3699999999999999999999999999999999765322 2345678899999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999887777666666899999999999999999999999999999999999999999999999999976543 3
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+....+...........+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---------- 223 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD---------- 223 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC----------
Confidence 345678999999999976 478999999999999999999999999988877776664421111100000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
.....+++++.+||.+||..+|.+|||+.++++||||...+|.
T Consensus 224 -----------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 224 -----------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred -----------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 0012578999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.32 Aligned_cols=292 Identities=37% Similarity=0.651 Sum_probs=236.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
..|+++..||+|+||.||+|....++ +.+|||+++........-...-+|+.+++.|+|||||.|..++... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 35999999999999999999655443 2699999976632222334466899999999999999999999874 689
Q ss_pred EEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC----CcEEEeeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE----GILKLGDFGL 271 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~----~~vKL~DFGl 271 (690)
++|++||.+.+++..+... ...++...+..|+.||+.|+.|||++=|+||||||.||||..+ |.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 9999999999998765432 2358889999999999999999999999999999999999887 8999999999
Q ss_pred ceeccccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHH
Q 041720 272 ANILTSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---------EVEQLHKIF 340 (690)
Q Consensus 272 a~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---------~~e~l~~I~ 340 (690)
++.+.+.-.. .....+.|.||+|||.|+|...|+.++|||++|||+.|||+-.|.|.+.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9987653222 23456789999999999999999999999999999999999999998753 468999999
Q ss_pred HHcCCCChhhhhccC-CCCCC----CCCCCCCCcc---ccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 341 KLCGSPPEEYWKKSK-LPHGD----MFKPQNPYEG---CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~-l~~~~----~~~~~~~~~~---~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
+.+|.|.++.|...+ .|+.. .|........ ......+.-++.+.+|+.+||.+||.+|.|++++|+|+||+.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 999999999997632 33321 1111111111 112233445667999999999999999999999999999998
Q ss_pred CCCC
Q 041720 413 QPYA 416 (690)
Q Consensus 413 ~p~~ 416 (690)
.+.+
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 7654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=393.94 Aligned_cols=285 Identities=29% Similarity=0.500 Sum_probs=229.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 56799999999999999999999999999999999765444455567889999999999999999999876421 24
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 689999999987665543 24788999999999999999999999999999999999999999999999999765332
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP- 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~- 357 (690)
.......+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+.+++...+.+..+++......
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 23345678999999999975 56899999999999999999999999999999999999998888877665542110
Q ss_pred --------CCCCCCCCCCCcc----ccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 --------HGDMFKPQNPYEG----CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 --------~~~~~~~~~~~~~----~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+........ .........+..+++||.+||+.||.+|||+.++|+||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000000000000 0011122346789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.43 Aligned_cols=278 Identities=35% Similarity=0.641 Sum_probs=216.7
Q ss_pred EeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 129 LEKIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
..+||+|+||.||+|++. .+++.||+|.+...... ..+.+|+.+|+.++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999965 46789999999754432 346789999999999999999999876556789999999
Q ss_pred cchhccccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE----ccCCcEEEeeccccee
Q 041720 207 MEHDLAGLSSC--------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANI 274 (690)
Q Consensus 207 ~~g~ll~~~~~--------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl----d~~~~vKL~DFGla~~ 274 (690)
+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99876544321 22358999999999999999999999999999999999999 4557899999999987
Q ss_pred ccccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHc
Q 041720 275 LTSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLHKIFKLC 343 (690)
Q Consensus 275 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~---------~e~l~~I~~~~ 343 (690)
+..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+++..++...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 2234568899999999998766789999999999999999999999976442 46788899999
Q ss_pred CCCChhhhhccCC-CCCCC----C----CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 344 GSPPEEYWKKSKL-PHGDM----F----KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 344 g~~~~~~w~~~~l-~~~~~----~----~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+.+....|..... +.... + .........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9888887765321 10000 0 000000111111122346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=394.28 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=222.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|++.+.||+|+||.||+|.+..++ ..||+|++..... .......+.+|+.+|+.++||||+++++++.+ .+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CC
Confidence 45677999999999999999999876655 6899999975432 23345678899999999999999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 89999999998877666666678999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------- 248 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----------- 248 (340)
T ss_pred ----cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC-----------
Confidence 235679999999999975 5688999999999999999999999999888777777654321111
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~~ 416 (690)
..+++.+.+||++||+.||.+|+ |++++++||||....|.
T Consensus 249 ------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 249 ------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred ------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 24788899999999999999995 89999999999986553
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=398.27 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=215.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58999999999999999999999999999999976532 34456678999999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc---
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK--- 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~--- 280 (690)
||||.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++++||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999887666665566799999999999999999999999999999999999999999999999999754311000
Q ss_pred -------------------------------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHH
Q 041720 281 -------------------------------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVF 317 (690)
Q Consensus 281 -------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviL 317 (690)
......+||+.|+|||++.+ ..++.++||||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 01124579999999999875 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhcc--CC
Q 041720 318 AELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI--EP 395 (690)
Q Consensus 318 yeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~--DP 395 (690)
|||++|.+||...+..+....+.......... ....+++++++||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIP-------------------------PQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCC-------------------------CCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999888777666664321111000 0125789999999996654 55
Q ss_pred CCCCCHHHHHcCccccCCCC
Q 041720 396 YKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 396 ~kRpTa~elL~hp~f~~~p~ 415 (690)
..|++++++|.||||....|
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcCcccCCCCh
Confidence 56999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=395.35 Aligned_cols=263 Identities=31% Similarity=0.476 Sum_probs=222.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|..++||||+++++++.+ .+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 3699999999999999999999999999999999765322 2445678899999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC---
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--- 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~--- 279 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999987666555555789999999999999999999999999999999999999999999999999998665432
Q ss_pred -------------------------cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 041720 280 -------------------------KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334 (690)
Q Consensus 280 -------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e 334 (690)
.......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112345678999999999976 478999999999999999999999999988877
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-HHHHHcCccccCC
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-ASSLLMCEYFTTQ 413 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-a~elL~hp~f~~~ 413 (690)
...++......... + ....+++++.+||.+||. ||.+||+ ++++|+||||...
T Consensus 238 ~~~~i~~~~~~~~~---------------p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRF---------------P----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccC---------------C----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 77776542111100 0 011378999999999997 9999999 9999999999876
Q ss_pred CC
Q 041720 414 PY 415 (690)
Q Consensus 414 p~ 415 (690)
.|
T Consensus 292 ~~ 293 (350)
T cd05573 292 DW 293 (350)
T ss_pred CH
Confidence 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=391.57 Aligned_cols=285 Identities=35% Similarity=0.562 Sum_probs=229.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.+.|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46799999999999999999999999999999999765433344556789999999999999999999886421 24
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|++||++.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 679999999766544332 34699999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+.+.......
T Consensus 171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 23456789999999999776678999999999999999999999999999899999998888877766554321111
Q ss_pred CCCCC--CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~--~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+. ........+...+...++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00000 00000111222334677889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=399.28 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=216.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|+++++||+|+||.||++++..+++.||||++..... .....+.+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 469999999999999999999999999999999875432 33455678899999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ- 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~- 281 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999998776665555667999999999999999999999999999999999999999999999999999643210000
Q ss_pred ---------------------------------------------cccccccccCCCCcccccCCCCCCcchhhHHHHHH
Q 041720 282 ---------------------------------------------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCV 316 (690)
Q Consensus 282 ---------------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGvi 316 (690)
.....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0013579999999999865 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCC
Q 041720 317 FAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPY 396 (690)
Q Consensus 317 LyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~ 396 (690)
||||++|.+||.+.+..+.+..|........ .+ ....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------~p----------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLY---------------FP----------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccC---------------CC----------CCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999999888777777654211100 00 011478899999999997 777
Q ss_pred CC---CCHHHHHcCccccCCCC
Q 041720 397 KR---GTASSLLMCEYFTTQPY 415 (690)
Q Consensus 397 kR---pTa~elL~hp~f~~~p~ 415 (690)
+| +|+.++|.||||....|
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=392.93 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=221.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|.+.+.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999986533 23455678899999999999999999999987 688999
Q ss_pred EEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||++++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999988766554443 367999999999999999999999999999999999999999999999999999876544333
Q ss_pred cccccccccCCCCcccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 282 KLTSRVVTLWYRPPELLMG-----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~-----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.....+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+..+.+.++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 3344578999999999863 34578899999999999999999999998888877777654311000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
. .....+++++.+||..||. ||.+|||+++++.||||....|
T Consensus 230 ------~----------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 230 ------F----------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ------C----------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 0 0012578899999999998 9999999999999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=397.64 Aligned_cols=262 Identities=29% Similarity=0.417 Sum_probs=216.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|+++++||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999975432 23455678899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC----
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---- 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~---- 279 (690)
||||.++.+...+.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999987666555555679999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------cccccccccccCCCCcccccCCCCCCcchhhHHHHHHH
Q 041720 280 ------------------------------------------KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVF 317 (690)
Q Consensus 280 ------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviL 317 (690)
.......+||+.|+|||++.+ ..|+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 001123578999999999975 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC
Q 041720 318 AELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397 (690)
Q Consensus 318 yeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k 397 (690)
|||++|++||.+.+..+...++.......... ....+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-------------------------~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIP-------------------------PQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCC-------------------------CcccCCHHHHHHHHHHc-cCHhH
Confidence 99999999999988877776665421111100 01257899999999987 59999
Q ss_pred CCC---HHHHHcCccccCCCC
Q 041720 398 RGT---ASSLLMCEYFTTQPY 415 (690)
Q Consensus 398 RpT---a~elL~hp~f~~~p~ 415 (690)
|++ ++++++||||....|
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcCh
Confidence 997 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.05 Aligned_cols=268 Identities=24% Similarity=0.387 Sum_probs=223.8
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|+++++||+|+||.||++++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 4567789999999999999999999999999999999975432 22334557889999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 89999999998766655433 36899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCCcccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGS---TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
........+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|........ +
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~---- 268 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---F---- 268 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---C----
Confidence 32333456899999999998653 2478999999999999999999999999888877777754321110 0
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
+ ....++.++.+||.+||+.+|.+ |+|++++|+||||+...|
T Consensus 269 --------~----------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 269 --------P----------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred --------C----------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 0 01247899999999999999988 999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=386.76 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=212.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||+|+||.||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++++.+ .+.+||||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975422 23445678899999999999999999999987 68999999999988
Q ss_pred cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccccc
Q 041720 211 LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290 (690)
Q Consensus 211 ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~ 290 (690)
.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 776666666789999999999999999999999999999999999999999999999999997643222 2334567999
Q ss_pred CCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcc
Q 041720 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEG 370 (690)
Q Consensus 291 ~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~ 370 (690)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~------------------------ 212 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF------------------------ 212 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC------------------------
Confidence 9999999975 568999999999999999999999999888777776664321111
Q ss_pred ccccccCCCChhHHHHHHHhhccCCCCCC---CHHHHHcCccccCC
Q 041720 371 CLRERCKDFTPTAVDLIDTCLSIEPYKRG---TASSLLMCEYFTTQ 413 (690)
Q Consensus 371 ~l~~~~~~is~~l~dLI~~~L~~DP~kRp---Ta~elL~hp~f~~~ 413 (690)
...+++++.+||.+||+.||.+|| ++.++|.||||...
T Consensus 213 -----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 213 -----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 125788999999999999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.17 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=214.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+|+.++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 369999999999999999999999999976432 23445667889999999999999999999987 678999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 9877666666667999999999999999999999999999999999999999999999999998753322 123345678
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+....+.......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 214 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---------------------- 214 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----------------------
Confidence 999999999865 568999999999999999999999999888777766664321111
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
...+++++.+||.+||+.||.+|+ ++.++|+|+||....
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 125789999999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=389.16 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=214.2
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+.||+|+||.||++++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999976532 23445678899999999999999999999987 689999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 8877666666667999999999999999999999999999999999999999999999999998754322 223345679
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+....+.......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 214 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF---------------------- 214 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC----------------------
Confidence 999999999865 568999999999999999999999999877766665553211111
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
...+++++.+||.+||+.||.+|+ ++.++|+||||....|
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 215 -------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred -------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 125788999999999999999997 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=397.69 Aligned_cols=261 Identities=27% Similarity=0.377 Sum_probs=215.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++.+.+ .+.+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 69999999999999999999999999999999965422 22345668899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC----
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---- 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~---- 279 (690)
||||.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999988776666666679999999999999999999999999999999999999999999999999975321000
Q ss_pred --------------------------------------cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH
Q 041720 280 --------------------------------------KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321 (690)
Q Consensus 280 --------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl 321 (690)
.......+||+.|+|||++.+ ..++.++||||||||||+|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence 001123579999999999965 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC--
Q 041720 322 IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-- 399 (690)
Q Consensus 322 tG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-- 399 (690)
+|++||.+.+..+....+......... .....+++++.+||.+|+ .+|.+|+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHI-------------------------PSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccC-------------------------CCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 999999998877776665432111100 001257899999999987 5999999
Q ss_pred -CHHHHHcCccccCCC
Q 041720 400 -TASSLLMCEYFTTQP 414 (690)
Q Consensus 400 -Ta~elL~hp~f~~~p 414 (690)
|+.++|+||||....
T Consensus 293 ~t~~ell~h~~~~~~~ 308 (376)
T cd05598 293 NGADEIKAHPFFKGID 308 (376)
T ss_pred CCHHHHhCCCCcCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=389.65 Aligned_cols=259 Identities=30% Similarity=0.453 Sum_probs=212.3
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+|++++.||+|+||.||++++. .+++.||+|++..... .....+.+..|+.+|..+ +||||+++++++.. .+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999864 5789999999975422 223445678899999999 59999999999887 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 89999999998877665555667999999999999999999999999999999999999999999999999999865443
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhhhcc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV----EQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~----e~l~~I~~~~g~~~~~~w~~~ 354 (690)
........+||+.|+|||++.+...++.++||||||||||+|++|..||...... .....+.... +
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~-------- 228 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--P-------- 228 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--C--------
Confidence 3333445689999999999976556889999999999999999999999753322 2222222110 0
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
.....+++.+.+||.+||+.||.+|| +++++|+||||+...
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 229 -------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00125788999999999999999999 889999999998743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=389.16 Aligned_cols=285 Identities=31% Similarity=0.505 Sum_probs=228.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 56799999999999999999999999999999999765444555677889999999999999999999886521 24
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 579999999987665443 25889999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC--
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL-- 356 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l-- 356 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..++|.....
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 23345688999999999975 5689999999999999999999999999999999888888888877666543210
Q ss_pred -------CCCCC-CCCCC---CCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 357 -------PHGDM-FKPQN---PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 357 -------~~~~~-~~~~~---~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+.... ..+.. .............+..+++||.+||..||.+|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00000 00000 00000011123356788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=393.24 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=221.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|++++.||+|+||.||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ .+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~ 116 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DK 116 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CC
Confidence 4456789999999999999999999999999999999975322 23344567899999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999998766555443 36899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCCcccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGS---TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
........+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+..|........- .
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---p--- 269 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF---P--- 269 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC---C---
Confidence 33333467899999999998653 23788999999999999999999999998888887777653221110 0
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
....++..+++||..||..++.+ |+|+.|+|+||||+...|
T Consensus 270 -------------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 270 -------------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -------------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 01247889999999999865543 899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=371.14 Aligned_cols=285 Identities=39% Similarity=0.660 Sum_probs=235.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||.|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4899999999999999999999999999999998765544555678999999999999999999999987 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99944455444444467999999999999999999999999999999999999999999999999999876544333344
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-CCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP-HGDMFK 363 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~-~~~~~~ 363 (690)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..+....+.+....|...... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5678999999999877667799999999999999999999999999999999999998888877666542211 111111
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
........+....+.++..+.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 111111112333456789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=387.44 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=214.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcE-EEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM-VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..+++.+.+.||.|+||+||+|.+ .|.. ||||++..........+.|.+|+.+|.+|+|||||+++|+|.+. ...
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~-~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP-PGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCc
Confidence 3344566677799999999999976 4555 99999987766655578899999999999999999999999873 227
Q ss_pred EEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCC-eEeccCCcccEEEccCC-cEEEeecccceec
Q 041720 200 IYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRG-IMHRDIKASNILVNNEG-ILKLGDFGLANIL 275 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~g-ivHrDLKp~NILld~~~-~vKL~DFGla~~~ 275 (690)
++||||||++|.+..++.. ...++...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999988776655 678999999999999999999999999 99999999999999998 9999999999876
Q ss_pred cccCcccccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.... ...+...||+.|||||++.+ ...|+.++|||||||+||||+||..||.+....+....+......++-
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~------ 267 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI------ 267 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC------
Confidence 5422 34455789999999999975 367999999999999999999999999999886655555433222221
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.+..||..||..||.+||+..+++.
T Consensus 268 ---------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 ---------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1237789999999999999999999999873
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=392.41 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=224.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
...|..++.||+|+||.||+|++..+++.||||++..+.. ......+++|+.+|.+++++||.++|+.|.. +..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHH
Confidence 3458888999999999999999999999999999987754 3456789999999999999999999999988 789999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
+||||.||.....+.....+.|..+..++++++.||.|||..+.+|||||+.||||..+|.+||+|||.+..+......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r- 167 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR- 167 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence 9999999988777777777799999999999999999999999999999999999999999999999999887654433
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
..+++|||.|||||++. ...|+.++||||||++.|||++|.|||....+...+..|-+.
T Consensus 168 r~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~-------------------- 226 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS-------------------- 226 (467)
T ss_pred cccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--------------------
Confidence 37899999999999997 468999999999999999999999999987664433333111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+. ....+++.+++||..||..||+.||||.++|.|+|++.
T Consensus 227 ----~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 227 ----APPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ----CCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 0000 11268999999999999999999999999999999997
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=382.94 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=217.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCC-ceeeeeceeeccCcceEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHP-NIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~~~L 202 (690)
+|++++.||+|+||.||+|++..+++.||||++..... .....+.+..|+.++..+.|+ +|+.+++++.+ .+.+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 58999999999999999999999999999999976432 234456678899999999765 58889888887 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999988776666566679999999999999999999999999999999999999999999999999987532211 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~--------------- 221 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--------------- 221 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 345678999999999975 5689999999999999999999999999888887777754221111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH-----HHHHcCccccCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-----SSLLMCEYFTTQP 414 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-----~elL~hp~f~~~p 414 (690)
..++.++.+||.+||..||.+|+++ +++++||||....
T Consensus 222 --------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 222 --------------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred --------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 2578899999999999999999986 8999999998743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=391.48 Aligned_cols=265 Identities=27% Similarity=0.412 Sum_probs=220.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||++++..+++.||||++..... .......+.+|+.++..++||||+++++.+.+ .+.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 469999999999999999999999999999999975422 23445678899999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc--
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-- 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-- 280 (690)
|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999887766666666899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 281 --------------------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 281 --------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01124579999999999975 568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC---CHHHHH
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG---TASSLL 405 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp---Ta~elL 405 (690)
+.+..+.+.++........ + + ....+++++++||.+|+ .||.+|+ ++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~-p----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETLV--------------F-P----------PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCcee--------------c-C----------CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9888887777654211000 0 0 00147889999999987 5999998 489999
Q ss_pred cCccccCCCCCC
Q 041720 406 MCEYFTTQPYAC 417 (690)
Q Consensus 406 ~hp~f~~~p~~~ 417 (690)
+||||....|..
T Consensus 292 ~hp~f~~~~~~~ 303 (360)
T cd05627 292 SHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCCCCHHH
Confidence 999999876643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=384.16 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=213.7
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||++..... .......+..|+.++..+ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 233456677888888877 79999999999987 68899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 98777666555668999999999999999999999999999999999999999999999999998754322 22334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.......+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 216 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP-------------------- 216 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC--------------------
Confidence 9999999999865 5689999999999999999999999999988888777754221111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH------HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA------SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa------~elL~hp~f~~~p 414 (690)
..++.++.+||.+||+.||.+||++ +++++||||....
T Consensus 217 ---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 217 ---------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ---------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 1478899999999999999999998 9999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=382.13 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=214.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH---hhcCCCceeeeeceeeccCcceEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMIL---RRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.++ ..++||||+++++++.+ .+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7889999999999999999999999999999975432 223345667776665 56689999999999987 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||||+.++.+..... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 9999999886655443 347999999999999999999999999999999999999999999999999998753322 22
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p-------------- 221 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP-------------- 221 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 3345789999999999875 5689999999999999999999999999888887777654321111
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
..+++.+.+||.+||+.||.+|| ++.++++||||....
T Consensus 222 ---------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 222 ---------------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred ---------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 24788999999999999999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=380.47 Aligned_cols=286 Identities=26% Similarity=0.363 Sum_probs=220.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++++.||+|+||.||++++..++..||+|++.... .......+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 78 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 34678999999999999999999999999999999997642 34556779999999999999999999999987 6789
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999887776666666799999999999999999999986 6999999999999999999999999999765332
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc-CCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS-KLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~-~l~~ 358 (690)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+....+...........+... ..+.
T Consensus 158 --~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2344678999999999975 56899999999999999999999999877665543322111111111111000 0000
Q ss_pred --CCCC----CCCCCCcc-----------ccc-cccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 --GDMF----KPQNPYEG-----------CLR-ERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 --~~~~----~~~~~~~~-----------~l~-~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.... ....+... ... .....+++++++||.+||+.||++|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 00000000 000 0012468899999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=399.97 Aligned_cols=284 Identities=23% Similarity=0.296 Sum_probs=220.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC------Cceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH------PNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~~~~~~ 194 (690)
....+|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.+.| .+|+++++++..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34578999999999999999999999999999999996432 223345667777777654 468999998876
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCC-----------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEG----------- 262 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~----------- 262 (690)
. ...+|||||++.++++..+.. ...+++..++.++.||+.||.|||+ .|||||||||+||||+.++
T Consensus 203 ~-~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 E-TGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred C-CceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 3 568999999997776665543 3579999999999999999999998 5999999999999998765
Q ss_pred -----cEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 041720 263 -----ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337 (690)
Q Consensus 263 -----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~ 337 (690)
.+||+|||++.... ...+..+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999985422 23355789999999999976 568999999999999999999999999999999999
Q ss_pred HHHHHcCCCChhhhhccCCCCCC-------CCCCCCCCccccccc-------cCCCChhHHHHHHHhhccCCCCCCCHHH
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGD-------MFKPQNPYEGCLRER-------CKDFTPTAVDLIDTCLSIEPYKRGTASS 403 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~-------~~~~~~~~~~~l~~~-------~~~is~~l~dLI~~~L~~DP~kRpTa~e 403 (690)
.|...++.++..++......... ...+.. ....+... ....++.+.|||.+||++||.+|||++|
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCT-DPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccC-CHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 99999998887765432111000 000000 00000000 0012466889999999999999999999
Q ss_pred HHcCccccCCCC
Q 041720 404 LLMCEYFTTQPY 415 (690)
Q Consensus 404 lL~hp~f~~~p~ 415 (690)
+|+||||.....
T Consensus 435 ~L~Hp~~~~~~~ 446 (467)
T PTZ00284 435 MTTHPYVLKYYP 446 (467)
T ss_pred HhcCccccccCC
Confidence 999999987543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=383.15 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=217.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||++++..+++.||||++.+.. ......+.+.+|+.++..++|+||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 47999999999999999999999999999999997532 223345668899999999999999999999987 689999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999998876554443 3557999999999999999999999999999999999999999999999999999766543333
Q ss_pred cccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 3334578999999999863 34578899999999999999999999998887777777654221110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
+......++..+++||++||..++.+ |+++.++|+||||....|
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 00011247899999999999765544 789999999999987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=380.56 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=218.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~L 202 (690)
+|++++.||+|+||.||+|++..+++.||||++.+... .......+..|+.++..+ +|++|+++++++.+ .+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 58999999999999999999999999999999986532 233345567788888887 58999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999987776666556679999999999999999999999999999999999999999999999999997543221 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 221 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--------------- 221 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 345678999999999975 5689999999999999999999999999888888877765322111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
..++.++.+||.+||+.||.+|++ ..++++||||....|
T Consensus 222 --------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 222 --------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred --------------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 257889999999999999999998 489999999987554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.73 Aligned_cols=277 Identities=34% Similarity=0.626 Sum_probs=214.0
Q ss_pred eEEeecCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVA--TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
.+||+|+||.||+|++.. ++..||+|.+...... ..+.+|+.+|+.++||||+++++++.......+++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998653 5688999998754322 3467899999999999999999998765567899999999
Q ss_pred chhccccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE----ccCCcEEEeecccceec
Q 041720 208 EHDLAGLSSC--------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANIL 275 (690)
Q Consensus 208 ~g~ll~~~~~--------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl----d~~~~vKL~DFGla~~~ 275 (690)
.+++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9876554321 22358899999999999999999999999999999999999 45679999999999876
Q ss_pred cccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHcC
Q 041720 276 TSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLHKIFKLCG 344 (690)
Q Consensus 276 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~---------~e~l~~I~~~~g 344 (690)
..... ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||....+ ..++..++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 1234567899999999997766789999999999999999999999976432 456778888888
Q ss_pred CCChhhhhccCCC-CC----CCC----CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 345 SPPEEYWKKSKLP-HG----DMF----KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 345 ~~~~~~w~~~~l~-~~----~~~----~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.+....|...... .. ..+ .................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8887777652211 00 000 000000001111122456679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=370.33 Aligned_cols=290 Identities=40% Similarity=0.677 Sum_probs=234.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ---PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ......+..|+.+++.++|+||+++++++.+ .+.++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 388899999999999999999999999999999866433 3334567789999999999999999999988 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.+++...+......+++..+..++.||++||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999444444433333379999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|........ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD-Y 236 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc-c
Confidence 233446688899999987666789999999999999999999999999999899999988888777776653221110 0
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
.................++..+.+||.+||+.||.+|||+.|+|.|+||.+.+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 011111111122334567889999999999999999999999999999999776554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=381.98 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=214.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||++..... .......+..|+.++..+ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999976432 234455677899999876 89999999999987 68899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 988776555556679999999999999999999999999999999999999999999999999997643222 2334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p-------------------- 216 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP-------------------- 216 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence 8999999999865 5689999999999999999999999999998888877754321111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCC-------CHHHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-------TASSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-------Ta~elL~hp~f~~~p 414 (690)
..++.++.+||.+||+.||.+|| ++.++++||||....
T Consensus 217 ---------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 217 ---------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred ---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 13678999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=388.52 Aligned_cols=269 Identities=25% Similarity=0.366 Sum_probs=221.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..+..++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--C
Confidence 34556889999999999999999999999999999999975322 23334567899999999999999999999987 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||||+++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 889999999998766555443 3589999999999999999999999999999999999999999999999999987654
Q ss_pred cCcccccccccccCCCCcccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGS---TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.........+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|........-
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------ 268 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF------ 268 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC------
Confidence 333333457899999999998653 23789999999999999999999999998888777777643221110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
.....++..+++||..||..++.+ |++++++++|+||...+|
T Consensus 269 -------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 269 -------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 001258899999999999844433 789999999999988654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=384.76 Aligned_cols=252 Identities=22% Similarity=0.381 Sum_probs=213.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|+.++..++||||+++++++.. .+.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999976432 23345667889999999999999999999987 688999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
++.+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 88776666666679999999999999999999997 79999999999999999999999999998754322 22334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--------------------- 215 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCC---------------------
Confidence 9999999999865 568999999999999999999999999887766666553321111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
...+++++.+||.+||+.||.+|+ ++.++|+||||....
T Consensus 216 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 216 --------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 125788999999999999999997 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.61 Aligned_cols=286 Identities=44% Similarity=0.738 Sum_probs=234.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||.|+||.||+|.+..+++.||||.++...........+.+|+.++++++||||+++++++.+...+.+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56999999999999999999999999999999998654443334456789999999999999999999887434899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ...
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 163 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPY 163 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-ccc
Confidence 9999986655555545569999999999999999999999999999999999999999999999999998765432 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC-CCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK-LPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~-l~~~~~~ 362 (690)
....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.+....|.... ++.....
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 445678899999998776667899999999999999999999999999999999999999988888776522 2221111
Q ss_pred CCCCCCccccccccCC--CChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKD--FTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~--is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.........+...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111222233333 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.16 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=232.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|..++.||+|+||.+++++++.+++.|++|.+..........+...+|+.+++++.|||||.+++.|... +..++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 4679999999999999999999999999999999998887766677889999999999999999999999883 344999
Q ss_pred EEeccchhccccccc-CC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 203 VFEYMEHDLAGLSSC-HD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||+||+|+.+...+. .. ..|+|..++.|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999987654443 33 469999999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
....+.+||+.||+||++.+ .+|+.++|||||||++|||++-+++|.+.+-.....+|++....|...
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~----------- 228 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS----------- 228 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc-----------
Confidence 45677899999999999975 789999999999999999999999999999999999999887555432
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.++.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 229 -----------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 229 -----------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 67899999999999999999999999999877764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=381.23 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=212.3
Q ss_pred EeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 129 LEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++.||+|+||.||++++. .+++.||||++..... .......+.+|+.+|+.++||||+++++++.. .+.+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999864 5788999999975432 12334557889999999999999999999987 6789999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++.+.......+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999988776666666778999999999999999999999999999999999999999999999999997543222 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+.+..+.......
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~----------------- 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL----------------- 219 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 44678999999999875 567899999999999999999999999988877777765422111
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQ 413 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~ 413 (690)
...+++.+.+||.+||+.||.+|| ++++++.||||...
T Consensus 220 ------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 220 ------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 124788999999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=382.33 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=209.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|+.+++||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++|+||+++++++.+ .+.+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEE
Confidence 4567899999999999999999999999999999996543 34455678999999999999999999999987 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+|||||.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 99999998765432 245678889999999999999999999999999999999999999999999998764321 2
Q ss_pred cccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.....+||..|+|||++.. ...++.++|||||||+||+|++|+.||......+....+.........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 294 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP--------- 294 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC---------
Confidence 2345688999999998743 233457899999999999999999999743322222222111111000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++.++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 295 ----------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 295 ----------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 01125788999999999999999999999999999998754
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=369.41 Aligned_cols=282 Identities=39% Similarity=0.710 Sum_probs=228.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|++++.||.|+||.||+|++..+|..||||++............+.+|+.++++++||||+++++++.+ .+.+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 3899999999999999999999999999999987654444444578899999999999999999999987 68899999
Q ss_pred eccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 205 EYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 205 Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||+.+++...+.. ....+++..+..++.||+.||.|||+.+++|+||+|+|||++.++.+||+|||++..+.... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998765544332 23568999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC-CCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL-PHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l-~~~~~~ 362 (690)
....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+.+++...+.+....|..... +.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3456788999999987766678899999999999999999999999999889999988888887776653111 100000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.+.. ....+....+.+++++++||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKW-ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccc-cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0110 0111222234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.47 Aligned_cols=257 Identities=26% Similarity=0.344 Sum_probs=221.4
Q ss_pred cCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeecc--Ccc
Q 041720 123 AESFEKL-EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSR--LSN 198 (690)
Q Consensus 123 ~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~--~~~ 198 (690)
.++|.+- ++||-|-.|.|..|.++.|++.+|+|++.-. ....+|+++.-.. .|||||.++|+|+.. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4556654 5799999999999999999999999998632 2356788776555 699999999999753 245
Q ss_pred eEEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC---CcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---~~vKL~DFGla~ 273 (690)
.+.||||.|+||.|+..+...+ .|+|.++..|++||..|+.|||+.+|.||||||+|+|+... ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6789999999998876665544 49999999999999999999999999999999999999654 579999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCChh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT----EVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~----~~e~l~~I~~~~g~~~~~ 349 (690)
.-.. ...+.+.|.||.|.|||++ |...|+..+|+||+|||+|.||||+|||.... ....-.+|....+.+|++
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 7543 3566788999999999988 56779999999999999999999999997653 345778899999999999
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.|+ .+|.+++|+|+.||..+|.+|.|+++++.|||+...+
T Consensus 290 EWs-------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 290 EWS-------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHh-------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 998 6999999999999999999999999999999998754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=364.22 Aligned_cols=283 Identities=37% Similarity=0.649 Sum_probs=227.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.|++...||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999999999999999987554333334567899999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||++++++.........+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+..... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999988877666666799999999999999999999999999999999999999999999999999987654321 23
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh---hhhccCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE---YWKKSKLPHGD 360 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~---~w~~~~l~~~~ 360 (690)
....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+..... .|.........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 345678899999998776678899999999999999999999999988888777776655543322 11111110000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
. .+.......+......++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 S-IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred c-CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 011000111222345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=377.77 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=209.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||+++.... .....+.+..|..++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986432 223344556677777654 89999999999987 67899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 988776666666689999999999999999999999999999999999999999999999999997653322 3334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF--------------------- 215 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 9999999999975 568999999999999999999999999988877776664321110
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH-HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-~elL~hp~f~~~p 414 (690)
...++.++.+||.+||+.||.+||++ .+++.||||....
T Consensus 216 --------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 216 --------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 12478899999999999999999986 5888999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.54 Aligned_cols=264 Identities=25% Similarity=0.414 Sum_probs=235.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|+.+++||+|.||+|.+|+.+.+++.+|||+++++.+ ..+.+..-+.|-.+|+..+||.+..|.-.|+. .+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~d 241 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QD 241 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--Cc
Confidence 3457889999999999999999999999999999999988743 44555667789999999999999999877877 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||..||.+...+.+...|+|+.++.+-..|+.||.|||+++||+||||.+|+|||.+|++||+||||++.-..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 9999999999999988888888899999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......++||||.|+|||+|.. ..|+.++|+|.+||+||||+||+.||...+...+...|+...-.+|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----------- 388 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----------- 388 (516)
T ss_pred ccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-----------
Confidence 3456788999999999999964 6799999999999999999999999999988888888876544444
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPYA 416 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~~ 416 (690)
..++++++.|+..+|..||.+|.- |.|+.+|+||....|.
T Consensus 389 ------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 389 ------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 268999999999999999999964 8999999999988774
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=369.28 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=207.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||+|+||+||++.+..+++.||||++...... ....+.+..|+.+|+.++|+||+++++++.. ...+||||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999999765332 2234567889999999999999999999887 67899999999987
Q ss_pred cccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccc
Q 041720 211 LAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 211 ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccccc
Confidence 665332 234569999999999999999999999999999999999999999999999999997764332 223446
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+.
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 218 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------------------ 218 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC------------------
Confidence 78999999999975 56889999999999999999999999875433222222211111110
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCCC
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~~ 416 (690)
.....+++.+.+||.+||+.||.+|| |++++|+||||+...|.
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 219 -------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 01125788999999999999999999 89999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.16 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=209.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+|+.||||+++.... .......+..|+.++..+ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999976432 122345567788888765 89999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 98776655555667999999999999999999999999999999999999999999999999998753221 22334578
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------- 215 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY--------------------- 215 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------------
Confidence 9999999999975 568999999999999999999999999888777666653321100
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH-HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-~elL~hp~f~~~p 414 (690)
...++.++.+||.+||..||.+||++ +++++||||....
T Consensus 216 --------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 216 --------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 11368899999999999999999998 5899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=379.03 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=210.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHH-HHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIM-ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||+||+|++..+|+.||||++...... ......+..|.. +++.++||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 3699999999999999999999999999754321 222344555554 5678999999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99877666666678999999999999999999999999999999999999999999999999998753222 22334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR---------------------- 214 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999875 56899999999999999999999999998887777766542111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f~~~p 414 (690)
....+++.+.+||.+||+.||.+||++ .++++||||....
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 215 -------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 112578899999999999999999997 6999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=380.90 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=212.8
Q ss_pred eEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
+.||+|+||.||++++. .+|+.||+|++............+.+|+.+|++++||||+++++++.+ .+.+||||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 57999999999999863 578999999998654333344567789999999999999999999987 6899999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccc
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9987666555556679999999999999999999999999999999999999999999999999997654322 233456
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p------------------- 218 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP------------------- 218 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC-------------------
Confidence 78999999999865 5678999999999999999999999999888877777654221111
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCC
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQ 413 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~ 413 (690)
..+++.+.+||.+||+.||.+||| +.+++.||||...
T Consensus 219 ----------~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 219 ----------QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ----------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 247889999999999999999999 7889999999874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=363.04 Aligned_cols=281 Identities=38% Similarity=0.581 Sum_probs=226.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|+++++||+|+||.||+|.+..++..||+|++......... ....+|+.++.++. |+||+++++++.+...+.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67899999999999999999999999999998754322222 23457899999985 99999999999874347899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++. +.+||+|||++..+... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99998777666555567899999999999999999999999999999999999999 99999999999876432 2223
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...+++.|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+++..+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987655667899999999999999999999999999999999998888887775543221111111111
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.......+......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111112222334678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.21 Aligned_cols=284 Identities=37% Similarity=0.678 Sum_probs=225.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||.|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++|+||+++++++.+ .+..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 467999999999999999999998899999999987543221 22346689999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999987666555545578999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhccCCCCC-C
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCGSPPEEYWKKSKLPHG-D 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g~~~~~~w~~~~l~~~-~ 360 (690)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.. ..+++..+.+..+.+....|........ .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2334568899999998766668899999999999999999999998766 6677888888888887777754221100 0
Q ss_pred CCCCCCCCccccccccCCCC--hhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is--~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...........+......++ .++.+||.+||+.||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000111222223444 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=368.52 Aligned_cols=288 Identities=45% Similarity=0.818 Sum_probs=232.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL------ 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 196 (690)
.++|++.++||.|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998765433222345678999999999999999999876532
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...+++||||+.+++...+......+++..+..++.||++||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999987776666555679999999999999999999999999999999999999999999999999997654
Q ss_pred ccCc----------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 277 SKNK----------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 277 ~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
.... ...+...+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112345678899999998766668999999999999999999999999999999999999998887
Q ss_pred ChhhhhccCC-CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 347 PEEYWKKSKL-PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 347 ~~~~w~~~~l-~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.+..|..... +..............+...+..+++.+.+||.+||+.||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7766654221 111110111111122233445677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=377.76 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=217.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|+++++||+|+||.||++++..+++.||+|++.+... .......+..|+.++..++|+||+++++++.+ .+.+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 469999999999999999999999999999999965321 22334557889999999999999999999987 689999
Q ss_pred EEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999988766544433 457999999999999999999999999999999999999999999999999999765443333
Q ss_pred cccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.....+||+.|+|||++.+ ...++.++|||||||+||+|++|++||.+.+..+.+.++.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------
Confidence 3344679999999999862 34688999999999999999999999999888888777754211110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
.......+++++++||.+||..++.+ |++++++++||||....|
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00112357899999999999765544 789999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.09 Aligned_cols=289 Identities=44% Similarity=0.802 Sum_probs=234.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC-----
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----- 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 196 (690)
..++|++.+.||.|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 356799999999999999999999999999999999765433333456778999999999999999999987632
Q ss_pred ---cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 197 ---SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 197 ---~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
...++|||||++++++..+......+++..+..++.||+.||.|||+.||+|+||||+|||+++++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 23789999999987766665555579999999999999999999999999999999999999999999999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.+............++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 76543333333445688899999887655678999999999999999999999999999999999999888887776653
Q ss_pred cC-CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 354 SK-LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 354 ~~-l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.. .+..............+...+..++..+.+||..||..||.+|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 21 1111111111111122333445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=377.88 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=206.3
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||+++..... ......+..|+.++..+ +||||+++++++.+ .+.+|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999999865332 34456688999999998 79999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 98877655555668999999999999999999999999999999999999999999999999998753221 22334568
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHH-HHHHHHcCCCChhhhhccCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--------EVEQL-HKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--------~~e~l-~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+ +.+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------------- 222 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--------------
Confidence 9999999999975 568999999999999999999999996321 11111 11211000
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC------HHHHHcCccccCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT------ASSLLMCEYFTTQP 414 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT------a~elL~hp~f~~~p 414 (690)
.....++..+.+||.+||+.||.+|+| ++++++||||....
T Consensus 223 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 223 ---------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 011257889999999999999999987 78999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=367.43 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=214.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|++.++||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+ .+.+|+||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEE
Confidence 88999999999999999999999999999999764332 2233557789999999999999999999987 57899999
Q ss_pred eccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..+... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 157 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ET 157 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--Cc
Confidence 9999876654332 2346899999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 223 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE------------- 223 (285)
T ss_pred cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc-------------
Confidence 234578999999999875 568999999999999999999999999876655444433321111110
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~~ 416 (690)
....++..+.+||.+||..||.+|| ++++++.||||....|.
T Consensus 224 ------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 224 ------------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ------------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 1125788999999999999999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.67 Aligned_cols=285 Identities=52% Similarity=0.952 Sum_probs=236.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++++.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.+...+.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 68899999999999999999999999999999876433344566889999999999999999999998732378999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+++++...+......+++..++.++.||+.||.|||+.|++|+||||+|||+++++.+||+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99987666665554679999999999999999999999999999999999999999999999999998765543333445
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC-CCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL-PHGDMFKP 364 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l-~~~~~~~~ 364 (690)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..+...++.+....|..... .....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56788999999887666689999999999999999999999999999999999999888888777764222 11122222
Q ss_pred CCCCccccccccCCC-ChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 365 QNPYEGCLRERCKDF-TPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 365 ~~~~~~~l~~~~~~i-s~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.......+....... ++.+.++|.+||+.||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 233333333444444 8999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=375.58 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=213.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||+||+|.+..++..||||++.+... .......+.+|+.++..+ +||||+++++++.+ .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986532 233456677899999888 79999999999987 67899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccccee
Confidence 98877666666668999999999999999999999999999999999999999999999999998753222 12334467
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY--------------------- 215 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999975 568999999999999999999999999888777666654321111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH-----HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-----SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-----~elL~hp~f~~~p 414 (690)
...++..+.+||.+||..||.+|||+ .+++.||||....
T Consensus 216 --------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 216 --------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred --------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 12478899999999999999999999 9999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.35 Aligned_cols=284 Identities=37% Similarity=0.644 Sum_probs=233.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+|+.++|+||+++++++.+ .+.+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 6999999999999999999999999999999987654444555778999999999999999999999987 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++++..+......+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++..+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 99999887766666667999999999999999999999999999999999999999999999999999876654433445
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-CCCC-C
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP-HGDM-F 362 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~-~~~~-~ 362 (690)
..+++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+..+...+...... .... .
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 5678999999999977547899999999999999999999999998888888888777776665544321110 0000 0
Q ss_pred CCCCCCcccccccc-CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERC-KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~-~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.++......+...+ ..++.++.+||.+||..||.+|||+++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00111111112222 2348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=374.31 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=216.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 202 (690)
+|+..+.||+|+||.||+|++..+|+.||||++..... .....+.+..|+.++..+. |++|+++++++.+ .+.+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47889999999999999999999999999999976432 2334456778999998885 5778889998887 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999988776666666679999999999999999999999999999999999999999999999999997543221 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p--------------- 221 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--------------- 221 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 344678999999999865 5689999999999999999999999999888877777765322111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
..++.++.+||.+||+.||.+|++ ..++++||||....|
T Consensus 222 --------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 222 --------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred --------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 247889999999999999999997 579999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.62 Aligned_cols=282 Identities=37% Similarity=0.684 Sum_probs=230.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|+++++||.|++|.||+|++..+|..||||++...... .....+.+|+.+++.++||||+++++++.+ .+.++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 489999999999999999999999999999999765432 223557789999999999999999999988 67899999
Q ss_pred eccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.+++...+.... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999987666544332 468999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|++||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..++.....+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23456789999999987766788999999999999999999999999999999999999888888777764331111000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
..+...........+.+++.+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000001111222334578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.08 Aligned_cols=287 Identities=39% Similarity=0.727 Sum_probs=232.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||.|+||.||+|.+..+|+.||||.+............+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 56999999999999999999999999999999987654433444568899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||+++++........ ..+++..++.++.||+.||.|||+++|+|+||+|+|||++. ++.+||+|||++...... ..
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VR 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-cc
Confidence 9999876655543322 23688889999999999999999999999999999999985 457999999999765432 12
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC-CCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK-LPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~-l~~~~ 360 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23445678999999998766678899999999999999999999999999989999999988888888876421 11111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
...+... ...+....+.+++.+.+||.+||+.||.+||++.++|.||||....
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1111100 1122223456889999999999999999999999999999998743
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=381.42 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=209.3
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc---CCCceeeeeceeeccCcceEEEEEecc
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL---DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
||+|+||+||+|++..+++.||||++..... .......+..|..++..+ .||||+++++++.+ .+.+||||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999975432 222334456677777765 69999999999987 68899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 987766555566789999999999999999999999999999999999999999999999999997543222 2334568
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+..+.+..+.......+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-------------------- 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence 999999999997666689999999999999999999999998887776666543211111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCC----CHHHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG----TASSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp----Ta~elL~hp~f~~~p 414 (690)
...+++++.+||.+||+.||.+|| ++.++|+||||....
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 014688999999999999999998 799999999998743
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.29 Aligned_cols=288 Identities=42% Similarity=0.695 Sum_probs=228.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL------ 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 196 (690)
.++|+++++||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998755433333345678999999999999999999886521
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...+++||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24569999999987776665555579999999999999999999999999999999999999999999999999997654
Q ss_pred ccCc---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNK---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.... .......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...++..+...|..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1223456788999999987766678999999999999999999999999998888888888888887776654
Q ss_pred cCCCC-CCCC-CCCCCCcccccc-ccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 354 SKLPH-GDMF-KPQNPYEGCLRE-RCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 354 ~~l~~-~~~~-~~~~~~~~~l~~-~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
..... .... .+.......... .....+..+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 32111 0000 111111000000 011245778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=364.16 Aligned_cols=284 Identities=36% Similarity=0.636 Sum_probs=229.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.|+++++||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.+ .+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46999999999999999999998899999999987654433445668899999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++++.........+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998777665555568999999999999999999999999999999999999999999999999998765433 333
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC-CC-CCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK-LP-HGDM 361 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~-l~-~~~~ 361 (690)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......-.... .+ ....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 456789999999998766667889999999999999999999999988888888887766554332111000 00 0001
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
..+............+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111111122233456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.36 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=217.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||++++..+++.||||++.... ........+.+|+.++..++|+||+++++++.+ .+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 47999999999999999999999999999999997532 223344567889999999999999999999987 689999
Q ss_pred EEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999998766554433 567999999999999999999999999999999999999999999999999999876543332
Q ss_pred cccccccccCCCCcccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGS----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~----~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.++......++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 33346799999999998642 3578899999999999999999999998888777776654211110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~ 415 (690)
+......++.++++||.+||..++.+ |+++++++.|+||....|
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 00111257899999999999976654 579999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=376.33 Aligned_cols=253 Identities=23% Similarity=0.405 Sum_probs=206.2
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986532 234456678899998877 89999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 988776666566689999999999999999999999999999999999999999999999999997543221 2334568
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHH-HHHHHHHHcCCCChhhhhccCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--------EVE-QLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--------~~e-~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ..+ ....+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------------- 222 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------------- 222 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------------
Confidence 8999999999975 568999999999999999999999995211 111 1122211100
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC------HHHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT------ASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT------a~elL~hp~f~~~p~ 415 (690)
.....++..+.+||.+||+.||.+||| +.++++||||....|
T Consensus 223 ---------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 223 ---------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 011257889999999999999999998 589999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=372.87 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=210.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||++..... ..........|..++..+ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999976432 122344566788888764 99999999999987 67899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 987776665555679999999999999999999999999999999999999999999999999997532211 2334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--------------------- 215 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------------
Confidence 8999999999875 568999999999999999999999999988777766653211000
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCHH-HHHcCccccCCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS-SLLMCEYFTTQPY 415 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~-elL~hp~f~~~p~ 415 (690)
...++.++.+||.+||+.||.+||++. ++++||||....|
T Consensus 216 --------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 216 --------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred --------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 013678899999999999999999996 8999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=358.44 Aligned_cols=260 Identities=32% Similarity=0.492 Sum_probs=215.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++.+.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++.+ ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998775444444445679999999999999999999988 688999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+.++.+..+......+++..++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||++... .........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999766555545567999999999999999999999999999999999999999999999999999764 223345556
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
..+++.|+|||++.....++.++||||||+++|+|++|..||......+....+...........+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 225 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ------------ 225 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc------------
Confidence 78899999999987346789999999999999999999999998754444444443332222111110
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....+..+.+||..||+.||.+|||+.++++||||
T Consensus 226 ----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 ----------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 01123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=375.75 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=209.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHH-HHHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREI-MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||+|++...... ......+..|. .+++.++||||+++++++.+ .+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999999754321 12223344444 45788999999999999987 68899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 99877766666677999999999999999999999999999999999999999999999999999754322 22344567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ---------------------- 214 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----------------------
Confidence 9999999999875 56899999999999999999999999998888877776542111
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCHH----HHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS----SLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~----elL~hp~f~~~p 414 (690)
....+++.+.+||.+||+.||.+|+++. ++++|+||....
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 215 -------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 1125789999999999999999999876 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.97 Aligned_cols=286 Identities=40% Similarity=0.704 Sum_probs=226.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCc---ce
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLS---NT 199 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~---~~ 199 (690)
+.|++.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999999999999998765433333456788999999995 6999999998876211 23
Q ss_pred EEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeeccccee
Q 041720 200 IYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANI 274 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~ 274 (690)
+|+||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999998765554322 235899999999999999999999999999999999999998 88999999999976
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 22233467889999999876667899999999999999999999999999999999999888887777666432
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.........+.. ....+....+.+++.+.+||.+||..||.+|||+.|+|.||||+
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111100000100 01112222356889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=376.09 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=209.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIM-ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||+||+|++..+|+.||||++..... .......+..|.. +++.++||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 2233344555655 5677999999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99877666666678999999999999999999999999999999999999999999999999998753322 12334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~---------------------- 214 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV---------------------- 214 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc----------------------
Confidence 9999999999875 56889999999999999999999999998877777666442100
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccccCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYFTTQP 414 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f~~~p 414 (690)
..+.++..+.+||.+||..||.+||++ .+++.||||....
T Consensus 215 -------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 215 -------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 112578899999999999999999986 5999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=359.90 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=224.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEeccc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+.||+|+|+.|--|....+|..||||+|.+. ......++.+|++++.++ .|+||++|+++|++ ...+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEeccc
Confidence 4699999999999999999999999999865 355667899999999999 59999999999998 789999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeecccceecc------ccC
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILT------SKN 279 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~~~~------~~~ 279 (690)
||.+-..+.+...|+|.++..++++|+.||.|||.+||.||||||+|||..... .||||||.|..-+. ...
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 987766677777899999999999999999999999999999999999996654 58999999875432 112
Q ss_pred cccccccccccCCCCccccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHH
Q 041720 280 KQKLTSRVVTLWYRPPELLM----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---------------EVEQLHKIF 340 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~----~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---------------~~e~l~~I~ 340 (690)
.-.+.+.+|+..|||||++. ....|+.++|.||||||||.||+|++||.|.- ...+++.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 23456788999999999863 23568999999999999999999999998752 345678888
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
...+.+|++.|- .+|.+++|||..+|..|+.+|.++.++|+|||++...
T Consensus 320 EGkYeFPdkdWa-------------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 320 EGKYEFPDKDWA-------------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred ccCCcCChhhhH-------------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 899999999997 6999999999999999999999999999999998743
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.63 Aligned_cols=281 Identities=39% Similarity=0.737 Sum_probs=227.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++++.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.+ .+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998664443344567889999999999999999999987 689999999
Q ss_pred ccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
|+.+.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+.... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99765554433322 368999999999999999999999999999999999999999999999999997654322 2223
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC-CCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG-DMFK 363 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~-~~~~ 363 (690)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.+++...+.+....|........ ....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 446688999999887656678999999999999999999999999999888889998888888777754221110 0000
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+.. ...........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 0111222345788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=372.54 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=207.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIM-ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||++.+... .......+..|+. +++.++||||+++++++.+ .+.+|||||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 1223344555554 6788999999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 98877665556667999999999999999999999999999999999999999999999999998753221 12334567
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ---------------------- 214 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999865 56899999999999999999999999998877766665432100
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccccCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYFTTQ 413 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f~~~ 413 (690)
.....+..+.+||.+||+.||.+||++ .++++|+||...
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 215 -------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 012467889999999999999999875 599999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=380.42 Aligned_cols=281 Identities=26% Similarity=0.325 Sum_probs=219.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...+|++++.||.|+||.||+|... .++..||+|.+.... ...+|+.+|+.|+|||||++++++.. ...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~ 160 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KST 160 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCE
Confidence 3457999999999999999999754 456789999886432 34689999999999999999999987 678
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+|||++.+++...+ .....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 161 ~~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999999988766655 445579999999999999999999999999999999999999999999999999997654332
Q ss_pred cc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhhhccC
Q 041720 280 KQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 280 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.. .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.. ....+..|...++..+.++.....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 2234678999999999865 568999999999999999999999997653 456677777776655544322110
Q ss_pred CC-------CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 356 LP-------HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 356 l~-------~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
.. ......+....+..+. ...++.++.+||.+||..||.+|||+.|+|.||||...|+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 0000001111111111 1246778999999999999999999999999999998764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=370.04 Aligned_cols=285 Identities=31% Similarity=0.520 Sum_probs=227.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
..+|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999999999999999998754444455566788999999999999999999886421 24
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
..||||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999998866654432 2899999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++...++.++.+++.......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred --CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22334567899999999975 568999999999999999999999999999999999999999988876654321100
Q ss_pred CCCC--------------CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMF--------------KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~--------------~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.... .+...+...........++.+.+||.+||+.||.+|||+.|+|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0000 000000000001122356678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=376.69 Aligned_cols=277 Identities=23% Similarity=0.325 Sum_probs=212.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
...|++++.||+|+||.||+|++..++..||+|+..... ...|+.+|+.++||||+++++++.. .+..++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 346999999999999999999999999999999864332 3469999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+++...+......+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9999998877776666667999999999999999999999999999999999999999999999999999753321 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCC---------HHHHHHHHHHHcCCCChhhhh
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRT---------EVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~-~PF~~~~---------~~e~l~~I~~~~g~~~~~~w~ 352 (690)
.....||+.|+|||++.+ ..++.++|||||||+||+|+++. ++|.... ....+..++...+..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 345678999999999975 56899999999999999999854 4554321 123445555555544433321
Q ss_pred ccC--CCC---CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 353 KSK--LPH---GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 353 ~~~--l~~---~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
... +.. ........+...........++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 000 000000011111101112357788999999999999999999999999999975
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=358.64 Aligned_cols=284 Identities=37% Similarity=0.596 Sum_probs=222.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|.+++.||+|+||.||+|.+..+|..||||++...... .....+.+|+.+|+.++|+||+++++++.+ .+..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 35799999999999999999999999999999998754322 222356789999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++++..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999887776665555568889999999999999999999999999999999999999999999999997643322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhccCC-CCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCGSPPEEYWKKSKL-PHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g~~~~~~w~~~~l-~~~~ 360 (690)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+....+.+.+..|..... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3345678999999998765668889999999999999999999998654 4466777777777776665543211 1000
Q ss_pred CCCCCCCCcccccccc--CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERC--KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~--~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...........+.... ...++.+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000000001111111 1236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=389.08 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=220.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc---
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS--- 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--- 197 (690)
...++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999999999999999998776666677788999999999999999999887754211
Q ss_pred ---ceEEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecc
Q 041720 198 ---NTIYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 198 ---~~~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFG 270 (690)
..+++||||+.++.+...+. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 24789999999876554332 23468999999999999999999999999999999999999999999999999
Q ss_pred cceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 271 LANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 271 la~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
+++.+..... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+..+.+..+......+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~--- 264 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--- 264 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---
Confidence 9987543221 22345689999999999975 568999999999999999999999999988877777665422111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
....+++++.+||..||+.||.+|||+.++|+|||++.
T Consensus 265 -------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 -------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 11257889999999999999999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.08 Aligned_cols=254 Identities=31% Similarity=0.520 Sum_probs=225.2
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|.-++.||+|+||.||-|++..+.+.||||++.....+ .+..+.++.|+.+|++|.|||+|.+.++|.. ....||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHHH
Confidence 77788899999999999999999999999999887654 4567889999999999999999999999987 67889999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
|||-|.-.+++.....++.|.++..|..+.+.||.|||+.+.||||||..||||++.|.|||+|||.|.+..+ ..
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----An 180 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----AN 180 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----hh
Confidence 9999987777777778899999999999999999999999999999999999999999999999999987643 45
Q ss_pred ccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
+++|||+|||||+++. .+.|+-++||||||++..||...+||+...+....+..|-...-+.-.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq-------------- 246 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-------------- 246 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--------------
Confidence 7899999999999854 467999999999999999999999999988888888888653221110
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+..+.+||..||+.-|.+|||.+++|.|+|....
T Consensus 247 -------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 -------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 12567889999999999999999999999999998763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=369.54 Aligned_cols=286 Identities=26% Similarity=0.404 Sum_probs=217.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++.++||.|+||.||++.+..++..+|+|++.... .......+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 78 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEE
Confidence 34678999999999999999999999999999999987643 34455678999999999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
||||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999877766665566789999999999999999999975 7999999999999999999999999999765322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK-LCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~-~~g~~~~~~w~~~~l~~ 358 (690)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+............
T Consensus 158 --~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2234578999999999875 5689999999999999999999999987655433222110 00111100000000000
Q ss_pred CC---CCCCC-CCCcc-----------ccccc-cCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GD---MFKPQ-NPYEG-----------CLRER-CKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~---~~~~~-~~~~~-----------~l~~~-~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.. .+.+. .+... ..... ...++.++.+||.+||+.||.+|||+.|+|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00 00000 00000 00000 11357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=384.54 Aligned_cols=279 Identities=26% Similarity=0.326 Sum_probs=210.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. .+..+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 235689999999999999999999887 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ- 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~- 281 (690)
|||++.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999988777666555557999999999999999999999999999999999999999999999999999876432221
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCC------HHHHHHHHHHHcCCCChhhhhcc
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPIL-KGRT------EVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF-~~~~------~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.....+||+.|+|||++.+ ..++.++||||||||||||++|..++ .... ...++.+++........++-...
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234678999999999976 56899999999999999999987544 3221 12344444444332211110000
Q ss_pred --CC----CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 355 --KL----PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 355 --~l----~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.+ ...................+..++.++.+||.+||+.||.+|||+.|||+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 00000000000000011112356778999999999999999999999999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=352.10 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=213.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ---PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4589999999999999999999999999999998755332 2234568899999999999999999999988 5799
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
++||||+.++.+.........+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999876665555556789999999999999999999999999999999999999999999999999976543221
Q ss_pred ccc--cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 281 QKL--TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 281 ~~~--~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+......+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 226 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP------------ 226 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC------------
Confidence 111 34567889999999976 458899999999999999999999998776665554443211100
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 227 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 ---------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0112578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=368.86 Aligned_cols=290 Identities=32% Similarity=0.552 Sum_probs=233.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--CcceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSNTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~ 201 (690)
++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999999999999999999976543334456678899999999999999999987642 245789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK- 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~- 280 (690)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 999999876555443 345699999999999999999999999999999999999999999999999999976543221
Q ss_pred --ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 281 --QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 281 --~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......+++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+...++..+....+.++...+....-..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 122345789999999998665568999999999999999999999999999999999999998988876654311100
Q ss_pred C----CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 359 G----DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 359 ~----~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
. ..+.... ........+.++.++.+||.+||+.||.+|||++++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQ--PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCC--CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 0 0000000 011122345678999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=385.54 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=216.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT-GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++.. .+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEE
Confidence 34499999999999999999998877 7889999875442 3444567889999999999999999999987 68999
Q ss_pred EEEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 202 LVFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
|||||+.++.+...+ .....+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999987664322 2345689999999999999999999999999999999999999999999999999987653
Q ss_pred cCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--------- 291 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF--------- 291 (478)
T ss_pred ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 322 12345679999999999865 5789999999999999999999999999888877777654322111
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+++++.+||.+||..||.+|||+.++|.|+|+..
T Consensus 292 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 -------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -------------------CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 1147889999999999999999999999999999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.09 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=207.4
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.++.++ +||||+++++++.+ .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 3699999999999999999999999999865332 34456788999999888 69999999999987 68899999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 98877665555567999999999999999999999999999999999999999999999999999753221 12334578
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT------EVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~------~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.... ..+.+..+.... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~-------------- 220 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PI-------------- 220 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CC--------------
Confidence 9999999999875 568999999999999999999999996422 122222221110 00
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC------HHHHHcCccccCCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT------ASSLLMCEYFTTQPY 415 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT------a~elL~hp~f~~~p~ 415 (690)
.....++..+.+||.+||+.||.+|++ .++++.||||....|
T Consensus 221 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 221 ------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 011247889999999999999999998 579999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=367.23 Aligned_cols=269 Identities=27% Similarity=0.444 Sum_probs=228.3
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.++..+.|...++||+||||.||-|+...||+.+|+|++.+..+. .......++|-.||.+++.+.||.+--.|++ .
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--k 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--K 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--C
Confidence 467788899999999999999999999999999999998766443 2334567899999999999999999877877 7
Q ss_pred ceEEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.+||||..|.||.+...+.+-+ .|+|..+..|+.+|+.||++||+.+||+|||||+|||||+.|++.|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999998877766554 7999999999999999999999999999999999999999999999999999877
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.. .......+||.+|||||++.+. .|+...|+|||||+||||+.|+.||....+...-..+-+..-..+.++-
T Consensus 338 ~~--g~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---- 410 (591)
T KOG0986|consen 338 PE--GKPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---- 410 (591)
T ss_pred CC--CCccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----
Confidence 53 4566778999999999999764 5999999999999999999999999876544333333222222233221
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCCCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~~~ 417 (690)
..+|+++++|.+.+|..||.+|.- ++++-+||||+...|..
T Consensus 411 ---------------------~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 411 ---------------------DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred ---------------------cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 268999999999999999999965 77999999999988754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=406.38 Aligned_cols=277 Identities=27% Similarity=0.391 Sum_probs=241.3
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+.+..++|++++.||+|+||.|.+++++.+++.||+|++++-. +.......|..|-.||..-+.+.||.++-.|.| .
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--E 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--c
Confidence 4577899999999999999999999999999999999997632 223344678899999999999999999999998 7
Q ss_pred ceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||+|| ++.++.... +++|.-++.|+..|+.||..||+.|+|||||||+|||||..|+|||+|||.+-.+.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999876 566666666 89999999999999999999999999999999999999999999999999998888
Q ss_pred ccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--cCCCChhh
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKL--CGSPPEEY 350 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~--~g~~~~~~ 350 (690)
.++.......+|||.|++||+|.. ...|+..+|+|||||++||||.|..||...+-.+.+.+|+.. ...+|++
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~- 305 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE- 305 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc-
Confidence 777677778899999999999842 256999999999999999999999999999999999999886 3333321
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC---HHHHHcCccccCCCCCCCCCCCCCCC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT---ASSLLMCEYFTTQPYACDPSSLPKYP 426 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT---a~elL~hp~f~~~p~~~~~~~lp~~~ 426 (690)
.++|.++++||.++| -+|..|.. ++++-.||||.+.+|..-....|.+.
T Consensus 306 --------------------------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~v 357 (1317)
T KOG0612|consen 306 --------------------------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVV 357 (1317)
T ss_pred --------------------------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCC
Confidence 159999999999988 67889998 99999999999999955444444443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.37 Aligned_cols=288 Identities=34% Similarity=0.556 Sum_probs=228.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 199 (690)
.++|++.++||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357999999999999999999999999999999986432 2234456788999999999999999999876521 246
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+||||+.+++..... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 89999999986655443 3469999999999999999999999999999999999999999999999999997654322
Q ss_pred c--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 280 K--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ......+|++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++.+.|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 12234578999999998866567899999999999999999999999998888888888888887776655432111
Q ss_pred CCCCC---CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMF---KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~---~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....+ .+..+ ..........+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKP-KVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCC-cccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 00000 1111122345788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.99 Aligned_cols=296 Identities=41% Similarity=0.728 Sum_probs=236.1
Q ss_pred cCCeeE-EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH------------HHHHHHHHHHHHhhcCCCceeeee
Q 041720 123 AESFEK-LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE------------SIRFMAREIMILRRLDHPNIIKLE 189 (690)
Q Consensus 123 ~~~y~~-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~ 189 (690)
.++|.. .+.||.|+||+||+|++..+++.||||++........ ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 4679999999999999999999999999875432210 012467899999999999999999
Q ss_pred ceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 190 ~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
+++.. .+.+++||||+.+++...+ .....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l-~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVV-DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99987 6889999999997655544 34457999999999999999999999999999999999999999999999999
Q ss_pred ccceecccc-------------CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 041720 270 GLANILTSK-------------NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQL 336 (690)
Q Consensus 270 Gla~~~~~~-------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l 336 (690)
|++...... .........+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 1122233456889999999977666899999999999999999999999999999999
Q ss_pred HHHHHHcCCCChhhhhccC-CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 337 HKIFKLCGSPPEEYWKKSK-LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 337 ~~I~~~~g~~~~~~w~~~~-l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
..+....+.+....|.... ++....+.. .............+..+.+||.+||+.||.+|||++++|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCc--CCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999998888877665421 111111111 1112223334567889999999999999999999999999999999887
Q ss_pred CCCCCCCC
Q 041720 416 ACDPSSLP 423 (690)
Q Consensus 416 ~~~~~~lp 423 (690)
.+.+..+|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 77665544
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=359.43 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=210.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|++.+.||+|+||.||++.+..+++.||||.+...... ......+.+|+.+|+.++|+||+.+++.+.+ .+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 378899999999999999999999999999998765433 2334567789999999999999999999887 6789999
Q ss_pred Eeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||+.++.+..... ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++...... .
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--c
Confidence 99999876644432 2235899999999999999999999999999999999999999999999999999765432 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------ 223 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE------------ 223 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhh------------
Confidence 2234578999999999975 568999999999999999999999998754322111111111000000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p 414 (690)
....+++++.+||..||+.||.+||| ++|+++||||....
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 224 -------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred -------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 11257889999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.42 Aligned_cols=260 Identities=24% Similarity=0.428 Sum_probs=215.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|+..+.||.|+||+||++.+..+++.||+|++...... ......+.+|+.+|+.++|+||+.+++.+.+ .+.+|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 78889999999999999999999999999999765433 2234557889999999999999999999887 67899999
Q ss_pred eccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ES 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--Cc
Confidence 9999876543332 2346999999999999999999999999999999999999999999999999999765432 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..........+
T Consensus 158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~------------ 224 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY------------ 224 (285)
T ss_pred ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc------------
Confidence 344678999999999875 5689999999999999999999999998776655555543322221111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
...++.++.+||..||+.||.+||| +.+++.|+||...++
T Consensus 225 -------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 225 -------------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred -------------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 1257889999999999999999999 899999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.22 Aligned_cols=286 Identities=37% Similarity=0.659 Sum_probs=222.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcC--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVA--TGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.|++.++||+|+||.||+|.+.. ++..||||.+..... .......+.+|+.++..++||||+++++++.+.....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 899999999986431 122235577899999999999999999999885448899
Q ss_pred EEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc----CCcEEEeecccce
Q 041720 202 LVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN----EGILKLGDFGLAN 273 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~----~~~vKL~DFGla~ 273 (690)
|||||++++++..+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999876654321 2236899999999999999999999999999999999999999 8999999999998
Q ss_pred eccccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHH
Q 041720 274 ILTSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV---------EQLHKIFKL 342 (690)
Q Consensus 274 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~---------e~l~~I~~~ 342 (690)
.+..... ......++++.|+|||++.+...++.++|||||||+||+|++|++||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7543322 12234567899999999877667899999999999999999999999876532 456777777
Q ss_pred cCCCChhhhhccC-CCCCCC---CCCCCCCc-cc---cccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 343 CGSPPEEYWKKSK-LPHGDM---FKPQNPYE-GC---LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 343 ~g~~~~~~w~~~~-l~~~~~---~~~~~~~~-~~---l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
++.+....|.... ++.... ......+. .. ........+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 7777666554311 111100 00000111 00 111113678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.88 Aligned_cols=293 Identities=34% Similarity=0.574 Sum_probs=233.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 199 (690)
..+|.+++.||+|+||.||+|++..+++.||||.+............+.+|+.+|+.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34699999999999999999999999999999998754333334456778999999999999999999886521 135
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+.+++...+. ....+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 89999999876655443 44579999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++.+.|........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2334567889999999987545688999999999999999999999999988888888888888877665532111110
Q ss_pred CCCC---CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 360 DMFK---PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 360 ~~~~---~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
..+. +..+ ........+.+++++.+||.+||+.||.+|||+.++|+||||.....+..
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 242 RRYIRSLPYTP-RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hHHHHhcCccc-ccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 0000 0000 01112234578999999999999999999999999999999987544443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=400.47 Aligned_cols=264 Identities=26% Similarity=0.427 Sum_probs=217.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+...++|+++++||.|+||+||+|++..++..||+|++............+..|+.+|+.|+|||||+++++|.+.....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 44567899999999999999999999999999999999877666666778999999999999999999999987655678
Q ss_pred EEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhC-------CeEeccCCcccEEEcc--------
Q 041720 200 IYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLR-------GIMHRDIKASNILVNN-------- 260 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~-------givHrDLKp~NILld~-------- 260 (690)
+||||||+.++.|..++. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999875544332 235699999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEeecccceeccccCcccccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 041720 261 ---------EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGR 330 (690)
Q Consensus 261 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~ 330 (690)
.+.+||+|||++..+... ......+||+.|+|||++.+ ...++.++||||||||||+|++|.+||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999999865432 22345678999999999864 345889999999999999999999999877
Q ss_pred CHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 331 TEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 331 ~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+....+..++......+ ...++.++.+||..||..+|.+|||+.++|.|+||
T Consensus 247 ~~~~qli~~lk~~p~lp----------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLP----------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHHHHHHHHhcCCCCC----------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 66555544332210000 12468899999999999999999999999999999
Q ss_pred cCC
Q 041720 411 TTQ 413 (690)
Q Consensus 411 ~~~ 413 (690)
...
T Consensus 299 k~i 301 (1021)
T PTZ00266 299 KNV 301 (1021)
T ss_pred hhc
Confidence 743
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.65 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=213.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|++++.||.|+||.||++.+..+++.||+|.+..........+.+.+|+.++++++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999987655555667789999999999999999999887642 45789999
Q ss_pred eccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+..... ....+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 9998765544332 23458999999999999999999999999999999999999999999999999998764332 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------------- 221 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---------------- 221 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence 344678999999999865 567889999999999999999999999877666555544321100
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....+++.+.+||.+||+.||.+|||+.++|.||||
T Consensus 222 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 ------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.01 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=211.8
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
...+..+.+.+++.||+|-||.||.|.+..+ ..||+|.++.....++ .+.+|+++|++|+|+|||+++++|.. .
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~---~f~~Ea~iMk~L~H~~lV~l~gV~~~--~ 273 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPE---AFLREAQIMKKLRHEKLVKLYGVCTK--Q 273 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChh---HHHHHHHHHHhCcccCeEEEEEEEec--C
Confidence 3445667788899999999999999986433 3699999987655543 47799999999999999999999988 5
Q ss_pred ceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+|||||||..|.|..++. ....+...+...++.||++||+||+++++|||||...||||+++..+||+|||||+..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 68999999999885554444 3567999999999999999999999999999999999999999999999999999955
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.++........--...|.|||.+.- ..++.++|||||||+||||+| |+.||.+.+..+.+..+.+...-|.+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------ 426 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------ 426 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------
Confidence 4332222222223556999999964 679999999999999999998 99999999999999998775443322
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
...|+++-+|+..||..+|++|||.+.+.
T Consensus 427 ----------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 ----------------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 26789999999999999999999998665
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.57 Aligned_cols=281 Identities=43% Similarity=0.742 Sum_probs=233.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+|+.++|+||+++++++.+ ...+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 677889999999999999998899999999997665554556678899999999999999999999987 689999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+.+++...+......+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||.+..+.... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99987776666655689999999999999999999999999999999999999999999999999998765433 23344
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC--CCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP--HGDMFK 363 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~--~~~~~~ 363 (690)
..++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+.++....+.+....|...... ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 567889999999876557899999999999999999999999999999999999888888877766653221 000000
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+. ............++.++.+||.+||..||.+||++.++|.||||
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 00111122234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.39 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=201.1
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
++..++|++.++||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|..+ +|||||++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 345678999999999999999999752 445789999997542 334456788999999999 8999999999887
Q ss_pred ccCcceEEEEEeccchhcccccccC-------------------------------------------------------
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH------------------------------------------------------- 218 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~------------------------------------------------------- 218 (690)
.. .+.+++||||+.++.+..++..
T Consensus 82 ~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 82 KP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred CC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 63 4578999999998765433221
Q ss_pred -------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-ccccccccc
Q 041720 219 -------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTL 290 (690)
Q Consensus 219 -------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~ 290 (690)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...... ......+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124778889999999999999999999999999999999999999999999999865432211 112334567
Q ss_pred CCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCc
Q 041720 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYE 369 (690)
Q Consensus 291 ~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~ 369 (690)
.|+|||++.+ ..++.++|||||||+||||++ |.+||.+....+.+...+... ...
T Consensus 241 ~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~---------------------- 296 (338)
T cd05102 241 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-TRM---------------------- 296 (338)
T ss_pred cccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-CCC----------------------
Confidence 8999999865 568999999999999999997 999998765444333322210 000
Q ss_pred cccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 370 GCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 370 ~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 297 ----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 ----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001256788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.62 Aligned_cols=289 Identities=36% Similarity=0.563 Sum_probs=235.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 201 (690)
+|++.+.||.|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.+.. ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 489999999999999999999889999999999765433445567899999999999999999999987731 14789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK- 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~- 280 (690)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999976555443 344899999999999999999999999999999999999999999999999999987654321
Q ss_pred -ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 -QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 -~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2234567799999999997754789999999999999999999999999999999999999998888776653211111
Q ss_pred CCCC--CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~--~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+. ........+......++..+.+||.+||+.||.+|||++++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1010 001111122233456889999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.39 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=216.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+ .+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4889999999999999999999999999999998766566667789999999999999999999999987 68899999
Q ss_pred eccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+..+... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99988665544332 3568999999999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--------------- 221 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 344578899999999875 5578999999999999999999999998887666666543211111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...++..+.++|.+||+.+|++||++.++|+|||+
T Consensus 222 -------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 222 -------------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------------ccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 11467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.33 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=201.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||+|+||.||++++..+|+.||+|++....... .....+..|+++|+.++||||+++++++.+ ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999997543321 223445679999999999999999999987 68899999999987
Q ss_pred ccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 211 LAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 211 ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
.+..... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+... .......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 6643332 2335888999999999999999999999999999999999999999999999999776432 22344578
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+........
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------------------- 214 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------------------
Confidence 999999999876 4589999999999999999999999986533211111111100000
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccccCCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYFTTQPY 415 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f~~~p~ 415 (690)
+......+++++.+||..||+.||.+||++ ++++.|+||+...|
T Consensus 215 ---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 ---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 000012578899999999999999999999 77889999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=358.13 Aligned_cols=266 Identities=28% Similarity=0.388 Sum_probs=220.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||+|+||.||+|.+..+++.||||.+....... ...+.+..|+.+|+.++||||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999999999999999998765442 456678999999999999999999999987 688999
Q ss_pred EEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 203 VFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999988765544432 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred c----------------------------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 041720 281 Q----------------------------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE 332 (690)
Q Consensus 281 ~----------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~ 332 (690)
. .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 1123467889999999975 4678999999999999999999999998888
Q ss_pred HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC----HHHHHcCc
Q 041720 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT----ASSLLMCE 408 (690)
Q Consensus 333 ~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT----a~elL~hp 408 (690)
.+.+..+.......+. ...++..+.+||.+||+.||.+||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVTFPG---------------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCccCCC---------------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 7777665432111110 1137889999999999999999999 99999999
Q ss_pred cccCCCCCCCC
Q 041720 409 YFTTQPYACDP 419 (690)
Q Consensus 409 ~f~~~p~~~~~ 419 (690)
||+...|+...
T Consensus 291 ~~~~~~~~~~~ 301 (316)
T cd05574 291 FFRGVNWALIR 301 (316)
T ss_pred hhhcCChhhcc
Confidence 99987776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=361.88 Aligned_cols=283 Identities=24% Similarity=0.372 Sum_probs=209.4
Q ss_pred EEeEEeec--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 128 KLEKIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 128 ~~~~LG~G--~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
++++||+| +|++||++++..+|+.||||++............+.+|+.+++.++||||+++++++.. .+.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 78999999999999999999998765555566778899999999999999999999988 688999999
Q ss_pred ccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc--
Q 041720 206 YMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-- 281 (690)
Q Consensus 206 y~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-- 281 (690)
|+.++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+||+.+..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998766544432 345899999999999999999999999999999999999999999999999876443211110
Q ss_pred ----cccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC--------CCh
Q 041720 282 ----KLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS--------PPE 348 (690)
Q Consensus 282 ----~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~--------~~~ 348 (690)
......++..|+|||++.+. ..|+.++|||||||++|+|++|.+||.................. +++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 11223567789999998653 45899999999999999999999999876554443333221110 000
Q ss_pred hhhhcc-------CCCCCCCCCCC--CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 349 EYWKKS-------KLPHGDMFKPQ--NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 349 ~~w~~~-------~l~~~~~~~~~--~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
+..... ........... .............+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000 00000000000 00000111122356789999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.84 Aligned_cols=282 Identities=43% Similarity=0.727 Sum_probs=232.6
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++.+.||+|+||.||+|++..+++.||+|++..........+.+..|+.+++.++|+||+++++++.+ .+.+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 677889999999999999999999999999998654334445667889999999999999999999987 589999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+.+++...+......+++..+..++.||+.||.|||++||+||||+|+||++++++.+||+|||++....... .....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCc
Confidence 99986655555443579999999999999999999999999999999999999999999999999998764332 23334
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+.+..|.............+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 55678899999987655789999999999999999999999999999999999999999888888764322211111111
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...........+.++..+.++|..||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122233445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.52 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=218.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+|++++||||+++++++.+ .+.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 369999999999999999999999999999999975432 23445678899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+.........+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999987766666555678999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 217 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF---------------- 217 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC----------------
Confidence 234578999999999865 467889999999999999999999999877666666554221111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~~ 416 (690)
...++..+.++|.+||..||.+|+ +++++++||||....|.
T Consensus 218 -------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 218 -------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 124678999999999999999999 99999999999886653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=361.17 Aligned_cols=285 Identities=34% Similarity=0.584 Sum_probs=227.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc----c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS----N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 198 (690)
.++|++++.||+|+||.||++.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 567999999999999999999999999999999986543334445568899999999999999999999875321 2
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+++||||+.+++..... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~- 170 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS- 170 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-
Confidence 569999999654443332 34689999999999999999999999999999999999999999999999999976532
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..++...+.++..++.......
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 22345678999999998765568899999999999999999999999999888888888887777766554322111
Q ss_pred CCCCCC--CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GDMFKP--QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~~~~~--~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+.. .......+......+++.+.+||.+||+.||.+|||+.++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 0000111222335788899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.46 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||.||+|++..++..||||++.... .......+.+|+.+|.+++||||+++++++.. .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36889999999999999999999999999999997653 34455678899999999999999999999988 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+... ..
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999998876543 25789999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhhhccCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ---LHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~---l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
...+++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+..........
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 218 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP----------- 218 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----------
Confidence 44678999999999875 5689999999999999999999999975321110 00111100000000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. .....+++++.+||.+||+.||.+||+++++|.||||...
T Consensus 219 ----~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 219 ----V--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----C--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0 0012467889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=362.43 Aligned_cols=289 Identities=38% Similarity=0.610 Sum_probs=230.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.++.++ +||||+++++++.......+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4579999999999999999999988999999999865433334445677899999999 999999999998764456789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK- 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~- 280 (690)
+||||+.+++...+.. . .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 86 lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9999999765544433 2 788999999999999999999999999999999999999999999999999986644322
Q ss_pred ---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 281 ---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 281 ---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+....+.+.++....+.++.+.|.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12344678999999999876667889999999999999999999999999999999998888877766554432111
Q ss_pred CCCCCCC--CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 HGDMFKP--QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 ~~~~~~~--~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+.. ............+.++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000 0000011122334578999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=360.29 Aligned_cols=286 Identities=35% Similarity=0.561 Sum_probs=227.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
..+|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35799999999999999999999999999999998754333333456789999999999999999999986521 23
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+...+.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 57999999976443322 23689999999999999999999999999999999999999999999999999976432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+...+++......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 22345778999999998765568899999999999999999999999998888888888888877766655432211
Q ss_pred CCCCCC--CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 359 GDMFKP--QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~--~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+.. .......+....+.+++.+.+||.+||+.||.+|||+.++|.||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 110000 000011112223467889999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=370.08 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=224.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccch
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH 209 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 209 (690)
+.||.|-||+||-|++..+|+.||||+|.+..+.......+.+|+.||+.++||.||.|.-.|+. .+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcc
Confidence 67999999999999999999999999999888877777889999999999999999999999988 7999999999999
Q ss_pred hcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeecccceeccccCcccccc
Q 041720 210 DLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 210 ~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
+.+..++ ...++|++.....++.||+.||.|||-++|+|+||||+||||.... .+||||||+|+++... ....+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRrs 725 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRRS 725 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhhhh
Confidence 9776554 4667899999999999999999999999999999999999997653 7999999999998654 45567
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
.+|||.|+|||+|.. +.|+...||||+|||+|.-|.|..||.... +.-.+|.+....+|..-|+
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~------------- 789 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWS------------- 789 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchh-------------
Confidence 899999999999975 679999999999999999999999998543 3334455555556666665
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++.|||..+|++.-.+|.|.+..|.|||+++.
T Consensus 790 ------------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 790 ------------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ------------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 699999999999999999999999999999999974
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=362.45 Aligned_cols=287 Identities=35% Similarity=0.585 Sum_probs=231.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc----c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS----N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 198 (690)
.++|++...||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567999999999999999999999999999999987543334455667889999999999999999998865211 3
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+++|+||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999997655444432 46999999999999999999999999999999999999999999999999999765322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+++.+|.+.....
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3445778999999998765568899999999999999999999999999999999999988888877765432211
Q ss_pred CCCCCCCC--CCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 359 GDMFKPQN--PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~--~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+.... ............+++.+.+||.+||+.||.+|||+.++|.||||.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 11110000 0001111223456899999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=376.47 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=221.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
++++..||.|+||.||+|..+.++-..|.|+|... ..+.++.++-||+||..++||+||+|++.|.. .+.++|+.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwiliE 109 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWILIE 109 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEEEe
Confidence 67788899999999999999999988999998644 35677889999999999999999999998876 689999999
Q ss_pred ccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+||-.+.+. .-+..|++.++..+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+..... ......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 99998665443 3455799999999999999999999999999999999999999999999999999865332 334567
Q ss_pred ccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 285 SRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
+++|||+|||||+++. ..+|+.++||||||++|.||..+.||...-+....+-+|.+.. || ...
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP-TLl--------- 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP-TLL--------- 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC-ccc---------
Confidence 8999999999999854 4679999999999999999999999999999988888875531 11 110
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....+..+.||+.+||..||..||++.++|.||||+..|
T Consensus 257 --------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 257 --------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred --------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 0125677899999999999999999999999999999754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=373.74 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=234.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..-|.++.+||+|.|++|.++++..++..||||++.+...+....+.+.+|+.+|+.|+|||||+++.+++. ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 345999999999999999999999999999999999998888877889999999999999999999999998 789999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.++.++.+.+++.+..+..++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+.. ...
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLM 210 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998863 466
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
..+.||++.|.|||++.+..+.++.+|+||+|++||.|++|..||.|.+-.+.-.+.+......+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-------------- 276 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-------------- 276 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--------------
Confidence 788999999999999999888899999999999999999999999998766665555443322221
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
-++-+..+||+++|..+|.+|++++++..|.|....
T Consensus 277 ---------------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 277 ---------------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ---------------eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 367889999999999999999999999999999754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.21 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=210.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+ .+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Confidence 356899999999999999999999999999999997553 2334567889999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||++++.+..+....+.+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999998777666555668999999999999999999999999999999999999999999999999999765432 222
Q ss_pred ccccccccCCCCccccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLM--GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~--~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....|++.|+|||++. ....++.++|||||||++|+|++|.+||........+..+......++ .+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~--------- 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KL--------- 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--cc---------
Confidence 34567899999999874 234578899999999999999999999976554443333222111110 00
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.....++..+.+||.+||+.||.+|||++++|.|||
T Consensus 232 -------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 -------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 001146788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=348.45 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=209.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 4579999999999999999999999999999999975432 234567899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||++++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987776655555679999999999999999999999999999999999999999999999999998664321 22
Q ss_pred ccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....+++.|+|||.+.+ ...++.++|||||||++|+|++|.+||......+....+......++
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 229 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP------------- 229 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-------------
Confidence 234578899999998842 34578899999999999999999999975544333222211100000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.. .....++..+.+||.+||..||.+|||++++|+|+|
T Consensus 230 -----~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 -----KL------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----CC------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00 001257889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=350.07 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=214.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|++++.||.|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEE
Confidence 688899999999999999999999999999986442 4455678899999999999999999999987 678999999
Q ss_pred ccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
|+.++.+.... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-ccccc
Confidence 99987765443 33457999999999999999999999999999999999999999999999999999765322 12234
Q ss_pred ccccccCCCCccccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 285 SRVVTLWYRPPELLM----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~----~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
...+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+....+........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------------- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-------------
Confidence 457899999999984 234577899999999999999999999998877776666543211100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 -------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0012467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=344.41 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=215.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.. .+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 46999999999999999999988899999999997654433 56789999999999999999999999887 6899999
Q ss_pred EeccchhcccccccC---CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 204 FEYMEHDLAGLSSCH---DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~---~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||+.++.+...... ...+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999998766554433 24689999999999999999999999999999999999999999999999999977654332
Q ss_pred c---cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 281 Q---KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 281 ~---~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. .....+++..|+|||++.....++.++|+|||||++|+|++|..||...+..+.+.++.... +..+ .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~----- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPSL-E----- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---CCCc-C-----
Confidence 2 12345688999999998765478999999999999999999999998877666555543321 1000 0
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
. ......+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 229 ------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 229 ------T--------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ------C--------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00023678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.67 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=215.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+++++||.|+||.||+|++..++..||+|++... .....+.+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEE
Confidence 45699999999999999999999999999999998754 34556778899999999999999999999887 678999
Q ss_pred EEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+.... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999988665433 33456899999999999999999999999999999999999999999999999998754322 22
Q ss_pred cccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+..+.+.++.... .+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~-------- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPTL-------- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--CccC--------
Confidence 2344567899999999853 3446889999999999999999999998877655554443211 0000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++.++.+||.+||..||.+||++.++|+||||....
T Consensus 236 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 236 ----------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ----------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00125678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.79 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=215.5
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++++.||.|+||.||++.+..++..||+|++..........+.+..|+.+++.++||||+++++++.......+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999987666666677889999999999999999999988765467889999
Q ss_pred eccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHH-----hCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 205 EYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCH-----LRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 205 Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH-----~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
||+.++.+..... ....+++..++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999865543332 2457899999999999999999999 899999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 161 ~~~~-~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 228 (265)
T cd08217 161 GHDS-SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF--R-------- 228 (265)
T ss_pred cCCc-ccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC--C--------
Confidence 5432 22344678999999999865 5578999999999999999999999998875555544432110 0
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++..+.+||.+||+.+|.+|||+.++|+|||+
T Consensus 229 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 ------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112577899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.95 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=219.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||++.+..+++.||||.+...... ......+.+|+.+++.++||||+++++.+.. .+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 3699999999999999999999999999999998765432 2345678899999999999999999999887 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc--
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-- 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-- 280 (690)
||||+.++.+...+.....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999877766665566799999999999999999999999999999999999999999999999999864211000
Q ss_pred ------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 281 ------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 281 ------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 01122457888999999865 56899999999999999999999999988777766665443211111
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC---HHHHHcCccccCCCCCCC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT---ASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT---a~elL~hp~f~~~p~~~~ 418 (690)
. ...++.++.+||.+||+.||.+||+ +.++|+||||...+|+..
T Consensus 238 ~--------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 238 G--------------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred c--------------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 0 0147888999999999999999998 799999999988666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.02 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=209.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.|+..+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 58999999999999999999999999999999875432 223456788999999999999999999998764457889
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC--
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN-- 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~-- 279 (690)
+||||+.++.+.........+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999987666555555578999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
........++..|+|||.+.+ ..++.++|||||||++|+|++|++||......+....+...... +
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~------------ 228 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-P------------ 228 (266)
T ss_pred CCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-C------------
Confidence 111233567889999999875 56889999999999999999999999876655544443221100 0
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.....+++.+.+|| .||..||.+|||++|+|+||||+
T Consensus 229 --------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 --------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00124677889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.20 Aligned_cols=280 Identities=28% Similarity=0.372 Sum_probs=214.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.++||+|+||.||++.+..++..||+|.+.... .......+.+|++++++++||||+++++++.+ .+.+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36999999999999999999999999999999987542 34455678899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||++++.+..+......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999988776666666779999999999999999999997 59999999999999999999999999998765322 2
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..... .++........ +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGE--AKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCcccccc--ccCCcccccCCC
Confidence 244678999999999865 56889999999999999999999999876643332 22221110000 000000000000
Q ss_pred CCC-CCC--cc---------ccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQ-NPY--EG---------CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~-~~~--~~---------~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
... ... .. ........++.++.+||.+||..||.+|||+.++|.||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000 000 00 0000011367889999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=350.15 Aligned_cols=260 Identities=24% Similarity=0.441 Sum_probs=212.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||.||++++..++..||+|.+... ........+.+|+.++++++||||+++++.+.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4689999999999999999999999999999998754 344455778899999999999999999999887 6899999
Q ss_pred EeccchhcccccccC---CCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 204 FEYMEHDLAGLSSCH---DIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~---~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
|||+.++.+..+... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999998766554433 2368999999999999999999996 59999999999999999999999999999765322
Q ss_pred cccccccccccCCCCcccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 280 KQKLTSRVVTLWYRPPELLMGS-----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.......+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT----- 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-----
Confidence 22345678899999988542 235889999999999999999999998655544433332222111111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....++.++.+||.+||+.+|.+||++.++++||||....
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 230 --------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1124788999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.48 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=215.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.+ ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 36889999999999999999999999999999997653 23345668899999999999999999999887 5889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
+||+.++.+....... .+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999987665554443 78999999999999999999999999999999999999999999999999998775432 233
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+....+........
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------------- 218 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL---------------- 218 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC----------------
Confidence 44678899999999976 4589999999999999999999999988776555544432210000
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+ ...++.++.++|.+||..||.+|||+++++.||||...
T Consensus 219 ---~--------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 219 ---E--------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ---c--------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0 01278889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=349.93 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=215.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||.|+||.||++.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 35699999999999999999999889999999999754 34455678899999999999999999999987 688999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 999999876655543 34569999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
......+++.|+|||.+.. ...++.++|||||||++|+|++|.+||.+.+..+.+.++........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL---------- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc----------
Confidence 2334578999999998752 34567899999999999999999999998877666655532110000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++.++.+||..||..||.+||++.++|+||||...
T Consensus 229 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 229 ----------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0012467899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.29 Aligned_cols=265 Identities=29% Similarity=0.496 Sum_probs=214.9
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL 196 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 196 (690)
.+.+....|+++++||+||.+.||++.. .+...||+|++.....+.....-+.+||..|.+| .|.+||+||||-..
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-- 431 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-- 431 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--
Confidence 3456677899999999999999999974 5567889998887777888889999999999999 59999999998776
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
++.+||||||-+.+|-..+.....-++.-.++.|..|++.|+.++|+.||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 432 d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 432 DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 7899999999998887777666555555689999999999999999999999999999999975 899999999999887
Q ss_pred ccCccc-ccccccccCCCCcccccCCC----------CCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcC
Q 041720 277 SKNKQK-LTSRVVTLWYRPPELLMGST----------NYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCG 344 (690)
Q Consensus 277 ~~~~~~-~~~~~gt~~Y~APE~l~~~~----------~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g 344 (690)
.+.... ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||.... ....+..|..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~--- 587 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD--- 587 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC---
Confidence 654433 34679999999999985421 14678999999999999999999997532 2223333321
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCC--hhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is--~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
|..+ + .++.++ .++.++++.||..||.+|||+.++|+|||++..|
T Consensus 588 -P~~~-----------I-------------efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 588 -PNHE-----------I-------------EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred -CCcc-----------c-------------cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 1110 0 011222 2489999999999999999999999999998754
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.34 Aligned_cols=254 Identities=26% Similarity=0.489 Sum_probs=213.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++++.||+|+||.||++++..+|+.||||.+............+.+|+.+++.++||||+++++++.+ .+.+++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4899999999999999999999999999999998655555556678999999999999999999999987 68999999
Q ss_pred eccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+...... ...+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 99987655433322 2358899999999999999999999999999999999999999999999999998764322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---------------- 220 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC----------------
Confidence 233567889999999865 557889999999999999999999998877777766664322111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....++.++.++|.+||+.+|.+||++.++|+||||
T Consensus 221 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 ------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.31 Aligned_cols=258 Identities=26% Similarity=0.480 Sum_probs=205.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHH-HhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMI-LRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++++.||+|+||.||++++..+|+.||||++......... ..+..|+.+ ++.++||||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 4699999999999999999999999999999999865433333 345556665 666799999999999987 678999
Q ss_pred EEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 203 VFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 203 V~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
||||+++++...+. .....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999976544332 2345699999999999999999999997 9999999999999999999999999999765422
Q ss_pred CcccccccccccCCCCcccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCChhhhhcc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGS---TNYNVSVDLWSVGCVFAELLIGKPILKGR-TEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~sDIWSlGviLyeLltG~~PF~~~-~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|..||... ...+.+..+.... .+ ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-~~---- 228 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SP-QL---- 228 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CC-CC----
Confidence 122335678999999988542 45788999999999999999999999743 3334444332210 00 00
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+ ...++.++.+||.+||..||.+|||+.+++.||||...
T Consensus 229 ------------~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 229 ------------P--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ------------C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 01478899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.32 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=210.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-------PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence 67788999999999999999889999999988754322 1234568899999999999999999999887 67
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
..++||||+.++.+..+......+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||+++.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 89999999998766656555567899999999999999999999999999999999999999999999999999876522
Q ss_pred Cc-----ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 279 NK-----QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 279 ~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.. .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+....+..+..... +
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------ 230 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS--P------ 230 (267)
T ss_pred cccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC--C------
Confidence 11 11123457889999999865 4678899999999999999999999998766555544432110 0
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++..+.+||.+||+.||.+||++.++|+||||
T Consensus 231 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 --------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0112578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=338.81 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=217.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|+.++.||.|+||.||.+++..+++.+++|.+............+.+|+.+|++++|+||+++++++.+ .+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 4899999999999999999999999999999998766666667788999999999999999999999988 68899999
Q ss_pred eccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||+.++.+...... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SM 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cc
Confidence 99998655544433 3568999999999999999999999999999999999999999999999999998764433 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV--------------- 221 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 345678999999999875 4578899999999999999999999998887777777653211110
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...++.++.+||.+||..||.+|||+.++|+|+||
T Consensus 222 -------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 222 -------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 12578899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=356.22 Aligned_cols=255 Identities=29% Similarity=0.521 Sum_probs=217.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|.++.+||+|+||.||+++++.+|..||||.+..+. ..+.+..||.||++++.|+||++||.|.. ...++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeehh
Confidence 788999999999999999999999999999987543 46778999999999999999999999887 578999999
Q ss_pred ccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||.-|... .+..++.+|+|.++..+++..+.||+|||...-||||||..||||+.+|+.||+|||.|-.+.. ......
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRN 187 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhC
Confidence 99976554 4455677899999999999999999999999999999999999999999999999999987654 234556
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
+.+|||.|||||++.. ..|+.++||||||++..||..|+|||..-.+...+..| -..||..+ +
T Consensus 188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF-~------------ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTF-K------------ 250 (502)
T ss_pred ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCC-C------------
Confidence 7899999999999964 67999999999999999999999999876554433332 11222211 1
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....|.++.|||+.||...|++|.||.++++|||++..|
T Consensus 251 ----------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 251 ----------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ----------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 1124678899999999999999999999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.25 Aligned_cols=244 Identities=21% Similarity=0.212 Sum_probs=204.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeec--cCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITS--RLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~~~LV~Ey 206 (690)
..||+|++|.||+|.. +|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+ .....++|||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999976 7899999999765433 2335678899999999999999999999876 334678999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
+.++.+.........+++.....++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.+... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99987777666666799999999999999999999984 9999999999999999999999999999865432 134
Q ss_pred cccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
.+++..|+|||++.+ ...++.++|||||||++|||++|..||.+.+..+.+..+......++.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 243 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---------------- 243 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC----------------
Confidence 578899999999865 256899999999999999999999999988877777666543222110
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.+.+||.+||+.||.+|||+.++|.
T Consensus 244 -----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 -----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1146789999999999999999999999984
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.81 Aligned_cols=258 Identities=28% Similarity=0.507 Sum_probs=214.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++++.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.+.||||+++++.+.. ...+|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 45799999999999999999999999999999999765433 34568899999999999999999999887 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+..+... ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 9999998766655533 368999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... ..++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------- 236 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC--------------
Confidence 234578899999999865 56789999999999999999999999887765544433221 11100
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 237 -----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 237 -----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0012577889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=355.62 Aligned_cols=286 Identities=34% Similarity=0.531 Sum_probs=226.0
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----c
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----S 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~ 197 (690)
..++|.+.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 357799999999999999999999999999999999764333344566889999999999999999999886421 2
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
..+|+|++++.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4578999998665543332 23689999999999999999999999999999999999999999999999999976432
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..+....+.++...+......
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 173 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred ----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 2234577899999999876567889999999999999999999999998888888888888877776655432111
Q ss_pred CCCCCC--CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 HGDMFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 ~~~~~~--~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+. ................++.+.+||.+||+.||.+|||+.++|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000000 00000001112223568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.21 Aligned_cols=286 Identities=36% Similarity=0.614 Sum_probs=220.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc-----
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS----- 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----- 197 (690)
..+|++.+.||.|+||.||+|++..+|..||+|++..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3579999999999999999999999999999999976543 344668899999999999999999988765321
Q ss_pred -------ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeec
Q 041720 198 -------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDF 269 (690)
Q Consensus 198 -------~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DF 269 (690)
..+|+||||+.+++...+. ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 3579999999875544332 346899999999999999999999999999999999999975 557899999
Q ss_pred ccceeccccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 270 GLANILTSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 270 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
|++..+..... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976543211 1122346788999999886656788999999999999999999999999888888777766544333
Q ss_pred hhhhhcc--CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 348 EEYWKKS--KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 348 ~~~w~~~--~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+... .++.. ................+.++.++.+||.+||+.||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 2222110 00000 00000111111222335688999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.05 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=207.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC----c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL----S 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~----~ 197 (690)
.+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++..+ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3458889999999999999999999999999999975432 234678899999998 7999999999987532 2
Q ss_pred ceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+|+||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 468999999998655544332 346899999999999999999999999999999999999999999999999999865
Q ss_pred cccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
.... .......|++.|+|||++.+ ...++.++|||||||++|+|++|.+||...........+... +..
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~--- 234 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAP--- 234 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCC---
Confidence 4322 23345678999999999853 235788999999999999999999999766554443332110 000
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
......++.++.+||.+||..||.+|||+.++|.||||
T Consensus 235 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00012467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=340.10 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=210.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
.+|++.+.||+|+||.||++.+..++..||||.+..... .....+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999865421 23445678899999999999999999998876445678
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
++||||++++.+.........+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999876665555555689999999999999999999999999999999999999999999999999976532111
Q ss_pred --ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 281 --QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 281 --~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP--------- 228 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC---------
Confidence 12233568889999999875 5678999999999999999999999987655554443321 11100
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.....++..+.++|.+|| .+|.+|||++++|+|||+.
T Consensus 229 ---------------~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ---------------VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 001246778999999999 5999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.14 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=211.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ----PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+|++.+.||.|+||.||+|.+ .+++.+|||.+...... ......+.+|+.+|+.++|+||+++++++.+ .+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478889999999999999985 58889999998754321 2344668899999999999999999999987 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc--
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK-- 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~-- 278 (690)
++||||+.++.+.........+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999998877766666567899999999999999999999999999999999999999999999999998764321
Q ss_pred ---CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 ---NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.........++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-------- 228 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC--------
Confidence 1112234568899999999865 5678999999999999999999999987766555444433211111
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++.++.+||.+||..||.+|||+.++|.||||
T Consensus 229 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.65 Aligned_cols=258 Identities=33% Similarity=0.578 Sum_probs=213.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++++.+ .+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 4889999999999999999998899999999998766555677889999999999999999999999876 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc--
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-- 282 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~-- 282 (690)
||+.++.+.........+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999988777666666678999999999999999999999999999999999999999999999999998765433222
Q ss_pred -ccccccccCCCCcccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhccCCCC
Q 041720 283 -LTSRVVTLWYRPPELLMGST--NYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 283 -~~~~~gt~~Y~APE~l~~~~--~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...... .....+.. +..+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~---------- 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKPP---------- 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCCC----------
Confidence 12356788999999986532 3788999999999999999999999765332 22222211 11110
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.+ ....+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 227 -------~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 -------IP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------CC-------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 012468889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.87 Aligned_cols=257 Identities=28% Similarity=0.519 Sum_probs=216.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
..|++.+.||.|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 4599999999999999999999999999999999754332 34568899999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++.+...... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ...
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-SKR 172 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-ccC
Confidence 999998877665543 368999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.... .+..
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~--------------- 235 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL--------------- 235 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cccc---------------
Confidence 34578899999998865 567899999999999999999999999888766655543311 1110
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 236 ----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 236 ----------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ----------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0112578899999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.09 Aligned_cols=280 Identities=40% Similarity=0.677 Sum_probs=220.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc---CCCceeeeeceeeccCc---ce
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL---DHPNIIKLEGVITSRLS---NT 199 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~---~~ 199 (690)
|++.+.||.|+||.||+|++..+++.||||++............+.+|+.+++++ .||||+++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6889999999999999999988899999999976543333344566788877766 69999999999887311 13
Q ss_pred EEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+++||||+.+.+...+... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999987655444332 235899999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+++.....+....|.......
T Consensus 161 --~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 --MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred --cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22234467889999999876 457899999999999999999999999999999999998877766554443221100
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...+. .............+++.+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00110 011111223334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=379.01 Aligned_cols=286 Identities=24% Similarity=0.312 Sum_probs=207.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEe--------------ec-CCCChHHHHHHHHHHHHHhhcCCCcee
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT-GKMVALKKV--------------RF-DNFQPESIRFMAREIMILRRLDHPNII 186 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-g~~vAvK~i--------------~~-~~~~~~~~~~~~~Ei~iL~~L~HpnIv 186 (690)
.++|+++++||+|+||+||+|..... +..+++|.+ .+ ..........+.+|+.+|++|+|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46799999999999999999875432 222222211 10 011223455688999999999999999
Q ss_pred eeeceeeccCcceEEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC
Q 041720 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG 262 (690)
Q Consensus 187 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~ 262 (690)
++++++.+ .+..|+|+|++.++++..+... .......+++.++.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999988 6789999999987765543321 22345677889999999999999999999999999999999999
Q ss_pred cEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCC--CCHHHHHHHH
Q 041720 263 ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP-ILKG--RTEVEQLHKI 339 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~-PF~~--~~~~e~l~~I 339 (690)
.+||+|||++..+...........+||+.|+|||++.+ ..|+.++|||||||+||||++|.. ||.. .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998775443333445789999999999976 568999999999999999999875 4432 3455666666
Q ss_pred HHHcCCCChhhhhc----cCC-CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 340 FKLCGSPPEEYWKK----SKL-PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 340 ~~~~g~~~~~~w~~----~~l-~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+..+.....++... ... ...............+. ...++.++.++|.+||++||.+|||+.|+|.||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 66555433322110 000 00000000001111111 12467889999999999999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.74 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=206.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..++|++.+.||+|+||.||+|.+. ..+..||+|+++... .......+.+|+.+|.+++||||+++++++.. .+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CC
Confidence 3567999999999999999999765 446689999997543 33445678899999999999999999999987 67
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.++|||||++++.+..+... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 89999999999877654433 45789999999999999999999999999999999999999999999999998765432
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 229 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA--------- 229 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---------
Confidence 21111112334678999998865 578999999999999999775 9999998888777766643211110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.+||..||+.+|.+|||++++++
T Consensus 230 -------------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 230 -------------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1257788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.59 Aligned_cols=258 Identities=31% Similarity=0.509 Sum_probs=214.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+ .+.+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEE
Confidence 3579999999999999999999989999999999976532 245778999999999999999999999887 688999
Q ss_pred EEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+.... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999987766555443 679999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+....+......++. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~--------- 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-L--------- 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-c---------
Confidence 23445788899999998653 26788999999999999999999999987766655544332111110 0
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.....++.++.+||.+||..||.+|||+.++|.|+|
T Consensus 227 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 227 --------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 001246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=352.64 Aligned_cols=288 Identities=32% Similarity=0.516 Sum_probs=227.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec--cCcce
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVAT--GKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS--RLSNT 199 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~~ 199 (690)
.|++.+.||+|+||.||++++..+ +..||||++..........+.+.+|+.+++++ +||||+++++.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999888 89999999875433333456678899999999 59999999986432 12356
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+++||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 89999999876555443 44579999999999999999999999999999999999999999999999999998654322
Q ss_pred c---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 280 K---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 280 ~---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. ......+|++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..++...+.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1223457899999999887656789999999999999999999999999999999999999998887766543221
Q ss_pred CCCCCCC--CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 357 PHGDMFK--PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 357 ~~~~~~~--~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+....+. ........+......++..+.+||.+||+.||.+|||+.++|.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 1100000 00000011112234568899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=351.78 Aligned_cols=286 Identities=34% Similarity=0.565 Sum_probs=229.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...+.|++++.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcE
Confidence 346779999999999999999999999999999999875443334456688999999999999999999998653 4678
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|+||||+.+++...+. ...+++..+..++.||+.||.|||+++|+||||+|.|||++.++.+||+|||++.....
T Consensus 86 ~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 86 YFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred EEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 9999999775544332 34688899999999999999999999999999999999999999999999999975432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+.+.++.++++.+.........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234567889999998866567899999999999999999999999998888888888888888887765431111000
Q ss_pred CCCCC--CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQ--NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~--~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+... ........+..+.++..+.+||.+||+.+|.+|||++++|.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00000 000111122345678999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=336.04 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=213.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||+|+||.||++.+..++..+|||.+............+.+|+.+|+.++||||+++++.+.. .+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4899999999999999999999999999999998766566667789999999999999999999999876 68899999
Q ss_pred eccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccceeccccCcc
Q 041720 205 EYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~~~~~~~~ 281 (690)
||+.++.+...... ...+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99998765544432 3358999999999999999999999999999999999999865 468999999998764322
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 220 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--------------- 220 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---------------
Confidence 2234567899999999865 557889999999999999999999999887766665554321111
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....++..+.+||..||..||.+|||+.++|+||||
T Consensus 221 -------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 -------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 012478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.28 Aligned_cols=280 Identities=37% Similarity=0.668 Sum_probs=226.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|.+.+.||.|+||.||+|+...+++.||||.+...... .......+|+..++++. ||||+++++++.+ .+..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 67889999999999999999889999999998754322 22234567999999999 9999999999987 68999999
Q ss_pred eccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 205 EYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||+.+.+...+.... ..+++..+..++.||+.+|.|||++||+|+||+|+|||++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999766655554433 46899999999999999999999999999999999999999999999999999876432 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC-CC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD-MF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~-~~ 362 (690)
....++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.++....+.+....|......... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 44678899999999866566889999999999999999999999999999999999998888887766542211111 01
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.........+.......+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111111111222334457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=349.38 Aligned_cols=258 Identities=27% Similarity=0.499 Sum_probs=213.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++++.||.|+||.||++.+..+++.||||.+...... ..+.+.+|+.+++.++|+||+++++++.. .+.+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 36799999999999999999999999999999999765432 33568899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||++++.+..+... ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 9999998876655543 358899999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+... +.++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~-------------- 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------- 235 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCC--------------
Confidence 334578899999999865 56789999999999999999999999876654433322111 11110
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++..+.+||.+||..||.+|||+.++|.||||...
T Consensus 236 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 236 -----------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 0012467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=341.49 Aligned_cols=260 Identities=31% Similarity=0.536 Sum_probs=210.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
.|+..+.||+|+||.||++.+..+++.||+|++..... +....+.+.+|+.+|+.++|+||+++++++.+ .+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 37888999999999999999999999999999975431 12345778999999999999999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 279 (690)
++||||+.++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999887766665566799999999999999999999999999999999999998776 69999999997664321
Q ss_pred c---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 280 K---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 280 ~---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 229 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-------- 229 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC--------
Confidence 1 11123467889999999865 56789999999999999999999999765433333333221100000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
......+++++.++|.+||..||.+|||+.++|+||||+
T Consensus 230 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 230 ----------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 001125788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.28 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=233.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+...+|..+.+||+|+||+|.++..+.+.+.+|||+++++.+ +.+.++--+.|-.+|... +-|.+++++.+|+. .+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mD 423 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MD 423 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hh
Confidence 556789999999999999999999999999999999998743 444555566777888777 56889999999988 78
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.||.+.+.++.-++|.|+.+..|+.+|+-||-+||++|||+||||.+|||||.+|++||+|||+++.-.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999999988888889999999999999999999999999999999999999999999999999999975332
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......++||||.|+|||++. .++|+.++|+||+||+|||||.|++||.|.++.++.+.|.......|
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----------- 570 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----------- 570 (683)
T ss_pred CCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-----------
Confidence 234556799999999999986 67899999999999999999999999999999999999988665554
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH-----HHHHcCccccCCCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-----SSLLMCEYFTTQPYAC 417 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-----~elL~hp~f~~~p~~~ 417 (690)
+.+|.++.++++.+|...|.+|.-+ .++-.||||+...|..
T Consensus 571 ------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 571 ------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred ------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 3689999999999999999999753 5788999999877743
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.88 Aligned_cols=261 Identities=31% Similarity=0.558 Sum_probs=210.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC--------ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--------QPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.|.+.+.||.|+||.||+|.+..+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 47888999999999999999988999999998864321 11234567889999999999999999999887
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+.+++||||+.++.+.......+.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 68899999999988766655555689999999999999999999999999999999999999999999999999997643
Q ss_pred ccCcc-cccccccccCCCCcccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQ-KLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
..... ......++..|+|||.+.... .++.++|||||||++|+|++|..||......+.+..+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP------- 232 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc-------
Confidence 22111 123456788999999986543 478999999999999999999999976655544433322110000
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
........++.++.+||..||..||.+|||++++|+||||
T Consensus 233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 ----------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0001123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=335.39 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=212.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 37778899999999999999988999999999876432 23456778999999999999999999999887 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||++++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999987666665555578999999999999999999999999999999999999999999999999998754332
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||......+....+..... .+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~-------------- 221 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LP-------------- 221 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-CC--------------
Confidence 234567899999999986543488999999999999999999999987765555544432110 00
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....+++.+.+||.+||+.+|.+|||+.++|.||||
T Consensus 222 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 ------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0112478899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=339.02 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=210.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC----
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL---- 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~---- 196 (690)
..++|++.+.||.|+||.||+|.+..+++.|++|++..... ....+.+|+.+++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35679999999999999999999988999999999875532 345688999999999 7999999999987632
Q ss_pred cceEEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
...+|+||||+.++.+..+.. .+..+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 356899999999865544332 2457899999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
....... .......+++.|+|||++.. ...++.++|||||||+||+|++|.+||........+..+.... ++
T Consensus 161 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~- 236 (275)
T cd06608 161 AQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--PP- 236 (275)
T ss_pred eecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--CC-
Confidence 7654322 23344678999999998753 2346789999999999999999999998766655555543211 00
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
. + .....++.++.+||.+||..||.+|||+.+++.|||+
T Consensus 237 ~-~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T-L----------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-C----------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 0012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.16 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=214.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
...|++.+.||+|+||.||+|.+..+++.||+|++.... ...+..+.+.+|+.+++.++||||+++++++.+ .+..|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEE
Confidence 345999999999999999999998899999999987543 234455678899999999999999999999987 67899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||||+.+++...+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 99999998776666555567999999999999999999999999999999999999999999999999999765322
Q ss_pred cccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .++.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~----------- 233 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT----------- 233 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC-----------
Confidence 24567889999998852 355788999999999999999999999887766655444221 0000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. ....++..+.+||.+||+.||.+|||+.+++.||||...
T Consensus 234 ------~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 ------L--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ------C--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0 001367789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.31 Aligned_cols=253 Identities=31% Similarity=0.452 Sum_probs=212.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+.+|+.++++++||||+++++++.+ ...+++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 489999999999999999999999999999999865432 3456789999999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++.+.........+++..+..++.||++||.|||+++++|+||+|+|||+++++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999988776666555689999999999999999999999999999999999999999999999999997754332 23
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE--VEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~--~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+. .+.+...... ...
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~------------- 219 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADV------------- 219 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccc-------------
Confidence 44567889999999865 4589999999999999999999999987664 2222222111 000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH--HHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA--SSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa--~elL~hp~f 410 (690)
.....++..+.++|.+||..||.+||++ .|+++||||
T Consensus 220 ------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 ------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0112467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.90 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=207.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATG-----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|..++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 457999999999999999999876554 679999987443 34455678999999999999999999999887 5
Q ss_pred ceEEEEEeccchhcccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHD----------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
...|++|||+.++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 7899999999976554333221 457889999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKI 339 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I 339 (690)
+.+||+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....|
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 22334566889999998865 568999999999999999998 99999988877766655
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
......+ ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~----------------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLP----------------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCC----------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4321100 112578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.38 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=207.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeecc----Cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSR----LS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~----~~ 197 (690)
.+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++.++ +|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 356899999999999999999999999999999986542 3345678899999998 799999999998532 24
Q ss_pred ceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 67899999999865544332 2345888899999999999999999999999999999999999999999999998765
Q ss_pred cccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
.... .......|++.|+|||.+.. ...++.++|||||||++|+|++|.+||......+.+..+.... ++
T Consensus 172 ~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~---- 244 (282)
T cd06636 172 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP---- 244 (282)
T ss_pred hccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC----
Confidence 4221 22334678999999998853 2457889999999999999999999998766554443332110 00
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
......++.++.+||.+||+.||.+|||+.|+|.||||
T Consensus 245 ---------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 ---------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00112578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.91 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=210.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEE
Confidence 357999999999999999999998889999999986442 15678999999999999999999999987 688999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.. ....+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++..+.... .
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 154 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-A 154 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-c
Confidence 999999876655443 34578999999999999999999999999999999999999999999999999998765432 1
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+... ... .+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-~~---------- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPP-TL---------- 219 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCC-CC----------
Confidence 2234557889999999865 46889999999999999999999999876655443332110 000 00
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 220 ------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 220 ------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0112467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.12 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=213.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+.. .+..|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEE
Confidence 3566678999999999999998999999999986543 3345668899999999999999999999887 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 9999887765543 3468999999999999999999999999999999999999999999999999997654322 2233
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 239 (292)
T cd06658 177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK---------------- 239 (292)
T ss_pred eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc----------------
Confidence 4678999999999865 56889999999999999999999999987776665554322111000
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....++..+.+||..||..||.+|||++++|+||||...+
T Consensus 240 ----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 240 ----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 0124678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=349.79 Aligned_cols=292 Identities=25% Similarity=0.430 Sum_probs=227.6
Q ss_pred ccccccccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC--C----ce
Q 041720 112 GEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH--P----NI 185 (690)
Q Consensus 112 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--p----nI 185 (690)
|-.++.......++|.+++.||+|+||.|..+.+..++..||||+++.-. ...+..+-||++|++|.+ | -+
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 34455555566788999999999999999999999999999999997322 222335569999999932 2 37
Q ss_pred eeeeceeeccCcceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc----
Q 041720 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---- 260 (690)
Q Consensus 186 v~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---- 260 (690)
|++.++|+- .+++|||+|.++-.+.+.+.. .-.+|+..+++.+..||+++++|||+++++|.||||||||+.+
T Consensus 154 v~m~~wFdy--rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 154 VQMRDWFDY--RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred Eeeehhhhc--cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 888888887 689999999998766655544 3456999999999999999999999999999999999999842
Q ss_pred ----------------CCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 041720 261 ----------------EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324 (690)
Q Consensus 261 ----------------~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~ 324 (690)
+..|||+|||.|.... +..++.+.|..|+|||++++ .+++.++||||+||||+||++|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccc
Confidence 2358999999998643 33367788999999999997 67999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhhhccC---CC-CCCCCCCCCCCcc---ccccccC-------C---CChhHHHHH
Q 041720 325 PILKGRTEVEQLHKIFKLCGSPPEEYWKKSK---LP-HGDMFKPQNPYEG---CLRERCK-------D---FTPTAVDLI 387 (690)
Q Consensus 325 ~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~---l~-~~~~~~~~~~~~~---~l~~~~~-------~---is~~l~dLI 387 (690)
..|++.++.|.+..+...+|++|.....+.. .. .+..-++.....+ +..+.++ . --.++.|||
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9999999999999999999988876554420 00 0111111111111 1111111 1 123588999
Q ss_pred HHhhccCCCCCCCHHHHHcCccccCC
Q 041720 388 DTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 388 ~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
++||.+||.+|+|+.|+|.||||...
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHHccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.04 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=208.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC---cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL---SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~---~~ 198 (690)
.++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.... .+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 567999999999999999999999999999999986532 2234577899999999 8999999999987521 24
Q ss_pred eEEEEEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+|+||||+.++.+.... .....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999987654433 2345689999999999999999999999999999999999999999999999999976
Q ss_pred ccccCcccccccccccCCCCcccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGST----NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
+.... .......++..|+|||.+.... .++.++|||||||++|+|++|++||...+..+.+..+.... +...
T Consensus 178 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~ 253 (291)
T cd06639 178 LTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PPTL 253 (291)
T ss_pred ccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CCCC
Confidence 54322 1223356789999999885432 36789999999999999999999998876665554443211 0000
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.....++..+.+||.+||+.||.+||++.++|+||||+
T Consensus 254 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -----------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -----------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.14 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=210.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||.|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+ ...+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 69999999999999989999999999765432 3455678999999999999999999999887 68899999999987
Q ss_pred cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccccc
Q 041720 211 LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290 (690)
Q Consensus 211 ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~ 290 (690)
.+.........+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 776666655678999999999999999999999999999999999999999999999999998765432 223357789
Q ss_pred CCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 291 ~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.... ..+.+..+......+.
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--------------------- 214 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---------------------
Confidence 9999999865 567899999999999999999999998776 5555555442111100
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
.....++++.+||.+||+.||.+||| +.|+++||||+..-|
T Consensus 215 ------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 215 ------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 00134788999999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=343.76 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=207.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|+.++.||+|+||.||++.+..+++.||||.+...... .....+.+|+.++.++. |+||+++++++.. .+..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4577888999999999999999999999999999765433 44567889999999996 9999999999887 678899
Q ss_pred EEeccchhccccc----ccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 203 VFEYMEHDLAGLS----SCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 203 V~Ey~~g~ll~~~----~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
||||+...+..+. ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999986543321 12335699999999999999999999975 999999999999999999999999999976543
Q ss_pred cCcccccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.. ......|++.|+|||++.+. ..++.++|||||||++|+|++|.+||..... ....+.......+...
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~----- 231 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL----- 231 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-----
Confidence 21 22334678999999998764 3689999999999999999999999976542 2222222111111000
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.......++.++.+||.+||+.||.+|||+++++.||||...
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 232 ----------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 000112578899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=339.62 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=209.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+..+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. .+.++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 358888999999999999999999999999999976543 3455678899999999999999999999988 5899999
Q ss_pred EeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||+.+..+..+... ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999997655544433 3679999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCChhhhhccCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-----EVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-----~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+.+..+... .....
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~------ 224 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPPRL------ 224 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCCCC------
Confidence 12678899999999865 578999999999999999999999997542 22333333211 10000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
+ ...++.++.+||..||..||.+|||+.+++.||||+.
T Consensus 225 ----------~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 225 ----------P--------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ----------C--------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0 0027888999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.86 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=201.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVA----------------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 185 (690)
..++|++.++||+|+||.||+|++.. ++..||||++.... .......+.+|+.+|.+++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 35679999999999999999997532 34579999987543 34456678999999999999999
Q ss_pred eeeeceeeccCcceEEEEEeccchhcccccccC-------------------CCCCChhHHHHHHHHHHHHHHHHHhCCe
Q 041720 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGI 246 (690)
Q Consensus 186 v~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-------------------~~~lse~~~~~i~~QIl~aL~yLH~~gi 246 (690)
+++++++.+ .+.++|||||+.++.+..++.. ...+++..+..++.||+.||.|||+.||
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 82 IRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred eEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 999999987 5789999999988655433211 1246778899999999999999999999
Q ss_pred EeccCCcccEEEccCCcEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh--C
Q 041720 247 MHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--G 323 (690)
Q Consensus 247 vHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt--G 323 (690)
+||||||+|||++.++.+||+|||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|+|++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999998654332211 223445788999999865 568999999999999999986 5
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHH
Q 041720 324 KPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403 (690)
Q Consensus 324 ~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~e 403 (690)
..||.+.+..+.+..+...........+ ......++..+.+||.+||+.||.+|||+.+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVY---------------------LFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhcccccc---------------------ccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 6888887766665554332111100000 0011246788999999999999999999999
Q ss_pred HH
Q 041720 404 LL 405 (690)
Q Consensus 404 lL 405 (690)
+.
T Consensus 298 i~ 299 (304)
T cd05096 298 IH 299 (304)
T ss_pred HH
Confidence 95
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=341.67 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=204.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||+|+||+||+|.+..+|+.||+|++...... ......+..|+.+|+.++||||+++++++.. .+.+|+||||+.++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999999754322 2234556789999999999999999999987 67899999999987
Q ss_pred cccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 211 LAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 211 ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
.+...+.... .+++..+..++.||+.||.|||+.|++|+||+|+|||+++++.+||+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 6654443333 689999999999999999999999999999999999999999999999999976543 222334567
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPY 368 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~ 368 (690)
+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.......+.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------- 215 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------------------- 215 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--------------------
Confidence 889999999876 44889999999999999999999999876542222222111100000
Q ss_pred ccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCCC
Q 041720 369 EGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 369 ~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~~ 416 (690)
.....+++.+.+||.+||+.||.+|| ++.+++.||||....|.
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 216 -----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred -----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 01125788999999999999999999 99999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.93 Aligned_cols=258 Identities=30% Similarity=0.533 Sum_probs=212.5
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD---HPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~ 201 (690)
.|++++.||.|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.+. ||||+++++++.+ ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 3788899999999999999999999999999987543 3344567889999999996 9999999999887 67899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.++.+..+... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 99999998766555443 378999999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......|+..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+... .++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~------------- 221 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPR------------- 221 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCC-------------
Confidence 2344578999999999876566789999999999999999999999876554433222110 0000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.+ ...++.++.+||.+||..||.+|||+.+++.|+||+...
T Consensus 222 ----~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 222 ----LE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ----CC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00 013678899999999999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.85 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=212.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++++.||+|+||+||++.+..+|..||+|++.... .......+.+|+.+++.++||||+++++++.. .+.++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEE
Confidence 4567999999999999999999999999999999987543 34455678999999999999999999999988 58999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||||++++.+.......+.+++..+..++.||+.||.|||+ .+++||||||+|||+++++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999998776666556679999999999999999999997 68999999999999999999999999998654322
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHHcCCCChh
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-----------EQLHKIFKLCGSPPEE 349 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-----------e~l~~I~~~~g~~~~~ 349 (690)
.....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... +.+..+.. ..+..
T Consensus 158 -~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---EPPPR 232 (284)
T ss_pred -ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---ccCCC
Confidence 1234578999999999865 46889999999999999999999999865442 11111111 00000
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+ ...++.++.+||.+||+.||.+|||+.|+++|+||...
T Consensus 233 ----------------~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 233 ----------------LP--------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ----------------CC--------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 01367889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.00 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=201.1
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHH---HHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREI---MILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei---~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
.||+|+||.||++++..+++.||||++....... ........|. .+++...||||+.+++++.+ .+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 3899999999999999999999999997654331 1112233333 44555689999999999987 6789999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccc
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
+.++.+.........+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 998877666666668999999999999999999999999999999999999999999999999999765432 12345
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV---EQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~---e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
+|+..|+|||++.+...++.++|||||||++|+|++|+.||.+.... +....+.. ...
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~--------------- 216 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAV--------------- 216 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----cCC---------------
Confidence 78999999999875556899999999999999999999999875322 21111110 000
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
.....++.++.+||.+||..||.+|| ++.++++||||....|
T Consensus 217 ----------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 217 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred ----------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 01124688999999999999999999 9999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.64 Aligned_cols=255 Identities=33% Similarity=0.527 Sum_probs=215.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 201 (690)
++|.+.+.||.|+||.||++.+..++..||+|++..... .......+.+|+.+++++. ||||+++++++.+ .+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 469999999999999999999999999999999976433 2344567889999999998 9999999999887 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK- 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~- 280 (690)
+||||+.++.+.........+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999997776655555556799999999999999999999999999999999999999999999999999986543321
Q ss_pred ------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 041720 281 ------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKL 342 (690)
Q Consensus 281 ------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~ 342 (690)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 12234567889999998865 45788999999999999999999999988876666665432
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccc
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYF 410 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f 410 (690)
....+ ..+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 238 ~~~~~-----------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFP-----------------------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCC-----------------------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22111 2468889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.60 Aligned_cols=262 Identities=30% Similarity=0.477 Sum_probs=208.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec---
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS--- 194 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--- 194 (690)
.....++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3445678999999999999999999999999999999886432 1234577899999999 79999999998743
Q ss_pred cCcceEEEEEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecc
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFG 270 (690)
...+.+++||||++++.+.... .....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 1246799999999987654432 234568999999999999999999999999999999999999999999999999
Q ss_pred cceeccccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 271 LANILTSKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 271 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
++..+.... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+... ..
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~ 246 (286)
T cd06638 170 VSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP 246 (286)
T ss_pred ceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC
Confidence 998764322 22334578999999998853 234788999999999999999999999876655444332111 00
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
+.. .....++..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 247 ~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTL------------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred Ccc------------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000 0011356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.30 Aligned_cols=257 Identities=26% Similarity=0.495 Sum_probs=213.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|...+.||.|++|.||++.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. .+..++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 4666789999999999999998999999999986443 2334568899999999999999999999887 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++.+...... .++++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 99998776655544 578999999999999999999999999999999999999999999999999987654322 2223
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.... ++. +
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~--~------------- 235 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PPK--L------------- 235 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CCC--C-------------
Confidence 4568999999999865 458899999999999999999999998877776666554321 100 0
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 236 ---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 236 ---------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ---------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 00113778999999999999999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.16 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=200.2
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHh---hcCCCceeeeeceeeccCcceEEEEEec
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILR---RLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~---~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
.||+|+||.||++.+..+++.||||.+....... .......+|..+++ ..+||||+.+++++.. .+.+++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999999999999999997654321 12223344544443 3479999999999987 5789999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccc
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
+.++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCc
Confidence 998877766666667999999999999999999999999999999999999999999999999999765332 22335
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV--EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~--e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
.|++.|+|||.+.+...++.++|||||||++|+|++|..||.+.... ..+..+.. ..+.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~---------------- 216 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVNV---------------- 216 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCCc----------------
Confidence 78999999999865456889999999999999999999999754321 11211110 0000
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
.....+++++.+||.+||..||.+|| |+.++++||||+...|
T Consensus 217 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 217 ---------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred ---------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 01235788999999999999999999 6999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.06 Aligned_cols=254 Identities=27% Similarity=0.491 Sum_probs=210.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|.+.+.||.|+||.||++.+..+|..||+|.+..........+.+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4889999999999999999999999999999997654444455678899999999999999999999887 68999999
Q ss_pred eccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccCcc
Q 041720 205 EYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~~~ 281 (690)
||+.++.+...... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .+||+|||++..+.... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99987655443332 23579999999999999999999999999999999999999886 56999999998764322 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---------------- 220 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC----------------
Confidence 2334568899999998865 45789999999999999999999999887766655544321100
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++.++.++|.+||..+|.+|||+.++|.||||
T Consensus 221 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 ------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0112577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.72 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=205.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHH-hhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMIL-RRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
+.||.|+||.||+|.+..+|+.||||++...... ......+..|..++ ..++|+||+++++++.. .+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999999999999998754322 22233345555544 45589999999999987 68999999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccc
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRV 287 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 287 (690)
.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9887766665556799999999999999999999999999999999999999999999999999976432 23356
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..+....+.......+..
T Consensus 155 ~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 215 (260)
T cd05611 155 GTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE------------------ 215 (260)
T ss_pred CCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCc------------------
Confidence 78899999998764 48899999999999999999999999887776666554321111110
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCC---HHHHHcCccccCCCC
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT---ASSLLMCEYFTTQPY 415 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT---a~elL~hp~f~~~p~ 415 (690)
....+++.+.+||.+||+.||.+||| ++|+|.||||....|
T Consensus 216 -------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 216 -------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 11247889999999999999999995 579999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.06 Aligned_cols=250 Identities=26% Similarity=0.471 Sum_probs=208.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||.|+||.||++++..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+ .+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48999999999999999999999999999999875432 3445678899999999999999999999987 68999999
Q ss_pred eccchhcccc-ccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 205 EYMEHDLAGL-SSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 205 Ey~~g~ll~~-~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||++++.+.. +.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9998764433 322 33458999999999999999999999999999999999999999999999999997764322 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL--------------- 220 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---------------
Confidence 334678999999999865 5588999999999999999999999998776666655533211111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...++..+.+||.+||+.||.+|||+.++|.-
T Consensus 221 -------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12467789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.34 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=203.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||++.+. .+..+|+|.+...... ...+.+|+.+|+.++||||+++++++.+ .+.+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~i 76 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYI 76 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEE
Confidence 456999999999999999999864 4567999988754433 2457889999999999999999999987 678999
Q ss_pred EEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999977555443 33456899999999999999999999999999999999999999999999999999765432222
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+.+..+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~------------- 222 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------------- 222 (256)
T ss_pred ccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-------------
Confidence 2222344667999999865 568899999999999999999 9999998888777777644211100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..+.+||.+||+.||.+|||+.++++
T Consensus 223 ---------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 223 ---------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.74 Aligned_cols=257 Identities=32% Similarity=0.525 Sum_probs=215.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++.+.||.|++|.||+|++..+++.||||++...... .....+.+|+.++..++|+||+++++++.. .+.+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 3689999999999999999999999999999999765432 456778999999999999999999999987 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||+.++.+.........+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC-Cc
Confidence 9999987776666555689999999999999999999999 999999999999999999999999999998765432 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.... ..+....+... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~----------- 221 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPP----------- 221 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCC-----------
Confidence 234567899999999865 578899999999999999999999998764 33333333211 000
Q ss_pred CCCCCCCCCccccccccCC-CChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKD-FTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~-is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..... ++..+.+||..||..+|.+|||+.++|+||||+..
T Consensus 222 --------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 222 --------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred --------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 00113 78899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.20 Aligned_cols=254 Identities=30% Similarity=0.513 Sum_probs=215.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 4889999999999999999999899999999998776655667788999999999999999999999887 58999999
Q ss_pred eccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 205 EYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 205 Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||++++.+...... ...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99998655444332 3679999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+......+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-------------- 222 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--------------
Confidence 23344578899999998865 558899999999999999999999998877665555543321100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....++..+.++|..||..+|.+|||+.++|+||||
T Consensus 223 --------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 223 --------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.75 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=200.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATG-----KMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|++.+.||+|+||.||+|++..+| ..||||++.... .......+.+|+.+|+.+ +|+|||++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34567999999999999999999865443 579999997553 334456788999999999 89999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC--------------------------------------------------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-------------------------------------------------------- 218 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-------------------------------------------------------- 218 (690)
.+.+|||||||.++.+...+..
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 6789999999987654432211
Q ss_pred --------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc-
Q 041720 219 --------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL- 283 (690)
Q Consensus 219 --------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~- 283 (690)
..++++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.+........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478889999999999999999999999999999999999999999999999976543222111
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+......+..
T Consensus 272 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR-------------- 336 (374)
T ss_pred cCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--------------
Confidence 12334667999999865 568999999999999999997 99999876554444443332111100
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++++.+||.+||+.||.+|||+.++++
T Consensus 337 -------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 337 -------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1136789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.38 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=214.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
..|+.+++||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.||||+++++++.+ .+.+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 348888999999999999999999999999999875432 3445678899999999999999999999988 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++.+...... .++++.++..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+.... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 999998766555443 468999999999999999999999999999999999999999999999999997764432 223
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+... .++
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~---------------- 219 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NPP---------------- 219 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CCC----------------
Confidence 34567889999999865 45789999999999999999999999877665544433111 010
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++..+.+||.+||..||.+||++.++|.|+||...+
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 220 ----------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ----------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 01124678899999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.68 Aligned_cols=256 Identities=26% Similarity=0.461 Sum_probs=212.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|+....||+|+||.||++.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.. .+.+|+|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEe
Confidence 55566899999999999999999999999999754322 34568899999999999999999999987 688999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+.++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .....
T Consensus 99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 999876655443 3468999999999999999999999999999999999999999999999999997654322 22344
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
.++++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+... . ...+
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-~~~~-------------- 237 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---P-PPKL-------------- 237 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---C-CCCc--------------
Confidence 678999999999865 46899999999999999999999999987777666554321 0 0000
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++..+.+||.+||+.||.+||++.++++||||....
T Consensus 238 --------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 238 --------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 01125778899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.44 Aligned_cols=254 Identities=31% Similarity=0.571 Sum_probs=216.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.+.||+|++|.||++++..+++.||+|.+............+.+|++++.+++||||+++++++.+ .+.+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999999999999999998776555667789999999999999999999999887 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++.+.........+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999876666555556899999999999999999999999999999999999999999999999999987654332 233
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...++..|+|||.+.+ ..++.++|||+||+++|+|++|.+||...+......++.... .+
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~----------------- 217 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HP----------------- 217 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--CC-----------------
Confidence 4567899999999865 447899999999999999999999998776655554432110 00
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....++..+.++|.+||..+|++|||+.++|.||||
T Consensus 218 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 ---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0012568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=337.22 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=208.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||++++++|.+...+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 368999999999999999999999999999999975532 3445678899999999999999999999876556689999
Q ss_pred Eeccchhccccc----ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 204 FEYMEHDLAGLS----SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~----~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
|||++++.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999988655432 2234568999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCChhhhhcc
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-----EVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-----~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+... ..... .
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-~-- 229 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPEL-K-- 229 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchhh-c--
Confidence 123457889999998864 568999999999999999999999998652 22333222210 00000 0
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+ .....+++.+.+||.+||..||.+|||+.|++.||||..
T Consensus 230 ----------~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 230 ----------DEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ----------cCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 000135678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=331.35 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=211.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN---FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46999999999999999999999999999999986432 223455678899999999999999999999877545678
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC-
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN- 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~- 279 (690)
++||||+.++.+.........+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999987665555455568999999999999999999999999999999999999999999999999997653211
Q ss_pred -cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 -KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........++..|+|||.+.+ ..++.++|||||||++|+|++|.+||......+...++.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCC---------
Confidence 112234568899999999876 4578999999999999999999999987766655544421 11110
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
.....+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0123578899999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=333.80 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=205.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
...+|.+.++||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.. .+.++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 78 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcE
Confidence 4456999999999999999999999999999999987442 234568899999999999999999999887 67899
Q ss_pred EEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+..... ....+++..++.++.||+.||.|||++|++||||||+|||+++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999998765554432 23458899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..... +
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~------------ 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-M------------ 224 (263)
T ss_pred eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-C------------
Confidence 222122233567999998865 568899999999999999998 9999998777666555432110 0
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++.++.+||.+||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 ---------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.01 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=202.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. .+.+++|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEE
Confidence 33445568999999999999999999999999987543 3345678999999999999999999999887 6889999
Q ss_pred EeccchhcccccccC-CCCC--ChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeecccceeccccC
Q 041720 204 FEYMEHDLAGLSSCH-DIKF--SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~-~~~l--se~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~ 279 (690)
|||+.++.+...... ...+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999998766554433 2345 78889999999999999999999999999999999976 6799999999997654322
Q ss_pred cccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||...................
T Consensus 164 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 230 (268)
T cd06624 164 -PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH------------ 230 (268)
T ss_pred -CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC------------
Confidence 223345678999999998543 347889999999999999999999997543221111000000000
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
......+++++.+||.+||+.+|.+|||+.+++.||||
T Consensus 231 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 231 --------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00112577889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=341.30 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=214.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
|...++||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.+ ....|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence 7778889999999999999999999999999976533 23445678899999999999999999999988 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++++..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.... ...
T Consensus 101 e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~ 175 (313)
T cd06633 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PAN 175 (313)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CCC
Confidence 999887776666556679999999999999999999999999999999999999999999999999986432 223
Q ss_pred ccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
...|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.... .+..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~------------- 240 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTL------------- 240 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCC-------------
Confidence 4578899999999842 3457889999999999999999999998887777666654321 1100
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....++..+.+||.+||+.+|.+||++.++|.||||...+
T Consensus 241 ------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 241 ------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0124677899999999999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.91 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=210.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||.|+||.||++++..+|+.||+|++..... .......+.+|+.++++++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999988999999999976533 23456678899999999999999999999887 68899999999987
Q ss_pred cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-------ccc
Q 041720 211 LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-------QKL 283 (690)
Q Consensus 211 ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-------~~~ 283 (690)
.+..+......+++..+..++.||+.||.|||+.+++|+||+|+|||++.++.+||+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 6655555545799999999999999999999999999999999999999999999999999876543211 122
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+......++.
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--------------- 222 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc---------------
Confidence 34567889999999865 44788999999999999999999999988877766665442111110
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH---HHHHcCccccCCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA---SSLLMCEYFTTQPY 415 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa---~elL~hp~f~~~p~ 415 (690)
...++..+.+||.+||+.+|.+|||+ .++|+||||+...|
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 223 ------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 01258899999999999999999999 99999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.00 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=204.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|+++++||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+ .+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCc
Confidence 4567899999999999999999985 4567799999865432 34678899999999999999999999877 6788
Q ss_pred EEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+...+. ....+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999998765544332 2346888999999999999999999999999999999999999999999999999876533
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP----------- 224 (261)
T ss_pred ceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2222233445678999999865 567889999999999999998 999999887777666654321110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.++.+||.+||..||.+|||++++++
T Consensus 225 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 -----------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11257789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.64 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=210.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|+.++.||.|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEE
Confidence 47778889999999999999999999999999875532 3345678999999999999999999999987 67899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||++++.+..... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+.... ....
T Consensus 82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 9999876655443 3468999999999999999999999999999999999999999999999999997764322 2223
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... .++
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~----------------- 219 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPP----------------- 219 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CCC-----------------
Confidence 3567889999999865 56889999999999999999999999866554443322110 000
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++.++.+||.+||..+|.+|||+.++|.||||...
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 220 ---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0112467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.44 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=207.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|++.++||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 456789999999999999999997542 34589999986543 22334457889999999999999999999887
Q ss_pred CcceEEEEEeccchhcccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEE
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vK 265 (690)
.+..|+||||+.++.+..+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 5789999999987765544322 12345678899999999999999999999999999999999999999
Q ss_pred EeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 266 LGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 266 L~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
|+|||+++.+....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997654322111 122345678999999865 568999999999999999998 789999877766655543211
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc------CccccCCCC
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM------CEYFTTQPY 415 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~------hp~f~~~p~ 415 (690)
. . ......++.+.+||.+||+.||.+|||+.++++ ||||.+..|
T Consensus 239 ~--~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 239 Y--L--------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred C--C--------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 0 0 001245788999999999999999999999986 899987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=327.46 Aligned_cols=262 Identities=25% Similarity=0.429 Sum_probs=222.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 199 (690)
...++.+.+..||.|+-|+|++++...+|..+|||.+.... +.+..++++..+.++... ++|+||+.+|+|.. ...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~d 165 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTD 165 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--Cch
Confidence 44566788899999999999999999999999999998765 345567788888887776 49999999999988 577
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++|.||.|..-...++..-.++++|.-+-++...++.||.||.++ +|||||+||+|||||..|++||||||++-.+...
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 889999998766666666667899999999999999999999865 7999999999999999999999999999776543
Q ss_pred CcccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
...+...|.+.|||||.+.. ...|+..+||||||++|+||.||..||.+ .++.+.+-+|++.. ||.
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP~------- 314 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PPL------- 314 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CCC-------
Confidence 34456688999999999853 34689999999999999999999999997 57888998887622 210
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+.. -..+|+.+.+|+..||..|+.+||...++|+|||+..+
T Consensus 315 ----------------L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 315 ----------------LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ----------------CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 000 12489999999999999999999999999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.40 Aligned_cols=255 Identities=30% Similarity=0.496 Sum_probs=212.8
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++++.+ .+.+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 47889999999999999999989999999999865432 3445678899999999999999999999987 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++.+..+.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 9999876655543 3468999999999999999999999999999999999999999999999999997664322 2223
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
...++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+... .++
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------- 219 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPP----------------- 219 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCC-----------------
Confidence 4567889999999865 46788999999999999999999999877665555444221 000
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++.++.++|.+||..||.+||++.++|.||||...
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0112467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.81 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=205.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..+|.+++.||+|+||.||+|.+. .++..||||++.... ..+..+.+.+|+++|+.+.|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 456899999999999999999864 346789999987543 33355788999999999999999999999988 5
Q ss_pred ceEEEEEeccchhcccccccC--------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH--------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~--------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
...++||||+.++.+..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 889999999998765544322 234888999999999999999999999999999999999999999
Q ss_pred EEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 041720 264 LKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 264 vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~ 341 (690)
+||+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999976533221 11223455788999999875 568999999999999999998 9999988877776666543
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+ ...++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQR----------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCC----------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 211111 1257889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.79 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=215.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..|...+.||+|+||.||++++..++..||||++..... ..+....+.+|+.+++.++|||++++++++.+ .+..+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 348889999999999999999999999999999976533 33455678899999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+.++.........+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999999877666555566799999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.........
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 245 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ------------ 245 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC------------
Confidence 234568899999998742 345788999999999999999999999887766666665442211100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+++.+.+||.+||+.+|.+|||+.+++.|+|+...
T Consensus 246 ---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 246 ---------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ---------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 12467789999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.93 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=199.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRARE-----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|++.++||+|+||.||+|++ ..++..||||+++.... ....+.+.+|+.+|..+ +|||||++++++.+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 3455799999999999999999974 34567899999975432 33446788999999999 89999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC--------------------------------------------------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-------------------------------------------------------- 218 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-------------------------------------------------------- 218 (690)
.+..++|||||+++.+......
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 6789999999987644322211
Q ss_pred -------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 219 -------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 219 -------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247788899999999999999999999999999999999999999999999998764332
Q ss_pred cccc-cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 280 KQKL-TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 ~~~~-~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+.+++.....+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 337 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML---------- 337 (375)
T ss_pred cccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC----------
Confidence 2111 12334667999999865 568999999999999999998 8999987654444433332111000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+.++.+||..||+.||.+|||+.++++
T Consensus 338 -----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 338 -----------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 01135778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=360.28 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=210.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++...||.|+|+.|..+.+..+++..++|++..... ...+|+.++... +||||+++++++.+ ...+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC--Ccee
Confidence 36779999999999999999999999999999999976622 234677666665 79999999999998 7899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE-ccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV-NNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl-d~~~~vKL~DFGla~~~~~~~ 279 (690)
|+|||++.|+++...+.....+. .++..|++||+.|+.|||++|||||||||+|||+ ++.++++|+|||.++.+...
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999988777666665555 8888999999999999999999999999999999 58899999999999876543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||...... +...+| +.++..
T Consensus 470 ---~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s--------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS--------- 532 (612)
T ss_pred ---hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc---------
Confidence 44567789999999997 578999999999999999999999999976655 333333 222211
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+|.++++||+.||++||.+||++.+++.||||..++
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 26899999999999999999999999999999995554
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=330.93 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=202.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||++.+. .+..||||.+...... ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEE
Confidence 457999999999999999999764 3456999998754432 2458899999999999999999999977 577899
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999998875554443 3346899999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR------------- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-------------
Confidence 1222334677999999865 458899999999999999998 9999988777666666543221110
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+..+.+||.+||+.||.+|||+.++|.+
T Consensus 223 ---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 ---------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 01357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=342.72 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=202.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+...+|++++.||+|+||.||+|++..++.. ||||++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-- 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--
Confidence 3466799999999999999999998766664 899998643 234455678899999999999999999999875
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++|+||+.++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4578999999887554433 33456889999999999999999999999999999999999999999999999999876
Q ss_pred cccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.. .++.....++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~----- 232 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ----- 232 (316)
T ss_pred cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC-----
Confidence 5332211 122334678999999865 568999999999999999997 99999887655443 33221111110
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+.++.++|..||..||.+|||+.+++.+
T Consensus 233 ----------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 ----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=336.82 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=210.6
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
.|++.+.||.|+||.||++.+. .+|..||+|++..... .....+.+.+|+.+|..+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 3889999999999999999874 4789999999975422 122345678899999999 69999999999887 67
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.++.+...+.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 89999999998766665555567899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.........
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 229 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------- 229 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC---------
Confidence 33333456789999999998643 34678999999999999999999999754332222222221100000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
+ ....+++.+.+||.+||+.||.+|| ++++++.||||+...|
T Consensus 230 ---------~-------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 230 ---------P-------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ---------C-------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 0124778899999999999999997 8999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.23 Aligned_cols=279 Identities=26% Similarity=0.404 Sum_probs=206.2
Q ss_pred eEEeec--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G--~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
..||+| +||+||++++..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. .+.+++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 346666 99999999999999999999998765555666789999999999999999999999988 67899999999
Q ss_pred chhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc---
Q 041720 208 EHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK--- 282 (690)
Q Consensus 208 ~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~--- 282 (690)
.++.+...... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 98655444332 2358999999999999999999999999999999999999999999999998654322111000
Q ss_pred ---ccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 283 ---LTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 283 ---~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+.+..++......+ |.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccch
Confidence 0112345679999998653 3478999999999999999999999998776665544443211111 11100000
Q ss_pred CC-----------------CCCC----CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 GD-----------------MFKP----QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 ~~-----------------~~~~----~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.. .... ..............+++.+.+||++||+.||.+|||+.|+|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 0000 0000000001123467789999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.70 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=204.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++||||+++++++.+ .+.+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 46999999999999999999999999999999886533 334555678899999999999999999999987 678999
Q ss_pred EEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 203 VFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 203 V~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999986554332 23345899999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--EVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+ .....++..
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~------- 229 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPLP------- 229 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCCC-------
Confidence 2 22234568889999999875 457889999999999999999999986543 22333332 211111110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.+||.+||..+|.+|||+.++|+
T Consensus 230 -------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 230 -------------------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -------------------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1146788999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=331.22 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=202.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 126 FEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
|++.+.||+|+||.||+|.+..+ +..||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57788999999999999987653 478999999876555556677899999999999999999999876521 12
Q ss_pred eEEEEEeccchhcccccc------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 199 TIYLVFEYMEHDLAGLSS------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
..++||||+.++.+.... .....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999987554332 12235899999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcccc-cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 273 NILTSKNKQKL-TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 273 ~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
+.......... ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL--- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC---
Confidence 87643322111 11234678999998854 568999999999999999999 999999877776665543211 00
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....++..+.++|.+||+.||.+|||+.+++.+
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.16 Aligned_cols=254 Identities=17% Similarity=0.273 Sum_probs=202.0
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 4567999999999999999999864 245679999986443 22344568899999999999999999999877
Q ss_pred cceEEEEEeccchhcccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEE
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCH----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKL 266 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL 266 (690)
....++||||+.++.+..+... ...++...+..++.||+.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 6789999999998765544322 123567788999999999999999999999999999999999999999
Q ss_pred eecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcC
Q 041720 267 GDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCG 344 (690)
Q Consensus 267 ~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g 344 (690)
+|||++..+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999997654322111 122345778999999865 568999999999999999999 7899998877666655433211
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.. .....+..+.+||.+||+.||.+|||+.|++.+
T Consensus 240 ~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LD----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 012467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=321.45 Aligned_cols=281 Identities=30% Similarity=0.570 Sum_probs=228.7
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+++|+|-|+.||.|++..+.+.++||+++ +-..+.+.+|+.||..|. |||||+|+++..+..+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3678999999999999999999999999999999986 334577999999999996 9999999999999778888
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~~~~~~ 279 (690)
.|||||+.+.....+ -..|+..+++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+|||.++...
T Consensus 111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 999999987433222 1258889999999999999999999999999999999999976 47999999999887543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHcCCCC-hhhhhccCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPP-EEYWKKSKLP 357 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~-~PF~~~~~~e~l~~I~~~~g~~~-~~~w~~~~l~ 357 (690)
....-.+.+..|--||.|...+.|+.+.|||||||+|..|+..+ |.|.|.++.+|+-+|.+.+|... ..+..+..+.
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 34455677889999999988888999999999999999999976 55689999999999999998754 2333333322
Q ss_pred CCCC------CCCCCCCcccccccc-CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 358 HGDM------FKPQNPYEGCLRERC-KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 358 ~~~~------~~~~~~~~~~l~~~~-~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.... .....++...+.... .-+++++.|||.++|.+|..+|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111 111122222222222 235699999999999999999999999999999975
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.67 Aligned_cols=258 Identities=28% Similarity=0.508 Sum_probs=212.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 4679999999999999999999888999999999864432 234668899999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+..+... ..+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-cc
Confidence 9999998766655443 358899999999999999999999999999999999999999999999999987654332 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+.+..+... +.+..
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------- 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------- 235 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCCC--------------
Confidence 334568899999999865 56789999999999999999999999877665544332210 00000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++..+.+||..||..+|.+||++.++|.|+||+..
T Consensus 236 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 236 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 0012467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=327.52 Aligned_cols=252 Identities=26% Similarity=0.467 Sum_probs=212.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|++.++||+|+||.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4899999999999999999999999999999998765555556778899999999999999999999987 58999999
Q ss_pred eccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 205 EYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 205 Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||+.+..+...... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99988655443322 346899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 220 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-------------- 220 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------
Confidence 2234567899999999865 567889999999999999999999999887766555543211111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....++.++.++|.+||+.+|.+|||+.++|+||++
T Consensus 221 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 221 --------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 011467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.68 Aligned_cols=149 Identities=29% Similarity=0.436 Sum_probs=133.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|.++++||+|+||.||+|++..+++.||||++..... .......+..|+.++..++||||+++++++.. .+.+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 4679999999999999999999999999999999976432 34556778999999999999999999998877 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
|||||+.++.+..++.....+++..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999887666555555678999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.40 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=205.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.++|++.+.||+|+||.||+|.+..+ ...||||++.... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 46799999999999999999988644 4579999987543 34455678899999999999999999999887 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999987655443 33457899999999999999999999999999999999999999999999999999876522
Q ss_pred Cccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 229 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP--------- 229 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 2111 112234678999998865 568899999999999999998 9999988777666665543211110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+..+.+||.+||+.||.+||++.+++++
T Consensus 230 -------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 -------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=329.77 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=200.5
Q ss_pred EEeecCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYSSVFRARE--VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
+||+|+||.||+|.+ ..++..||+|+++.........+.+.+|+.+++.++||||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4577899999997665555667789999999999999999999998864 56799999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc--cccc
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK--LTSR 286 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~--~~~~ 286 (690)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 87666555555679999999999999999999999999999999999999999999999999998764332211 1222
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
.+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+......+
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~------------------- 218 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME------------------- 218 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-------------------
Confidence 33578999998854 568889999999999999998 999999887777666654321100
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||.+||+.||.+||++++|..
T Consensus 219 ---------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 219 ---------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01257889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.82 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=202.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.+.||+|+||.||+|.+. +++.||||.+...... .+.+.+|+.++++++||||+++++++.. .+.+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCee
Confidence 4567999999999999999999864 5578999998765432 3558899999999999999999999887 67899
Q ss_pred EEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+...... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999976655444332 2368999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.........+..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+....+..+......+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 225 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC----------- 225 (261)
T ss_pred ccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 111122223457999998865 568899999999999999999 9999998887776666543211000
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.+||.+||+.||.+||++.+++.
T Consensus 226 -----------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 -----------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1246788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.93 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=217.2
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+...+||+|+|-+||+|.|..+|..||.-.++...+ .+...++|..|+.+|+.|+|||||++|+.+.+.....+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 445679999999999999999999999665544332 466678999999999999999999999999987677899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccC-CcEEEeecccceeccccCcc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~-~~vKL~DFGla~~~~~~~~~ 281 (690)
|+|..|.|..++.+.+++....+..|++||+.||.|||++. |||||||.+||||+.+ |.|||+|+|||..+.. .
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---S 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc---c
Confidence 99999999999888889999999999999999999999986 9999999999999764 8999999999988653 3
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....+|||.|||||++. ..|+..+||||||++|+||+|+..||.. .+..+.++++.. |..|..+-
T Consensus 200 ~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~--------- 266 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS--------- 266 (632)
T ss_pred ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh---------
Confidence 345589999999999996 5799999999999999999999999985 455555666544 33333221
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+--.+++++||.+||.. ...|||+.|+|.||||...
T Consensus 267 ----------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ----------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12367899999999999 9999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.79 Aligned_cols=252 Identities=34% Similarity=0.544 Sum_probs=210.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|.+.+.||.|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 48899999999999999999988999999999976543 345678999999999999999999999987 58899999
Q ss_pred eccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 205 EYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||++++.+....... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999976555444333 5799999999999999999999999999999999999999999999999999977654321 3
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+... ..+...+
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~------------ 219 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGLRN------------ 219 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCcCc------------
Confidence 45678899999999865 45788999999999999999999999887655555444321 1110000
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
...++..+.+||.+||+.||.+|||+.++|.|||
T Consensus 220 ------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 ------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.71 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=203.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREV----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 467999999999999999999853 456789999997543 34445678899999999999999999999887 67
Q ss_pred eEEEEEeccchhcccccccC-----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
..|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 89999999987654433211 1247888999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKI 339 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I 339 (690)
+.+||+|||+++.+..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 12233445678999999865 568999999999999999998 99999887766665555
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..... ++ ....+++.+.+||.+||+.||.+||++.+++++
T Consensus 240 ~~~~~-~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQL-LP---------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCc-CC---------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 32110 00 112578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=331.95 Aligned_cols=292 Identities=33% Similarity=0.509 Sum_probs=238.7
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc---c
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS---N 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~ 198 (690)
..-+.+-.+.||.|+||+||.+.+..+|+.||+|++..-...-...+.+-+|+.+|.-++|.|++..+|+...... .
T Consensus 51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 3445566788999999999999999999999999986432223455678899999999999999999988754211 3
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+|+|+|..++.. ++.....++.+.+.-++.||+.||.|||+.+|+||||||.|+|++.+..+||||||||+..+.+
T Consensus 131 EiYV~TELmQSDLHK-IIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHK-IIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHHHhhhhh-eeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 568899999887655 4445557999999999999999999999999999999999999999999999999999998887
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP- 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~- 357 (690)
....++..+.|..|+|||+|+|...|+.++||||+|||+.|||-.+..|+..++.++++.|..++|.|..+-++.-..-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 7778888999999999999999999999999999999999999999999999999999999999999987766531111
Q ss_pred --CCCCCCCCCCCcccccccc--CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 --HGDMFKPQNPYEGCLRERC--KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 --~~~~~~~~~~~~~~l~~~~--~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
+.-.-.+..|.-..+.... .+-..++.+++..||.+||.+|.+.+++|.|+|+.+..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 1000111112222222222 13345788999999999999999999999999997644
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.20 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=201.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.++.++ +|+||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34567999999999999999999753 345789999987543 334456688899999999 89999999998875
Q ss_pred cCcceEEEEEeccchhcccccccC--------------------------------------------------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-------------------------------------------------------- 218 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-------------------------------------------------------- 218 (690)
. ...+++||||+.++.+...+..
T Consensus 83 ~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 P-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred C-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 3 5688999999998655433211
Q ss_pred -----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc-ccccccccCC
Q 041720 219 -----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWY 292 (690)
Q Consensus 219 -----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y 292 (690)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....... .....++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1257889999999999999999999999999999999999999999999999998764322211 2234456789
Q ss_pred CCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccc
Q 041720 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGC 371 (690)
Q Consensus 293 ~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~ 371 (690)
+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+.+...+.....+.
T Consensus 242 ~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 296 (337)
T cd05054 242 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR------------------------ 296 (337)
T ss_pred cCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC------------------------
Confidence 99999875 568999999999999999998 9999987554444433322110000
Q ss_pred cccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 372 LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 372 l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+++++.+|+.+||+.+|.+|||+.|+++|
T Consensus 297 ---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 ---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012467889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.51 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=212.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
+|.+.+.||+|++|.||+|.+..++..|++|++..........+.+.+|+.++++++||||+++++.+.+.....+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999988999999999987655456678899999999999999999999999873227899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-cc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-KL 283 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-~~ 283 (690)
||+.++.+..+......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99987766655555558999999999999999999999999999999999999999999999999999876543321 12
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... .......+... ...
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------- 222 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS-GEP---------------- 222 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc-CCC----------------
Confidence 34567899999998865 448899999999999999999999998765 22222211100 000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
......++..+.+||.+||+.||.+||++.++|.||||
T Consensus 223 ----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 223 ----------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ----------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 01112458899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.56 Aligned_cols=251 Identities=19% Similarity=0.279 Sum_probs=199.6
Q ss_pred eEEeEEeecCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----CcceE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGK--MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSNTI 200 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~~ 200 (690)
.+.+.||+|+||.||+|++..++. .||+|.++.........+.+.+|+.+|+.++||||+++++++... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999877775 699999876654556677889999999999999999999976431 12357
Q ss_pred EEEEeccchhcccccc------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 201 YLVFEYMEHDLAGLSS------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
++||||+.++.+.... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999976544322 1233589999999999999999999999999999999999999999999999999987
Q ss_pred ccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 275 LTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 275 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
+....... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+..... ++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~----- 234 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LK----- 234 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CC-----
Confidence 64322111 122345678999999865 568999999999999999999 8999998777665555432110 00
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 235 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 235 ----------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01256788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.12 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=201.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++.+.||+|+||.||++.+. ++..+|+|++....... ..+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFI 76 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEE
Confidence 346899999999999999999875 56689999987544332 357789999999999999999999877 578999
Q ss_pred EEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||++++.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999887554443 33457899999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-------------- 221 (256)
T ss_pred ccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC--------------
Confidence 1112223457999999875 568899999999999999999 899998877776665553221100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+.++.+||.+||..+|.+|||+.++|+
T Consensus 222 --------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 222 --------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred --------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01246889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.54 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=195.6
Q ss_pred CeeEEeEE--eecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKI--GQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~L--G~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.|++.+.+ |.|+||.||++++..++..+|+|.+........ |+.+...+ +||||+++++.+.. .+.+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 85 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTT--LKGHV 85 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEec--CCeeE
Confidence 45565555 999999999999999999999999875533211 22222222 79999999999988 57899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~~ 280 (690)
+||||++++.+..+......+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999998876655555555899999999999999999999999999999999999999998 9999999999765432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-LHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ....
T Consensus 164 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~----------- 227 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL----------- 227 (267)
T ss_pred ---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC-----------
Confidence 23467899999999965 5688999999999999999999999986543321 11111111 1000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-HHHHHcCccccC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-ASSLLMCEYFTT 412 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-a~elL~hp~f~~ 412 (690)
...+.+++.+.+||.+||+.||.+||+ ++++|+||||..
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 228 --------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred --------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 011258899999999999999999996 599999999963
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.50 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=204.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
...+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+|++++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE-- 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 4567999999999999999999752 34567999988643 24455678999999999999999999999987
Q ss_pred cceEEEEEeccchhcccccccC-------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCH-------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~-------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
.+.+++||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 6889999999997765433321 224899999999999999999999999999999999999999999
Q ss_pred EEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 041720 264 LKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 264 vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~ 341 (690)
+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999765432211 1123345778999999865 568999999999999999998 9999998877776666643
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..... ....++.++.+||.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQ----------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCC----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21100 01246789999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.92 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=202.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|+++++||+|+||.||+|.+. ++..||+|.+....... ..+.+|+.++++++|+||+++++++.. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE---EPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC---CCc
Confidence 34567999999999999999999764 66679999997654433 458899999999999999999998754 568
Q ss_pred EEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999988655444332 345899999999999999999999999999999999999999999999999999876433
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 223 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMP---------- 223 (260)
T ss_pred ccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC----------
Confidence 2222223345678999998864 568899999999999999999 999999887777666654321 100
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+..+.+||.+||..||.+|||+.++++
T Consensus 224 -----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 -----------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01256788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.16 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=204.8
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeec-eeecc--
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEG-VITSR-- 195 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~-~~~~~-- 195 (690)
.+..-++++.+.|.+|||+.||+|++...|..||+|++-.. ++...+.+.+||++|++|+ |+|||.++| ....+
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 34455689999999999999999999888899999998754 5778899999999999996 999999999 33321
Q ss_pred -C-cceEEEEEeccch-hccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEeec
Q 041720 196 -L-SNTIYLVFEYMEH-DLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 196 -~-~~~~~LV~Ey~~g-~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~DF 269 (690)
. .-.++|.||||.| ++++++.. ....|+|.++++|+.|+++|+.+||... |||||||-|||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 2467899999995 66665542 2345999999999999999999999998 999999999999999999999999
Q ss_pred ccceeccccC--ccc------ccccccccCCCCccccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 041720 270 GLANILTSKN--KQK------LTSRVVTLWYRPPELLM--GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339 (690)
Q Consensus 270 Gla~~~~~~~--~~~------~~~~~gt~~Y~APE~l~--~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I 339 (690)
|.|.-..... ... .....-|+.|+|||++- .....+.|+|||+|||+||-||....||.+.-.. .|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence 9996432111 000 11233489999999973 3456799999999999999999999999864332 24
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+...+.+|. ++.++..+++||+.||+.||.+||++-+++.+
T Consensus 267 lng~Y~~P~---------------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 267 LNGNYSFPP---------------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred EeccccCCC---------------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 444444432 13688899999999999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.16 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=196.9
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccch
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH 209 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 209 (690)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+.+|+.++||||+++++++.. ...+||||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3699999999999999999999999988643 345556778999999999999999999999987 6789999999988
Q ss_pred hcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc-cccc
Q 041720 210 DLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL-TSRV 287 (690)
Q Consensus 210 ~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~-~~~~ 287 (690)
+.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 7655444 3344689999999999999999999999999999999999999999999999999976432111100 1112
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... ++
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-~~------------------- 216 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-LP------------------- 216 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CC-------------------
Confidence 2456999999865 558899999999999999997 9999987766555444432110 00
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 217 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 217 --------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.35 Aligned_cols=256 Identities=29% Similarity=0.513 Sum_probs=212.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..|...+.||+|+||.||+|++..++..||||.+..... .......+.+|+.+++.++|+|++++++++.. ....++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence 348888999999999999999999999999999875432 23445678899999999999999999999987 678999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+.+...+......+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 9999988766655555556899999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+.+..+........
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 234 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 234 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc-------------
Confidence 34567889999999752 24578899999999999999999999987666555554432111000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....++..+.+||.+||..+|.+||++.+++.|+|+...
T Consensus 235 --------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 235 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 012477889999999999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.74 Aligned_cols=273 Identities=25% Similarity=0.370 Sum_probs=201.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhccccc
Q 041720 136 TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS 215 (690)
Q Consensus 136 ~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~ 215 (690)
++|.||.+++..+++.||||++............+.+|+.+|+.++|+||+++++++.+ .+.++++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44555666666799999999998765556677889999999999999999999999987 6889999999998766544
Q ss_pred ccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc------ccccccc
Q 041720 216 SCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK------QKLTSRV 287 (690)
Q Consensus 216 ~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~------~~~~~~~ 287 (690)
... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 432 34589999999999999999999999999999999999999999999999999876532211 1123345
Q ss_pred cccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC-----
Q 041720 288 VTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM----- 361 (690)
Q Consensus 288 gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~----- 361 (690)
++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..... +..+. .+.....+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcc
Confidence 67889999998653 4588999999999999999999999987665544322222 11110 111111000000
Q ss_pred ---CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 ---FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ---~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.................++.++.+||..||..||.+|||++++|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000000000111123456789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.42 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=202.0
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
..+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--
Confidence 34669999999999999999999877 77889999886443 23344568899999999999999999998877
Q ss_pred cceEEEEEeccchhcccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEE
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHD-------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKL 266 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~-------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL 266 (690)
.+..++||||+.++.+..+.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 56789999999876555433221 2588999999999999999999999999999999999998765 6999
Q ss_pred eecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcC
Q 041720 267 GDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCG 344 (690)
Q Consensus 267 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g 344 (690)
+|||+++.+...... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~- 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999865322111 1112233567999999865 568999999999999999997 999999887766555443211
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
... ....++..+.+||.+||+.||.+|||+.++|+|
T Consensus 239 ~~~---------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLD---------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 012578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.59 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=210.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..+++.+...||+|.||+||+|++-. .||||+++.+...++..+.|.+|+.+|++-+|.||+-+.|+|.. ..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~---p~ 461 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN---PP 461 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC---Cc
Confidence 4556778899999999999999998743 39999999998889999999999999999999999999999986 34
Q ss_pred EEEEEeccchhcc-cccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc-
Q 041720 200 IYLVFEYMEHDLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS- 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~- 277 (690)
+.||+.+|+|..| ..+.....+|.......|++||++||.|||.++|||||||..||||.+++.|||+||||+..-.-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 5999999999755 45555667899999999999999999999999999999999999999999999999999965321
Q ss_pred cCcccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.....+....|...|||||++.. ..+|++.+||||||||+|||+||..||........+..+-++...+.
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd-------- 613 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD-------- 613 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc--------
Confidence 12233445567888999999864 35689999999999999999999999995554444433322222221
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.....+.+.++++|+..||.+++++||+..+||.
T Consensus 614 ----------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 ----------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ----------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11112355679999999999999999999999985
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.64 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=203.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|+++++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++|+||+++++++.. +.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCc
Confidence 4567899999999999999999985 56788999999765443 2468899999999999999999998754 568
Q ss_pred EEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+..... ....+++.++..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999998765543332 2346899999999999999999999999999999999999999999999999999876532
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------
Confidence 2222233445678999998864 567899999999999999999 999999888776666553321110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.++.+||.+||..||.+|||+++++.
T Consensus 224 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -----------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.42 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=202.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+...+|+++++||.|+||+||+|++..++. .||+|++.... .......+.+|+.++..++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--
Confidence 346789999999999999999999877776 48999987543 34455678899999999999999999999865
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...+++|||++++.+.... .....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999876554443 33557999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+.. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~----- 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQ----- 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCC-----
Confidence 532221 1122334678999999865 568999999999999999998 9999987665554433322 111110
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+.++.+||..||..||.+|||+.+++.
T Consensus 233 ----------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 ----------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.96 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=204.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
...+|++.+.||.|+||.||+|.+..+ +..||||++.... .....+.+.+|+.++..++||||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-- 79 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-- 79 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 345688999999999999999987543 5789999997543 33445678899999999999999999999987
Q ss_pred cceEEEEEeccchhccccccc----------------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSC----------------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN 260 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~ 260 (690)
...+++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 578999999998765443321 1234788899999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 041720 261 EGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHK 338 (690)
Q Consensus 261 ~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~ 338 (690)
++.+||+|||+++.+..... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999876543221 12233455788999999865 458899999999999999998 8999998887777766
Q ss_pred HHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 339 I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+......+ ....++..+.+||..||+.||.+||++.+++.
T Consensus 239 i~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQVLP----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCcCC----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 65432111 01257888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.24 Aligned_cols=254 Identities=19% Similarity=0.298 Sum_probs=204.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 4567899999999999999999987643 4789999986443 33445568899999999999999999999987
Q ss_pred CcceEEEEEeccchhcccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEE
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vK 265 (690)
....++||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 6889999999987655433321 22467889999999999999999999999999999999999999999
Q ss_pred EeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 266 LGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 266 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
|+|||+++.+..... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 237 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG- 237 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-
Confidence 999999976543221 12233456788999999865 568999999999999999998 99999988776666554311
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+. ....++..+.+||.+||+.+|.+|||+.+++.
T Consensus 238 ~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHLD---------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1000 01135788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.19 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=200.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.++||+|+||.||+|++..+ ..||||++...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcE
Confidence 346799999999999999999987655 46999999754432 2467899999999999999999998754 5679
Q ss_pred EEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+...... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999998655444332 3357899999999999999999999999999999999999999999999999998765333
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..... .+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 223 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP----------- 223 (262)
T ss_pred cccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC-----------
Confidence 222223445678999998864 568999999999999999999 8999998877766665533110 00
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 224 ----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01257888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.27 Aligned_cols=263 Identities=26% Similarity=0.411 Sum_probs=209.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|++.+.||.|+||.||+|.+..+++.||||.+...... .....+..|+.++..+ .||||+++++++.+ ..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~ 87 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DS 87 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CC
Confidence 45567899999999999999999999888999999999765432 3345566777777666 59999999999987 67
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+|+||||+.+.+..+.......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+..
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 899999999876555555445579999999999999999999997 5999999999999999999999999999976543
Q ss_pred cCcccccccccccCCCCcccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhc
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGS---TNYNVSVDLWSVGCVFAELLIGKPILKGRT-EVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~sDIWSlGviLyeLltG~~PF~~~~-~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||.... ..+.+..+....... +.
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~- 240 (296)
T cd06618 168 SK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS----LP- 240 (296)
T ss_pred CC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC----CC-
Confidence 22 22334578899999998653 347889999999999999999999997633 234444433211000 00
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....++.++.+||.+||..||.+|||+++++.|+||...
T Consensus 241 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 ---------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 001467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.72 Aligned_cols=260 Identities=32% Similarity=0.492 Sum_probs=206.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL------ 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 196 (690)
..+|+.+..||+||||.||+++++-+|+.||||+|.... .......+.+|+.+|.+|+|||||++|..+....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 567999999999999999999999999999999998765 5667788999999999999999999865421100
Q ss_pred --------------------------------------------------------------------------------
Q 041720 197 -------------------------------------------------------------------------------- 196 (690)
Q Consensus 197 -------------------------------------------------------------------------------- 196 (690)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------c--------ceEEEEEeccchhcccccccCCCCC-ChhHHHHHHHHHHHHHHHHHhC
Q 041720 197 -----------------------S--------NTIYLVFEYMEHDLAGLSSCHDIKF-SEPQVKCYMRQLLHGVEHCHLR 244 (690)
Q Consensus 197 -----------------------~--------~~~~LV~Ey~~g~ll~~~~~~~~~l-se~~~~~i~~QIl~aL~yLH~~ 244 (690)
. ..+||-||||+..++..++..+... ....+|++++||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 2478999999999988888776555 4678999999999999999999
Q ss_pred CeEeccCCcccEEEccCCcEEEeecccceecc-----------------ccCcccccccccccCCCCcccccCCC--CCC
Q 041720 245 GIMHRDIKASNILVNNEGILKLGDFGLANILT-----------------SKNKQKLTSRVVTLWYRPPELLMGST--NYN 305 (690)
Q Consensus 245 givHrDLKp~NILld~~~~vKL~DFGla~~~~-----------------~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~ 305 (690)
|||||||||.||+|+.++.|||+|||+|.... ..+....++.+||.-|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999997621 11223567889999999999997765 699
Q ss_pred cchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHH
Q 041720 306 VSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV 384 (690)
Q Consensus 306 ~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~ 384 (690)
.|+||||||||||||+. ||...-+. ..+..+.+..-+.+..+|. +--+.-.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~-------------------------~~~~~e~ 848 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFD-------------------------PEHPEEA 848 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccc-------------------------ccchHHH
Confidence 99999999999999984 47643222 2233322111111111111 2234567
Q ss_pred HHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 385 DLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 385 dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.+|+.||+.||.+||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 899999999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.77 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=205.2
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeecee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVI 192 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 192 (690)
+.+..++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.+++.+ +|+||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567899999999999999999987643 3689999987543 334456688999999999 899999999998
Q ss_pred eccCcceEEEEEeccchhcccccc----------------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 193 TSRLSNTIYLVFEYMEHDLAGLSS----------------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~ll~~~~----------------~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
.. .+.+++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred cC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 87 67899999999876554333 2234689999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e 334 (690)
|++.++.+||+|||+++.+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999865432211 1122234567999998864 568999999999999999997 999999877666
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+..... + ......+..+.+||.+||..||.+|||+.++|++
T Consensus 243 ~~~~~~~~~~--~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR--M--------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc--C--------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5554432110 0 0012467889999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=353.50 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=203.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..+....++-||.|+.|.||+|+ -.++.||||+++. .-..+|..|++|+|||||.|.|+|.. ...+
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq--sPcy 187 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ--SPCY 187 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeee--ccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC--Ccee
Confidence 334445567789999999999996 4678899998852 12358899999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||||||..|-|...+.....++......|..+|+.||.|||.++|||||||.-||||..+..|||+|||.++.+...
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 999999999988888888888999999999999999999999999999999999999999999999999999887543
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....++||..|||||++.+ .+.+.|+|||||||||||||||..||..-+...++ -..|...
T Consensus 266 STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsNs------------- 327 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSNS------------- 327 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccCCc-------------
Confidence 45567999999999999975 78899999999999999999999999864433222 1111110
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+-.......++.++=||+.||+..|..||++.++|.|
T Consensus 328 ----------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 328 ----------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ----------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0001112467788999999999999999999999987
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.59 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=204.5
Q ss_pred eEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++|+||+++++++.+ ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 3699999999999998766 8899999998654333 46788999999999999999999999987 6889999999
Q ss_pred cchhcccccccC---------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 207 MEHDLAGLSSCH---------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 207 ~~g~ll~~~~~~---------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.++.+...... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 977655544443 36799999999999999999999999999999999999999999999999999987654
Q ss_pred cCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 278 KNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 278 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RL-------- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------
Confidence 321 12234556889999998865 468999999999999999999 699999887777666654311 00
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....+++++.++|.+||..||.+|||+.+++.+
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 ------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0112468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.30 Aligned_cols=256 Identities=25% Similarity=0.448 Sum_probs=211.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|....+||+|+||.||++....++..||||++.... ......+.+|+.+++.++|+||+++++++.. .+..++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444567999999999999999999999999986432 3345668899999999999999999999987 689999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 285 (690)
|+.++.+..+.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 999887665543 3468999999999999999999999999999999999999999999999999987654322 22234
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
..+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+.+..+........
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------------ 236 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL------------------ 236 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc------------------
Confidence 568899999998864 5678999999999999999999999998777666555432211000
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....+++.+.++|.+||..||.+||++.++|.||||....
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 237 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred --------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00124688899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.84 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=205.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|.+.++||+|+||.||+|.+. .+..||||.+...... ...+.+|+.+++.++|+||+++++++.. ...+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCce
Confidence 45678999999999999999999864 5578999998765433 3468899999999999999999999876 5789
Q ss_pred EEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+...... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999988655444332 236899999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 225 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---------- 225 (261)
T ss_pred hhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2111222334567999999875 568999999999999999998 9999998887777776644221110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+.++.++|.+||+.||.+||+++++++
T Consensus 226 ------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 ------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1145788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.97 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=205.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATG----------------KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 185 (690)
...+|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|+.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 3567999999999999999999876543 568999987553 33556778999999999999999
Q ss_pred eeeeceeeccCcceEEEEEeccchhcccccccCCC-----------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcc
Q 041720 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKAS 254 (690)
Q Consensus 186 v~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~-----------~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~ 254 (690)
+++++++.. .+.+++||||+.++.+..++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 999999987 578999999998765554433322 6899999999999999999999999999999999
Q ss_pred cEEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCC
Q 041720 255 NILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--GKPILKGRT 331 (690)
Q Consensus 255 NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt--G~~PF~~~~ 331 (690)
|||++.++.++|+|||+++.+...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ +..||...+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999765432211 2233456788999999865 468999999999999999998 778998777
Q ss_pred HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 332 EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 332 ~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+.+..+.......... ........++.++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766665554321111000 000011246789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.98 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=205.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|+++++||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+|+.++||||+++++++.+ ...+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 4569999999999999999999877 8899999987543 2234568899999999999999999999987 678999
Q ss_pred EEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 203 VFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999865554433 23458999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...... +
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------ 224 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-P------------ 224 (261)
T ss_pred ccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-C------------
Confidence 11223345678999999865 568899999999999999998 89999988877777766532111 1
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++.+.++|.+||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ---------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01257889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.60 Aligned_cols=252 Identities=31% Similarity=0.492 Sum_probs=203.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||.|+||.||++++..++..||||.+..... .......+.+|+.+++.++||||+++++++.+ .+.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 468899999999999999999999999999998865432 33445678899999999999999999999987 678999
Q ss_pred EEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 203 VFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999865543322 3446899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE--VEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~--~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+... .+....+.... .++.
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------- 228 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPL-------- 228 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CCCC--------
Confidence 2 22234578899999999865 5678899999999999999999999976432 22222222110 0000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||..||.+|||+.++++
T Consensus 229 ------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 ------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01247789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.75 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=204.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
..+|++.+.||+|+||.||+|++..++. .+|+|.++... .....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 4579999999999999999998865543 79999987543 34455678999999999999999999999977 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|+||||++++.+.... .....+++.++..++.||+.||.|||+++++||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999987555443 33456899999999999999999999999999999999999999999999999999876543
Q ss_pred Cccccc--ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLT--SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.....+ ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..... ++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~-------- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP-------- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC--------
Confidence 222221 1223567999999865 568999999999999999886 9999998777666655543211 00
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||.+||+.+|.+|||+.++++
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01246789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.67 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=197.7
Q ss_pred eEEeEEeecCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREV----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.+.||.|.||.||+|.+. ..+..|+||.+.. ....+..+.+.+|+++|++++||||+++++++.. .+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 56789999999999999987 4467899999954 3345557889999999999999999999999995 567999
Q ss_pred EEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC-
Q 041720 203 VFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN- 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~- 279 (690)
|||||.++.+..++.. ...+++..+..|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998766554443 4679999999999999999999999999999999999999999999999999998763211
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
............|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+......+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI----------- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS-----------
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccee-----------
Confidence 122233456778999999865 458999999999999999999 7899998888887777743321111
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.+||..||..||.+|||+.++++
T Consensus 227 -----------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 227 -----------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------------ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1257888999999999999999999999984
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=323.08 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=199.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+...... .+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcE
Confidence 346699999999999999999987554 46999988654322 3457889999999999999999998754 5689
Q ss_pred EEEeccchhcccccc-c-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSS-C-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~-~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+.... . ....+++..+..++.||+.||.|||+.||+|+||||+|||+++++.+||+|||++..+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999976444333 2 22347899999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~----------- 223 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMP----------- 223 (260)
T ss_pred ccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----------
Confidence 222223345678999998864 568899999999999999999 999999888777666653321 110
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||..||.+||+++++++
T Consensus 224 ----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 ----------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01256789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.27 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=197.3
Q ss_pred eEEeecCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVATG---KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+|+.++||||+++++++.. +.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876544 78999999766543 445678899999999999999999998764 568999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccc-
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS- 285 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~- 285 (690)
+.++.+...+.....+++..+..++.||+.||.|||..+|+|+||||+|||++.++.+||+|||+++.+..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9887666555555579999999999999999999999999999999999999999999999999998764433221111
Q ss_pred -cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 286 -RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 286 -~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... .
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~----------------- 217 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-L----------------- 217 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-C-----------------
Confidence 122457999998865 568999999999999999998 9999988777665555432110 0
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++..+.+||.+||..||.+|||+.+++.
T Consensus 218 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.35 Aligned_cols=252 Identities=32% Similarity=0.510 Sum_probs=203.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... ........+.+|+.++++++|+||+++++++.+ .+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 46999999999999999999998899999999987533 233446778999999999999999999999987 678999
Q ss_pred EEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 203 VFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 203 V~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
||||+.++.+..+. .....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999986554332 23445899999999999999999999999999999999999999999999999999765433
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--EVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+......+
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP---------- 227 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC----------
Confidence 2 22234568899999999865 568899999999999999999999996543 122222221110000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+ ...++..+.++|.+||..+|.+|||+.++++
T Consensus 228 ---------~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ---------LP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 1146778999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.18 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=201.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 456899999999999999999854 345679999886432 3344678899999999999999999999987 6
Q ss_pred ceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
+..++||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 789999999987655443321 2348899999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKI 339 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I 339 (690)
+.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 11233456788999999875 568899999999999999998 99999887776655544
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..... + .....++..+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~--~--------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRV--L--------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCC--C--------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 22110 0 001246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.23 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=214.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+....||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 4558889999999999999999988899999999976532 45668899999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCC-CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~-~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-S 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-h
Confidence 999999766655554443 79999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.... .+..
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------------- 236 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPPL------------- 236 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCC-------------
Confidence 2234467889999999865 568999999999999999999999999877665555443211 1100
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.....++..+.+||.+||+.+|.+|||+.++|.|+||..
T Consensus 237 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 ------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001136788999999999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=323.63 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=205.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+.|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 4568999999999999999999876654 79999987543 33445678899999999999999999999987 678
Q ss_pred EEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|+||||+.++.+..... ....+++.++..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999876655443 3457899999999999999999999999999999999999999999999999999866433
Q ss_pred Ccccccc--cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLTS--RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~~--~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
....... ...++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 231 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------- 231 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC--------
Confidence 2222221 122457999999865 567899999999999999997 9999988877776666643211110
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..+.+||.+||+.||.+||++.++++
T Consensus 232 --------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 --------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1146788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.76 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=198.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGK--MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 200 (690)
++|++.+.||+|+||.||+|++..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 469999999999999999999877765 4788887632 2334456788999999999 79999999999887 5789
Q ss_pred EEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcE
Q 041720 201 YLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGIL 264 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~v 264 (690)
|+||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999987655433321 1248889999999999999999999999999999999999999999
Q ss_pred EEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 265 KLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 265 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999986432111 1111222457999998865 568999999999999999997 999999887777666543211
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
... ....++..+.+||.+||+.||.+|||++++++
T Consensus 236 ~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 236 RME----------------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 100 01257889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.58 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=199.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..++|++++.||+|+||+||+|.+..++.. |++|.+... ........+..|+.++..+.||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--- 80 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--- 80 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence 456799999999999999999998877764 677776532 223445678889999999999999999998754
Q ss_pred ceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...++|+||+.++.+.... .....+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999876554443 445578999999999999999999999999999999999999999999999999998764
Q ss_pred ccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+... ..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~------ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLAQ------ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC------
Confidence 33222 2233456778999999865 568999999999999999998 99999887665543333211 11100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+.++.++|.+||..||.+|||+.|+++
T Consensus 233 ---------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 ---------------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ---------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0124567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=334.22 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=199.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~ 80 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 80 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--C
Confidence 3456799999999999999999998877764 577766532 2344556788999999999 89999999999987 6
Q ss_pred ceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
+.+|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 789999999987654433221 1357899999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIF 340 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~ 340 (690)
+.+||+|||++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 161 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CcEEeCccccCcccchh--hhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999998643211 11111233567999998864 568899999999999999998 999998877666555442
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
... .. .....+++++.+||.+||+.||.+|||++++|.+
T Consensus 238 ~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGY--RL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC--cC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 00 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=346.64 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=200.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 193 (690)
....++|.++++||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|.++. |||||++++++.
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34567899999999999999999986433 3479999997543 3344567899999999996 999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccC-------------------------------------------------------
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH------------------------------------------------------- 218 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~------------------------------------------------------- 218 (690)
+ .+.+|||||||.++.+..++..
T Consensus 112 ~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 K--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 7 6889999999987654322211
Q ss_pred -----------------------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEE
Q 041720 219 -----------------------------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNIL 257 (690)
Q Consensus 219 -----------------------------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NIL 257 (690)
...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124778888999999999999999999999999999999
Q ss_pred EccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 041720 258 VNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQ 335 (690)
Q Consensus 258 ld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~ 335 (690)
++.++.+||+|||+++.+...... ......+++.|+|||.+.+ ..++.++|||||||+||+|++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999865432221 1223456788999999865 568999999999999999997 9999987544433
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.........++ ....++.++.+||.+||+.||.+|||+.++.+
T Consensus 349 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 349 FYNKIKSGYRMA---------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333222111110 01257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.23 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=207.0
Q ss_pred CeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+|++.+.||+|+||.||++++. .+++.||||++..... .......+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 3889999999999999999864 4678999999875422 123345678999999999 69999999999877 67
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.++.+.........+++..+..++.||+.||.|||+.+++||||||.|||++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 89999999998766655555567899999999999999999999999999999999999999999999999999775443
Q ss_pred CcccccccccccCCCCcccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhhhc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKGRTEV----EQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~sDIWSlGviLyeLltG~~PF~~~~~~----e~l~~I~~~~g~~~~~~w~~ 353 (690)
.........|+..|+|||.+.+.. .++.++||||||+++|+|++|..||...... +..+.+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 230 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-------- 230 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--------
Confidence 322223456889999999986532 3678999999999999999999999754322 222222111100
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC---HHHHHcCccccCCCC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT---ASSLLMCEYFTTQPY 415 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT---a~elL~hp~f~~~p~ 415 (690)
....++..+.+||.+||+.||.+||| +.++|+||||+..-|
T Consensus 231 ---------------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 231 ---------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ---------------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 01246788999999999999999998 567799999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.01 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=202.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
...+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE-- 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--
Confidence 3457899999999999999999742 35678999988643 34456679999999999999999999999887
Q ss_pred cceEEEEEeccchhcccccccCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHD---------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~---------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
....++||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 67899999999877554433221 348899999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKI 339 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I 339 (690)
+.+||+|||++......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999765432211 1122345678999998875 568999999999999999998 99999887777666555
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..... . .....+++.+.+||.+||+.||.+||++.+++.
T Consensus 238 ~~~~~--~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRE--L--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCcc--C--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33211 0 001247889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.66 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=203.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++.+.||.|+||.||++.+. .+..+|+|++....... ..+.+|+.+++.++||||+++++++.. ...+++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEE
Confidence 457899999999999999999874 46789999987554332 357889999999999999999999887 578899
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..... ....+++..++.++.||+.||.|||+.+++|+||||+||+++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999876654443 3456899999999999999999999999999999999999999999999999999765432221
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+........
T Consensus 157 ~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK------------- 222 (256)
T ss_pred ccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC-------------
Confidence 1223344678999998865 568899999999999999998 9999998877776666532111000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..+.+||.+||+.+|.+|||+.++|+
T Consensus 223 ---------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 223 ---------------PRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred ---------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1135788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=367.01 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=204.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|++.++||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+ .+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 579999999999999999999999999999999975432 23445678999999999999999999999987 688999
Q ss_pred EEeccchhcccccccC-----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 203 VFEYMEHDLAGLSSCH-----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~-----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
||||++|+.+..+... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998765443321 12356677899999999999999999999999999999999999999999999
Q ss_pred ceeccccCc-----------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 041720 272 ANILTSKNK-----------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334 (690)
Q Consensus 272 a~~~~~~~~-----------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e 334 (690)
+........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 987521110 01123578999999999875 568999999999999999999999998755433
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC---cccc
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC---EYFT 411 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h---p~f~ 411 (690)
..... ... .+... .....+++.+.++|.+||+.||.+|++..+.|.+ +|++
T Consensus 239 i~~~~--~i~-~P~~~-----------------------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRD--VIL-SPIEV-----------------------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh--hcc-Chhhc-----------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 32211 000 01000 0013678899999999999999999887666543 4554
Q ss_pred CC
Q 041720 412 TQ 413 (690)
Q Consensus 412 ~~ 413 (690)
..
T Consensus 293 ~~ 294 (932)
T PRK13184 293 GS 294 (932)
T ss_pred cC
Confidence 43
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.76 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=194.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc-eEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN-TIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~-~~~ 201 (690)
.+.|.....||+|+||.||+|.. .+|..||||++.....+. .++|.+|+.+|.+++|||||+|+|||.+ .+ ..+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e--~~~~~~ 148 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE--GGEHRL 148 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec--CCceEE
Confidence 46688889999999999999984 566899999887654332 4559999999999999999999999998 45 699
Q ss_pred EEEeccchhcccccccCC-C-CCChhHHHHHHHHHHHHHHHHHhCC---eEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 202 LVFEYMEHDLAGLSSCHD-I-KFSEPQVKCYMRQLLHGVEHCHLRG---IMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~-~-~lse~~~~~i~~QIl~aL~yLH~~g---ivHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
||+|||.+|.|...+... . .+++....+|+.+++.||+|||... ||||||||+|||||.+++.||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 999999987765554433 3 8999999999999999999999864 9999999999999999999999999997654
Q ss_pred ccCccccccc-ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhhh
Q 041720 277 SKNKQKLTSR-VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 277 ~~~~~~~~~~-~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~w~ 352 (690)
.. ....... .||.+|+|||++.. ...+.++|||||||+|+||++|+.+..... ......-... .|.
T Consensus 229 ~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~--------~~~ 298 (361)
T KOG1187|consen 229 EG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP--------LLE 298 (361)
T ss_pred cc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH--------HHH
Confidence 31 1222222 89999999999864 678999999999999999999998877432 1111111101 111
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCC-----hhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFT-----PTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is-----~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+..+ ..+..+.-.. ..++ ..+..+..+|++.+|.+||++.|++.
T Consensus 299 ~~~~--~eiiD~~l~~--------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 299 EGKL--REIVDPRLKE--------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred Ccch--hheeCCCccC--------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1100 0011111000 0112 23668889999999999999999753
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=350.24 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=206.9
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
+||+|+||+||.|++..+...+|||.+.... ....+-+..||.+.++|+|.|||+++|.+.. ++.+-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 6999999999999999999999999986433 3345668899999999999999999999877 67899999999998
Q ss_pred ccccc-ccCCCCC--ChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-cCCcEEEeecccceeccccCccccccc
Q 041720 211 LAGLS-SCHDIKF--SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 211 ll~~~-~~~~~~l--se~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
.+..+ ...-+++ .|..+..|.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+..-+ -...++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 76544 4444566 8889999999999999999999999999999999996 47899999999998875432 344568
Q ss_pred ccccCCCCccccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLM-GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 287 ~gt~~Y~APE~l~-~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
.||..|||||++- |...|+.++|||||||++.||.||+|||........ .+++. .+|..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV-----------------GmyKvH 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV-----------------GMYKVH 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh-----------------cceecC
Confidence 8999999999985 356799999999999999999999999985332221 11211 111112
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++ ..++.+++.||.+|+.+||.+||+|.++|..||++..
T Consensus 798 P~iP-------eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 798 PPIP-------EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCc-------HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 2221 2578899999999999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.29 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=203.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---C
Confidence 456789999999999999999987544 3469999886443 34456678999999999999999999999875 5
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
..|+||||+.++.+..++.. ...+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 67899999987655544433 34589999999999999999999999999999999999999999999999999987654
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 228 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---------- 228 (270)
T ss_pred ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC----------
Confidence 32222222334567999998864 568899999999999999996 999999888777665553321100
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||..+|.+|||+.+++.
T Consensus 229 ------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 229 ------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11257889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.82 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=204.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
..+|++.+.||+|+||.||+|.+..+++ .||||++... ........+..|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence 3468999999999999999999877665 5999998754 345556789999999999999999999999877 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+++||||+.++.+..+. .....+++.+++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999987655443 33456899999999999999999999999999999999999999999999999999765432
Q ss_pred Ccc-cccccc---cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 279 NKQ-KLTSRV---VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 279 ~~~-~~~~~~---gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
... ...... .+..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 232 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP------ 232 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC------
Confidence 211 111111 2457999999865 568999999999999999886 9999998877766666532211000
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.++|..||..+|.+||++.+++.
T Consensus 233 ----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 ----------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.02 Aligned_cols=246 Identities=32% Similarity=0.497 Sum_probs=206.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
||.|+||.||++.+..+++.||+|++...... ......+..|+.+++.++||||+++++.+.+ .+.+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 69999999999999888999999999765432 3356678899999999999999999999987 68999999999776
Q ss_pred cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccccc
Q 041720 211 LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290 (690)
Q Consensus 211 ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~ 290 (690)
.+.........+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 665555555578999999999999999999999999999999999999999999999999997764332 2234566788
Q ss_pred CCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcc
Q 041720 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEG 370 (690)
Q Consensus 291 ~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~ 370 (690)
.|+|||.+.+ ...+.++|+|||||++|+|++|..||...+..+....+.......
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 212 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF------------------------ 212 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC------------------------
Confidence 9999999865 457889999999999999999999998877655555554311100
Q ss_pred ccccccCCCChhHHHHHHHhhccCCCCCCCH---HHHHcCccc
Q 041720 371 CLRERCKDFTPTAVDLIDTCLSIEPYKRGTA---SSLLMCEYF 410 (690)
Q Consensus 371 ~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa---~elL~hp~f 410 (690)
...++..+.+||.+||..||.+|||+ +++++||||
T Consensus 213 -----~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 213 -----PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 11357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.02 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=200.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeecee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA-------TGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVI 192 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 192 (690)
+..++|.+.+.||+|+||.||++++.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345679999999999999999998643 23569999997543 334456788899999999 799999999999
Q ss_pred eccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 193 TSRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
.. .+.+|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++|++||||||+||
T Consensus 94 ~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 94 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 87 5789999999997655433322 12478889999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e 334 (690)
|++.++.+||+|||++..+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 99999999999999997654321111 112233568999999875 568999999999999999998 899998766555
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+.... .. .....++.++.+||.+||..+|.+|||+.++++
T Consensus 251 ~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 251 LFKLLKEGH--RM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHcCC--CC--------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 444432210 00 011257889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.49 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=201.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.+.||.|+||.||+|.. .|+.||||.+..... ..+.+.+|+.+++.++|+||+++++++.+ ....+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeE
Confidence 456799999999999999999975 488999999975532 45678899999999999999999999987 68899
Q ss_pred EEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+..+..... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999765554443332 68999999999999999999999999999999999999999999999999998753221
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+.... .+
T Consensus 157 ----~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~------------ 218 (256)
T cd05039 157 ----DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM------------ 218 (256)
T ss_pred ----ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC------------
Confidence 12334667999998864 568889999999999999997 999998877665554442210 00
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++.+.+||.+||..+|.+|||+.+++.
T Consensus 219 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ---------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001246889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.22 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=204.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.++|+++..||.|+||.||+|+.+. +.+.|++|.+.... .......+.+|+.+|++++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--C
Confidence 4679999999999999999998653 34679999886432 23356678999999999999999999999877 5
Q ss_pred ceEEEEEeccchhcccccccCCC---------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEee
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDI---------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~---------~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~D 268 (690)
...|+||||+.++.+..+..... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 78899999999766654443322 689999999999999999999999999999999999999999999999
Q ss_pred cccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 269 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
||++...............++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-- 237 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-- 237 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC--
Confidence 99987544333233344566788999998865 457889999999999999998 88999876666555544321100
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
|. ....++..+.++|.+||+.||.+|||+.++|.+
T Consensus 238 ---~~----------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 ---LP----------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---CC----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 012477899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.44 Aligned_cols=255 Identities=21% Similarity=0.312 Sum_probs=202.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|.+.+.||+|+||.||++.+. .++..||||+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 44567999999999999999999752 345689999987543 334456788999999999 79999999999887
Q ss_pred cCcceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
.+.+++||||+.++.+..+... ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 6789999999997655444332 233899999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 273 NILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 273 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
..+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 264 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--- 264 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC---
Confidence 865432211 1122345778999998865 458899999999999999998 9999987766555444332110000
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||.+||..+|++|||+.+++.
T Consensus 265 ------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 ------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01246789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.79 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=233.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+...+++++..||-|+||.|=++........+|+|++++... ...+.+-+..|-+||..++.|.||++|-.|.+ ...
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chh
Confidence 345678899999999999999998666666799999987643 34555668899999999999999999999988 789
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+.||-|-||.+..++...+.|.+..++.|+..+++|++|||++|||+|||||+|+||+.+|.+||.|||+|+.+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999988888888889999999999999999999999999999999999999999999999999999988643
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
...-++||||.|.|||++++ +..+.++|.||||+++||||+|.|||.+.++...+..|++.....
T Consensus 574 -~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------- 638 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------- 638 (732)
T ss_pred -CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------------
Confidence 55677999999999999986 567999999999999999999999999999999999998864321
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPYA 416 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~~ 416 (690)
+..+.++..+.+||+++...+|.+|.- +.++-.|.||.+..|.
T Consensus 639 --------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 --------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred --------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 112368889999999999999999987 8899999999987664
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.99 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=198.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+|+.+.||||+++++.+.. .+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998753 23578999886543 33445678899999999999999999999887 578
Q ss_pred EEEEEeccchhccccccc------------------------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 200 IYLVFEYMEHDLAGLSSC------------------------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~------------------------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
.++||||+.++.+..++. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999999765543321 11347889999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
||+++++.+||+|||+++.+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765432221 1122345678999998865 568999999999999999998 99999887766
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+....+...... .....++.++.+||..||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRM----------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 555443221100 001256789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.23 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=203.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
|++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+.+|+.++|+||+++++++.+ .+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 356788999999999999988766 8999999975532 2355678999999999999999999999987 58899
Q ss_pred EEEeccchhcccccccC-CCC-CChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSCH-DIK-FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~-~~~-lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+.++.+...... ... +++..+..++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999988665544433 223 8999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
........+++.|+|||.+. ...++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP------------ 224 (258)
T ss_pred ccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 22111233678899999885 4668999999999999999998 899999877777766654321100
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.++.++|.+||..||.+|||+.++++
T Consensus 225 ----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 225 ----------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 01136889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=346.68 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=219.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-NFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..-|..++.||-|+||.|.+++...|...||+|.+++. .+....+.-+..|-.||..-+.+.||+||-.|.| .+.+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceE
Confidence 44589999999999999999999999999999999765 3445566778899999999999999999999988 78999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc----
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS---- 277 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~---- 277 (690)
+||||++||.+.-++.+-+-|.|..++.|+.+|..|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.-
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999876655555556899999999999999999999999999999999999999999999999999854210
Q ss_pred ----cCcc---------------------------------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHH
Q 041720 278 ----KNKQ---------------------------------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320 (690)
Q Consensus 278 ----~~~~---------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeL 320 (690)
.+.+ .....+||+.|+|||+|.. ..|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 0000 1124689999999999975 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC
Q 041720 321 LIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400 (690)
Q Consensus 321 ltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT 400 (690)
+.|++||...+..+...+|++ |.+.- . ...+.+++.++.+||.++. -+++.|+-
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~l-----~-----------~~~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNFL-----H-----------IPYQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhcc-----c-----------cccccccCHHHHHHHHHHh-cChhhhhc
Confidence 999999999888877766643 43210 0 0123578999999999854 67788865
Q ss_pred ---HHHHHcCccccCCCC
Q 041720 401 ---ASSLLMCEYFTTQPY 415 (690)
Q Consensus 401 ---a~elL~hp~f~~~p~ 415 (690)
++++-.||||+...|
T Consensus 919 kng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred ccchhhhhcCccccccch
Confidence 788999999998644
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.52 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--
Confidence 3567999999999999999999874 367889999987542 34455678899999999999999999999887
Q ss_pred cceEEEEEeccchhcccccccC----------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCH----------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKAS 254 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~----------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~ 254 (690)
...+++||||+.++.+...... ...+++..++.++.||+.||.|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 5789999999997654433221 124788899999999999999999999999999999
Q ss_pred cEEEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 041720 255 NILVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTE 332 (690)
Q Consensus 255 NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~ 332 (690)
|||++.++.+||+|||++..+..... ........+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999976533221 11122334667999998865 568999999999999999997 8899988777
Q ss_pred HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 333 ~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+....+......+ ....++.++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 239 EEVIYYVRDGNVLS----------------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77666553311100 01246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.90 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=204.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~- 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED- 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 456789999999999999999999875 3578999988643 3455567789999999999999999999987663
Q ss_pred cceEEEEEeccchhcccccccC--------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEee
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCH--------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~--------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~D 268 (690)
....++++||+.++.+..+... ...+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999987655443321 13589999999999999999999999999999999999999999999999
Q ss_pred cccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 269 FGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 269 FGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+... ..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC
Confidence 99998654332221 122345677999999865 568999999999999999998 99999887766654443321 110
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
. ....+++++.++|.+||..||.+|||+.++++
T Consensus 239 ~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 A---------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred C---------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 01146788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.23 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=203.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeecee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-------ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVI 192 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 192 (690)
+..++|.+.+.||+|+||.||+|++. .++..||+|.+... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 45677999999999999999999753 23457999998744 2344557789999999999 899999999999
Q ss_pred eccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 193 TSRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
.. ...+|+||||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 91 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 91 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 87 6789999999988655433321 23477888999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e 334 (690)
|++.++.+||+|||+++.+....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999998764332221 222345678999999865 568999999999999999998 889998887766
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..... . .....++..+.+||.+||..+|.+|||+.++|+
T Consensus 248 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 248 LFKLLKEGHR-M---------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHcCCc-C---------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 6655432110 0 001257889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.11 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=198.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+...+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|+||+++++++... .+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCce
Confidence 3456799999999999999999965 47889999986432 235688999999999999999999976542 5678
Q ss_pred EEEEeccchhcccccccC-C-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSCH-D-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~-~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+...... . ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999997655443332 2 24889999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... +
T Consensus 156 ~----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~---------- 218 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--M---------- 218 (256)
T ss_pred C----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--C----------
Confidence 1 23344667999998865 568899999999999999997 9999987766555555432110 0
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 219 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ----------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001257889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.78 Aligned_cols=243 Identities=22% Similarity=0.280 Sum_probs=195.2
Q ss_pred EEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|++++||||+++++++.. ..+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999765 455679999987543 34455678999999999999999999998854 57899999999
Q ss_pred hhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc--cc
Q 041720 209 HDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL--TS 285 (690)
Q Consensus 209 g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~--~~ 285 (690)
++.+..+.. ....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+........ ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 876654443 455799999999999999999999999999999999999999999999999999976543322211 11
Q ss_pred cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 286 ~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
..+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+..... ++
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~----------------- 218 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LD----------------- 218 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC-----------------
Confidence 223578999998864 568899999999999999996 9999998877766555432110 00
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++++.+||.+||..||.+||++.++++
T Consensus 219 ----------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 219 ----------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.13 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=201.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeee
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT--------------GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~--------------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 188 (690)
..+|++.++||+|+||.||+|++..+ ...||||++.... .......+.+|+++|++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45799999999999999999986543 2359999987543 34555678999999999999999999
Q ss_pred eceeeccCcceEEEEEeccchhcccccccCC------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHD------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 189 ~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
++++.. .+.+++||||+.++.+....... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999987 67899999999986554333211 2367889999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--GKPILKGRTEV 333 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt--G~~PF~~~~~~ 333 (690)
|++.++.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999765332211 1122344678999998865 568999999999999999988 67899887776
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.+..+........... + ......+++.+.+||.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQI-----------Y----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccc-----------c----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655433211100000 0 0011246789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=379.00 Aligned_cols=257 Identities=31% Similarity=0.544 Sum_probs=218.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
++...+||.|.||.||-|.+..+|+..|+|-++...........+.+|..+|..|+|||+|+.||+-.. .+.++|.||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFME 1314 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFME 1314 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHHH
Confidence 566778999999999999999999999999998765555556778999999999999999999998776 588999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC---ccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN---KQK 282 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~---~~~ 282 (690)
||.+|.+........-.+|.....+..|++.||.|||+.|||||||||+||||+.+|.+|++|||.|..+.... ...
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999888888777778888999999999999999999999999999999999999999999999998876432 123
Q ss_pred ccccccccCCCCcccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGST--NYNVSVDLWSVGCVFAELLIGKPILKGR-TEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~--~~~~~sDIWSlGviLyeLltG~~PF~~~-~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
+...+||+.|||||++.+.. +..-+.||||||||+.||+||+.||... +++..+.++-. |..|
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--gh~P------------ 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--GHKP------------ 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--cCCC------------
Confidence 45789999999999998743 4566899999999999999999999864 44555555422 2221
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
+.| ..++++.+|||.+||..||.+|.++.|+|+|.|-+.
T Consensus 1461 -----q~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 -----QIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred -----CCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 111 148999999999999999999999999999988765
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=337.38 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=198.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeecc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRARE-----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSR 195 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 195 (690)
..++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 456799999999999999999984 3567899999997543 234456788999999999 689999999988653
Q ss_pred CcceEEEEEeccchhcccccccC---------------------------------------------------------
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH--------------------------------------------------------- 218 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~--------------------------------------------------------- 218 (690)
...+++|||||.++.+..++..
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4678999999998755433211
Q ss_pred ----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-cccccc
Q 041720 219 ----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRV 287 (690)
Q Consensus 219 ----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~ 287 (690)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123677888999999999999999999999999999999999999999999999765322211 112233
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+.........++
T Consensus 243 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 302 (343)
T cd05103 243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------- 302 (343)
T ss_pred CCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-------------------
Confidence 4677999999865 568999999999999999997 9999987544333322221110000
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+++++.++|..||+.||.+|||+.++++|
T Consensus 303 --------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.21 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeecee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA-------TGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVI 192 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 192 (690)
+..++|.+.++||+|+||.||+|++.. ....||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 445679999999999999999997632 34579999987543 344566788999999999 699999999999
Q ss_pred eccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 193 TSRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
.+ .+.+|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 88 ~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 88 TQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred cc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 87 5789999999998755433321 23588899999999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e 334 (690)
|++.++.+||+|||+++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999997654322111 112233567999999865 568999999999999999999 899998877766
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+..+.... .. .....++.++.+||.+||..||.+|||+.++++
T Consensus 245 ~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGH--RM--------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665543210 00 001246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.03 Aligned_cols=244 Identities=24% Similarity=0.322 Sum_probs=196.3
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccch
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH 209 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 209 (690)
++||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++.. .+..++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999985 578899999987543 34445568899999999999999999999987 5789999999987
Q ss_pred hcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc
Q 041720 210 DLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288 (690)
Q Consensus 210 ~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g 288 (690)
+.+.... .....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 7554433 334568999999999999999999999999999999999999999999999999997643221111122234
Q ss_pred ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCC
Q 041720 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNP 367 (690)
Q Consensus 289 t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~ 367 (690)
++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+......
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 213 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---------------------- 213 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 567999999864 568899999999999999998 99999987766655554321100
Q ss_pred CccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 368 YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 368 ~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++..+.+||.+||+.+|.+|||+.++++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.44 Aligned_cols=253 Identities=26% Similarity=0.452 Sum_probs=204.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecC---CCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD---NFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
+|.+.+.||+|+||.||++.+..++..+++|+++.. .........+..|+.+++.++||||+++++++.+ ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 488999999999999999998887777777766532 2233334456789999999999999999999987 57899
Q ss_pred EEEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 202 LVFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+||||+.++.+.... .....+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999987655433 23456999999999999999999999999999999999999975 5799999999977643
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+... ..+.
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~--------- 224 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTPS--------- 224 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCC---------
Confidence 22 22334567889999998864 55788999999999999999999999887766665554321 1110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....++.++.+||.+||..||.+||++.++|+||||
T Consensus 225 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 -----------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 012577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.20 Aligned_cols=239 Identities=22% Similarity=0.285 Sum_probs=188.9
Q ss_pred eEEeecCceEEEEEEEcC------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 130 EKIGQGTYSSVFRAREVA------------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+.||+|+||.||+|.... ....||+|.+.... ......+..|+.+++.++||||+++++++.+ .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999997532 22358889876432 3344567889999999999999999999887 5
Q ss_pred ceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc-------EEEeec
Q 041720 198 NTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI-------LKLGDF 269 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~-------vKL~DF 269 (690)
...++||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++. +||+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 77899999999887665554 3456999999999999999999999999999999999999987664 899999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl-tG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
|++..+.. .....++..|+|||.+.....++.++|||||||+||+|+ .|..||......+... +......
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~--- 227 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM--- 227 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc---
Confidence 99865432 123567888999998865567899999999999999998 5889988765443321 1111000
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....+.++.+||.+||+.||.+||++.++|++
T Consensus 228 --------------------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --------------------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 011245678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.61 Aligned_cols=268 Identities=25% Similarity=0.386 Sum_probs=198.1
Q ss_pred cCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+|++++.||+|+||.||++. +..++..||||.+... .....+.+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4579999999999999999997 3467889999998644 344567789999999999999999999987654456
Q ss_pred eEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 789999999876555444 3345689999999999999999999999999999999999999999999999999987643
Q ss_pred cCcccc--cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh-cc
Q 041720 278 KNKQKL--TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK-KS 354 (690)
Q Consensus 278 ~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~-~~ 354 (690)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+...... ....+. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQG-QMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccccc-ccchHHHHH
Confidence 322111 11223456999999865 5688999999999999999999877654322 111111000000 000000 00
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+..... ......++.++.+||.+||..+|.+|||+.+++.
T Consensus 238 ~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNGR-----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCCc-----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000000 0012357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.78 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=196.7
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccch
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH 209 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 209 (690)
++||.|+||.||++.+.. ++.||+|++...... .....+.+|+.++++++|+||+++++++.+ ....++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 369999999999999877 999999998765432 455678999999999999999999999887 6789999999987
Q ss_pred hcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc-cccc
Q 041720 210 DLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL-TSRV 287 (690)
Q Consensus 210 ~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~-~~~~ 287 (690)
+.+.... .....+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 6554433 3344688999999999999999999999999999999999999999999999999976542111111 1123
Q ss_pred cccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 288 gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-------------------- 215 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-------------------- 215 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC--------------------
Confidence 3567999998865 568999999999999999999 899998877665555442211000
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.++.+||.+||+.+|.+|||+.|+|+
T Consensus 216 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 --------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.95 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=197.2
Q ss_pred eeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 126 FEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
|++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++.......++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4899999999999998764 34578899999997553 233456688999999999999999999988765456789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
+||||+.++.+...... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 85 lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999998766655443 35999999999999999999999999999999999999999999999999999876432211
Q ss_pred c--ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCChhhhhccCCCC
Q 041720 282 K--LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG-SPPEEYWKKSKLPH 358 (690)
Q Consensus 282 ~--~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g-~~~~~~w~~~~l~~ 358 (690)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+..... ......+... ...
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~ 239 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL-LER 239 (283)
T ss_pred hccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-hhc
Confidence 1 122344667999998865 56889999999999999999999998654321 111111000 0000000000 000
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
. .. ......++.++.+||..||+.||.+|||++++++
T Consensus 240 ~----~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 G----MR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred C----CC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 00 0011357789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=316.67 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=201.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++.++||+|+||.||++.+ ..+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCe
Confidence 4567899999999999999999975 455679999886432 234568899999999999999999998875 568
Q ss_pred EEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||+.++.+..+.. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999998765443332 2345788899999999999999999999999999999999999999999999999876433
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-----------
Confidence 2222223345677999999865 568899999999999999998 999999877766665543211100
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++.++.++|.+||..||.+||++.+++.
T Consensus 224 -----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 -----------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11257789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.88 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=199.3
Q ss_pred eEEeecCceEEEEEEEcC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVA-TGK--MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
+.||+|+||.||+|.+.. .+. .||||.+...... ...+.+.+|+.++++++||||+++++++.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999765 333 6999999876543 566789999999999999999999999876 788999999
Q ss_pred cchhcccccccC-C-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc--
Q 041720 207 MEHDLAGLSSCH-D-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-- 282 (690)
Q Consensus 207 ~~g~ll~~~~~~-~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~-- 282 (690)
+.++.+...... . ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 987655443332 2 468999999999999999999999999999999999999999999999999998765422211
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.......+
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE-------------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--------------
Confidence 122456788999998864 568999999999999999998 9999988887777766643110000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.+|.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 -------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.90 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=202.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVAT-------GKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+...+|++.+.||+|+||.||+|++... +..||+|++... ......+.+.+|+.+++++ +||||++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34556799999999999999999986432 236899988743 3344567789999999999 89999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+.. .+.+++||||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 87 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 87 CTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred Ecc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 987 5789999999988655433321 2247778889999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
||++.++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999865432211 1122233567999999865 568899999999999999998 89999988776
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+....+..... . ......+.++.+||.+||+.+|.+|||+.++|.+
T Consensus 244 ~~~~~~~~~~~--~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHR--M--------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCC--C--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66655532110 0 0012467889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=356.29 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=213.8
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
..+...+.+..+.||+|.||+||+|+-. .+...||||.++... .....++|.+|+++|..|+|||||+|+|+|.
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3455667788999999999999999743 234579999998553 4456788999999999999999999999999
Q ss_pred ccCcceEEEEEeccchhcccccccC--------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH--------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN 259 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~--------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld 259 (690)
. ++.+|||||||..|.|..++.. ..+|+..+...|+.||+.||.||-++.+|||||-..|+||.
T Consensus 560 ~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 560 E--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred c--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 8 7999999999998766544321 22388899999999999999999999999999999999999
Q ss_pred cCCcEEEeecccceeccccCccccc-ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 041720 260 NEGILKLGDFGLANILTSKNKQKLT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLH 337 (690)
Q Consensus 260 ~~~~vKL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~ 337 (690)
++..|||+||||++.+-+.+..... ...-...|||||.++- ..|+.++|||||||+|||+++ |..||.+.++.|.++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999999876554443333 3344778999999974 679999999999999999998 999999999999999
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
.|....- .....+-|.++.+|+..||+.+|.+||++.||-
T Consensus 717 ~i~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9865321 112236789999999999999999999999974
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.96 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=205.3
Q ss_pred cccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc-
Q 041720 117 GLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR- 195 (690)
Q Consensus 117 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~- 195 (690)
+.+-++.++|++.+.||+|||+-||+++...+++.||+|++.... .+..+..++|++..++++||||++++++....
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 445678899999999999999999999999999999999998665 45567889999999999999999999986542
Q ss_pred --CcceEEEEEeccchh-ccccc---ccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEe
Q 041720 196 --LSNTIYLVFEYMEHD-LAGLS---SCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLG 267 (690)
Q Consensus 196 --~~~~~~LV~Ey~~g~-ll~~~---~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~ 267 (690)
.....||+++|...| +++.+ ..++..++|.++..|+.+|++||.+||+.. ++||||||.|||+.+.+.++|+
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 345799999999876 44332 234446999999999999999999999999 9999999999999999999999
Q ss_pred ecccceecccc--Cc------ccccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 041720 268 DFGLANILTSK--NK------QKLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337 (690)
Q Consensus 268 DFGla~~~~~~--~~------~~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~ 337 (690)
|||.+....-. +. +.......|..|+|||.+.-. ...+.++|||||||+||+|+.|..||.-
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~-------- 243 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER-------- 243 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH--------
Confidence 99999754311 00 111234568899999988432 3467899999999999999999999963
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+...-++..-. ...+....|+. ..+|..+.+||+.||++||.+||++.++|.+
T Consensus 244 -~~~~GgSlaLA------v~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 244 -IYQQGGSLALA------VQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred -HhhcCCeEEEe------eeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111111000 00011111111 1388999999999999999999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.43 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=198.7
Q ss_pred CeeEEeEEeecCceEEEEEEE----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 125 SFEKLEKIGQGTYSSVFRARE----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
-|++++.||+|+||.||+++. ..++..||+|.+.... .......+.+|+.+|+.+.||||+++++++.+.....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 378999999999999999974 4578899999987543 34445678999999999999999999999887545678
Q ss_pred EEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
++||||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999988766655433 3458999999999999999999999999999999999999999999999999998764322
Q ss_pred cc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh-hc-cC
Q 041720 280 KQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW-KK-SK 355 (690)
Q Consensus 280 ~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w-~~-~~ 355 (690)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|+++..|+..... .. ....+....+.. .. ..
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHHHHH
Confidence 11 1123456778999999875 4688999999999999999998876543211 11 111111110000 00 00
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....... ......++..+.+||.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 238 VLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000000 0011257889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.14 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=188.3
Q ss_pred EEeecCceEEEEEEEcCC------------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee
Q 041720 131 KIGQGTYSSVFRAREVAT------------------------GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~------------------------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 186 (690)
+||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 2358899886432 23345678899999999999999
Q ss_pred eeeceeeccCcceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---
Q 041720 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG--- 262 (690)
Q Consensus 187 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~--- 262 (690)
++++++.+ ....+|||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999987 678899999999987765553 355789999999999999999999999999999999999997643
Q ss_pred ----cEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHH
Q 041720 263 ----ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLH 337 (690)
Q Consensus 263 ----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl-tG~~PF~~~~~~e~l~ 337 (690)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|.+||.+.+..+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999998643221 23457788999999876567899999999999999995 6999998776554332
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.+ ......+ ...++.+.+||.+||+.+|.+|||+.++|++
T Consensus 233 ~~-~~~~~~~-----------------------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKHRLP-----------------------------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HhccCCC-----------------------------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 1100000 1245679999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.22 Aligned_cols=238 Identities=20% Similarity=0.273 Sum_probs=189.6
Q ss_pred eEEeecCceEEEEEEEcCCCc-------EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 130 EKIGQGTYSSVFRAREVATGK-------MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~-------~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+..|+.+|+.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 369999999999998865544 48888875432 3344668889999999999999999999987 578899
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc--------EEEeecccce
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI--------LKLGDFGLAN 273 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~--------vKL~DFGla~ 273 (690)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999886655543 3446899999999999999999999999999999999999987764 6999999986
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
.... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+........ ......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~------ 224 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQL------ 224 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccC------
Confidence 5432 23356788999999997656689999999999999999998 5777665554433221 110000
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+.++.+||.+||+.||.+|||++++++
T Consensus 225 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 225 -----------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred -----------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1134578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=342.77 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=213.8
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCc---E-EEEEEeecC-CCChHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGK---M-VALKKVRFD-NFQPESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~-vAvK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
+.+..++..+.++||+|+||.||+|..+..+. . ||||..+.+ ....+....+.+|+++|++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34566777788999999999999998765422 3 899999863 356788889999999999999999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccCCC-CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~~-~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
. ...++||||+|.||.+..++.... .++..+...++.+++.||+|||++++|||||-..|+|++.++.+||+||||+
T Consensus 232 ~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 232 L--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred C--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 8 689999999999987766666554 5999999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+...... ...........|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|.......+.
T Consensus 310 ~~~~~~~-~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--- 384 (474)
T KOG0194|consen 310 RAGSQYV-MKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--- 384 (474)
T ss_pred cCCccee-eccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC---
Confidence 7643110 11111234577999999964 589999999999999999998 89999999999999998654332221
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...-+.++..++..|+..||++|||+.++.+
T Consensus 385 ------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1145678899999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=349.41 Aligned_cols=280 Identities=21% Similarity=0.269 Sum_probs=188.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCC----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeecee----
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVAT----GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVI---- 192 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~---- 192 (690)
...++|++.++||+|+||.||+|++..+ +..||||++...... +.+..| .+....+.+++.++..+
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4568899999999999999999999888 899999988643211 111111 12222233333222221
Q ss_pred eccCcceEEEEEeccchhcccccccCCC--------------------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCC
Q 041720 193 TSRLSNTIYLVFEYMEHDLAGLSSCHDI--------------------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIK 252 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~ll~~~~~~~~--------------------~lse~~~~~i~~QIl~aL~yLH~~givHrDLK 252 (690)
.......++|||||+.++.+..+..... ...+..+..++.||+.||.|||+++|||||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 1122578999999999875543332111 11234567899999999999999999999999
Q ss_pred cccEEEcc-CCcEEEeecccceeccccCcccccccccccCCCCcccccCCC---------------------CCCcchhh
Q 041720 253 ASNILVNN-EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST---------------------NYNVSVDL 310 (690)
Q Consensus 253 p~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---------------------~~~~~sDI 310 (690)
|+||||+. ++.+||+|||+|+.+...........++++.|+|||.+.... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 579999999999876544434445678899999999764321 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHh
Q 041720 311 WSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTC 390 (690)
Q Consensus 311 WSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~ 390 (690)
||||||||||+++.. ...+....+..++..++.... .|.....+. ..+. .....+........+++||.+|
T Consensus 363 wSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHH-HHHHhhccc---cchh---hhhhhhhccccchHHHHHHHHH
Confidence 999999999998654 444556666666655544332 333211100 0000 0000011122345677999999
Q ss_pred hccCCCCCCCHHHHHcCccccCCCC
Q 041720 391 LSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 391 L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
|+.||.+|||+.++|+||||+...+
T Consensus 434 L~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999998654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=319.06 Aligned_cols=242 Identities=27% Similarity=0.380 Sum_probs=191.3
Q ss_pred EEeecCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEEEecc
Q 041720 131 KIGQGTYSSVFRAREVATGK--MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
.||+|+||.||+|++..++. .+|+|.+... ......+.+.+|+.++.++ +||||+++++++.. .+.+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999888776 4688887632 2344556788999999999 89999999999987 57889999999
Q ss_pred chhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 208 EHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 208 ~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
.++.+..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 87655433321 12478899999999999999999999999999999999999999999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
+....... .......++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+..... .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--~--- 230 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--L--- 230 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC--C---
Confidence 86422111 1111223567999998854 568999999999999999997 9999988776665555422100 0
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++.++.+||.+||..||.+|||+.+++.
T Consensus 231 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 -----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.90 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=203.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
...+|++++.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+|..++||||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 45679999999999999999999877665 58999887553 24455678899999999999999999999875
Q ss_pred ceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...++||||+.++.+... ......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 678999999987655443 3334569999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcccc-cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQKL-TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
....... ....++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+.... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~------ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ------ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCCC------
Confidence 3322111 11223567999998864 568899999999999999998 999999877766555553211 1100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..+.++|.+||..||.+|||+.++++
T Consensus 233 ---------------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 ---------------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1135678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.18 Aligned_cols=282 Identities=32% Similarity=0.528 Sum_probs=228.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
..+|.-+..+|.|.- .|..+.+.-.++.||+|++..........++..+|..++..+.|+||++++.+|.-.. -.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456888999999999 7888888899999999998655333445567889999999999999999999987521 24
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+|||||..++-.... -.+....+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.....
T Consensus 95 e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 679999999987765544 24677889999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC---
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK--- 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~--- 355 (690)
-..+.+++|..|+|||++.+.+ |...+||||+||++.||++|...|.|.+..++..+|...+|.|.+.+.+...
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4668899999999999999865 9999999999999999999999999999999999999999999988876511
Q ss_pred ------CCCCCCC--CCCCCCccc--cccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 356 ------LPHGDMF--KPQNPYEGC--LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 356 ------l~~~~~~--~~~~~~~~~--l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
++....+ ....|.... ..+..+--+..++||+.+||..||++|.+++++|+||||+
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111111 000110000 0011112245689999999999999999999999999998
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.27 Aligned_cols=249 Identities=18% Similarity=0.282 Sum_probs=191.2
Q ss_pred EEeecCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYSSVFRAREVA--TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+||||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 58999999999996432 34578888876432 34445678899999999999999999999887 678999999999
Q ss_pred hhcccccccCC-----CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-c
Q 041720 209 HDLAGLSSCHD-----IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-K 282 (690)
Q Consensus 209 g~ll~~~~~~~-----~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-~ 282 (690)
++.+..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 87665443321 23567788999999999999999999999999999999999999999999998654322111 1
Q ss_pred ccccccccCCCCcccccC------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 283 LTSRVVTLWYRPPELLMG------STNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~------~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.....+++.|+|||++.. ...++.++|||||||++|+|++ |.+||....+.+.+..+..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK------ 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC------
Confidence 123345678999998742 2356889999999999999999 889998887777666654432111100
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
......++..+.+++..|+ .||.+|||++++++
T Consensus 233 -----------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 -----------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011257788899999998 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=338.50 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=200.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 194 (690)
+..++|.+.++||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|.++. |||||++++++..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 44566889999999999999999853 345689999997643 2334456889999999997 9999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC--------------------------------------------------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-------------------------------------------------------- 218 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-------------------------------------------------------- 218 (690)
.+.++||||||.++.+..++..
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 5789999999998655433211
Q ss_pred ------------------------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccE
Q 041720 219 ------------------------------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNI 256 (690)
Q Consensus 219 ------------------------------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NI 256 (690)
...+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 11356778899999999999999999999999999999
Q ss_pred EEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 041720 257 LVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVE 334 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e 334 (690)
|++.++.+||+|||+++.+..... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999986543221 11223456788999999865 568899999999999999998 899998766555
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+...+.....++ ....++.++.+||.+||..||.+||++.++|+
T Consensus 350 ~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 350 QFYNAIKRGYRMA---------------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5444332111000 01246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.30 Aligned_cols=251 Identities=24% Similarity=0.461 Sum_probs=204.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHhh-cCCCceeeeeceeec
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDN--------FQPESIRFMAREIMILRR-LDHPNIIKLEGVITS 194 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~ 194 (690)
.|++.+.||+|+||.||+|++.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999877 67899999886432 223445667789998875 799999999999987
Q ss_pred cCcceEEEEEeccchhccccc----ccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeec
Q 041720 195 RLSNTIYLVFEYMEHDLAGLS----SCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~----~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DF 269 (690)
.+..++||||+.++.+... ......+++..++.++.||+.||.|||+ .+|+|+||+|+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 6899999999987654432 2334568999999999999999999996 78999999999999999999999999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
|++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+......+..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 234 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP- 234 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC-
Confidence 9998755432 3445678999999999975 55899999999999999999999999887766665555432221110
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||.+||+.||.+|||+.|+..+
T Consensus 235 --------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 --------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 01467889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.75 Aligned_cols=288 Identities=30% Similarity=0.494 Sum_probs=232.2
Q ss_pred ccccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC------CCceeeee
Q 041720 116 YGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD------HPNIIKLE 189 (690)
Q Consensus 116 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~ 189 (690)
+....+....|.+....|+|-|++|.+|.+..-|..||||+|+... ...+.=+.|++||++|. --|+++|+
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 3334566788999999999999999999999999999999998543 33444578999999994 34889998
Q ss_pred ceeeccCcceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEE
Q 041720 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKL 266 (690)
Q Consensus 190 ~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL 266 (690)
-.|.. .+++|||||-+.-+|...+... +..|....+..|+.|++.||..|-..||+|.||||.|||+++. ..+||
T Consensus 501 r~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 501 RHFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HHhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence 88876 6999999999887665544432 3358888999999999999999999999999999999999876 47899
Q ss_pred eecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 267 GDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 267 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
||||.|.... ....+.+..+..|+|||+++| ..|+...|+||+||+||||.||+..|.|.++..++...+.+.|.+
T Consensus 579 CDfGSA~~~~---eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 579 CDFGSASFAS---ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccCccccccc---cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 9999997754 345677888999999999997 679999999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCC-----CC-----------------CCCCCcccccc--ccCCCC-------hhHHHHHHHhhccCC
Q 041720 347 PEEYWKKSKLPHGDM-----FK-----------------PQNPYEGCLRE--RCKDFT-------PTAVDLIDTCLSIEP 395 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~-----~~-----------------~~~~~~~~l~~--~~~~is-------~~l~dLI~~~L~~DP 395 (690)
|..+..+..+....+ |. ...|....... .+..++ ..+++||..||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 988877655432110 00 00110000000 011122 358899999999999
Q ss_pred CCCCCHHHHHcCccccC
Q 041720 396 YKRGTASSLLMCEYFTT 412 (690)
Q Consensus 396 ~kRpTa~elL~hp~f~~ 412 (690)
++|.|+.++|.||||+.
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.51 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=191.3
Q ss_pred eEEeecCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... .+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 3457999988532 2334556788999999999999999999987642 4568899999
Q ss_pred cchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc---cc
Q 041720 207 MEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK---QK 282 (690)
Q Consensus 207 ~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~---~~ 282 (690)
+.++.+..+.. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99765554433 334567788899999999999999999999999999999999999999999999976533211 11
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... ++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------- 222 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--RLL------------- 222 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CCC-------------
Confidence 123345678999998865 568899999999999999999 578888776666554443211 000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||..||..+|.+||++.++|.
T Consensus 223 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 223 -------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00146788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.19 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=198.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVA----------------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 186 (690)
.++|++.++||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3569999999999999999986432 34579999987543 344556788999999999999999
Q ss_pred eeeceeeccCcceEEEEEeccchhcccccccC-----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 187 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
++++++.. .+.+++||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999987 5789999999987655433221 1236778999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI--GKPILKGRTE 332 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt--G~~PF~~~~~ 332 (690)
||++.++.+||+|||++..+....... .....+++.|+|||.+.+ ..++.++|||||||++|||++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999997654322111 122344678999998765 468999999999999999998 7799987776
Q ss_pred HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 333 ~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+.+.......... +. ..+. .....+++.+.+||..||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~----~~-------~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQ----GR-------QVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhc----cc-------cccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66554432211000 00 0000 011246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=323.53 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=199.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|+.++.||+|+||.||+|++..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 346779999999999999999999887776 47888886543 33444568899999999999999999999865
Q ss_pred cceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++|+||+.++.+... ......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 356799999997654443 333446899999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+ .....++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~----- 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQ----- 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCC-----
Confidence 432221 1223345778999999865 568999999999999999997 99999876544433322 21111110
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+..+.++|..||..||++||++.+++.
T Consensus 233 ----------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 233 ----------------------PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1135678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=313.85 Aligned_cols=242 Identities=25% Similarity=0.384 Sum_probs=196.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 4579999999999999999985 578899999986432 23568899999999999999999999865 45799
Q ss_pred EEeccchhccccccc-C-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 203 VFEYMEHDLAGLSSC-H-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||+.++.+..+.. . ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999765544332 2 235889999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+.......
T Consensus 154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 217 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME------------- 217 (254)
T ss_pred --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-------------
Confidence 122334567999998864 568899999999999999997 999999877766555443211000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.+|.+|||+++++.
T Consensus 218 ---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 ---------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01257889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.50 Aligned_cols=271 Identities=25% Similarity=0.401 Sum_probs=218.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-----hHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-----PESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
-+...++|-++.+||+|||+.||+|.+....+.||||+-...... ....+-..+|..|.+.|+||.||++||+|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 455677899999999999999999999999999999987544221 223445678999999999999999999997
Q ss_pred ccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEcc---CCcEEEee
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNN---EGILKLGD 268 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~---~~~vKL~D 268 (690)
-. .+.+|-|+|||+|+.+++++.....++|.+++.|+.||+.||.||.+.. |||-||||.||||.+ -|.+||+|
T Consensus 538 lD-tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 538 LD-TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ec-cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 53 6789999999999999988888888999999999999999999999875 999999999999954 47899999
Q ss_pred cccceeccccCcc------cccccccccCCCCcccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 041720 269 FGLANILTSKNKQ------KLTSRVVTLWYRPPELLMG---STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339 (690)
Q Consensus 269 FGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~---~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I 339 (690)
|||+++++.+... ......||.||++||.+.- ....+.++||||+|||+|..|.|+.||....... .|
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HH
Confidence 9999988754332 2345789999999999853 2447889999999999999999999997543322 22
Q ss_pred HHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 340 ~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+.... .+.......|.. +.+++++++||++||++.-+.|....++-.||||..+
T Consensus 694 LqeNT----------IlkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 694 LQENT----------ILKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred Hhhhc----------hhcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 22110 001111111222 3689999999999999999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.49 Aligned_cols=286 Identities=26% Similarity=0.427 Sum_probs=222.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-----C---Cceeeeecee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-----H---PNIIKLEGVI 192 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~ 192 (690)
+...+|.+.++||.|.|++||+|.|..+.+.||+|+++... ...+..+.||.+|+++. | .+||+|+|.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34578999999999999999999999999999999997543 33345678999999982 3 4799999998
Q ss_pred ecc--CcceEEEEEeccchhcccccccCCCC-CChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccC-------
Q 041720 193 TSR--LSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNE------- 261 (690)
Q Consensus 193 ~~~--~~~~~~LV~Ey~~g~ll~~~~~~~~~-lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~------- 261 (690)
.-. ++.++|||||++...||.++...+.+ ++...++.|++|||.||.|||.. ||||.||||+||||..+
T Consensus 152 khsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred eecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 753 35689999999999999988776544 99999999999999999999975 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 041720 262 -------------------------------------------------------------------------------- 261 (690)
Q Consensus 262 -------------------------------------------------------------------------------- 261 (690)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 041720 262 -------------------------------------------------------------------------------G 262 (690)
Q Consensus 262 -------------------------------------------------------------------------------~ 262 (690)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC------CHHHHH
Q 041720 263 ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR------TEVEQL 336 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~------~~~e~l 336 (690)
.|||+|||.|.-.. ..++.-+.|..|+|||+++| ..|+..+||||++|++|||+||..+|... -+.+.+
T Consensus 392 ~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhh----hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 14666666665432 34455667888999999998 46899999999999999999999999743 366889
Q ss_pred HHHHHHcCCCChhhhhccCC-----------CCCCCCCCCCCCccccccccCCCC----hhHHHHHHHhhccCCCCCCCH
Q 041720 337 HKIFKLCGSPPEEYWKKSKL-----------PHGDMFKPQNPYEGCLRERCKDFT----PTAVDLIDTCLSIEPYKRGTA 401 (690)
Q Consensus 337 ~~I~~~~g~~~~~~w~~~~l-----------~~~~~~~~~~~~~~~l~~~~~~is----~~l~dLI~~~L~~DP~kRpTa 401 (690)
..|+.++|..|...-...+. .+.....+. +....+.+.+ .++ .++.|||.-||+.+|++||||
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~W-pL~~VL~eKY-~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPW-PLYEVLIEKY-EWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCC-cHHHHHHHHh-CCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 99999999988654433221 111111111 1111222222 233 457899999999999999999
Q ss_pred HHHHcCccccCCCCC
Q 041720 402 SSLLMCEYFTTQPYA 416 (690)
Q Consensus 402 ~elL~hp~f~~~p~~ 416 (690)
.++|+||||...+.+
T Consensus 545 ~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHhcCccccCCCCC
Confidence 999999999987654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.67 Aligned_cols=244 Identities=22% Similarity=0.353 Sum_probs=194.3
Q ss_pred EEeecCceEEEEEEEcCCC------cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 131 KIGQGTYSSVFRAREVATG------KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.||+|+||.||+|++.... ..||||.+.... .......+.+|+.+|+.++||||+++++++.+ ....++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 5899999999999876433 689999886542 23445678899999999999999999999887 57899999
Q ss_pred eccchhccccccc-------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-----cEEEeecccc
Q 041720 205 EYMEHDLAGLSSC-------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-----ILKLGDFGLA 272 (690)
Q Consensus 205 Ey~~g~ll~~~~~-------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-----~vKL~DFGla 272 (690)
||+.++.+...+. ....+++.++..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999765543332 223478899999999999999999999999999999999999877 8999999999
Q ss_pred eeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 273 NILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 273 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
..+..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL---- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc----
Confidence 76532211 11123345678999999865 568999999999999999998 999998877766655542211 00
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....++..+.+||.+||+.+|.+||+++++++
T Consensus 233 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -----------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 011256789999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.24 Aligned_cols=248 Identities=19% Similarity=0.257 Sum_probs=189.0
Q ss_pred EEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+ ...+++||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence 5899999999999754 3456799999875542 3334568889999999999999999999887 577899999999
Q ss_pred hhcccccccC-----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-c
Q 041720 209 HDLAGLSSCH-----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-K 282 (690)
Q Consensus 209 g~ll~~~~~~-----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~-~ 282 (690)
++.+..++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++......... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 7766544321 224566788899999999999999999999999999999999999999999999754322211 1
Q ss_pred ccccccccCCCCcccccCC------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC-CChhhhhcc
Q 041720 283 LTSRVVTLWYRPPELLMGS------TNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGS-PPEEYWKKS 354 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~------~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~-~~~~~w~~~ 354 (690)
.....++..|+|||++.+. ..++.++|||||||++|+|++ |.+||...+..+........... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 233 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP----- 233 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC-----
Confidence 1234567889999988532 135789999999999999996 99999877665544332221100 0000
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
......++.+.+||..|+ .+|.+|||+++|+.
T Consensus 234 -------------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 -------------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 001246778999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.37 Aligned_cols=236 Identities=22% Similarity=0.305 Sum_probs=188.2
Q ss_pred eEEeecCceEEEEEEEcCCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 130 EKIGQGTYSSVFRAREVATG----------KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g----------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+.||+|+||.||+|.+..++ ..|++|.+..... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36999999999999987776 3578887764432 15678899999999999999999998876 45
Q ss_pred EEEEEeccchhcccccccCCC-CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-------cEEEeeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDI-KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-------ILKLGDFGL 271 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~-~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-------~vKL~DFGl 271 (690)
.++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 799999999887766555443 689999999999999999999999999999999999999887 799999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+........ ..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~---- 224 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HR---- 224 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CC----
Confidence 976533 2234567789999998764 368999999999999999999 58888776533332222100 00
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
. .......+.+||.+||..||.+|||+.++|+
T Consensus 225 ------~-------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 ------L-------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------C-------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0012268899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.23 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=198.4
Q ss_pred eeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc----c
Q 041720 126 FEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS----N 198 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 198 (690)
|.+.+.||+|+||.||+|.+. .++..||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357899999998765555666778999999999999999999998765211 1
Q ss_pred eEEEEEeccchhccccccc------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSC------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
..++++||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478899998765533221 1224788999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 273 NILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 273 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
+.+...... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--- 235 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LK--- 235 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CC---
Confidence 865432211 1122345678999998864 567889999999999999999 8999988777665554432110 00
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....++..+.+||.+||+.+|.+|||+.+++.
T Consensus 236 ------------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 ------------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.63 Aligned_cols=265 Identities=23% Similarity=0.396 Sum_probs=221.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
.+...+|.++++||+|+|.+|.+++.+.|.+.+|+|++++.-.+ .+...-++.|-.+..+- +||.+|-|+.+|.. .
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--e 323 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--E 323 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--c
Confidence 35578899999999999999999999999999999999887544 34455667788887776 79999999999988 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
..+++|.||+.|+.+....+...+++|+.++.+...|+.||.|||++|||+||||.+|||||..|++||+|+|+++.-..
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 89999999999998888888888999999999999999999999999999999999999999999999999999986433
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-------CCHHHHH-HHHHHHcCCCChh
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-------RTEVEQL-HKIFKLCGSPPEE 349 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-------~~~~e~l-~~I~~~~g~~~~~ 349 (690)
.....+++||||.|.|||+|.| ..|+..+|+|+|||+|+||+.|+.||.- .+..+.+ +-|+......
T Consensus 404 -~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri--- 478 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI--- 478 (593)
T ss_pred -CCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---
Confidence 3456678999999999999986 6799999999999999999999999962 1222322 2232211111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC------HHHHHcCccccCCCCCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT------ASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT------a~elL~hp~f~~~p~~~ 417 (690)
...+|-.+..+++..|+.||.+|.. ..++-.|+||....|..
T Consensus 479 --------------------------prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 479 --------------------------PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred --------------------------cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 1245667788999999999999965 67899999999876643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=353.82 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=210.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC-CC----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA-TG----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+.....++++.||+|.||.||.|.-.. .| ..||||.+.+.. ......+|.+|..+|+.++|||||+++|++.+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3567778999999999999999998543 23 249999987553 45667889999999999999999999999998
Q ss_pred cCcceEEEEEeccchhcc-cccccC------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEe
Q 041720 195 RLSNTIYLVFEYMEHDLA-GLSSCH------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLG 267 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll-~~~~~~------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~ 267 (690)
....+|++|||.+|.| .++... ...++..+...++.||+.|+.||+++++|||||...|+||+....+||+
T Consensus 767 --~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 --SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred --CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 6889999999998654 444433 3458999999999999999999999999999999999999999999999
Q ss_pred ecccceeccccCccccccc-ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 041720 268 DFGLANILTSKNKQKLTSR-VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGS 345 (690)
Q Consensus 268 DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~ 345 (690)
|||||+.+........... .-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+.+......-.-
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 9999994433222222222 22467999999975 679999999999999999998 99999999999988766553211
Q ss_pred CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 346 ~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
++ ....+..+.+|+..||+.+|++||+...+++
T Consensus 924 ~~----------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DP----------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC----------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11 1256788999999999999999999999996
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.34 Aligned_cols=263 Identities=19% Similarity=0.199 Sum_probs=188.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCCh--HH-------HHHHHHHHHHHhhcCCCceeee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQP--ES-------IRFMAREIMILRRLDHPNIIKL 188 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~--~~-------~~~~~~Ei~iL~~L~HpnIv~l 188 (690)
+...+|++.++||+|+||.||+|.+..+ +..+|+|+........ +. ......++..+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999998777 6778888754433211 10 0112234445667799999999
Q ss_pred eceeeccCc--ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEE
Q 041720 189 EGVITSRLS--NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKL 266 (690)
Q Consensus 189 ~~~~~~~~~--~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL 266 (690)
++++..... ...+++||++...+...+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 987654211 1346788887654433322 2234678889999999999999999999999999999999999999999
Q ss_pred eecccceeccccCc------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 041720 267 GDFGLANILTSKNK------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340 (690)
Q Consensus 267 ~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~ 340 (690)
+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+......+....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999987643221 11223468999999999875 568999999999999999999999998764322221111
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.. +++... ... .......++.+.+++..|+..+|.+||++.++++
T Consensus 247 ~~------~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KC------DFIKRL--HEG-------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HH------HHHHHh--hhh-------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 10 000000 000 0011245788999999999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.00 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=198.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREV----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.++|++++.||+|+||.||++... .++..||||++...... .....+.+|+.+++.+.||||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356889999999999999999864 34789999999765432 4567799999999999999999999998775566
Q ss_pred eEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
..++||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999998765554443 333689999999999999999999999999999999999999999999999999987653
Q ss_pred cCccc--ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHHHcC
Q 041720 278 KNKQK--LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-----------LHKIFKLCG 344 (690)
Q Consensus 278 ~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-----------l~~I~~~~g 344 (690)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ...+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 22111 112234566999998865 4688999999999999999999999865432110 011110000
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.. ..+ ......+.++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~-------------~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EG-------------ERL-----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cC-------------CcC-----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 000 001245678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.50 Aligned_cols=229 Identities=23% Similarity=0.321 Sum_probs=185.3
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhcccc
Q 041720 135 GTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGL 214 (690)
Q Consensus 135 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~ 214 (690)
|.||.||++++..+++.||+|.+.... ...+|...+....||||+++++++.+ .+.+||||||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997543 12345555566679999999999987 688999999999876655
Q ss_pred cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCC
Q 041720 215 SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294 (690)
Q Consensus 215 ~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~A 294 (690)
.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 5545556999999999999999999999999999999999999999999999999988655322 233456778999
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcccccc
Q 041720 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRE 374 (690)
Q Consensus 295 PE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~ 374 (690)
||.+.+ ..++.++|||||||++|+|++|+.||...... + .. ... ..
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~----~~~------------~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT----HTT------------LN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc----ccc------------cC
Confidence 998854 56789999999999999999999887532110 0 00 000 00
Q ss_pred ccCCCChhHHHHHHHhhccCCCCCCCH-----HHHHcCccc
Q 041720 375 RCKDFTPTAVDLIDTCLSIEPYKRGTA-----SSLLMCEYF 410 (690)
Q Consensus 375 ~~~~is~~l~dLI~~~L~~DP~kRpTa-----~elL~hp~f 410 (690)
....+++.+.+||.+||+.||.+|||+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 112478899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.97 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=189.6
Q ss_pred EEeecCceEEEEEEEcCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYSSVFRAREVAT--GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+ ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975433 2356777766443 23345678999999999999999999999987 678999999999
Q ss_pred hhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC-cccc
Q 041720 209 HDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN-KQKL 283 (690)
Q Consensus 209 g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~-~~~~ 283 (690)
++.+...... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 8655443322 2246677888999999999999999999999999999999999999999999986432111 1122
Q ss_pred cccccccCCCCcccccC------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 284 TSRVVTLWYRPPELLMG------STNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~------~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
...+++..|+|||++.. ...++.++|||||||++|+|++ |.+||...++.+.+..+........ +
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~----- 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---F----- 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---C-----
Confidence 34567889999998743 1235779999999999999997 5789988887777776644211100 0
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+ .....+++.+.++|..|| .+|.+|||++++++
T Consensus 231 ------~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 ------KP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------CC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00 011246788999999999 78999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=334.78 Aligned_cols=308 Identities=22% Similarity=0.300 Sum_probs=239.9
Q ss_pred cCCCCcccccccccCCCCCCCCcchhhhccCcccccChHHhhcccchhhhhhcccccccccccCcCCeeEEeEEeecCce
Q 041720 59 EDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYS 138 (690)
Q Consensus 59 ~~~~~~~r~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG 138 (690)
.+++.++|..+.+++-+...+..++..+.-........++. .+ .........++ |..++..+.++||+|+||
T Consensus 53 MgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~h~~~t---~~---~~~p~~~lkcl--Ipee~i~l~e~LG~GsFg 124 (1039)
T KOG0199|consen 53 MGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPSHPAQT---NS---VANPSIDLKCL--IPEEQIKLYELLGEGSFG 124 (1039)
T ss_pred cCcHHHHHHHHHHHHhhhhccccchHHHHhccCCccccccc---cC---CCCcCCCccee--ccHHHHHHHHHhcCccee
Confidence 45788888888888877776667776554333222221111 11 11112222333 446778899999999999
Q ss_pred EEEEEEEcC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhccccc
Q 041720 139 SVFRAREVA-TGK--MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS 215 (690)
Q Consensus 139 ~Vy~a~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~ 215 (690)
+|++|.|.. .|+ .||||+++.+.... ....|++|+.+|.+|+|+|+|+|||++.+ ..+.||||++..|.|...
T Consensus 125 vV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~ELaplGSLldr 200 (1039)
T KOG0199|consen 125 VVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFELAPLGSLLDR 200 (1039)
T ss_pred eEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhhcccchHHHH
Confidence 999999874 343 59999998776554 67889999999999999999999999986 688999999998765544
Q ss_pred cc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc--cccccccC
Q 041720 216 SC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL--TSRVVTLW 291 (690)
Q Consensus 216 ~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~--~~~~gt~~ 291 (690)
+. ....|....++.|+.||+.||.||..+++|||||-..||||-....|||+||||.+.+........ ......+.
T Consensus 201 Lrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfA 280 (1039)
T KOG0199|consen 201 LRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFA 280 (1039)
T ss_pred HhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCccc
Confidence 43 345688899999999999999999999999999999999999999999999999998865443322 12233667
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcc
Q 041720 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEG 370 (690)
Q Consensus 292 Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~ 370 (690)
|+|||.|.. ..++.++|||+|||+||||++ |..||.|....+++++|-+..
T Consensus 281 WCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e--------------------------- 332 (1039)
T KOG0199|consen 281 WCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE--------------------------- 332 (1039)
T ss_pred ccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc---------------------------
Confidence 999999964 679999999999999999998 789999999999998884321
Q ss_pred ccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 371 CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 371 ~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+.+..+.++.+++..||..+|.+|||+..|.+.
T Consensus 333 -rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 -RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 112234678899999999999999999999988643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=310.15 Aligned_cols=265 Identities=25% Similarity=0.430 Sum_probs=215.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-hhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMIL-RRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..+..+-+..||.|+||+|++..++.+|+.+|||.|+..... ...++++.|.+.. +.-+.||||++||.+.. ++.
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGd 137 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGD 137 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCc
Confidence 4455677788899999999999999999999999999977653 3445677777654 44589999999999887 688
Q ss_pred EEEEEeccchhccccc----ccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 200 IYLVFEYMEHDLAGLS----SCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~----~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.||.||+|+-.+..++ ...+..++|.-+..|....+.||.||-. .+|||||+||+||||+..|.+||||||++-.
T Consensus 138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999997654433 2345579999999999999999999975 5899999999999999999999999999976
Q ss_pred ccccCcccccccccccCCCCcccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhhh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~sDIWSlGviLyeLltG~~PF~~~~~-~e~l~~I~~~~g~~~~~~w~ 352 (690)
+... ...+.-+|...|||||.+.... .|+.++||||||++|||+.||..|+.+-+. .+++..+.. |.||.-.
T Consensus 218 Lv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~-- 291 (361)
T KOG1006|consen 218 LVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL-- 291 (361)
T ss_pred HHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec--
Confidence 6432 3345567888899999997643 499999999999999999999999998654 456655533 3333211
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+.+++..+..||..||..|-..||...+++.+||+...
T Consensus 292 -------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 292 -------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 011234689999999999999999999999999999999764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.36 Aligned_cols=266 Identities=28% Similarity=0.471 Sum_probs=222.6
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec--
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS-- 194 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~-- 194 (690)
..+...+.|++.+.||.|.+|.||+++++.+++.+|||++..... ..+.+..|.+||+.+ .|||++.+|++|..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 345667789999999999999999999999999999999986642 234577899999998 69999999999864
Q ss_pred -cCcceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 195 -RLSNTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 195 -~~~~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
..++.+|||||||.+|...++.. .+.++.|..+..|++.++.||.|||.+.+||||||-.|||++.++.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 23679999999999986544332 256799999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGS----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
+..++.. .....+.+|||.|||||++... ..|+..+|+||||++..||--|.||+-+..+...+-.|.+ .||
T Consensus 170 SaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP 245 (953)
T KOG0587|consen 170 SAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP 245 (953)
T ss_pred eeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC
Confidence 9887753 3556778999999999999653 3477899999999999999999999998777666655422 222
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
... ......+.++.+||..||..|-.+||+..++|.|||++..
T Consensus 246 PkL-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 246 PKL-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccc-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 211 1123578899999999999999999999999999999854
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.09 Aligned_cols=202 Identities=32% Similarity=0.497 Sum_probs=174.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cceEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SNTIY 201 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~~~ 201 (690)
+..-+.||+|+||.||+++++.+|+.||||.++... ...-.+.+-+|+++|++|+|+|||+++++=++.. ...-.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 566778999999999999999999999999998654 3334567889999999999999999999876643 45568
Q ss_pred EEEeccchhcccccccC---CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc--cCC--cEEEeeccccee
Q 041720 202 LVFEYMEHDLAGLSSCH---DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN--NEG--ILKLGDFGLANI 274 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~---~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld--~~~--~vKL~DFGla~~ 274 (690)
+|||||.||.+...... ...|+|.+...++..+..||.|||++|||||||||.||++- .+| .-||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999877655543 33599999999999999999999999999999999999983 334 579999999998
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR 330 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~ 330 (690)
++.+ ...++.+||+.|.+||++...+.|+..+|.|||||++|+++||..||...
T Consensus 174 l~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 8653 47889999999999999976688999999999999999999999999743
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.94 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=208.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC--CC--cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA--TG--KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~--~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..+...+.+.||.|-||.||+|.... .| -.||||..+.+. .++..+.|+.|..+|+.++|||||+|+|+|.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-- 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-- 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec--
Confidence 444555667789999999999997542 23 359999998654 45567889999999999999999999999986
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..++||||++.-|.+..++ .+...++......++.||+.||.|||+.++|||||...|||+.....|||+||||++.+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 7899999999987766554 45556999999999999999999999999999999999999999999999999999998
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
..+.....+...-..-|||||.+. ...++.++|||.|||++||++. |..||.|-.+.+.+-.|.++...|-
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~------- 613 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC------- 613 (974)
T ss_pred cccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC-------
Confidence 766544444333356699999984 5789999999999999999875 9999999877777666544322221
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
.++.++.+..|+.+||.+||.+||+..++.
T Consensus 614 ---------------------P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 614 ---------------------PPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------------------CCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 136788999999999999999999998875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.47 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=222.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+......+.++||.|.||.||+|+.+..|+ .||||.++.. ..+.+...|+.|+.||.+++||||++|.|+... .
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s 702 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--S 702 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--C
Confidence 344557889999999999999999876664 6999999854 566777889999999999999999999999988 7
Q ss_pred ceEEEEEeccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
..+.||+|||+++.|+ ++..+++.|+..++..+++.|+.||.||-++++|||||...||||+.+..+|++||||++.+.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 8999999999988665 555677889999999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccccccc--ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
++.....++.-| ...|.|||.+. ...++.++||||+||+|||.++ |..||...++++.+..|.....-|++-
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---- 857 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---- 857 (996)
T ss_pred cCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC----
Confidence 665444555444 57799999996 4678999999999999999875 999999999999999998876655532
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.|..+-+|+..||++|-..||+..+|+.
T Consensus 858 ------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 858 ------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 67889999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=289.18 Aligned_cols=243 Identities=37% Similarity=0.573 Sum_probs=198.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhccccc
Q 041720 136 TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLS 215 (690)
Q Consensus 136 ~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~ 215 (690)
+||.||+|.+..+|+.||+|++........ .+.+.+|+.++++++|+||+++++++.. ....++||||+.++.+...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999976543321 5778999999999999999999999987 5789999999998655544
Q ss_pred ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCc
Q 041720 216 SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295 (690)
Q Consensus 216 ~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~AP 295 (690)
......+++..++.++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4444348999999999999999999999999999999999999999999999999998765432 33456778899999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcccccc
Q 041720 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRE 374 (690)
Q Consensus 296 E~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~ 374 (690)
|.+.+ ..++.++|||+||+++|+|++|..||......+ ....+..........
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------- 209 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP------------------------- 209 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-------------------------
Confidence 99864 567889999999999999999999998743333 333332211111100
Q ss_pred ccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 375 RCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 375 ~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...++.++.++|.+||..||.+||++.++++||||
T Consensus 210 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 -EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 01277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=322.04 Aligned_cols=276 Identities=21% Similarity=0.270 Sum_probs=188.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc----------------CCCcEEEEEEeecCCCCh--H----------HHHHHHH
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV----------------ATGKMVALKKVRFDNFQP--E----------SIRFMAR 172 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~~g~~vAvK~i~~~~~~~--~----------~~~~~~~ 172 (690)
...++|++.++||+|+||+||+|.+. ..++.||||.+....... + ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45778999999999999999999752 345679999986542110 0 1122345
Q ss_pred HHHHHhhcCCCce-----eeeeceeecc------CcceEEEEEeccchhcccccccC-----------------------
Q 041720 173 EIMILRRLDHPNI-----IKLEGVITSR------LSNTIYLVFEYMEHDLAGLSSCH----------------------- 218 (690)
Q Consensus 173 Ei~iL~~L~HpnI-----v~l~~~~~~~------~~~~~~LV~Ey~~g~ll~~~~~~----------------------- 218 (690)
|+.++.+++|.++ ++++++|... ..+..+|||||+.++.+..++..
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888876654 6677776531 13568999999998655433221
Q ss_pred -CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCccc
Q 041720 219 -DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297 (690)
Q Consensus 219 -~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 297 (690)
...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+............+|+.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1124567789999999999999999999999999999999999999999999997654322222222344889999999
Q ss_pred ccCCCC-------------------CC--cchhhHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 298 LMGSTN-------------------YN--VSVDLWSVGCVFAELLIGKP-ILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 298 l~~~~~-------------------~~--~~sDIWSlGviLyeLltG~~-PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
+..... |+ .+.||||+|||||+|++|.. ||.+....... +.. .......|....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~-~~~~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQ-YDNDLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhh-ccchHHHHHhhc
Confidence 853211 12 24799999999999999874 77543221111 000 011112232211
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCC---CCCCCHHHHHcCccccC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEP---YKRGTASSLLMCEYFTT 412 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP---~kRpTa~elL~hp~f~~ 412 (690)
.... ....+..+++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 458 ~~~~------------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQKY------------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccCC------------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0000 001133578999999999999876 68999999999999964
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=315.02 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=210.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+......+.++||+|-||.|.+|+ ...+..||||+++.+. +.+....|.+||.+|.+|+|||||+|+++|.. .+.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCch
Confidence 445668889999999999999998 4557899999998664 44556889999999999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCC-CC-CChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSCHD-IK-FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~-~~-lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+||+|||++|.+..++... .+ +.-.....|+.||+.||+||.+.+||||||.+.|||++.++++||+|||+++-+-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999987665544332 22 355667779999999999999999999999999999999999999999999976655
Q ss_pred Ccccccc-cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 NKQKLTS-RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL--IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~~~~~~~-~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl--tG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
....... .+-...|||||.++. ..++.++|+|+|||+|||++ |...||...++.+...+.-..+...+..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~------ 763 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ------ 763 (807)
T ss_pred CceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc------
Confidence 4444433 444788999999875 56899999999999999985 5789999888777776654443332211
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
....+..-.+..+.+||.+|+..|-.+|||.+++-
T Consensus 764 ---------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 764 ---------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ---------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 11122335778899999999999999999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.43 Aligned_cols=251 Identities=21% Similarity=0.371 Sum_probs=205.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+...+.....+||-|-||.||.|.|+.-...||||.++-+.+ .++.|+.|+.+|+.++|||+|+|+++|.. ...+
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPF 338 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPF 338 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCe
Confidence 344556778899999999999999999999999999985543 45679999999999999999999999987 6889
Q ss_pred EEEEeccchh-ccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHD-LAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~-ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
|||+|||..| ||+++.. ....++.-.+..++.||..||+||..+++|||||-..|+|+.++..|||+||||++++..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999865 5554433 3334677778889999999999999999999999999999999999999999999988654
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........-..-|.|||.|. ...++.++|||+|||+|||+.| |-.||.|-+-...+..+.+...
T Consensus 419 TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR------------- 484 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR------------- 484 (1157)
T ss_pred ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc-------------
Confidence 433333333356699999985 4668999999999999999998 8899999776655544433211
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
.+.....++....|++.||++.|..||+..|+-
T Consensus 485 ---------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 ---------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ---------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 111236788999999999999999999998874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=319.19 Aligned_cols=250 Identities=29% Similarity=0.416 Sum_probs=194.4
Q ss_pred eeEEeEEeecCce-EEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEEE
Q 041720 126 FEKLEKIGQGTYS-SVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 126 y~~~~~LG~G~fG-~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
|.-.+.+|.|+.| .||+|. ..|+.||||.+-. +......+||..|+.- .|||||++|+.-.+ ...+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEE
Confidence 4445679999998 479995 6889999998753 3455678999999998 69999999876555 7999999
Q ss_pred EeccchhcccccccC--CCCC-ChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CC--cEEEeecccceec
Q 041720 204 FEYMEHDLAGLSSCH--DIKF-SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EG--ILKLGDFGLANIL 275 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~--~~~l-se~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~--~vKL~DFGla~~~ 275 (690)
.|+|...+..++... +... .....+.++.|++.||+|||+.+||||||||.||||+. ++ .++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999877766553 1111 22566889999999999999999999999999999976 33 7899999999988
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..+... ...+..||-+|+|||+|... .-+.++||||||||+|+.++| ..||... .+...+|+.......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~----- 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLV----- 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCcccee-----
Confidence 754332 24567889999999999764 346799999999999999986 8999853 334445544321110
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
........++.|||.+||.+||..||+|.++|.||+|...
T Consensus 734 ---------------------~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 734 ---------------------HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ---------------------eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 0001111289999999999999999999999999999763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=297.83 Aligned_cols=284 Identities=31% Similarity=0.519 Sum_probs=217.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeecc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSR 195 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 195 (690)
+...+.|..+++||.|+|++||++.+.. ..+.||+|.+...... .++.+|+++|..+ .+.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn- 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN- 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc-
Confidence 3445679999999999999999999877 7889999999765432 4588999999999 69999999999877
Q ss_pred CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeeccccee
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANI 274 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~ 274 (690)
.+.+++||||+++.....+.. .++..++..+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||||..
T Consensus 107 -nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 -NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred -CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 789999999999865544432 36789999999999999999999999999999999999864 6789999999962
Q ss_pred cccc-------------------------------------------CcccccccccccCCCCcccccCCCCCCcchhhH
Q 041720 275 LTSK-------------------------------------------NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLW 311 (690)
Q Consensus 275 ~~~~-------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIW 311 (690)
.+.. .........||++|+|||++.....-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1100 000112457899999999999888889999999
Q ss_pred HHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC--------hh--hhhccCCCCCC----CC-----CCCCC--Cc
Q 041720 312 SVGCVFAELLIGKPIL-KGRTEVEQLHKIFKLCGSPP--------EE--YWKKSKLPHGD----MF-----KPQNP--YE 369 (690)
Q Consensus 312 SlGviLyeLltG~~PF-~~~~~~e~l~~I~~~~g~~~--------~~--~w~~~~l~~~~----~~-----~~~~~--~~ 369 (690)
|.|||+..+++++.|| ...++.+.+..|....|... .. +|.++..+... .| ..... ..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999998775 56677777777776666532 22 45432221100 00 00000 00
Q ss_pred cccccc-cCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 370 GCLRER-CKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 370 ~~l~~~-~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
++.... ...++..+.||+.+||..||.+|.||+++|.||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 122222 2345668999999999999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=268.55 Aligned_cols=217 Identities=24% Similarity=0.435 Sum_probs=183.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++...+..||+|++|.|-+.++..+|...|+|.+...- .....+++++|+++..+. .+|.+|++||.+.+ ..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--eg 118 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EG 118 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cc
Confidence 345566777888999999999999999999999999998653 345566788899887665 79999999998887 68
Q ss_pred eEEEEEeccchhcccc---cccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGL---SSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~---~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.++|.||.|...+..+ ....+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|.+||||||++-.
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999999765443 445677899999999999999999999986 899999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHH
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMG---STNYNVSVDLWSVGCVFAELLIGKPILK-GRTEVEQLHKIFK 341 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~sDIWSlGviLyeLltG~~PF~-~~~~~e~l~~I~~ 341 (690)
+.+. -..+-..|...|||||.+.. ...|+.++||||||+++.||.+++.||. ..++.+++.++..
T Consensus 199 L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7542 22333567788999999853 3479999999999999999999999997 4688899988865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.31 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=225.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|+++.++|.|+||.||+++++.+++..|+|+++... .+...-+.+||-+++.++|||||.+++.|.. ...++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 578999999999999999999999999999999998764 2345567899999999999999999999987 588999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
+||||++|.+..+-.--+.++|.++..+.+..++||+|||++|-+|||||-.|||+++.|.+||+|||.+-.+.. ....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh-hhhh
Confidence 999999999988888888999999999999999999999999999999999999999999999999999876543 2344
Q ss_pred ccccccccCCCCccccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLM--GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~--~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
...++||+.|||||+.. ....|...+|||++|+...|+---++|.....+...+..+-+-.+.||.- -
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l-k--------- 238 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL-K--------- 238 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-c---------
Confidence 56789999999999852 35679999999999999999988888887777777776665555444421 0
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.....++.+-+|++.+|..+|.+|||++.+|.|||...
T Consensus 239 --------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 239 --------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 01245778999999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=330.63 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=185.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|...+.||+|+||.||+|++..++..||||++...... ...|+.+|++++|||||++++++.+ .+..|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 466778899999999999999899999999998643211 2346889999999999999999987 57889999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHH---hCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH---LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH---~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||+++.+..+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999877665553 3789999999999999999999 6799999999999999998888776 666543321
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCC-CChhhhhccCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGS-PPEEYWKKSKLPHG 359 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~-~~~~~w~~~~l~~~ 359 (690)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+......... .....|....+
T Consensus 835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 909 (968)
T PLN00113 835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI--- 909 (968)
T ss_pred -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc---
Confidence 123467899999999865 56899999999999999999999998532110 111111111100 00011100000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..... .......++.+++.+||+.||.+|||+.|+++.
T Consensus 910 ---~~~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ---RGDVS-------VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---cCCCC-------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000 000112357789999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=293.61 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=178.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHhhcC---CCceeeeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE------SIRFMAREIMILRRLD---HPNIIKLEG 190 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~---HpnIv~l~~ 190 (690)
.....+|..+..||.|+||.|++|+++.+...|+||.|.+...-.+ ..-.+--||.||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 3456679999999999999999999999999999999987643111 1122456999999997 999999999
Q ss_pred eeeccCcceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 191 VITSRLSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 191 ~~~~~~~~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
+|++ .+.+||+||--..+ .|+.++.....++|.++..|++||+.|+++||+.||||||||-+||.++.+|-+||+||
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9999 78999999987655 45666667778999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
|.|.... ...+..++||..|.|||+|.|..+.+..-|||+||++||.++...-||.
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9997653 3567789999999999999988888999999999999999998877774
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=301.39 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=201.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc---C----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV---A----TGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+..+...+.+.||+|.||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+ .|+||+.++++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 344555667779999999999999632 1 1457999999866544 6678899999999999 69999999999
Q ss_pred eeccCcceEEEEEeccchhcccc-cccCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGL-SSCHD---------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~-~~~~~---------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
|.. .+.+++|+||+..|.+.. +.... ..++..+...++.||+.|++||++.++|||||-..|
T Consensus 371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 988 789999999999765443 33322 238889999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCccccccccc--ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC-
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRT- 331 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~- 331 (690)
|||..+..+||+|||+|+..............+ ...|||||.+.. ..|+.++|||||||+||||++ |..||.+-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999998654433333232332 344999999976 779999999999999999998 889998854
Q ss_pred HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 332 EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 332 ~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+.+..+..+.. .+.....++++.++++.|++.+|.+||+..++.+
T Consensus 528 ~~~l~~~l~~G~r----------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 528 TEELLEFLKEGNR----------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4444443332211 1112246889999999999999999999999873
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=293.38 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=204.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.....+..++||.|+||+||+|.+...|+ +||||++.... .+.....++.|+.+|.+|+|||+++|++++..
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--- 769 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCML--- 769 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhccc---
Confidence 34456778899999999999999987775 58999887543 34455778999999999999999999999986
Q ss_pred ceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
..+.||++||+.| |++.+..++..+-......|..||++||.|||.+++|||||-..||||..-.++||.|||+++.+.
T Consensus 770 s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 770 STLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred chHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 4488999999976 566666777789999999999999999999999999999999999999999999999999999887
Q ss_pred ccCcccccc-cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQKLTS-RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~~~~~-~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.+....... ....+-|||=|.+.. ..|+.++|||||||++|||+| |..|+.+....+.-..+.....
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---------- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---------- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc----------
Confidence 655443322 222555889898864 679999999999999999998 9999998766554433322110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.++. +.-+-++..++.+||..|+..||+++++..
T Consensus 919 --------LsqP----------piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 --------LSQP----------PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------CCCC----------CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0111 245678899999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.54 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=190.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhh--cCCCceeeeeceeecc--Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR--LDHPNIIKLEGVITSR--LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~--~~~ 198 (690)
..-.++++.||+|.||.||+|+ -+++.||||++. ....+.+.+|-+|... ++|+||+++++.-... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3446788999999999999996 467999999985 3455678888888766 4899999998875431 134
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC---------CeEeccCCcccEEEccCCcEEEeec
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR---------GIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~---------givHrDLKp~NILld~~~~vKL~DF 269 (690)
.++||+||.+.|.|..++..+ .+++....+++.-++.||+|||+- .|+|||||..||||.+|++..|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 789999999988887776654 689999999999999999999963 4999999999999999999999999
Q ss_pred ccceeccccCc-ccccccccccCCCCcccccCCCCCC-----cchhhHHHHHHHHHHHhCCCCC------------CC--
Q 041720 270 GLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYN-----VSVDLWSVGCVFAELLIGKPIL------------KG-- 329 (690)
Q Consensus 270 Gla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~-----~~sDIWSlGviLyeLltG~~PF------------~~-- 329 (690)
|||..+..... ......+||..|||||+|.+...+. ...||||+|.|||||++....+ ..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99988764322 2344589999999999998865555 3689999999999999754332 20
Q ss_pred ---CCHHHHHHHHHHHcCCC-ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHH
Q 041720 330 ---RTEVEQLHKIFKLCGSP-PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404 (690)
Q Consensus 330 ---~~~~e~l~~I~~~~g~~-~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~el 404 (690)
.+-.++...+......| ..+.|.+. ....-+.+.|..|+..||+.|.||.=+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h-----------------------~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH-----------------------AGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcC-----------------------ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 11222222222222222 13334321 233467899999999999999998655
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-29 Score=244.30 Aligned_cols=213 Identities=39% Similarity=0.630 Sum_probs=180.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhc
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDL 211 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~l 211 (690)
||.|.+|.||++....+++.++||++....... ....+.+|+.+++.+.|++|+++++++.. ....++||||+.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999988889999999998654322 34678999999999999999999999987 578999999999655
Q ss_pred ccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeecccceeccccCcccccccccc
Q 041720 212 AGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANILTSKNKQKLTSRVVT 289 (690)
Q Consensus 212 l~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~gt 289 (690)
+..+.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||++........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 54443332 46899999999999999999999999999999999999999 89999999999987643321 23345678
Q ss_pred cCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCc
Q 041720 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYE 369 (690)
Q Consensus 290 ~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~ 369 (690)
..|++||.+.....++.+.|+|+||+++|+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999886543678899999999999999
Q ss_pred cccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCc
Q 041720 370 GCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408 (690)
Q Consensus 370 ~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp 408 (690)
..+.++|..||+.||.+||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1367899999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=247.49 Aligned_cols=212 Identities=35% Similarity=0.569 Sum_probs=176.9
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|.+.+.||.|++|.||++.+..+++.+|||.+...... ...+.+.+|+..++.++|+|++++++++.. ....++|+|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56788999999999999999888999999999865433 246788999999999999999999999877 578999999
Q ss_pred ccchhcccccccCCCC-CChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAGLSSCHDIK-FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~-lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
|+.++.+......... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++..+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998655544444334 899999999999999999999999999999999999999999999999999876543211334
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHH
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEV-EQLHKIF 340 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~-e~l~~I~ 340 (690)
...++..|++||.+.+...++.++|||+||+++|+|++|++||.. .+.. +..+.|.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 467788999999884445678899999999999999999999987 4444 4555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=304.84 Aligned_cols=204 Identities=19% Similarity=0.232 Sum_probs=147.4
Q ss_pred hcCC-Cceeeeeceeecc-----CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCC
Q 041720 179 RLDH-PNIIKLEGVITSR-----LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIK 252 (690)
Q Consensus 179 ~L~H-pnIv~l~~~~~~~-----~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLK 252 (690)
.+.| +||++++|++... ....++++|||+.+++...+......+++.+++.+++||+.||.|||++||||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 5777788876221 124678889999887766665545569999999999999999999999999999999
Q ss_pred cccEEEcc-------------------CCcEEEeecccceeccccCc---------------ccccccccccCCCCcccc
Q 041720 253 ASNILVNN-------------------EGILKLGDFGLANILTSKNK---------------QKLTSRVVTLWYRPPELL 298 (690)
Q Consensus 253 p~NILld~-------------------~~~vKL~DFGla~~~~~~~~---------------~~~~~~~gt~~Y~APE~l 298 (690)
|+||||+. ++.+||+|||+++....... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 34566677777654211000 001124689999999998
Q ss_pred cCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCC
Q 041720 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKD 378 (690)
Q Consensus 299 ~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~ 378 (690)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .+... ..
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~--------------------------~~ 236 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI--------------------------LL 236 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh--------------------------hh
Confidence 76 568999999999999999999999876422 1222221111 01100 01
Q ss_pred CChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 379 FTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 379 is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+.+.+++..||.+||.+|||+.|+|+||||...
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 23456789999999999999999999999999763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.76 Aligned_cols=251 Identities=26% Similarity=0.319 Sum_probs=186.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhh--cCCCceeeeeceeecc--Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR--LDHPNIIKLEGVITSR--LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~--~~~ 198 (690)
..+..+.+.||+|.||.||+|.+ .|+.||||++.... .+.+.+|.+|.+. |+|+||+.+++.=... .-.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 56689999999999999999975 68899999986432 2457778888776 4999999998753321 124
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC--------CeEeccCCcccEEEccCCcEEEeecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~--------givHrDLKp~NILld~~~~vKL~DFG 270 (690)
.++||++|.+.|.|.+++.. ..++.....+++..++.||+|||.. .|.|||||..||||..++.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 78999999999998888877 4789999999999999999999953 49999999999999999999999999
Q ss_pred cceeccccCc---ccccccccccCCCCcccccCCCCC-----CcchhhHHHHHHHHHHHhC----------CCCCCCC--
Q 041720 271 LANILTSKNK---QKLTSRVVTLWYRPPELLMGSTNY-----NVSVDLWSVGCVFAELLIG----------KPILKGR-- 330 (690)
Q Consensus 271 la~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~-----~~~sDIWSlGviLyeLltG----------~~PF~~~-- 330 (690)
||........ ......+||..|||||+|..+... -..+||||||.||||++.. .+||.+-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9987654432 234568999999999999543221 1258999999999999742 3666532
Q ss_pred --CHHHHHHHHHH--HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHH
Q 041720 331 --TEVEQLHKIFK--LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404 (690)
Q Consensus 331 --~~~e~l~~I~~--~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~el 404 (690)
...+.+.+++- .+.+..+..|... ..=..+..|++.||..+|.-|.||--+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~-----------------------~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSD-----------------------PALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccC-----------------------HHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 12233333211 1111122222210 011246688999999999999998554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.71 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=205.1
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATG-----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
+.+...++++...+-+|.||.||.|++.... +.|-+|.++.. ..+-+...++.|..+|..+.|||+..+.+++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3455667888999999999999999876433 34677877643 34566778999999999999999999999987
Q ss_pred ccCcceEEEEEeccchhccccccc--C------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEE
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSC--H------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~--~------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vK 265 (690)
.. ....++++.++.-+.+..++. + ...++..++..++.||+.|++|||+.||||.||...|++||+...+|
T Consensus 358 e~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 358 ED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 63 567788889988655443332 1 12367778899999999999999999999999999999999999999
Q ss_pred EeecccceeccccCcccccc-cccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 266 LGDFGLANILTSKNKQKLTS-RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 266 L~DFGla~~~~~~~~~~~~~-~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
|+|=.|++-+-+.+.+-+.. .-....||+||.+.+ ..|+.++|+|||||+||||+| |+.|+..-++.|....+.++.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 99999998765544333222 222556999999975 679999999999999999998 899999999998887775532
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.-. +| -+.|+++..++..||..+|++||+.+++..
T Consensus 516 Rla-------------------QP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 RLA-------------------QP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred eec-------------------CC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111 11 167899999999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-28 Score=240.11 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=184.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.+.|.+.+.||+|.||.+.+|+|+.+...+++|.+.... ...+.|.+|..---.| .|.||+.-|++-... .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 456999999999999999999999999999999987543 3456788898776666 589999988874432 67899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-c-CCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-N-EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~-~~~vKL~DFGla~~~~~~~ 279 (690)
+++||++-+.|..-... ..+-|.....++.|+++||.|+|++++||||||.+||||- . ...|||||||+.+..+.
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 99999997655433322 3588999999999999999999999999999999999993 2 34899999999875432
Q ss_pred cccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhcc
Q 041720 280 KQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-LHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-l~~I~~~~g~~~~~~w~~~ 354 (690)
.....--+..|.+||.+.. .-...+.+|||.||+|+|.+|+|.+||+.....+. +...+. |.+.
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~r 244 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLKR 244 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------Hhcc
Confidence 1122223566999998643 12246789999999999999999999984322211 111111 1111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kR 398 (690)
+. ..+...+..+++.+..+.++-|..+|++|
T Consensus 245 k~-------------~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 245 KN-------------PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cC-------------ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 11 12334456799999999999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-25 Score=228.72 Aligned_cols=263 Identities=33% Similarity=0.487 Sum_probs=207.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHhhcCCC-ceeeeeceeeccCcceEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLDHP-NIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~~~LV 203 (690)
|.+...||.|+||.||++.+. ..+++|.+....... .....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788899999999999999876 789999998765443 2567899999999999988 79999999965 4568999
Q ss_pred EeccchhcccccccCCC---CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccC
Q 041720 204 FEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKN 279 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 279 (690)
++|+.++.+........ .+.+..+..++.|++.+|.|+|+.+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999877664444443 689999999999999999999999999999999999999988 79999999998655433
Q ss_pred cc-----cccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCC-Ch
Q 041720 280 KQ-----KLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTE---VEQLHKIFKLCGSP-PE 348 (690)
Q Consensus 280 ~~-----~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~---~e~l~~I~~~~g~~-~~ 348 (690)
.. .....+||..|+|||.+.+. ..+....|+|++|++++++++|..||..... .......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22 34678899999999999764 5788999999999999999999999887764 33333333332222 00
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.... .... ......+.+++..|+..+|..|.+..+...++|....
T Consensus 237 ~~~~--------------~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 SPLS--------------PSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccC--------------cccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000 0000 1233578999999999999999999999988666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=273.57 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=202.7
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRF----DNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~----~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.....+|.|++|.|+.+......+.++.|.... ..........+..|+.+-..|.|||++..+..+.+ ...++-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchh
Confidence 456789999999999888777777677775542 22122222237788888999999999988888776 344455
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc--
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-- 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-- 280 (690)
+||||++ .+..+....+.+...++..++.||+.||.|||+.||.||||||+|+|+..+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999 4444444456899999999999999999999999999999999999999999999999999987654433
Q ss_pred -ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 -QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 -~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+|+..|+|||++.+..+....+||||.|++++.|++|+.||......+....-.... .|.
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------~~~------- 544 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------DQR------- 544 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------ccc-------
Confidence 455678999999999999876656678999999999999999999998654443321000000 000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
............++...+.+|.+||++||.+|.|+++||+.+||+...
T Consensus 545 -------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 545 -------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred -------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 001111122236788899999999999999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=224.31 Aligned_cols=158 Identities=21% Similarity=0.289 Sum_probs=122.6
Q ss_pred CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCccc
Q 041720 218 HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297 (690)
Q Consensus 218 ~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 297 (690)
....+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+.|||||+
T Consensus 10 ~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~~y~aPE~ 75 (176)
T smart00750 10 RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDPYFMAPEV 75 (176)
T ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCcccccChHH
Confidence 3456999999999999999999999998 999999999999999 9999875432 2368999999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcccccccc
Q 041720 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERC 376 (690)
Q Consensus 298 l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~ 376 (690)
+.+ ..|+.++|||||||++|||++|.+||...... ..+..+........ +. .. ...
T Consensus 76 ~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~------------~~-------~~~ 132 (176)
T smart00750 76 IQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---PR------------DR-------SNL 132 (176)
T ss_pred hcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---cc------------cc-------ccH
Confidence 975 56899999999999999999999999765443 23333322211100 00 00 000
Q ss_pred CCCCh--hHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 377 KDFTP--TAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 377 ~~is~--~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..++. .+.+||.+||..||.+|||+.++++|+|+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 12333 6999999999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=239.48 Aligned_cols=168 Identities=21% Similarity=0.261 Sum_probs=132.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHhhcCCCceee-eeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHPNIIK-LEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~-l~~~~~~ 194 (690)
+...+.|.+.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+.+|++|.|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4456789999999999999999998876 778889998753311 2334567899999999999999985 4432
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccC-CcccEEEccCCcEEEeecccce
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDI-KASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDL-Kp~NILld~~~~vKL~DFGla~ 273 (690)
+..|||||||.|+.+..... .. ...++.||+.+|.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 35799999999876653211 11 2568899999999999999999999 9999999999999999999998
Q ss_pred eccccCc-------ccccccccccCCCCcccccC
Q 041720 274 ILTSKNK-------QKLTSRVVTLWYRPPELLMG 300 (690)
Q Consensus 274 ~~~~~~~-------~~~~~~~gt~~Y~APE~l~~ 300 (690)
.+..... ...++.++++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7654321 12246678899999998853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-26 Score=252.61 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=205.1
Q ss_pred EEeecCceEEEEEEE---cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEEEec
Q 041720 131 KIGQGTYSSVFRARE---VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey 206 (690)
.+|.|+||.|++++. ...|..+|+|++++.............|..++..++ ||.+|+++-.++. ...++++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 379999999998763 245677999988765432222224456778888886 9999999988887 6899999999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccc
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 286 (690)
..++.+.........+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++|+.|||+++....... .
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99988888777777899999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQN 366 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~ 366 (690)
|||..|||||++. .+..++|+||||+++|+|++|..||.+ +....|.+..-..|.
T Consensus 154 cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~------------------ 208 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR------------------ 208 (612)
T ss_pred ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch------------------
Confidence 9999999999996 467899999999999999999999998 788888876555554
Q ss_pred CCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCCC
Q 041720 367 PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPYA 416 (690)
Q Consensus 367 ~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~~ 416 (690)
.++..+.+++..|+..+|..|.- +.|+++|+||+.+-|.
T Consensus 209 -----------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 209 -----------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -----------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 35667999999999999999976 4789999999998775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=223.86 Aligned_cols=253 Identities=21% Similarity=0.203 Sum_probs=190.7
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC----Cceeeeeceee-ccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRLDH----PNIIKLEGVIT-SRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv~l~~~~~-~~~~~ 198 (690)
.|.+.++||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|..+.. +++..+++... . ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~--~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST--ED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC--Cc
Confidence 7999999999999999999987775 6799998765432211 147778888888863 58888888874 3 57
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-----CcEEEeecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-----GILKLGDFGLA 272 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-----~~vKL~DFGla 272 (690)
.-||||++++.++..+.... ...|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||++
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 88999999998887766444 3789999999999999999999999999999999999999765 46999999999
Q ss_pred e--eccccCcc----c---ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Q 041720 273 N--ILTSKNKQ----K---LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 273 ~--~~~~~~~~----~---~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~ 343 (690)
+ .+...... . .....||..|+++.+..+ ...+.+.|+||++.++.+|+.|..||.+........++....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 43222211 1 123559999999998876 567999999999999999999999998765433333332211
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...... ..+...+.++.++...+-..+...+|....+..
T Consensus 254 ~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 254 RKLLTD------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhhccc------------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 110000 011234566777777777788888888777654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=204.50 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=198.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC-CceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~ 199 (690)
+....|+++++||.|+||.+|+|....+|+.||||+-......+ .+..|..+.+.|.+ ..|..+..+..+ ...
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--ccc
Confidence 45678999999999999999999999999999999876554443 37789999999965 566666666555 567
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC---CcEEEeecccceecc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLANILT 276 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---~~vKL~DFGla~~~~ 276 (690)
-.||||++...+..++......|+...+.-++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||||+.+.
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 78999999988877776666789999999999999999999999999999999999999643 468999999998765
Q ss_pred ccCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCC
Q 041720 277 SKNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---VEQLHKIFKLCGSPP 347 (690)
Q Consensus 277 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~---~e~l~~I~~~~g~~~ 347 (690)
+.... .-....||..|.+--...+ ..-+...|+=|+|.+|..+..|..||+|-.. .+.+++|.+.....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 43222 1234678999998776665 3446788999999999999999999998644 445556655433333
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~ 402 (690)
+...|+++|.++.-.|..|-..--++-|...
T Consensus 245 ------------------------ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 245 ------------------------IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred ------------------------HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 3345778999999999999877777777643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=243.70 Aligned_cols=226 Identities=28% Similarity=0.388 Sum_probs=174.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
..+|..++.|..|+||.||.++|+.+.+.+|+| +++.++ +.+- ||.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 578999999999999999999999999999994 443321 1111 23333333333
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC---
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN--- 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~--- 279 (690)
|+...++ ...+.++... +.+++|||+.||+|||+||+|+||..-|++|++|||+.+......
T Consensus 136 ------gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 2222222 2222333332 788999999999999999999999999999999999987532110
Q ss_pred ---------ccc--ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 280 ---------KQK--LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 280 ---------~~~--~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
.+. -...||||.|+|||++.. +.|+..+|+|+||+|+|+.+-|..||.|.+..+++...+......++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 011 134589999999999975 67999999999999999999999999999999999988876665555
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC---CHHHHHcCccccCCCCC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG---TASSLLMCEYFTTQPYA 416 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp---Ta~elL~hp~f~~~p~~ 416 (690)
+.| .++++++++|.++|..+|..|. .+-++-+|+||+...|.
T Consensus 280 ~de--------------------------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 EDE--------------------------ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCc--------------------------CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 433 4889999999999999999994 47778899999987775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=208.26 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=196.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.-.|++.++||+|+||+++.|.+..+++.||||.-......+ ++..|....+.| ..++|...|-+-.. +..-.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~Ni 100 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNI 100 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccc--cchhh
Confidence 445999999999999999999999999999999865543333 466788888888 56888887655444 55668
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-----cEEEeecccceecc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-----ILKLGDFGLANILT 276 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-----~vKL~DFGla~~~~ 276 (690)
||||++...|.+++...+.+|+...++.++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+|+.+.
T Consensus 101 LVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 101 LVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999999988888888888999999999999999999999999999999999999996543 68999999999876
Q ss_pred ccCccc------ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHcCCCC
Q 041720 277 SKNKQK------LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR---TEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 277 ~~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~---~~~e~l~~I~~~~g~~~ 347 (690)
+..... ....-||..||+--..+| ..-+..-|+=|||-|++..|.|..||+|. +..+.+++|-......+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 544332 245678999999888877 44678899999999999999999999974 56677777744333222
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~ 402 (690)
+.+.|.++|.++...++..-..+-.+-|..+
T Consensus 260 ------------------------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 260 ------------------------IEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ------------------------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 2233456777776666666556666666643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=201.79 Aligned_cols=141 Identities=20% Similarity=0.222 Sum_probs=110.1
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHhhcCCCc
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES------------------------IRFMAREIMILRRLDHPN 184 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~iL~~L~Hpn 184 (690)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|.+|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 8999999999765321110 122346999999998877
Q ss_pred eeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHH-HhCCeEeccCCcccEEEccCCc
Q 041720 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC-HLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 185 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yL-H~~givHrDLKp~NILld~~~~ 263 (690)
+...+.+... ..+|||||++++.+.........+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7443332222 2389999999875543333456799999999999999999999 799999999999999998 478
Q ss_pred EEEeecccceec
Q 041720 264 LKLGDFGLANIL 275 (690)
Q Consensus 264 vKL~DFGla~~~ 275 (690)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=194.71 Aligned_cols=142 Identities=21% Similarity=0.275 Sum_probs=112.7
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHhhcCCCc
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP------------------------ESIRFMAREIMILRRLDHPN 184 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~iL~~L~Hpn 184 (690)
...||+|+||.||+|.+. +|+.||||+++...... .....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999976 89999999998652110 01223468999999999998
Q ss_pred eeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCc
Q 041720 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 185 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~ 263 (690)
|.....+... ..||||||++++.+.........+++.++..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7554444332 238999999987433222234568889999999999999999999 9999999999999999 889
Q ss_pred EEEeecccceecc
Q 041720 264 LKLGDFGLANILT 276 (690)
Q Consensus 264 vKL~DFGla~~~~ 276 (690)
++|+|||++..+.
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=205.36 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=152.3
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCC----------Cceeeeeceee
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH----------PNIIKLEGVIT 193 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~H----------pnIv~l~~~~~ 193 (690)
.+...+.||.|+++.||.+.+..||+.+|||+....... ...++.+.+|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 367788999999999999999999999999998765432 3456777777755555322 22333333322
Q ss_pred c---------cC-cc-----eEEEEEeccchhccccccc----CCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCC
Q 041720 194 S---------RL-SN-----TIYLVFEYMEHDLAGLSSC----HDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIK 252 (690)
Q Consensus 194 ~---------~~-~~-----~~~LV~Ey~~g~ll~~~~~----~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLK 252 (690)
- .. .. ..+++|+-+.+++...... ... .+.......+..|++..+++||..||||+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1 00 11 2367888888776543321 111 12222234455899999999999999999999
Q ss_pred cccEEEccCCcEEEeecccceeccccCcccccccccccCCCCcccccCC-------CCCCcchhhHHHHHHHHHHHhCCC
Q 041720 253 ASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS-------TNYNVSVDLWSVGCVFAELLIGKP 325 (690)
Q Consensus 253 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~~~~sDIWSlGviLyeLltG~~ 325 (690)
|+|+|++.+|.++|+||+....... .......+..|.+||..... ..++.+.|.|+||+++|.|+||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999998865432 11223446779999976331 247889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCC
Q 041720 326 ILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398 (690)
Q Consensus 326 PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kR 398 (690)
||......... + | ....|.++++.+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~-----------~--~--------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-----------E--W--------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-----------G--G--------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-----------c--c--------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99854221100 0 0 123456799999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-22 Score=226.62 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=182.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN--FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
+|...+.||.+.|=+|.+|++ ..|. |+||++-+.. ..-....+.+.|+. ...++|||++.+.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 578889999999999999975 4454 9999886543 23333444555666 666799999999887665 567789
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee--ccccCc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI--LTSKNK 280 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~--~~~~~~ 280 (690)
|-+|+.+.|.+-+.. +..+.+.+.+.|+.||+.||.-||..||+|+|||.|||||+.-.-+.|+||..-+. +..++.
T Consensus 99 vRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 999998877665544 33578888999999999999999999999999999999999999999999987653 333333
Q ss_pred ccccccccc----cCCCCcccccCCC---------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 041720 281 QKLTSRVVT----LWYRPPELLMGST---------N-YNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGS 345 (690)
Q Consensus 281 ~~~~~~~gt----~~Y~APE~l~~~~---------~-~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~ 345 (690)
..++.+..| ..|.|||.+.... . .+++.||||+||+++||++ |+|||.- .|+-........
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCcc
Confidence 344333333 3499999985421 1 5778999999999999988 7999962 222222221111
Q ss_pred CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 346 ~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.++....+ --+..++.||..|++.||.+|.+|++.|+-
T Consensus 254 ~~e~~Le~------------------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEK------------------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHh------------------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111110 113468999999999999999999999963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=196.93 Aligned_cols=174 Identities=13% Similarity=0.154 Sum_probs=132.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHH------HHHHHHHHhhcCCCceeeeeceeecc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRF------MAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~------~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
..+|+.++.||.|+||.||++.+ ++..+|||++....... ..... +.+|+..+.+|.|++|..+.+++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 56799999999999999999654 46689999997553222 22222 67999999999999999999886642
Q ss_pred C------cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 196 L------SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 196 ~------~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
. .+..+|||||++|..+.... .+++ ..+.+|+.+|..||+.||+||||||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 24579999999987554432 2333 3566999999999999999999999999999988 999999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl 321 (690)
|............ .+++ ...|+.++|+|+|||+|..+.
T Consensus 179 g~~~~~~e~~a~d-------------~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-------------RIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-------------HHHH-HhHhcccccccceeEeehHHH
Confidence 9987553221111 0233 245778999999999987664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=188.15 Aligned_cols=190 Identities=16% Similarity=0.143 Sum_probs=140.2
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.+...|++|+||+||.+.. .+..++.+.+.....- .-....+.+|+++|++|. |++|++++++ +..+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 4567899999999998753 7777887777654331 122336789999999995 5889999885 235999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccC-CcccEEEccCCcEEEeecccceeccccCcc-
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDI-KASNILVNNEGILKLGDFGLANILTSKNKQ- 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDL-Kp~NILld~~~~vKL~DFGla~~~~~~~~~- 281 (690)
|||+.|..+.... +.. ...++.|++.+|.+||++||||||| ||+|||++.++.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999987664321 111 2457899999999999999999999 799999999999999999999865432210
Q ss_pred ---c--------ccccccccCCCCcccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCC
Q 041720 282 ---K--------LTSRVVTLWYRPPELLMGSTNYN-VSVDLWSVGCVFAELLIGKPILKGRT 331 (690)
Q Consensus 282 ---~--------~~~~~gt~~Y~APE~l~~~~~~~-~~sDIWSlGviLyeLltG~~PF~~~~ 331 (690)
. ..-...++.|+.|+.-.--...+ ...++++.|+.+|.++|+..|+.+.+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00122477888887643222223 46688999999999999998886543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=197.51 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=170.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCC-----------------------------------cEEEEEEeecCCCC--
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATG-----------------------------------KMVALKKVRFDNFQ-- 163 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----------------------------------~~vAvK~i~~~~~~-- 163 (690)
+..++|++...||+|....||.++-..+| -+.|||.+-.-..+
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 45678999999999999999998644321 13567765322111
Q ss_pred -hHHHHHHHHHHH------H--------Hhh--------cCCCceeeeeceeeccC------------------------
Q 041720 164 -PESIRFMAREIM------I--------LRR--------LDHPNIIKLEGVITSRL------------------------ 196 (690)
Q Consensus 164 -~~~~~~~~~Ei~------i--------L~~--------L~HpnIv~l~~~~~~~~------------------------ 196 (690)
....+.+.+|+- + .+. -+|||||++...|.+..
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 222333333331 1 111 26999999988876521
Q ss_pred -cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE--ccCC--cEEEeeccc
Q 041720 197 -SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV--NNEG--ILKLGDFGL 271 (690)
Q Consensus 197 -~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl--d~~~--~vKL~DFGl 271 (690)
+..+|+||......+..++-.. ..+.....-++.|+++|+.|||++||.|||||.+|||| |+|+ .+.|+|||.
T Consensus 314 ~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 3568899988887666554433 35677888899999999999999999999999999998 4444 689999999
Q ss_pred ceeccccC-----cccccccccccCCCCcccccCCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 041720 272 ANILTSKN-----KQKLTSRVVTLWYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 272 a~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~-----~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~ 341 (690)
+-.-+... ....-...|.-.-||||+...... .-.+.|.|+.|.+.||++...-||.+.-+.-.--.
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--- 468 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--- 468 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---
Confidence 85422210 011123345666899998743211 12368999999999999999999987432211100
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~ 402 (690)
.+....+| .....+++.+++||..+|+.||.+|+++.
T Consensus 469 --------~Yqe~qLP----------------alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 469 --------TYQESQLP----------------ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred --------hhhhhhCC----------------CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 01111111 11235788999999999999999999953
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-20 Score=186.55 Aligned_cols=246 Identities=17% Similarity=0.238 Sum_probs=193.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+...++.++.+|.+...|..|+|++ .|..+++|++..........+.|..|.-.|+-+.||||+.+++.|.. +..+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--ppnl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNL 262 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--CCCc
Confidence 4455667788899999999999987 45568889998777777777889999999999999999999999988 6889
Q ss_pred EEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEe--eccccee
Q 041720 201 YLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLG--DFGLANI 274 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~--DFGla~~ 274 (690)
.+|..||+.+.+...+.... ..+..++..++.+|+.|+.|||+.. |.---|....|+||++.+.+|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 99999999876665544433 3677899999999999999999975 4455688889999999876654 322221
Q ss_pred ccccCcccccccccccCCCCcccccCCCCC--CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNY--NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~--~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
......-.|.||+||.|...... -.++|||||.++||||.|...||..-.+.+.-.+|--
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------- 403 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------- 403 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----------
Confidence 11234457899999999764332 2478999999999999999999999888887666521
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
++......++++..+..|+.-|+..||.+||..+.++
T Consensus 404 ----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1112223457889999999999999999999987765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=185.12 Aligned_cols=146 Identities=22% Similarity=0.218 Sum_probs=113.7
Q ss_pred CeeEEeEEeecCceEEEEEE-EcCCCcEEEEEEeecCCCC--------------------h--HHHHHHHHHHHHHhhcC
Q 041720 125 SFEKLEKIGQGTYSSVFRAR-EVATGKMVALKKVRFDNFQ--------------------P--ESIRFMAREIMILRRLD 181 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~-~~~~g~~vAvK~i~~~~~~--------------------~--~~~~~~~~Ei~iL~~L~ 181 (690)
.|.+.+.||+|+||.||+|. +..+|+.||||+++..... + .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37889999999999999998 6789999999999754321 0 01234678999999997
Q ss_pred CCceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC-eEeccCCcccEEEcc
Q 041720 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG-IMHRDIKASNILVNN 260 (690)
Q Consensus 182 HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g-ivHrDLKp~NILld~ 260 (690)
+. ++.+..++.. ...+|||||++++.+.........+.+..+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~-~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EA-GVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hc-CCCCCeeeEe---cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 2222233322 234899999999766544434445677778899999999999999999 99999999999999
Q ss_pred CCcEEEeecccceec
Q 041720 261 EGILKLGDFGLANIL 275 (690)
Q Consensus 261 ~~~vKL~DFGla~~~ 275 (690)
++.++|+|||++...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-19 Score=178.11 Aligned_cols=138 Identities=16% Similarity=0.145 Sum_probs=105.4
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-----CCCceeeeeceeeccCc-ce-
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-----DHPNIIKLEGVITSRLS-NT- 199 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~~-~~- 199 (690)
.-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.| +||||+++++++++..+ +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3456799999999995 6666665 69998764322 346789999999999 67999999999988422 34
Q ss_pred EEEEEeccc--hhcccccccCCCCCChhHHHHHHHHHHHHH-HHHHhCCeEeccCCcccEEEccC----CcEEEeecccc
Q 041720 200 IYLVFEYME--HDLAGLSSCHDIKFSEPQVKCYMRQLLHGV-EHCHLRGIMHRDIKASNILVNNE----GILKLGDFGLA 272 (690)
Q Consensus 200 ~~LV~Ey~~--g~ll~~~~~~~~~lse~~~~~i~~QIl~aL-~yLH~~givHrDLKp~NILld~~----~~vKL~DFGla 272 (690)
+.+||||++ ++.+..+... ..+++. ..++.|++.++ .|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 337899944 5566555544 346666 46688888888 99999999999999999999743 37999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-20 Score=214.94 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=209.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
...|.+.+.||+|+|+.|-...... ....+|+|.+............+..|+.+-..+. |.|++++++...+ .+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence 3458888999999999999887543 3445777777655433445556677888888887 9999999999887 7889
Q ss_pred EEEEeccchhcccccc-cCCC-CCChhHHHHHHHHHHHHHHHHH-hCCeEeccCCcccEEEccCC-cEEEeecccceecc
Q 041720 201 YLVFEYMEHDLAGLSS-CHDI-KFSEPQVKCYMRQLLHGVEHCH-LRGIMHRDIKASNILVNNEG-ILKLGDFGLANILT 276 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~-~~~~-~lse~~~~~i~~QIl~aL~yLH-~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~ 276 (690)
+++++|..++.+...+ ..+. ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999998888777666 5554 6888999999999999999999 99999999999999999999 99999999998776
Q ss_pred c--cCccccccccc-ccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 S--KNKQKLTSRVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~--~~~~~~~~~~g-t~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
. .........+| ++.|+|||.+.+.....+..|+||+|+++..+++|..|+.......... ..|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~ 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKS 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeecc
Confidence 5 22334456788 9999999999876677899999999999999999999987544333110 01111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.+. ..-...+..++..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 246 ~~~-------------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKG-------------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccc-------------ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 100 0001123468889999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=196.76 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=147.8
Q ss_pred HHHHHHHHHHhhcCCCceeeeec-------eeecc-C--cceEEEEEeccchhcccccccCCC---CCChhHHHHHHHHH
Q 041720 168 RFMAREIMILRRLDHPNIIKLEG-------VITSR-L--SNTIYLVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQL 234 (690)
Q Consensus 168 ~~~~~Ei~iL~~L~HpnIv~l~~-------~~~~~-~--~~~~~LV~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QI 234 (690)
....+++..+....|.+..-+.+ .+... . ...+||.|++|..+.+.+.+.... ..+......++.||
T Consensus 289 ~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~ 368 (516)
T KOG1033|consen 289 KYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQI 368 (516)
T ss_pred hhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhh
Confidence 34455666666665544444433 11110 0 235789999999887766664332 35667889999999
Q ss_pred HHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC-----cccccccccccCCCCcccccCCCCCCcchh
Q 041720 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN-----KQKLTSRVVTLWYRPPELLMGSTNYNVSVD 309 (690)
Q Consensus 235 l~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~sD 309 (690)
+.|++| ++.+|||+||.||++..+..+||.|||+........ ....+..+||.+||+||.+.+ ..|+.++|
T Consensus 369 ~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvd 444 (516)
T KOG1033|consen 369 APAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVD 444 (516)
T ss_pred ccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcc
Confidence 999999 999999999999999999999999999997765443 335677899999999999986 67999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHH
Q 041720 310 LWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLID 388 (690)
Q Consensus 310 IWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~ 388 (690)
|||||+|||||+. +|....+. ..+..| + .+..|+.+|. --+.-.+|+.
T Consensus 445 IyaLGlil~EL~~---~f~T~~er~~t~~d~-r-~g~ip~~~~~--------------------------d~p~e~~ll~ 493 (516)
T KOG1033|consen 445 IYALGLILAELLI---QFSTQFERIATLTDI-R-DGIIPPEFLQ--------------------------DYPEEYTLLQ 493 (516)
T ss_pred hhhHHHHHHHHHH---HhccHHHHHHhhhhh-h-cCCCChHHhh--------------------------cCcHHHHHHH
Confidence 9999999999996 22221111 111111 1 1223333332 1234569999
Q ss_pred HhhccCCCCCCCHHHHHcCccc
Q 041720 389 TCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 389 ~~L~~DP~kRpTa~elL~hp~f 410 (690)
.||...|.+||++.+.-.|+|.
T Consensus 494 ~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 494 QLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhcCCCcccCchHHHHhhhhhc
Confidence 9999999999988888777775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-18 Score=199.08 Aligned_cols=196 Identities=28% Similarity=0.328 Sum_probs=154.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccC
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD---HPNIIKLEGVITSRL 196 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~ 196 (690)
.+..+.|.+-+.||+|+||+||+|.+.. |+.||||+-+.....+ |.=-.+++.+|+ -+.|+.+...+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~-- 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVF-- 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHcc--
Confidence 3456779999999999999999999765 9999999877654221 111223444444 2345555555544
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-------CCcEEEeec
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-------EGILKLGDF 269 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-------~~~vKL~DF 269 (690)
.+..+||+||.+.|.+..+......+++..+..+..|++..|++||..+|||+||||+|+||.. .--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 5677999999998877666667778999999999999999999999999999999999999942 236999999
Q ss_pred ccceeccc-cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 041720 270 GLANILTS-KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324 (690)
Q Consensus 270 Gla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~ 324 (690)
|-+.-+.- .+...+...++|-.+-.+|+..| ..++..+|.|.|..+++.||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 99854321 22346677888999999999976 67999999999999999999995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=167.22 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=108.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHhhcCCCc-
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP--------------------ESIRFMAREIMILRRLDHPN- 184 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hpn- 184 (690)
|.+.+.||.|+||.||++.+ .+|+.||||++....... ........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 77889999999999999986 489999999987543110 01123678999999998874
Q ss_pred -eeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 185 -IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 185 -Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
++.+++ ....++||||+.+..+..... ......++.+|+.++.++|+.||+||||||+||||+.++.
T Consensus 96 ~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 344433 234589999999876544321 1456789999999999999999999999999999999999
Q ss_pred EEEeecccceeccc
Q 041720 264 LKLGDFGLANILTS 277 (690)
Q Consensus 264 vKL~DFGla~~~~~ 277 (690)
++|+|||++..+..
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=167.28 Aligned_cols=136 Identities=21% Similarity=0.252 Sum_probs=109.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE------SIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.||+|++|.||+|.+ .|..|+||+......... ....+.+|+.++..+.|++|+....++.+ ....+||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999986 777899998764432211 12457889999999999998776666655 4677899
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
|||++|..+....... .. ....++.+|+.+|.+||+.+++|+||+|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999987665544322 12 7889999999999999999999999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-17 Score=161.97 Aligned_cols=132 Identities=21% Similarity=0.224 Sum_probs=101.9
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP------ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.||+|+||.||+|. .+|..|++|+........ .....+.+|+.++..+.|+++....-++.+ ....+|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 38999999999997 467889999865433211 123567789999999988765444333333 45678999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
||++|..+........ . .++.||+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999876654432211 1 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.2e-17 Score=159.30 Aligned_cols=138 Identities=24% Similarity=0.267 Sum_probs=99.0
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHhhcCCCc--
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF----------------------MAREIMILRRLDHPN-- 184 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hpn-- 184 (690)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999875 8999999998764322111111 135666666664433
Q ss_pred eeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCc
Q 041720 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 185 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~ 263 (690)
+.+++++ ...+|||||++++............. .++..++.+++.++.+||. .+|+|+||||+|||++ ++.
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 3344332 23589999999843221111111111 6788999999999999999 9999999999999999 899
Q ss_pred EEEeecccceec
Q 041720 264 LKLGDFGLANIL 275 (690)
Q Consensus 264 vKL~DFGla~~~ 275 (690)
++|+|||++...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.9e-17 Score=177.64 Aligned_cols=203 Identities=26% Similarity=0.373 Sum_probs=153.9
Q ss_pred HhhcCCCceeeeeceeeccCcceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCe-EeccCCcc
Q 041720 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGI-MHRDIKAS 254 (690)
Q Consensus 177 L~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~gi-vHrDLKp~ 254 (690)
|+.+.|.|+.++++.+.+ +..+++|.+||..+.+.+.... ...++.-....++++|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 467899999999999998 5899999999998766655544 6678888899999999999999998865 99999999
Q ss_pred cEEEccCCcEEEeecccceecccc-CcccccccccccCCCCcccccCCC--C----CCcchhhHHHHHHHHHHHhCCCCC
Q 041720 255 NILVNNEGILKLGDFGLANILTSK-NKQKLTSRVVTLWYRPPELLMGST--N----YNVSVDLWSVGCVFAELLIGKPIL 327 (690)
Q Consensus 255 NILld~~~~vKL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~--~----~~~~sDIWSlGviLyeLltG~~PF 327 (690)
|+++|....+||+|||+....... .........-..-|.|||.+.+.. . .+.+.||||||+++||+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999776420 001111122345699999987631 1 366799999999999999999999
Q ss_pred CCCC----HHHHHHHHHHHcCC--CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH
Q 041720 328 KGRT----EVEQLHKIFKLCGS--PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401 (690)
Q Consensus 328 ~~~~----~~e~l~~I~~~~g~--~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa 401 (690)
.... ..+.+..+.. .+. +.+..|. . ..+.+++..++..|+..+|.+||++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~----------------------~-~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNPFRPSIEL----------------------L-NELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCCcCcchhh----------------------h-hhcchHHHHHHHHhcccChhhCccH
Confidence 8532 2344444433 111 1111111 0 1456689999999999999999999
Q ss_pred HHHH
Q 041720 402 SSLL 405 (690)
Q Consensus 402 ~elL 405 (690)
+.+-
T Consensus 215 ~~i~ 218 (484)
T KOG1023|consen 215 EQIR 218 (484)
T ss_pred HHHH
Confidence 9885
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=181.36 Aligned_cols=136 Identities=19% Similarity=0.180 Sum_probs=105.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ------PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
|...+.||+|+||.||++.+. +..+++|+....... ......+.+|+.+|..++|++|+..+.++.+ ...
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~ 410 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEE 410 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCC
Confidence 456789999999999999764 334455543222111 1123568899999999999999887766655 456
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+|||||++++.+..... ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 789999999876654332 457899999999999999999999999999999 678999999999965
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=141.21 Aligned_cols=132 Identities=23% Similarity=0.209 Sum_probs=109.7
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC--CceeeeeceeeccCcceEEEEEe
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH--PNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~LV~E 205 (690)
+++.||.|.++.||++... +..++||.+..... ...+.+|+.+++.+.| .++++++.++.. .+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 3578999999999999863 37899999865432 3468899999999976 588898887766 478899999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC---CeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR---GIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~---givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
|+.+..+... +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988655433 5566778899999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.2e-16 Score=169.75 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=201.5
Q ss_pred cCCeeEEeEEee--cCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 123 AESFEKLEKIGQ--GTYSSVFRARE--VATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 123 ~~~y~~~~~LG~--G~fG~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+..-..-.+|+...+.+ .|+|.++.+..+++ .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 344677888999 99999999988 78899999998443322222223345677777777 59999999888887 7
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHH----HHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLH----GVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLA 272 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~----aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla 272 (690)
+..|+-+|+|...+.........-+++..++.++.+..+ ||.++|..+++|-|+||+||++..+ ...+++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 899999999998777777666666899999999999999 9999999999999999999999999 78999999999
Q ss_pred eeccccCcccc----cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCC
Q 041720 273 NILTSKNKQKL----TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR--TEVEQLHKIFKLCGSP 346 (690)
Q Consensus 273 ~~~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~--~~~e~l~~I~~~~g~~ 346 (690)
..+...+.... ....|...|++||.+.+ -++...|||+||.++.+..++..++... +.+.++.++. .
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----i 343 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----I 343 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----C
Confidence 88765442221 22256777999998854 5789999999999999999987776654 3333333321 1
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
+. +.+...+.++...+..|+..+|..|+++..+++|+++..
T Consensus 344 p~-------------------------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 PL-------------------------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ch-------------------------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11 223456777777999999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.1e-15 Score=153.03 Aligned_cols=138 Identities=17% Similarity=0.167 Sum_probs=101.9
Q ss_pred eEEe-ecCceEEEEEEEcCCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHhhcCCCce--eeeeceeecc
Q 041720 130 EKIG-QGTYSSVFRAREVATGKMVALKKVRFDNF-----------QPESIRFMAREIMILRRLDHPNI--IKLEGVITSR 195 (690)
Q Consensus 130 ~~LG-~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~ 195 (690)
..|| .|+.|+||.+.. .+..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 889999998864 477899998864321 11233567889999999998775 6677664432
Q ss_pred Ccc--eEEEEEeccch-hcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 196 LSN--TIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 196 ~~~--~~~LV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
... ..+|||||++| ..+..+... ..+++. .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 111 23599999997 344433322 245543 3678999999999999999999999999999899999999998
Q ss_pred ee
Q 041720 273 NI 274 (690)
Q Consensus 273 ~~ 274 (690)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=7e-16 Score=178.13 Aligned_cols=270 Identities=21% Similarity=0.248 Sum_probs=206.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...+.+.+.+-+-.|.++.++.+.-..+|...++|+..... +.....+.+..+-+++-...+|-++...--+.. ...
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP 878 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSP 878 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCC
Confidence 35677889999999999999999877888778887765432 222233445555555555667877766544333 567
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc--
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-- 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~-- 277 (690)
.+||++|+.++.+.-.+...+..++.-++.++..+..+++|||...++|||++|.|+|+..+++.++.|||+......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 899999998865555555555678888888999999999999999999999999999999999999999984432110
Q ss_pred ----c------------------------CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 041720 278 ----K------------------------NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG 329 (690)
Q Consensus 278 ----~------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~ 329 (690)
. ........++|+.|.+||.+.+. ..+..+|+|++|+++++.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00011235679999999999874 567888999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH---HHHc
Q 041720 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS---SLLM 406 (690)
Q Consensus 330 ~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~---elL~ 406 (690)
.+.....+.|.......+. . ....+.++.++|..+|..+|.+|..+. ++-.
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~-----------------g---------~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~ 1091 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPE-----------------G---------PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKG 1091 (1205)
T ss_pred cchhhhhhccccCCCCCCC-----------------C---------ccccChhhhhhhhhhhccCchhccCccccccccc
Confidence 9988888777553322111 0 124788999999999999999999987 8889
Q ss_pred CccccCCCCCCCC
Q 041720 407 CEYFTTQPYACDP 419 (690)
Q Consensus 407 hp~f~~~p~~~~~ 419 (690)
|+||+...|....
T Consensus 1092 ~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1092 HPFFQDVDWENLA 1104 (1205)
T ss_pred CCccCCCCccccc
Confidence 9999998876543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-13 Score=156.00 Aligned_cols=146 Identities=21% Similarity=0.294 Sum_probs=99.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---------------------------Ch-----HHHHHH-
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---------------------------QP-----ESIRFM- 170 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------------------------~~-----~~~~~~- 170 (690)
.+|+. +.||.|++|+||+|+...+|+.||||+++.... .. +..+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 789999999999999887799999999975421 00 111223
Q ss_pred -----HHHHHHHhhc----CCCceeeeeceeeccCcceEEEEEeccchhcccccc--cCCC----CCChhHHHHHHHHHH
Q 041720 171 -----AREIMILRRL----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSS--CHDI----KFSEPQVKCYMRQLL 235 (690)
Q Consensus 171 -----~~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~--~~~~----~lse~~~~~i~~QIl 235 (690)
.+|+..+.++ .+.+.+.+-.+|.+- ....+|||||+.|..+.... ...+ .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 3344444444 244445554555442 45678999999997554321 1111 245555555566655
Q ss_pred HHHHHHHhCCeEeccCCcccEEEccCC----cEEEeecccceecccc
Q 041720 236 HGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANILTSK 278 (690)
Q Consensus 236 ~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~~~~~ 278 (690)
..|++|+|+||.|||++.++ .++++|||++..+...
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 58999999999999999888 9999999999877543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=146.50 Aligned_cols=143 Identities=22% Similarity=0.259 Sum_probs=98.1
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----------------------------H----HHH------HHH
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----------------------------E----SIR------FMA 171 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----------------------------~----~~~------~~~ 171 (690)
+.||.|++|.||+|+. .+|+.||||+.+...... . ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 589999999986542100 0 000 134
Q ss_pred HHHHHHhhc----CCCceeeeeceeeccCcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHH-HHHHHHhCC
Q 041720 172 REIMILRRL----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLH-GVEHCHLRG 245 (690)
Q Consensus 172 ~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~-aL~yLH~~g 245 (690)
+|+..+.++ .|.+-|.+-.+|.+. ....+|||||++|..+....... ..+ ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 455555555 233344444444432 34569999999987665433211 111 23456666665 468899999
Q ss_pred eEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 246 IMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 246 ivHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
++|+|+||.|||++.++.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=129.47 Aligned_cols=140 Identities=18% Similarity=0.190 Sum_probs=102.0
Q ss_pred eEEeecCceEEEEEEEcC------CCcEEEEEEeecCCC-----------C---------hHHHHHHH----HHHHHHhh
Q 041720 130 EKIGQGTYSSVFRAREVA------TGKMVALKKVRFDNF-----------Q---------PESIRFMA----REIMILRR 179 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~------~g~~vAvK~i~~~~~-----------~---------~~~~~~~~----~Ei~iL~~ 179 (690)
..||.|--+.||.|.... .+..+|||+.+.... . ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357899998754210 0 11122333 89999999
Q ss_pred cCC--CceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHH-HhCCeEeccCCcccE
Q 041720 180 LDH--PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC-HLRGIMHRDIKASNI 256 (690)
Q Consensus 180 L~H--pnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yL-H~~givHrDLKp~NI 256 (690)
|.. -++..++++. .-+|||||++++.+......+..+++.++..++.|++.+|..| |+.||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 943 4566666542 3389999998754332222333466677788899999999999 899999999999999
Q ss_pred EEccCCcEEEeecccceecc
Q 041720 257 LVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~~ 276 (690)
|++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4789999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.6e-13 Score=149.35 Aligned_cols=253 Identities=21% Similarity=0.216 Sum_probs=186.7
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 199 (690)
...+|..+..||.|.|+.|+.+... .++..|++|.+............-..|+.+...+ .|.+++..+..+.. ...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--ccc
Confidence 3567899999999999999998755 6788999998876654433333445677777776 58888887776665 466
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~~~~~ 278 (690)
.||-.|||.++...+.+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++.++ +..++.|||++..+.-
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 77999999987766655444458889999999999999999999999999999999999886 7889999999864211
Q ss_pred CcccccccccccCCC-CcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYR-PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~-APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
........-+++ ..|++.....+..+.|+++||..+++.++|.+.-...+. ...|....
T Consensus 420 ---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~-------------- 479 (524)
T KOG0601|consen 420 ---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD-------------- 479 (524)
T ss_pred ---ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--------------
Confidence 111223344455 366666667788999999999999999998755432211 11111110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
....+....++..+.+.++..|+..||.+.++..|.-|..
T Consensus 480 ---------------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 ---------------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---------------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0011234467888999999999999999999988876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-11 Score=139.07 Aligned_cols=184 Identities=23% Similarity=0.300 Sum_probs=133.2
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|.+ ...+-++.+..-.|..+.++.+|.|..++.... .......+-+..|+.|+||||+++++.++. .+.+|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEee
Confidence 444 333333333332466678889999998876543 445667788899999999999999999988 679999999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHH-hCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH-LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH-~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
.+.--. .... .+....+...+.||+.||.||| +.+++|++|.-..|+|+..|..||++|.++......+. ...
T Consensus 90 rV~Pl~--~~lk---~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~ 163 (690)
T KOG1243|consen 90 RVRPLE--TVLK---ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAK 163 (690)
T ss_pred ccccHH--HHHH---HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccc
Confidence 886411 1111 2346778888999999999997 66899999999999999999999999999865433221 111
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG 323 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG 323 (690)
...---.|..|+.+-.. .-..|.|-|||++++++.|
T Consensus 164 ~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 11112236777755321 2457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.4e-12 Score=122.40 Aligned_cols=127 Identities=17% Similarity=0.120 Sum_probs=94.5
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee-eeeceeeccCcceEEEEEecc
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII-KLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
++.|+.|.++.||+++. .+..|+||+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 46789999999999975 477899998754421 122457899999998655544 4544432 2347999999
Q ss_pred chhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCe-----EeccCCcccEEEccCCcEEEeecccce
Q 041720 208 EHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGI-----MHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 208 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~gi-----vHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
+|..+... ......++.+|+.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98654422 11123567899999999999985 9999999999999 6789999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8e-12 Score=128.93 Aligned_cols=238 Identities=20% Similarity=0.247 Sum_probs=154.7
Q ss_pred EEEEEEEcCCCcEEEEEEeecCC-----CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cceEEEEEeccchh
Q 041720 139 SVFRAREVATGKMVALKKVRFDN-----FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNTIYLVFEYMEHD 210 (690)
Q Consensus 139 ~Vy~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~LV~Ey~~g~ 210 (690)
.||++-+...|.+|+.-.+.... .+++. ...-..-|-++.|-|||+++.|+.+.. ...+.++.|||..+
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek---~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg 157 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEK---RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG 157 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHH---HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence 45666666666665543332211 11222 222234466678999999999987632 34678999999977
Q ss_pred cccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEeecccceecc---ccCcc
Q 041720 211 LAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLGDFGLANILT---SKNKQ 281 (690)
Q Consensus 211 ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~DFGla~~~~---~~~~~ 281 (690)
.+..++ .....+.+....+|+.||+.||.|||+.. |+|++|...-|++..+|-+||+--.-...-. .....
T Consensus 158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence 554433 33445888999999999999999999985 9999999999999999988886321111000 00001
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI-LKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~P-F~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+-++|.+||.-. ....+.++|||+||....+|..+..- -.+.+..+.-..|.....
T Consensus 238 Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~---------------- 300 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII---------------- 300 (458)
T ss_pred hhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee----------------
Confidence 112234568899999653 34467789999999999999876532 222222222222211110
Q ss_pred CCCCCCCCccccccccCCCCh-hHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTP-TAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~-~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+.. --+++|..||+..|..||++.++|.||.+-+.
T Consensus 301 -----------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 301 -----------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred -----------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 1111 23478999999999999999999999987653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.7e-10 Score=112.10 Aligned_cols=142 Identities=18% Similarity=0.262 Sum_probs=104.7
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC--ceeeeeceeeccC-cceEEEEEec
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP--NIIKLEGVITSRL-SNTIYLVFEY 206 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~-~~~~~LV~Ey 206 (690)
+.|+.|.++.||++.. .+|..+++|+....... .....+.+|+.+++.+.+. ++.+++.+..... .+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5689999999999975 34678999997654321 1234678999999999653 4566666654311 1356899999
Q ss_pred cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 041720 207 MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL------------------------------------------- 243 (690)
Q Consensus 207 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~------------------------------------------- 243 (690)
++|..+...... ..+++.+...++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998765544322 356777777888888888888874
Q ss_pred -------------CCeEeccCCcccEEEcc--CCcEEEeeccccee
Q 041720 244 -------------RGIMHRDIKASNILVNN--EGILKLGDFGLANI 274 (690)
Q Consensus 244 -------------~givHrDLKp~NILld~--~~~vKL~DFGla~~ 274 (690)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-09 Score=117.10 Aligned_cols=212 Identities=19% Similarity=0.285 Sum_probs=156.7
Q ss_pred eEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--CcceEEEEEeccchh--ccc
Q 041720 138 SSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSNTIYLVFEYMEHD--LAG 213 (690)
Q Consensus 138 G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~LV~Ey~~g~--ll~ 213 (690)
.+.|++....+|..|++|++.-...+ .......-+++++++.|+|||++.+++... +...++||++|.++. |..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 57899999999999999999433222 111233457889999999999999988732 246789999999863 322
Q ss_pred ccc--------------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 214 LSS--------------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 214 ~~~--------------~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
++. ..+.+.+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..++|...|+..++..+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 221 123357889999999999999999999999999999999999999899999988887765443
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHH-HHHHHHHcCCCChhhhhccCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPIL-KGRTEVEQ-LHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF-~~~~~~e~-l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. |-+.+ -.+-|.=.||.+++.|.||..-- ......+. +..|
T Consensus 448 ~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------ 490 (655)
T KOG3741|consen 448 T---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------ 490 (655)
T ss_pred C---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence 1 11222 12458999999999999995431 11111221 2222
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...++.++.++|..+...++++ -++.++|.+
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1257889999999999999987 588998865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.3e-09 Score=104.19 Aligned_cols=127 Identities=24% Similarity=0.242 Sum_probs=84.9
Q ss_pred EEEEEEEcCCCcEEEEEEeecCCC-----------------------C-hHHHHHHHHHHHHHhhcCCC--ceeeeecee
Q 041720 139 SVFRAREVATGKMVALKKVRFDNF-----------------------Q-PESIRFMAREIMILRRLDHP--NIIKLEGVI 192 (690)
Q Consensus 139 ~Vy~a~~~~~g~~vAvK~i~~~~~-----------------------~-~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~ 192 (690)
.||.|.. .+|..+|||+.+.... . ........+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899974 6788999998764311 0 01233467899999999765 566676553
Q ss_pred eccCcceEEEEEeccc--hhcccccccCCCCCChhHHHHHHHHHHHHHHH-HHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 193 TSRLSNTIYLVFEYME--HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH-CHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~--g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~y-LH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred C------CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 279999999 5444333222 23356778889999996665 579999999999999999887 9999999
Q ss_pred ccceec
Q 041720 270 GLANIL 275 (690)
Q Consensus 270 Gla~~~ 275 (690)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.8e-09 Score=104.63 Aligned_cols=131 Identities=24% Similarity=0.305 Sum_probs=94.0
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChH-----HHHHHHHHHHHHhhcCCCc--eeeeeceeeccCcceEE
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPE-----SIRFMAREIMILRRLDHPN--IIKLEGVITSRLSNTIY 201 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~-----~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~~~ 201 (690)
..|++|+-+.||.+.. -|..+++|.=..... .++ ......+|+.+|.++.--. +..++++. .....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD----~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD----PDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc----CCCCE
Confidence 3578999999999854 455577775433322 122 2334678999999885433 33444433 45668
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
|+|||++|.++...+... ...++..|=.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998877544332 255677777888889999999999999999998755 99999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.2e-09 Score=101.63 Aligned_cols=143 Identities=20% Similarity=0.277 Sum_probs=98.8
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-h-----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-P-----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.+..|-+|+-+.|+++. ..|+...||.-...... + -..++..+|+.+|.++.--.|.-..=++.| ...-+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCe
Confidence 67789999999999995 57888888854333221 1 234567889999999853333221112333 23447
Q ss_pred EEEeccch--hcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeeccccee
Q 041720 202 LVFEYMEH--DLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANI 274 (690)
Q Consensus 202 LV~Ey~~g--~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~~ 274 (690)
|+|||++| ...+.+... ...........++++|=+.+.-||.++|||+||..+||||..++ .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 89999988 333333222 22233334478999999999999999999999999999997665 468999999854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.9e-10 Score=125.62 Aligned_cols=156 Identities=19% Similarity=0.273 Sum_probs=113.9
Q ss_pred HHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccccCccccc--------ccccccCCCCcccccCCCC
Q 041720 233 QLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT--------SRVVTLWYRPPELLMGSTN 303 (690)
Q Consensus 233 QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~--------~~~gt~~Y~APE~l~~~~~ 303 (690)
+++.||.|+|.. ++||++|.|++|.++.++.+||+.|+.+............ ...-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999975 8999999999999999999999999998654432111110 1122556999999976 66
Q ss_pred CCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChh
Q 041720 304 YNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPT 382 (690)
Q Consensus 304 ~~~~sDIWSlGviLyeLl-tG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~ 382 (690)
.+.++|+|||||++|.+. .|+..|.+.........-....+... ......++++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~-------------------------~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA-------------------------FGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc-------------------------ccccccCcHH
Confidence 789999999999999999 56666665433332222111111000 0111478999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 383 AVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 383 l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
+++=|.++|..|+..||++.+++..+||....
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.4e-08 Score=100.31 Aligned_cols=137 Identities=28% Similarity=0.248 Sum_probs=103.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC--------------------ChHHHHHHHHHHHHHhhcCCC--
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--------------------QPESIRFMAREIMILRRLDHP-- 183 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--------------------~~~~~~~~~~Ei~iL~~L~Hp-- 183 (690)
+.+..+||-|--|.||.|.+ ..|..+|||.-+.... ..-......+|..+|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678899999999999985 5788999997543211 011234467899999999654
Q ss_pred ceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 184 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
.|.+.+++ +.-.+||||++|-.+.... +.......++..|++-+.-+-..||||+||.+-|||++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 67777664 4458999999995554332 245566667777777777666899999999999999999999
Q ss_pred EEEeeccccee
Q 041720 264 LKLGDFGLANI 274 (690)
Q Consensus 264 vKL~DFGla~~ 274 (690)
+.|+||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.2e-08 Score=100.09 Aligned_cols=131 Identities=18% Similarity=0.146 Sum_probs=88.5
Q ss_pred EEEEEEcCCCcEEEEEEeecCCCChHHHH----------HHHHHHHHHhhcCCCce--eeeeceeeccC---cceEEEEE
Q 041720 140 VFRAREVATGKMVALKKVRFDNFQPESIR----------FMAREIMILRRLDHPNI--IKLEGVITSRL---SNTIYLVF 204 (690)
Q Consensus 140 Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~----------~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~---~~~~~LV~ 204 (690)
|+++. -.|+.|.||........ +..+ .+.+|...+..|..-+| +.++.+.+... ...-+|||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 55553 35678999976433211 1111 36788888888743332 23333443211 23568999
Q ss_pred eccchh-cccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-------CCcEEEeecccce
Q 041720 205 EYMEHD-LAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-------EGILKLGDFGLAN 273 (690)
Q Consensus 205 Ey~~g~-ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-------~~~vKL~DFGla~ 273 (690)
|++++. .+..+... ....++.....++.+|+..+.-||..||+|+||++.||||+. +..+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999984 33333221 234566778899999999999999999999999999999975 4689999999885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.1e-07 Score=95.26 Aligned_cols=252 Identities=16% Similarity=0.117 Sum_probs=154.2
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece-----eeccCcceE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV-----ITSRLSNTI 200 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~-----~~~~~~~~~ 200 (690)
...+.||+|+-+.+|-.-. -+. .+.|++....- .... +.+..|... .||-+-.-+.+ +-.+.+..+
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Ppp--a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPP--AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCc--hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3456799999999997632 222 34577764321 1111 122334333 56644331111 111113347
Q ss_pred EEEEeccchh--ccccc-----ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 201 YLVFEYMEHD--LAGLS-----SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 201 ~LV~Ey~~g~--ll~~~-----~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
-+.|..+.+- ....+ ...-..+.++.+.++.+.|+.+.+.||..|.+-+|+.++|+|+++++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7888888763 11111 1122236778899999999999999999999999999999999999999999865544
Q ss_pred eccccCcccccccccccCCCCccccc-C---CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCC-------HHHHHHHHHH
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLM-G---STNYNVSVDLWSVGCVFAELLIG-KPILKGRT-------EVEQLHKIFK 341 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~-~---~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~-------~~e~l~~I~~ 341 (690)
+. .+.......+|...|.+||.-. + .-.-+...|.|.|||++|+||.| +.||.|-. ..| ..|-.
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~ 241 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIAH 241 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhhc
Confidence 33 2344566788999999999653 1 11235678999999999999987 99998731 111 01111
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhcc--CCCCCCCHHH
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI--EPYKRGTASS 403 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~--DP~kRpTa~e 403 (690)
..+....+ ....+.+... .--+.-+++++..|..+|+.. ++.-|||++.
T Consensus 242 g~f~ya~~--------~~~g~~p~P~-----~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASD--------QRRGLKPPPR-----SIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechh--------ccCCCCCCCC-----CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11100000 0001111000 011235788899999999875 4678999765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.8e-07 Score=91.94 Aligned_cols=140 Identities=19% Similarity=0.260 Sum_probs=100.0
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC--------------------hHHH--HHHHHHHHHHhhcC--CCc
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--------------------PESI--RFMAREIMILRRLD--HPN 184 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--------------------~~~~--~~~~~Ei~iL~~L~--Hpn 184 (690)
...|..|--+.||+|. ..++..||||+.+..... .... .-..+|+.-|+++. +=.
T Consensus 53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3467788888999997 367889999998653211 1111 11346788888873 444
Q ss_pred eeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCc
Q 041720 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 185 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~ 263 (690)
+.+.+.+... .|||||++....-.-...+..+...++..+..++++.+.-|-. .++||+||..-|||+. ++.
T Consensus 132 vP~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFRNN------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeecCC------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 5555555433 7999999875322222233344555788899999999988876 8999999999999999 889
Q ss_pred EEEeecccceecc
Q 041720 264 LKLGDFGLANILT 276 (690)
Q Consensus 264 vKL~DFGla~~~~ 276 (690)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999986554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.8e-07 Score=92.81 Aligned_cols=107 Identities=22% Similarity=0.169 Sum_probs=78.8
Q ss_pred HHHHHHHHHHhhcCCCc--eeeeeceeeccC--cceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHH
Q 041720 168 RFMAREIMILRRLDHPN--IIKLEGVITSRL--SNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242 (690)
Q Consensus 168 ~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~--~~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH 242 (690)
....+|...+..|..-. +...+.+.+... ....+||+|++++. .+..+......++......++.+|+..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34677888777774322 334444444321 13458999999874 34444333223677788999999999999999
Q ss_pred hCCeEeccCCcccEEEccCC---cEEEeeccccee
Q 041720 243 LRGIMHRDIKASNILVNNEG---ILKLGDFGLANI 274 (690)
Q Consensus 243 ~~givHrDLKp~NILld~~~---~vKL~DFGla~~ 274 (690)
.+||+|+||++.|||++.++ .+.|+||+.++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998865
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.8e-08 Score=108.58 Aligned_cols=246 Identities=19% Similarity=0.194 Sum_probs=170.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc-eeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN-IIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~~~LV 203 (690)
-|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++. +...+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc--ccccchh
Confidence 3566677999999999999876666555 6666432 22445788999999999 5555554443 6788999
Q ss_pred Eeccchh--cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 204 FEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 204 ~Ey~~g~--ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|+++.++ ...........|-+.+...+.+.-+.+|++||+--=+||| |||..+ +..|+.||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999976 3333333344466667777788888999999998779999 887765 778999999997765432
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
...+..+++.++|||+... ..+....|.|++|+--.+|--|-+|-... ...+..+ +..+ .
T Consensus 386 ~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~----g~~p----------~--- 445 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMI----GNGP----------N--- 445 (829)
T ss_pred ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCC----CCCC----------C---
Confidence 4456788999999998865 56788899999998777777787775541 0000000 0000 0
Q ss_pred CCCCCCCccccccccCCCCh-hHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTP-TAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~-~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+.... ..++ .-.++...||..-|..|++..+++-|.+|.+-|.
T Consensus 446 -------s~~L~~~~-aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 446 -------SPMLTDKS-AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred -------ccccchhh-hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 00000000 0011 1125788899999999999999999999988553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=99.01 Aligned_cols=145 Identities=21% Similarity=0.228 Sum_probs=89.8
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---------------------------Ch-HH----HH------HHH
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---------------------------QP-ES----IR------FMA 171 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------------------------~~-~~----~~------~~~ 171 (690)
+.|+.++-|.||+|+. .+|+.||||+.+.+-. .. .. .+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5799999999999985 5699999999875321 00 00 11 133
Q ss_pred HHHHHHhhc----CCCceeeeeceeeccCcceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCe
Q 041720 172 REIMILRRL----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246 (690)
Q Consensus 172 ~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~gi 246 (690)
+|...+.++ +...-+.+=.+|.+. ...-.|+|||+.|--+.... .....++...+.....++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 455555554 222223333334332 45668999999985443332 1222344333322222221 233334799
Q ss_pred EeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 247 MHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 247 vHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|.|.+|.||+++.+|.+.+.|||+...+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.6e-06 Score=82.03 Aligned_cols=141 Identities=18% Similarity=0.236 Sum_probs=90.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH-HHH------HHHHHHHHHhhc---CCCceeeeecee
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE-SIR------FMAREIMILRRL---DHPNIIKLEGVI 192 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~------~~~~Ei~iL~~L---~HpnIv~l~~~~ 192 (690)
..+|..++.+-......|.+.. -+|..+++|..+......+ ... ...+++..+..+ ..-.++.++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4568889999888888887764 4678899998765432111 111 122344444444 223333333333
Q ss_pred ecc---CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 193 TSR---LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 193 ~~~---~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
+.. -....+|||||++|-.+..... +++ .+...|.++|.-||+.|++|+|++|.|+++++++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 221 1245578999999965543321 222 2446677889999999999999999999998655 999999
Q ss_pred cccee
Q 041720 270 GLANI 274 (690)
Q Consensus 270 Gla~~ 274 (690)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.4e-06 Score=82.14 Aligned_cols=139 Identities=17% Similarity=0.192 Sum_probs=95.9
Q ss_pred eecCceEEEEEEEcCCCcEEEEEEeecC---CCC-hHHHHHHHHHHHHHhhcCCCc--eeeeeceee---ccCcceEEEE
Q 041720 133 GQGTYSSVFRAREVATGKMVALKKVRFD---NFQ-PESIRFMAREIMILRRLDHPN--IIKLEGVIT---SRLSNTIYLV 203 (690)
Q Consensus 133 G~G~fG~Vy~a~~~~~g~~vAvK~i~~~---~~~-~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~---~~~~~~~~LV 203 (690)
|+||-+.|++... .|..+=||.-... ... +.....+.+|+..|..|..-+ +.+++ ++. ....-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6789999998753 4446778865311 111 334456889999999985322 34443 222 1112346899
Q ss_pred Eeccch--hcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc--EEEeeccccee
Q 041720 204 FEYMEH--DLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI--LKLGDFGLANI 274 (690)
Q Consensus 204 ~Ey~~g--~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~--vKL~DFGla~~ 274 (690)
+|-+++ ++...+... -.+.++.....++.+|+..|.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998885 332222221 224677778899999999999999999999999999999987776 99999987754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=78.74 Aligned_cols=140 Identities=21% Similarity=0.272 Sum_probs=79.9
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC--ceeeeeceeec-cCcceEEEEEe
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP--NIIKLEGVITS-RLSNTIYLVFE 205 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~-~~~~~~~LV~E 205 (690)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|... .+.+++..... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5689999999999997533 48999997533 4556788999999888433 34566653322 11345799999
Q ss_pred ccchhcccc--------------------cccC---CCCCChhH---------HHHH------------HHHHHH-HHHH
Q 041720 206 YMEHDLAGL--------------------SSCH---DIKFSEPQ---------VKCY------------MRQLLH-GVEH 240 (690)
Q Consensus 206 y~~g~ll~~--------------------~~~~---~~~lse~~---------~~~i------------~~QIl~-aL~y 240 (690)
+++|..+.. +... ...+.... .... +..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998754333 0000 00000000 0000 011112 2233
Q ss_pred HH-------hCCeEeccCCcccEEEc-cCCcEEEeeccccee
Q 041720 241 CH-------LRGIMHRDIKASNILVN-NEGILKLGDFGLANI 274 (690)
Q Consensus 241 LH-------~~givHrDLKp~NILld-~~~~vKL~DFGla~~ 274 (690)
++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33 24599999999999999 666678999998743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=82.10 Aligned_cols=133 Identities=12% Similarity=0.081 Sum_probs=80.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc--eeeeeceeeccCcceEEEEEecc
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN--IIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
..||.|..+.||+. .+..+++|...... . ...+.+|.++++.+..-. +.+.+++..+ .+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57899999999984 24567888876432 2 234688999999885433 3566666655 56678999999
Q ss_pred chhc-ccccc--------------------cCCC---CCChhHH-HHHHHH----------HHHH-HHHHH----hCCeE
Q 041720 208 EHDL-AGLSS--------------------CHDI---KFSEPQV-KCYMRQ----------LLHG-VEHCH----LRGIM 247 (690)
Q Consensus 208 ~g~l-l~~~~--------------------~~~~---~lse~~~-~~i~~Q----------Il~a-L~yLH----~~giv 247 (690)
+|.. ..... .+.. ....... ..+..+ +... ..+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9852 11000 0000 0110100 011000 1111 12222 12478
Q ss_pred eccCCcccEEEccCCcEEEeecccce
Q 041720 248 HRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 248 HrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
|+|+.|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.4e-07 Score=111.44 Aligned_cols=259 Identities=13% Similarity=-0.051 Sum_probs=170.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEee---cCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR---FDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~---~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.+.+.+++.--+|-|.++.--.-+.+.++ +.+|+.+ ...+.+...+.+..|...++...|+++...+.-+.....
T Consensus 1226 s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1226 SAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred HHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 34566777666666665443222222222 3444443 333334445666777777888899999988877776667
Q ss_pred ceEEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCC-----eEeccCCcccEEEccCCcEEEee
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRG-----IMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~g-----ivHrDLKp~NILld~~~~vKL~D 268 (690)
...|.+++|+.+|.+...+.+ ...+.+.-+.....+.+.+..-+|+.. .+|++||+-|.+|..+.++|+++
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 788999999998765544332 223444455555555577777777542 89999999999999999999999
Q ss_pred cccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 269 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
+|+.++.. .........++++.|+.|++.. ...++.++|+|..|+.+|++..|.++|. ..++.+++..-...
T Consensus 1384 ~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiidn~- 1455 (2724)
T KOG1826|consen 1384 GGLDKIKN-PVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIIDNH- 1455 (2724)
T ss_pred cccccccC-chHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCccccc-
Confidence 99998433 2334456677889999999764 4567888999999999999999988875 33433333211110
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.. .....-.|.++-..+..+|-+.-..||.-...+.-+.|.
T Consensus 1456 -----------tf-----------~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1456 -----------TF-----------FSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred -----------cc-----------ccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 00 001112344555566666667777888888888776663
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.8e-05 Score=78.98 Aligned_cols=73 Identities=16% Similarity=0.134 Sum_probs=48.7
Q ss_pred EEeecCc-eEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTY-SSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~f-G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.|-.|.+ ..||+... .+..+.||+..... ...+.+|+.+++.+. +--+.+++++... .+..+||||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3455555 78999853 34678888875432 234678999988884 3345566766654 356789999998
Q ss_pred hhcc
Q 041720 209 HDLA 212 (690)
Q Consensus 209 g~ll 212 (690)
|..+
T Consensus 76 G~~l 79 (244)
T cd05150 76 GVPA 79 (244)
T ss_pred CccH
Confidence 8543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.5e-05 Score=93.28 Aligned_cols=207 Identities=19% Similarity=0.185 Sum_probs=139.9
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeceeeccCcce--EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC
Q 041720 167 IRFMAREIMILRRLDHPNIIKLEGVITSRLSNT--IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244 (690)
Q Consensus 167 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~--~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~ 244 (690)
.....-|+..+.++.|+|++.++.|-..+.... +.+.-|+|....+......-+..+...++.+..++++||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344556777888889999999988765432221 223446676665655666666789999999999999999999999
Q ss_pred CeEeccCCcc---cEEEccCCcEEEe--ecccceeccccCcccccccccccCCCCcccccCCCCCCc--chhhHHHHHHH
Q 041720 245 GIMHRDIKAS---NILVNNEGILKLG--DFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV--SVDLWSVGCVF 317 (690)
Q Consensus 245 givHrDLKp~---NILld~~~~vKL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~--~sDIWSlGviL 317 (690)
.+.|.-|... +-..+.++.+.+. ||+....+.... ......-...|.+||.+.. ..+.. ..|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence 7666655555 4444556667777 998887665432 2222344566888887753 33333 36999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC
Q 041720 318 AELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397 (690)
Q Consensus 318 yeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k 397 (690)
..+..|..+-.- ...+.. +.+ ........+++.+|+.-|+++
T Consensus 383 ~~~~~~~~i~~~------~~~~~~--------~l~------------------------~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEK------SAVPVS--------LLD------------------------VLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccc------ccchhh--------hhc------------------------cccchhhhhhhhhhcchhhhh
Confidence 999887543211 000000 000 011126788999999999999
Q ss_pred CCCHHHHHcCccccCCC
Q 041720 398 RGTASSLLMCEYFTTQP 414 (690)
Q Consensus 398 RpTa~elL~hp~f~~~p 414 (690)
|+.+.++|.|+|.....
T Consensus 425 Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFPT 441 (1351)
T ss_pred ccchhhhhhchhccccc
Confidence 99999999999997543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.6e-05 Score=91.48 Aligned_cols=83 Identities=25% Similarity=0.390 Sum_probs=57.6
Q ss_pred EEeEEeecCceEEEEEEEcCCC--cEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCce--eeeeceeecc-CcceEE
Q 041720 128 KLEKIGQGTYSSVFRAREVATG--KMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNI--IKLEGVITSR-LSNTIY 201 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~~-~~~~~~ 201 (690)
.+..|+.|.+..+|+......+ ..+++|+........ ....+.+|+.+|+.|. |.+| .+++.++.+. ..+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3677899999999998754332 467888765432211 2246789999999995 6665 6777777652 124678
Q ss_pred EEEeccchhc
Q 041720 202 LVFEYMEHDL 211 (690)
Q Consensus 202 LV~Ey~~g~l 211 (690)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999853
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.3e-05 Score=74.80 Aligned_cols=130 Identities=21% Similarity=0.211 Sum_probs=90.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee-eeeceeeccCcceEEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII-KLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~~~LV~ 204 (690)
.+..+.||+|++|.||+|.+ .|..+|+|+-+.+. ....+..|+++|..+.--++. ++|.+-. .++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech------hhhhh
Confidence 35567799999999999975 56689999877554 235688999999999876665 4444332 35669
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCC-cccEEEccCCcEEEeeccccee
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIK-ASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLK-p~NILld~~~~vKL~DFGla~~ 274 (690)
||+.|-.+....... -.+-+..+++.---|-..||-|..|. |..++|.+++.+.|+||.-|++
T Consensus 92 e~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 999985443322110 13344556666566778899999985 4444555555999999999974
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.8e-05 Score=86.17 Aligned_cols=145 Identities=21% Similarity=0.187 Sum_probs=88.6
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-----------------------------hHHHHH------HHHHH
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-----------------------------PESIRF------MAREI 174 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-----------------------------~~~~~~------~~~Ei 174 (690)
+.||.-+.|.||+|+. .+|+.||||+-+.+-.. .+..+. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5699999999999985 45999999987643210 111122 22333
Q ss_pred HHH----hhcCCCc---eeeeeceeeccCcceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCe
Q 041720 175 MIL----RRLDHPN---IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGI 246 (690)
Q Consensus 175 ~iL----~~L~Hpn---Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~gi 246 (690)
+-. +.+.|-+ -|.+=.+|.+- .....|+||||+|.-+.+.. .....++...+...+.++..-+ |-..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCC
Confidence 322 2234555 22233333331 45679999999985333221 1222355554444443333222 334689
Q ss_pred EeccCCcccEEEcc----CCcEEEeecccceecccc
Q 041720 247 MHRDIKASNILVNN----EGILKLGDFGLANILTSK 278 (690)
Q Consensus 247 vHrDLKp~NILld~----~~~vKL~DFGla~~~~~~ 278 (690)
+|+|-+|.|||+.. ++.+.|-|||+...+...
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999984 568999999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00031 Score=70.11 Aligned_cols=129 Identities=26% Similarity=0.342 Sum_probs=89.8
Q ss_pred CCeeEEeEEeecCc-eEEEEEEEcCCCcEEEEEEeec---CC-------CCh---------HHHHHHHHHHHHHhhc---
Q 041720 124 ESFEKLEKIGQGTY-SSVFRAREVATGKMVALKKVRF---DN-------FQP---------ESIRFMAREIMILRRL--- 180 (690)
Q Consensus 124 ~~y~~~~~LG~G~f-G~Vy~a~~~~~g~~vAvK~i~~---~~-------~~~---------~~~~~~~~Ei~iL~~L--- 180 (690)
.+++.++.||.|.- |.||+++ -.|+.+|||+... .. ... ....-|..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 9999996 4788999999322 11 000 1123466777776666
Q ss_pred CCCce--eeeeceeecc----------------CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHH
Q 041720 181 DHPNI--IKLEGVITSR----------------LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242 (690)
Q Consensus 181 ~HpnI--v~l~~~~~~~----------------~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH 242 (690)
.+.++ |+++||..=. ......||.||+.... .+ ...-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence 45566 8999886211 0122357788776533 12 2334667888889999
Q ss_pred hCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 243 LRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 243 ~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3479999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00017 Score=73.93 Aligned_cols=29 Identities=28% Similarity=0.438 Sum_probs=25.4
Q ss_pred CeEeccCCcccEEEccCCcEEEeecccce
Q 041720 245 GIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 245 givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999877666799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00015 Score=72.55 Aligned_cols=130 Identities=20% Similarity=0.180 Sum_probs=87.4
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHhhcC------CCceeee
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDN--------------FQPESIRFMAREIMILRRLD------HPNIIKL 188 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIv~l 188 (690)
...||+|+.=.||.- ......+||++.... ......++..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356999999999974 445568899987665 11123455667776666665 8899999
Q ss_pred eceeeccCcceEEEEEeccchhc------ccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC
Q 041720 189 EGVITSRLSNTIYLVFEYMEHDL------AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG 262 (690)
Q Consensus 189 ~~~~~~~~~~~~~LV~Ey~~g~l------l~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~ 262 (690)
+|+.++ +..+-+|+|.+.... +..+. ....+++ .+...+-+-..||-+.+|+.+||+|.||++....
T Consensus 83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEec--CCceEEEEEEEECCCCCcCccHHHHH-HcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999988 566789999876421 22222 2223444 2333333445688899999999999999995432
Q ss_pred ----cEEEee
Q 041720 263 ----ILKLGD 268 (690)
Q Consensus 263 ----~vKL~D 268 (690)
.+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00018 Score=71.38 Aligned_cols=99 Identities=23% Similarity=0.177 Sum_probs=78.9
Q ss_pred HHHHHHHhhcCC-CceeeeeceeeccCcceEEEEEeccchhccc-c--cccCCCCCChhHHHHHHHHHHHHHHHHHh---
Q 041720 171 AREIMILRRLDH-PNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-L--SSCHDIKFSEPQVKCYMRQLLHGVEHCHL--- 243 (690)
Q Consensus 171 ~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~-~--~~~~~~~lse~~~~~i~~QIl~aL~yLH~--- 243 (690)
..|..+|+.+.+ +++++++|.|-. ++|.||...+.+. . ....-...++..+.+|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999976 699999999854 6788999864332 1 01111246889999999999999999987
Q ss_pred CCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 244 RGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
..+.-.|++|+|+-|++++.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35888999999999999999999999988654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00067 Score=69.18 Aligned_cols=73 Identities=18% Similarity=0.233 Sum_probs=45.8
Q ss_pred EeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc-eeeeeceeeccCcceEEEEEec
Q 041720 129 LEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN-IIKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~~~LV~Ey 206 (690)
++.|..|-...||++.... .+..|++|+..... ...-...+|+.++..+.... ..+++.... + .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEe
Confidence 4568888888999986432 35678899765321 11122357888888885433 344444332 1 379999
Q ss_pred cchh
Q 041720 207 MEHD 210 (690)
Q Consensus 207 ~~g~ 210 (690)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 8874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00015 Score=76.28 Aligned_cols=135 Identities=18% Similarity=0.168 Sum_probs=94.1
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHhhcC-CC-
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP--------------------ESIRFMAREIMILRRLD-HP- 183 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~iL~~L~-Hp- 183 (690)
+.+.+.||-|--+.||.+-+ ..|.+.++|+-+.....- -..-...+|+..|+.|. |.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67788999999999999974 678899999654322110 01112457888999884 32
Q ss_pred ceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 184 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
-|.+.+++ +.-++|||++.|-.+..... ...+..+...++.-+.-|-.+|+||+|+.-=||+|++++.
T Consensus 173 pVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 34455553 45589999998854433221 1223445555666667788899999999999999999999
Q ss_pred EEEeecccce
Q 041720 264 LKLGDFGLAN 273 (690)
Q Consensus 264 vKL~DFGla~ 273 (690)
++++||--..
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999996543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=70.79 Aligned_cols=142 Identities=20% Similarity=0.248 Sum_probs=101.3
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC----------------------ChHHHHH--HHHHHHHHhhcCCC
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----------------------QPESIRF--MAREIMILRRLDHP 183 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----------------------~~~~~~~--~~~Ei~iL~~L~Hp 183 (690)
+-..|..|--+.||.+. ..+|..+|||+++..-+ ++..+-. ...|+.-|.+|...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34457889999999997 57888899998753211 1222212 24677788888655
Q ss_pred ceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHH-HhCCeEeccCCcccEEEccCC
Q 041720 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC-HLRGIMHRDIKASNILVNNEG 262 (690)
Q Consensus 184 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yL-H~~givHrDLKp~NILld~~~ 262 (690)
.|.-..-+.. ..-+|||+|++.+-.-.-...+..++...+..+-.|++.-|.-| |..++||.||.--|+|+- +|
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 5432222222 22379999999755544455566788889999999999999877 567999999999999985 58
Q ss_pred cEEEeecccceec
Q 041720 263 ILKLGDFGLANIL 275 (690)
Q Consensus 263 ~vKL~DFGla~~~ 275 (690)
.+.|+|-+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999999887543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00079 Score=69.87 Aligned_cols=132 Identities=23% Similarity=0.243 Sum_probs=74.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceEEEEEeccchh
Q 041720 132 IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 132 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
+..|-...+|+.. .++..+++|......... . -...+|..+|+.+....+ .+++.... -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 4567778899886 456678888754321110 0 124678889988854333 33333321 26899999985
Q ss_pred cccccc----------------cCC-----CCCCh-hHHHHHHHHH---------HHHHHHHHh--------CCeEeccC
Q 041720 211 LAGLSS----------------CHD-----IKFSE-PQVKCYMRQL---------LHGVEHCHL--------RGIMHRDI 251 (690)
Q Consensus 211 ll~~~~----------------~~~-----~~lse-~~~~~i~~QI---------l~aL~yLH~--------~givHrDL 251 (690)
.+.... .+. ..++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 432110 000 01111 1122222122 111222211 24899999
Q ss_pred CcccEEEccCCcEEEeeccccee
Q 041720 252 KASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 252 Kp~NILld~~~~vKL~DFGla~~ 274 (690)
.|.|||++.++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0039 Score=66.48 Aligned_cols=79 Identities=16% Similarity=0.166 Sum_probs=54.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC---Cceeeeeceeecc-CcceEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH---PNIIKLEGVITSR-LSNTIY 201 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~~-~~~~~~ 201 (690)
....+.||.|..+.||+... .++ .+.+|..+. ... ...+..|...|+.|.- -.+.++++++.+. ..+..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD-SQG-NPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEc-CCC-CEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567799999999999853 334 467777432 111 1468899999998843 3567778776542 135689
Q ss_pred EEEeccchh
Q 041720 202 LVFEYMEHD 210 (690)
Q Consensus 202 LV~Ey~~g~ 210 (690)
||||++++.
T Consensus 90 LVmE~i~G~ 98 (297)
T PRK10593 90 LLLERLRGV 98 (297)
T ss_pred EEEeccCCE
Confidence 999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0024 Score=68.19 Aligned_cols=142 Identities=17% Similarity=0.172 Sum_probs=81.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc--eeeeeceee----ccCcce
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN--IIKLEGVIT----SRLSNT 199 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~----~~~~~~ 199 (690)
...+..|+.|....||++.. .+| .+++|+..... .. ..+..|+.++..|.... +.+++.... ....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34466788888889999863 344 58889875422 12 23556777777774222 334433211 111456
Q ss_pred EEEEEeccchhcccc---------------cccCCCCCCh-------hHHH----------------HHHHHHHHHHHHH
Q 041720 200 IYLVFEYMEHDLAGL---------------SSCHDIKFSE-------PQVK----------------CYMRQLLHGVEHC 241 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~---------------~~~~~~~lse-------~~~~----------------~i~~QIl~aL~yL 241 (690)
.++||||++|..... +......++. ...+ .....+...+.++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 789999988743210 0000000100 0000 0011223345555
Q ss_pred Hh-------CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 242 HL-------RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 242 H~-------~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 32 579999999999999988877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.004 Score=68.82 Aligned_cols=77 Identities=21% Similarity=0.177 Sum_probs=52.6
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecC-----CCChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccCcceE
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFD-----NFQPESIRFMAREIMILRRLD---HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~-----~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~ 200 (690)
.+.||.|.+..||++.....++.|+||.-... ..-+-...+...|.+.|+.+. -.++.+++.+- ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 46799999999999987543358999985321 101223456677888888862 34567777653 3457
Q ss_pred EEEEeccch
Q 041720 201 YLVFEYMEH 209 (690)
Q Consensus 201 ~LV~Ey~~g 209 (690)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0009 Score=74.34 Aligned_cols=171 Identities=22% Similarity=0.313 Sum_probs=112.2
Q ss_pred HHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEec
Q 041720 170 MAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHR 249 (690)
Q Consensus 170 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHr 249 (690)
+.--..+++.+.|+|+...+++.... .....+|||++..++.+...... +-.. +++ .+++.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~----------s~~----~~~~~~~ 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE----------SLL----AHGVLHL 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh----------hhc----cccccee
Confidence 55567899999999999999887764 45689999999876655443322 1100 011 2222222
Q ss_pred cCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 041720 250 DIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG 329 (690)
Q Consensus 250 DLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~ 329 (690)
| .++++| -++ + . | |- ..++++|||++|.++.++.-|...+..
T Consensus 92 -----~-------~~~~td-~~~-----------t-~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFL-----------T-K-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----h-------hhhccc-ccc-----------c-c-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 2 233333 111 0 0 0 11 112489999999999999999999998
Q ss_pred CCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 330 ~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.+..+++..|.+....+.+..-. .+........+....++...|+-..|..||...+++.++-
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLST-----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHH-----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 88889888887765444322100 0011112345667889999999999999999999999988
Q ss_pred ccC
Q 041720 410 FTT 412 (690)
Q Consensus 410 f~~ 412 (690)
|..
T Consensus 197 ~~e 199 (725)
T KOG1093|consen 197 FTE 199 (725)
T ss_pred HHH
Confidence 876
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0025 Score=67.70 Aligned_cols=73 Identities=22% Similarity=0.301 Sum_probs=44.9
Q ss_pred EeEEeecCceEEEEEEEcC------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceEE
Q 041720 129 LEKIGQGTYSSVFRAREVA------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTIY 201 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~ 201 (690)
++.|..|--..||++.... .++.+++|+..... .......+|+.++..+....+ .+++.++.+ .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 3456667777899886432 25789999965432 112345678888888853333 345544432 3
Q ss_pred EEEeccchh
Q 041720 202 LVFEYMEHD 210 (690)
Q Consensus 202 LV~Ey~~g~ 210 (690)
+|+||++|.
T Consensus 74 ~v~e~i~G~ 82 (302)
T cd05156 74 RIEEFIPSR 82 (302)
T ss_pred chhheeCCC
Confidence 588988874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0074 Score=63.84 Aligned_cols=140 Identities=14% Similarity=0.125 Sum_probs=81.9
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc--eeeeeceeec----cCcceE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN--IIKLEGVITS----RLSNTI 200 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~----~~~~~~ 200 (690)
.-++.|..|....+|+... ++..+++|+.... . ...+..|+.++..|.+.. +.+++..... ...+..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3356788888889999853 3446899987531 1 234667888888884332 4444332110 113566
Q ss_pred EEEEeccchhcccccc---------------cCCCCCChh-------H-----H--------HHHHHHHHHHHHHHHh--
Q 041720 201 YLVFEYMEHDLAGLSS---------------CHDIKFSEP-------Q-----V--------KCYMRQLLHGVEHCHL-- 243 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~---------------~~~~~lse~-------~-----~--------~~i~~QIl~aL~yLH~-- 243 (690)
++||+|++|....... .....+... . . ......+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 8999999875432100 000000000 0 0 0011112333444443
Q ss_pred -----CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 244 -----RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 244 -----~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999998778999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.01 Score=63.51 Aligned_cols=30 Identities=30% Similarity=0.532 Sum_probs=26.2
Q ss_pred CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 244 RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.++||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976666899999884
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.023 Score=59.88 Aligned_cols=30 Identities=23% Similarity=0.433 Sum_probs=25.5
Q ss_pred CeEeccCCcccEEEccCCc-EEEeeccccee
Q 041720 245 GIMHRDIKASNILVNNEGI-LKLGDFGLANI 274 (690)
Q Consensus 245 givHrDLKp~NILld~~~~-vKL~DFGla~~ 274 (690)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999999854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.023 Score=61.91 Aligned_cols=137 Identities=13% Similarity=0.195 Sum_probs=77.4
Q ss_pred EEeEEeecCceEEEEEEEcC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceEEE
Q 041720 128 KLEKIGQGTYSSVFRAREVA----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTIYL 202 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~L 202 (690)
.+..|-.|-.-.+|++.... .++.|++|+..... .... ...+|+.+++.+..-++ .++++.+.. + .
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~---g---~ 110 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN---G---R 110 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECC---c---e
Confidence 34456558888999986432 24679999875432 1111 23578889888854333 345555432 2 5
Q ss_pred EEeccchhccccccc----------------CCCC-------CChhHHHHHHHHHH-----------------HHHHHH-
Q 041720 203 VFEYMEHDLAGLSSC----------------HDIK-------FSEPQVKCYMRQLL-----------------HGVEHC- 241 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~----------------~~~~-------lse~~~~~i~~QIl-----------------~aL~yL- 241 (690)
|+||+.+..+..... +... .....+..++.++. ..+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 788887643321100 0000 11122333332211 111111
Q ss_pred ---H----hCCeEeccCCcccEEEcc-CCcEEEeecccce
Q 041720 242 ---H----LRGIMHRDIKASNILVNN-EGILKLGDFGLAN 273 (690)
Q Consensus 242 ---H----~~givHrDLKp~NILld~-~~~vKL~DFGla~ 273 (690)
. ...++|+||++.|||+++ ++.+.|+||..+.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235999999999999986 4689999999885
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.036 Score=61.40 Aligned_cols=76 Identities=14% Similarity=0.145 Sum_probs=50.7
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-----ChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccCcce
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-----QPESIRFMAREIMILRRLD---HPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~ 199 (690)
..+.||.|....||+..+ .+..|+||.-..... -+....+...|...|+.+. ..++.++|.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 467899999999999875 345689997642111 0112344455677776663 2477788887753 4
Q ss_pred EEEEEeccch
Q 041720 200 IYLVFEYMEH 209 (690)
Q Consensus 200 ~~LV~Ey~~g 209 (690)
.+|||||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.019 Score=62.40 Aligned_cols=75 Identities=17% Similarity=0.197 Sum_probs=47.4
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeec-----CCCChHHHHHHHHHHHHHhhcC--CC-ceeeeeceeeccCcceEEE
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRF-----DNFQPESIRFMAREIMILRRLD--HP-NIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~-----~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~~~L 202 (690)
.||.|....||++.....++.|+||.-.. ....+-...+...|...|+... -| .+.++|.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 47999999999998743346899996431 1111223344556778887763 34 455565432 356679
Q ss_pred EEeccch
Q 041720 203 VFEYMEH 209 (690)
Q Consensus 203 V~Ey~~g 209 (690)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.039 Score=58.56 Aligned_cols=76 Identities=16% Similarity=0.217 Sum_probs=46.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccCcceEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD---HPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+..+.|+.|....+|+.. .+++.+.||+-.... ...+..|..-|+.|. --.+.+++.+... .+.-||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceE
Confidence 3566789999999999985 778889999876322 245778888888883 3356677777665 344599
Q ss_pred EEeccchh
Q 041720 203 VFEYMEHD 210 (690)
Q Consensus 203 V~Ey~~g~ 210 (690)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.072 Score=57.15 Aligned_cols=146 Identities=17% Similarity=0.163 Sum_probs=83.4
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC--CceeeeeceeeccCcceEEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH--PNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.+++.+-.|-.-.+|.... +++.+++. ...............+|..+|+.+.- --+...+++|.+..-+..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 4444453444445555543 37788888 33222333455667889999888843 2334556666653224679999
Q ss_pred eccchhcccccccC--C------------------------------CCCChhHHHHHHHHH--------------HHHH
Q 041720 205 EYMEHDLAGLSSCH--D------------------------------IKFSEPQVKCYMRQL--------------LHGV 238 (690)
Q Consensus 205 Ey~~g~ll~~~~~~--~------------------------------~~lse~~~~~i~~QI--------------l~aL 238 (690)
+|+.|......... . ..+...++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99998321100000 0 001111222222222 1223
Q ss_pred HHHHhC--------CeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 239 EHCHLR--------GIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 239 ~yLH~~--------givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+|+.+ .++|+|+++.||||+.++-+=|.||+++.+-
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 344432 3899999999999999988999999999653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.053 Score=58.69 Aligned_cols=140 Identities=16% Similarity=0.238 Sum_probs=76.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcce
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNT 199 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~ 199 (690)
+.+.+ +.|..|--..+|++..... +..|++|+..... . ..-.-.+|+.+++.+..-++ .++++++.. +
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~---G- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFGN---G- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeCC---c-
Confidence 33444 4454477778998864322 2378899875332 1 11123578888888865444 345554422 2
Q ss_pred EEEEEeccchhcccccc----------------cCCCC------C-ChhHHHHHHHHH----------------------
Q 041720 200 IYLVFEYMEHDLAGLSS----------------CHDIK------F-SEPQVKCYMRQL---------------------- 234 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~----------------~~~~~------l-se~~~~~i~~QI---------------------- 234 (690)
+|.+|+.+..+.... .+... + ....+..++.++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 588888764331100 01111 1 112222222221
Q ss_pred ---HHHHH-HHHhC----CeEeccCCcccEEEcc-CCcEEEeecccce
Q 041720 235 ---LHGVE-HCHLR----GIMHRDIKASNILVNN-EGILKLGDFGLAN 273 (690)
Q Consensus 235 ---l~aL~-yLH~~----givHrDLKp~NILld~-~~~vKL~DFGla~ 273 (690)
+..+. ++... -++|.||.+.|||+++ ++.++|+||..|.
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11111 12122 2899999999999975 4789999999884
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.033 Score=55.96 Aligned_cols=30 Identities=40% Similarity=0.619 Sum_probs=21.5
Q ss_pred CeEeccCCcccEEE-ccCCcEEEeeccccee
Q 041720 245 GIMHRDIKASNILV-NNEGILKLGDFGLANI 274 (690)
Q Consensus 245 givHrDLKp~NILl-d~~~~vKL~DFGla~~ 274 (690)
-++|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999999854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.027 Score=61.98 Aligned_cols=77 Identities=21% Similarity=0.182 Sum_probs=50.7
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEee----cCCCChHHHHHHHHHHHHHhhcC--CC-ceeeeeceeeccCcceEE
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRRLD--HP-NIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~----~~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~~~ 201 (690)
++.||.|.-.-||++.+...++.|+||.-. ....-+-...+...|.++|+.+. .| ++.++|.+ + .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D--~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D--SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C--cHHhh
Confidence 678999999999999874335679999642 21111333455667888888763 34 45566543 2 35667
Q ss_pred EEEeccch
Q 041720 202 LVFEYMEH 209 (690)
Q Consensus 202 LV~Ey~~g 209 (690)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89998753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.063 Score=59.33 Aligned_cols=76 Identities=20% Similarity=0.256 Sum_probs=43.6
Q ss_pred EEeEEeecCceEEEEEEEcCC-CcE-----EEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceE
Q 041720 128 KLEKIGQGTYSSVFRAREVAT-GKM-----VALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTI 200 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~-g~~-----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~ 200 (690)
.++.|..|--..+|++..... +.. |.+.... . .....-.-.+|+.+++.|...++ .++++.+..
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------ 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--T-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------ 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--C-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence 344566688889999864322 222 3333321 1 11111123568999999965544 456665533
Q ss_pred EEEEeccchhcc
Q 041720 201 YLVFEYMEHDLA 212 (690)
Q Consensus 201 ~LV~Ey~~g~ll 212 (690)
++|.||++|..+
T Consensus 125 g~l~efIeGr~l 136 (383)
T PTZ00384 125 FTIQEWVEGNTM 136 (383)
T ss_pred EEEEEEeccccC
Confidence 589999987543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.095 Score=56.02 Aligned_cols=30 Identities=17% Similarity=0.165 Sum_probs=27.7
Q ss_pred CeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 245 GIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 245 givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998854
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.17 Score=54.78 Aligned_cols=136 Identities=21% Similarity=0.288 Sum_probs=77.6
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc------eeeeeceeeccCcc--eEEE
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN------IIKLEGVITSRLSN--TIYL 202 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~~~~~--~~~L 202 (690)
.|.. .-..||+... .+|+. ++|+.... ... ..+..|+..|..|.-.. |..+-|-....... ..+-
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEe-cCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3444 5567899864 44444 99998765 332 34667788888773211 22222222211234 7788
Q ss_pred EEeccchhcccc-ccc-----------------CCCC---------CChh----H---------HHHHHHHHHHHHHHHH
Q 041720 203 VFEYMEHDLAGL-SSC-----------------HDIK---------FSEP----Q---------VKCYMRQLLHGVEHCH 242 (690)
Q Consensus 203 V~Ey~~g~ll~~-~~~-----------------~~~~---------lse~----~---------~~~i~~QIl~aL~yLH 242 (690)
|++|++|..+.. ... .+.+ ..+. . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999865441 100 0000 0110 0 0112233444444444
Q ss_pred h--------CC--eEeccCCcccEEEccCCc-EEEeecccce
Q 041720 243 L--------RG--IMHRDIKASNILVNNEGI-LKLGDFGLAN 273 (690)
Q Consensus 243 ~--------~g--ivHrDLKp~NILld~~~~-vKL~DFGla~ 273 (690)
+ .+ +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 24 999999999999998874 8999999873
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.19 Score=56.55 Aligned_cols=84 Identities=12% Similarity=0.150 Sum_probs=50.0
Q ss_pred cccccCcCCeeEEeEEeecCceEEEEEEEcC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee-e
Q 041720 117 GLVPMRAESFEKLEKIGQGTYSSVFRAREVA--------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII-K 187 (690)
Q Consensus 117 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~ 187 (690)
+|..+..++. .++.|..|---.+|++.... .++.|.+++.-... +..-.-..|..+++.+..-+|- +
T Consensus 99 ~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~P~ 174 (442)
T PTZ00296 99 EWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIAPQ 174 (442)
T ss_pred ccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCCCc
Confidence 3444444555 66777778888899986432 14678888874332 1111234688888877544443 4
Q ss_pred eeceeeccCcceEEEEEeccchh
Q 041720 188 LEGVITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 188 l~~~~~~~~~~~~~LV~Ey~~g~ 210 (690)
+++.+.. +.|.||++|.
T Consensus 175 l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 175 LLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred eEEEeCC------CEEEEeeCCc
Confidence 5555432 4578888764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.088 Score=56.88 Aligned_cols=72 Identities=19% Similarity=0.312 Sum_probs=55.1
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
....|++|++-.+.+... . .-...++..++.+.+..|.-|..+ .+-||||...||||+ +|+|-|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 355678888766543321 1 124567888888888877777654 699999999999999 99999999999984
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.55 Score=58.48 Aligned_cols=31 Identities=35% Similarity=0.485 Sum_probs=26.2
Q ss_pred CCeEeccCCcccEEEccCC--cEE-Eeeccccee
Q 041720 244 RGIMHRDIKASNILVNNEG--ILK-LGDFGLANI 274 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~--~vK-L~DFGla~~ 274 (690)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999999853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.25 Score=50.05 Aligned_cols=116 Identities=17% Similarity=0.190 Sum_probs=72.9
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEeccchhcccc
Q 041720 135 GTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGL 214 (690)
Q Consensus 135 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~ 214 (690)
|+.++.-.+.-.. | ...+|+++.....-. ...+..+..++.+++ .|+++.. + ..-.+-+|+|+|-.--.
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~i-- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIKI-- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCccc--
Confidence 4555544443222 3 456676654433311 234677888888876 4777762 2 25667899998853110
Q ss_pred cccCCCCCChhHHHHHHHHHHHHHHHHHh--CCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 215 SSCHDIKFSEPQVKCYMRQLLHGVEHCHL--RGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 215 ~~~~~~~lse~~~~~i~~QIl~aL~yLH~--~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
.-..++.-=+.+|.-.|+ .+.+|+|..|+||+.|..|.+||.|=+..
T Consensus 142 -----------~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -----------NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -----------chhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 011122222456777784 46999999999999999999999997654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.23 E-value=1.7 Score=46.98 Aligned_cols=71 Identities=13% Similarity=0.114 Sum_probs=40.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC--ceeeee---c-eeeccCcceEEEEEeccc
Q 041720 135 GTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP--NIIKLE---G-VITSRLSNTIYLVFEYME 208 (690)
Q Consensus 135 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~---~-~~~~~~~~~~~LV~Ey~~ 208 (690)
+.-..||+.. ..+|..+++|+.+..... ...+..|+.++..|... .++... + .+.. .++..+.|+++++
T Consensus 36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~-~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFG-DEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE-HQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEe-cCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE-ECCEEEEEEeeeC
Confidence 3445788886 356678999988644333 23466777777766321 122211 1 0111 1356788999988
Q ss_pred hh
Q 041720 209 HD 210 (690)
Q Consensus 209 g~ 210 (690)
|.
T Consensus 111 G~ 112 (325)
T PRK11768 111 GR 112 (325)
T ss_pred CC
Confidence 64
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.19 Score=53.30 Aligned_cols=29 Identities=31% Similarity=0.509 Sum_probs=25.6
Q ss_pred CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 244 RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.51 Score=52.74 Aligned_cols=28 Identities=25% Similarity=0.372 Sum_probs=21.7
Q ss_pred eEeccCCcccEEEccCCc-----EEEeecccce
Q 041720 246 IMHRDIKASNILVNNEGI-----LKLGDFGLAN 273 (690)
Q Consensus 246 ivHrDLKp~NILld~~~~-----vKL~DFGla~ 273 (690)
++|+||...|||.+.++. ..|+||=++.
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 899999999999987432 4677875553
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 690 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-59 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-58 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-58 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-58 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-57 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-57 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-54 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-54 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-54 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-54 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-54 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-54 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-54 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-54 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-54 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-54 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-54 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-54 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-54 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-54 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-54 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-54 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-54 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-54 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-54 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-54 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-54 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-54 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-53 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-53 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-53 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-53 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-53 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-53 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-53 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-53 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-53 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-53 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-53 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-53 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-53 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-53 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-52 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-52 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-52 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-51 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-50 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-48 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-47 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-47 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-47 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-47 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-46 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-46 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-46 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-45 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-44 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-41 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-41 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-40 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-40 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-40 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-40 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-40 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-40 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-39 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-39 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-39 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-39 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-39 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-39 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-39 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-39 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-39 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-39 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-39 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-39 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-39 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-38 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-38 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-38 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-38 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-38 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-38 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-38 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-37 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-37 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-37 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-37 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-36 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-36 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-36 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-36 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-36 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-36 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-36 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-36 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-36 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-36 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-36 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-36 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-36 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-36 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-36 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-36 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-35 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-35 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-35 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-35 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-35 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-35 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-35 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-35 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-35 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-35 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-35 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-33 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-33 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-33 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-33 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-33 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-32 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-32 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-32 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-31 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-31 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-31 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-31 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-31 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-30 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-30 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-30 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-30 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-30 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-30 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-30 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-29 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-29 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-28 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-24 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-24 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-24 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-24 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-23 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-23 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-23 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-17 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-11 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 500 bits (1290), Expect = e-174
Identities = 127/339 (37%), Positives = 187/339 (55%), Gaps = 17/339 (5%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRL 180
+EKL KIGQGT+ VF+AR TG+ VALKKV +N + E A REI IL+ L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 73
Query: 181 DHPNIIKLEGVITSRLS------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
H N++ L + ++ S +IYLVF++ EHDLAGL S +KF+ ++K M+ L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA---NILTSKNKQKLTSRVVTLW 291
L+G+ + H I+HRD+KA+N+L+ +G+LKL DFGLA ++ + + T+RVVTLW
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351
YRPPELL+G +Y +DLW GC+ AE+ PI++G TE QL I +LCGS E W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 352 KK-SKLPHGDMFKPQNPYEGCLRERCKDF--TPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
+ + + +++R K + P A+DLID L ++P +R + L +
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 409 YFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRAR 447
+F + P D + + RRK
Sbjct: 314 FFWSDPMPSDLKGMLSTHLTSMFEYLAP---PRRKHHHH 349
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-159
Identities = 122/345 (35%), Positives = 184/345 (53%), Gaps = 10/345 (2%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMA-REIM 175
V RA+ +EKL+ +G+G +++V++AR+ T ++VA+KK++ + + I A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 176 ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLL 235
+L+ L HPNII L + + I LVF++ME DL + + + + +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G+E+ H I+HRD+K +N+L++ G+LKL DFGLA S N+ T +VVT WYR P
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAP 181
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-S 354
ELL G+ Y V VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P EE W
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
LP FK L +DLI P R TA+ L +YF+ +P
Sbjct: 242 SLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 415 YACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRR 459
LP+ E +Q + A K R R ++
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIK-RKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-134
Identities = 107/325 (32%), Positives = 168/325 (51%), Gaps = 14/325 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN---FQPESIRFMAREIMILRRL 180
E++ KL+K+G+GTY++V++ + T +VALK++R ++ +IR E+ +L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
H NI+ L +I + ++ LVFEY++ DL + VK ++ QLL G+ +
Sbjct: 58 KHANIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH + ++HRD+K N+L+N G LKL DFGLA + K + VVTLWYRPP++L+G
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLG 174
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHG 359
ST+Y+ +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P EE W
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDP 419
+ L DL+ L E R +A + +F +
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294
Query: 420 SSLPKYPPKKEIDAKQ-RDEARRRK 443
LP + Q + EA R
Sbjct: 295 --LPDTTSIFALKEIQLQKEASLRS 317
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-132
Identities = 98/311 (31%), Positives = 162/311 (52%), Gaps = 9/311 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
E +E L +G+G+Y V + R TG++VA+KK + + ++ +A REI +L++L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRH 83
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
N++ L V + YLVFE+++H + V+ Y+ Q+++G+ CH
Sbjct: 84 ENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRDIK NILV+ G++KL DFG A L + + V T WYR PELL+G
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDV 200
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLP--HG 359
Y +VD+W++GC+ E+ +G+P+ G ++++QL+ I G+ + + +K P G
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDP 419
E L R + +DL CL I+P KR + LL ++F +A
Sbjct: 261 VRLPEIKEREP-LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319
Query: 420 SSLPKYPPKKE 430
S + +K+
Sbjct: 320 SQELQLKVQKD 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-132
Identities = 107/310 (34%), Positives = 160/310 (51%), Gaps = 7/310 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
E +EK+ KIG+G+Y VF+ R TG++VA+KK I+ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKH 61
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PN++ L V + ++LVFEY +H + + E VK Q L V CH
Sbjct: 62 PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+HRD+K NIL+ ++KL DFG A +LT + V T WYR PELL+G T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDT 178
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
Y VD+W++GCVFAELL G P+ G+++V+QL+ I K G + + S +
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 362 FKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
K +P + L + + + A+ L+ CL ++P +R T LL YF D +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298
Query: 421 SLPKYPPKKE 430
P +
Sbjct: 299 KEHDKPAENL 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-131
Identities = 111/323 (34%), Positives = 164/323 (50%), Gaps = 22/323 (6%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN---FQPESIRFMAREIMILR 178
+ F++LEK+G GTY++V++ TG VALK+V+ D+ +IR EI +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-----FSEPQVKCYMRQ 233
L H NI++L VI + N + LVFE+M++DL + VK + Q
Sbjct: 59 ELKHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
LL G+ CH I+HRD+K N+L+N G LKLGDFGLA +S VVTLWYR
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYR 175
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
P++LMGS Y+ S+D+WS GC+ AE++ GKP+ G + EQL IF + G+P E W
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 354 -SKLPHGDMFKPQNPYEGCLRERCKD-----FTPTAVDLIDTCLSIEPYKRGTASSLLMC 407
+KLP + Q P LR+ + +D + L + P R +A L
Sbjct: 236 VTKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 408 EYFTTQPYACDPSSLPKYPPKKE 430
+F + +
Sbjct: 295 PWFAEYYHHASMGGSRSHHHHHH 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-131
Identities = 115/310 (37%), Positives = 165/310 (53%), Gaps = 18/310 (5%)
Query: 117 GLVPMRA-ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF---MAR 172
G + A +E + +IG G Y +V++AR+ +G VALK VR N R
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 173 EIMILRRL---DHPNIIKLEGVITSRLSNT---IYLVFEYMEHDLAG-LSSCHDIKFSEP 225
E+ +LRRL +HPN+++L V + ++ + LVFE+++ DL L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 226 QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285
+K MRQ L G++ H I+HRD+K NILV + G +KL DFGLA I + + LT
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTP 178
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
VVTLWYR PE+L+ ST Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G
Sbjct: 179 VVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237
Query: 346 PPEEYWKK-SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
PPE+ W + LP G F P+ P ++ + + L+ L+ P+KR +A
Sbjct: 238 PPEDDWPRDVSLPRGA-FPPRGPRP--VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 405 LMCEYFTTQP 414
L Y
Sbjct: 295 LQHSYLHKDE 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-131
Identities = 106/379 (27%), Positives = 176/379 (46%), Gaps = 42/379 (11%)
Query: 122 RAESFEKL-EKIGQGTYSSVFRAR--EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ FE K+G+GTY V++A+ + K ALK++ + R EI +LR
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLR 73
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGL--------SSCHDIKFSEPQVKCY 230
L HPN+I L+ V S ++L+F+Y EHDL + ++ ++ VK
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNKQ--KLT 284
+ Q+L G+ + H ++HRD+K +NILV G +K+ D G A + S K L
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV---------EQ 335
VVT WYR PELL+G+ +Y ++D+W++GC+FAELL +PI R E +Q
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 336 LHKIFKLCGSPPEEYWKK-SKLPHGDMFKP---QNPYEGC-----LRERCKDFTPTAVDL 386
L +IF + G P ++ W+ K+P +N Y C + + A L
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 387 IDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLP---KYPPKKEIDAKQRDEARRRK 443
+ L+++P KR T+ + YF P YP ++ + ++ D+ +K
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKK 373
Query: 444 VRARMREPASSKRQRRARQ 462
+ + + +
Sbjct: 374 NQQQQQGNNHTNGTGHPGN 392
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 115/294 (39%), Positives = 166/294 (56%), Gaps = 8/294 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+ +EKLEKIG+GTY +VF+A+ T ++VALK+VR D+ E + A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKH 60
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI++L V+ S + LVFE+ + DL + VK ++ QLL G+ CH
Sbjct: 61 KNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R ++HRD+K N+L+N G LKL +FGLA + ++ VVTLWYRPP++L G+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAK 177
Query: 303 NYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGD 360
Y+ S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P EE W +KLP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
+ P P L T DL+ L P +R +A L YF+
Sbjct: 238 PY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 120/295 (40%), Positives = 171/295 (57%), Gaps = 7/295 (2%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRL 180
E ++KLEK+G+GTY V++A++ + G++VALK++R D E I A REI +L+ L
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAED-EGIPSTAIREISLLKEL 76
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
HPNI+ L VI S + LVFE+ME DL + + + Q+K Y+ QLL GV H
Sbjct: 77 HHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
CH I+HRD+K N+L+N++G LKL DFGLA + T VVTLWYR P++LMG
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMG 193
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHG 359
S Y+ SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+P W + +LP
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
Q + F +DL+ L +P KR +A + YF
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-129
Identities = 111/290 (38%), Positives = 166/290 (57%), Gaps = 8/290 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
E + LEKIG+GTY V++A+ G+ ALKK+R + E I REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKH 59
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+KL VI ++ + LVFE+++ DL L + K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R ++HRD+K N+L+N EG LK+ DFGLA + K T +VTLWYR P++LMGS
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSK 176
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDM 361
Y+ ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P + W ++LP D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
K + +DL+ L ++P +R TA L YF
Sbjct: 237 NFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-128
Identities = 118/323 (36%), Positives = 172/323 (53%), Gaps = 21/323 (6%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREV-ATGKMVALKKVRFDNFQPESIRFMA-REIMILRRL- 180
+ +E + +IG+G Y VF+AR++ G+ VALK+VR + E + RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLE 69
Query: 181 --DHPNIIKLEGVITSRLS---NTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQL 234
+HPN+++L V T + + LVFE+++ DL L + +K M QL
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
L G++ H ++HRD+K NILV + G +KL DFGLA I + + LTS VVTLWYR
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRA 187
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK- 353
PE+L+ S+ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P EE W +
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 354 SKLPHGDMFK-PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
LP P + + D DL+ CL+ P KR +A S L YF
Sbjct: 247 VALPRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 413 QPYACD--PSSLPKYPPKKEIDA 433
+ S LP E++
Sbjct: 303 LERCKENLDSHLPPSQNTSELNT 325
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-127
Identities = 102/299 (34%), Positives = 174/299 (58%), Gaps = 12/299 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+ + ++ K+G+GTY V++A + T + VA+K++R ++ + E + A RE+ +L+ L H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQH 92
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NII+L+ VI + ++L+FEY E+DL + S +K ++ QL++GV CH
Sbjct: 93 RNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH 149
Query: 243 LRGIMHRDIKASNILVN-----NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
R +HRD+K N+L++ +LK+GDFGLA + + T ++TLWYRPPE+
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEI 208
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKL 356
L+GS +Y+ SVD+WS+ C++AE+L+ P+ G +E++QL KIF++ G P + W + L
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
P P+ + R +DL+ L ++P KR +A + L YF+ +
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-101
Identities = 106/392 (27%), Positives = 168/392 (42%), Gaps = 28/392 (7%)
Query: 104 PAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ 163
+ +T G + S+ + IG G++ V++A+ +G++VA+KKV D
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-- 91
Query: 164 PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT----IYLVFEYMEHDLAGLS---S 216
RF RE+ I+R+LDH NI++L S + LV +Y+ + ++ S
Sbjct: 92 ----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 147
Query: 217 CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANIL 275
VK YM QL + + H GI HRDIK N+L++ + +LKL DFG A L
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ 335
+ S + + +YR PEL+ G+T+Y S+D+WS GCV AELL+G+PI G + V+Q
Sbjct: 208 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265
Query: 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEP 395
L +I K+ G+P E ++ + + PQ + P A+ L L P
Sbjct: 266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 396 YKRGTASSLLMCEYFTT--QPYACDPSSLP----------KYPPKKEIDAKQRDEARRRK 443
R T +F P P+ + + R +
Sbjct: 326 TARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 385
Query: 444 VRARMREPASSKRQRRARQTLQLQEPNSYSSK 475
A A++ Q S S+
Sbjct: 386 AAASTPTNATAASDANTGDRGQTNNAASASAS 417
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 4e-95
Identities = 103/302 (34%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++ + IG G++ VF+A+ V + + VA+KKV D RF RE+ I+R + HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHP 92
Query: 184 NIIKLEGVITSRLSNT----IYLVFEYMEHDLAGLS---SCHDIKFSEPQVKCYMRQLLH 236
N++ L+ S + LV EY+ + S + +K YM QLL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 237 GVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ + H GI HRDIK N+L++ G+LKL DFG A IL + + S + + +YR P
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAP 210
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK--- 352
EL+ G+TNY ++D+WS GCV AEL+ G+P+ G + ++QL +I K+ G+P E K
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 353 ----KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
+ K P +P P+ R R P A+DLI L P R TA L
Sbjct: 271 PNYMEHKFPQ---IRPH-PFSKVFRPRT---PPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 409 YF 410
+F
Sbjct: 324 FF 325
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-89
Identities = 96/317 (30%), Positives = 147/317 (46%), Gaps = 25/317 (7%)
Query: 111 AGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFM 170
A A + F+ GQGT+ +V +E +TG VA+KKV D RF
Sbjct: 10 AAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRFR 63
Query: 171 AREIMILRRL---DHPNIIKLEGVITSRLSNT-----IYLVFEYMEHDLAGLS---SCHD 219
RE+ I++ L HPNI++L+ + + +V EY+ L
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 220 IKFSEPQVKCYMRQLLHGVEHCHLR--GIMHRDIKASNILVNNE-GILKLGDFGLANILT 276
+ +K ++ QL+ + HL + HRDIK N+LVN G LKL DFG A L+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQL 336
+ + + + +YR PEL+ G+ +Y +VD+WSVGC+FAE+++G+PI +G QL
Sbjct: 184 PS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 337 HKIFKLCGSPPEEYWKKSKLPHGDMFKPQ---NPYEGCLRERCKDFTPTAVDLIDTCLSI 393
H+I ++ G P E +K H D+ P+ + A DL+ L
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301
Query: 394 EPYKRGTASSLLMCEYF 410
P +R L YF
Sbjct: 302 LPEERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-87
Identities = 91/365 (24%), Positives = 146/365 (40%), Gaps = 65/365 (17%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
++ + + +G G++ V ++ +GK ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 180 LDHPNIIKLEGVITSRLSNT------------------------------------IYLV 203
LDH NIIKL + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 204 FEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN- 259
EY+ L + + Y+ QL V H GI HRDIK N+LVN
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 260 NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAE 319
+ LKL DFG A L + + + + +YR PEL++G+T Y S+DLWS+GCVF E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 320 LLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK-------KSKLPHGDMFKPQNPYEGCL 372
L++GKP+ G T ++QL +I ++ G+P +E + + P + L
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT----LKAKDWRKIL 290
Query: 373 RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEID 432
E A+DL++ L EP R + +F +
Sbjct: 291 PEGT---PSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPH 344
Query: 433 AKQRD 437
++
Sbjct: 345 GVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 4e-87
Identities = 86/301 (28%), Positives = 145/301 (48%), Gaps = 27/301 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
+ ++ + K+G+G YS VF A + + V +K ++ + + I+ REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIK---REIKILENLRGG 90
Query: 183 PNIIKLEGVITSRLSNTIYLVFEY-MEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVE 239
PNII L ++ +S T LVFE+ D + ++ ++ YM ++L ++
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALD 144
Query: 240 HCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+CH GIMHRD+K N+++++E L+L D+GLA Q+ RV + +++ PELL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELL 202
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEE-YWKKSKL 356
+ Y+ S+D+WS+GC+ A ++ K P G +QL +I K+ G+ Y K +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 357 PHGDMFKPQNPY-------EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
F E +P A+D +D L + R TA + Y
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 410 F 410
F
Sbjct: 323 F 323
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 7e-83
Identities = 101/311 (32%), Positives = 158/311 (50%), Gaps = 23/311 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ L+ +G G VF A + K VA+KK+ + P+S++ REI I+RRLDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 186 IKLEGVITSRLS------------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
+K+ ++ S N++Y+V EYME DLA + + E + +M Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQ 128
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTS--KNKQKLTSRVVTL 290
LL G+++ H ++HRD+K +N+ +N E +LK+GDFGLA I+ +K L+ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
WYR P LL+ NY ++D+W+ GC+FAE+L GK + G E+EQ+ I + EE
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 351 WKKSKLPHGDMFKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
++ + L + + AVD ++ L+ P R TA L Y
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 410 FTTQPYACDPS 420
Y+ P
Sbjct: 309 M--SIYS-FPM 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 3e-82
Identities = 100/319 (31%), Positives = 164/319 (51%), Gaps = 24/319 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH 182
+++ +G G Y SV A + +G+ VA+KK+ FQ + RE+++L+ + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 183 PNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLL 235
N+I L V T S YLV +M+ DL I KFSE +++ + Q+L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL------QKIMGLKFSEEKIQYLVYQML 136
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G+++ H G++HRD+K N+ VN + LK+ DFGLA ++ +T VVT WYR P
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 192
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E+++ +YN +VD+WSVGC+ AE+L GK + KG+ ++QL +I K+ G P E+ +K
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 356 LPHG-DMFKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
+ + +P A DL++ L ++ KR TA+ L +F +
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF--E 310
Query: 414 PYACDPSSLPKYPPKKEID 432
P+ DP + +
Sbjct: 311 PFR-DPEEETEAQQPFDDS 328
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-82
Identities = 102/327 (31%), Positives = 154/327 (47%), Gaps = 18/327 (5%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMIL 177
V R + L IG+G Y V A + VA+KK+ F++ Q R REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQR-TLREIKIL 79
Query: 178 RRLDHPNIIKLEGVITSRLS---NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQL 234
R H NII + +I + +Y+V + ME DL L + S + ++ Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQI 137
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK--LTSRVVTLWY 292
L G+++ H ++HRD+K SN+L+N LK+ DFGLA + + LT V T WY
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+++ S Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP +E
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 353 KSKLPHG-DMFKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ + A+DL+D L+ P+KR L Y
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 411 TTQPYACDPSSLPKYPPKKEIDAKQRD 437
+ Y DPS P + D + D
Sbjct: 318 --EQYY-DPSDEPIAEAPFKFDMELDD 341
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 3e-81
Identities = 101/326 (30%), Positives = 155/326 (47%), Gaps = 39/326 (11%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRLDHPN 184
F+ +G+G Y V A TG++VA+KK+ FD ++R REI IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALR-TLREIKILKHFKHEN 70
Query: 185 IIKLEGVITSRLS---NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
II + + N +Y++ E M+ DL + S + S+ ++ ++ Q L V+
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVL 128
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA---------NILTSKNKQKLTSRVVTLWY 292
H ++HRD+K SN+L+N+ LK+ DFGLA N + + + V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+++ S Y+ ++D+WS GC+ AEL + +PI GR QL IF + G+P +
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 353 KS-----------KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
+ LP P P L + P +DL+ L +P KR TA
Sbjct: 249 RCIESPRAREYIKSLPM----YPAAP----LEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 402 SSLLMCEYFTTQPYACDPSSLPKYPP 427
L Y Q Y DP+ P+ P
Sbjct: 301 KEALEHPYL--QTYH-DPNDEPEGEP 323
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-81
Identities = 110/388 (28%), Positives = 179/388 (46%), Gaps = 57/388 (14%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI--RFMAREIMILRRL-DH 182
+E ++K+G+G Y V+++ + TG++VA+KK+ FD FQ + R REIMIL L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQR-TFREIMILTELSGH 68
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI+ L V+ + +YLVF+YME DL H + + + QL+ +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDL------HAVIRANILEPVHKQYVVYQLIKVI 122
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK-------------------- 278
++ H G++HRD+K SNIL+N E +K+ DFGL+ +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK 338
++ LT V T WYR PE+L+GST Y +D+WS+GC+ E+L GKPI G + + QL +
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 339 IFKLCGSPPEEYW----------------KKSKLPHGDMFKPQNPYEGCLRERC--KDFT 380
I + P E +K ++ + ++ L + D
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 381 PTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEAR 440
A+DL+D L P KR +A+ L + + +P+ P I +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFV--SIFH-NPNEEPNCDHIITIPINDNVKHS 359
Query: 441 RRKVRARM-REPASSKRQRRARQTLQLQ 467
R + E + KR+ + + +Q
Sbjct: 360 IDDYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-80
Identities = 87/317 (27%), Positives = 130/317 (41%), Gaps = 21/317 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR-FMA--------REIMI 176
+ I G+Y +V + + G VA+K+V ++ REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 177 LRRLDHPNIIKLEGVITSRLS---NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
L HPNI+ L + + +YLV E M DLA + I S ++ +M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+L G+ H G++HRD+ NIL+ + + + DF LA T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYR 200
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PEL+M + VD+WS GCV AE+ K + +G T QL+KI ++ G+P E
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 354 SKLPHG-DMFKPQNP-YEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
P D + P A+DLI L P +R + L YF
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 411 TTQPYACDPSSLPKYPP 427
+ DP L +
Sbjct: 321 --ESLF-DPLDLTEGLS 334
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-80
Identities = 99/311 (31%), Positives = 158/311 (50%), Gaps = 17/311 (5%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH 182
+ L+ +G G Y +V A + TG VA+KK+ + FQ + RE+ +L+ + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 183 PNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
N+I L V T + YLV +M DL L K E +++ + Q+L G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGL 141
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H GI+HRD+K N+ VN + LK+ DFGLA S+ +T VVT WYR PE++
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 197
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ Y +VD+WSVGC+ AE++ GK + KG ++QL +I K+ G+PP E+ ++ +
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257
Query: 359 G-DMFKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416
+ K E + +P AV+L++ L ++ +R TA L YF +
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--ESLH 315
Query: 417 CDPSSLPKYPP 427
D P+
Sbjct: 316 -DTEDEPQVQK 325
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-80
Identities = 106/317 (33%), Positives = 157/317 (49%), Gaps = 22/317 (6%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMI 176
VP R ++ L +G G Y SV A + TG VA+KK+ F + + RE+ +
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRL 81
Query: 177 LRRLDHPNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
L+ + H N+I L V T S N +YLV M DL + C + ++ V+ +
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIY 139
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
Q+L G+++ H I+HRD+K SN+ VN + LK+ DFGLA + +T V T WY
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWY 195
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+++ +YN +VD+WSVGC+ AELL G+ + G ++QL I +L G+P E K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 353 KSKLPHG-DMFKPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
K + + P AVDL++ L ++ KR TA+ L YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 411 TTQPYACDPSSLPKYPP 427
Y DP P P
Sbjct: 316 --AQYH-DPDDEPVADP 329
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 7e-79
Identities = 109/416 (26%), Positives = 175/416 (42%), Gaps = 79/416 (18%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
+E IG G+Y V A + ++VA+KK+ F++ + R + REI IL RL+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKR-ILREIAILNRLNHD 112
Query: 184 NIIKLEGVITSRLS---NTIYLVFEYMEHDLAGL--SSCHDIKFSEPQVKCYMRQLLHGV 238
+++K+ ++ + + +Y+V E + D L + + +E +K + LL GV
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP---VYLTELHIKTLLYNLLVGV 169
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA-------------------------- 272
++ H GI+HRD+K +N LVN + +K+ DFGLA
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL----------- 321
T K++LT VVT WYR PEL++ NY ++D+WS+GC+FAELL
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 322 IGKPILKG--------------------RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
P+ G R +QL+ IF + G+P EE + +
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349
Query: 362 FKPQNP-YEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDP 419
+ P EG L ER + A+ L+ L P KR T + L +F +
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF--KEVR-IA 406
Query: 420 SSLPKYPPKKEIDAKQRDEARRRKVRARM-REPASSKRQRRARQTLQLQEPNSYSS 474
K + ++R +E + + L + PN SS
Sbjct: 407 EVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQ----LPRRSPNRASS 458
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-78
Identities = 97/353 (27%), Positives = 159/353 (45%), Gaps = 41/353 (11%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMIL 177
V R ++ L+ IG G V A + + VA+KK+ FQ + RE++++
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLM 78
Query: 178 RRLDHPNIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDI---KFSEPQVKCY 230
+ ++H NII L V T + S +Y+V E M+ +L + + ++
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL------CQVIQMELDHERMSYL 132
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
+ Q+L G++H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VVT
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+YR PE+++G Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P E+
Sbjct: 191 YYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 351 W---------------KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEP 395
K + +F E K A DL+ L I+
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA--DSEHNKLKASQARDLLSKMLVIDA 307
Query: 396 YKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARM 448
KR + L Y + DPS PPK E + + +
Sbjct: 308 SKRISVDEALQHPYI--NVWY-DPSEAEAPPPKIPDKQLDEREHTIEEWKELI 357
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 254 bits (649), Expect = 4e-77
Identities = 104/420 (24%), Positives = 179/420 (42%), Gaps = 48/420 (11%)
Query: 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMIL 177
V R ++ L+ IG G V A + + VA+KK+ FQ + RE++++
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLM 115
Query: 178 RRLDHPNIIKLEGVITSRLS----NTIYLVFEYMEHDL-----AGLSSCHDIKFSEPQVK 228
+ ++H NII L V T + + +YLV E M+ +L L +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER--------MS 167
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288
+ Q+L G++H H GI+HRD+K SNI+V ++ LK+ DFGLA T+ +T VV
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 225
Query: 289 TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348
T +YR PE+ + Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P
Sbjct: 226 TRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 349 EYWKK---------SKLPH------GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393
E+ KK P +F + E K A DL+ L I
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFP--DSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 394 EPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARM-REPA 452
+P KR + L Y + DP+ + PP+ E + + + +E
Sbjct: 343 DPAKRISVDDALQHPYI--NVWY-DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE-- 397
Query: 453 SSKRQRRARQTLQLQEPNSYSSKELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGREPRN 512
+ + + + +P+ + E+ N+ + ++ + E
Sbjct: 398 VMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASA 457
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-74
Identities = 108/408 (26%), Positives = 170/408 (41%), Gaps = 63/408 (15%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLDHP 183
+ IG+G+Y V+ A + T K VA+KKV F++ + R + REI IL RL
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKR-ILREITILNRLKSD 85
Query: 184 NIIKLEGVITSRLS---NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
II+L +I + +Y+V E + DL L I +E +K + LL G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENF 144
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLA---------------------NILTSKN 279
H GI+HRD+K +N L+N + +K+ DFGLA
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-----------KPILK 328
K++LTS VVT WYR PEL++ NY S+D+WS GC+FAELL P+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 329 G-----------------RTEVEQLHKIFKLCGSPPEEYWKKSKLPHG-DMFKPQNPYEG 370
G ++ +QL+ IF + G+P E+ K P K +
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 371 C-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKK 429
L+++ + ++L+++ L P KR T L Y + K
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDVR-KKKLENFSTKKI 381
Query: 430 EIDAKQRDEARRRKVRARM-REPASSKRQRRARQTLQLQEPNSYSSKE 476
+ ++R +E S + + E N Y++++
Sbjct: 382 ILPFDDWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNFYNNEK 429
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-67
Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 55/308 (17%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
A FE++ +GQG + V +AR + A+KK+R + +I E+M+L L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNH 61
Query: 183 PNIIKLEGVITSRL-----------SNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCY 230
+++ R +T+++ EY E L L ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS------------- 277
RQ+L + + H +GI+HRD+K NI ++ +K+GDFGLA +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337
+ LTS + T Y E+L G+ +YN +D++S+G +F E++ P G V L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397
K+ + P ++ + +I + +P K
Sbjct: 240 KLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDPNK 274
Query: 398 RGTASSLL 405
R A +LL
Sbjct: 275 RPGARTLL 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-65
Identities = 72/329 (21%), Positives = 123/329 (37%), Gaps = 57/329 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L++IG G S VF+ ++ A+K V + +++ EI L +L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 184 N--IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+ II+L + IY+V E DL + K Y + +L V
Sbjct: 87 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-KNKQKLTSRVVTLWYRPPELLMG 300
H GI+H D+K +N L+ + G+LKL DFG+AN + S+V T+ Y PPE +
Sbjct: 144 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 301 STN----------YNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKLCGSPPEE 349
++ + D+WS+GC+ + GK + + +LH I + E
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIE 260
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
+ D++ CL +P +R + LL Y
Sbjct: 261 FP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295
Query: 410 FTTQPYACDPSSLPKYPPKKEIDAKQRDE 438
+ P ++ +E
Sbjct: 296 VQ-----------IQTHPVNQMAKGTTEE 313
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 8e-65
Identities = 81/295 (27%), Positives = 135/295 (45%), Gaps = 39/295 (13%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
P RAE +E L IG G+Y + R + GK++ K++ + + + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGL---SSCHDIKFSEPQVKCYMRQLL 235
L HPNI++ I R + T+Y+V EY E DLA + + E V M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 236 HGVEHCHLRG-----IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
++ CH R ++HRD+K +N+ ++ + +KLGDFGLA IL + + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTP 180
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+Y PE + +YN D+WS+GC+ EL P ++ E KI + G
Sbjct: 181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR--- 234
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
++P ++ ++I L+++ Y R + +L
Sbjct: 235 ----RIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEIL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-64
Identities = 74/366 (20%), Positives = 132/366 (36%), Gaps = 49/366 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L++IG G S VF+ ++ A+K V + +++ EI L +L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 184 N--IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+ II+L + IY+V E DL + K Y + +L V
Sbjct: 68 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 124
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-KNKQKLTSRVVTLWYRPPELLMG 300
H GI+H D+K +N L+ + G+LKL DFG+AN + S+V T+ Y PPE +
Sbjct: 125 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 301 STN----------YNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKLCGSPPEE 349
++ + D+WS+GC+ + GK + + +LH I + E
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIE 241
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
+ D++ CL +P +R + LL Y
Sbjct: 242 FPDI-------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
Query: 410 FTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEP 469
Q P + +E+ + ++ + ++
Sbjct: 277 VQIQT---HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 333
Query: 470 NSYSSK 475
++ K
Sbjct: 334 KTFEKK 339
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-64
Identities = 77/370 (20%), Positives = 148/370 (40%), Gaps = 46/370 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + +L+KIG+G++ + G+ +K++ + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
NI++ ++Y+V +Y E DL +++ + F E Q+ + Q+ ++H
Sbjct: 84 NIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H R I+HRDIK+ NI + +G ++LGDFG+A +L S + + + T +Y PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICENK 200
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
YN D+W++GCV EL K + + + KI GS P +
Sbjct: 201 -PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP-------PVS---- 246
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSS 421
++ L+ P R + +S+L + +
Sbjct: 247 ---------------LHYSYDLRSLVSQLFKRNPRDRPSVNSIL------EKGF------ 279
Query: 422 LPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDEA 481
+ K K +E + +P +KR + ++ + + +
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGI 339
Query: 482 HFADRKNNNN 491
A +K +
Sbjct: 340 PLAYKKYGDK 349
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 9e-63
Identities = 73/367 (19%), Positives = 132/367 (35%), Gaps = 46/367 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L++IG G S VF+ ++ A+K V + +++ EI L +L
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 184 N--IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+ II+L + IY+V E DL + K Y + +L V
Sbjct: 115 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 171
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMG 300
H GI+H D+K +N L+ + G+LKL DFG+AN + S+V + Y PPE +
Sbjct: 172 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 301 STN----------YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEE 349
++ + D+WS+GC+ + GK P + ++ +LH I + E
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIE 288
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
+ D++ CL +P +R + LL Y
Sbjct: 289 FP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 410 FTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEP 469
Q + + + K + + + + + + +
Sbjct: 324 VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 383
Query: 470 NSYSSKE 476
K+
Sbjct: 384 EKKRGKK 390
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 4e-62
Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 37/283 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
+SF++L ++G G+Y VF+ R G++ A+K+ P+ E+ ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
P ++LE +YL E L E QV Y+R L + H H
Sbjct: 117 PCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+G++H D+K +NI + G KLGDFGL L + + + Y PELL G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQEGDPRYMAPELLQG-- 230
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
+Y + D++S+G E+ + G E ++ + G P E+
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQ--GYLPPEFTAG--------- 276
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ ++ L +P R TA +LL
Sbjct: 277 ----------------LSSELRSVLVMMLEPDPKLRATAEALL 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-62
Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 58/296 (19%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
F+++E IG G + VF+A+ GK +K+V+++N E RE+ L +LDH NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE---REVKALAKLDHVNI 66
Query: 186 IKL--------------EGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKC 229
+ + + +++ E+ + L + K +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT 289
Q+ GV++ H + +++RD+K SNI + + +K+GDFGL L KN K T T
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGT 184
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
L Y PE + +Y VDL+++G + AELL T E L
Sbjct: 185 LRYMSPEQISSQ-DYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDL------- 231
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + F L+ LS +P R S +L
Sbjct: 232 --RDGIIS-------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 38/289 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-REIMILRRLDH 182
+F +KIG+G +S V+RA + G VALKKV+ + R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGL---SSCHDIKFSEPQVKCYMRQLLHGV 238
PN+IK N + +V E + DL+ + E V Y QL +
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
EH H R +MHRDIK +N+ + G++KLGD GL +SK S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERI 208
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGR-TEVEQL-HKIFKLCGSPPEEYWKKSKL 356
+ YN D+WS+GC+ E+ + G + L KI + P L
Sbjct: 209 HENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP-------L 258
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P ++ L++ C++ +P KR + +
Sbjct: 259 PSD------------------HYSEELRQLVNMCINPDPEKRPDVTYVY 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-61
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 27/299 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNI 69
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+KL + + L+ E+ L + + E + +R ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 243 LRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
GI+HR+IK NI+ + + + KL DFG A L + ++ S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 299 MGST-------NYNVSVDLWSVGCVFAELLIGKP----ILKGRTEVEQLHKIFKLCGSPP 347
+ Y +VDLWS+G F G R E ++KI G P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 348 EEYWKKSKLPHGDM-FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
K +G + + P L + ++ L + K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQFF 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-59
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 51/292 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++G+G++ V R ++ TG A+KKVR + F+ E E++ L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSP 110
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHGV 238
I+ L G + + + E +E G S + E + Y+ Q L G+
Sbjct: 111 RIVPLYGAVREG--PWVNIFMELLE---GG--SLGQLIKQMGCLPEDRALYYLGQALEGL 163
Query: 239 EHCHLRGIMHRDIKASNILVNNEGIL-KLGDFGLANILTSKNKQKLTSRVVTL----WYR 293
E+ H R I+H D+KA N+L++++G L DFG A L K + +
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE++MG + VD+WS C+ +L G T+ + K+ PP
Sbjct: 224 APEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPPP----- 274
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ P P I L EP R +A L
Sbjct: 275 ---------IREIP---------PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-59
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 27/299 (9%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNI 69
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+KL + + L+ E+ L + + E + +R ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 243 LRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
GI+HR+IK NI+ + + + KL DFG A L + ++ S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 299 MGST-------NYNVSVDLWSVGCVFAELLIGKP----ILKGRTEVEQLHKIFKLCGSPP 347
+ Y +VDLWS+G F G R E ++KI G P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 348 EEYWKKSKLPHGDM-FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
K +G + + P L + ++ L + K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQFF 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-58
Identities = 69/313 (22%), Positives = 120/313 (38%), Gaps = 56/313 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
FE ++ +G+G + VF A+ A+K++R N + + + RE+ L +L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 184 NIIK----------LEGVITSRLSNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCY 230
I++ E + S +Y+ + +L C +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-----------KN 279
Q+ VE H +G+MHRD+K SNI + ++K+GDFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
+ T +V T Y PE + G+ +Y+ VD++S+G + ELL P V L +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV 240
Query: 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG 399
P + +K P ++ LS P +R
Sbjct: 241 RN--LKFPPLFTQKY--------------------------PCEYVMVQDMLSPSPMERP 272
Query: 400 TASSLLMCEYFTT 412
A +++ F
Sbjct: 273 EAINIIENAVFED 285
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 85/335 (25%), Positives = 142/335 (42%), Gaps = 51/335 (15%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-MAREIMILR 178
P + + +G+G ++ F + T ++ A K V R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQ 233
L H +++ G + +++V E S ++ +EP+ + Y+RQ
Sbjct: 97 SLAHQHVVGFHGFFEDN--DFVFVVLEL-----CRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
++ G ++ H ++HRD+K N+ +N + +K+GDFGLA + ++K T Y
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYI 208
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE+L ++ VD+WS+GC+ LL+GKP + E +I K EY
Sbjct: 209 APEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY--- 258
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
+P K P A LI L +P R T + LL E+FT+
Sbjct: 259 -SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS- 297
Query: 414 PYACDPSSLPKY----PPKKEIDAKQRDEARRRKV 444
P+ LP PP+ I D + R+ +
Sbjct: 298 --GYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 58/307 (18%), Positives = 116/307 (37%), Gaps = 62/307 (20%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-D 181
F +LEKIG G + SVF+ + G + A+K+ + + RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIK---FSEPQVKCYMRQLLHG 237
H ++++ + + + EY LA S + F E ++K + Q+ G
Sbjct: 70 HSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGIL-------------------KLGDFGLANILTSK 278
+ + H ++H DIK SNI ++ I K+GD G ++S
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK 338
++ SR + E+L + + D++++ +P+ + +Q H+
Sbjct: 188 QVEEGDSR-----FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHE 239
Query: 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
I + G P +P + + +L+ + +P +R
Sbjct: 240 IRQ--GRLPR-------IP-------------------QVLSQEFTELLKVMIHPDPERR 271
Query: 399 GTASSLL 405
+A +L+
Sbjct: 272 PSAMALV 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-57
Identities = 84/319 (26%), Positives = 136/319 (42%), Gaps = 43/319 (13%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-MAREIMILR 178
P + + +G+G ++ F + T ++ A K V R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
L H +++ G + +++V E L L +EP+ + Y+RQ++ G
Sbjct: 71 SLAHQHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
++ H ++HRD+K N+ +N + +K+GDFGLA + ++K T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 186
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
L ++ VD+WS+GC+ LL+GKP + E +I K EY +P
Sbjct: 187 LSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 235
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417
K P A LI L +P R T + LL E+FT+
Sbjct: 236 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS---GY 273
Query: 418 DPSSLPK----YPPKKEID 432
P+ LP PP+ I
Sbjct: 274 IPARLPITCLTIPPRFSIA 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-56
Identities = 61/299 (20%), Positives = 118/299 (39%), Gaps = 46/299 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + ++K+G+G +S V + G ALK++ + RE + R +HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHP 86
Query: 184 NIIKLEGVI--TSRLSNTIYLVFEYMEH-DLAGL---SSCHDIKFSEPQVKCYMRQLLHG 237
NI++L + +L+ + + L +E Q+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK--------QKLTSRVVT 289
+E H +G HRD+K +NIL+ +EG L D G N + Q ++ T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 290 LWYRPPELLMGSTN--YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSP 346
+ YR PEL ++ + D+WS+GCV ++ G+ P + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--------------YDMVFQK 252
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + PQ+P + L+++ ++++P++R LL
Sbjct: 253 GDSVALAV---QNQLSIPQSPR----------HSSALWQLLNSMMTVDPHQRPHIPLLL 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIK 187
+G+GTY V+ R+++ +A+K++ + + + EI + + L H NI++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 188 LEGVITSRLSNTIYLVFEYMEHD-LAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
G + I + E + L+ L S +K +E + Y +Q+L G+++ H
Sbjct: 84 YLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 245 GIMHRDIKASNILVNN-EGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPE-LLMGS 301
I+HRDIK N+L+N G+LK+ DFG + L N T TL Y PE + G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-LHKIFKLCGSPPEEYWKKSKLPHGD 360
Y + D+WS+GC E+ GKP E + + K+ P +P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE--------IP--- 248
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + A I C +P KR A+ LL
Sbjct: 249 ----------------ESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-55
Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 46/294 (15%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
+IG+G++ +V++ + T VA +++ + E +L+ L HPNI++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 190 G--VITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLLHGVEHCH 242
T + I LV E M +G + ++ + RQ+L G++ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMT---SG--TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 243 LRG--IMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
R I+HRD+K NI + G +K+GD GLA T K + + T + PE M
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPE--M 201
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y+ SVD+++ G E+ + +E + +I++ S
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGV------------ 246
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
KP + K P ++I+ C+ +R + LL +F +
Sbjct: 247 ---KPASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 9e-55
Identities = 64/305 (20%), Positives = 111/305 (36%), Gaps = 45/305 (14%)
Query: 112 GEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA 171
G+ +V + SF + +G G ++ R + + VA+K++ PE F
Sbjct: 12 GDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFAD 65
Query: 172 REIMILRRLD-HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCY 230
RE+ +LR D HPN+I+ R Y+ E L D +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIELCAATLQEYVEQKDFAHLGLEPITL 123
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-----ILKLGDFGLANILTSKNK--QKL 283
++Q G+ H H I+HRD+K NIL++ + DFGL L +
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 284 TSRVVTLWYRPPELLMGSTN--YNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIF 340
+ T + PE+L +VD++S GCVF ++ G + + +
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
+ A +LI+ ++++P KR +
Sbjct: 244 ACSLDCLHPEKHED--------------------------VIARELIEKMIAMDPQKRPS 277
Query: 401 ASSLL 405
A +L
Sbjct: 278 AKHVL 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 79/300 (26%), Positives = 137/300 (45%), Gaps = 35/300 (11%)
Query: 114 AVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-MAR 172
++ + + E F+ +G+G+++ V+RA + TG VA+K + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYM 231
E+ I +L HP+I++L SN +YLV E + ++ FSE + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW 291
Q++ G+ + H GI+HRD+ SN+L+ +K+ DFGLA L +++ T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351
Y PE+ S + + D+WS+GC+F LLIG+P T L+K+ +Y
Sbjct: 178 YISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
++P + A DLI L P R + SS+L + +
Sbjct: 230 ---EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 68/352 (19%), Positives = 129/352 (36%), Gaps = 43/352 (12%)
Query: 123 AESFEKLEKIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
+E L IG+G +V AR TG+ V ++++ + E + F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-------KFSEPQVKCYMRQ 233
+HPNI+ + N +++V +M G S D+ +E + ++
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMA---YG--SAKDLICTHFMDGMNELAIAYILQG 136
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT------SRV 287
+L +++ H G +HR +KAS+IL++ +G + L + S +++ V
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 288 VTLWYRPPELLMGSTN-YNVSVDLWSVGCVFAELLIGKP-------------ILKGRT-- 331
L + PE+L + Y+ D++SVG EL G L G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 332 --EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDT 389
+ + + + + F+P ++
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 390 CLSIEPYKRGTASSLLMCEYFTT---QPYACDPSSLPKYPPKKEIDAKQRDE 438
CL P R +AS+LL +F + P L P + Q +
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQD 368
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 89/375 (23%), Positives = 155/375 (41%), Gaps = 56/375 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI++L I + YLVF+ + +L DI +SE ++Q+L +
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGEL-----FEDIVAREFYSEADASHCIQQILESI 141
Query: 239 EHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+CH GI+HR++K N+L+ ++ +KL DFGLA + + + T Y P
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSP 199
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKK 353
E+L Y+ VD+W+ G + LL+G P + +I G+ P W
Sbjct: 200 EVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW-- 254
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
TP A LID+ L++ P KR TA L
Sbjct: 255 -----------------------DTVTPEAKSLIDSMLTVNPKKRITADQAL------KV 285
Query: 414 PYACDPSSLPKYPPKKEIDAKQRDEARRRKVR-ARMREPASSKRQRRARQTLQLQEPNS- 471
P+ C+ + +++ + RRK++ A + +++ + L ++
Sbjct: 286 PWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGP 345
Query: 472 -YSSKELEDEAHFAD 485
+ KE + + D
Sbjct: 346 PSTIKESSESSQTID 360
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-54
Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI++L I + YLVF+ + +L DI +SE ++Q+L +
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGEL-----FEDIVAREFYSEADASHCIQQILESI 118
Query: 239 EHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+CH GI+HR++K N+L+ ++ +KL DFGLA + + + T Y P
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSP 176
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKK 353
E+L Y+ VD+W+ G + LL+G P + +I G+ P W
Sbjct: 177 EVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW-- 231
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
TP A LID+ L++ P KR TA L
Sbjct: 232 -----------------------DTVTPEAKSLIDSMLTVNPKKRITADQAL 260
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-54
Identities = 93/374 (24%), Positives = 158/374 (42%), Gaps = 58/374 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E +++++K+G G Y V R+ T A+K +R + S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVE 239
NI+KL + YLV E + G +I KF+E ++Q+L GV
Sbjct: 97 NIMKLYDFFEDK--RNYYLVMECYK----GGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 240 HCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ H I+HRD+K N+L+ + + ++K+ DFGL+ + +N++K+ R+ T +Y PE
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE 208
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
+L Y+ D+WS+G + LL G P G+T+ E L K+ K + WK
Sbjct: 209 VLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN--- 263
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416
+ A DLI L + +R +A L P+
Sbjct: 264 ----------------------VSEGAKDLIKQMLQFDSQRRISAQQAL------EHPWI 295
Query: 417 CDPSSLPKYPPKKEIDAKQRDEARRRKVRARMRE-PASSKRQRRARQTLQLQEPNSYSSK 475
+ S + + MR+ S K + A + + + +K
Sbjct: 296 KEMCSKKESGIELPSL---------ANAIENMRKFQNSQKLAQAALLYMASKLTSQEETK 346
Query: 476 ELEDEAHFADRKNN 489
EL D D+ +
Sbjct: 347 ELTDIFRHIDKNGD 360
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-53
Identities = 68/297 (22%), Positives = 108/297 (36%), Gaps = 19/297 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+E E++G G + V R TG+ VA+K+ R + P++ EI I+++L+HPN+
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNV 74
Query: 186 IKLEGVITSR----LSNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCYMRQLLHGV 238
+ V ++ L EY E DL + E ++ + + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 239 EHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ H I+HRD+K NI++ I K+ D G A L + T V TL Y P
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAP 192
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
ELL Y V+VD WS G + E + G + Q H + + +
Sbjct: 193 ELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
P + L +RGT F
Sbjct: 252 GAVKFSSVLPTP-----NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-53
Identities = 72/295 (24%), Positives = 130/295 (44%), Gaps = 54/295 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + + +G+G++ V + ++ T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSC------HDI----KFSEPQVKCYMRQ 233
NI+KL ++ ++ Y+V E +I +FSE ++Q
Sbjct: 82 NIMKLFEILEDS--SSFYIVGEL----------YTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKNKQKLTSRVVTL 290
+ G+ + H I+HRD+K NIL+ + + +K+ DFGL+ + K+ R+ T
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTA 187
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+Y PE+L G Y+ D+WS G + LL G P G+ E + L ++ +
Sbjct: 188 YYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
W+ + A DLI L+ P R TA+ L
Sbjct: 246 WRT-------------------------ISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + + +G+G++ V + ++ T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVE 239
NI+KL ++ ++ Y+V E G +I +FSE ++Q+ G+
Sbjct: 82 NIMKLFEILEDS--SSFYIVGELYT----GGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 240 HCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ H I+HRD+K NIL+ ++ +K+ DFGL+ + K+ R+ T +Y PE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE 193
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKKS 354
+L G Y+ D+WS G + LL G P G+ E + L ++ G W
Sbjct: 194 VLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQW--- 246
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + A DLI L+ P R TA+ L
Sbjct: 247 ----------------------RTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 74/321 (23%), Positives = 127/321 (39%), Gaps = 49/321 (15%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ + +E E IG G + V A + VA+K++ + Q + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 180 LDHPNIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI-------------KFSEP 225
HPNI+ TS + ++LV + + G S DI E
Sbjct: 70 CHHPNIVS---YYTSFVVKDELWLVMKLLS---GG--SVLDIIKHIVAKGEHKSGVLDES 121
Query: 226 QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285
+ +R++L G+E+ H G +HRD+KA NIL+ +G +++ DFG++ L +
Sbjct: 122 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 286 RVVTLWYRP----PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
T P PE++ Y+ D+WS G EL G + + +
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLML 238
Query: 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
+ P P +E K + + +I CL +P KR TA
Sbjct: 239 TLQNDP----------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282
Query: 402 SSLLMCEYFTTQPYACDPSSL 422
+ LL ++F A + L
Sbjct: 283 AELLRHKFFQK---AKNKEFL 300
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 61/331 (18%), Positives = 118/331 (35%), Gaps = 43/331 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMA----------- 171
+ + + QG ++ + + K ALK K + + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 172 -REIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME--------HDLAGLSSCHDIKF 222
E+ I+ + + + EG+IT+ + +Y+++EYME L +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 223 SEPQVKCYMRQLLHGVEHCH-LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281
+KC ++ +L+ + H + I HRD+K SNIL++ G +KL DFG + + K
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--- 205
Query: 282 KLTSRVVTLWYRPPELLMGSTNY-NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH-KI 339
K+ T + PPE ++Y VD+WS+G + + + +L I
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG 399
+ + P + +D + L P +R
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 400 TASSLLMCEYFTTQPYACDPSSLPKYPPKKE 430
T+ L E+ + K++
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKELYKKRK 346
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 83/302 (27%), Positives = 127/302 (42%), Gaps = 56/302 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIR----FMAREIMI 176
E++E E +G+G S V R T K A+K +F E ++ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 177 LRRLD-HPNIIKLEGVITSRLSNTIYLVFEYME-----HDLAGLSSCHDIKFSEPQVKCY 230
LR++ HPNII+L+ + +LVF+ M+ L + SE + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKI 129
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
MR LL + H I+HRD+K NIL++++ +KL DFG + L +KL T
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 187
Query: 291 WYRPPELLMGS-----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
Y PE++ S Y VD+WS G + LL G P R ++ L I + G+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 346 P--PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403
W D++ T DL+ L ++P KR TA
Sbjct: 246 YQFGSPEW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 404 LL 405
L
Sbjct: 281 AL 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-52
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDH 182
+ ++ +G+G++ V ++ TG+ A+K + Q + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
PNI+KL + YLV E G +I +FSE +RQ+L G+
Sbjct: 86 PNIMKLYEFFEDK--GYFYLVGEVYT----GGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 239 EHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ H I+HRD+K N+L+ + + +++ DFGL+ + +K+ ++ T +Y P
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E+L G Y+ D+WS G + LL G P G E + L K+ K + WKK
Sbjct: 198 EVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK-- 253
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ +A DLI L+ P R +A L
Sbjct: 254 -----------------------VSESAKDLIRKMLTYVPSMRISARDAL 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-52
Identities = 92/397 (23%), Positives = 149/397 (37%), Gaps = 66/397 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E ++ E++G+G +S V R +V G+ A + + + RE I R L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI++L I+ YL+F+ + +L DI +SE ++Q+L V
Sbjct: 71 NIVRLHDSISEE--GHHYLIFDLVTGGEL-----FEDIVAREYYSEADASHCIQQILEAV 123
Query: 239 EHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
HCH G++HR++K N+L+ ++ +KL DFGLA + +Q T Y P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSP 182
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKK 353
E+L Y VDLW+ G + LL+G P + +I G+ P W
Sbjct: 183 EVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEW-- 237
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
TP A DLI+ L+I P KR TA+ L
Sbjct: 238 -----------------------DTVTPEAKDLINKMLTINPSKRITAAEAL------KH 268
Query: 414 PYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMRE-PASSKRQRRARQTLQLQEPNSY 472
P+ S++ ++E +++ A K + + S
Sbjct: 269 PWISHRSTVASCMHRQE-------------TVDCLKKFNARRKLKGAILTVMLATRNFSV 315
Query: 473 SSKELEDEAHFADRKNNNNDNNTSRTYKGRGSAVGRE 509
+E+ +N D + G
Sbjct: 316 RKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEP 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-52
Identities = 80/345 (23%), Positives = 134/345 (38%), Gaps = 58/345 (16%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKV------RFDNFQPESIRFMAREIMILRRLDHP 183
+ +G G V A E T K VA+K + + + + EI IL++L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDI----KFSEPQVKCYMRQLL 235
IIK++ + Y+V E ME D + + E K Y Q+L
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGELFD--------KVVGNKRLKEATCKLYFYQML 124
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
V++ H GI+HRD+K N+L++++ ++K+ DFG + IL + + T Y
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTY 182
Query: 293 RPPELLMGS--TNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEE 349
PE+L+ YN +VD WS+G + L G P + RT+V +I + E
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
W + + A+DL+ L ++P R T L +
Sbjct: 243 VW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 410 FTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASS 454
+ L + + + + R R E +
Sbjct: 278 LQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 71/333 (21%), Positives = 114/333 (34%), Gaps = 80/333 (24%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRL 180
+ + IGQG+Y V A E T + A+K K + P+ + + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYME-------------------------------- 208
HPNI +L V I LV E
Sbjct: 86 HHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 209 --------HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV-- 258
+ G D E + MRQ+ + + H +GI HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 259 NNEGILKLGDFGLANILTSKNK---QKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVG 314
N +KL DFGL+ N +T++ T ++ PE+L + +Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 315 CVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKKSKLPHGDMFKPQNPYEGCL 372
+ LL+G G + + + ++ +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY--------------------- 300
Query: 373 RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+P A DL+ L+ +R A L
Sbjct: 301 ----NVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-51
Identities = 82/295 (27%), Positives = 127/295 (43%), Gaps = 52/295 (17%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRRLD 181
FE +G+G + +V+ ARE + ++ALK + +R RE+ I L
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLR 67
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIKFSEPQVKCYMRQLLH 236
HPNI++L G + +YL+ EY G L KF E + Y+ +L +
Sbjct: 68 HPNILRLYGYFHD--ATRVYLILEYAPL---GTVYRELQKLS--KFDEQRTATYITELAN 120
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ +CH + ++HRDIK N+L+ + G LK+ DFG + S + T TL Y PPE
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPE 177
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ G ++ VDLWS+G + E L+GKP + T E +I +
Sbjct: 178 MIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------------- 221
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+ P T A DLI L P +R +L + T
Sbjct: 222 --VEFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
K+G G + V E ++G +K + D Q + + EI +L+ LDHPNIIK+
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 190 GVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
V + +Y+V E E + + SE V M+Q+++ + + H +
Sbjct: 87 EVFEDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 246 IMHRDIKASNILVNN---EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
++H+D+K NIL + +K+ DFGLA + K+ + T+ T Y PE+
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPEVFKR-- 200
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
+ D+WS G V LL G G + E K + E +
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT-------- 252
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P AVDL+ L+ +P +R +A+ +L
Sbjct: 253 ------------------PQAVDLLKQMLTKDPERRPSAAQVL 277
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 96/380 (25%), Positives = 141/380 (37%), Gaps = 67/380 (17%)
Query: 52 SKEGERSEDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAGWPAWLTAAA 111
+ P +RE ++ S + + L + + DA+ +
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLY--FQSM 77
Query: 112 GEAVYGLVPMRAESFEKL----EKIGQGTYSSVFRAREVATGKMVALK-----KVRFDNF 162
G A+ F + + IG+G S V R ATG A+K R
Sbjct: 78 GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 163 QPESIRFM-AREIMILRRL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSS 216
Q E +R RE ILR++ HP+II L S + ++LVF+ M D
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESS--SFMFLVFDLMRKGELFD------ 189
Query: 217 CHDI----KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ SE + + MR LL V H I+HRD+K NIL+++ ++L DFG +
Sbjct: 190 --YLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 273 NILTSKNKQKLTSRVVTLWYRPPELLMGS-----TNYNVSVDLWSVGCVFAELLIGKPIL 327
L + +KL T Y PE+L S Y VDLW+ G + LL G P
Sbjct: 248 CHL--EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 328 KGRTEVEQLHKIFKLCGSP--PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVD 385
R ++ L I + G W D + T D
Sbjct: 306 WHRRQILMLRMI--MEGQYQFSSPEW-------------------------DDRSSTVKD 338
Query: 386 LIDTCLSIEPYKRGTASSLL 405
LI L ++P R TA L
Sbjct: 339 LISRLLQVDPEARLTAEQAL 358
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-50
Identities = 84/301 (27%), Positives = 123/301 (40%), Gaps = 55/301 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-----------FDNFQPESIRFMAR 172
ES+ K+ K+G G Y V +E A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 173 EIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME-----HDLAGLSSCHDIKFSEPQV 227
EI +L+ LDHPNIIKL V + YLV E+ E + KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRH-----KFDECDA 148
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKNKQKLT 284
M+Q+L G+ + H I+HRDIK NIL+ N +K+ DFGL++ KL
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLR 206
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG 344
R+ T +Y PE+L YN D+WS G + LL G P G+ + + + K+ K
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
WK + A +LI L+ + KR TA
Sbjct: 265 YFDFNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCTAEEA 299
Query: 405 L 405
L
Sbjct: 300 L 300
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-50
Identities = 89/362 (24%), Positives = 141/362 (38%), Gaps = 69/362 (19%)
Query: 108 TAAAGEAVYGLVPMRAESFEKL----EKIGQGTYSSVFRAREVATGKMVALK---KVRFD 160
+ G + + FE + E IG+G +S V R TG+ A+K +F
Sbjct: 5 ISGGGGGILDM-ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63
Query: 161 NFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHD 219
+ S + RE I L HP+I++L +S +Y+VFE+M+ DL C +
Sbjct: 64 SSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GMLYMVFEFMDGADL-----CFE 116
Query: 220 I--------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGD 268
I +SE YMRQ+L + +CH I+HRD+K +L+ N +KLG
Sbjct: 117 IVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328
FG+A L ++ RV T + PE++ Y VD+W G + LL G
Sbjct: 177 FGVAIQL-GESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 329 GRTEVEQLHKIFK--LCGSP--PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV 384
G E ++F+ + G W + +A
Sbjct: 235 GTKE-----RLFEGIIKGKYKMNPRQW-------------------------SHISESAK 264
Query: 385 DLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKV 444
DL+ L ++P +R T L P+ + E + R RRK+
Sbjct: 265 DLVRRMLMLDPAERITVYEAL------NHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318
Query: 445 RA 446
+
Sbjct: 319 KG 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 56/301 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKV------RFDNFQPESIRFMAREIMIL 177
+ + + +G G V A E T K VA++ + + + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL------AGLSSCHDIKFSEPQVKCY 230
++L+HP IIK++ + Y+V E ME +L + E K Y
Sbjct: 195 KKLNHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 244
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRV 287
Q+L V++ H GI+HRD+K N+L++++ ++K+ DFG + IL + +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC 302
Query: 288 VTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLCG 344
T Y PE+L+ YN +VD WS+G + L G P + RT+V +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
+ E W + + A+DL+ L ++P R T
Sbjct: 363 NFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEA 397
Query: 405 L 405
L
Sbjct: 398 L 398
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-50
Identities = 48/336 (14%), Positives = 84/336 (25%), Gaps = 57/336 (16%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES-IRFMAREIMILRRL 180
+ +E + G S VF R+V + ALK S + + RL
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 181 DHPN------------------------IIKLEGVITSRLSNTIYLVFEYMEHDLAGL-- 214
+ +L L+ DL L
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 215 ----SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFG 270
+ QL+ + +G++H N+ + +G L LGD
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 271 LANILTSKNKQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKG 329
+ + + + V + Y P E L S + +++ W +G +
Sbjct: 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDT 389
T + P + C LI
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLA--------------------FGSCTPLPDFVKTLIGR 335
Query: 390 CLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKY 425
L+ + +R + F Q SSL
Sbjct: 336 FLNFDRRRRLLPLEAMETPEF-LQLQNEISSSLSTG 370
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 74/311 (23%), Positives = 118/311 (37%), Gaps = 64/311 (20%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPN 184
+ +G G+ +V + G+ VA+K++ + EI +L D HPN
Sbjct: 17 VVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPN 70
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLA------GLSSCHDIKFSEPQVKCYMRQLLHGV 238
+I+ T+ +Y+ E +L +S + E +RQ+ GV
Sbjct: 71 VIRYYCSETTD--RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 239 EHCHLRGIMHRDIKASNILVNNEGI-------------LKLGDFGLANILT---SKNKQK 282
H H I+HRD+K NILV+ + + DFGL L S +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 283 LTSRVVTLWYRPPELLMGSTN------YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQL 336
L + T +R PELL S N S+D++S+GCVF +L
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------------- 235
Query: 337 HKIFKLCGSPP--EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIE 394
G P ++Y ++S + G + + A DLI + +
Sbjct: 236 -------GKHPFGDKYSRESNIIRGIFSLDEMKCLH-----DRSLIAEATDLISQMIDHD 283
Query: 395 PYKRGTASSLL 405
P KR TA +L
Sbjct: 284 PLKRPTAMKVL 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 74/305 (24%), Positives = 125/305 (40%), Gaps = 50/305 (16%)
Query: 117 GLVPMRAESFEKL----EKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIR 168
G+ P + + E E++G G ++ V + RE +TG A K ++ + + S
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSE 224
+ RE+ ILR++ H N+I L V +R + L+ E + D SE
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFL----AQKESLSE 114
Query: 225 PQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNK 280
+ +++Q+L GV + H + I H D+K NI++ +KL DFGLA+ + ++
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDG 172
Query: 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
+ + T + PE++ + D+WS+G + LL G G T+ E L I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
+ EE++ + A D I L E KR T
Sbjct: 232 SVSYDFDEEFF-------------------------SHTSELAKDFIRKLLVKETRKRLT 266
Query: 401 ASSLL 405
L
Sbjct: 267 IQEAL 271
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 80/288 (27%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRLDHPNII 186
IG+G++ V A + T A K K ++ + + +EI I++ LDHPNII
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFK---QEIEIMKSLDHPNII 69
Query: 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVEHCH 242
+L IYLV E G + F E M+ +L V +CH
Sbjct: 70 RLYETFEDN--TDIYLVMELCT----GGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 243 LRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ HRD+K N L + LKL DFGLA K + + ++V T +Y P++L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLE 181
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEEYWKKSKLP 357
G Y D WS G + LL G P T+ E + KI G+ PE+ W
Sbjct: 182 G--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDW------ 231
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ +P A LI L+ P +R T+ L
Sbjct: 232 -------------------LNVSPQAESLIRRLLTKSPKQRITSLQAL 260
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 94/336 (27%), Positives = 156/336 (46%), Gaps = 71/336 (21%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
E F KLEKIG+G++ VF+ + T K+VA+K + + + E I + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 183 PNIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHG 237
P + K G S L +T ++++ EY+ G S D+ E Q+ +R++L G
Sbjct: 80 PYVTKYYG---SYLKDTKLWIIMEYLG---GG--SALDLLEPGPLDETQIATILREILKG 131
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+++ H +HRDIKA+N+L++ G +KL DFG+A LT + K + V T ++ PE+
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEV 190
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
+ S Y+ D+WS+G EL G+P P
Sbjct: 191 IKQSA-YDSKADIWSLGITAIELARGEP-------------------------------P 218
Query: 358 HGD------MFK-PQNP---YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407
H + +F P+N EG +++ + ++ CL+ EP R TA LL
Sbjct: 219 HSELHPMKVLFLIPKNNPPTLEG-------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271
Query: 408 EYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRK 443
++ A S L + ID +R +A +
Sbjct: 272 KFILRN--AKKTSYL-----TELIDRYKRWKAEQSH 300
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 58/296 (19%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDH 182
++F +E +G G +S VF ++ TGK+ ALK ++ + S+ EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDI----KFSEPQVKCYMRQL 234
NI+ LE + S YLV + + D I ++E ++Q+
Sbjct: 66 ENIVTLEDIYEST--THYYLVMQLVSGGELFD--------RILERGVYTEKDASLVIQQV 115
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLW 291
L V++ H GI+HRD+K N+L + + DFGL+ + +++ T
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPG 172
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP--PEE 349
Y PE+L Y+ +VD WS+G + LL G P TE + KI + G
Sbjct: 173 YVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESP 229
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+W D + +A D I L +P +R T L
Sbjct: 230 FW-------------------------DDISESAKDFICHLLEKDPNERYTCEKAL 260
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 82/333 (24%), Positives = 146/333 (43%), Gaps = 43/333 (12%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRLD 181
+ F L +IG G++ +V+ AR+V ++VA+KK+ + Q E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 182 HPNIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
HPN I+ G L +LV EY + L H E ++ L G+ +
Sbjct: 113 HPNTIQYRG---CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
H ++HRD+KA NIL++ G++KLGDFG A+I+ N S V T ++ PE+++
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFVGTPYWMAPEVILA 224
Query: 301 STN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y+ VD+WS+G EL KP L + + ++ + +
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNES----------- 270
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
P L+ ++ + +D+CL P R T+ LL +
Sbjct: 271 -----PA------LQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR---ERP 314
Query: 419 PSSL-PKYPPKKEIDAKQRDEARRRKVRARMRE 450
P+ + K+ + + R+ + +E
Sbjct: 315 PTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 347
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-49
Identities = 84/360 (23%), Positives = 141/360 (39%), Gaps = 45/360 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ ++ LE++G G + V R E ATG++ K + P + EI I+ +L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHP 108
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+I L + + L+ E++ +L + D K SE +V YMRQ G++H H
Sbjct: 109 KLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 243 LRGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
I+H DIK NI+ +K+ DFGLA L + + T + PE++
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 224
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
D+W++G + LL G G ++E L + + E+ +
Sbjct: 225 EP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 274
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL----MCEYFTTQPYA 416
+P A D I L EP KR T L + +
Sbjct: 275 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
Query: 417 CDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKE 476
S K +++I K D + R+ +S ++ R + Q +SY ++
Sbjct: 319 IPSSRYNKI--RQKIKEKYADWPAPQPAIGRIANFSSLRKHRP----QEYQIYDSYFDRK 372
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-49
Identities = 89/357 (24%), Positives = 137/357 (38%), Gaps = 64/357 (17%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKL 188
+ +G+G++S + + + A+K + + + +EI L+ + HPNI+KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVEHCHLR 244
V + +LV E + G I FSE + MR+L+ V H H
Sbjct: 72 HEVFHDQ--LHTFLVMELLN----GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 245 GIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
G++HRD+K N+L +E +K+ DFG A + N Q L + TL Y PELL
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQ- 183
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTE---VEQLHKIFK--LCGSP--PEEYWKKS 354
Y+ S DLWS+G + +L G+ + +I K G E W
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW--- 240
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
K+ + A DLI L+++P KR S L
Sbjct: 241 ----------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLR------YNE 272
Query: 415 YACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNS 471
+ D S L P A V+A A +K +R LQ +
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFH--AFNKYKREG---FCLQNVDK 324
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-49
Identities = 85/387 (21%), Positives = 151/387 (39%), Gaps = 53/387 (13%)
Query: 117 GLVPMRAESFEKL----EKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIR 168
G+ + + E E++G G ++ V + RE +TG A K ++ + +
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 169 FMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSE 224
+ RE+ ILR++ HPNII L V +R + L+ E + D SE
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENR--TDVVLILELVSGGELFDFL----AQKESLSE 114
Query: 225 PQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNK 280
+ +++Q+L GV + H + I H D+K NI++ +KL DFGLA+ + ++
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDG 172
Query: 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
+ + T + PE++ + D+WS+G + LL G G T+ E L I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
+ EE++ + A D I L E KR T
Sbjct: 232 AVSYDFDEEFF-------------------------SQTSELAKDFIRKLLVKETRKRLT 266
Query: 401 ASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRA 460
L + T ++ + ++ ++ RRR + + R
Sbjct: 267 IQEALRHPWITPVD---TQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSL 323
Query: 461 RQTLQLQEPNSYSSKELEDEAHFADRK 487
+ + L+ + E + E + A RK
Sbjct: 324 MKKVHLRTSEDLRNCESDTEENIARRK 350
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-49
Identities = 77/320 (24%), Positives = 124/320 (38%), Gaps = 56/320 (17%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIM 175
+ F+ +G+G + +V+ ARE ++ALK + +R REI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR---REIE 66
Query: 176 ILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-----LSSCHDIKFSEPQVKCY 230
I L HPNI+++ R IYL+ E+ G L +F E + +
Sbjct: 67 IQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPR---GELYKELQKHG--RFDEQRSATF 119
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
M +L + +CH R ++HRDIK N+L+ +G LK+ DFG + S + + TL
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTL 176
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
Y PPE++ G T ++ VDLW G + E L+G P + E +I
Sbjct: 177 DYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--------- 226
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
D+ P + + DLI L P +R ++ +
Sbjct: 227 --------VDLKFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
Query: 411 TTQPYACDPSSLPKYPPKKE 430
LP +
Sbjct: 267 KANS----RRVLPPVYQSTQ 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 66/351 (18%), Positives = 118/351 (33%), Gaps = 62/351 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + E +G+G + V R E ++ K K V+ ++ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYME----HD--LAGLSSCHDIKFSEPQVKCYMRQLLHG 237
NI+ L S + ++FE++ + + +E ++ Y+ Q+
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINT-----SAFELNEREIVSYVHQVCEA 114
Query: 238 VEHCHLRGIMHRDIKASNILVNNE--GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
++ H I H DI+ NI+ +K+ +FG A L K Y P
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAP 172
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E+ + + D+WS+G + LL G T + + I + EE +
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---- 227
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
K+ + A+D +D L E R TAS L + +
Sbjct: 228 ---------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 416 ACDPSSLPKYPPKKEIDAKQRDEARRRKVRA--------RMREPASSKRQR 458
+ K R + R+ + + Q+
Sbjct: 267 RVSTKVIRTL--------KHRRYYHTLIKKDLNMVVSAARISCGGAIRSQK 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 81/304 (26%), Positives = 141/304 (46%), Gaps = 46/304 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + + EKIGQG +V+ A +VATG+ VA++++ Q + EI+++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 184 NIIKLEGVITSRL-SNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
NI+ S L + +++V EY+ G S D+ E Q+ R+ L +
Sbjct: 78 NIVNYLD---SYLVGDELWVVMEYLA---GG--SLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
E H ++HRDIK+ NIL+ +G +KL DFG +T + K ++ V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVV 188
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
Y VD+WS+G + E++ G+P L ++ + +
Sbjct: 189 TRK-AYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGT----------- 233
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
P+ L+ K + D ++ CL ++ KRG+A LL ++ A
Sbjct: 234 -----PE------LQNPEK-LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI---AKP 278
Query: 419 PSSL 422
SSL
Sbjct: 279 LSSL 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 48/295 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRR 179
+ +E E++G G ++ V + R+ TGK A K ++ + + S + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYME-----HDLAGLSSCHDIKFSEPQVKCYMRQL 234
+ HPNII L + ++ + L+ E + L +E + +++Q+
Sbjct: 65 IRHPNIITLHDIFENK--TDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQI 117
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGI----LKLGDFGLANILTSKNKQKLTSRVVTL 290
L GV + H + I H D+K NI++ ++ + +KL DFG+A+ + + + + T
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTP 175
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+ PE++ + D+WS+G + LL G G T+ E L I + EEY
Sbjct: 176 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + + A D I L +P +R T + L
Sbjct: 235 F-------------------------SNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 50/302 (16%)
Query: 120 PMRAESFEKL----EKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMA 171
R E+ + E++G G ++ V + RE +TG A K ++ + + S +
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 172 REIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQV 227
RE+ IL+ + HPN+I L V ++ + L+ E + D +E +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE----GILKLGDFGLANILTSKNKQKL 283
+++Q+L+GV + H I H D+K NI++ + +K+ DFGLA+ + +
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEF 174
Query: 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC 343
+ T + PE++ + D+WS+G + LL G G T+ E L + +
Sbjct: 175 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403
+EY+ + + A D I L +P KR T
Sbjct: 234 YEFEDEYF-------------------------SNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 404 LL 405
L
Sbjct: 269 SL 270
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 73/307 (23%), Positives = 125/307 (40%), Gaps = 35/307 (11%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
++ + FEK+ ++G G VF+ +G ++A K + + +P + RE+ +L
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC 88
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI-----KFSEPQVKCYMRQLL 235
+ P I+ G S I + E+M+ G S + + E + ++
Sbjct: 89 NSPYIVGFYGAFYS--DGEISICMEHMD---GG--SLDQVLKKAGRIPEQILGKVSIAVI 141
Query: 236 HGVEHCHLRG-IMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRVVTLWYR 293
G+ + + IMHRD+K SNILVN+ G +KL DFG++ L S S V T Y
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYM 197
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
PE L G+ +Y+V D+WS+G E+ +G+ + E E +
Sbjct: 198 SPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 354 SKLPHGDMFKPQN---------------PYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ P + K E + F+ D ++ CL P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 399 GTASSLL 405
L+
Sbjct: 317 ADLKQLM 323
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-48
Identities = 84/372 (22%), Positives = 138/372 (37%), Gaps = 49/372 (13%)
Query: 51 GSKEGERSEDKPKGSRELK--------KLKKGSSNKKSNAFSIKLGLSLRHVDAEQIAAG 102
G S G+ L S + ++ L+ R + +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSA 61
Query: 103 WPAWLTAAAGEAVYGLVPMRAESFE------KLEKIGQGTYSSVFRAREVATGKMVALKK 156
+ A + +V + + K E +G G + V + E ATG +A K
Sbjct: 62 LAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 157 VRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYME-HDLAGLS 215
++ + + EI ++ +LDH N+I+L S+ N I LV EY++ +L
Sbjct: 122 IKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEYVDGGELFDRI 177
Query: 216 SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN--EGILKLGDFGLAN 273
+E +M+Q+ G+ H H I+H D+K NIL N +K+ DFGLA
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV 333
K ++KL T + PE++ + D+WSVG + LL G G +
Sbjct: 238 RY--KPREKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393
E L+ I +E + +D + A + I L
Sbjct: 295 ETLNNILACRWDLEDEEF-------------------------QDISEEAKEFISKLLIK 329
Query: 394 EPYKRGTASSLL 405
E R +AS L
Sbjct: 330 EKSWRISASEAL 341
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-47
Identities = 98/494 (19%), Positives = 164/494 (33%), Gaps = 76/494 (15%)
Query: 34 NLNYVF--SSKNPSGALDFGSKEGERSEDKPKGSRELKKLKKGSSNKKSNAFSIKLGLSL 91
Y F ++N G SK E + E K+ + +++ K
Sbjct: 75 GKQYEFRIIAENKHGQ----SKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGK----- 125
Query: 92 RHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKL----EKIGQGTYSSVFRAREVA 147
+++ + ++ + V ++ + E++G G + V R E A
Sbjct: 126 -----GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 148 TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYM 207
TG A K V + +EI + L HP ++ L N + +++E+M
Sbjct: 181 TGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFM 236
Query: 208 E-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN--EGIL 264
+L + K SE + YMRQ+ G+ H H +H D+K NI+ L
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 265 KLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324
KL DFGL L KQ + T + PE+ G D+WSVG + LL G
Sbjct: 297 KLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGL 353
Query: 325 PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV 384
G + E L + + + + +
Sbjct: 354 SPFGGENDDETLRNVKSCDWNMDDSAF-------------------------SGISEDGK 388
Query: 385 DLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKV 444
D I L +P R T L ++P +A RD
Sbjct: 389 DFIRKLLLADPNTRMTIHQAL------------------EHPWLTPGNAPGRDSQIPSSR 430
Query: 445 RARMREPASSKRQRRARQTLQLQEPNSYSS--KELEDEAHFADRKNNNNDNNTSRTYKGR 502
++R+ +K L ++YSS K E D + ++ K
Sbjct: 431 YTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPY 490
Query: 503 GSAVGREPRNPTFD 516
G+ V E ++ F
Sbjct: 491 GTEV-GEGQSANFY 503
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 72/310 (23%), Positives = 132/310 (42%), Gaps = 49/310 (15%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
E +E + ++G G + V++A+ TG + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI------KFSEPQVKCYMRQLLH 236
P I+KL G ++++ E+ G + I +EPQ++ RQ+L
Sbjct: 76 PYIVKLLG--AYYHDGKLWIMIEFCP---GG--AVDAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ H + I+HRD+KA N+L+ EG ++L DFG++ +++ + + T ++ PE
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPE 187
Query: 297 LLMGSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
++M T Y+ D+WS+G E+ +P E+ + + K+ S P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDP----- 239
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
P L ++ D + L P R +A+ LL + ++
Sbjct: 240 -----------PT------LLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281
Query: 413 QPYACDPSSL 422
+L
Sbjct: 282 ---ITSNKAL 288
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 73/343 (21%), Positives = 120/343 (34%), Gaps = 63/343 (18%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKL 188
+ +G G V TG+ ALK + R +E+ + P+I+ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 189 EGVI--TSRLSNTIYLVFEYMEHDLAG------LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
V + ++ E ME G + D F+E + MR + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 241 CHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
H I HRD+K N+L ++ +LKL DFG A T L + T +Y PE+
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPEV 200
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK--LCGSP--PEEYWKK 353
L Y+ S D+WS+G + LL G P T + + G P W
Sbjct: 201 LGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW-- 257
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
+ + A LI L +P +R T + +
Sbjct: 258 -----------------------SEVSEDAKQLIRLLLKTDPTERLTITQFM------NH 288
Query: 414 PYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKR 456
P+ +P+ P Q D+ +V+ M ++ R
Sbjct: 289 PWINQSMVVPQ-TPLHTARVLQEDKDHWDEVKEEMTSALATMR 330
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 77/304 (25%), Positives = 139/304 (45%), Gaps = 46/304 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ KIG+G+ V ARE +G+ VA+K + D + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 184 NIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGV 238
N++++ S L ++++ E+++ G + DI + +E Q+ +L +
Sbjct: 103 NVVEMYK---SYLVGEELWVLMEFLQ---GG--ALTDIVSQVRLNEEQIATVCEAVLQAL 154
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H +G++HRDIK+ +IL+ +G +KL DFG ++ K+ K S V T ++ PE++
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVI 213
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
S Y VD+WS+G + E++ G+P + + +L SPP P
Sbjct: 214 SRS-LYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPP---------P- 259
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
K +N +P D ++ L +P +R TA LL +
Sbjct: 260 ----KLKNS---------HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ---TGL 303
Query: 419 PSSL 422
P L
Sbjct: 304 PECL 307
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 96/331 (29%), Positives = 159/331 (48%), Gaps = 55/331 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E F+ LEK+G+G+Y SV++A TG++VA+K+V ++ + I +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 184 NIIKLEGVITSRLSNT-IYLVFEYMEHDLAGLSSCHDI------KFSEPQVKCYMRQLLH 236
+++K G S NT +++V EY AG S DI +E ++ ++ L
Sbjct: 85 HVVKYYG---SYFKNTDLWIVMEYCG---AG--SVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
G+E+ H +HRDIKA NIL+N EG KL DFG+A LT K + + T ++ PE
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD-TMAKRNTVIGTPFWMAPE 195
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
++ YN D+WS+G E+ GKP ++ + IF + +PP
Sbjct: 196 VIQEI-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPP--------- 242
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416
P R+ + ++ D + CL P +R TA+ LL + + A
Sbjct: 243 -------PT------FRKP-ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS---A 285
Query: 417 CDPSSLPKYPPKKEIDAKQRDEARRRKVRAR 447
S L + I+ + +R++ + R
Sbjct: 286 KGVSIL-----RDLINEAMDVKLKRQESQQR 311
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 88/359 (24%), Positives = 133/359 (37%), Gaps = 66/359 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRL 180
+ +E E IG G+YS R AT A+K K + D EI IL R
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRY 72
Query: 181 -DHPNIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDI----KFSEPQVKCYM 231
HPNII L+ V +Y+V E M+ D I FSE + +
Sbjct: 73 GQHPNIITLKDVYDDG--KYVYVVTELMKGGELLD--------KILRQKFFSEREASAVL 122
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANILTSKNKQKLTSRV 287
+ VE+ H +G++HRD+K SNIL N +++ DFG A L ++N L +
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPC 181
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP---ILKGRTEVEQLHKIFKLCG 344
T + PE+L Y+ + D+WS+G + +L G T E L +I
Sbjct: 182 YTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
S YW + TA DL+ L ++P++R TA+ +
Sbjct: 241 SLSGGYW-------------------------NSVSDTAKDLVSKMLHVDPHQRLTAALV 275
Query: 405 LMCEYFTTQPYACD-PSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQ 462
L + + P + A R + S +R
Sbjct: 276 LRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGI 334
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 69/307 (22%), Positives = 117/307 (38%), Gaps = 55/307 (17%)
Query: 117 GLVPMRAESFEKL-----EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA 171
L E+F +++G+G ++ V + +TG+ A K ++ + +
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 172 REIMILRRLDH-PNIIKLEGVITSRLSNTIYLVFEYME---------HDLAGLSSCHDIK 221
EI +L P +I L V + + I L+ EY +LA
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENT--SEIILILEYAAGGEIFSLCLPELAE-------M 127
Query: 222 FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLANILTSK 278
SE V ++Q+L GV + H I+H D+K NIL+++ G +K+ DFG++ +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--G 185
Query: 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK 338
+ +L + T Y PE+L + D+W++G + LL G E
Sbjct: 186 HACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
Query: 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
I ++ EE + + A D I + L P KR
Sbjct: 245 ISQVNVDYSEETF-------------------------SSVSQLATDFIQSLLVKNPEKR 279
Query: 399 GTASSLL 405
TA L
Sbjct: 280 PTAEICL 286
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 39/296 (13%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
AE + L +IG+G Y SV + +G+++A+K++R + + + ++ ++ R
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMR 76
Query: 180 L-DHPNIIKLEGVITSRLSNTIYLVFEYM----EHDLAGLSSCHDIKFSEPQVKCYMRQL 234
D P I++ G + ++ E M + + S D E +
Sbjct: 77 SSDCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 235 LHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYR 293
+ + H I+HRDIK SNIL++ G +KL DFG++ L + Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYM 192
Query: 294 PPELLMGSTN---YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEE 349
PE + S + Y+V D+WS+G EL G+ P K + +QL ++ K G PP
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP-- 248
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+L + + ++F+P+ ++ ++ CL+ + KR LL
Sbjct: 249 -----QLSNSE---------------EREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 50/299 (16%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
E L ++G GT V++ R TG ++A+K++R E + + ++ ++ +
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLK 79
Query: 180 L-DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-----FSEPQVKCYMRQ 233
D P I++ G + + +++ E M G + K E +
Sbjct: 80 SHDCPYIVQCFGTFIT--NTDVFIAMELM-----GTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 234 LLHGVEHCH-LRGIMHRDIKASNILVNNEGILKLGDFGLANILT-SKNKQKLTSRVVTLW 291
++ + + G++HRD+K SNIL++ G +KL DFG++ L K K
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAA 189
Query: 292 YRPPELLMGSTN----YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSP 346
Y PE + Y++ D+WS+G EL G+ P +T+ E L K+ + P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP 247
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P LP F+ + CL+ + KR + LL
Sbjct: 248 P-------LLPGHM-----------------GFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 87/348 (25%), Positives = 147/348 (42%), Gaps = 61/348 (17%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR----EIMILRRL- 180
+E L+ IG+G++ V +A + + VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 181 -----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQL 234
+ N+I + T R N I + FE + +L L + + FS P V+ + +
Sbjct: 152 KQDKDNTMNVIHMLENFTFR--NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEG--ILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
L ++ H I+H D+K NIL+ +G +K+ DFG + Q++ + + + +Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFY 265
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
R PE+++G Y + +D+WS+GC+ AELL G P+L G E +QL + +L G P ++
Sbjct: 266 RAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTA----------------------------- 383
SK + + C D +
Sbjct: 325 ASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 384 --VDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKK 429
+D + CL +P R T L + + P + K K+
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK--PPTGEKTSVKR 429
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 82/345 (23%), Positives = 139/345 (40%), Gaps = 63/345 (18%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-D 181
A FE +E +G GTY V++ R V TG++ A+K + + + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 182 HPNIIKLEG----VITSRLSNTIYLVFEYMEHDLAGLSSCHDI-------KFSEPQVKCY 230
H NI G + + ++LV E+ AG S D+ E +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCG---AG--SVTDLIKNTKGNTLKEEWIAYI 134
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
R++L G+ H H ++HRDIK N+L+ +KL DFG++ L ++ T + T
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTP 193
Query: 291 WYRPPELLMGSTN----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
++ PE++ N Y+ DLWS+G E+ G P L ++ + +F + +P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNP 250
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
P K K ++ I++CL +R L+
Sbjct: 251 A---------P---RLKS------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
Query: 407 CEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREP 451
+ QP + K ID R +K R E
Sbjct: 287 HPFIRDQP----NERQVRIQLKDHID-------RTKKKRGEKDET 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 69/321 (21%), Positives = 124/321 (38%), Gaps = 67/321 (20%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALK-----KVRFDNFQPESIRFMAREIMILRRL 180
+ +G+G + +VF + VA+K +V + +S+ E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 181 D----HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI--------KFSEPQVK 228
HP +I+L ++ LV E D+ E +
Sbjct: 92 GAGGGHPGVIRLLDWFETQ--EGFMLVLERPL-------PAQDLFDYITEKGPLGEGPSR 142
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQKLTSRV 287
C+ Q++ ++HCH RG++HRDIK NIL++ G KL DFG +L + T
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD 199
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
T Y PPE + + + +WS+G + L+ + +CG P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGIL-------------------LYDM--VCGDIP 238
Query: 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407
E + ++ ++ P + +P LI CL+ +P R + +L+
Sbjct: 239 FE--RDQEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEILLD 284
Query: 408 EYFTTQPYACDPSSLPKYPPK 428
+ P P + K P
Sbjct: 285 PWM-QTPAEDVPLNPSKGGPA 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 76/287 (26%), Positives = 120/287 (41%), Gaps = 52/287 (18%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
++G+G S V+R ++ T K ALK ++ + + + EI +L RL HPNIIKL+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVEHCHLRG 245
+ + I LV E + G I +SE ++Q+L V + H G
Sbjct: 115 EIFETP--TEISLVLELVT----GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 246 IMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRD+K N+L LK+ DFGL+ I+ +++ + + T Y PE+L G
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRG-C 225
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK--LCGSP--PEEYWKKSKLPH 358
Y VD+WSVG + LL G +F+ L +W
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCEYYFISPWW------- 275
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + A DL+ + ++P KR T L
Sbjct: 276 ------------------DEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 47/346 (13%), Positives = 94/346 (27%), Gaps = 81/346 (23%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-ESIRFMAREIMILRRL 180
R + + +GQ + A + TG+ + F P +I+ M E++ LR L
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 181 -------------------------DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGL- 214
+I++ + + ++ M+ +L
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 215 -----SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269
S Q++ + H G++H ++ +I+++ G + L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 270 GLANILTSKNKQKLTSRVVTLWYRPPELL----------MGSTNYNVSVDLWSVGCVFAE 319
V+ + PPEL T S D W++G V
Sbjct: 251 EHL-----VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 320 LLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDF 379
+ + + IF+ CK+
Sbjct: 306 IWCADLPITKDAALGGSEWIFR---------------------------------SCKNI 332
Query: 380 TPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKY 425
L++ L R + + ++LP Y
Sbjct: 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 79/324 (24%), Positives = 127/324 (39%), Gaps = 52/324 (16%)
Query: 132 IGQGTYSSVFRAREVATGKMVALK-----KVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+G+G+Y V + T A+K K+R +++ +EI +LRRL H N+I
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVEHCH 242
+L V+ + +Y+V EY G+ D +F Q Y QL+ G+E+ H
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVC---GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-KNKQKLTSRVVTLWYRPPELLMGS 301
+GI+H+DIK N+L+ G LK+ G+A L + + ++PPE+ G
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 302 TNYN-VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
++ VD+WS G + G +G + I K Y +P
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------GSY----AIP--- 233
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
D P DL+ L EP KR + + +F + P
Sbjct: 234 ----------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH----PP 273
Query: 421 SLPKYPPKKEIDAKQRDEARRRKV 444
+ P D +D R V
Sbjct: 274 AEAPVPIPPSPD--TKDRWRSMTV 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMI-LRRL 180
+A+ E + ++G+G Y V + R V +G+++A+K++R + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTV 63
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYME---HDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
D P + G + +++ E M+ E + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 238 VEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+EH H ++HRD+K SN+L+N G +K+ DFG++ L K Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDID-AGCKPYMAPE 179
Query: 297 LLMGSTN---YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWK 352
+ N Y+V D+WS+G EL I + P T +QL ++ + P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSP----- 232
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+LP F+ VD CL +R T L+
Sbjct: 233 --QLPAD------------------KFSAEFVDFTSQCLKKNSKERPTYPELM 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 62/305 (20%), Positives = 113/305 (37%), Gaps = 59/305 (19%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPN 184
+ +G ++ V+ A++V +G+ ALK++ + E R + +E+ +++L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 185 IIKLEGVI---TSRLSNTIYLVFEYMEHDLAGL-----SSCHDIKFSEPQVKCYMRQLLH 236
I++ E L S V Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 237 GVEHCHLRG--IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--------- 285
V+H H + I+HRD+K N+L++N+G +KL DFG A ++ ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 286 --RVVTLWYRPPEL--LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
R T YR PE+ L + D+W++GC+ ++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI----------------------LYL 245
Query: 342 LC-GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
LC P E K ++ +G P + LI L + P +R +
Sbjct: 246 LCFRQHPFEDGAKLRIVNGKYSIPPHDT----------QYTVFHSLIRAMLQVNPEERLS 295
Query: 401 ASSLL 405
+ ++
Sbjct: 296 IAEVV 300
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 64/292 (21%), Positives = 107/292 (36%), Gaps = 55/292 (18%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKL 188
+ +G G V + T + ALK + + RE+ + R P+I+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 189 EGVI--TSRLSNTIYLVFEYMEHDLAG------LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
V + +V E ++ G + D F+E + M+ + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 241 CHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
H I HRD+K N+L ++ ILKL DFG A + LT+ T +Y PE+
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEV 234
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK--LCGSP--PEEYWKK 353
L G Y+ S D+WS+G + LL G P + + G P W
Sbjct: 235 L-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-- 291
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ + LI L EP +R T + +
Sbjct: 292 -----------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFM 320
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 78/358 (21%), Positives = 139/358 (38%), Gaps = 52/358 (14%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRL------- 180
+ K+G G +S+V+ A+++ VA+K VR + + EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTK 79
Query: 181 ----DHPNIIKLEGVITSRLSNT--IYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQ 233
+I+KL + N + +VFE + +L + VK +Q
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 234 LLHGVEHCHLR-GIMHRDIKASNILVNNE------GILKLGDFGLANILTSKNKQKLTSR 286
LL G+++ H R GI+H DIK N+L+ +K+ D G A + T+
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNS 195
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT------EVEQLHKIF 340
+ T YR PE+L+G+ + D+WS C+ EL+ G + + + + + +I
Sbjct: 196 IQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 341 KLCGSPP----------EEYWKKSKLPHGDMFKPQNPYEGCLRER---CKDFTPTAVDLI 387
+L G P ++ L P E L E+ KD D +
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 388 DTCLSIEPYKRGTASSLLMCEYFTTQPYACD--PSSLPKYPPKKEIDAKQRDEARRRK 443
L ++P KR A L+ + + Y +I + ++
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDHKR 372
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 81/309 (26%), Positives = 136/309 (44%), Gaps = 37/309 (11%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
+L K IG+G ++ V AR + TG+ VA+K + P S++ + RE+ I++ L+HPNI+
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
KL VI + T+YL+ EY ++ H + E + + RQ++ V++CH +
Sbjct: 78 KLFEVIETE--KTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
I+HRD+KA N+L++ + +K+ DFG +N KL + Y PEL G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 306 VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365
VD+WS+G + L+ G G+ E ++ + G P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-----------------GKYRIP- 234
Query: 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKY 425
+ +L+ L + P KRGT ++ + + D
Sbjct: 235 -----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGHEEDELKPFVE 282
Query: 426 PPKKEIDAK 434
P D K
Sbjct: 283 PELDISDQK 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 59/310 (19%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMA--------------- 171
++IG+G+Y V A A+K K + R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 172 ------REIMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDIKFS 223
+EI IL++LDHPN++KL V+ + +Y+VFE + G + S
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ---GPVMEVPTLKPLS 135
Query: 224 EPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283
E Q + Y + L+ G+E+ H + I+HRDIK SN+LV +G +K+ DFG++N + L
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-L 194
Query: 284 TSRVVTLWYRPPELLMGST-NYN-VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341
++ V T + PE L + ++ ++D+W++G + G+ + KI
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254
Query: 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401
+ P P D DLI L P R
Sbjct: 255 -----------------QALEFPDQP----------DIAEDLKDLITRMLDKNPESRIVV 287
Query: 402 SSLLMCEYFT 411
+ + + T
Sbjct: 288 PEIKLHPWVT 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 79/278 (28%), Positives = 117/278 (42%), Gaps = 46/278 (16%)
Query: 132 IGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
+G+G Y V A T + VA+K R + PE+I+ +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 189 EGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
G N YL EY D DI EP + + QL+ GV + H
Sbjct: 71 YGHRREG--NIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGSTN 303
GI HRDIK N+L++ LK+ DFGLA + N+++L +++ TL Y PELL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 304 YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
+ VD+WS G V +L G+ P + +EY + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE---KKTY 227
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
P+ K + L+ L P R T
Sbjct: 228 LN--PW--------KKIDSAPLALLHKILVENPSARIT 255
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 73/340 (21%), Positives = 128/340 (37%), Gaps = 51/340 (15%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALK-----KVRFDNF-QPESIRFMAREIMILRR 179
+ + +G G + V+ A + K V +K KV D + + + + EI IL R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH--DLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
++H NIIK+ + ++ LV E DL H + EP RQL+
Sbjct: 86 VEHANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSA 142
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
V + L+ I+HRDIK NI++ + +KL DFG A L + + + T+ Y PE+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEV 200
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP-EEYWKKSKL 356
LMG+ +++WS+G L + P E + +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCELEETVE- 238
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416
+ P + + L+ L P +R T L+ + TQP
Sbjct: 239 --AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV-TQPVN 283
Query: 417 CDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKR 456
+ + + ++ A + + A ++
Sbjct: 284 LADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 66/343 (19%), Positives = 114/343 (33%), Gaps = 83/343 (24%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKL 188
+ +G G V + T + ALK ++ R RE+ + R P+I+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 76
Query: 189 EGVI--TSRLSNTIYLVFEYMEHDLAG------LSSCHDIKFSEPQVKCYMRQLLHGVEH 240
V + +V E ++ G + D F+E + M+ + +++
Sbjct: 77 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 241 CHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
H I HRD+K N+L ++ ILKL DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KET 170
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK--LCGSP--PEEYWKK 353
Y+ S D+WS+G + LL G P + + G P W
Sbjct: 171 TGE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS- 227
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
+ + LI L EP +R T + +
Sbjct: 228 ------------------------EVSEEVKMLIRNLLKTEPTQRMTITEFM------NH 257
Query: 414 PYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKR 456
P+ + +P+ P + D+ R V+ M ++ R
Sbjct: 258 PWIMQSTKVPQ-TPLHTSRVLKEDKERWEDVKEEMTSALATMR 299
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 69/319 (21%), Positives = 112/319 (35%), Gaps = 64/319 (20%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA----REIMILRRLD 181
++ +G G + SV+ V+ VA+K V D E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 182 H--PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI--------KFSEPQVKCYM 231
+I+L ++ L+ E D+ E + +
Sbjct: 105 SGFSGVIRLLDWFERP--DSFVLILERP-------EPVQDLFDFITERGALQEELARSFF 155
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
Q+L V HCH G++HRDIK NIL++ N G LKL DFG +L T T
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTR 212
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
Y PPE + + S +WS+G + ++ +CG P E
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFE- 250
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
++ G +F Q + LI CL++ P R T + +
Sbjct: 251 -HDEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297
Query: 411 T--TQPYACDPSSLPKYPP 427
P L P
Sbjct: 298 QDVLLPQETAEIHLHSLSP 316
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 70/336 (20%), Positives = 136/336 (40%), Gaps = 58/336 (17%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRRL- 180
+ +E IG+G++ V +A + + VA+K ++ F ++ E+ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMN 108
Query: 181 -----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQL 234
I+ L+ R N + LVFE + ++L L + + S + + +Q+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFR--NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 235 LHGVEHCHLR--GIMHRDIKASNILVNNEG--ILKLGDFGLANILTSKNKQKLTSRVVTL 290
+ I+H D+K NIL+ N +K+ DFG + + Q++ + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSR 222
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
+YR PE+L+G Y++++D+WS+GC+ E+ G+P+ G EV+Q++KI ++ G PP
Sbjct: 223 FYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 351 WKKSKLPH-------GDMFKPQNPYEGCLRERCKDFTPTA-------------------- 383
++ + + +G +
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 384 --------VDLIDTCLSIEPYKRGTASSLLMCEYFT 411
DLI L +P R L +F
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 84/346 (24%), Positives = 129/346 (37%), Gaps = 53/346 (15%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMILRRLDHP 183
L + +G+G Y V A T + VA+K R + PE+I+ +EI I + L+H
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHE 65
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
N++K G N YL EY D DI EP + + QL+ GV
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELL 298
+ H GI HRDIK N+L++ LK+ DFGLA + N+++ L TL Y PELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
+ VD+WS G V +L G+ P + +EY +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE-- 223
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT----- 412
+ P+ K + L+ L P R T + ++
Sbjct: 224 -KKTYLN--PW--------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272
Query: 413 -QPYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQ 457
+ + + P + + +R SK
Sbjct: 273 AKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEH 318
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 64/309 (20%), Positives = 118/309 (38%), Gaps = 66/309 (21%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKL 188
+ +G+G ++ V + T + A+K + + + RE+ +L + H N+++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDI----KFSEPQVKCYMRQLLHGVEHCHLR 244
+ YLVFE M G S I F+E + ++ + ++ H +
Sbjct: 77 IEFFEEE--DRFYLVFEKMR----GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 245 GIMHRDIKASNILVNNEG---ILKLGDFGLA------NILTSKNKQKLTSRVVTLWYRPP 295
GI HRD+K NIL + +K+ DF L + + +L + + Y P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 296 ELLMG----STNYNVSVDLWSVGCVFAELLIGKP-----------ILKGRTEVEQLHKIF 340
E++ ++ Y+ DLWS+G + LL G P +G + +F
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 341 K--LCGSP--PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPY 396
+ G P++ W + A DLI L +
Sbjct: 251 ESIQEGKYEFPDKDW-------------------------AHISCAAKDLISKLLVRDAK 285
Query: 397 KRGTASSLL 405
+R +A+ +L
Sbjct: 286 QRLSAAQVL 294
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 65/337 (19%), Positives = 121/337 (35%), Gaps = 64/337 (18%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAR----EIMILRRL 180
+E ++ +G+G + V + G + VA+K V+ ++ EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 181 ------DHPNIIKLEGVITSRLSNTIYLVFEYME---HDLAGLSSCHDIKFSEPQVKCYM 231
+++ I +VFE + +D + + F ++
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHH--GHICIVFELLGLSTYDF--IKENGFLPFRLDHIRKMA 124
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGI-------------------LKLGDFGLA 272
Q+ V H + H D+K NIL +K+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE 332
+ + + ++ V T YR PE+++ ++ D+WS+GC+ E +G +
Sbjct: 185 ----TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 333 VEQLHKIFKLCGSPPEEYWKKSKLP----HGDMFKPQNPYEG-CLRERCKD--------- 378
E L + ++ G P+ +K++ H + ++ G + CK
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 379 -FTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
DLI L +P KR T L +F
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 68/349 (19%), Positives = 130/349 (37%), Gaps = 60/349 (17%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGK-MVALKKVRFDNFQPESIRFMAR----EIMILRRL 180
+E + +G+GT+ V + A GK VALK +R ++ EI +L+++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73
Query: 181 ------DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQ 233
+ + + + + FE + + ++ + + P V+ Q
Sbjct: 74 KEKDKENKFLCVLMSDWFNFH--GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGI-------------------LKLGDFGLANI 274
L H + H + H D+K NIL N +++ DFG A
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334
+ + + T+ V T YRPPE+++ + D+WS+GC+ E G + + E
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 335 QLHKIFKLCGSPPEEYWKKSKLPH-----GDMFKPQNPYEGCLRERCKD----------F 379
L + K+ G P +++ G ++ + ++E CK
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 380 TPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPK 428
DL+ L +P +R T + L+ +F + P +
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 71/339 (20%), Positives = 133/339 (39%), Gaps = 70/339 (20%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAR----EIMILRRL- 180
F + K+G GT+ V + + K A+K VR +I+ R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 181 ----DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQLL 235
++ NI+K G + + L+FE + L + + ++ F +K Y ++L
Sbjct: 90 NDDINNNNIVKYHGKFMYY--DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGI-------------------------LKLGDFG 270
+ + + H D+K NIL+++ +KL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 271 LANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR 330
A + S + T YR PE+++ ++VS D+WS GCV AEL G + +
Sbjct: 208 CA----TFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 331 TEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGC------------------- 371
+E L + + P+ ++ +G + ++ +
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 372 LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
L + K D + + L I+P R + + LL ++
Sbjct: 323 LYKIIKH--ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-41
Identities = 45/374 (12%), Positives = 97/374 (25%), Gaps = 74/374 (19%)
Query: 90 SLRHVDAEQIAAGWPAWLTAAAGEAVYGLVPMRAESFEKLEKIGQGTYSSVFRAREVATG 149
D+ + W V + R + + +GQ + A + TG
Sbjct: 48 MQSAADSLVSTSLWNT----GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 103
Query: 150 KMVALKKVRFDNFQPES-IRFMAREIMILRRL-------------------------DHP 183
+ + F P + I+ M E++ LR L
Sbjct: 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGL------SSCHDIKFSEPQVKCYMRQLLHG 237
+I++ + + ++ M+ +L S Q++
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+ H G++H ++ +I+++ G + L F + + +
Sbjct: 224 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERM 283
Query: 298 LMGS----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
L T + D W++G + + IF+ C + P+
Sbjct: 284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP---- 339
Query: 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
L++ L R + + Q
Sbjct: 340 -----------------------------VRALLEGFLRYPKEDRLLPLQAMETPEY-EQ 369
Query: 414 PYACDPSSLPKYPP 427
++LP Y
Sbjct: 370 LRTELSAALPLYQT 383
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 68/338 (20%), Positives = 132/338 (39%), Gaps = 52/338 (15%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
R E +G+G + + TG+++ +K+ F E+ R +E+ ++R L+
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLE 65
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
HPN++K GV+ + + EY++ L G+ D ++ Q + + + G+ +
Sbjct: 66 HPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-------------KNKQKLTSRV 287
H I+HRD+ + N LV + + DFGLA ++ +++K + V
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347
++ PE++ G +Y+ VD++S G V E+ +
Sbjct: 184 GNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEI---------------------IGRVNA 221
Query: 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAV-DLIDTCLSIEPYKRGTASSLL- 405
+ + + G G L C P + + C ++P KR + L
Sbjct: 222 DPDYLPRTMDFGLN------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 406 MCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRK 443
E LP P +++D + RR +
Sbjct: 276 WLETLRMHL----AGHLPLGPQLEQLDRGFWETYRRGE 309
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-40
Identities = 42/253 (16%), Positives = 87/253 (34%), Gaps = 30/253 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ +G+G ++ V+ A + + LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHD-----LAGLSSCHDIKFSEPQVKCYMRQ 233
+K + N LV E + + + + + V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNN-----------EGILKLGDFGLANILTS-KNKQ 281
+L+ +E H I+H DIK N ++ N L L D G + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI-LKGRTEVEQLHKIF 340
T++ T ++ E+L +N +D + V +L G + +K + +F
Sbjct: 241 IFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 341 KLCGSPPEEYWKK 353
+ P + W +
Sbjct: 300 R--RLPHLDMWNE 310
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 64/359 (17%), Positives = 113/359 (31%), Gaps = 105/359 (29%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVA----------------------LKKVRFDN 161
FE ++ +G+G + VF A+ A L K+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 162 F----------------------------------QPESIRFMAREIMILRRLDHPNIIK 187
P + + +I + N +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 188 LEGVITSRLSNTIYLVFEYMEH-DLAGL--SSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
+ S +Y+ + +L C Q+ VE H +
Sbjct: 126 --QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK-----------LTSRVVTLWYR 293
G+MHRD+K SNI + ++K+GDFGL + +++ T +V T Y
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 294 PPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC-GSPPEEYWK 352
PE + G NY+ VD++S+G + ELL T++E++ I + P + +
Sbjct: 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMERVRIITDVRNLKFPLLFTQ 297
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
K P ++ LS P +R A+ ++ F
Sbjct: 298 KY--------------------------PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 78/327 (23%), Positives = 132/327 (40%), Gaps = 51/327 (15%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKMVALK---KVRFDNFQ-PESIRFMAREIMILRRLDH 182
+ + +G+G++ V A T + VALK + + REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
P+IIKL VIT+ I +V EY +L + +E + + + +Q++ +E+CH
Sbjct: 69 PHIIKLYDVITTP--TDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH 125
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRD+K N+L+++ +K+ DFGL+NI+ + L + + Y PE++ G
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
VD+WS G V +L+G+ K+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS-----------------CVYV 226
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSL 422
P +P A LI + +P +R T + +F +L
Sbjct: 227 MP------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--------NL 266
Query: 423 PKY-PPKKEIDAKQRDEARRRKVRARM 448
P Y P +E+ D K+ M
Sbjct: 267 PDYLRPMEEVQGSYADSRIVSKLGEAM 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 77/286 (26%), Positives = 133/286 (46%), Gaps = 46/286 (16%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRR 179
R E F+ + +G+G++S+V ARE+AT + A+K + + + + ++ RE ++ R
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCYMRQ 233
LDHP +KL T + +Y Y + + + F E + Y +
Sbjct: 87 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKY----IRKIG--SFDETCTRFYTAE 138
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWY 292
++ +E+ H +GI+HRD+K NIL+N + +++ DFG A +L+ ++KQ + V T Y
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PELL + S DLW++GC+ +L+ G P + E KI K
Sbjct: 199 VSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------L 247
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ P + F P A DL++ L ++ KR
Sbjct: 248 EYDFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 74/347 (21%), Positives = 133/347 (38%), Gaps = 49/347 (14%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
++ ++ ++ IG G + R+ T ++VA+K + E+++ REI+ R L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLR 74
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DL------AGLSSCHDIKFSEPQVKCYMRQL 234
HPNI++ + VI + + ++ EY +L AG +FSE + + + +QL
Sbjct: 75 HPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAG-------RFSEDEARFFFQQL 125
Query: 235 LHGVEHCHLRGIMHRDIKASNILV--NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
L GV +CH I HRD+K N L+ + LK+ DFG + S + S V T Y
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAY 183
Query: 293 RPPELLMGSTNYN-VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351
PE+L+ Y+ D+WS G +L+G + E K +
Sbjct: 184 IAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---------- 232
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
++ P + +P LI +P R + + +F
Sbjct: 233 ---RILSVKYSIPDDIR----------ISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
Query: 412 TQ-PYACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQ 457
P S ++ Q + + + ++
Sbjct: 280 KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCL 326
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-MAREIMILRRLDHPNI 185
L +G GT+ V TG VA+K + + + + REI L+ HP+I
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
IKL VI++ ++V EY+ +L H + E + + +Q+L V++CH
Sbjct: 74 IKLYQVISTP--TDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH 130
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
++HRD+K N+L++ K+ DFGL+N++ + + L + + Y PE++ G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364
VD+WS G + LL G KI G + P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG-----------------GVFYIP 231
Query: 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
+ + L+ L ++P KR T + E+F
Sbjct: 232 ------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+ G T+ + +V ++ E L + KF ++ RQ G+++ H
Sbjct: 81 NILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTS-KNKQKLTSRVVTLWYRPPELLMGS 301
+ I+HRD+K++NI ++ + +K+GDFGLA + + ++ + PE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 302 TN--YNVSVDLWSVGCVFAELLIGK 324
+ Y+ D+++ G V EL+ G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPES-----IRFMAREIMILR 178
E ++IG+G + V + R V +VA+K + + + E+ + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
L+HPNI+KL G++ N +V E++ DL M + G
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 238 VEHCHLRG--IMHRDIKASNILVNNEG-----ILKLGDFGLANILTSKNKQKLTSRVVTL 290
+E+ + I+HRD+++ NI + + K+ DFGL+ ++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNF 190
Query: 291 WYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGK 324
+ PE + +Y D +S + +L G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 79/326 (24%), Positives = 136/326 (41%), Gaps = 47/326 (14%)
Query: 128 KLEK-IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRF-MAREIMILRRLDHPNI 185
L +G GT+ V + TG VA+K + + + + REI L+ HP+I
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 186 IKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
IKL VI++ + I++V EY+ +L + + E + + +Q+L GV++CH
Sbjct: 79 IKLYQVISTP--SDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH 135
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNY 304
++HRD+K N+L++ K+ DFGL+N++ + + L + + Y PE++ G
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 305 NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364
VD+WS G + LL G KI G + P
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD-----------------GIFYTP 236
Query: 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPK 424
+ P+ + L+ L ++P KR T + E+F LPK
Sbjct: 237 ------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ--------DLPK 276
Query: 425 Y--PPKKEIDAKQRDEARRRKVRARM 448
Y P + D+ ++V +
Sbjct: 277 YLFPEDPSYSSTMIDDEALKEVCEKF 302
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
EKIG G++ +V RA G VA+K + +F E + RE+ I++RL HP
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 184 NIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
NI+ G +T + +V EY+ + L S + + E + + G+
Sbjct: 95 NIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMN 151
Query: 240 HCHLRG--IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+ H R I+HR++K+ N+LV+ + +K+ DFGL+ + + S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEV 210
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGK 324
L N D++S G + EL +
Sbjct: 211 LRDEP-SNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 45/217 (20%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR---EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
E E E IG+G + V+ R EVA ++ + + + ++ RE+M R+
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGEVA------IRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
H N++ G S + ++ + L + I + + ++++ G+
Sbjct: 87 RHENVVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT----SKNKQKLTSRVVTLWYRPP 295
+ H +GI+H+D+K+ N+ +N G + + DFGL +I + + KL + L + P
Sbjct: 145 YLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 296 ELLMGSTN--------YNVSVDLWSVGCVFAELLIGK 324
E++ + ++ D++++G ++ EL +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 32/209 (15%), Positives = 75/209 (35%), Gaps = 18/209 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L K+ + +++ R G + +K ++ ++ R E LR HP
Sbjct: 10 KQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 184 NIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
N++ + G S + L+ +M +++ L + + Q + + G+
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 240 --HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
H I + + +++++ + ++ + S R+ + PE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEA 179
Query: 298 LMG--STNYNVSVDLWSVGCVFAELLIGK 324
L S D+WS + EL+ +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ E E +G+G + V +A+ K VA+K++ ++ + F+ E+ L R++HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKA---FI-VELRQLSRVNHP 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYME----HDLAGLSSCH-DIKFSEPQVKCYMRQLLHGV 238
NI+KL G N + LV EY E +++ L ++ + Q GV
Sbjct: 62 NIVKLYGACL----NPVCLVMEYAEGGSLYNV--LHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 239 EHCH---LRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
+ H + ++HRD+K N+L+ G +LK+ DFG A + + +T+ + +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMA 171
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGK 324
PE+ GS NY+ D++S G + E++ +
Sbjct: 172 PEVFEGS-NYSEKCDVFSWGIILWEVITRR 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 12/229 (5%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMIL 177
++ + FE L+ IG+G +S V + TG++ A+K + + + E F E +L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE-ERDVL 115
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLH 236
D I +L N +YLV EY DL L S + + Y+ +++
Sbjct: 116 VNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
++ H G +HRDIK NIL++ G ++L DFG L + + V T Y PE
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 297 LLMG------STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
+L + +Y D W++G E+ G+ + E KI
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRA--REVATGKMVALKKVRFDNFQP--ESIRFMAREIMILRR 179
E IG G + V+RA G VA+K R D + ++I + +E +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L HPNII L GV + LV E+ L + + + + Q+ G+
Sbjct: 63 LKHPNIIALRGVCLKE--PNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQIARGM 118
Query: 239 EHCHLRG---IMHRDIKASNILVNNEG--------ILKLGDFGLANILTSKNKQKLTSRV 287
+ H I+HRD+K+SNIL+ + ILK+ DFGLA ++ S
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA 175
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGK 324
+ PE++ S ++ D+WS G + ELL G+
Sbjct: 176 GAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 10/226 (4%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMILR 178
+ E FE L+ IG+G + V + K+ A+K + + E+ F E +L
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLV 129
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
D I L N +YLV +Y DL L S + + E + Y+ +++
Sbjct: 130 NGDSKWITTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
++ H +HRDIK NIL++ G ++L DFG L + + V T Y PE+
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 298 LM----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
L G Y D WS+G E+L G+ + VE KI
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR-FDNFQPESIRFMAREIMILRR 179
M+AE +E ++ IG+G + V R +T K+ A+K + F+ + F E I+
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+ P +++L +Y+V EYM DL L S + E + Y +++ +
Sbjct: 126 ANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLAL 181
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
+ H G +HRD+K N+L++ G LKL DFG + + + + V T Y PE+L
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 299 M---GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
G Y D WSVG E+L+G + V KI
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 80/365 (21%), Positives = 139/365 (38%), Gaps = 90/365 (24%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-----DHP 183
+ K+G G +S+V+ + ++ K VA+K V+ E+ EI +L+ + + P
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 184 N---IIKLEG--VITSRLSNTIYLVFEYMEHDLAGLSSCHDIK-FSEPQVKCYMRQLLHG 237
N +++L I+ I +VFE + H L + + P VK ++Q+L G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 238 VEHCHLR-GIMHRDIKASNILVNNE----------------------------------- 261
+++ H + I+H DIK NIL++
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 262 --------------GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVS 307
+K+ D G A + + T + T YR E+L+GS YN
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEVLIGSG-YNTP 273
Query: 308 VDLWSVGCVFAELLIGKPILKGRT------EVEQLHKIFKLCGSPPEEYWKKSK------ 355
D+WS C+ EL G + + + + + + I +L G P + K
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 356 -----LPHGDMFKPQNPYEGCLRERCK---DFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407
L H KP +E L E+ + + D + L + P KR TA+ L
Sbjct: 334 TKKGDLKHITKLKPWGLFE-VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 408 EYFTT 412
+ +
Sbjct: 393 PWLNS 397
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-33
Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 41/286 (14%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILR 178
P+ +F + +G+G + V + ATGKM A KK+ + + E IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCYMR 232
+++ ++ L ++ + + LV M H + F E + Y
Sbjct: 240 KVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAA 293
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
++ G+E H I++RD+K NIL+++ G +++ D GLA + Q + RV T+ Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGRVGTVGY 351
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE++ Y S D W++GC+ E++ G+ + R + + ++ +L PEEY
Sbjct: 352 MAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY-- 408
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ F+P A L L +P +R
Sbjct: 409 -----------SER------------FSPQARSLCSQLLCKDPAER 431
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 70/319 (21%), Positives = 108/319 (33%), Gaps = 67/319 (21%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
A+ + +++IG+G Y V+ + G+ VA+K F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASW---FRETEIYQTVLMRH 90
Query: 183 PNIIKLEGVIT--SRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLH 236
NI+ + +YL+ +Y E +D L + +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY--L---KSTTLDAKSMLKLAYSSVS 145
Query: 237 GVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ---KLTS 285
G+ H H I HRD+K+ NILV G + D GLA S + +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 286 RVVTLWYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
RV T Y PPE+L S N + D++S G + E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-------------- 251
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCK--------------DFTPTAVDL 386
G EEY +LP+ D+ YE C + L
Sbjct: 252 ---GGIVEEY----QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 387 IDTCLSIEPYKRGTASSLL 405
+ C + P R TA +
Sbjct: 305 MTECWAHNPASRLTALRVK 323
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDH 182
+ FE L IG+G++ V ++ T KM A+K + + +R + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCYMRQLLH 236
P ++ L +++V + + H L F E VK ++ +L+
Sbjct: 75 PFLVNLWYSFQDE--EDMFMVVDLLLGGDLRYH----LQQNV--HFKEETVKLFICELVM 126
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+++ + I+HRD+K NIL++ G + + DF +A +L + ++T+ T Y PE
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--PRETQITTMAGTKPYMAPE 184
Query: 297 LLM--GSTNYNVSVDLWSVGCVFAELLIGKP---ILKGRTEVEQLHKIFKLCGSPPEEYW 351
+ Y+ +VD WS+G ELL G+ I + E +H
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---------- 234
Query: 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P ++ V L+ L P +R
Sbjct: 235 TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 70/319 (21%), Positives = 107/319 (33%), Gaps = 67/319 (21%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
A LE +G+G Y V+R G+ VA+K + + F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSW---FRETELYNTVMLRH 61
Query: 183 PNIIKLEGVIT--SRLSNTIYLVFEYME----HDLAGLSSCHDIKFSEPQVKCYMRQLLH 236
NI+ S ++L+ Y E +D L + +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY--L---QLTTLDTVSCLRIVLSIAS 116
Query: 237 GVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFGLANILTS---KNKQKLTS 285
G+ H H+ I HRD+K+ NILV G + D GLA + + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 286 RVVTLWYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
RV T Y PE+L + VD+W+ G V E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV--------------- 221
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYE------GCLRER-------CKDFTPTAV-DL 386
E+Y K P D+ +E ++R D T T++ L
Sbjct: 222 --SNGIVEDY----KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL 275
Query: 387 IDTCLSIEPYKRGTASSLL 405
+ C P R TA +
Sbjct: 276 MKECWYQNPSARLTALRIK 294
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILR 178
PM + F +G+G + VF + ATGK+ A KK+ + + + E IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCYMR 232
++ I+ L ++ + LV M H + + + F EP+ Y
Sbjct: 241 KVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTA 296
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
Q++ G+EH H R I++RD+K N+L++++G +++ D GLA + + K T +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGF 355
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PELL+G Y+ SVD +++G E++ + + R E + ++ + Y
Sbjct: 356 MAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY-- 412
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P F+P + D + L +P KR
Sbjct: 413 ----P-------------------DKFSPASKDFCEALLQKDPEKR 435
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+++ +G+G + V R TG+ VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L H NI+K +G+ T N I L+ E++ L + K + Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLW 291
++ R +HRD+ A N+LV +E +K+GDFGL + T K+ + W
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----W 195
Query: 292 YRPPELLMGSTNYNV---SVDLWSVGCVFAELL 321
Y PE + + D+WS G ELL
Sbjct: 196 Y-APE----CLMQSKFYIASDVWSFGVTLHELL 223
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 70/316 (22%), Positives = 105/316 (33%), Gaps = 67/316 (21%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
A + E IG+G + V+R + G+ VA+K + F EI L H
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW---FREAEIYQTVMLRH 95
Query: 183 PNIIKLEGVIT--SRLSNTIYLVFEYMEH----DLAGLSSCHDIKFSEPQVKCYMRQLLH 236
NI+ + ++LV +Y EH D L + + +
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--L---NRYTVTVEGMIKLALSTAS 150
Query: 237 GVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFGLANIL---TSKNKQKLTS 285
G+ H H+ I HRD+K+ NILV G + D GLA T
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 286 RVVTLWYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF 340
RV T Y PE+L S N D++++G VF E+ I
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-------------- 256
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYE------GCLRER--------CKDFTPTAVDL 386
G E+Y +LP+ D+ E + R + +
Sbjct: 257 ---GGIHEDY----QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 387 IDTCLSIEPYKRGTAS 402
+ C R TA
Sbjct: 310 MRECWYANGAARLTAL 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ L+++G+G + SV R + TG++VA+KK++ E +R REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 67
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L H NI+K +GV S + L+ EY+ + L H + ++ Y Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLW 291
E+ + +HRD+ NILV NE +K+GDFGL +L K + W
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----W 183
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
Y PE L S S D+WS G V EL
Sbjct: 184 Y-APESLTESKFSVAS-DVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ L+++G+G + SV R + TG++VA+KK++ E +R REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 98
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L H NI+K +GV S + L+ EY+ + L H + ++ Y Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLW 291
E+ + +HRD+ NILV NE +K+GDFGL +L K + W
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----W 214
Query: 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
Y PE L S S D+WS G V EL
Sbjct: 215 Y-APESLTESKFSVAS-DVWSFGVVLYELF 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 33/303 (10%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
++ + LE +G + V++A+ + VA+K F +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 182 HPNIIKLEG-VITSRLSNTIY-LVFEYMEH-DLAGLSSCHDIKFSEPQVK---------C 229
H NI++ G + L+ + E L+ + + ++E
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE-LCHIAETMARGLA 135
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV- 288
Y+ + + G++ H I HRDIK+ N+L+ N + DFGLA + T V
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 289 TLWYRPPELLMGSTNYNVS----VDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG 344
T Y PE+L G+ N+ +D++++G V EL G + L ++
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCK--DFTPTAVDLIDTCLSIEPYKRGTAS 402
P E ++ + + P LR+ + + I+ C + R +A
Sbjct: 256 HPSLEDMQEVVVHKK-----KRPV---LRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 403 SLL 405
+
Sbjct: 308 CVG 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ + ++G+G + SV R TG +VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKA 80
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L I+K GV ++ LV EY+ L H + ++ Y Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLW 291
E+ R +HRD+ A NILV +E +K+ DFGLA +L + + W
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----W 196
Query: 292 YRPPELLMGSTNYNV---SVDLWSVGCVFAELL 321
Y PE S + N+ D+WS G V EL
Sbjct: 197 Y-APE----SLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 66/323 (20%), Positives = 112/323 (34%), Gaps = 66/323 (20%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++ + LE IG+G Y +V++ + VA+K F N Q I + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQ-NFINE--KNIYRVPLMEHD 67
Query: 184 NIIKLEGV---ITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
NI + +T+ LV EY + L + G+
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY--LSLHTSDWVSSCRLAHSVTRGLA 125
Query: 240 HCHL---------RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL------- 283
+ H I HRD+ + N+LV N+G + DFGL+ LT +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 284 TSRVVTLWYRPPELLMGSTN------YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337
S V T+ Y PE+L G+ N VD++++G ++ E+ + L
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL---------- 235
Query: 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGC------------LRERCKDFTPTA-- 383
G EY ++ +E E K+ +
Sbjct: 236 ----FPGESVPEY----QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 384 -VDLIDTCLSIEPYKRGTASSLL 405
+ I+ C + R TA
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAE 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+K+ +G+G + V TG+MVA+K ++ + P+ +EI ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRT 89
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
L H +IIK +G + ++ LV EY+ L Q+ + +Q+ G+
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLW 291
+ H + +HRD+ A N+L++N+ ++K+GDFGLA + + W
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----W 203
Query: 292 YRPPELLMGSTNYNV---SVDLWSVGCVFAELL 321
Y PE + D+WS G ELL
Sbjct: 204 Y-APE----CLKEYKFYYASDVWSFGVTLYELL 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 63/292 (21%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMI 176
+ F+ L +G G++ V R G+ A+K ++ + Q E E ++
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DERLM 59
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCY 230
L + HP II++ G T + + I+++ +Y+E L +F P K Y
Sbjct: 60 LSIVTHPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSL----LRKSQ--RFPNPVAKFY 111
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
++ +E+ H + I++RD+K NIL++ G +K+ DFG A K +T TL
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-----KYVPDVTY---TL 163
Query: 291 W----YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
Y PE++ YN S+D WS G + E+L G ++ KI
Sbjct: 164 CGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----- 217
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ + P F DL+ ++ + +R
Sbjct: 218 -----AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 47/289 (16%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMIL- 177
+ F IG+G + V+ R+ TGKM A+K + + E ++L
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 178 --RRLDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKC 229
D P I+ + + + + + + M H LS FSE ++
Sbjct: 245 LVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYH----LS--QHGVFSEADMRF 296
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT 289
Y +++ G+EH H R +++RD+K +NIL++ G +++ D GLA + K+K + V T
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGT 353
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
Y PE+L Y+ S D +S+GC+ +LL G + ++ H+I ++ + E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVE 412
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P + F+P L++ L + +R
Sbjct: 413 L-------------PDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 64/289 (22%), Positives = 122/289 (42%), Gaps = 63/289 (21%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRR 179
+ F++++ +G G++ V + +G A+K + Q E E IL+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQA 97
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYME------HDLAGLSSCHDIKFSEPQVKCYMRQ 233
++ P ++KLE + + ++ +Y+V EY+ H L +FSEP + Y Q
Sbjct: 98 VNFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSH----LRRIG--RFSEPHARFYAAQ 149
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL--- 290
++ E+ H +++RD+K N+L++ +G +++ DFG A +++ R TL
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWTLCGT 201
Query: 291 -WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
PE+++ YN +VD W++G + E+ G P ++ KI
Sbjct: 202 PEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------- 252
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
K + P F+ DL+ L ++ KR
Sbjct: 253 --GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 126 FEKLEKIGQGTYSSVFRAR-EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
+E I G ++ A G+ V LK + M E L + HP+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVVHPS 140
Query: 185 IIKLEGVI---TSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
I+++ + Y+V EY+ L K + Y+ ++L + +
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSY 197
Query: 241 CHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLM 299
H G+++ D+K NI++ E + KL D G + + S + T ++ PE++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGYLYGTPGFQAPEIVR 250
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRT 331
V+ D+++VG A L + P GR
Sbjct: 251 TGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 58/292 (19%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDN-FQPESIRFMAREIMI 176
FE L+ +GQG++ VF ++++ ++ A+K ++ + +R E I
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDI 79
Query: 177 LRRLDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVK 228
L ++HP I+KL +L YL+ ++ LS F+E VK
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKL----YLILDFLRGGDLFTR----LSKEV--MFTEEDVK 129
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSR 286
Y+ +L ++H H GI++RD+K NIL++ EG +KL DFGL+ +I +++K S
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---DHEKKAYSF 186
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
T+ Y PE++ + S D WS G + E+L G +G+ E + I K
Sbjct: 187 CGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----- 240
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
K +P + +P A L+ P R
Sbjct: 241 -----AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIK 187
+G+G V+ A + ++VALK + P M RE RL P+++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 188 L--EGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
+ G I +L Y+ + DLA + + P+ +RQ+ ++ H
Sbjct: 99 IHDFGEIDGQL----YVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA 153
Query: 245 GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVV-TLWYRPPELLMGS 301
G HRD+K NILV+ + L DFG+A+ T +KLT V TL+Y PE S
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTD---EKLTQLGNTVGTLYYMAPERFSES 210
Query: 302 TNYNVSVDLWSVGCVFAELLIGKP 325
D++++ CV E L G P
Sbjct: 211 H-ATYRADIYALTCVLYECLTGSP 233
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRR 179
A + + +G G + V R K VA+K ++ + + F+ E I+ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQ 102
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
DHPNII+LEGV+T S + +V EYME+ L HD +F+ Q+ +R + G+
Sbjct: 103 FDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL---WYRPP 295
++ G +HRD+ A NIL+N+ + K+ DFGL +L + T+R + W P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SP 219
Query: 296 ELLMGSTNYNV---SVDLWSVGCVFAELL 321
E + Y + D+WS G V E++
Sbjct: 220 E----AIAYRKFTSASDVWSYGIVLWEVM 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-NFQPESI-RFMAREIMILRRLDHP 183
++ ++K+G G S+V+ A + VA+K + + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 184 NIIKLEGVI-TSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
NI+ +I + YLV EY+E L+ H S + Q+L G++H
Sbjct: 72 NIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA 127
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMG 300
H I+HRDIK NIL+++ LK+ DFG+A L+ T+ V+ T+ Y PE G
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQAKG 186
Query: 301 STNYNVSVDLWSVGCVFAELLIGKP 325
+ D++S+G V E+L+G+P
Sbjct: 187 EATDECT-DIYSIGIVLYEMLVGEP 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 62/293 (21%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRR 179
+ F+ L+ +G+GT+ V RE ATG+ A+K +R + + + E +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 180 LDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKCYM 231
HP + L+ RL V EY H LS + F+E + + Y
Sbjct: 62 TRHPFLTALKYAFQTHDRL----CFVMEYANGGELFFH----LS--RERVFTEERARFYG 111
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--- 288
+++ +E+ H R +++RDIK N++++ +G +K+ DFGL K+ ++
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKT 164
Query: 289 ---TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
T Y PE+L +Y +VD W +G V E++ G+ + I
Sbjct: 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---- 219
Query: 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
++ + P + +P A L+ L +P +R
Sbjct: 220 ------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRL 180
+ IG G V R G+ VA+K ++ + + F+ E I+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQF 107
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHPNII+LEGV+T +V EYME+ L HD +F+ Q+ +R + G+
Sbjct: 108 DHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL---WYRPPE 296
+ G +HRD+ A N+LV++ + K+ DFGL+ +L T+ + W PE
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE 224
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
+ + S D+WS G V E+L
Sbjct: 225 ----AIAFRTFSSAS-DVWSFGVVMWEVL 248
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRL 180
E E IG+G + V + ++ VA+K + +F+ +E + +R+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 73
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHP+I+KL GVIT N ++++ E +L + Y QL +
Sbjct: 74 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRP 294
+ + +HRDI A N+LV++ +KLGDFGL+ + +K KL + W
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WM-A 185
Query: 295 PELLMGSTNYNV----SVDLWSVGCVFAELL 321
PE S N+ S D+W G E+L
Sbjct: 186 PE----SINFRRFTSAS-DVWMFGVCMWEIL 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (277), Expect = 8e-27
Identities = 44/274 (16%), Positives = 81/274 (29%), Gaps = 64/274 (23%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF------QPESIRFMAREIMIL 177
E ++ EKIG+G + VF+ A VA+K + + ++ + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 178 RRL---------DHPNIIKLEGVI----------------------------TSRLSNTI 200
+ L I L V + +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVN 259
++V E E L S K + QL + HRD+ N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 260 NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAE 319
+ KL T + S + +Y +S VF +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSII---------------DYTLSRLERDGIVVFCD 241
Query: 320 LLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353
+ + + + G + + I++L W +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
K+G G Y V+ VA+K ++ D + E F+ E +++ + HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKEIKHP 276
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GV T Y++ E+M + +L L C+ + S + Q+ +E+
Sbjct: 277 NLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
+ +HR++ A N LV ++K+ DFGL+ + T+ K + W P
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPES 390
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
L +++ D+W+ G + E+
Sbjct: 391 LAYN--KFSIKSDVWAFGVLLWEIA 413
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ + IG G + V++ VA+K ++ + + + F+ E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 102
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
H NII+LEGVI+ + ++ EYME+ L D +FS Q+ +R + G+
Sbjct: 103 FSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL---WYRPP 295
++ +HRD+ A NILVN+ + K+ DFGL+ +L + T+ + W P
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-AP 219
Query: 296 ELLMGSTNYNV----SVDLWSVGCVFAELL 321
E + +Y S D+WS G V E++
Sbjct: 220 E----AISYRKFTSAS-DVWSFGIVMWEVM 244
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFD-----NFQPESIRFMAREIMILRRL 180
+E E +G G S V AR++ + VA+K +R D +F +RF RE L
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFY---LRF-RREAQNAAAL 69
Query: 181 DHPNIIKL--EGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
+HP I+ + G + Y+V EY++ L + + + +
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 128
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPP 295
+ H GI+HRD+K +NI+++ +K+ DFG+A + + V T Y P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
E G + S D++S+GCV E+L G+P
Sbjct: 189 EQARGDSVDARS-DVYSLGCVLYEVLTGEP 217
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 62/289 (21%), Positives = 120/289 (41%), Gaps = 51/289 (17%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILR 178
+ FE L+ +G+GT+ V +E ATG+ A+K ++ + + + E +L+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKCYMR 232
HP + L+ + + + V EY H LS FSE + + Y
Sbjct: 204 NSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFH----LSRER--VFSEDRARFYGA 255
Query: 233 QLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSRVVT 289
+++ +++ H + +++RD+K N++++ +G +K+ DFGL I K+ + + T
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---KDGATMKTFCGT 312
Query: 290 LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
Y PE+L +Y +VD W +G V E++ G+ + + I
Sbjct: 313 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------- 363
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
++ + P P A L+ L +P +R
Sbjct: 364 --EEIRFPRT-------------------LGPEAKSLLSGLLKKDPKQR 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 58/293 (19%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNF--QPESIRFMAREIM 175
+R E FE L +G+G Y VF+ R+V TGK+ A+K ++ + E
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 176 ILRRLDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQV 227
IL + HP I+ L +L YL+ EY L + F E
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGKL----YLILEYLSGGELFMQ----LE--REGIFMEDTA 123
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTS 285
Y+ ++ + H H +GI++RD+K NI++N++G +KL DFGL +I + +
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI---HDGTVTHT 180
Query: 286 RVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
T+ Y PE+LM + +N +VD WS+G + ++L G P G + + KI K
Sbjct: 181 FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK---- 235
Query: 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
K LP T A DL+ L R
Sbjct: 236 ------CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMILRR 179
F+K++ +G G + +V++ + G+ VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+D+P++ +L G+ + +T+ L+ + M L H + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPE 296
+ R ++HRD+ A N+LV +K+ DFGLA +L ++ K+ +V W E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
S + + S D+WS G EL+
Sbjct: 190 ----SILHRIYTHQS-DVWSYGVTVWELM 213
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 4/150 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E E+IG+G + VF R A +VA+K R +F+ +E IL++ HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHP 172
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI++L GV T IY+V E ++ D + + + G+E+
Sbjct: 173 NIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ +HRD+ A N LV + +LK+ DFG++
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + L+ IG+G + V G VA+K ++ ++ ++ F+ E ++ +L H
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATAQA--FL-AEASVMTQLRHS 74
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GVI +Y+V EYM L L S + + + +E+
Sbjct: 75 NLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMG 300
+HRD+ A N+LV+ + + K+ DFGL ++++ KL + W PE L
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APEAL-- 186
Query: 301 STNYNV----SVDLWSVGCVFAELL 321
S D+WS G + E+
Sbjct: 187 --REKKFSTKS-DVWSFGILLWEIY 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILR 178
P+ + F+ L IG+G+Y+ V R T ++ A+K V+ + E I ++ E +
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 179 R-LDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKC 229
+ +HP ++ L SRL + V EY M H + K E +
Sbjct: 65 QASNHPFLVGLHSCFQTESRL----FFVIEYVNGGDLMFH----MQRQR--KLPEEHARF 114
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV- 288
Y ++ + + H RGI++RD+K N+L+++EG +KL D+G+ K+ L
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTT 167
Query: 289 -----TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
T Y PE+L G +Y SVD W++G + E++ G+
Sbjct: 168 STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
K+G G Y V+ VA+K ++ D + E F+ +E +++ + HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHP 69
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GV T Y++ E+M + +L L C+ + S + Q+ +E+
Sbjct: 70 NLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRPPE 296
+ +HRD+ A N LV ++K+ DFGL+ ++ T+ K + W PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WT-APE 182
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
S YN S D+W+ G + E+
Sbjct: 183 ----SLAYNKFSIKS-DVWAFGVLLWEIA 206
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRL 180
E E IG+G + V + ++ VA+K + +F+ +E + +R+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQF 448
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHP+I+KL GVIT N ++++ E +L + Y QL +
Sbjct: 449 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRP 294
+ + +HRDI A N+LV++ +KLGDFGL+ + +K KL + W P
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAP 561
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELL 321
+ + + D+W G E+L
Sbjct: 562 ESINFR--RFTSASDVWMFGVCMWEIL 586
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 20/216 (9%)
Query: 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREI 174
++ + E IG+G + V+ + A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQ 233
+I++ HPN++ L G+ R + +V YM+H DL + + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL--- 290
+ G+++ + +HRD+ A N +++ + +K+ DFGLA + K + ++
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 291 -WYRPPELLMGSTNYNV----SVDLWSVGCVFAELL 321
W E S S D+WS G + EL+
Sbjct: 197 KWM-ALE----SLQTQKFTTKS-DVWSFGVLLWELM 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+++IG G + V + K VA+K +R E F+ E ++ +L HP
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEVMMKLSHP 63
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+++L GV I LV E+MEH L+ F+ + + G+ +
Sbjct: 64 KLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPEL 297
++HRD+ A N LV ++K+ DFG+ + TS K + W PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WA-SPE- 175
Query: 298 LMGSTNYNV----SVDLWSVGCVFAELL 321
+++ S D+WS G + E+
Sbjct: 176 ---VFSFSRYSSKS-DVWSFGVLMWEVF 199
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-EVATGKM--VALKKVRFDNFQPESIR--FMAREIMILR 178
+ LEK+G G++ V R + +GK VA+K ++ D F+ RE+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMH 76
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
LDH N+I+L GV+ + + +V E L H F + Y Q+ G
Sbjct: 77 SLDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL---WYRP 294
+ + + +HRD+ A N+L+ ++K+GDFGL L + + + W
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-A 192
Query: 295 PELLMGSTNYNV----SVDLWSVGCVFAELL 321
PE S S D W G E+
Sbjct: 193 PE----SLKTRTFSHAS-DTWMFGVTLWEMF 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 131 KIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + SV + K VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 75
Query: 189 EGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
GV + + LV E L + V + Q+ G+++ + +
Sbjct: 76 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 248 HRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLWYRPPELLMG 300
HRD+ A N+L+ N K+ DFGL+ L T+++ K + WY PE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WY-APE---- 183
Query: 301 STNYNV----SVDLWSVGCVFAELL 321
N+ S D+WS G E L
Sbjct: 184 CINFRKFSSRS-DVWSYGVTMWEAL 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 70/292 (23%), Positives = 115/292 (39%), Gaps = 59/292 (20%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALK----KVRFDNFQPESIRFMAREIMI 176
+ F L+ IG+G++ V AR A A+K K + + I R ++
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL- 92
Query: 177 LRRLDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVK 228
L+ + HP ++ L +L Y V +Y H L F EP+ +
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKL----YFVLDYINGGELFYH----LQRER--CFLEPRAR 142
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA--NILTSKNKQKLTSR 286
Y ++ + + H I++RD+K NIL++++G + L DFGL NI ++ ++
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---EHNSTTSTF 199
Query: 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346
T Y PE+L Y+ +VD W +G V E+L G P R E I
Sbjct: 200 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----- 253
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
K +L + T +A L++ L + KR
Sbjct: 254 -----KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 27/211 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM---VALKKVRFDNFQPESIRFMAREIMILRRL 180
E +G+G + V+ VA+K + D +FM E +I++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNL 70
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHP+I+KL G+I +++ E + +L + + Y Q+ +
Sbjct: 71 DHPHIVKLIGIIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRP 294
+ +HRDI NILV + +KLGDFGL+ + + +L + W
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WM-S 182
Query: 295 PELLMGSTNYNV----SVDLWSVGCVFAELL 321
PE S N+ S D+W E+L
Sbjct: 183 PE----SINFRRFTTAS-DVWMFAVCMWEIL 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRR 179
F+K++ +G G + +V++ + G+ VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
+D+P++ +L G+ + +T+ L+ + M L H + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPE 296
+ R ++HRD+ A N+LV +K+ DFGLA +L ++ K+ +V W E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
S + + S D+WS G EL+
Sbjct: 190 ----SILHRIYTHQS-DVWSYGVTVWELM 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-VALKKVRFDNFQPESIRFMAREIMILRRLDH 182
E L+++G G + V G+ VA+K ++ + + F +E + +L H
Sbjct: 8 EEITLLKELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSED--EFF-QEAQTMMKLSH 62
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
P ++K GV + IY+V EY+ + L H Q+ + G+
Sbjct: 63 PKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
+HRD+ A N LV+ + +K+ DFG+ + S K + W PE
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WS-APE 175
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
+Y S D+W+ G + E+
Sbjct: 176 ----VFHYFKYSSKS-DVWAFGILMWEVF 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 38/224 (16%), Positives = 69/224 (30%), Gaps = 38/224 (16%)
Query: 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI--RFMAREIMILRRLDHPNII 186
L G ++A + A + VAL V P+ + + + L R+D P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 187 KLEGVITSRLSNTIYLVFEYME-HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
++ V+ +R +V E++ L ++ D S M+ L + H G
Sbjct: 95 RVLDVVHTR--AGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
+ S + V+ +G + L P N
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------N 180
Query: 306 VSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
D+ +G LL+ + L L + P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 52/294 (17%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNF--QPESIRFMAREIM 175
+ E+FE L+ +G G Y VF R+++ TGK+ A+K ++ + ++ E
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 176 ILRRLDH-PNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQ 226
+L + P ++ L ++L +L+ +Y H LS +F+E +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKL----HLILDYINGGELFTH----LSQRE--RFTEHE 160
Query: 227 VKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR 286
V+ Y+ +++ +EH H GI++RDIK NIL+++ G + L DFGL+ + ++
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 287 VVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF-KLCG 344
T+ Y P+++ G + ++ +VD WS+G + ELL G E +I ++
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
S P P ++ + A DLI L +P KR
Sbjct: 281 SEP-------PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 63/295 (21%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILR 178
M+ F L +G+G++ V + T ++ A+K ++ D Q + + E +L
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 179 RLD-HPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKC 229
P + +L RL Y V EY M H + +F EP
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRL----YFVMEYVNGGDLMYH----IQQVG--RFKEPHAVF 125
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV- 288
Y ++ G+ +GI++RD+K N+++++EG +K+ DFG+ K+ + V
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTT 178
Query: 289 -----TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC 343
T Y PE++ Y SVD W+ G + E+L G+ +G E E I +
Sbjct: 179 KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-- 235
Query: 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P K + AV + ++ P KR
Sbjct: 236 --------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 62/293 (21%), Positives = 118/293 (40%), Gaps = 59/293 (20%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILR 178
+ ++FE + +G+G++ V AR TG + A+K ++ D Q + + E IL
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 179 R-LDHPNIIKLEGVITSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKCYM 231
+HP + +L + + ++ V E+ M H + +F E + + Y
Sbjct: 79 LARNHPFLTQLFCCFQT--PDRLFFVMEFVNGGDLMFH----IQKSR--RFDEARARFYA 130
Query: 232 RQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW 291
+++ + H +GI++RD+K N+L+++EG KL DFG+ K+ + + V T
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGVTTAT 183
Query: 292 ------YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
Y PE+L Y +VD W++G + E+L G + E + I
Sbjct: 184 FCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---- 238
Query: 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
+ P A ++ + ++ P R
Sbjct: 239 ------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E+ + +E++G G + V+ K VA+K ++ + P++ F+A E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANLMKQLQHQ 68
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V+T IY++ EYME+ L L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
R +HRD++A+NILV++ K+ DFGLA N T++ K + W PE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WT-APE 180
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
+ NY S D+WS G + E++
Sbjct: 181 AI----NYGTFTIKS-DVWSFGILLTEIV 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-VALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+ L+++G G + V + G+ VA+K ++ + + F+ E ++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSEDE--FI-EEAKVMMNLSH 78
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L GV T I+++ EYM + L +F Q+ + + +E+
Sbjct: 79 EKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
+ +HRD+ A N LVN++G++K+ DFGL+ + TS K R W PPE
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WS-PPE 191
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
Y+ S D+W+ G + E+
Sbjct: 192 ----VLMYSKFSSKS-DIWAFGVLMWEIY 215
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/229 (27%), Positives = 114/229 (49%), Gaps = 31/229 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++F +G+G + V++ R +A G +VA+K+++ + Q ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 184 NIIKLEGV-ITS--RLSNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQ------ 233
N+++L G +T RL LV+ YM + ++SC + S+P + RQ
Sbjct: 88 NLLRLRGFCMTPTERL-----LVYPYMANG--SVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 234 ---L--LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288
L LH +HC + I+HRD+KA+NIL++ E +GDFGLA L +T+ V
Sbjct: 141 ARGLAYLH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 196
Query: 289 -TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQ 335
T+ + PE L + + D++ G + EL+ G + R +
Sbjct: 197 GTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILR 178
+ + F+ L IG+G+Y+ V R T ++ A++ V+ + E I ++ E +
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 179 R-LDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKC 229
+ +HP ++ L SRL + V EY M H + K E +
Sbjct: 108 QASNHPFLVGLHSCFQTESRL----FFVIEYVNGGDLMFH----MQRQR--KLPEEHARF 157
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV- 288
Y ++ + + H RGI++RD+K N+L+++EG +KL D+G+ K+ L
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTT 210
Query: 289 -----TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP 325
T Y PE+L G +Y SVD W++G + E++ G+
Sbjct: 211 STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 239
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V++ IY+V EYM L L PQ+ Q+ G+ +
Sbjct: 240 KLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
+HRD++A+NILV + K+ DFGLA N T++ K + W P
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 352
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
L G + + D+WS G + EL
Sbjct: 353 ALYG--RFTIKSDVWSFGILLTELT 375
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + L+ IG+G + V G VA+K ++ D F+ E ++ +L H
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FL-AEASVMTQLRHS 246
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GVI +Y+V EYM L L S + + + +E+
Sbjct: 247 NLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMG 300
+HRD+ A N+LV+ + + K+ DFGL ++++ KL + W PE L
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APEAL-- 358
Query: 301 STNYNV----SVDLWSVGCVFAELL 321
S D+WS G + E+
Sbjct: 359 --REKKFSTKS-DVWSFGILLWEIY 380
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMILRR 179
KL+ +G G + +V + + G+ V +K + + + ++ +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGS 71
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
LDH +I++L G+ +++ LV +Y+ L H + + Q+ G+
Sbjct: 72 LDHAHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPE 296
+ G++HR++ A N+L+ + +++ DFG+A++L +KQ L S + W E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALE 187
Query: 297 LLMGSTNYNV----SVDLWSVGCVFAELL 321
S ++ S D+WS G EL+
Sbjct: 188 ----SIHFGKYTHQS-DVWSYGVTVWELM 211
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 63/295 (21%)
Query: 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILR 178
++ E F + +G+G++ VF A T + A+K ++ D + + E +L
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 179 R-LDHPNIIKLEGVI--TSRLSNTIYLVFEY------MEHDLAGLSSCHDIKFSEPQVKC 229
+HP + + L + V EY M H + SCH KF +
Sbjct: 73 LAWEHPFLTHMFCTFQTKENL----FFVMEYLNGGDLMYH----IQSCH--KFDLSRATF 122
Query: 230 YMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVT 289
Y +++ G++ H +GI++RD+K NIL++ +G +K+ DFG+ K+ + T
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGDAKT 175
Query: 290 LW------YRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC 343
Y PE+L+G YN SVD WS G + E+LIG+ G+ E E H I
Sbjct: 176 NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-- 232
Query: 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR 398
P + A DL+ EP KR
Sbjct: 233 --------DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMIL-R 178
M+ F L +G+G++ V + T ++ A+K ++ D Q + + E +L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLH 236
P + +L + + +Y V EY+ DL + +F EP Y ++
Sbjct: 398 PGKPPFLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAI 453
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV------TL 290
G+ +GI++RD+K N+++++EG +K+ DFG+ K+ + V T
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGTP 506
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
Y PE++ Y SVD W+ G + E+L G+ +G E E I
Sbjct: 507 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 322
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V++ IY+V EYM L L PQ+ Q+ G+ +
Sbjct: 323 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLA-----NILTSKNKQKLTSRVVTLWYRPPE 296
+HRD++A+NILV + K+ DFGLA N T++ K + W P
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 435
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
L G + + D+WS G + EL
Sbjct: 436 ALYG--RFTIKSDVWSFGILLTELT 458
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 20/216 (9%)
Query: 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKM---VALKKVRFDNFQPESIRFMAREI 174
++ + E IG+G + V+ + A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQ 233
+I++ HPN++ L G+ R + +V YM+H DL + + + Q
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL--- 290
+ G++ + +HRD+ A N +++ + +K+ DFGLA + K + ++
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 291 -WYRPPELLMGSTNYNV----SVDLWSVGCVFAELL 321
W E S S D+WS G + EL+
Sbjct: 261 KWM-ALE----SLQTQKFTTKS-DVWSFGVLLWELM 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 131 KIGQGTYSSVFRA--REVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + +V + + K VA+K ++ + P + E ++++LD+P I+++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 189 EGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
G+ + + LV E E L + + + + Q+ G+++ +
Sbjct: 84 IGICE---AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 248 HRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLWYRPPELLMG 300
HRD+ A N+L+ + K+ DFGL+ L ++ K + WY PE
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WY-APE---- 190
Query: 301 STNYNV----SVDLWSVGCVFAELL 321
NY S D+WS G + E
Sbjct: 191 CINYYKFSSKS-DVWSFGVLMWEAF 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 20/216 (9%)
Query: 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREI 174
L+P IG+G + V+ + + A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 175 MILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQ 233
+++R L+HPN++ L G++ +++ YM H DL + + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTL--- 290
+ G+E+ + +HRD+ A N +++ +K+ DFGLA + + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 291 -WYRPPELLMGSTNYNV----SVDLWSVGCVFAELL 321
W E S S D+WS G + ELL
Sbjct: 193 KWT-ALE----SLQTYRFTTKS-DVWSFGVLLWELL 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 26/204 (12%)
Query: 131 KIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + SV + K VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 189 EGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
GV + + LV E L + V + Q+ G+++ + +
Sbjct: 402 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 248 HRDIKASNILVNNEGILKLGDFGLANIL-------TSKNKQKLTSRVVTLWYRPPELLMG 300
HR++ A N+L+ N K+ DFGL+ L T+++ K + WY PE
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WY-APE---- 509
Query: 301 STNYNV---SVDLWSVGCVFAELL 321
N+ D+WS G E L
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEAL 533
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 45/214 (21%), Positives = 81/214 (37%), Gaps = 25/214 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-------VALKKVRFDNFQPESIRFMAREIMI 176
E E +GQGT++ +F+ G V LK + + S F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFF-EAASM 65
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLL 235
+ +L H +++ GV + LV E+++ L + + +QL
Sbjct: 66 MSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEG--------ILKLGDFGLANILTSKNKQKLTSRV 287
+ ++H ++ A NIL+ E +KL D G++ + K+ +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 288 VTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321
W PPE + N N++ D WS G E+
Sbjct: 183 ---WV-PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES + +K+G G + V+ A K VA+K ++ + E+ F+ E +++ L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEANVMKTLQHD 243
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
++KL V+T IY++ E+M L L S K P++ + Q+ G+
Sbjct: 244 KLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANIL-----TSKNKQKLTSRVVTLWYRPPE 296
R +HRD++A+NILV+ + K+ DFGLA ++ T++ K + W P
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEA 356
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL 321
+ GS + + D+WS G + E++
Sbjct: 357 INFGS--FTIKSDVWSFGILLMEIV 379
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 33/216 (15%)
Query: 129 LEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+G+G + SV A+ VA+K ++ D I RE ++ DHP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 186 IKLEGVIT----SRLSNTIYLVFEYMEH-DL-----AGLSSCHDIKFSEPQVKCYMRQLL 235
KL GV ++ +M+H DL A + + +M +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA------NILTSKNKQKLTSRVVT 289
G+E+ R +HRD+ A N ++ + + + DFGL+ + KL +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK--- 204
Query: 290 LWYRPPELLMGSTNYNV----SVDLWSVGCVFAELL 321
W E S N+ S D+W+ G E++
Sbjct: 205 -WL-ALE----SLADNLYTVHS-DVWAFGVTMWEIM 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 129 LEKIGQGTYSSVFRAR---EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ +G+G + SV E T VA+K ++ DN I E ++ HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 186 IKLEGVIT---SRLSNTIYLVFEYMEH-DL-----AGLSSCHDIKFSEPQVKCYMRQLLH 236
I+L GV S+ ++ +M++ DL + +M +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
G+E+ R +HRD+ A N ++ ++ + + DFGL+
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 24/165 (14%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+E++G+ + V++ VA+K ++ P F E M+ RL HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHP 72
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL---------------AGLSSCHDIKFSEPQV 227
N++ L GV+T + ++F Y H DL P
Sbjct: 73 NVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ Q+ G+E+ ++H+D+ N+LV ++ +K+ D GL
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 33/159 (20%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++GQG++ V+ K VA+K V E I F+ E +++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCH 88
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG--LSSCHDIKFSEPQVKCYMRQLLH---- 236
++++L GV++ ++ E M DL S + + + +++
Sbjct: 89 HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 237 ---GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
G+ + + +HRD+ A N +V + +K+GDFG+
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++G+G + VF A +VA+K ++ D F RE +L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHE 77
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL--------AGLSSCHDIKFSEPQVKCYMRQL 234
+I+K GV + + +VFEYM+H DL D + + + + + Q+
Sbjct: 78 HIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 235 LH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
LH G+ + + +HRD+ N LV ++K+GDFG++
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 24/164 (14%)
Query: 129 LEKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++G+G + VF A VA+K ++ + + F RE +L L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQ 103
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL--------------AGLSSCHDIKFSEPQVK 228
+I++ GV T + +VFEYM H DL AG Q+
Sbjct: 104 HIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
Q+ G+ + +HRD+ N LV ++K+GDFG++
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 35/159 (22%), Positives = 65/159 (40%), Gaps = 18/159 (11%)
Query: 129 LEKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ +G G + V+ + VA+K + + + + F+ E +I+ + +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 93
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL------AGLSSCHDIKFSEPQVKCYMRQLLH 236
NI++ GV S +++ E M DL + + R +
Sbjct: 94 NIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLA 272
G ++ +HRDI A N L+ G + K+GDFG+A
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 32/173 (18%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ IG+G + VF+AR MVA+K ++ + F RE ++ D+P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL----------------AGLSSCHDIKFSEPQ 226
NI+KL GV + + L+FEYM + DL S S
Sbjct: 111 NIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 227 VKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ L G+ + R +HRD+ N LV ++K+ DFGL+
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 130 EKIGQGTYSSVFRAREVATGK--MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNII 186
+ IG+G + V +AR G A+K+++ + + F E+ +L +L HPNII
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNII 89
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DL---------------AGLSSCHDIKFSEPQVKCY 230
L G R +YL EY H +L +++ S Q+ +
Sbjct: 90 NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ G+++ + +HRD+ A NILV + K+ DFGL+
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 35/159 (22%), Positives = 65/159 (40%), Gaps = 18/159 (11%)
Query: 129 LEKIGQGTYSSVFRAREVATGKM-----VALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ +G G + V+ + VA+K + + + + F+ E +I+ + +H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 134
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DL------AGLSSCHDIKFSEPQVKCYMRQLLH 236
NI++ GV S +++ E M DL + + R +
Sbjct: 135 NIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLA 272
G ++ +HRDI A N L+ G + K+GDFG+A
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIRFMAREIMILRRLDHP 183
F+ IG G + V++ + G VALK+ ++ Q E F EI L HP
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE---FET-EIETLSFCRHP 95
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYM--RQLLH----- 236
+++ L G R N + L+++YME+ + + M Q L
Sbjct: 96 HLVSLIGFCDER--NEMILIYKYMENG-----NLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 237 --GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYR 293
G+ + H R I+HRD+K+ NIL++ + K+ DFG++ T ++ L++ V TL Y
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 294 PPELLMGSTNY-NVSVDLWSVGCVFAELLIGKPILKGRTEVEQLH 337
PE + D++S G V E+L + + E ++
Sbjct: 209 DPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 24/171 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ + + +G+G + V A + AT + VA+K ++ E M E+ IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILI 85
Query: 179 RLD-HPNIIKLEGVITSRLSNTIYLVFEYMEH-DL---------------AGLSSCHDIK 221
+ H N++ L G T + + ++ E+ + +L +
Sbjct: 86 HIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 222 FSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ + CY Q+ G+E R +HRD+ A NIL++ + ++K+ DFGLA
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 38/178 (21%), Positives = 74/178 (41%), Gaps = 32/178 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILR 178
++ + +G+G + V +A VA+K ++ + E + E +L+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLK 81
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL----------------AGLSSCHDIK 221
+++HP++IKL G + + L+ EY ++ L +G S
Sbjct: 82 QVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 222 FSEPQVKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ M L+ G+++ ++HRD+ A NILV +K+ DFGL+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 58/261 (22%), Positives = 97/261 (37%), Gaps = 44/261 (16%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
+ KIG G++ ++ ++A G+ VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 183 -PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I + N +V E + L L + KFS V Q++ +E+
Sbjct: 64 GVGIPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 242 HLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELL 298
H + +HRD+K N L+ ++ + DFGLA + YR + L
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP------YRENKNL 175
Query: 299 MGSTNYNVSV------------DLWSVGCVFAELLIGK---PILKGRTEVEQLHKIFK-- 341
G+ Y S+ DL S+G V +G LK T+ ++ +I +
Sbjct: 176 TGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 342 -------LC-GSPPE--EYWK 352
LC G P E Y
Sbjct: 235 MSTPIEVLCKGYPSEFATYLN 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 48/257 (18%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PNIIKL 188
+IG+G++ +F + + VA+K + P+ + E + L I +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNV 71
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
L N LV + + L L KFS V +Q+L V+ H + +++
Sbjct: 72 YYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 249 RDIKASNILV-----NNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMGST 302
RDIK N L+ N ++ + DFG+ KQ + YR + L G+
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREKKNLSGTA 182
Query: 303 NYNVSV------------DLWSVGCVFAELLIGK---PILKGRTEVEQLHKIFK------ 341
Y +S+ DL ++G VF L G LK T ++ +I +
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241
Query: 342 ---LC-GSPPE--EYWK 352
LC G P E +Y
Sbjct: 242 LRELCAGFPEEFYKYMH 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 47/260 (18%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PN 184
F +KIG G + + + + T + VA+K + P+ + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDG 66
Query: 185 IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR 244
I ++ N +V E + L L D FS V QL+ +E+ H +
Sbjct: 67 IPQVYYFGPCGKYN--AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 245 GIMHRDIKASNILV-----NNEGILKLGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELL 298
+++RD+K N L+ + ++ + DF LA + + K+ + YR + L
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-------YREHKSL 177
Query: 299 MGSTNYNVSV------------DLWSVGCVFAELLIGK-P--ILKGRTEVEQLHKIFK-- 341
G+ Y +S+ DL ++G +F L G P LK T E+ KI
Sbjct: 178 TGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236
Query: 342 -------LCGSPPE--EYWK 352
LC + PE Y +
Sbjct: 237 RATPIEVLCENFPEMATYLR 256
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 37/173 (21%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-------EVATGKMVALKKVRFDNFQPESIRFMAREIMI 176
+ + +G+G + V A + VA+K ++ D + + + E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93
Query: 177 LRRL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL--------AGLSSCHDIKFSEPQ 226
++ + H NII L G T +Y++ EY +L P+
Sbjct: 94 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 227 VKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ + L+ G+E+ + +HRD+ A N+LV ++K+ DFGLA
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 41/173 (23%), Positives = 66/173 (38%), Gaps = 27/173 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILR 178
+ +G G + V A K VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 179 RL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL----------AGLSSCHDIKFSEPQ 226
L +H NI+ L G T + ++ EY + DL S + +
Sbjct: 82 YLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 227 VKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ + LL G+ + +HRD+ A NIL+ + I K+ DFGLA
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 53/229 (23%)
Query: 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR----FMAREIMILRRLDHPNII 186
K+G+G + V++ VA+KK+ + F EI ++ + H N++
Sbjct: 38 KMGEGGFGVVYKG--YVNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENLV 93
Query: 187 KL-----EGVITSRLSNTIYLVFEYM-----EHDLAGLSSCHDIKFSEPQVKCYMRQL-- 234
+L +G LV+ YM L+ L + + MR
Sbjct: 94 ELLGFSSDG--DDLC-----LVYVYMPNGSLLDRLSCLDGTPPLSWH-------MRCKIA 139
Query: 235 ---------LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS 285
LH E+ H+ HRDIK++NIL++ K+ DFGLA + +TS
Sbjct: 140 QGAANGINFLH--ENHHI----HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 286 RVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTE 332
R+V T Y PE L G D++S G V E++ G + + R
Sbjct: 194 RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 45/164 (27%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRLD-H 182
+ +G G + V A GK VA+K ++ E M E+ I+ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQH 109
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DL------AGLSSCHDIKFSEPQVKCYMRQLL 235
NI+ L G T + ++ EY + DL D F+ R LL
Sbjct: 110 ENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 236 H-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
H G+ + +HRD+ A N+L+ N + K+GDFGLA
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 37/173 (21%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-------EVATGKMVALKKVRFDNFQPESIRFMAREIMI 176
+ + +G+G + V A + VA+K ++ D + + + E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139
Query: 177 LRRL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL--------AGLSSCHDIKFSEPQ 226
++ + H NII L G T +Y++ EY +L P+
Sbjct: 140 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 227 VKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ + L+ G+E+ + +HRD+ A N+LV ++K+ DFGLA
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 27/168 (16%)
Query: 129 LEKIGQGTYSSVFRAR-------EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL- 180
+ +G+G + V A + VA+K ++ D + + + E+ +++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DL--------AGLSSCHDIKFSEPQVKCYM 231
H NII L G T +Y++ EY +L P+ +
Sbjct: 133 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 232 RQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
+ L+ G+E+ + +HRD+ A N+LV + ++K+ DFGLA
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 50/266 (18%), Positives = 91/266 (34%), Gaps = 57/266 (21%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLE 189
+KIG G + ++ A + A V+ + + + E+ +R+ + IK
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVE---YQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 190 -----------------GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMR 232
G+ + + ++V E + DL +S + F + V
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGI 158
Query: 233 QLLHGVEHCHLRGIMHRDIKASNILV--NNEGILKLGDFGLANILTSKNKQKLTSRVVTL 290
++L +E+ H +H DIKA+N+L+ N + L D+GL+ K
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----- 213
Query: 291 WYRPPELLMGSTNYNVSV------------DLWSVGCVFAELLIGK-P---ILKGRTEVE 334
P + G+ + S+ D+ +G L GK P LK V+
Sbjct: 214 -ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271
Query: 335 QLH-----------KIFKLCGSPPEE 349
+ GS E
Sbjct: 272 TAKTNLLDELPQSVLKWAPSGSSCCE 297
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 7e-17
Identities = 86/461 (18%), Positives = 149/461 (32%), Gaps = 71/461 (15%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKL 188
KIG G++ ++ + T + VA+K P+ + E I R L I +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGGTGIPNV 68
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
N LV + + L L + K S V Q+++ VE H + +H
Sbjct: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 249 RDIKASNILV---NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYN 305
RDIK N L+ + + DFGLA + + YR + L G+ Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP------YRENKNLTGTARY- 179
Query: 306 VSV------------DLWSVGCVFAELLIGK---PILKGRTEVEQLHKIFK--------- 341
SV DL S+G V L G LK T+ ++ KI +
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239
Query: 342 LC-GSPPE-------------------EYWKK--SKLPHGDMFKPQNPYEGCL----RER 375
LC G P E Y K+ L + F+ ++ + + +
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 376 CKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQ 435
P AV + P + E T+ + D P AKQ
Sbjct: 300 IASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQ 359
Query: 436 RDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYSSKELEDEAHFADRKNNNNDNNT 495
+ ++ ++S R+ + + +S D + + +
Sbjct: 360 KAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEP----SRTRATDA 415
Query: 496 SRTYKGRGSAVGREPRNPTFDTISETSRATSTSHASHGDTV 536
S R S + + + +S S++ ++ +
Sbjct: 416 SPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESAL 456
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 32/173 (18%)
Query: 129 LEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
+ +G G + V A K VA+K ++ E M E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSH 108
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEH-DL---------------AGLSSCHDIKFSEPQ 226
NI+ L G T LS IYL+FEY + DL + ++ E
Sbjct: 109 ENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 227 VKCYMRQLLH-------GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272
LL G+E + +HRD+ A N+LV + ++K+ DFGLA
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 49/266 (18%), Positives = 90/266 (33%), Gaps = 53/266 (19%)
Query: 130 EKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
IGQG + ++ A V + +K DN + E+ +R P
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP------LFTELKFYQRAAKPE 94
Query: 185 IIKLE-----------------GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQV 227
I+ G+ + +++ + DL + + +FS V
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 228 KCYMRQLLHGVEHCHLRGIMHRDIKASNILVN--NEGILKLGDFGLANILTSKNKQKLTS 285
++L +E+ H +H DIKASN+L+N N + L D+GLA + K +
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 286 RVVTLWYRPPELLMGSTNYNVSV------------DLWSVGCVFAELLIGK-P--ILKGR 330
P G+ + S+ DL +G + L G P
Sbjct: 215 ------ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 331 TEVEQLHKI-FKLCGSPPEEYWKKSK 355
+ + KI ++ + + +
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAA 293
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 46/270 (17%), Positives = 67/270 (24%), Gaps = 62/270 (22%)
Query: 130 EKIGQGTYSSVFRAREVATGKM--------VALKKVRFDNFQPESIRFMAREI------- 174
+ ++ A +T +LK D F R
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 175 -MILRRLDHPNIIKLEGVITSRLSNTIY--LVFEYMEHDLAGL-SSCHDIKFSEPQVKCY 230
L I G + Y LV + L SE V
Sbjct: 108 WKKLYSTPLLAIPTCMG---FGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 231 MRQLLHGVEHCHLRGIMHRDIKASNILV--NNEGILKLGDFGLANILTSKNKQKLTSRVV 288
+LL +E H +H ++ A NI V ++ + L +G A K
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA----- 219
Query: 289 TLWYR--PPELLMGSTNYNVSV------------DLWSVGCVFAELLIGK-P--ILKGRT 331
Y G + +S+ DL S+G + L G P T
Sbjct: 220 ---YVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275
Query: 332 EVEQLHKI---------FKLC---GSPPEE 349
E K C P E
Sbjct: 276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSET 305
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 29/116 (25%), Positives = 53/116 (45%), Gaps = 2/116 (1%)
Query: 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265
+ + + + CY Q+ G+E R +HRD+ A NIL++ + ++K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 266 LGDFGLA-NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAEL 320
+ DFGLA +I + + + L + PE + Y + D+WS G + E+
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 27/160 (16%), Positives = 59/160 (36%), Gaps = 14/160 (8%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ + + +G+G + V A + AT + VA+K ++ E M E+ IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILI 80
Query: 179 RLD-HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLH 236
+ H N++ L G T + + ++ E+ + +L ++ + Y +
Sbjct: 81 HIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNL-----STYLRSKRNEFVPYKTKGAR 134
Query: 237 GVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276
+ G + D+K + + F L+
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 75/560 (13%), Positives = 157/560 (28%), Gaps = 153/560 (27%)
Query: 49 DFGSKEGERSEDKPKG---SRELKKLKKGSS-------------NKKSNAFSIKLGLSLR 92
+F K+ +D PK E+ + +K+ + LR
Sbjct: 32 NFDCKD---VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLR 88
Query: 93 HVDAEQIAAGW------PAWLTAAAGEAVYGL-----------VPMRAESFEKLEKIGQG 135
++ + + + P+ +T E L V R + + KL +
Sbjct: 89 -INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYLKLRQ---- 142
Query: 136 TYSSVFRAREVA---------TGKMV-ALKKVRFDNFQPESIRFMAREI--MILRRLDHP 183
++ R +GK AL Q M +I + L+ + P
Sbjct: 143 ---ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ----CKMDFKIFWLNLKNCNSP 195
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
+ LE + + + + SS +IK ++ +R+LL +
Sbjct: 196 ETV-LE------MLQKLLYQIDPNWTSRSDHSS--NIKLRIHSIQAELRRLLK--SKPYE 244
Query: 244 RGIMHRDIKASNIL--VNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
++ +L V N + +LT++ KQ VT + L +
Sbjct: 245 NCLL--------VLLNVQNAKAWNAFNLSCKILLTTRFKQ------VT------DFLSAA 284
Query: 302 TNYNVSVDLWSVGCVFAELL------IGKPILKGRTEVEQLH----KIF-KLCGSPPE-- 348
T ++S+D S+ E+ + EV + I +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 349 EYWKK---SKLPHG-DMF-KPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTA 401
+ WK KL + P E R+ + P + + P
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAE--YRKMFDRLSVFPPSAHI--------PTI---- 390
Query: 402 SSLLMCEYFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRR--KVRARMREPASSKRQRR 459
L+ + + + K ++ KQ E+ + ++ ++
Sbjct: 391 ---LLSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIPSIYLELKVKLENEYALH 446
Query: 460 ARQTLQLQEPNSYSSKELEDEA-----------HFADRKNNNNDNNTSRTY--------K 500
P ++ S +L H + ++ + K
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 501 GRGSAVGREPRNPTFDTISE 520
R + +T+ +
Sbjct: 507 IRHDSTAWNASGSILNTLQQ 526
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.1 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.54 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-61 Score=507.83 Aligned_cols=265 Identities=29% Similarity=0.473 Sum_probs=232.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+|||||+++++|++ .+.
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 106 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEK 106 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 345789999999999999999999999999999999976432 12335678999999999999999999999998 689
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||||.|+.|..++...+.++|.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999998777777677789999999999999999999999999999999999999999999999999999875433
Q ss_pred -cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 -KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+.+||+.|||||++.+ ..|+.++||||||||||+|++|++||.+.+..+.+.+|......++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----------- 254 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----------- 254 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 234567899999999999976 5789999999999999999999999999999999999987543322
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHH------HHcCccccCCCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS------LLMCEYFTTQPYAC 417 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~e------lL~hp~f~~~p~~~ 417 (690)
..+++++++||.+||++||.+|||++| +++||||++..|..
T Consensus 255 ------------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 255 ------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ------------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ------------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 258899999999999999999999988 57888888776643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=512.83 Aligned_cols=260 Identities=25% Similarity=0.467 Sum_probs=225.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|++|+|||||++++++.+ .+.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999999887777778889999999999999999999999998 68999
Q ss_pred EEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 202 LVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
||||||+|+.|..++. ....++|.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999876655543 3345899999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
....++.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|......+.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~------------ 245 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV------------ 245 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------------
T ss_pred cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC------------
Confidence 233456789999999999976 5799999999999999999999999999999999999876432211
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 246 ----------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 246 ----------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ----------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 12589999999999999999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=507.56 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=227.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ .+.+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 35699999999999999999999999999999999765433 23457899999999999999999999998 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||+|+.+..++.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 9999999877766554 479999999999999999999999999999999999999999999999999998875432 34
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.++.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..... +....|
T Consensus 227 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~----------- 293 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNL----------- 293 (346)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCG-----------
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCcc-----------
Confidence 567899999999999865 6799999999999999999999999999999999888865321 111111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus 294 --------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 294 --------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 25899999999999999999999999999999999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=517.13 Aligned_cols=294 Identities=30% Similarity=0.492 Sum_probs=245.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 198 (690)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ..+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4679999999999999999999999999999999987666666677889999999999999999999987642 246
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||+|++...+ .....+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i-~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHH-TSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 89999999998765544 44568999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 ---NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.....++.+||++|||||++.+..+|+.++||||||||||||++|++||.+.+..+++..|+...+.++...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 22345678999999999999887788999999999999999999999999999999999999999999988775422
Q ss_pred CCCCCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 356 LPHGDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 356 l~~~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
......+ .........+...++.++++++|||.+||.+||.+|||++|+|+||||+..+.+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 1110000 0001111223445568899999999999999999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=490.51 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=210.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.|+|||||++++++.+ .+.+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 35799999999999999999999999999999999876443 3345678999999999999999999999988 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||+|+++..+. ..+.+++.+++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+..... .
T Consensus 90 ivmEy~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EEEECCCEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 999999776665544 4568999999999999999999999999999999999999999999999999999876432 3
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
...+.+||+.|||||++.+..+++.++|||||||+||+|++|++||.+.+..+.+.+|......++
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p-------------- 232 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP-------------- 232 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 445689999999999998766667899999999999999999999999998888888866432221
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 233 ---------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 233 ---------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 258899999999999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=508.96 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=227.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ .+.+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEE
Confidence 35699999999999999999999999999999999865433 23568899999999999999999999998 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||.||.|..++.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... ...
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 303 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPR 303 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Ccc
Confidence 9999999877766543 47999999999999999999999999999999999999999999999999999887543 244
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
..+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..... +....
T Consensus 304 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~------------ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN------------ 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSC------------
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcc------------
Confidence 567899999999999965 6799999999999999999999999999999999888865321 11111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 370 -------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 370 -------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 12689999999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=497.31 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=221.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
...++|++++.||+|+||+||+|++. .+++.||||++++..........+.+|+.+|++|+|||||++++++.+ .
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 98 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--E 98 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--T
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--C
Confidence 34578999999999999999999974 468899999997654332223457889999999999999999999998 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||||+|+.|..++...+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 89999999999988877777777899999999999999999999999999999999999999999999999999987543
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.. ....+.+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+..+.+.+|.+....+|
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p---------- 246 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP---------- 246 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred CC-ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence 22 34456899999999999976 6789999999999999999999999999999999999876432222
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
..+|+++++||.+||+.||.+||| ++|+|+||||++..|
T Consensus 247 -------------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 247 -------------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp -------------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 258999999999999999999998 589999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=483.52 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=219.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--CcceEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSNTIYLV 203 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~LV 203 (690)
|++.++||+|+||+||+|++..++..||||++..........+.+.+|+.+|++|+|||||+++++|.+. ..+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999999999999999987776777778899999999999999999999998752 24678999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEcc-CCcEEEeecccceeccccCc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNN-EGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~~ 280 (690)
||||+++.|..++.....+++..++.|+.||+.||.|||++| ||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999999888777777778999999999999999999999998 999999999999985 78999999999986432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
....+.+||+.|||||++.+ .|+.++||||||||||||+||++||.+.+....+...+... ..+...+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~~~~--------- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPASFD--------- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGGGG---------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCCCCC---------
Confidence 34456899999999999864 59999999999999999999999998766655554433221 1222111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+++++++||.+||+.||.+|||++|+|+||||++
T Consensus 253 ----------------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 ----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 257889999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=485.42 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=218.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45699999999999999999999999999999999876432 469999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~~~ 281 (690)
|||||+|+.|..++...+.|++.+++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999988877777777899999999999999999999999999999999999999988 6999999999887543221
Q ss_pred ----cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 ----KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ----~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+|.... ++.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~--------- 275 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPI--------- 275 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGG---------
T ss_pred cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCc---------
Confidence 1234689999999999976 679999999999999999999999999988877777776531 110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHH-------------HcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL-------------LMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~el-------------L~hp~f~~~p 414 (690)
.+....+++++.+||.+||+.||.+|||+.|+ |+|||+....
T Consensus 276 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 276 ---------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp ---------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ---------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 11223689999999999999999999999998 5788887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=480.24 Aligned_cols=286 Identities=28% Similarity=0.415 Sum_probs=224.3
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+|...+.|+++++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.+ +|||||+++++|.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3444677999999999999999999875 4678999999875432 24578999999998 69999999999988
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeecccce
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLAN 273 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~ 273 (690)
.+.+|||||||+++.+..+. ..+++.+++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus 92 --~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 --NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp --TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 68999999999987665554 259999999999999999999999999999999999999877 799999999998
Q ss_pred eccccC---------------------------cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 041720 274 ILTSKN---------------------------KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI 326 (690)
Q Consensus 274 ~~~~~~---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~P 326 (690)
...... ....++.+||++|||||++.+...|+.++||||+|||||||++|++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 654321 12235578999999999998877799999999999999999999988
Q ss_pred C-CCCCHHHHHHHHHHHcCCCChhhhhcc---------CCCCCC------------CCCCC----CCCccccccccCCCC
Q 041720 327 L-KGRTEVEQLHKIFKLCGSPPEEYWKKS---------KLPHGD------------MFKPQ----NPYEGCLRERCKDFT 380 (690)
Q Consensus 327 F-~~~~~~e~l~~I~~~~g~~~~~~w~~~---------~l~~~~------------~~~~~----~~~~~~l~~~~~~is 380 (690)
| .+.++.+++..|+..+|.++...|... ..+... ...+. ........+.+..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 8 567888999999998886543332210 000000 00000 000011122345789
Q ss_pred hhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 381 PTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 381 ~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
++++|||.+||++||.+|||++|+|+||||++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=464.44 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=200.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC-------
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL------- 196 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------- 196 (690)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999998654 3455677899999999999999999999987632
Q ss_pred ---cceEEEEEeccchhcccccccCCCCCC---hhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecc
Q 041720 197 ---SNTIYLVFEYMEHDLAGLSSCHDIKFS---EPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 197 ---~~~~~LV~Ey~~g~ll~~~~~~~~~ls---e~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFG 270 (690)
...+|||||||.++.+..++.....++ +..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 124799999999987776665544443 45688999999999999999999999999999999999999999999
Q ss_pred cceeccccCc-----------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 041720 271 LANILTSKNK-----------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339 (690)
Q Consensus 271 la~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I 339 (690)
+|+.+..... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||.+.. +....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 9987654321 12345789999999999976 579999999999999999996 776532 333322
Q ss_pred HHHcC-CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 340 FKLCG-SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 340 ~~~~g-~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
..... .+| ..|. ..++.+.+||.+||+.||.+|||+.|+|+||||++..|
T Consensus 238 ~~~~~~~~p-~~~~-------------------------~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 238 TDVRNLKFP-PLFT-------------------------QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTTCCC-HHHH-------------------------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHhcCCCC-CCCc-------------------------ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 22221 122 1121 35677899999999999999999999999999997644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=495.86 Aligned_cols=268 Identities=26% Similarity=0.366 Sum_probs=236.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+ .+.+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997643 4445678899999999999999999999998 789999
Q ss_pred EEeccchhcccc-cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC--CcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGL-SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE--GILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~--~~vKL~DFGla~~~~~~~ 279 (690)
|||||.|+.|.. +....+.|++.+++.|+.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 999999876554 44455689999999999999999999999999999999999999864 89999999999987543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|||||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++.+|......++...|.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 381 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------- 381 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT-------
T ss_pred -CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc-------
Confidence 34566799999999999976 578999999999999999999999999999999999998876666655554
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSL 422 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~l 422 (690)
.+|+++++||.+||+.||.+|||+.|+|+||||+...++.....+
T Consensus 382 ------------------~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~ 426 (573)
T 3uto_A 382 ------------------GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426 (573)
T ss_dssp ------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred ------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence 689999999999999999999999999999999987665544333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=458.18 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=213.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.++||+|+||+||+|++. ..||||+++......+..+.|.+|+.+|++|+|||||++++++.+ +.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~ 105 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DN 105 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---Ce
Confidence 456788999999999999999999753 359999998776677778889999999999999999999998864 56
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|||||||+++.|..++ .....+++.++..|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999988766544 44567999999999999999999999999999999999999999999999999999876532
Q ss_pred C-cccccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 N-KQKLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~-~~~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
. .......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+..+.+..+......+|.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~------- 258 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD------- 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-------
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-------
Confidence 2 2344567899999999999642 35899999999999999999999999988777766665543222221
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
+.....++++++.+||.+||+.||.+|||+.|++++-.
T Consensus 259 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 259 ----------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp ----------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred ----------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 00112368899999999999999999999999876533
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-54 Score=491.49 Aligned_cols=263 Identities=23% Similarity=0.376 Sum_probs=223.1
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.++..++|+++++||+|+||+||+|+++.+|+.||||++.+... ..........++.+++.++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 35668899999999999999999999999999999999975421 22223333455677888899999999999998
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||||.||.|..++...+.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 --~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 --PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred --CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 789999999999988877777777899999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~w 351 (690)
+... ...+.+||+.|||||++.+...|+.++||||||||||||++|++||.+.+ ..+....+.......
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~----- 413 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----- 413 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC-----
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC-----
Confidence 6532 34567999999999999765679999999999999999999999998643 333444443321111
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
...+|+++++||.+||+.||.+|++ ++||++||||++..|
T Consensus 414 ------------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 414 ------------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ------------------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ------------------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 1258999999999999999999998 799999999998766
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=452.28 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=216.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence 55678999999999999999999875 46789999999743 45567789999999999999999999999988
Q ss_pred CcceEEEEEeccchhcccccccC-------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH-------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG 262 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~-------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~ 262 (690)
.+.+|||||||++|.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 6889999999998877655432 24699999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccccCccc-ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 041720 263 ILKLGDFGLANILTSKNKQK-LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIF 340 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~ 340 (690)
++||+|||+|+......... ....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998765433222 234578999999999975 579999999999999999998 999999999998888886
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.....+. ...+|+++.+||.+||+.||.+|||+.+++ +||+.
T Consensus 245 ~~~~~~~----------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 245 QGRVLQR----------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp HTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred cCCCCCC----------------------------CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 6322111 125789999999999999999999999995 56654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=452.96 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=208.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++++|.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE- 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 45678999999999999999999864 46889999999743 45667789999999999999999999999987
Q ss_pred CcceEEEEEeccchhcccccccC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH---------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN 260 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~---------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~ 260 (690)
.+.+|||||||+++.|..++.. ..++++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 6889999999998877654432 246999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 041720 261 EGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHK 338 (690)
Q Consensus 261 ~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~ 338 (690)
++++||+|||+|+.+...... ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999876543322 2345689999999999975 678999999999999999999 9999999999888888
Q ss_pred HHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 339 I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
|......+. ...+++++.+||.+||+.||.+|||+.|++++
T Consensus 273 i~~g~~~~~----------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRELER----------------------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCCCC----------------------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCC----------------------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 765321110 12578999999999999999999999999854
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=448.78 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=213.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+...+++++++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++|+|||||+++|+|.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK- 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence 44567899999999999999999853 467899999997543 33345679999999999999999999999987
Q ss_pred CcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN 259 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld 259 (690)
.+.+|||||||++|.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 6789999999998866554422 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 041720 260 NEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLH 337 (690)
Q Consensus 260 ~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~ 337 (690)
+++++||+|||+|+.+..... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654332 23456789999999999975 579999999999999999998 899999999988888
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.|......+. ...+++++.+||.+||+.||.+|||+.||+++
T Consensus 259 ~i~~~~~~~~----------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPC----------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCC----------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7754321111 12578899999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=431.36 Aligned_cols=287 Identities=38% Similarity=0.659 Sum_probs=246.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++.+ .+.++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998776666666788999999999999999999999988 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccc
Confidence 999999888877777778999999999999999999999999999999999999999999999999999876532 2344
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP-ILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~-PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
...+||+.|+|||++.+...++.++|||||||++|+|++|.. +|.+.+..+.+..++...+.+....|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 567889999999999876668999999999999999997765 4788889999999999999998888765332111111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+..+....+....+.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 222222333344456789999999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=433.27 Aligned_cols=289 Identities=40% Similarity=0.693 Sum_probs=238.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...++|+++++||+|+||+||+|++. +|+.||||++............+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 94 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCL 94 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEE
Confidence 34678999999999999999999984 68999999998665444556778899999999999999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
+||||||.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... .
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 999999999888777776677999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-CC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP-HG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~-~~ 359 (690)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...... ..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 33455688999999999987677899999999999999999999999999999999999999998887776642211 00
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...................+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 000001111122233446789999999999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=425.40 Aligned_cols=284 Identities=38% Similarity=0.675 Sum_probs=234.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||.||+|++ .+|+.||||++............+.+|+.+|+.++||||+++++++.+ .+.++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5799999999999999999998 788999999997654333334568899999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-cccc
Confidence 999999777766666678999999999999999999999999999999999999999999999999999765432 2234
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC-CCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL-PHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l-~~~~~~ 362 (690)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|..... +....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP- 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc-
Confidence 4568899999999998766789999999999999999999999999999999999999999888777754221 11100
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
................+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000111223344678999999999999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=444.41 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=212.8
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC-Cceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~ 193 (690)
.+..++|++.++||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|.++.| ||||+++++|.
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 45678899999999999999999987654 4689999997553 34556779999999999965 89999999986
Q ss_pred ccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEE
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNIL 257 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NIL 257 (690)
.. .+.+|||||||++|.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+|||
T Consensus 139 ~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 139 KP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 53 4678999999998876654432 234899999999999999999999999999999999999
Q ss_pred EccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 041720 258 VNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQ 335 (690)
Q Consensus 258 ld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~ 335 (690)
|+.++++||+|||+|+.+...... ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543322 3345788999999999975 579999999999999999998 9999998765554
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+.+++.....++ ....+++++.+||..||+.||.+|||+.|+++|
T Consensus 297 ~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 444443221111 012578999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=430.14 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=231.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 3567999999999999999999999999999999998877677777889999999999999999999999987 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
|||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--G 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--C
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--C
Confidence 99999998777666655668999999999999999999999999999999999999999999999999999866432 3
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+....+.......|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p-------------- 234 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-------------- 234 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 456678999999999998766566899999999999999999999999998888888876433222
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 235 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 235 ---------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ---------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ---------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 14788999999999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=449.27 Aligned_cols=295 Identities=32% Similarity=0.511 Sum_probs=228.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc---Ccce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR---LSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~~~~ 199 (690)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.|+|||||++++++... ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4679999999999999999999999999999999976655566678899999999999999999999998542 1367
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+.+++...+. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 132 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 99999999877665544 44579999999999999999999999999999999999999999999999999998764321
Q ss_pred c--------------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-----------
Q 041720 280 K--------------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI----------- 322 (690)
Q Consensus 280 ~--------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt----------- 322 (690)
. ...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 234567899999999987666779999999999999999999
Q ss_pred CCCCCCCCC--------------------HHHHHHHHHHHcCCCChhhhhccCCCCCCC--CCCCCCCccccccccCCCC
Q 041720 323 GKPILKGRT--------------------EVEQLHKIFKLCGSPPEEYWKKSKLPHGDM--FKPQNPYEGCLRERCKDFT 380 (690)
Q Consensus 323 G~~PF~~~~--------------------~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~--~~~~~~~~~~l~~~~~~is 380 (690)
|.++|.+.+ ..+++..|+..++.++.+.|.......... ..........+...++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788888765 368899999999999988776422110000 0001111223445567789
Q ss_pred hhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 381 PTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 381 ~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
+++.+||.+||.+||.+|||++|+|+||||+...+...
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 99999999999999999999999999999998766543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=438.22 Aligned_cols=290 Identities=33% Similarity=0.560 Sum_probs=227.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46799999999999999999999999999999999766555666778889999999997 99999999999865456899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc---
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK--- 278 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~--- 278 (690)
||||||.+++...+.. ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999876555443 36999999999999999999999999999999999999999999999999999875321
Q ss_pred -----------------CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 041720 279 -----------------NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 279 -----------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~ 341 (690)
.....+..+||++|+|||++.+...|+.++||||||||||+|++|++||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 122345678999999999998767899999999999999999999999999999999999999
Q ss_pred HcCCCChhhhhccCCCCCCCC---------CCCCCCcccc---------ccccCCCChhHHHHHHHhhccCCCCCCCHHH
Q 041720 342 LCGSPPEEYWKKSKLPHGDMF---------KPQNPYEGCL---------RERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~---------~~~~~~~~~l---------~~~~~~is~~l~dLI~~~L~~DP~kRpTa~e 403 (690)
..+.|+.+.+.....+....+ .......... ......+++++.+||.+||+.||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 999988776653221110000 0000000000 0011267899999999999999999999999
Q ss_pred HHcCccccCCC
Q 041720 404 LLMCEYFTTQP 414 (690)
Q Consensus 404 lL~hp~f~~~p 414 (690)
+|+||||+...
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=433.51 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=233.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+.|++++.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 467999999999999999999999999999999998754321 134678899999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC----cEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~ 274 (690)
.+|||||||.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999887777766677899999999999999999999999999999999999998877 799999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++...|.
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 243 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS-- 243 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT--
T ss_pred cCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc--
Confidence 6542 33456789999999999865 568999999999999999999999999999999999998877777777665
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 244 -----------------------~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 -----------------------QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp -----------------------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred -----------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 589999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=426.69 Aligned_cols=290 Identities=37% Similarity=0.659 Sum_probs=224.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+ .+.+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 4579999999999999999999999999999999976542 2223567899999999999999999999987 689999
Q ss_pred EEeccchhcccccccC-----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 203 VFEYMEHDLAGLSSCH-----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~-----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999998665544322 23589999999999999999999999999999999999999999999999999987643
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC-C
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK-L 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~-l 356 (690)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..|+...+.++...|.... +
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 22 334556889999999999876678999999999999999999999999999999999999999999888876522 1
Q ss_pred CCCCCCCCC---CCCcccc-ccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 357 PHGDMFKPQ---NPYEGCL-RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 357 ~~~~~~~~~---~~~~~~l-~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
+........ ......+ ......+++++.+||.+||+.||.+|||+.|+|+||||+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 111100000 1111111 12234688999999999999999999999999999999986443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=425.52 Aligned_cols=298 Identities=38% Similarity=0.661 Sum_probs=241.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP---ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..++|++++.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CC
Confidence 4567999999999999999999999999999999997543221 123467899999999999999999999987 67
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.++|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 89999999999877766666667999999999999999999999999999999999999999999999999999876533
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC-CC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK-LP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~-l~ 357 (690)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|.... ++
T Consensus 166 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 N-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp C-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 344567889999999999776678999999999999999999999999999999999999999998888776522 11
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPK 424 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~ 424 (690)
....+.. .....+...+..+++++.+||.+||+.||.+|||+.|+|+||||+..+++.....+|.
T Consensus 245 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~~~ 309 (346)
T 1ua2_A 245 DYVTFKS--FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 309 (346)
T ss_dssp TCCCCCC--CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred ccccccc--cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccCCC
Confidence 1111110 0011123344678899999999999999999999999999999999887765544443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=427.49 Aligned_cols=296 Identities=40% Similarity=0.673 Sum_probs=241.8
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC-----
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----- 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 196 (690)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.+..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 457899999999999999999999999999999999766544444456789999999999999999999987632
Q ss_pred -cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 -SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 -~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+||||||+.++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3578999999999888777776678999999999999999999999999999999999999999999999999999876
Q ss_pred ccc---CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSK---NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.++...|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 422 22234557889999999999876778999999999999999999999999999999999999999999888776
Q ss_pred ccCCCC-CCCCCCCCCCcccccccc--CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 353 KSKLPH-GDMFKPQNPYEGCLRERC--KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 353 ~~~l~~-~~~~~~~~~~~~~l~~~~--~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
...... .............+.... ...++.+.+||.+||+.||.+|||++|+|+||||+..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 422110 000000000000000000 12477899999999999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=414.60 Aligned_cols=291 Identities=35% Similarity=0.578 Sum_probs=236.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|++++||||+++++++.+ .+.++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 357999999999999999999999999999999998776666667788999999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++++..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 99999998887777767789999999999999999999999999999999999999999999999999998765332 33
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC--CCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP--HGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~--~~~ 360 (690)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+...... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 455688999999999987677899999999999999999999999999999999999888887765433221100 000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
...+.......+......+++++.+||.+||+.||.+|||++|+|+||||+...+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 01111111122233446789999999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=438.76 Aligned_cols=295 Identities=33% Similarity=0.501 Sum_probs=238.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc---ce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS---NT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~ 199 (690)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999999999999999998665556667789999999999999999999999876321 67
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+++++...+ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 9999999998665544 445579999999999999999999999999999999999999999999999999998765432
Q ss_pred c---------------------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-----------CCCCC
Q 041720 280 K---------------------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-----------GKPIL 327 (690)
Q Consensus 280 ~---------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-----------G~~PF 327 (690)
. ...+..+||++|+|||++.....|+.++||||||||||||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124678999999999997666789999999999999999998 66777
Q ss_pred CCCC-----------------HHHHHHHHHHHcCCCChhhhhccCCCCCCC--CCCCCCCccccccccCCCChhHHHHHH
Q 041720 328 KGRT-----------------EVEQLHKIFKLCGSPPEEYWKKSKLPHGDM--FKPQNPYEGCLRERCKDFTPTAVDLID 388 (690)
Q Consensus 328 ~~~~-----------------~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~--~~~~~~~~~~l~~~~~~is~~l~dLI~ 388 (690)
.+.+ ..+++..|+..+|.++.+.|.......... ..........+...++.+++++.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7655 478999999999999988776422110000 000011112233445678999999999
Q ss_pred HhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 389 TCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 389 ~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
+||+.||.+|||++|+|+||||+...+...
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence 999999999999999999999998766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=425.35 Aligned_cols=290 Identities=34% Similarity=0.669 Sum_probs=229.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|+++++||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 3567999999999999999999999999999999998765555555678899999999999999999999988 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-----cCCcEEEeecccceecc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-----NEGILKLGDFGLANILT 276 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-----~~~~vKL~DFGla~~~~ 276 (690)
|||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999999986655444 344699999999999999999999999999999999999994 45569999999998764
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.++...|.....
T Consensus 189 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 32 23345568899999999998766789999999999999999999999999999999999999999888877764221
Q ss_pred -CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 357 -PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 357 -~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
+......+..............+++++.+||.+||+.||.+|||++|+|+||||+...|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11111111111111111222347899999999999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=442.40 Aligned_cols=262 Identities=30% Similarity=0.470 Sum_probs=232.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 456999999999999999999999999999999998877666667789999999999999999999999987 789999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc---cCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN---NEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld---~~~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+...+.....+++.++..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999987766666667899999999999999999999999999999999999998 45789999999998765432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+..+......++...|.
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 238 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD------- 238 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT-------
T ss_pred -ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc-------
Confidence 33456789999999999965 568999999999999999999999999999999999998876666655554
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ------------------~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 239 ------------------TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ------------------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ------------------cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 589999999999999999999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=446.18 Aligned_cols=285 Identities=30% Similarity=0.497 Sum_probs=229.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++|||||++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56799999999999999999999999999999999866555666778999999999999999999999986531 25
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++++..+.. .+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 216 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 216 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC------
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-
Confidence 7899999999987665532 489999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
....+..+||++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++.+|+..++.+..++|.......
T Consensus 217 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred -CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 234566899999999999986 578999999999999999999999999999999999999999999888776421000
Q ss_pred -----CCCCCCCCCCcccccc--------ccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 359 -----GDMFKPQNPYEGCLRE--------RCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 359 -----~~~~~~~~~~~~~l~~--------~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.........+...... .....++++++||.+||.+||.+|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000000000000000 001125679999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=427.48 Aligned_cols=287 Identities=34% Similarity=0.646 Sum_probs=232.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.+ .+.++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 579999999999999999999999999999999975432 1112235579999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccc
Confidence 999998877777666667999999999999999999999999999999999999999999999999999865432 2334
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC-CCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH-GDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~-~~~~ 362 (690)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.++...|....... ...+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 556889999999999876778999999999999999999999999999999999999999999888776421100 0000
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.........+......+++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 1111111222334467899999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=428.21 Aligned_cols=261 Identities=29% Similarity=0.468 Sum_probs=232.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 356999999999999999999999999999999998877777777889999999999999999999999988 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 999999877766666666899999999999999999999999999999999999998654 5999999999876532
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++...|.
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 255 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD------- 255 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG-------
T ss_pred -cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc-------
Confidence 33456789999999999965 568999999999999999999999999999999988888776666655554
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 256 ------------------~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 256 ------------------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ------------------GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ------------------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 588999999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=428.02 Aligned_cols=290 Identities=32% Similarity=0.543 Sum_probs=232.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.+.|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56799999999999999999999999999999999766555666778899999999999999999999987631 14
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5799999996554444332 4699999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
..+..++|++|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|+...+.++.+++.......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 24567889999999999876779999999999999999999999999999999999999999999988775421100
Q ss_pred CCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 359 GDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 359 ~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
...+ .........+...+..+++.+.+||.+||..||.+|||++|+|+||||+....+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 0000 00000111223345678999999999999999999999999999999998654443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=424.43 Aligned_cols=261 Identities=24% Similarity=0.416 Sum_probs=226.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 45789999999999999999999999999999999975421 12234568899999999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-C
Confidence 999999999877666666668999999999999999999999999999999999999999999999999999864332 2
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|......++
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 225 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------- 225 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 34456789999999999975 5689999999999999999999999999988888887765322211
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+|| +++|+++||||....|
T Consensus 226 ----------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 226 ----------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 25789999999999999999999 9999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=418.07 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=229.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+|+.++||||+++++++.+ .+.+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 46799999999999999999999999999999999744 2345668899999999999999999999988 689999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc--CCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~--~~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+..... ....+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 999999866554444 3457999999999999999999999999999999999999987 789999999999876543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 228 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK------- 228 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT-------
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc-------
Confidence 33456789999999999975 568999999999999999999999999999999999998877777666654
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 229 ------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 229 ------------------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ------------------cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 6899999999999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=430.22 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=222.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|..+ +||||+++++++.+ .+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CC
Confidence 456789999999999999999999999999999999976421 123345678999999998 79999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+.........+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+++.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 89999999999877766666678999999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------- 244 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----------- 244 (353)
T ss_dssp ---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred -CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 234456789999999999875 5689999999999999999999999999999999999876433222
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH------HHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA------SSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa------~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+||++ +++++||||+...|
T Consensus 245 ------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 245 ------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 1478899999999999999999999 89999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=407.99 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=217.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHH
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP------------------------ESIRFMAREIMIL 177 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~iL 177 (690)
..++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999999999999999997653211 1235688999999
Q ss_pred hhcCCCceeeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEE
Q 041720 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNIL 257 (690)
Q Consensus 178 ~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NIL 257 (690)
+.++||||+++++++.+.....+||||||+.++.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999998755678999999999887765543 347999999999999999999999999999999999999
Q ss_pred EccCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 041720 258 VNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ 335 (690)
Q Consensus 258 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~ 335 (690)
|+.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|.+||.+.+....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9999999999999998765432 33455789999999999976432 47889999999999999999999998887776
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+.......+. ...+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 249 HSKIKSQALEFPD---------------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHCCCCCCS---------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhcccCCCCC---------------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 6666443221110 1368899999999999999999999999999999963
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=414.93 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=230.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+.|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+.|+||||+++++++.+ ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 356999999999999999999999999999999998654321 134678899999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC----cEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~ 274 (690)
.++|||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 8999999999877776666667899999999999999999999999999999999999999887 899999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|.
T Consensus 168 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (326)
T 2y0a_A 168 IDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-- 242 (326)
T ss_dssp CCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT--
T ss_pred CCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc--
Confidence 6532 23455789999999999865 568999999999999999999999999999999988888776666655554
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 243 -----------------------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 243 -----------------------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -----------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -----------------------cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 588999999999999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=412.49 Aligned_cols=287 Identities=37% Similarity=0.632 Sum_probs=230.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHhhc---CCCceeeeeceeecc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ---PESIRFMAREIMILRRL---DHPNIIKLEGVITSR 195 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~ 195 (690)
..++|+++++||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999999999999999999754321 11123456777777766 499999999999763
Q ss_pred Cc---ceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 196 LS---NTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 196 ~~---~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
.. ..+++||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 21 1589999999986666554433 2399999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+..+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.++...|
T Consensus 167 a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 167 ARIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp TTTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9865432 33456789999999999976 56899999999999999999999999999999999999999999988887
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..........+.+. ....+....+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 244 PRDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CSSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cchhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 65322111111111 1222334456789999999999999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=424.64 Aligned_cols=290 Identities=34% Similarity=0.543 Sum_probs=224.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 198 (690)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4679999999999999999999999999999999976555556677889999999999999999999998652 125
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999997655544432 4799999999999999999999999999999999999999999999999999986542
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
..+..+||++|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|+..++.++.+.|.......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 24567899999999999876789999999999999999999999999999999999999999999888776422110
Q ss_pred CCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 359 GDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 359 ~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
...+ .........+...+..+++.+.+||.+||+.||.+|||+.|+|+||||.....+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 0000 00000011223344578999999999999999999999999999999998655443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=429.19 Aligned_cols=285 Identities=33% Similarity=0.520 Sum_probs=231.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 198 (690)
..+|++++.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.|+|||||+++++|... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4469999999999999999999999999999999975432 234799999999999999999988542 123
Q ss_pred eEEEEEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-CcEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-GILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-~~vKL~DFGla~~ 274 (690)
.++|||||+.+++...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 478999999987654433 345579999999999999999999999999999999999999965 6789999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... ......+||+.|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|+..++.+..+.|...
T Consensus 207 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6432 23345788999999999987667999999999999999999999999999999999999999999988877653
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
.-.......+..............+++++++||.+||.+||.+|||+.|+|+||||....+
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 2111111111111111111123467899999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=416.10 Aligned_cols=289 Identities=32% Similarity=0.600 Sum_probs=238.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEE
Confidence 35678999999999999999999999999999999998776666667778899999999999999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999999999888777667789999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh---ccCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK---KSKLP 357 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~---~~~l~ 357 (690)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+. .....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 334556889999999999876678999999999999999999999999999999999999888877654432 11111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. ....+............+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 259 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 A-GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp T-TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred c-cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 011111111222334456789999999999999999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=415.17 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=225.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||.||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 457899999999999999999999999999999999754211 1234567899999999999999999999987 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999877776666667899999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------- 223 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP------------- 223 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred -ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 2345789999999999875 5689999999999999999999999999999888888876432221
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||..||.+|| +++++++||||+...|
T Consensus 224 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 224 ----------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ----------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 25789999999999999999999 9999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=422.47 Aligned_cols=283 Identities=31% Similarity=0.515 Sum_probs=231.8
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc------
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR------ 195 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 195 (690)
..++|++++.||+|+||+||+|++..+|+.||||++..+... ..+|+.+|+.++|||||++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456899999999999999999999999999999999755322 34799999999999999999998542
Q ss_pred ------------------------------CcceEEEEEeccchhccccc---ccCCCCCChhHHHHHHHHHHHHHHHHH
Q 041720 196 ------------------------------LSNTIYLVFEYMEHDLAGLS---SCHDIKFSEPQVKCYMRQLLHGVEHCH 242 (690)
Q Consensus 196 ------------------------------~~~~~~LV~Ey~~g~ll~~~---~~~~~~lse~~~~~i~~QIl~aL~yLH 242 (690)
....++||||||++++...+ ......+++..++.++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 13458999999998644333 345567999999999999999999999
Q ss_pred hCCeEeccCCcccEEEc-cCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHH
Q 041720 243 LRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL 321 (690)
Q Consensus 243 ~~givHrDLKp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLl 321 (690)
++||+||||||+||||+ .++.+||+|||+++.+... ......+||+.|+|||++.+...|+.++|||||||++|+|+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 99999999999999998 6889999999999876433 33455688999999999987677999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH
Q 041720 322 IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA 401 (690)
Q Consensus 322 tG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa 401 (690)
+|.+||.+.+..+++..|+...+.+..+.|............+..............+++++.+||.+||++||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999999999999999999998877765322211111122111112222334688999999999999999999999
Q ss_pred HHHHcCccccC
Q 041720 402 SSLLMCEYFTT 412 (690)
Q Consensus 402 ~elL~hp~f~~ 412 (690)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=437.41 Aligned_cols=273 Identities=23% Similarity=0.347 Sum_probs=230.1
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+.+..++|+++++||+|+||+||+|++..+++.||||++.+.... ......+.+|+.+|..++||||++++++|.+ .
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~ 146 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--D 146 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--S
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 345678899999999999999999999999999999999753211 1112237889999999999999999999988 6
Q ss_pred ceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||.++.+..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 899999999988766555544 5689999999999999999999999999999999999999999999999999998776
Q ss_pred ccCcccccccccccCCCCccccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLM----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~----~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..........+||+.|+|||++. +...|+.++|||||||+||||++|++||.+.+..+.+.+|+.....+.
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----- 301 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----- 301 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-----
Confidence 54444455678999999999986 245689999999999999999999999999999999988875321111
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCCCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~~~ 417 (690)
++ .....+++++++||++||+.+|.+ |++++|+++||||+...|..
T Consensus 302 ---~p----------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 302 ---FP----------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp ---CC----------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ---CC----------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 00 011258999999999999998888 99999999999999887754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=416.61 Aligned_cols=263 Identities=24% Similarity=0.420 Sum_probs=222.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
++..++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+.+|.++ +||||+++++++.+ .
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~ 82 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--E 82 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--C
Confidence 3456789999999999999999999999999999999987643 345567788999999988 89999999999988 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+||||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 89999999999877766665556799999999999999999999999999999999999999999999999999986432
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHHHcCCCCh
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR---------TEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~---------~~~e~l~~I~~~~g~~~~ 348 (690)
. .......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||... ........|.......
T Consensus 163 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-- 238 (345)
T 3a8x_A 163 P-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-- 238 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC--
T ss_pred C-CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC--
Confidence 2 234456789999999999976 56899999999999999999999999752 2233334443321111
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH------HHHHcCccccCCCC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA------SSLLMCEYFTTQPY 415 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa------~elL~hp~f~~~p~ 415 (690)
...+++++.+||.+||+.||.+||++ +++++||||....|
T Consensus 239 ---------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 239 ---------------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ---------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ---------------------------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 12578999999999999999999995 89999999998655
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=406.21 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=223.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++++.||+|+||.||+|++..+++.||||++....... .+.+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV--GDELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEE
Confidence 3567999999999999999999999999999999997654332 3568899999999999999999999987 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||.++.+..+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 171 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-c
Confidence 999999887766555433 69999999999999999999999999999999999999999999999999998765433 3
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 172 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------------- 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-------------
T ss_pred ccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-------------
Confidence 3456789999999999976 56899999999999999999999999999888877776554221110
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 238 -------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 012578899999999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=433.68 Aligned_cols=271 Identities=25% Similarity=0.361 Sum_probs=228.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+.+..++|+++++||+|+||.||+|++..+++.||||++.+.... ......+.+|+.+|..++|||||++++++.+ .
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 141 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 141 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--C
Confidence 345678899999999999999999999999999999999752110 0112347789999999999999999999988 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||||.++.+..+... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+++.+..
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 899999999988766655443 4699999999999999999999999999999999999999999999999999987765
Q ss_pred cCcccccccccccCCCCcccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGST---NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.......+.+||+.|+|||++.+.. .|+.++|||||||+||+|++|.+||.+.+..+.+.+|........-.
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p----- 295 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP----- 295 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-----
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-----
Confidence 4434455789999999999997533 27899999999999999999999999999999999887642111100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC--CCCHHHHHcCccccCCCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK--RGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k--RpTa~elL~hp~f~~~p~~~ 417 (690)
....+++++++||.+||..+|.+ ||+++|+++||||+...|..
T Consensus 296 --------------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 296 --------------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp --------------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred --------------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 01258999999999999999988 99999999999999876643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=426.05 Aligned_cols=262 Identities=23% Similarity=0.407 Sum_probs=219.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|+++++||+|+||.||+|++..+++.||||++++.... ....+.+.+|+.+|.++ +|||||++++++.+ .+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ES 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CC
Confidence 4467899999999999999999999999999999999875432 33445678899999887 89999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+...+.....+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+++.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999877766666678999999999999999999999999999999999999999999999999999863322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHcCCCChh
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---------EVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---------~~e~l~~I~~~~g~~~~~ 349 (690)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.. .......|.......
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--- 281 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--- 281 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC---
T ss_pred -CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC---
Confidence 234566899999999999976 578999999999999999999999996432 222333443321111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH------HHHHcCccccCCCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA------SSLLMCEYFTTQPY 415 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa------~elL~hp~f~~~p~ 415 (690)
...+++++++||.+||+.||.+||++ +|+++||||+...|
T Consensus 282 --------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 282 --------------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp --------------------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred --------------------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 12578999999999999999999995 89999999998665
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=415.31 Aligned_cols=256 Identities=25% Similarity=0.294 Sum_probs=191.2
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc--ceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS--NTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~~~ 201 (690)
.+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+.++.+|+|||||++++++.+... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999986 68999999996542 222234457777788999999999999986322 3689
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC--------CeEeccCCcccEEEccCCcEEEeecccce
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~--------givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
||||||+++.|..++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999998877766544 3689999999999999999999987 99999999999999999999999999998
Q ss_pred eccccCcc---cccccccccCCCCcccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------------
Q 041720 274 ILTSKNKQ---KLTSRVVTLWYRPPELLMGST-----NYNVSVDLWSVGCVFAELLIGKPILKGRTE------------- 332 (690)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~-----~~~~~sDIWSlGviLyeLltG~~PF~~~~~------------- 332 (690)
........ .....+||+.|||||++.+.. .|+.++||||||||||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543322 223468999999999997532 367899999999999999999887753221
Q ss_pred -HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 333 -VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 333 -~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+.+.+.....+. .|..+ ... .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~-----------------rp~~p--~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL-----------------RPNIP--NRW--QSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSCC-----------------CCCCC--GGG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhcccC-----------------CCCCC--ccc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122211110000 00000 000 00123346889999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=421.10 Aligned_cols=261 Identities=29% Similarity=0.445 Sum_probs=220.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+.|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 4569999999999999999999999999999999964321 11124668899999999999999999999988 689
Q ss_pred EEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc---EEEeecccc
Q 041720 200 IYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI---LKLGDFGLA 272 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~---vKL~DFGla 272 (690)
+|||||||.++.+..... ....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999765543322 2335899999999999999999999999999999999999987654 999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..+.... ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+. ..+.+..+.......+...|.
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 8765432 23456789999999999975 56899999999999999999999999885 455666666655555555443
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 258 -------------------------~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 258 -------------------------HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 589999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=410.39 Aligned_cols=262 Identities=28% Similarity=0.386 Sum_probs=218.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+ .+.+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 4679999999999999999999999999999999975532 2233568899999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC-cc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN-KQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~-~~ 281 (690)
|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999998777777777789999999999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+.................
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------------- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST-------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC-------------
Confidence 3456789999999999987655688999999999999999999999876654332222221111100
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 -------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 230 -------------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 012588999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=431.92 Aligned_cols=277 Identities=25% Similarity=0.362 Sum_probs=230.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..++||||+++++++.+ .+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--EN 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CC
Confidence 4567889999999999999999999999999999999975321 11223447889999999999999999999988 68
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+|||||||.++.+..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+++.+..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 99999999987766554443 44799999999999999999999999999999999999999999999999999987755
Q ss_pred cCcccccccccccCCCCcccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC--CCChh
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMG------STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG--SPPEE 349 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~------~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g--~~~~~ 349 (690)
.........+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+.+|..... ..+.
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~- 293 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL- 293 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc-
Confidence 44333445789999999999862 34689999999999999999999999999999998888875321 1110
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCC---CCHHHHHcCccccCCCCCCCCCCCCCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR---GTASSLLMCEYFTTQPYACDPSSLPKY 425 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kR---pTa~elL~hp~f~~~p~~~~~~~lp~~ 425 (690)
....+++++++||.+||+ +|.+| |+++|+++||||+...|.......|.+
T Consensus 294 -------------------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~ 346 (412)
T 2vd5_A 294 -------------------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPF 346 (412)
T ss_dssp ----------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSC
T ss_pred -------------------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCC
Confidence 012689999999999999 99998 599999999999998886554333333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=421.35 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=225.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
.+..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+..|+.+|..+ +||||+++++++.+ .
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--K 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--S
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--C
Confidence 3557889999999999999999999999999999999976421 112345577899999887 99999999999988 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||||.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 88999999999887766666666899999999999999999999999999999999999999999999999999976432
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.......+
T Consensus 171 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p---------- 238 (345)
T 1xjd_A 171 G-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP---------- 238 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred C-CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 2 233456789999999999976 5689999999999999999999999999999888888865321111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH-HHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS-SLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~-elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||..||.+||++. ++++||||+...|
T Consensus 239 -------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 239 -------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -------------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 24789999999999999999999998 9999999998665
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=420.03 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=225.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+..|+.+|..+ +||||+++++++.+ .+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CC
Confidence 456789999999999999999999999999999999976421 112345678899999988 89999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+...+.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999998777666665567999999999999999999999999999999999999999999999999999864322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------- 241 (353)
T 2i0e_A 175 -GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------- 241 (353)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred -CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 234456789999999999975 5689999999999999999999999999999998888876432222
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||..||.+|| +++++++||||+...|
T Consensus 242 ------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 242 ------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred ------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 25889999999999999999999 4799999999998665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=417.87 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=226.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 456789999999999999999999999999999999975421 11234568899999999999999999999988 689
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999998777666655567999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......++
T Consensus 195 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------ 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------ 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred ---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 345789999999999975 5689999999999999999999999999999888888876432221
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+||+ ++++++||||....|
T Consensus 259 -----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 259 -----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -----------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 257899999999999999999999 999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=397.29 Aligned_cols=263 Identities=29% Similarity=0.460 Sum_probs=230.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 567999999999999999999999999999999998877677777889999999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc---EEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI---LKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~---vKL~DFGla~~~~~~~ 279 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999998766555555567999999999999999999999999999999999999987655 999999999776532
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+...|
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-------- 231 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT--------
T ss_pred -ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh--------
Confidence 33345789999999999975 56899999999999999999999999999988888888766554443332
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 232 -----------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred -----------------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 258899999999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=419.74 Aligned_cols=285 Identities=29% Similarity=0.510 Sum_probs=222.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999999999999999999876555666778899999999999999999999987632 23
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.+++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 789999999987665553 35899999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP- 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~- 357 (690)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++..++..++.+..++|......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23455789999999999976 56899999999999999999999999999999999999999998887776532100
Q ss_pred -----CCCCCCCCCCCcccccc--------ccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 -----HGDMFKPQNPYEGCLRE--------RCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 -----~~~~~~~~~~~~~~l~~--------~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
....+. .......... .....++++++||.+||+.||.+|||++|+|+||||+...
T Consensus 258 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 258 RTYVENRPKYA-GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHSSCCCC-CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHhhCcccc-ccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000000 0000000000 0011256799999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=412.18 Aligned_cols=295 Identities=31% Similarity=0.493 Sum_probs=240.5
Q ss_pred ccccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 116 YGLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 116 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
.+.+....++|++++.||+|+||.||+|++..++..||||++.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 3434444578999999999999999999999999999999997543 345557789999999999999999999998752
Q ss_pred C---cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccc
Q 041720 196 L---SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 196 ~---~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
. ...+|+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 98 ~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp STTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 1 257899999999876655433 36999999999999999999999999999999999999999999999999999
Q ss_pred eeccccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 273 NILTSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 273 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
......... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..|....+.++.+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 876543221 235568999999999987767789999999999999999999999999999999999999999998876
Q ss_pred hhccCCCCCCC--CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 351 WKKSKLPHGDM--FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 351 w~~~~l~~~~~--~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
|.......... .................+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 65321100000 0000011111233445789999999999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=419.68 Aligned_cols=285 Identities=34% Similarity=0.520 Sum_probs=230.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
..+|++++.||+|+||+||+|++..++. ||+|++...... ..+|+.+|+.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4569999999999999999999877766 888887654321 236999999999999999999986521 23
Q ss_pred eEEEEEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-cCCcEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~~~~vKL~DFGla~~ 274 (690)
.++||||||.++++.... .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999987655433 2355799999999999999999999999999999999999999 789999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|++||.+.+..+++..|...++.+..+.|...
T Consensus 192 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6433 23456788999999999987677999999999999999999999999999999999999999999988766542
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
.........+..............+++++.+||.+||++||.+|||+.|+|+||||+...+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 21111111111111111112234588999999999999999999999999999999976543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=415.61 Aligned_cols=256 Identities=31% Similarity=0.430 Sum_probs=218.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+|+.+|.++ +||||+++++++.+ .+.+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 45699999999999999999999999999999999866432 34688888888 79999999999987 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC----CcEEEeecccceeccc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE----GILKLGDFGLANILTS 277 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~----~~vKL~DFGla~~~~~ 277 (690)
||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+.++ +.+||+|||++..+..
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999987766666666789999999999999999999999999999999999998543 3599999999987654
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG---RTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~---~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+ .+..+.+..|......++..+|.
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~-- 248 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN-- 248 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT--
T ss_pred CC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc--
Confidence 32 34456789999999999865 4588999999999999999999999986 45566777776654444444443
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++++||.+||..||.+|||+.++|+||||...
T Consensus 249 -----------------------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 -----------------------SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -----------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -----------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 689999999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=417.41 Aligned_cols=295 Identities=23% Similarity=0.346 Sum_probs=223.1
Q ss_pred cccCcCCeeEEeEEeec--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 119 VPMRAESFEKLEKIGQG--TYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G--~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+....++|+++++||+| +||.||+|++..+|+.||||++..........+.+.+|+.+|+.++|||||++++++.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 97 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-- 97 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--
Confidence 33456789999999999 99999999999999999999998876667777889999999999999999999999988
Q ss_pred cceEEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||||.++.+..+.... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 68999999999987666554432 5699999999999999999999999999999999999999999999999999875
Q ss_pred ccccCc------ccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-
Q 041720 275 LTSKNK------QKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP- 346 (690)
Q Consensus 275 ~~~~~~------~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~- 346 (690)
...... ......+||+.|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+.+..+.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432211 112335789999999999763 568999999999999999999999999877666655543322110
Q ss_pred -------ChhhhhccC-------CCCCCCCCCCCC--CccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 347 -------PEEYWKKSK-------LPHGDMFKPQNP--YEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 347 -------~~~~w~~~~-------l~~~~~~~~~~~--~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
....+.... +..........+ ...........+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 000000000 000000000000 0000112235688999999999999999999999999999999
Q ss_pred cCCCC
Q 041720 411 TTQPY 415 (690)
Q Consensus 411 ~~~p~ 415 (690)
+...+
T Consensus 338 ~~~~~ 342 (389)
T 3gni_B 338 KQIKR 342 (389)
T ss_dssp GGC--
T ss_pred HHHhh
Confidence 98654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=425.01 Aligned_cols=291 Identities=34% Similarity=0.620 Sum_probs=218.4
Q ss_pred CCeeE-EeEEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 124 ESFEK-LEKIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~-~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+.|++ .++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.|+|||||++++++.+.....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34666 457999999999999966 57889999999765443 347789999999999999999999976557899
Q ss_pred EEEEeccchhccccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE----ccCCcEEEee
Q 041720 201 YLVFEYMEHDLAGLSSC--------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGD 268 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl----d~~~~vKL~D 268 (690)
||||||+.++++..+.. ....+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999877665432 12249999999999999999999999999999999999999 6778999999
Q ss_pred cccceeccccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 041720 269 FGLANILTSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE---------VEQLH 337 (690)
Q Consensus 269 FGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~---------~e~l~ 337 (690)
||+++.+..... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 2345578999999999998766799999999999999999999999987665 58899
Q ss_pred HHHHHcCCCChhhhhccCC-CCCC--------CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCc
Q 041720 338 KIFKLCGSPPEEYWKKSKL-PHGD--------MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l-~~~~--------~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp 408 (690)
.|+..++.++...|..... +... ...........+.......++.+.+||.+||++||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 9999999999888865221 1000 000000000111112234478899999999999999999999999999
Q ss_pred cccCCCCCCC
Q 041720 409 YFTTQPYACD 418 (690)
Q Consensus 409 ~f~~~p~~~~ 418 (690)
||...+++..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9999877654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=409.91 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=216.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQ--PESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|++++.||+|+||.||+|++. .+|+.||||++...... ......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 355778999999999999999999985 68999999999865322 2334567899999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 688999999999877766665566799999999999999999999999999999999999999999999999999976
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|.......+
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p------- 241 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP------- 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------
T ss_pred cccCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 43322 23445789999999999975 5689999999999999999999999999999888888876432221
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||..||.+|| ++.++|+||||+...|
T Consensus 242 ----------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 242 ----------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ----------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 25789999999999999999999 8999999999987644
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=419.47 Aligned_cols=263 Identities=24% Similarity=0.419 Sum_probs=223.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|+.++|||||++++++.+ .+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~ 88 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EE 88 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 3556789999999999999999999999999999999975421 12234678899999999999999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+.........+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999888777777778999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhhhc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+ ..+....+.......+
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p------ 240 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP------ 240 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC------
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC------
Confidence 34566889999999999864 2458999999999999999999999998543 3333444333211111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-HHHHHcCccccCCCC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-ASSLLMCEYFTTQPY 415 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-a~elL~hp~f~~~p~ 415 (690)
..+++.+.+||.+||+.||.+||+ ++++++||||....|
T Consensus 241 -----------------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 241 -----------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -----------------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -----------------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 257899999999999999999999 999999999987665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=415.80 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=224.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+|+.|+||||+++++++.+ ...++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 467999999999999999999999999999999997543 3445678899999999999999999999987 689999
Q ss_pred EEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc--CCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~--~~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+.... .....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999987655444 34457999999999999999999999999999999999999974 468999999999876543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+......++...|
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 274 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF-------- 274 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT--------
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc--------
Confidence 23345689999999999975 56899999999999999999999999999998888888765433332222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 275 -----------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 275 -----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 26899999999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=413.64 Aligned_cols=287 Identities=32% Similarity=0.552 Sum_probs=234.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc----
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN---- 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---- 198 (690)
.++|.+.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4679999999999999999999999999999999987665666678899999999999999999999999863211
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 24999999998665544 23599999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.++.+++.......
T Consensus 197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 23456889999999999876779999999999999999999999999999999999999999999887765421100
Q ss_pred CCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 359 GDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 359 ~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
...+ ................+++.+.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 0000 000001112223345789999999999999999999999999999999875443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=431.97 Aligned_cols=260 Identities=30% Similarity=0.509 Sum_probs=224.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|+++++||+|+||+||+|++..++..||||++............+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 346999999999999999999999999999999998765444445678899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC---CcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+.........+++..++.++.||+.||.|||++|||||||||+||||+.. +.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999987766555555679999999999999999999999999999999999999764 45999999999876543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|.
T Consensus 193 -~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 262 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK------- 262 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT-------
T ss_pred -ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc-------
Confidence 3445678999999999985 358999999999999999999999999999999999998877666655554
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++.+++||.+||+.||.+|||+.++|+||||+..
T Consensus 263 ------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 263 ------------------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ------------------cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 689999999999999999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=410.19 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=205.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|+.|+||||+++++++.+ .+.++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 467999999999999999999999999999999997543 23557899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~~~~~~~ 279 (690)
||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999998777666666677999999999999999999999999999999999999975 789999999999876432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhccCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....+ .+..+......++..+|
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------- 275 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW------- 275 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT-------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh-------
Confidence 23355789999999999975 568999999999999999999999998766554 55555543333332222
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..++.++.+||.+||+.||.+|||+.++|+||||....
T Consensus 276 ------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 276 ------------------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------------------hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 26889999999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=426.76 Aligned_cols=260 Identities=27% Similarity=0.463 Sum_probs=227.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|.+.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 4567899999999999999999999999999999999754221 1234578899999999999999999999988 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||||.++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999998877777767778999999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+|.......+
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------ 236 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP------------ 236 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC------------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC------------
Confidence 3445678999999999998765568899999999999999999999999888888887765432221
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 237 -----------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 -----------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1478899999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=428.93 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=231.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|++|+|||||++++++.+ .+.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 346799999999999999999999999999999999765432 3345678999999999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTS 277 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~ 277 (690)
|||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999988776666666789999999999999999999999999999999999999 4678999999999987653
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...|.
T Consensus 182 ~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 252 (484)
T 3nyv_A 182 S--KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK----- 252 (484)
T ss_dssp C--CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGG-----
T ss_pred c--cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccc-----
Confidence 3 34456789999999999975 58999999999999999999999999999999999988766655555444
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 253 --------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 253 --------------------KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp --------------------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred --------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 5899999999999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=428.03 Aligned_cols=262 Identities=23% Similarity=0.399 Sum_probs=217.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCE
Confidence 456789999999999999999999999999999999975421 23344567899999999999999999999988 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|||||||.++.+.........+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+++.....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999998776666666689999999999999999999998 99999999999999999999999999999764332
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+....+......++
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------- 369 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----------- 369 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred -CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 234556789999999999975 5689999999999999999999999999998888888765432222
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+|| |++|+|+||||....|
T Consensus 370 ------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 370 ------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ------------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 25789999999999999999999 9999999999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=402.36 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=210.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~L 202 (690)
++|+++++||+|+||+||+|++..+|+.||||++...............|+..+..+ .||||+++++++.+ .+.+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 569999999999999999999999999999999876655555555566677666665 99999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.+++...+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GA 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CC
Confidence 9999988777776666667999999999999999999999999999999999999999999999999999876432 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +..+..+
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~~~------------ 273 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPPEF------------ 273 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCHHH------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCccc------------
Confidence 345679999999999875 589999999999999999999877765433222 211 1112222
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 274 -------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 274 -------------TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 2368899999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=417.56 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=219.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHH-HhhcCCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMI-LRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|..+ ++.++|||||++++++.+ .+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--AD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CC
Confidence 4567899999999999999999999999999999999876432 3344556777777 577899999999999988 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+...+.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999877666666668999999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|.......
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 258 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL------------ 258 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC------------
T ss_pred -CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC------------
Confidence 234556789999999999975 568999999999999999999999999999999888887632111
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH----HHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA----SSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa----~elL~hp~f~~~p~ 415 (690)
...+++++.+||.+||+.||.+||++ .++++||||+...|
T Consensus 259 -----------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 259 -----------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp -----------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred -----------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 12588999999999999999999996 69999999998655
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=431.85 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=226.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|++|+|||||++++++.+ .+.+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 456999999999999999999999999999999997543222234678899999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc---cCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN---NEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld---~~~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+.........+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999877665555556899999999999999999999999999999999999995 4567999999999866432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......++...|.
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 247 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR------- 247 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG-------
T ss_pred -CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC-------
Confidence 33456789999999999975 58999999999999999999999999999999999988766655555454
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 248 ------------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 248 ------------------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ------------------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ------------------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 5899999999999999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=402.71 Aligned_cols=261 Identities=27% Similarity=0.363 Sum_probs=228.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+.|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 456999999999999999999999999999999998654321 134678899999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC----cEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~ 274 (690)
.+++||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 8999999998877766666666899999999999999999999999999999999999999888 799999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+.
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 243 (321)
T 2a2a_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS-- 243 (321)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT--
T ss_pred cCcc--ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc--
Confidence 6542 23355679999999999865 568999999999999999999999999999999888887765555544433
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 244 -----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 244 -----------------------HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -----------------------TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -----------------------ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 688999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=392.21 Aligned_cols=258 Identities=31% Similarity=0.447 Sum_probs=228.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+.+|+.++||||+++++++.+ .+.+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 34699999999999999999999999999999999765332 24568899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~~ 279 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999987766555556679999999999999999999999999999999999999 77889999999999876533
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......++...|.
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 232 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL------- 232 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT-------
T ss_pred -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh-------
Confidence 33455689999999999865 48999999999999999999999999999999998888876666666554
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 233 ------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 233 ------------------NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 588999999999999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=417.39 Aligned_cols=282 Identities=29% Similarity=0.478 Sum_probs=230.0
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc------CCCceeeeeceeecc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL------DHPNIIKLEGVITSR 195 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~~ 195 (690)
...+|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 356799999999999999999999999999999999743 34456678899888887 57799999999988
Q ss_pred CcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc--EEEeecccc
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI--LKLGDFGLA 272 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~--vKL~DFGla 272 (690)
.+.+||||||+.+++...+.... ..+++..++.++.||+.||.|||++|||||||||+||||+.++. +||+|||++
T Consensus 171 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 -RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred -CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 68999999999987766555443 35999999999999999999999999999999999999999887 999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++..++..++.++..++.
T Consensus 250 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQ----RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTC----CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCC----cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 76432 3345789999999999976 568999999999999999999999999999999999999999999988765
Q ss_pred ccCCCC----CCCCCC--------------------------CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH
Q 041720 353 KSKLPH----GDMFKP--------------------------QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS 402 (690)
Q Consensus 353 ~~~l~~----~~~~~~--------------------------~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~ 402 (690)
...... ...+.. ...............++.+.+||.+||++||.+|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 422100 000000 00000000111224578899999999999999999999
Q ss_pred HHHcCccccCC
Q 041720 403 SLLMCEYFTTQ 413 (690)
Q Consensus 403 elL~hp~f~~~ 413 (690)
|+|+||||+..
T Consensus 405 e~L~Hpw~~~~ 415 (429)
T 3kvw_A 405 QALRHPWLRRR 415 (429)
T ss_dssp HHHTSTTTC--
T ss_pred HHhCChhhccC
Confidence 99999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=428.52 Aligned_cols=260 Identities=33% Similarity=0.478 Sum_probs=227.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHhhcCCCceeeeece
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP-----------ESIRFMAREIMILRRLDHPNIIKLEGV 191 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 191 (690)
.++|+++++||+|+||+||+|++..++..||||++....... ...+.+.+|+.+|+.|+|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567999999999999999999999999999999998654321 234678899999999999999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEee
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGD 268 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~D 268 (690)
+.+ ...+|||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 689999999999877665555556799999999999999999999999999999999999998876 699999
Q ss_pred cccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Q 041720 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 269 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~ 348 (690)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999876543 34456789999999999864 5899999999999999999999999999999999999887666666
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..|. .+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 269 ~~~~-------------------------~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 269 NDWK-------------------------NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHT-------------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred cccC-------------------------CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 6665 689999999999999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=406.94 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=220.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN---FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.++|++++.||+|+||.||+|++..++..||||++.... ......+.+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 456999999999999999999999999999999997542 234456789999999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccC----------------------------------------CCCCChhHHHHHHHHHHHHHH
Q 041720 200 IYLVFEYMEHDLAGLSSCH----------------------------------------DIKFSEPQVKCYMRQLLHGVE 239 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~----------------------------------------~~~lse~~~~~i~~QIl~aL~ 239 (690)
++||||||.++.+...... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999988655433320 223567889999999999999
Q ss_pred HHHhCCeEeccCCcccEEEccCC--cEEEeecccceeccccCc---ccccccccccCCCCcccccCC-CCCCcchhhHHH
Q 041720 240 HCHLRGIMHRDIKASNILVNNEG--ILKLGDFGLANILTSKNK---QKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSV 313 (690)
Q Consensus 240 yLH~~givHrDLKp~NILld~~~--~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSl 313 (690)
|||++||+||||||+||||+.++ .+||+|||++..+..... .......||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 899999999987643221 124567899999999998642 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhcc
Q 041720 314 GCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSI 393 (690)
Q Consensus 314 GviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~ 393 (690)
||+||+|++|.+||.+.+..+.+..+......++...| ..+++++.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY-------------------------NVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG-------------------------GGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc-------------------------ccCCHHHHHHHHHHcCC
Confidence 99999999999999999999988888775444433322 25789999999999999
Q ss_pred CCCCCCCHHHHHcCccccCCCC
Q 041720 394 EPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 394 DP~kRpTa~elL~hp~f~~~p~ 415 (690)
||.+|||+.++|+||||+...+
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=407.09 Aligned_cols=282 Identities=26% Similarity=0.403 Sum_probs=227.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-----CCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-----HPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~~~~~~ 194 (690)
.+..++|+++++||+|+||.||+|++..+++.||||++... ......+..|+.+|+.+. |||||++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34567899999999999999999999999999999999632 344566788999999996 9999999999988
Q ss_pred cCcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN------------- 260 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~------------- 260 (690)
.+.+||||||+.+++...+.... ..+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 108 --~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 108 --YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp --TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred --CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 68899999999655555544332 35999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 261 ------------EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 261 ------------~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999986443 2345688999999999976 568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC---------CCCCCCCc--------cccccccCCCChhHHHHHHHhh
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM---------FKPQNPYE--------GCLRERCKDFTPTAVDLIDTCL 391 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~---------~~~~~~~~--------~~l~~~~~~is~~l~dLI~~~L 391 (690)
+.+..+.+..+....+.++...+.......... ..+..... .++.......++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 999999999999999888876654322110000 00000000 0000111233577889999999
Q ss_pred ccCCCCCCCHHHHHcCcccc
Q 041720 392 SIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 392 ~~DP~kRpTa~elL~hp~f~ 411 (690)
+.||.+|||+.|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=419.42 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=213.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 356799999999999999999999999999999999753211 1123468899999999999999999999988 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
+|||||+.++++..+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 99999997766655443 457999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------------------- 221 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-------------------- 221 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--------------------
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------------------
Confidence 344567899999999999875555889999999999999999999997643221111100
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.........+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 222 ---------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 ---------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00011123578999999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=407.84 Aligned_cols=291 Identities=31% Similarity=0.498 Sum_probs=226.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC-----
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----- 196 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 196 (690)
..++|++.+.||+|+||.||+|++..+|+.||||++....... ....+|+..+..++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3567999999999999999999999999999999987553222 24567888889999999999999986521
Q ss_pred cceEEEEEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHH--hCCeEeccCCcccEEEcc-CCcEEEeecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCH--LRGIMHRDIKASNILVNN-EGILKLGDFG 270 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH--~~givHrDLKp~NILld~-~~~vKL~DFG 270 (690)
...++|||||+.+++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 22388999999987654332 35567899999999999999999999 999999999999999997 8999999999
Q ss_pred cceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Q 041720 271 LANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 271 la~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~ 350 (690)
++..+... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.+.
T Consensus 178 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 178 SAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 99876533 2334567899999999997766789999999999999999999999999999999999999999999888
Q ss_pred hhccCCCCCCCC---CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 351 WKKSKLPHGDMF---KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 351 w~~~~l~~~~~~---~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
|........... ....++...........++++.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 765332211110 1111112222223334678999999999999999999999999999999865443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=411.60 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=205.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...++|++++.||+|+||+||+|++..+++.||||++....... +.+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT--PTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEee--CCEE
Confidence 34678999999999999999999999999999999998654322 457899999999999999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc--EEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI--LKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~--vKL~DFGla~~~~~~ 278 (690)
|||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998777666655667999999999999999999999999999999999999987765 999999999753322
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhhhcc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV----EQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~----e~l~~I~~~~g~~~~~~w~~~ 354 (690)
......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.... ..+..+.......+.
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 243 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------ 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT------
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC------
Confidence 23345689999999999987554455699999999999999999999875543 333333322111111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 244 ---------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 244 ---------------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 12578999999999999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=405.88 Aligned_cols=255 Identities=31% Similarity=0.460 Sum_probs=198.8
Q ss_pred CeeEE---eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 125 SFEKL---EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 125 ~y~~~---~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
+|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.+ ...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~ 81 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHT 81 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEE
Confidence 35654 7799999999999999999999999999743 2356788999999997 9999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeecccceeccc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLANILTS 277 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~~~~~ 277 (690)
|||||||.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999877766666667899999999999999999999999999999999999998765 899999999987554
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHcCCCChhh
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE-------VEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~-------~e~l~~I~~~~g~~~~~~ 350 (690)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+.+..+......++...
T Consensus 162 ~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 162 D-NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred C-CCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 3 234456788999999999865 5689999999999999999999999987543 455666655544445444
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
|. .+++++++||.+||+.||.+|||++++|+||||+..
T Consensus 240 ~~-------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 240 WK-------------------------NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HH-------------------------TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cc-------------------------CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 44 589999999999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=401.61 Aligned_cols=293 Identities=32% Similarity=0.511 Sum_probs=232.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc---Ccc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR---LSN 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~~~ 198 (690)
..++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3578999999999999999999999999999999996432 345566788999999999999999999987652 136
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7899999999866554433 36999999999999999999999999999999999999999999999999999876532
Q ss_pred Ccc---------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 279 NKQ---------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 279 ~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+....+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 211 12345789999999998766778999999999999999999999999999999999999888877632
Q ss_pred hhhccCC-CCCC---CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCC
Q 041720 350 YWKKSKL-PHGD---MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418 (690)
Q Consensus 350 ~w~~~~l-~~~~---~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~ 418 (690)
....... .... ...+. .....+......+++++.+||.+||+.||.+|||+.|+|+||||+...++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPM-YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred ccccccccchhhHHhhcccC-CCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 2110000 0000 00000 0011223334578999999999999999999999999999999998765543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=403.85 Aligned_cols=285 Identities=34% Similarity=0.563 Sum_probs=232.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc----c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS----N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 198 (690)
.++|.+.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999999999999998765556667788999999999999999999999976321 2
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 459999999976554432 3599999999999999999999999999999999999999999999999999976542
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
.....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+....+.++.+++.......
T Consensus 179 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 23456889999999999776778999999999999999999999999999999999999999998877765421100
Q ss_pred CCC---CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 359 GDM---FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~---~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
... ..+.. ....+......+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 256 AKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHTSCBC-SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhCcCC-CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 000 00000 011112233568999999999999999999999999999999987544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=411.25 Aligned_cols=256 Identities=28% Similarity=0.392 Sum_probs=216.7
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEEe
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 205 (690)
|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ .+.++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 344678999999999999999999999999998643 3455678999999999999999999999988 688999999
Q ss_pred ccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE--ccCCcEEEeecccceeccccCccc
Q 041720 206 YMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV--NNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 206 y~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl--d~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+... ..
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EK 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CB
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cc
Confidence 99886554 344444579999999999999999999999999999999999999 56679999999999876543 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..++.++||||||||||+|++|.+||.+.+..+.+..|......++...|
T Consensus 245 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF----------- 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG-----------
T ss_pred cccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh-----------
Confidence 445679999999999864 57899999999999999999999999999999999998876544443333
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 313 --------------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 313 --------------QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 2689999999999999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=393.15 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=220.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|++.+.||+|+||.||+|++..++..||||++...... ......+.+|+.+++.++||||+++++++.+ .+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCE
Confidence 4567899999999999999999999999999999999654221 1224568899999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+++||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999999877665555556799999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 227 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------ 227 (279)
T ss_dssp -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------
T ss_pred -ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC------------
Confidence 22345688999999999875 5678999999999999999999999999988888887765433222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+++.+.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 228 -----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 228 -----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 24788999999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=404.37 Aligned_cols=256 Identities=30% Similarity=0.517 Sum_probs=222.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
+.|++++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+|+.++||||+++++++.+ .+.++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence 4599999999999999999999999999999999866433 4455778999999999999999999999987 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.|++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999999887776665666899999999999999999999999999999999999999999999999999976543
Q ss_pred ccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
....+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+.+..+.+..+........
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 273 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 273 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 235689999999999853 45689999999999999999999999999888887777654321110
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 274 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 274 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 012578899999999999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=398.79 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=223.4
Q ss_pred cCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceE
Q 041720 123 AESFEKL-EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 123 ~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 200 (690)
.+.|.+. +.||+|+||.||+|++..+++.||||++............+.+|+.+|..+ +||||+++++++.+ .+.+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 4457887 889999999999999999999999999986654444456789999999999 56999999999987 6889
Q ss_pred EEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccceec
Q 041720 201 YLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANIL 275 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~~~ 275 (690)
||||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999998766555433 356999999999999999999999999999999999999987 789999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...+
T Consensus 185 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 257 (327)
T 3lm5_A 185 GHA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF---- 257 (327)
T ss_dssp -----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT----
T ss_pred CCc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh----
Confidence 432 23345689999999999865 56899999999999999999999999999999888888776555443332
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
..+++.+.+||.+||+.||.+|||++++|+||||+...|.
T Consensus 258 ---------------------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 258 ---------------------SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ---------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 2588999999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=394.85 Aligned_cols=256 Identities=24% Similarity=0.440 Sum_probs=219.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLVF 204 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 204 (690)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.. .+.++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 378889999999999999999999999999999865432 34568899999999999999999999988 68899999
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccc
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 284 (690)
||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99998877665543 469999999999999999999999999999999999999999999999999998765432 2345
Q ss_pred ccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCC
Q 041720 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364 (690)
Q Consensus 285 ~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~ 364 (690)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 262 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK---------------- 262 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT----------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC----------------
Confidence 5789999999999965 56899999999999999999999999998888877766542111100
Q ss_pred CCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 365 ~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 263 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 263 ----------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 012578899999999999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.71 Aligned_cols=290 Identities=29% Similarity=0.443 Sum_probs=229.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---------ChHHHHHHHHHHHHHhhcCCCceeeeecee
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---------QPESIRFMAREIMILRRLDHPNIIKLEGVI 192 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 192 (690)
..++|++.+.||+|+||.||+|++. +|..||||++..... .....+.+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 4567999999999999999999875 499999999865432 223457789999999999999999999998
Q ss_pred ecc---CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 193 TSR---LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 193 ~~~---~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
... ....+||||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 542 24578999999999888877777778999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
|++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+
T Consensus 179 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 179 NLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Ccccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 999754432 234556889999999999876778999999999999999999999999999999999999999988766
Q ss_pred hhhccCCCCCC---CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 350 YWKKSKLPHGD---MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 350 ~w~~~~l~~~~---~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.+.....+... ..................+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 44321110000 000000111222334457889999999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=393.99 Aligned_cols=289 Identities=38% Similarity=0.638 Sum_probs=233.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc---CCCceeeeeceeec---
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV-ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL---DHPNIIKLEGVITS--- 194 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~--- 194 (690)
..++|++++.||+|+||.||+|++. .+|+.||||++............+.+|+.+++.+ .||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3567999999999999999999985 6789999999975433222223456777777766 89999999999862
Q ss_pred cCcceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.....++|||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 125789999999998665554433 3359999999999999999999999999999999999999999999999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...|..
T Consensus 169 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 76432 23455788999999999975 5689999999999999999999999999999999999999999888877764
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
........+. ......+......++..+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 246 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 246 DVALPRQAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TCSSCGGGSC--CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchhhhc--ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 2211111111 01111233445678999999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=402.94 Aligned_cols=260 Identities=32% Similarity=0.461 Sum_probs=226.8
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHhhc-CCCceeeeeceeeccC
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QP----ESIRFMAREIMILRRL-DHPNIIKLEGVITSRL 196 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 196 (690)
++|++.+.||+|+||.||+|++..+|+.||||++..... .. ...+.+.+|+.+|+.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 569999999999999999999999999999999976532 21 2345678999999999 89999999999987
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
...+||||||+.++.+..+......+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 68999999999987766665555679999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcccccccccccCCCCcccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMG-----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
.. ......+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+.+..+.+..+......++...|
T Consensus 252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 43 33456789999999999853 235889999999999999999999999999988888888776665555555
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
. .+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 330 ~-------------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 D-------------------------DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp S-------------------------SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred c-------------------------cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 3 57899999999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=414.42 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=209.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ------PESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|++++|||||++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 46799999999999999999999999999999999764321 1223357899999999999999999999865
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cEEEeecccce
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---ILKLGDFGLAN 273 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~vKL~DFGla~ 273 (690)
+.+|||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 56899999999987776666777899999999999999999999999999999999999997544 59999999998
Q ss_pred eccccCcccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEY 350 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-~l~~I~~~~g~~~~~~ 350 (690)
.+... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+..... ....+......+....
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 76432 33456789999999999853 4568899999999999999999999998754433 3333433333333443
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
|. .+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 369 ~~-------------------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 369 WA-------------------------EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HT-------------------------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hc-------------------------ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 33 68999999999999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=391.14 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=205.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|++..+|+.||||++..........+.+..+..+++.++||||+++++++.+ .+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCC
Confidence 456788999999999999999999999999999999997664444444555666666888999999999999987 678
Q ss_pred EEEEEeccchhcccccc---cCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 200 IYLVFEYMEHDLAGLSS---CHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
++|||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999999986644332 3456799999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccc---cCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhh
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELL---MGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l---~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w 351 (690)
... .......||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+........
T Consensus 161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 234 (290)
T 3fme_A 161 VDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---- 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC----
T ss_pred ccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc----
Confidence 433 223345789999999997 3446689999999999999999999999986 344455544443211110
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 235 -----------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 012578899999999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=396.01 Aligned_cols=287 Identities=35% Similarity=0.607 Sum_probs=225.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc-------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR------- 195 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------- 195 (690)
.++|++++.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 46799999999999999999999999999999999754 356667889999999999999999999987431
Q ss_pred -----CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-cCCcEEEeec
Q 041720 196 -----LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDF 269 (690)
Q Consensus 196 -----~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~~~~vKL~DF 269 (690)
..+.+||||||+.+++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 246889999999976555443 35699999999999999999999999999999999999997 5679999999
Q ss_pred ccceeccccC--cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 270 GLANILTSKN--KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 270 Gla~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
|++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 12234457799999999987666789999999999999999999999999999999999988776665
Q ss_pred hhhhhccCCCC-----CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 348 EEYWKKSKLPH-----GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 348 ~~~w~~~~l~~-----~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
.+.+....... .....+ ...+......++.++.+||.+||+.||.+|||++|+|+||||+..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEP----HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSC----CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcCcccccccccCC----CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 55443210000 000000 0112233457899999999999999999999999999999999876554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=397.40 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=210.8
Q ss_pred cCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceE
Q 041720 123 AESFEKL-EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 123 ~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 200 (690)
.+.|++. +.||+|+||.||+|++..+++.||||++..... .....+.+|+.+|.++ +||||+++++++.+ .+.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 4668885 789999999999999999999999999976532 2345688999999995 79999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc---EEEeecccceeccc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI---LKLGDFGLANILTS 277 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~---vKL~DFGla~~~~~ 277 (690)
||||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999998766655555567999999999999999999999999999999999999988775 99999999976542
Q ss_pred cC------cccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------------
Q 041720 278 KN------KQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTE--------------- 332 (690)
Q Consensus 278 ~~------~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~--------------- 332 (690)
.. .......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 112234579999999999863 13478999999999999999999999987642
Q ss_pred HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 333 ~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
......+......++...|. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~-------------------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWA-------------------------HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHT-------------------------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHhccCcccCchhcc-------------------------cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 33444554444444433332 58899999999999999999999999999999987
Q ss_pred C
Q 041720 413 Q 413 (690)
Q Consensus 413 ~ 413 (690)
.
T Consensus 302 ~ 302 (316)
T 2ac3_A 302 C 302 (316)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.05 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=218.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ .+.+|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 4699999999999999999999999999999999765432 345678999999999999999999999987 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-cc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-QK 282 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-~~ 282 (690)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999877766666667899999999999999999999999999999999999999999999999999987643221 22
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+... .+..+.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 228 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------------- 228 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS---------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc---------------
Confidence 3456789999999999765555789999999999999999999998765432 222222110000
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 229 ------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0012578999999999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=389.62 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=221.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|++.+.||+|+||.||+|++..++..||||++...... ......+.+|+.+++.++||||+++++++.+ .+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCE
Confidence 4567899999999999999999999999999999999753211 1123568899999999999999999999987 689
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999998666555555567999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.......+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 232 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP------------ 232 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC------------
T ss_pred --ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC------------
Confidence 2345678999999999975 5689999999999999999999999999888887777654321111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..++..+.+||..||+.||.+|||++++|+||||+...
T Consensus 233 -----------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 233 -----------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -----------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 25788999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=392.53 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=221.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.+ .+.+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3569999999999999999999999999999999985432 233568899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~~ 279 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999987665555555679999999999999999999999999999999999999 7788999999999976432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 231 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW-------- 231 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT--------
T ss_pred -CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc--------
Confidence 23345678999999999865 56899999999999999999999999999988888888765444333222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 232 -----------------DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 2688999999999999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=389.57 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=211.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|.+.++||+|+||.||+|++..++..||+|++...... ...+.+.+|+.+|+.++||||+++++++.+ ...+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 45699999999999999999999999999999999865432 234678899999999999999999999987 688999
Q ss_pred EEeccchhcccccc----cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceec
Q 041720 203 VFEYMEHDLAGLSS----CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANIL 275 (690)
Q Consensus 203 V~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~ 275 (690)
||||+.++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999986544333 223579999999999999999999999999999999999999 44578999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 246 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV------- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-------
T ss_pred CCc--ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-------
Confidence 432 2345567899999999985 36899999999999999999999999998877776665442211110
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 247 -------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 -------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 11247899999999999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=439.95 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=227.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 198 (690)
+..++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|+.+|..+ +||||+++++++.+ .+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CC
Confidence 456789999999999999999999999999999999975421 122345678899999988 79999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.++.+...+.....+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+++.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999877766666678999999999999999999999999999999999999999999999999999864332
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
. ......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|......++
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----------- 562 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------- 562 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC-----------
T ss_pred C-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 2 34566889999999999965 5789999999999999999999999999999999999876432222
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCH-----HHHHcCccccCCCC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTA-----SSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa-----~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+||++ +||++||||+...|
T Consensus 563 ------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 563 ------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 2588999999999999999999997 99999999998665
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=406.57 Aligned_cols=282 Identities=25% Similarity=0.410 Sum_probs=227.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC--------CCceeeeeceeec
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD--------HPNIIKLEGVITS 194 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIv~l~~~~~~ 194 (690)
.++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 57899999999999999999999999999999999743 445667889999999995 7889999999873
Q ss_pred c--CcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCC--------
Q 041720 195 R--LSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEG-------- 262 (690)
Q Consensus 195 ~--~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~-------- 262 (690)
. ....+||||||+.++++..+.... ..+++..++.++.||+.||.|||++ |||||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 1 256899999999888877665543 5699999999999999999999998 999999999999998775
Q ss_pred -----------------------------------------cEEEeecccceeccccCcccccccccccCCCCcccccCC
Q 041720 263 -----------------------------------------ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301 (690)
Q Consensus 263 -----------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 301 (690)
.+||+|||++..... .....+||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~- 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG- 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcC-
Confidence 799999999987643 2355689999999999976
Q ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCChhhhhccCCCCCCC--------CCCCCC
Q 041720 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRT------EVEQLHKIFKLCGSPPEEYWKKSKLPHGDM--------FKPQNP 367 (690)
Q Consensus 302 ~~~~~~sDIWSlGviLyeLltG~~PF~~~~------~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~--------~~~~~~ 367 (690)
..|+.++||||||||||+|++|.+||.+.+ ..+.+..+....+.++...|.......... .....+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 468999999999999999999999998765 677888899999998877664432210000 000000
Q ss_pred Cc--cccc---cccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 368 YE--GCLR---ERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 368 ~~--~~l~---~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.. ..+. ......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 0000 011233567889999999999999999999999999973
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.47 Aligned_cols=262 Identities=31% Similarity=0.434 Sum_probs=225.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHhhcC-CCceeeeeceeec
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---Q----PESIRFMAREIMILRRLD-HPNIIKLEGVITS 194 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 194 (690)
.++|++.+.||+|+||.||+|++..+|+.||||++..... . ....+.+.+|+.+|+++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 5689999999999999999999999999999999976531 1 123456889999999995 9999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.++|||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 689999999999876666655556799999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCccccc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLM-----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
+... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+....+......++..
T Consensus 174 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 174 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 6532 2345567899999999985 23568899999999999999999999999998888888877654444332
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.| ..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 252 ~~-------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 252 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TG-------------------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cc-------------------------cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 22 2578999999999999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.62 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=226.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence 345679999999999999999999999999999999976543 35566788999999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+++||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999987766666555679999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 234 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------- 234 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-------------
T ss_pred -cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC-------------
Confidence 23345678999999999865 568999999999999999999999999988877776664422111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+++.+.+||.+||+.||.+|||++++|+||||...+.
T Consensus 235 ----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 235 ----------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ----------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 1257889999999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=386.87 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=222.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CC
Confidence 356999999999999999999999999999999998654321 135678999999999999999999999987 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC----cEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~ 274 (690)
.+++||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 8999999998876666555556799999999999999999999999999999999999998877 899999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+...+
T Consensus 162 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (283)
T 3bhy_A 162 IEAG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF--- 235 (283)
T ss_dssp CC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred ccCC--CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc---
Confidence 6432 23345678999999999865 56899999999999999999999999999988888887665544444433
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 236 ----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 236 ----------------------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ----------------------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 2678999999999999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=392.74 Aligned_cols=282 Identities=30% Similarity=0.516 Sum_probs=223.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+|+.|. ||||+++++++.+.....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3577999999999999999999999999999999997432 356889999999997 9999999999987556789
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 279 (690)
+|||||+.++.+..+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+...
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 99999999876655443 489999999999999999999999999999999999999777 8999999999876543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChh-hhhccCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPIL-KGRTEVEQLHKIFKLCGSPPEE-YWKKSKLP 357 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF-~~~~~~e~l~~I~~~~g~~~~~-~w~~~~l~ 357 (690)
......+||+.|+|||++.+...++.++|||||||+||+|++|..|| .+.+..+.+..+....+.+... ++......
T Consensus 185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 23455688999999999987677999999999999999999999888 4566777777777666543211 11111110
Q ss_pred CCCC------CCCCCCCcccc-ccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 358 HGDM------FKPQNPYEGCL-RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 358 ~~~~------~~~~~~~~~~l-~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.... ......+.... ......+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000 00000000000 01123478999999999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=408.76 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=203.7
Q ss_pred cCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhh-cCCCceeeeeceeec--cCcc
Q 041720 123 AESFEKL-EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR-LDHPNIIKLEGVITS--RLSN 198 (690)
Q Consensus 123 ~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~--~~~~ 198 (690)
.++|.+. +.||+|+||+||+|++..+|+.||||++... ..+.+|+.++.+ ++||||++++++|.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678887 6899999999999999999999999999632 346788888754 589999999999864 2246
Q ss_pred eEEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~ 273 (690)
.+|||||||.++.+..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 789999999987665544432 35999999999999999999999999999999999999997 7899999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCChh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE----QLHKIFKLCGSPPEE 349 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e----~l~~I~~~~g~~~~~ 349 (690)
..... ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+... ....+......++..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 75432 33456789999999999865 678999999999999999999999998765332 334444333333322
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.| ..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 290 ~~-------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 EW-------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TT-------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cc-------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 22 2689999999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=431.32 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=219.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
++..++|++++.||+|+||.||+|++..+|+.||||++.+.... ......+.+|+.+|+.++|||||++++++.+ .+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CC
Confidence 45678899999999999999999999999999999999754211 1223567899999999999999999999988 68
Q ss_pred eEEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+...+... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||++..+.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999987766544433 349999999999999999999999999999999999999999999999999998764
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChhhhh
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE----VEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~----~e~l~~I~~~~g~~~~~~w~ 352 (690)
.. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+. .+....+.......
T Consensus 338 ~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~------ 408 (576)
T 2acx_A 338 EG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY------ 408 (576)
T ss_dssp TT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC------
T ss_pred cC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC------
Confidence 32 33455789999999999975 5689999999999999999999999987642 33333333211100
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
...+++++++||.+||+.||.+|| +++|+++||||+...|
T Consensus 409 -----------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 409 -----------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp -----------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred -----------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 125899999999999999999999 8999999999998655
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=384.33 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=218.8
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--Ccce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSNT 199 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 199 (690)
....|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34558999999999999999999999999999999987777777788899999999999999999999998652 2467
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEc-cCCcEEEeecccceecc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVN-NEGILKLGDFGLANILT 276 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld-~~~~vKL~DFGla~~~~ 276 (690)
++|||||+.++.+..+......+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999998777666665567999999999999999999999999 99999999999998 78899999999997543
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+......... +..
T Consensus 184 ~---~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~------- 250 (290)
T 1t4h_A 184 A---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PAS------- 250 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGG-------
T ss_pred c---cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccc-------
Confidence 2 23345678999999998864 5899999999999999999999999886655544433322111 111
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.....++++.+||..||+.||.+|||+.++|+||||++
T Consensus 251 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 251 ------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11256789999999999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=396.65 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=219.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc--c
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS--N 198 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~ 198 (690)
..++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 35679999999999999999999999999999999987543 34556778999999999999999999999876322 2
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 46999999998777766666668999999999999999999999999999999999999999999999999999876433
Q ss_pred Cc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......++...
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 242 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR------ 242 (311)
T ss_dssp ------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH------
T ss_pred ccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc------
Confidence 22 22334678999999999976 5689999999999999999999999999988888777766443333222
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+++++.+||.+||+.||.+||++.++|.|+|+...
T Consensus 243 -------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 -------------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -------------------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 23689999999999999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=394.44 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=204.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc------
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS------ 197 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 197 (690)
++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|++|+|||||++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46999999999999999999999999999999998654 33455778999999999999999999999865311
Q ss_pred -------------------------------------------------ceEEEEEeccchhcccccccCCCC---CChh
Q 041720 198 -------------------------------------------------NTIYLVFEYMEHDLAGLSSCHDIK---FSEP 225 (690)
Q Consensus 198 -------------------------------------------------~~~~LV~Ey~~g~ll~~~~~~~~~---lse~ 225 (690)
..++||||||.++.+..+...... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 238999999998766655544333 4555
Q ss_pred HHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-----------ccccccccccCCCC
Q 041720 226 QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-----------QKLTSRVVTLWYRP 294 (690)
Q Consensus 226 ~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~A 294 (690)
.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 6899999999999999999999999999999999999999999999987654321 22345679999999
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcccccc
Q 041720 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRE 374 (690)
Q Consensus 295 PE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~ 374 (690)
||++.+ ..++.++|||||||++|+|++|..|+.. .......+.. ...+. .+
T Consensus 245 PE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~~-~~----------------------- 295 (332)
T 3qd2_B 245 PEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFPL-LF----------------------- 295 (332)
T ss_dssp HHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCCH-HH-----------------------
T ss_pred hHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCCc-cc-----------------------
Confidence 999976 5689999999999999999998776532 1122222211 11111 11
Q ss_pred ccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 375 RCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 375 ~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 296 --~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 --TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp --HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred --ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 135678899999999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.89 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=226.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
....+|.+.+.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCe
Confidence 345679999999999999999999999999999999976533 45566788999999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999987766665555679999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 261 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP------------ 261 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------
T ss_pred -ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 23345678999999999975 5689999999999999999999999999888777776654322111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
..+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 262 -----------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 262 -----------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred -----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 25788999999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=422.73 Aligned_cols=263 Identities=26% Similarity=0.447 Sum_probs=221.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
++..++|++++.||+|+||.||+|++..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KT 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CC
Confidence 45678899999999999999999999999999999999754221 1224568899999999999999999999988 68
Q ss_pred eEEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+|||||||.|+.+...+.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 89999999998766544432 34699999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCChhh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT----EVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~----~~e~l~~I~~~~g~~~~~~ 350 (690)
+.... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+ ..+....+.......+
T Consensus 339 ~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 339 LKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp CCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 65432 23345689999999999976 578999999999999999999999998763 3455555544221111
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||+.||.+||+ ++++++||||+...|
T Consensus 414 --------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 414 --------------------------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp --------------------------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred --------------------------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 258899999999999999999996 589999999998665
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=392.62 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=212.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ------PESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 35699999999999999999999999999999999754321 1223457899999999999999999999876
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc---EEEeecccce
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI---LKLGDFGLAN 273 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~---vKL~DFGla~ 273 (690)
+.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 87 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 348999999998766665566678999999999999999999999999999999999999987664 9999999998
Q ss_pred eccccCcccccccccccCCCCccccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLM--GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~~ 350 (690)
.+... ......+||+.|+|||++. +...++.++|||||||++|+|++|.+||.+.... .....+......+....
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 76432 2334567899999999974 3456899999999999999999999999875443 23333433333333333
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
| ..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 244 ~-------------------------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 W-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp H-------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred h-------------------------hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 3 268899999999999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=384.33 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=222.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...++|++++.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+|++++||||+++++++.+.....+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 45678999999999999999999999999999999998877777777889999999999999999999998865446789
Q ss_pred EEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhCC-----eEeccCCcccEEEccCCcEEEeeccc
Q 041720 201 YLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLRG-----IMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~g-----ivHrDLKp~NILld~~~~vKL~DFGl 271 (690)
|+||||++++.+..+... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999988655444322 334999999999999999999999999 99999999999999999999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----- 235 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----- 235 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-----
Confidence 97654322 22344678999999999975 468999999999999999999999999988877777765532111
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++++.+||.+||+.||.+|||+.|+|+|+|+...
T Consensus 236 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 -----------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 012578999999999999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=401.16 Aligned_cols=281 Identities=26% Similarity=0.436 Sum_probs=224.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CC-----ceeeeeceeeccC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HP-----NIIKLEGVITSRL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~~~~ 196 (690)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 56899999999999999999999999999999999743 344566788999998885 55 49999999987
Q ss_pred cceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHH--hCCeEeccCCcccEEEc--cCCcEEEeeccc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCH--LRGIMHRDIKASNILVN--NEGILKLGDFGL 271 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH--~~givHrDLKp~NILld--~~~~vKL~DFGl 271 (690)
.+.+||||||+.+++...+.... ..+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 68999999999987766555443 46999999999999999999999 57999999999999995 467899999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+..... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++..|....+.++...+
T Consensus 208 a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQ----RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeccc----ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987643 2345789999999999976 46899999999999999999999999999999999999999998887766
Q ss_pred hccC--------CCCCC---------CCCCCCCCccccccccC-----------C-------CChhHHHHHHHhhccCCC
Q 041720 352 KKSK--------LPHGD---------MFKPQNPYEGCLRERCK-----------D-------FTPTAVDLIDTCLSIEPY 396 (690)
Q Consensus 352 ~~~~--------l~~~~---------~~~~~~~~~~~l~~~~~-----------~-------is~~l~dLI~~~L~~DP~ 396 (690)
.... ++... ......+....+..... . .++++++||.+||++||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 4311 01000 00000000000000000 0 013789999999999999
Q ss_pred CCCCHHHHHcCccccCC
Q 041720 397 KRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 397 kRpTa~elL~hp~f~~~ 413 (690)
+|||++|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=397.17 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=210.4
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC--CceeeeeceeeccC
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH--PNIIKLEGVITSRL 196 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~ 196 (690)
+.+..+.|++++.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|..|.| |||+++++++.+
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-- 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--
Confidence 345677899999999999999999986 578999999998777677777889999999999976 999999999987
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+.+|||||++.+++...+ .....+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.
T Consensus 81 ~~~~~lv~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEECCCSEEHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEeCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 6899999997666555444 4455799999999999999999999999999999999999997 6889999999998765
Q ss_pred ccCcc-cccccccccCCCCcccccC----------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcC
Q 041720 277 SKNKQ-KLTSRVVTLWYRPPELLMG----------STNYNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKLCG 344 (690)
Q Consensus 277 ~~~~~-~~~~~~gt~~Y~APE~l~~----------~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~-~e~l~~I~~~~g 344 (690)
..... .....+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||..... ...+..+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 43222 2345689999999999853 25688999999999999999999999987433 333433322111
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.. ......+.++.+||..||+.||.+|||+.|+|+||||+...
T Consensus 239 ~~---------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 EI---------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CC---------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cc---------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 00 00123567899999999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=382.00 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=209.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++..+ +||||+++++++.+ .+.++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 4569999999999999999999999999999999987655555667788999999999 99999999999987 68999
Q ss_pred EEEeccchhcccccccCC----CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC----------------
Q 041720 202 LVFEYMEHDLAGLSSCHD----IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---------------- 261 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~----~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---------------- 261 (690)
|||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999886555444332 568999999999999999999999999999999999999844
Q ss_pred ---CcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 041720 262 ---GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHK 338 (690)
Q Consensus 262 ---~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~ 338 (690)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+...... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HH
Confidence 47999999999876432 23468999999999987656778999999999999999999887654332 22
Q ss_pred HHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 339 I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+.... .+ .....+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 240 ~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGR--LP--------------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTC--CC--------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHcCC--CC--------------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 22211 00 1113578999999999999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=404.30 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=210.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC--CCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD--HPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 197 (690)
.+....|++++.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.|. |||||++++++.. .
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~ 128 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--D 128 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--C
Confidence 3445679999999999999999998754 899999999887667777788999999999996 5999999999987 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||++.+++...+ .....+++.+++.++.||+.||.|||++|||||||||+||||+ ++.+||+|||+++.+..
T Consensus 129 ~~~~lv~E~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp SEEEEEEECCSEEHHHHH-HHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred CEEEEEEecCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 789999996555554443 3445789999999999999999999999999999999999995 58999999999987654
Q ss_pred cCcc-cccccccccCCCCcccccC----------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCC
Q 041720 278 KNKQ-KLTSRVVTLWYRPPELLMG----------STNYNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKLCGS 345 (690)
Q Consensus 278 ~~~~-~~~~~~gt~~Y~APE~l~~----------~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~-~e~l~~I~~~~g~ 345 (690)
.... .....+||+.|+|||++.+ ...|+.++||||||||||+|++|.+||.+... ...+..+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 3222 2345789999999999864 23689999999999999999999999987543 3444444321111
Q ss_pred CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 346 ~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.. .....+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 287 ~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 IE---------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CC---------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CC---------------------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00 0113467899999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=387.18 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=219.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.+...+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35799999999999999999999999999999999754211 2345678999999999999999999999865446789
Q ss_pred EEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
||||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999886554433 34569999999999999999999999999999999999999999999999999998764321
Q ss_pred -cccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 280 -KQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 -~~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 232 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----------- 232 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC-----------
Confidence 2233456789999999998753 234779999999999999999999999988888777765532111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 233 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 233 ------------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ------------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ------------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 1257889999999999999999999999999999987644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=401.73 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=212.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE------SIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.++|++++.||+|+||.||+|++..+++.||||++........ ....+.+|+.+|+.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 3569999999999999999999999999999999987643211 23457789999999999999999999987
Q ss_pred cceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.++|||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 68999999999765 55555566667999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||..... +....
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~------------ 240 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAA------------ 240 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTC------------
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhc------------
Confidence 543 2345578999999999998765558999999999999999999999975211 00000
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
......+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 241 -----------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 241 -----------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00012478999999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=386.23 Aligned_cols=259 Identities=30% Similarity=0.453 Sum_probs=192.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 456799999999999999999999999999999999754211 1224668899999999999999999999987 6889
Q ss_pred EEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999998866554443 34679999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 228 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD---------------- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC----------------
T ss_pred -CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc----------------
Confidence 22334678999999999865 567899999999999999999999998765443332221000
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
......++.++.+||.+||+.||.+|||++++|+||||...
T Consensus 229 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 -------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00112578899999999999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=383.80 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=213.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCe
Confidence 4467899999999999999999999999999999999754211 1234578899999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 9999999988766655555567999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 231 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP------------ 231 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc------------
Confidence 2334567899999999997655457899999999999999999999998887777776654321111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 232 -----------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 232 -----------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 2468899999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=386.16 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=214.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||.||+|++..++..||||++..... .....+.+.+|+.++..++||||+++++++.+ .+.+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 86 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCY 86 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeE
Confidence 45789999999999999999999999999999999976533 35566789999999999999999999999987 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999877766666666899999999999999999999999999999999999999999999999999987654433
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+...++........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 232 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV------------- 232 (294)
T ss_dssp --------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH-------------
T ss_pred cccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc-------------
Confidence 44455689999999999976 5689999999999999999999999999888776655543211111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.......+++.+.++|.+||+.||.+||+..+.|.+.|..
T Consensus 233 -----------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 233 -----------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp -----------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred -----------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 1112246899999999999999999999655655565544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=406.01 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=215.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|++++.||+|+||.||+|++. .+++.||||+++.... .....+.+.+|+.+|+.+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34578999999999999999999984 5899999999865321 111223467899999999 79999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||||.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 688999999999877766665556799999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCChh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRT----EVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~~----~~e~l~~I~~~~g~~~~~ 349 (690)
+...........+||+.|+|||++.+ ...++.++||||||||||+|++|..||.... ..+....+.......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 285 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--- 285 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC---
Confidence 65444444556789999999999975 3457899999999999999999999997543 233333332211111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
...++..+.+||.+||..||.+|| |++|+|+||||+...|
T Consensus 286 --------------------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 286 --------------------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp --------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred --------------------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 125788999999999999999999 9999999999987543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=385.26 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=222.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.+ .+.+++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 356999999999999999999999999999999997654444445678899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC---CcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE---GILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~---~~vKL~DFGla~~~~~~~ 279 (690)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 99999887665444445579999999999999999999999999999999999999764 47999999999765432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 246 (287)
T 2wei_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-------- 246 (287)
T ss_dssp -SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG--------
T ss_pred -CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh--------
Confidence 23345578999999999865 4899999999999999999999999999888888877664433332222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 247 -----------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 247 -----------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -----------------hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 2688999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=386.74 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=210.8
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|++ +|..||||++..........+.+.+|+.+|++++||||+++++++.+ .+.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 108 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPN 108 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCc
Confidence 45677899999999999999999976 68899999998777777777889999999999999999999999987 678
Q ss_pred EEEEEeccchhcccccccCCC---CCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEeeccccee
Q 041720 200 IYLVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
++|||||+.++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999876665554433 3999999999999999999999999 99999999999999999999999999976
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 189 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------- 259 (309)
T 3p86_A 189 KAST-FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE------- 259 (309)
T ss_dssp --------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred cccc-ccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence 5432 223345789999999999975 5689999999999999999999999999888877766543221111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc--CccccC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM--CEYFTT 412 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~--hp~f~~ 412 (690)
....+++++.+||.+||+.||.+|||+.++++ .+++..
T Consensus 260 --------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 --------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11368899999999999999999999999987 466554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=395.11 Aligned_cols=287 Identities=24% Similarity=0.363 Sum_probs=219.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|++..++..||+|++.... .....+.+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCE
Confidence 456778999999999999999999999999999999998653 45666789999999999999999999999987 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+||||||+.++.+..+......+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+..
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999877766666666799999999999999999999996 999999999999999999999999999976532
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-ChhhhhccC--
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP-PEEYWKKSK-- 355 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~-~~~~w~~~~-- 355 (690)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+....... ....+....
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp --HC----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred --ccccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22345688999999999975 568999999999999999999999999877665543332111111 100000000
Q ss_pred CCCCC-CC--CCCCCCccc---------cccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 356 LPHGD-MF--KPQNPYEGC---------LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 356 l~~~~-~~--~~~~~~~~~---------l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..... .. .+....... .......++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000 00 000000000 000112478899999999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=389.13 Aligned_cols=282 Identities=23% Similarity=0.394 Sum_probs=227.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc------eeeeeceeec
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATG-KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN------IIKLEGVITS 194 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~ 194 (690)
..++|++++.||+|+||.||+|++..++ ..||||++... ....+.+.+|+.+|+.+.|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4578999999999999999999998777 68999999643 345567889999999997665 8999999887
Q ss_pred cCcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV--------------- 258 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl--------------- 258 (690)
.+.+||||||+.++++..+.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 94 --~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 94 --HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred --CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 68999999999888777665443 469999999999999999999999999999999999999
Q ss_pred ----ccCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 041720 259 ----NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334 (690)
Q Consensus 259 ----d~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e 334 (690)
+.++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999986432 2345689999999999975 568999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCChhhhhccCCCC----CCCCCCCCCC-cccccc----------ccCCCChhHHHHHHHhhccCCCCCC
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPH----GDMFKPQNPY-EGCLRE----------RCKDFTPTAVDLIDTCLSIEPYKRG 399 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~----~~~~~~~~~~-~~~l~~----------~~~~is~~l~dLI~~~L~~DP~kRp 399 (690)
.+..+....+.++..++....... .....+.... ...... .....+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 999999999998887665422110 0000000000 000000 0112245789999999999999999
Q ss_pred CHHHHHcCccccCC
Q 041720 400 TASSLLMCEYFTTQ 413 (690)
Q Consensus 400 Ta~elL~hp~f~~~ 413 (690)
|+.|+|+||||+..
T Consensus 327 t~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 327 TLAEALLHPFFAGL 340 (355)
T ss_dssp CHHHHTTSGGGGGC
T ss_pred CHHHHhcChhhcCC
Confidence 99999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=385.48 Aligned_cols=282 Identities=22% Similarity=0.342 Sum_probs=225.7
Q ss_pred CcCCeeEEeEEeecCceEEEEEEE-cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC------ceeeeeceeec
Q 041720 122 RAESFEKLEKIGQGTYSSVFRARE-VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP------NIIKLEGVITS 194 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIv~l~~~~~~ 194 (690)
..++|++++.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.+.|+ +|+++++++.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 456899999999999999999998 568899999999643 34556788999999998665 49999999987
Q ss_pred cCcceEEEEEeccchhcccccccCC-CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-------------
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN------------- 260 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~------------- 260 (690)
.+.+||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 --~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 89 --HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 68999999999766666554433 36899999999999999999999999999999999999987
Q ss_pred ------CCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 041720 261 ------EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE 334 (690)
Q Consensus 261 ------~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e 334 (690)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999986432 2345688999999999975 568999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCChhhhhccCCCCC---C-CCCCCCC-Ccc----------ccccccCCCChhHHHHHHHhhccCCCCCC
Q 041720 335 QLHKIFKLCGSPPEEYWKKSKLPHG---D-MFKPQNP-YEG----------CLRERCKDFTPTAVDLIDTCLSIEPYKRG 399 (690)
Q Consensus 335 ~l~~I~~~~g~~~~~~w~~~~l~~~---~-~~~~~~~-~~~----------~l~~~~~~is~~l~dLI~~~L~~DP~kRp 399 (690)
.+..+....+.++...+........ . ....... ... .........++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 9999999999888876654221100 0 0000000 000 00000112356789999999999999999
Q ss_pred CHHHHHcCccccCC
Q 041720 400 TASSLLMCEYFTTQ 413 (690)
Q Consensus 400 Ta~elL~hp~f~~~ 413 (690)
|+.|+|+||||+..
T Consensus 322 t~~ell~hp~f~~~ 335 (339)
T 1z57_A 322 TLREALKHPFFDLL 335 (339)
T ss_dssp CHHHHTTSGGGGGG
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=382.68 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=214.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+ .+.+++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 567999999999999999999999999999999997543 2234678899999999999999999999987 678999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 999999876655433 3556999999999999999999999999999999999999999999999999998543221 12
Q ss_pred cccccccccCCCCccccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 282 KLTSRVVTLWYRPPELLM----GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~----~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||...+..+.+..+........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 242 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---------- 242 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----------
Confidence 234467899999999984 345688999999999999999999999999888877766654321110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++..+.+||..||+.||.+|||+.++|+||||+...
T Consensus 243 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 ----------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00124788999999999999999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=397.33 Aligned_cols=268 Identities=17% Similarity=0.213 Sum_probs=196.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhc--CCCceeeee-------ce
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRL--DHPNIIKLE-------GV 191 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L--~HpnIv~l~-------~~ 191 (690)
....|++++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.| +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345599999999999999999999999999999999876543 34556777886555555 699988755 44
Q ss_pred eeccCc---------------ceEEEEEeccchhcccccccCCCCCChhHH------HHHHHHHHHHHHHHHhCCeEecc
Q 041720 192 ITSRLS---------------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQV------KCYMRQLLHGVEHCHLRGIMHRD 250 (690)
Q Consensus 192 ~~~~~~---------------~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~------~~i~~QIl~aL~yLH~~givHrD 250 (690)
+..... ..+|||||||++++...+......+.+..+ ..++.||+.||.|||++||||||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433211 458999999997666655544444555555 67779999999999999999999
Q ss_pred CCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 041720 251 IKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKG 329 (690)
Q Consensus 251 LKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~ 329 (690)
|||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987542 2224567799999999964 24689999999999999999999999987
Q ss_pred CCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 330 ~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.+... ...|....... ..........+..+++.+.+||.+||+.||.+|||+.++|+|||
T Consensus 296 ~~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 296 VTPGI-------------KGSWKRPSLRV-------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp CCTTC-------------TTCCCBCCTTS-------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cCccc-------------ccchhhhhhhh-------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 53220 01111100000 00001111123478999999999999999999999999999999
Q ss_pred ccCC
Q 041720 410 FTTQ 413 (690)
Q Consensus 410 f~~~ 413 (690)
|+..
T Consensus 356 f~~~ 359 (371)
T 3q60_A 356 FLQL 359 (371)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=390.40 Aligned_cols=276 Identities=23% Similarity=0.372 Sum_probs=219.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh---------------HHHHHHHHHHHHHhhcCCCcee
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP---------------ESIRFMAREIMILRRLDHPNII 186 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIv 186 (690)
..++|++++.||+|+||.||+|++ +|+.||||++....... ...+.+.+|+.+|+.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 457899999999999999999998 99999999997542111 1126789999999999999999
Q ss_pred eeeceeeccCcceEEEEEeccchhccccc------ccC--CCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEE
Q 041720 187 KLEGVITSRLSNTIYLVFEYMEHDLAGLS------SCH--DIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNIL 257 (690)
Q Consensus 187 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~------~~~--~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NIL 257 (690)
++++++.+ .+.+|+||||+.++.+..+ ... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999988 6899999999998666554 333 5679999999999999999999999 99999999999999
Q ss_pred EccCCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 041720 258 VNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNV-SVDLWSVGCVFAELLIGKPILKGRTE-VEQ 335 (690)
Q Consensus 258 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~sDIWSlGviLyeLltG~~PF~~~~~-~e~ 335 (690)
|+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999876432 3455788999999999976545666 99999999999999999999998777 666
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
...+.......+..... ...+. ...........+++++.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 262 ~~~i~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNH--------FLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHTSCCCCCCCSSSS--------STTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHhccCcCCccchhh--------hhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 66654432222211000 00000 00001112246899999999999999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=377.81 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=220.7
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 45699999999999999999999999999999999866433 345678999999999999999999999987 688999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998766655543 479999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+..... +
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------------- 237 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--P--------------- 237 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C---------------
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--C---------------
Confidence 345678999999999975 5688999999999999999999999998887776665543211 0
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....++..+.+||..||+.||.+|||+.++|+||||...
T Consensus 238 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 -----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0112578899999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=382.29 Aligned_cols=265 Identities=25% Similarity=0.430 Sum_probs=212.6
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccC-
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRL- 196 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~- 196 (690)
+....+.|++++.||+|+||.||+|++..+|+.||||++...... ...+.+|+.+|+++ +||||+++++++....
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344567899999999999999999999999999999999765432 34688999999999 8999999999997632
Q ss_pred ---cceEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 197 ---SNTIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 197 ---~~~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
.+.+||||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 4689999999998655544332 34699999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
+..+.... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 176 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 253 (326)
T 2x7f_A 176 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR- 253 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-
T ss_pred ceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc-
Confidence 98754322 22345678999999999863 3568899999999999999999999999888777766554321100
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....+++.+.+||.+||..||.+|||+.++|+||||+..+
T Consensus 254 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 --------------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp --------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred --------------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 01135789999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.01 Aligned_cols=272 Identities=24% Similarity=0.385 Sum_probs=196.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 87 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDE 87 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSC
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCC
Confidence 3557889999999999999999999988999999999875432 2345668899999999999999999999987 678
Q ss_pred EEEEEeccchhccccccc--------CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 200 IYLVFEYMEHDLAGLSSC--------HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~--------~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
+++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999998865544432 245699999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCc----ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 272 ANILTSKNK----QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 272 a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
+..+..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+...........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 976543211 1223467899999999986545689999999999999999999999998777665544433211110
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.. ..........+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 ~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 ET-------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TC------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cc-------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00 000112234688999999999999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=406.39 Aligned_cols=253 Identities=17% Similarity=0.238 Sum_probs=199.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHH---HHHhhcCCCceeeee-------
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREI---MILRRLDHPNIIKLE------- 189 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei---~iL~~L~HpnIv~l~------- 189 (690)
...++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+ .+|+.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34577999999999999999999998999999999998653 2345567889999 455556899999998
Q ss_pred ceeeccCc----------c-----eEEEEEeccchhcccccccCCCCCCh-------hHHHHHHHHHHHHHHHHHhCCeE
Q 041720 190 GVITSRLS----------N-----TIYLVFEYMEHDLAGLSSCHDIKFSE-------PQVKCYMRQLLHGVEHCHLRGIM 247 (690)
Q Consensus 190 ~~~~~~~~----------~-----~~~LV~Ey~~g~ll~~~~~~~~~lse-------~~~~~i~~QIl~aL~yLH~~giv 247 (690)
+++.+... + ..||||||+.|++...+.. ...+++ ..++.|+.||+.||.|||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~-~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV-LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHH-HHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHh-ccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 55554210 1 3899999997655544432 233444 78888999999999999999999
Q ss_pred eccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCcccccCC----------CCCCcchhhHHHHHHH
Q 041720 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS----------TNYNVSVDLWSVGCVF 317 (690)
Q Consensus 248 HrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------~~~~~~sDIWSlGviL 317 (690)
||||||+||||+.++.+||+|||+++... ......+| +.|+|||++.+. ..|+.++|||||||+|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999998643 23455677 999999999753 2689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCC
Q 041720 318 AELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397 (690)
Q Consensus 318 yeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~k 397 (690)
|+|++|++||.+.+..+....+ ......+++++.+||.+||+.||.+
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchh
Confidence 9999999999765433222111 1112368999999999999999999
Q ss_pred CCCHHHHHcCccccC
Q 041720 398 RGTASSLLMCEYFTT 412 (690)
Q Consensus 398 RpTa~elL~hp~f~~ 412 (690)
|||+.++|+||||+.
T Consensus 351 Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 351 RLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHTSHHHHH
T ss_pred CCCHHHHhhChHHHH
Confidence 999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=377.68 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=213.6
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..+.|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|+.+|+.++||||+++++++.+ .+.+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEE
Confidence 35679999999999999999999999999999999986542 2457899999999999999999999987 68899
Q ss_pred EEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999866554443 45679999999999999999999999999999999999999999999999999998765322
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF------------- 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-------------
Confidence 23345678999999999875 5689999999999999999999999998887766655433211000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p 414 (690)
.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 246 -------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 246 -------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00124688999999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.10 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=204.0
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--------
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR-------- 195 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-------- 195 (690)
++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4699999999999999999999999999999999643 45567789999999999999999999987642
Q ss_pred ---CcceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 196 ---LSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 196 ---~~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
....+|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 246789999999876554444 3455688999999999999999999999999999999999999999999999999
Q ss_pred ceeccccC-------------cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHH
Q 041720 272 ANILTSKN-------------KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLH 337 (690)
Q Consensus 272 a~~~~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~ 337 (690)
+....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 97654211 1233456789999999999766678999999999999999998 5543 23333444
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+.......+.. .....++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 240 KLRSVSIEFPPD-------------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHSTTCCCCTT-------------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hccccccccCcc-------------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 443322211111 112567789999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=390.61 Aligned_cols=279 Identities=22% Similarity=0.323 Sum_probs=214.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+|+.++||||+++++++.......+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 456799999999999999999999999999999999754322 2245678999999999999999999999875556899
Q ss_pred EEEeccchhcccccccCCC---CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE----ccCCcEEEeeccccee
Q 041720 202 LVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANI 274 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl----d~~~~vKL~DFGla~~ 274 (690)
|||||+.++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999876655444322 39999999999999999999999999999999999999 7778899999999987
Q ss_pred ccccCcccccccccccCCCCcccccC-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMG-------STNYNVSVDLWSVGCVFAELLIGKPILKGRT----EVEQLHKIFKLC 343 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~sDIWSlGviLyeLltG~~PF~~~~----~~e~l~~I~~~~ 343 (690)
+... ......+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.... ..+.+..+...
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 242 (319)
T 4euu_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG- 242 (319)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH-
T ss_pred cCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC-
Confidence 6543 23445679999999999852 3568999999999999999999999997533 34455555443
Q ss_pred CCCChhhhhccCCCCCCC--CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 344 GSPPEEYWKKSKLPHGDM--FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~--~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
.+...|.......... +....+.. ......++..+.+||.+||+.||.+|||++|+|+||-
T Consensus 243 --~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 --KPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp --CCTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred --CCcccchhhhcccCCccccCccCCcc---cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2222222111000000 00000000 0111245668899999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=372.66 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=214.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|++. ++..||||++....... +.+.+|+.+|++++||||+++++++.+ .+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAP 79 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEec--CCc
Confidence 456778999999999999999999975 57789999998654433 458899999999999999999999987 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999987665444 44556999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 228 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------- 228 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------
T ss_pred ccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----------
Confidence 3333445567888999999865 568999999999999999999 9999999988888877754321111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||..||+.||.+|||+.++|+|
T Consensus 229 ------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 ------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12468899999999999999999999999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=370.36 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=213.9
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
+.+..++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 76 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK--EY 76 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 4566788999999999999999999764 67789999998665433 458899999999999999999999987 67
Q ss_pred eEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+++||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 899999999887554443 3344599999999999999999999999999999999999999999999999999987655
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR--------- 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---------
T ss_pred hhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---------
Confidence 44334445566788999999865 468999999999999999999 9999999888887777654321111
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||..||+.||.+|||+.++|++
T Consensus 227 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 -------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12467899999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=379.41 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=201.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
...++|++++.||+|+||.||+|++..+|+.||||++..........+.+..+..+++.++||||+++++++.+ .+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~ 99 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDV 99 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcE
Confidence 45678999999999999999999999999999999998765444444555566667888999999999999987 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
||||||+.+.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+...
T Consensus 100 ~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp EEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 99999995444444444456799999999999999999999995 9999999999999999999999999999765432
Q ss_pred cccccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 280 KQKLTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.. .+..+.+..+........
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 250 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL------- 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-------
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-------
Confidence 23345678999999999852 35688999999999999999999999987 455566666554211110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 -------------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp -------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0012578999999999999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.22 Aligned_cols=286 Identities=27% Similarity=0.429 Sum_probs=222.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-----------CCceeeee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-----------HPNIIKLE 189 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~ 189 (690)
+..++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++++. ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4567899999999999999999999999999999999743 344566889999999886 89999999
Q ss_pred ceeeccC--cceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEcc-----
Q 041720 190 GVITSRL--SNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNN----- 260 (690)
Q Consensus 190 ~~~~~~~--~~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~----- 260 (690)
+++.... ...++|||||+.+++...+... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 9987631 2378999999966666555432 34599999999999999999999998 9999999999999953
Q ss_pred -CCcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HH
Q 041720 261 -EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT------EV 333 (690)
Q Consensus 261 -~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~------~~ 333 (690)
.+.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+ ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCC----CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 34899999999987643 2345688999999999976 568999999999999999999999998754 56
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCC-----CCCCCCC-----CCCccccc---cccCCCChhHHHHHHHhhccCCCCCCC
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPH-----GDMFKPQ-----NPYEGCLR---ERCKDFTPTAVDLIDTCLSIEPYKRGT 400 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~-----~~~~~~~-----~~~~~~l~---~~~~~is~~l~dLI~~~L~~DP~kRpT 400 (690)
+.+..+...++.++...|....... ....... .+....+. .....+++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 7888889999998877665432110 0000000 00000000 111234578899999999999999999
Q ss_pred HHHHHcCccccCCC
Q 041720 401 ASSLLMCEYFTTQP 414 (690)
Q Consensus 401 a~elL~hp~f~~~p 414 (690)
+.|+|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=383.39 Aligned_cols=266 Identities=21% Similarity=0.310 Sum_probs=196.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+.+..++|++.+.||+|+||.||+|++..++. .||||++..........+.+.+|+.+|+.++||||+++++++.+.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34567789999999999999999999877765 899999987655556678899999999999999999999998763
Q ss_pred Ccc----eEEEEEeccchhcccccccC------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEE
Q 041720 196 LSN----TIYLVFEYMEHDLAGLSSCH------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 196 ~~~----~~~LV~Ey~~g~ll~~~~~~------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vK 265 (690)
... ..++||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 111 23999999998765544322 22589999999999999999999999999999999999999999999
Q ss_pred EeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 266 LGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 266 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
|+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999999987643322 12233456788999999865 568999999999999999999 999999988887777765432
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-------HHHHHcCccccCC
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-------ASSLLMCEYFTTQ 413 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-------a~elL~hp~f~~~ 413 (690)
... ....+++++.+||.+||+.||.+||| ++++|.|+|+...
T Consensus 257 ~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RLK----------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCC----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 111 11257889999999999999999999 7777899999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=373.16 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=212.9
Q ss_pred cccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 117 GLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 117 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+...+..++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+|+.++||||+++++++.+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 90 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK-- 90 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec--
Confidence 344567889999999999999999999864 67789999998654443 458899999999999999999999987
Q ss_pred cceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 688999999998765554443 3567999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------- 242 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------- 242 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------
T ss_pred cccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------
Confidence 5433333344566888999999875 468999999999999999998 9999999988888877755322111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||..||+.||.+|||+.++|+|
T Consensus 243 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 ---------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12467899999999999999999999999965
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=380.81 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=212.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.+..++|++.+.||+|+||.||+|++..++. .||||++... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-- 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 3557789999999999999999999886554 5999999754 345566789999999999999999999999987
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+||||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 67899999999886665444 44567999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 275 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----- 275 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-----
T ss_pred ccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-----
Confidence 543222 2223455788999999965 568999999999999999999 9999999988888877754322111
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++.+.+||..||..||.+|||+.++++
T Consensus 276 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 -----------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1257899999999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=388.89 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=211.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-------ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+..++|++.+.||+|+||.||+|++. .++..||||++... ......+.+.+|+.+|+.+ +||||++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345678999999999999999999875 34567999999755 3455667899999999999 89999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+.+ .+.+||||||+.++.+..++.. ...+++.++..++.||+.||.|||++|||||||||+|
T Consensus 156 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 156 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred Ecc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 987 6789999999998765544332 1348899999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
|||+.++.+||+|||+++.+..... .......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999987654322 22334566889999999976 568999999999999999999 99999988777
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+....+...... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 313 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 313 ELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666655432110 011257889999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=385.87 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=210.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.+.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|.++ +|||||++++++.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 4557789999999999999999998 45677899999997543 445567799999999999 8999999999988
Q ss_pred ccCcceEEEEEeccchhcccccccCCC-----------------------------------------------------
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHDI----------------------------------------------------- 220 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~~----------------------------------------------------- 220 (690)
+. ...+++|||||.++.+..++....
T Consensus 97 ~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 97 KP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred cC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 73 456899999999876554433221
Q ss_pred -------------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-cccccc
Q 041720 221 -------------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-QKLTSR 286 (690)
Q Consensus 221 -------------~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~ 286 (690)
.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+..... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 289999999999999999999999999999999999999999999999999986643222 233456
Q ss_pred ccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCC
Q 041720 287 VVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365 (690)
Q Consensus 287 ~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~ 365 (690)
.||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.........+.
T Consensus 256 ~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 316 (359)
T 3vhe_A 256 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------ 316 (359)
T ss_dssp EECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------------------
T ss_pred CCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC------------------
Confidence 78999999999875 568999999999999999998 9999998775555544444321111
Q ss_pred CCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 366 ~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+++++.+||..||+.||.+|||+.|+++|
T Consensus 317 ---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 012578899999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=379.67 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=208.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+|+.| +||||+++++++.+ .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~ 80 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYN 80 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCcc
Confidence 356799999999999999999999999999999999765432 2478899999999 99999999999988 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc-----EEEeecccceec
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI-----LKLGDFGLANIL 275 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~-----vKL~DFGla~~~ 275 (690)
+|||||+.+++..++......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.+
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999955555555444568999999999999999999999999999999999999998887 999999999876
Q ss_pred cccCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHcCCC
Q 041720 276 TSKNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR---TEVEQLHKIFKLCGSP 346 (690)
Q Consensus 276 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~---~~~e~l~~I~~~~g~~ 346 (690)
...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+. +..+.+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543221 1246789999999999976 56899999999999999999999999974 4445555554433222
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.+.+ +..++ ++.+||..||+.||.+||+++++++
T Consensus 240 ~~~~~------------------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVL------------------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHH------------------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHH------------------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22211 12344 9999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.38 Aligned_cols=250 Identities=22% Similarity=0.400 Sum_probs=207.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.. ......+.+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRL 82 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCee
Confidence 456789999999999999999999999999999999854 346667889999999999999999999999987 6889
Q ss_pred EEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 201 YLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
++||||+.++.+..+.. ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999876655443 35679999999999999999999999999999999999999999999999999998764332
Q ss_pred ccc-------------ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Q 041720 280 KQK-------------LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-----QLHKIFK 341 (690)
Q Consensus 280 ~~~-------------~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e-----~l~~I~~ 341 (690)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 125689999999999975 678999999999999999999999987532110 0000000
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 -------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 -------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0112367889999999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=392.33 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=214.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|++++.||+|+||.||+|+ +..++..||||++... ........+.+|+.+|+.++|||||++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3556789999999999999999999 4467889999999744 344555678899999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC-------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---cE
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH-------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG---IL 264 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~-------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~---~v 264 (690)
....|||||||.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 6788999999988655443322 13589999999999999999999999999999999999999555 59
Q ss_pred EEeecccceeccccC-cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 041720 265 KLGDFGLANILTSKN-KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKL 342 (690)
Q Consensus 265 KL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~ 342 (690)
||+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997653322 122344677999999999875 568999999999999999998 99999999988888777543
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..... ...+++.+.+||.+||+.||.+|||+.++|++.++..
T Consensus 303 ~~~~~----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMDP----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 21111 1257889999999999999999999999999877643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=371.15 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=200.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
..+..++|++.+.||+|+||.||+|++..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 345677899999999999999999998654 4579999987542 45556779999999999999999999999854
Q ss_pred CcceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 196 LSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
+.+|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 6789999999986555444 3444699999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~------- 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------- 237 (281)
T ss_dssp -------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred cCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-------
Confidence 65443333344566889999999864 568999999999999999996 999999988877776664421111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 238 ---------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11367899999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.19 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=206.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|.....||+|+||.||+|++..++..||||++.... ....+.+.+|+.+++.++||||+++++++.+ .+.+++
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 96 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKI 96 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEE
Confidence 344555668999999999999999999999999997653 3345678899999999999999999999987 688999
Q ss_pred EEeccchhcccccccCC---CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeecccceecccc
Q 041720 203 VFEYMEHDLAGLSSCHD---IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANILTSK 278 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~~~~~ 278 (690)
||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999876655444322 34678899999999999999999999999999999999987 899999999999876432
Q ss_pred CcccccccccccCCCCcccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-LHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||........ ...... ....+
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~--------- 245 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKVHP--------- 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCCCC---------
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccccc---------
Confidence 2 223456789999999998643 2478999999999999999999999976543322 222111 11000
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 246 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 246 -----------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -----------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0113578999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=366.87 Aligned_cols=255 Identities=20% Similarity=0.220 Sum_probs=210.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+ +|+||+++++++.+ ...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~ 80 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH 80 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--Cce
Confidence 3467899999999999999999999999999999999754322 3477899999999 89999999999987 689
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc-----EEEeeccccee
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI-----LKLGDFGLANI 274 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~-----vKL~DFGla~~ 274 (690)
.+|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999955555555444556999999999999999999999999999999999999987775 99999999987
Q ss_pred ccccCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHcCC
Q 041720 275 LTSKNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR---TEVEQLHKIFKLCGS 345 (690)
Q Consensus 275 ~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~---~~~e~l~~I~~~~g~ 345 (690)
+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+. +..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 6543221 2345678999999999875 56899999999999999999999999874 445555555443322
Q ss_pred CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 346 ~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
++.. .....+++++.+||..||+.||.+|||++++++
T Consensus 240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 2211 122368999999999999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=394.63 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=211.1
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.+.||+|+||.||+|.+. ++..||||+++..... .+.+.+|+.+|+.|+|||||++++++.. +
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~ 255 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTK---E 255 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEECS---S
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEeC---C
Confidence 3466788999999999999999999874 5778999999865432 4578999999999999999999999864 5
Q ss_pred eEEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+..++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999987665554432 358899999999999999999999999999999999999999999999999998764
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
...........+++.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+.+..+......+.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------- 406 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------- 406 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC--------
T ss_pred CCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 332222334456788999999864 568999999999999999999 9999999998888877765322111
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++++.+||.+||..||.+|||+++++.
T Consensus 407 --------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 --------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1257889999999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.11 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=212.1
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|++++.||+|+||.||+|++. .+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 345678999999999999999999987 455899999997543 45566789999999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEecc
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH------------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~------------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrD 250 (690)
.+.+||||||+.++.+..++.. ...+++.+++.++.||+.||.|||++||+|||
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 6789999999998655444322 15689999999999999999999999999999
Q ss_pred CCcccEEEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 041720 251 IKASNILVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILK 328 (690)
Q Consensus 251 LKp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~ 328 (690)
|||+||||+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999976543221 22344567899999999875 568999999999999999999 999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.+..+....+....... ....+++.+.+||..||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILA----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCChHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 988888777665421110 11257889999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.68 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=211.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|.+.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 455778999999999999999999873 45689999999754 345667789999999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCC------------------------CCCChhHHHHHHHHHHHHHHHHHhCCeEecc
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD------------------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~------------------------~~lse~~~~~i~~QIl~aL~yLH~~givHrD 250 (690)
.+.+++||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 67899999999976555444322 2389999999999999999999999999999
Q ss_pred CCcccEEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 041720 251 IKASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILK 328 (690)
Q Consensus 251 LKp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~ 328 (690)
|||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876443221 2234566889999999875 568999999999999999999 999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+.+..+....+...... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM----------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88776666555332110 0112578999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=372.23 Aligned_cols=267 Identities=27% Similarity=0.427 Sum_probs=209.6
Q ss_pred cccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC--CCceeeeeceeec
Q 041720 117 GLVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD--HPNIIKLEGVITS 194 (690)
Q Consensus 117 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~ 194 (690)
..+.+..++|++++.||+|+||.||+|++ .+++.||||++..........+.+.+|+.+|..+. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34456677899999999999999999987 45889999999877666777788999999999997 5999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||+..+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 --~~~~~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 --DQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp --SSEEEEEECCCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred --CCEEEEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 67899999966655554443 445799999999999999999999999999999999999996 48999999999987
Q ss_pred ccccCcc-cccccccccCCCCcccccCC----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Q 041720 275 LTSKNKQ-KLTSRVVTLWYRPPELLMGS----------TNYNVSVDLWSVGCVFAELLIGKPILKGRTE-VEQLHKIFKL 342 (690)
Q Consensus 275 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~----------~~~~~~sDIWSlGviLyeLltG~~PF~~~~~-~e~l~~I~~~ 342 (690)
+...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..+...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 6433221 22356789999999998641 3688899999999999999999999987543 3333333221
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
.... ......+.++.+||.+||+.||.+|||+.++|+||||+..+.
T Consensus 256 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 256 NHEI---------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp TSCC---------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cccc---------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 1000 001245788999999999999999999999999999997643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=360.89 Aligned_cols=252 Identities=15% Similarity=0.230 Sum_probs=212.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|++ ++..||||++..........+.+.+|+.+|+.++||||+++++++.+...+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 35567899999999999999999987 4889999999887767777788999999999999999999999998754578
Q ss_pred EEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEeecccceec
Q 041720 200 IYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+++||||+.++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999866655544433 4899999999999999999999999 999999999999999999999999987543
Q ss_pred cccCcccccccccccCCCCcccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
. .....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 164 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 231 (271)
T 3kmu_A 164 Q------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------ 231 (271)
T ss_dssp S------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred c------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------
Confidence 2 234578999999999976322 33389999999999999999999999888887766654322111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||..||+.||.+|||+.++++
T Consensus 232 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ---------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11357899999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.62 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=215.4
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
...+..++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--E 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 34566788999999999999999999999999999999997543 345678899999999999999999999987 6
Q ss_pred ceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 198 NTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.+++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 78999999999765554443 2345999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 232 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------- 232 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC--------
T ss_pred cCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC--------
Confidence 6544444455667889999999865 568999999999999999999 999999887766665554321110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||..||..||.+|||+.++++
T Consensus 233 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 --------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 11257899999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=378.47 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=192.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHH-HHhhcCCCceeeeeceeeccCcc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIM-ILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+..|+. +++.++||||+++++++.+ .+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~ 94 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EG 94 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SS
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CC
Confidence 355788999999999999999999999999999999998654 3334445556666 7788899999999999987 68
Q ss_pred eEEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhC-CeEeccCCcccEEEccCCcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLR-GIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~-givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
.++|||||+.+++...+.. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 8999999999876544432 345799999999999999999999999 99999999999999999999999999998
Q ss_pred eccccCcccccccccccCCCCccccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLM---GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKLCGSPPEE 349 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~~g~~~~~ 349 (690)
.+... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+.. +.+
T Consensus 175 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~--- 247 (327)
T 3aln_A 175 QLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP--- 247 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCC---
T ss_pred ecccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCC---
Confidence 76432 2233457899999999984 2356899999999999999999999999864322 11111100 000
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
+ .........+++.+.+||..||+.||.+|||+.++|+||||...
T Consensus 248 --------------~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 248 --------------P-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp --------------C-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------C-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0 00011123688999999999999999999999999999999763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.10 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=211.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|++..+++.||||++... ......+.+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 186 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQP 186 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCC
Confidence 45678899999999999999999999999999999999754 345556678899999999999999999999987 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|||||||.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999876554433 34446999999999999999999999999999999999999999999999999999865432
Q ss_pred Ccccc-cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 279 NKQKL-TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 279 ~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..... ....+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+......+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 336 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC--------- 336 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---------
T ss_pred ceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 11111 12335778999999864 568999999999999999998 9999999888776665543211110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++++.+||.+||+.||.+|||+.++++
T Consensus 337 -------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 337 -------------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1247889999999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.31 Aligned_cols=271 Identities=26% Similarity=0.403 Sum_probs=202.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 456789999999999999999998 5678999999999744 3556678999999999999999999999987644
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++|||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 56789999999886555444 44446999999999999999999999999999999999999999999999999999876
Q ss_pred cccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
..... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ... ..+..+...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~---~~~~~~~~~~~~ 238 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR---MIGNDKQGQMIV 238 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---HHCTTCCTHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---hhcCccccchhH
Confidence 54322 12233456788999999875 56899999999999999999999998753221 111 111111000000
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..... ... ..........+++++.+||..||+.||.+|||+.|+++
T Consensus 239 ~~~~~--~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIE--LLK-----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHH--HHH-----TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHH--HHh-----ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 000 00000112367899999999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.59 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=212.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 77 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAP 77 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCC
Confidence 456778999999999999999999975 67889999998654432 468899999999999999999999987 678
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999876555443 34456999999999999999999999999999999999999999999999999999866433
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---------- 226 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------- 226 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------
T ss_pred cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC----------
Confidence 2233344567888999999864 568999999999999999999 8999999888887777654321110
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 227 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 227 ------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12468899999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=370.50 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=201.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 35679999999999999999999999999999999976532 34456779999999999999999999999987 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999876666555556799999999999999999999999999999999999999999999999999987655443
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..... .........+.
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~------------ 255 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPS------------ 255 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGG------------
T ss_pred ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCcc------------
Confidence 44456788999999999875 56899999999999999999999999986654333 33222111111
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-CHHHHHc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-TASSLLM 406 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-Ta~elL~ 406 (690)
.....+++++.+||.+||+.||.+|| |++++++
T Consensus 256 -------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 256 -------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11236889999999999999999999 8888874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=378.77 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=180.8
Q ss_pred CcCCeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--Ccc
Q 041720 122 RAESFEKLE-KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSN 198 (690)
Q Consensus 122 ~~~~y~~~~-~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~ 198 (690)
..++|++++ .||+|+||.||+|++..+|+.||||++... ... .......++.+.||||+++++++... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 356799966 599999999999999999999999999743 221 22223346677999999999998752 135
Q ss_pred eEEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~ 273 (690)
.++||||||.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 689999999986555444332 36999999999999999999999999999999999999976 4569999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHcCCCChh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIF----KLCGSPPEE 349 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~----~~~g~~~~~ 349 (690)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+. ......+..
T Consensus 180 ~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 180 ETTQ---NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred eccc---cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 6543 23345678999999999854 568899999999999999999999998765443322111 111111111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 256 -------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 256 -------------------------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -------------------------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -------------------------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 123689999999999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=365.64 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=201.8
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.++||+|+||.||+|++. ..||||++..........+.+.+|+.+|+.++||||+++++++.. .
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~ 92 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---P 92 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---S
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---C
Confidence 3566888999999999999999999753 359999998776677777889999999999999999999997643 6
Q ss_pred eEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+++||||+.++.+.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 689999999977554443 4556799999999999999999999999999999999999999999999999999976543
Q ss_pred c-CcccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 278 K-NKQKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 278 ~-~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
. .........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+....+.+..+.......+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 246 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------ 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC------
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc------
Confidence 1 2233445678999999999862 356788999999999999999999999987776666555443221110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+......+++.+.+||..||+.||.+|||+.++|+
T Consensus 247 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -----------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01112367899999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=378.40 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=210.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcC--CCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLD--HPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~ 194 (690)
...++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.+. ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999999999999999999997653321 11234678999999996 5999999999987
Q ss_pred cCcceEEEEEeccch-hcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-cCCcEEEeecccc
Q 041720 195 RLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLA 272 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~~~~vKL~DFGla 272 (690)
.+.+++||||+.+ +.+..+......+++..++.++.||+.||.|||++||+||||||+||||+ +++.+||+|||++
T Consensus 120 --~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 --PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 6889999999974 44444444456799999999999999999999999999999999999999 7899999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..+... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +......
T Consensus 198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~------- 261 (320)
T 3a99_A 198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF------- 261 (320)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCC-------
T ss_pred cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccc-------
Confidence 876532 334567899999999987655567899999999999999999999975321 1111000
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++++.+||.+||+.||.+|||++++|+||||+..
T Consensus 262 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 262 ----------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ----------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ----------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 012578999999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=381.33 Aligned_cols=256 Identities=22% Similarity=0.339 Sum_probs=213.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVAT-------GKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+..++|++.++||+|+||.||+|++..+ +..||||++... ........+.+|+.+|+.+ +|||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 45567899999999999999999997543 357999999765 3455667899999999999 99999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCHD----------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+.+ .+.++|||||+.++.+..++... ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 144 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 144 CTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 987 67899999999986655443322 359999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
|||+.++.+||+|||+++.+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987653322 22344567889999999975 568999999999999999999 99999998887
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+....+....... ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 301 ~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776664422111 112578999999999999999999999999963
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=367.30 Aligned_cols=248 Identities=20% Similarity=0.254 Sum_probs=204.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATG-------KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
+..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999999988777 479999996543 334567899999999999999999999998
Q ss_pred ccCcceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc--------E
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI--------L 264 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~--------v 264 (690)
+ .+..+|||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++. +
T Consensus 83 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 C--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp C--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred e--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 7 678899999999765554444 3344999999999999999999999999999999999999998887 9
Q ss_pred EEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHc
Q 041720 265 KLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 265 KL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~~~~ 343 (690)
||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+........ ...
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR 234 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc
Confidence 9999999965432 23456799999999998656789999999999999999995 5666665554444332 211
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
... ....++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQL-----------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCC-----------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCC-----------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 12457789999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.85 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=202.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhc----CCCceeeeeceee
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRL----DHPNIIKLEGVIT 193 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIv~l~~~~~ 193 (690)
..++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4567999999999999999999999999999999997654322 1233466799999999 8999999999998
Q ss_pred ccCcceEEEEEec-cchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc-cCCcEEEeeccc
Q 041720 194 SRLSNTIYLVFEY-MEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN-NEGILKLGDFGL 271 (690)
Q Consensus 194 ~~~~~~~~LV~Ey-~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld-~~~~vKL~DFGl 271 (690)
+ .+.+++|||| +.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 7 5788999999 67666655555556799999999999999999999999999999999999999 789999999999
Q ss_pred ceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 272 ANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 272 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+..+... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... .+......
T Consensus 187 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~------ 251 (312)
T 2iwi_A 187 GALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH------ 251 (312)
T ss_dssp CEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC------
T ss_pred hhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC------
Confidence 9876542 34556789999999998765555669999999999999999999997532 12211110
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 252 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 252 -----------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -----------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 112578899999999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=360.86 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=199.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ--PESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
.+..++|++.+.||+|+||.||+|.+ ++..||||++...... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--E 78 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--C
Confidence 45577899999999999999999986 4889999998765322 2334678899999999999999999999987 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC---eEeccCCcccEEEcc--------CCcEEE
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG---IMHRDIKASNILVNN--------EGILKL 266 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g---ivHrDLKp~NILld~--------~~~vKL 266 (690)
+.+++||||+.++.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 78999999999887765554 347999999999999999999999999 999999999999986 678999
Q ss_pred eecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 267 GDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 267 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
+|||++..+... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 158 ~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 158 TDFGLAREWHRT---TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred ccCCcccccccc---cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 999999865432 2234678999999999875 568999999999999999999999999988777766654321111
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+ ....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 234 ~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 P---------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1 112578899999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.30 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=205.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHH-----HHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESI-----RFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|++.+.||+|+||.||+|++..+++.||||++.......... +.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 55688999999999999999999999999999999997654332211 6788999999999999999999998762
Q ss_pred CcceEEEEEeccchhcc-cccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCc-----EEEe
Q 041720 196 LSNTIYLVFEYMEHDLA-GLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGI-----LKLG 267 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~-----vKL~ 267 (690)
. +|||||+.++.+ ..+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+
T Consensus 96 --~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 --P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 2 799999996544 555555567999999999999999999999999 999999999999988776 9999
Q ss_pred ecccceeccccCcccccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcC
Q 041720 268 DFGLANILTSKNKQKLTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ--LHKIFKLCG 344 (690)
Q Consensus 268 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~--l~~I~~~~g 344 (690)
|||++.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+. ...+... +
T Consensus 172 Dfg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 246 (287)
T 4f0f_A 172 DFGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-G 246 (287)
T ss_dssp CCTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-C
T ss_pred CCCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-C
Confidence 999997543 23455789999999999843 34578899999999999999999999987553332 3333221 1
Q ss_pred CCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 345 SPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 345 ~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+ .....+++++.+||..||+.||.+|||+.++++
T Consensus 247 ~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRP--------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC--------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 110 011367899999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=392.56 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=207.1
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+||||+++++++.+ +
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---C
Confidence 34567889999999999999999999754 467999999865433 3468899999999999999999999865 5
Q ss_pred eEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+..++.. ...+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 68999999998766554432 2458999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
...........+++.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+......+.
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------- 402 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------- 402 (452)
T ss_dssp -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred CCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 433223334556788999999875 568999999999999999999 9999999988888777654321110
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC--ccccC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC--EYFTT 412 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h--p~f~~ 412 (690)
...+++.+.+||.+||+.||.+|||++++++. .+|..
T Consensus 403 --------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 403 --------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 12578899999999999999999999999862 45543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.12 Aligned_cols=276 Identities=20% Similarity=0.236 Sum_probs=204.0
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC--
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL-- 196 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 196 (690)
+.+..++|+++++||+|+||.||+|++. ++.||||++... ........+|+.+|++++|||||++++++.+..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 4466788999999999999999999864 789999999654 233445667999999999999999999998732
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC----------CeEeccCCcccEEEccCCcEEE
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR----------GIMHRDIKASNILVNNEGILKL 266 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~----------givHrDLKp~NILld~~~~vKL 266 (690)
...++||||||.++.+..+... ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 3458999999998766655543 3599999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccccCc-ccccccccccCCCCcccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 041720 267 GDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGS----TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 267 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~----~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~ 341 (690)
+|||+++.+..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+.....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987654322 223446899999999999763 3456789999999999999999999987543221111111
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+....+........ ..+ ....... ....++++.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKK--KRP--VLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTTSC--CCC--CCCGGGG--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhccc--CCC--Ccccccc--ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111222111111000000 000 0000000 0112355999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.52 Aligned_cols=256 Identities=19% Similarity=0.274 Sum_probs=210.2
Q ss_pred cccCcCCeeEEe-EEeecCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 119 VPMRAESFEKLE-KIGQGTYSSVFRARE--VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 119 ~~~~~~~y~~~~-~LG~G~fG~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+.+...+|++.+ .||+|+||.||+|.+ ..+++.||||++..........+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-- 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--
Confidence 345567899998 999999999999954 567789999999876555556778999999999999999999999994
Q ss_pred CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+++||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 4678999999998777666666667999999999999999999999999999999999999999999999999999876
Q ss_pred cccCccc--ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQK--LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------ 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 5433221 223445788999999865 457899999999999999999 999999988877766654321100
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++.+.+||..||+.||.+|||+.++++
T Consensus 241 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 241 ----------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11257899999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.77 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=206.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+.|++++..+.++... .+.++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 56799999999999999999999999999999998765433 2478999999999998877777666542 678899
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~~ 279 (690)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999555555555455679999999999999999999999999999999999999 478899999999998765433
Q ss_pred cc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhh
Q 041720 280 KQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 280 ~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~~~ 350 (690)
.. ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+ ..+.+..+......++..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 21 1345688999999999976 568999999999999999999999998743 223444443322222211
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++++.+||..||+.||.+|||+.++++
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 -----------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 112368899999999999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.45 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=205.4
Q ss_pred ccccCcCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 118 LVPMRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 118 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+.+..++|.+.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.+|++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 345667889999999999999999998765 55689999998776667777889999999999999999999999876
Q ss_pred cCc---ceEEEEEeccchhcccccc------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEE
Q 041720 195 RLS---NTIYLVFEYMEHDLAGLSS------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 195 ~~~---~~~~LV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vK 265 (690)
... ...++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 322 2469999999986655443 2345699999999999999999999999999999999999999999999
Q ss_pred EeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 041720 266 LGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLC 343 (690)
Q Consensus 266 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~ 343 (690)
|+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 999999987643321 12233456889999999975 568999999999999999999 999999888777776664422
Q ss_pred CCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 344 g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
... ....+++.+.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLK----------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC----------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC----------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 112578899999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=375.42 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=200.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMV----ALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~v----AvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.+|++++||||+++++++.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 45678999999999999999999998887754 777765432 23345678999999999999999999999986
Q ss_pred cceEEEEEeccchhcccc-cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGL-SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++||||+.++.+.. +......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 34789999998865544 4444567999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------ 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC------
Confidence 543222 2234456889999999975 568999999999999999999 9999998877666555433211110
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...++.++.+||.+||+.||.+|||+.++|++
T Consensus 241 ----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 ----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ----------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 12467899999999999999999999999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=364.42 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=207.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.+..++|++.+.||+|+||.||+|++.. ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--
Confidence 4567789999999999999999998654 34569999997653 45566789999999999999999999999875
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+..|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4568999999976555444 34456999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~------- 235 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------- 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-------
T ss_pred ccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-------
Confidence 5443333445567889999999864 568999999999999999998 9999988777666665544321111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 ---------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12578899999999999999999999999953
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=367.31 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=211.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRARE-----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 35567899999999999999999985 4577899999997553 344567899999999999 9999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccCC------------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHD------------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~------------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+ .+.++|||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 98 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 98 I--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp S--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred c--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 7 67889999999886554433222 248999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
|||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999876543322 2234567889999999865 568999999999999999998 99999987765
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..+..+......+. ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555544322111 012578899999999999999999999999963
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=373.64 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=207.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|.++ +||||+++++++.
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345678999999999999999999973 466789999997543 233456789999999999 9999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccCC-----------------------CCCChhHHHHHHHHHHHHHHHHHhCCeEecc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHD-----------------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRD 250 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~-----------------------~~lse~~~~~i~~QIl~aL~yLH~~givHrD 250 (690)
+ .+.++|||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 120 L--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred e--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 7 67899999999886554433322 2378999999999999999999999999999
Q ss_pred CCcccEEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 041720 251 IKASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILK 328 (690)
Q Consensus 251 LKp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~ 328 (690)
|||+||||+.++.+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999876543322 2334567889999999865 568999999999999999998 999999
Q ss_pred CCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 329 GRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 329 ~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+....+.+..+......++ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8776655555544221111 012578899999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=369.65 Aligned_cols=266 Identities=17% Similarity=0.263 Sum_probs=217.7
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceee
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVIT 193 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 193 (690)
..+..++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 3456778999999999999999999876 467889999997543 3445567889999999999999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI 263 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~ 263 (690)
+ .+.++|||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 99 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 99 Q--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred c--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 7 6789999999998655444322 135789999999999999999999999999999999999999999
Q ss_pred EEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 041720 264 LKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFK 341 (690)
Q Consensus 264 vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~ 341 (690)
+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999986543221 12234567899999999865 568999999999999999999 8999999888777766644
Q ss_pred HcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC------ccccCCCC
Q 041720 342 LCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC------EYFTTQPY 415 (690)
Q Consensus 342 ~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h------p~f~~~p~ 415 (690)
..... ....+++.+.+||.+||+.||.+|||+.++++| ++|+...+
T Consensus 256 ~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 256 GGLLD----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp TCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred CCcCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 21110 112578899999999999999999999999875 66665444
Q ss_pred C
Q 041720 416 A 416 (690)
Q Consensus 416 ~ 416 (690)
.
T Consensus 308 ~ 308 (322)
T 1p4o_A 308 Y 308 (322)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=358.65 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=210.1
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|.+ .++..||||++...... .+.+.+|+.+|+.++||||+++++++.+ +.
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 81 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CC
Confidence 34567899999999999999999986 46778999999765433 3568899999999999999999999865 56
Q ss_pred EEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999998876655544332 699999999999999999999999999999999999999999999999999987754
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.......
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 230 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---------- 230 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------
T ss_pred cccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC----------
Confidence 43333344566889999999864 568999999999999999999 999999988887777664421110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||..||..||.+|||++++++
T Consensus 231 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 ------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11257899999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=374.79 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=205.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM----VALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|++..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-- 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 4567899999999999999999999888876 7777775432 12223456789999999999999999999864
Q ss_pred cceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.+++||||+.++.+... ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 568999999997655444 344467999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ------ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC------
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC------
Confidence 543322 2345667889999999975 568999999999999999999 9999998877666665543211110
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...++.++.+||.+||+.||.+|||+.+++++
T Consensus 239 ----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 ----------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12467789999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.83 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=202.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+..+... .+..+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 46799999999999999999999999999999987654332 2477899999999998888777766542 678899
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~~ 279 (690)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999555555555455679999999999999999999999999999999999999 788999999999998765433
Q ss_pred cc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhh
Q 041720 280 KQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV---EQLHKIFKLCGSPPEEY 350 (690)
Q Consensus 280 ~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~---e~l~~I~~~~g~~~~~~ 350 (690)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.. +.+..+.......+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-
Confidence 21 2235688999999999976 56899999999999999999999999874332 2333333322222211
Q ss_pred hhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 351 w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++++.+||..||+.||.+|||++++++
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 -----------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112368899999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=381.08 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+...+|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|++++||||+++++++.+ .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--S 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 45667999999999999999999876 467789999997543 45566789999999999999999999999987 6
Q ss_pred ceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.++||||||.++.+..+. .....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 7899999999876655444 344579999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcccc--cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNKQKL--TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
....... ....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~------ 271 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------ 271 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC------
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 4322222 22344778999999875 568999999999999999998 9999999888877776644321111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++..+.+||..||+.||.+|||+.++++
T Consensus 272 ----------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 ----------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1257889999999999999999999999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=369.26 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=211.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-------ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 456788999999999999999999975 467789999997543 455667899999999999 89999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCHD----------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+.+ .+.+||||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 110 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 110 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp ECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred Ecc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 987 67899999999986655444322 248999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
|||+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999987654322 12233456889999999865 568999999999999999999 99999998887
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+....+....... ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHRMD----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776665432111 112578899999999999999999999999853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.23 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=211.8
Q ss_pred ccCcCCeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 120 PMRAESFEKLE-KIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 120 ~~~~~~y~~~~-~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.+..++|.+++ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence 45567788887 9999999999999854 568889999998653 45567789999999999999999999999954
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.+++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5699999999987655444 34556999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~------- 232 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------- 232 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------
T ss_pred ccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-------
Confidence 533221 1233456889999999864 568999999999999999998 99999998887777666442110
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....+++++.+||..||+.||.+|||+.+++++
T Consensus 233 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 233 ---------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112678999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=367.37 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=209.5
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRARE-----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.+.||+|+||.||+|++ ..+++.||||++.... .....+.+.+|+.+|..+ +||||+++++++.
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 34567899999999999999999985 3567899999997553 445567789999999999 7999999999987
Q ss_pred ccCcceEEEEEeccchhcccccccCCC----------------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEE
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCHDI----------------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNIL 257 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~~~----------------~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NIL 257 (690)
.. ...+++||||+.++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 102 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 102 KP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 63 456899999999866554443322 2899999999999999999999999999999999999
Q ss_pred EccCCcEEEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 041720 258 VNNEGILKLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQ 335 (690)
Q Consensus 258 ld~~~~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~ 335 (690)
|+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999987643322 22344667899999999875 568999999999999999998 9999988765444
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+...+.....+. ....+++.+.+||..||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433333211111 012478899999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=389.24 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=199.6
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
+.+...+|.+.+.||+|+||+||. ....+|+.||||++...... .+.+|+.+|+.+ +|||||++++++.+ .
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~--~ 90 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKD--R 90 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEE--T
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEec--C
Confidence 344556799999999999999764 34578999999999754322 256899999999 79999999999987 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---C--CcEEEeecccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---E--GILKLGDFGLA 272 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~--~~vKL~DFGla 272 (690)
..+|||||||.+++...+......+.+..++.++.||+.||.|||++|||||||||+||||+. + ..+||+|||++
T Consensus 91 ~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 91 QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 889999999998777776666666778888999999999999999999999999999999953 2 36889999999
Q ss_pred eeccccCc--ccccccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCC
Q 041720 273 NILTSKNK--QKLTSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPP 347 (690)
Q Consensus 273 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~ 347 (690)
+.+..... ......+||+.|+|||++.+ ...++.++||||||||+|+|++ |.+||......... .+. +...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~ 246 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS 246 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC
Confidence 87653221 23355789999999999974 3457789999999999999999 99999765443322 211 1111
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+ . .....+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 247 ~~~~-----------~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 247 LDCL-----------H-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTS-----------C-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccc-----------C-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0000 0 00123556899999999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.31 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=189.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeec----
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITS---- 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~---- 194 (690)
.+...+|++.++||+|+||.||+|++..+++.||||++... .....+.+.+|+.+|.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 44566799999999999999999999999999999998654 3455677899999999996 9999999999842
Q ss_pred --cCcceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEccCCcEEEee
Q 041720 195 --RLSNTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 195 --~~~~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld~~~~vKL~D 268 (690)
.....++|||||+.+++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 22567899999999877665543 3456999999999999999999999999 99999999999999999999999
Q ss_pred cccceeccccCcc-----------cccccccccCCCCccccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 041720 269 FGLANILTSKNKQ-----------KLTSRVVTLWYRPPELLM--GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ 335 (690)
Q Consensus 269 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~--~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~ 335 (690)
||++..+...... .....+||+.|+|||++. ....++.++|||||||++|+|++|..||.+......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999876532211 112456899999999983 235688999999999999999999999976544332
Q ss_pred HHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 336 LHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 336 l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+... ...+ .....+..+.+||.+||+.||.+|||+.|+|+|
T Consensus 262 ~~~~----~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 262 VNGK----YSIP---------------------------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp --------CCCC---------------------------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCc----ccCC---------------------------cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2111 0000 012467789999999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=393.63 Aligned_cols=254 Identities=20% Similarity=0.342 Sum_probs=213.4
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.++||+|+||.||+|++..++..||||++...... .+.+.+|+.+|++|+|||||++++++.+ ..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~ 289 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP 289 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec--CC
Confidence 345677899999999999999999999999999999999765433 4568899999999999999999999987 67
Q ss_pred eEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+..++. ....+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 8999999999765554443 23458999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
...........+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+......
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 438 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 438 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------
T ss_pred CCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 433333344556788999999865 568999999999999999999 99999988776666555332110
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 439 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 ------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011257899999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.41 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=209.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|++++.||+|+||.||+|+ +..++..||||++... ........+.+|+.+|+.++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3556789999999999999999998 5567889999999744 344556678999999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccCC-------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcE
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD-------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGIL 264 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~-------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~v 264 (690)
...+||||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+. +..+
T Consensus 105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 57889999999876554443322 34899999999999999999999999999999999999984 4469
Q ss_pred EEeecccceeccccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 041720 265 KLGDFGLANILTSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKL 342 (690)
Q Consensus 265 KL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~ 342 (690)
||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999999975533221 22234567899999999865 568999999999999999998 99999998887777666543
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..... ...+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 262 ~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRMDP----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 21111 1257889999999999999999999999999988753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.63 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=208.4
Q ss_pred cCcCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 456789999999999999999998 4678999999999754 3556677999999999999999999999987655
Q ss_pred cceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+||||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 678999999998776554443 3456999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC--hhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPP--EEYW 351 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~--~~~w 351 (690)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ......+ ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLL 254 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHH
Confidence 543221 2234567888999999865 5679999999999999999999999975433211100 0000000 0000
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..... .........+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEE-------------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc-------------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 00001123688999999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.67 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=205.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEE--EEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMV--ALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~v--AvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
+..++|++.+.||+|+||.||+|++..++..+ |||.+.... .....+.+.+|+.+|+++ +||||+++++++.+ .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 45678999999999999999999999888865 999987432 334456788999999999 99999999999987 6
Q ss_pred ceEEEEEeccchhcccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHD----------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
+.+||||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 8899999999886555444332 369999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIF 340 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~ 340 (690)
+.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999753321 12233456889999999865 568999999999999999998 999999988877766553
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..... .....+++.+.+||.+||+.||.+|||+.++|++
T Consensus 256 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32100 0112578899999999999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=362.39 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=202.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
....|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 35669999999999999999998 56789999999997553 22334678899999999999999999999987545
Q ss_pred ceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 7899999999886555444 455679999999999999999999999999999999999999999999999999998765
Q ss_pred ccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc-
Q 041720 277 SKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK- 353 (690)
Q Consensus 277 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~- 353 (690)
.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+... ... +....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~---~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP--MAL---FLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHH---HHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch--hhH---HhhccCCcccccCHHH
Confidence 4332 22344667888999999875 56789999999999999999999886532 111 111111111110000
Q ss_pred --cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 --SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 --~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+... ........+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEG-----------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTT-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcc-----------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000000 000112368899999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.05 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=200.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMV----ALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~v----AvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence 45678999999999999999999998888765 666665332 23345678899999999999999999999986
Q ss_pred cceEEEEEeccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 3488999999876554 44444567999999999999999999999999999999999999999999999999999876
Q ss_pred cccCc-ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNK-QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------ 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred cCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 43322 22234456888999999975 568999999999999999999 9999998877776665543221111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...++.++.+||.+||..||.+|||+.|+|+
T Consensus 241 ----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 ----------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1257889999999999999999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=366.04 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=205.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
.+...+|.+.+.||+|+||.||+|++..++ ..||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK- 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-
Confidence 456778999999999999999999876553 459999997543 45556678999999999999999999999987
Q ss_pred CcceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 196 LSNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.++|||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred -CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 68899999999986655444 3446799999999999999999999999999999999999999999999999999987
Q ss_pred ccccCccc--ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 275 LTSKNKQK--LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 275 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---- 271 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---- 271 (333)
T ss_dssp --------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----
T ss_pred hccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC----
Confidence 65432211 223345788999999865 568999999999999999999 9999999888877776644311110
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 272 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 ------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12578899999999999999999999999853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=374.75 Aligned_cols=266 Identities=18% Similarity=0.173 Sum_probs=199.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCC-----CcEEEEEEeecCCCChH-H--------HHHHHHHHHHHhhcCCCcee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVAT-----GKMVALKKVRFDNFQPE-S--------IRFMAREIMILRRLDHPNII 186 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~-~--------~~~~~~Ei~iL~~L~HpnIv 186 (690)
+..++|++.+.||+|+||.||+|.+..+ ++.||||++........ . ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999998764 57899999876531100 0 11234566677888999999
Q ss_pred eeeceeeccC--cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc--cCC
Q 041720 187 KLEGVITSRL--SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN--NEG 262 (690)
Q Consensus 187 ~l~~~~~~~~--~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld--~~~ 262 (690)
++++++.... ...+|||||||.+++...+......+++..++.++.||+.||.|||++|||||||||+||||+ .++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9999987632 256899999994445555544556799999999999999999999999999999999999999 889
Q ss_pred cEEEeecccceeccccCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 041720 263 ILKLGDFGLANILTSKNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQL 336 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l 336 (690)
.+||+|||+++.+...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999876543221 1134569999999999976 56899999999999999999999999864332222
Q ss_pred HHHHHH-cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 337 HKIFKL-CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 337 ~~I~~~-~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...... ........... ++ ....+++++.+||..||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~-----------------~~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDK-----------------CF--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHH-----------------HS--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHH-----------------hc--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222111 11111111100 00 01367899999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=366.94 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=210.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4556789999999999999999999877664 79999997543 445567799999999999 8999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccC--------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH--------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN 259 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~--------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld 259 (690)
+ .+.+||||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 121 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 H--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp S--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred c--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 7 6789999999988655443321 33589999999999999999999999999999999999999
Q ss_pred cCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 041720 260 NEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLH 337 (690)
Q Consensus 260 ~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~ 337 (690)
.++.+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+.
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999876543222 2234567889999999875 568999999999999999998 999999877666555
Q ss_pred HHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 338 ~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+......+.. ....++.+.+||..||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 278 KLVKDGYQMAQ---------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHTCCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCC---------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 55443222110 1246789999999999999999999999995
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.37 Aligned_cols=264 Identities=17% Similarity=0.129 Sum_probs=200.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC---CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHhhcCCCceeee
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNFQPE---------SIRFMAREIMILRRLDHPNIIKL 188 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l 188 (690)
+..++|++.+.||+|+||.||+|++.. ++..||||++........ ....+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 788999999986532110 11235678899999999999999
Q ss_pred eceeecc--CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC--cE
Q 041720 189 EGVITSR--LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG--IL 264 (690)
Q Consensus 189 ~~~~~~~--~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~--~v 264 (690)
++++.+. ....+||||||+ ++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 9998762 247899999999 555555555555899999999999999999999999999999999999999887 99
Q ss_pred EEeecccceeccccCc------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC--CCHHHHH
Q 041720 265 KLGDFGLANILTSKNK------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG--RTEVEQL 336 (690)
Q Consensus 265 KL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~--~~~~e~l 336 (690)
||+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+ .+.....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999987653321 11245688999999999976 5689999999999999999999999965 2333333
Q ss_pred HHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 337 HKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 337 ~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..........+....... ....+++++.+||..||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 332222222232211100 01168899999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=360.64 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=196.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN-FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.+ .+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcE
Confidence 3567999999999999999999999999999999997643 345667788999999999999999999999987 6899
Q ss_pred EEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 201 YLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999865554432 34568999999999999999999999999999999999999999999999999998764
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT--EVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~--~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+... ..++.
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~------ 258 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPL------ 258 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSCCC------
T ss_pred CCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCCCC------
Confidence 332 23345678999999999875 568999999999999999999999997643 22333333221 11100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||.+||..||.+|||+.++++
T Consensus 259 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 259 --------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp --------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01257889999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=397.15 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=212.2
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.+ +
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~ 334 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 334 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---c
Confidence 34667889999999999999999999754 467999999865433 3468899999999999999999999865 5
Q ss_pred eEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+..++.. ...+++.++..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 68999999998765544432 2458999999999999999999999999999999999999999999999999998764
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
...........++..|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..+......+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------- 484 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------- 484 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred CCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 322222334456788999999875 568999999999999999999 999999998888877765432111
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC--cccc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC--EYFT 411 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h--p~f~ 411 (690)
....+++.+.+||.+||+.||.+|||+++|++. .+|.
T Consensus 485 -------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 012578899999999999999999999999863 4444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=384.36 Aligned_cols=276 Identities=23% Similarity=0.338 Sum_probs=210.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..+.|++.++||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.+.....+|
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45679999999999999999999999999999999975432 22245678999999999999999999999875556889
Q ss_pred EEEeccchhcccccccCCC---CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE----ccCCcEEEeeccccee
Q 041720 202 LVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV----NNEGILKLGDFGLANI 274 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl----d~~~~vKL~DFGla~~ 274 (690)
||||||.++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999876655544332 29999999999999999999999999999999999999 7778899999999987
Q ss_pred ccccCcccccccccccCCCCcccccCC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGS-------TNYNVSVDLWSVGCVFAELLIGKPILKGR----TEVEQLHKIFKLC 343 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~~~~sDIWSlGviLyeLltG~~PF~~~----~~~e~l~~I~~~~ 343 (690)
+... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+.++...
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~- 242 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG- 242 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS-
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC-
Confidence 6543 334557899999999998531 45788999999999999999999999743 344555555442
Q ss_pred CCCChhhhhccCC-CCCC-CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 344 GSPPEEYWKKSKL-PHGD-MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 344 g~~~~~~w~~~~l-~~~~-~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+...|..... .... .+....+.. ......+++.+.+||.+||+.||.+|||++++++
T Consensus 243 --~p~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 --KPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --CCTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCcccchhheeccCCCcccCccCCcc---cccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22222221110 0000 000000000 0111245667899999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=381.56 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=205.3
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++++.||+|+||.||+|.+ .|+.||||+++... ..+.+.+|+.+|++++|||||++++++... .+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CC
Confidence 346678899999999999999999986 47899999997654 235688999999999999999999998763 45
Q ss_pred eEEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+|||||||.++.+..++.... .+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 7999999999866554443322 37999999999999999999999999999999999999999999999999998643
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.. .....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......+
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------- 406 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--------- 406 (450)
T ss_dssp ----------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC---------
T ss_pred cc----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 21 223466889999999975 568999999999999999998 999999887777666664321110
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||..||+.||.+|||+.++++
T Consensus 407 -------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 -------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11257899999999999999999999999974
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=370.41 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=206.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
....++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 109 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNE 109 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCe
Confidence 34567899999999999999999985 578999999987553 3345678999999999999999999999987 678
Q ss_pred EEEEEeccchhcccccccCC----CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 200 IYLVFEYMEHDLAGLSSCHD----IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~----~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+++||||+.++.+....... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999987665554332 25899999999999999999999999999999999999999999999999999865
Q ss_pred cccC-cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKN-KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.... ......
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~ 263 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ESHNNG 263 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HHHTTT
T ss_pred ccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hccccc
Confidence 4322 222344578999999999865 568999999999999999999999998654322111110000 000000
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.+. ....+ ..........+..+.+||.+||+.||.+|||+.++|++
T Consensus 264 ~~~--~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 264 QLE--QIVDP-----NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCC--SSSSS-----SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHH--HhcCh-----hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 00000 00011112345678999999999999999999999965
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.88 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=203.2
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--Cc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LS 197 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~ 197 (690)
.+..++|++++.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 45667899999999999999999999999999999998754 345667889999999999999999999998632 24
Q ss_pred ceEEEEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 198 NTIYLVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
..+++||||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 68899999999865543332 35679999999999999999999999999999999999999999999999999987
Q ss_pred eccccCcc--------cccccccccCCCCcccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Q 041720 274 ILTSKNKQ--------KLTSRVVTLWYRPPELLMGST--NYNVSVDLWSVGCVFAELLIGKPILKGRTEV-EQLHKIFKL 342 (690)
Q Consensus 274 ~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~--~~~~~sDIWSlGviLyeLltG~~PF~~~~~~-e~l~~I~~~ 342 (690)
........ ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +.+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 65321111 113456799999999986532 3688999999999999999999999531100 001111110
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+ ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 263 ~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIP---------------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC---------------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000 013578899999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.91 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=204.8
Q ss_pred cccccCcCCe-eEEeEEeecCceEEEEEEE----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeece
Q 041720 117 GLVPMRAESF-EKLEKIGQGTYSSVFRARE----VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGV 191 (690)
Q Consensus 117 ~~~~~~~~~y-~~~~~LG~G~fG~Vy~a~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 191 (690)
+...+...+| ++++.||+|+||.||++.. ..+++.||||++... ......+.+.+|+.+|+.++||||++++++
T Consensus 23 g~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 3333344455 9999999999999988753 457899999999865 345666789999999999999999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGL 271 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGl 271 (690)
+.+.....++|||||+.++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 9886567899999999987666555443 499999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHH
Q 041720 272 ANILTSKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-----------LHK 338 (690)
Q Consensus 272 a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-----------l~~ 338 (690)
+..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 987654322 12334567888999999975 4678999999999999999999999975422110 000
Q ss_pred HHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 339 IFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 339 I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.... ... ........+++++.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~--------~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELL--------ERG----------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHH--------HTT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH--------hcc----------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10000 000 000112367899999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.82 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=205.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.-.|.+.++||+|+||.||+|++..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++.+. ...
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCC
Confidence 3347888999999999999999765554 7999998753 3445667889999999999999999999999763 344
Q ss_pred EEEEEeccchhcccc-cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGL-SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.++||||+.++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 589999998765544 4444567899999999999999999999999999999999999999999999999999765432
Q ss_pred C---cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 279 N---KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
. ........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~------- 249 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ------- 249 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------
Confidence 2 122334567899999999965 568999999999999999999 5677777776666655544321111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++.+.+||..||+.||.+|||+.++++
T Consensus 250 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 250 ---------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1257889999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.21 Aligned_cols=253 Identities=19% Similarity=0.255 Sum_probs=204.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.+|++++||||+++++++... .+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCc
Confidence 44699999999999999999987543 346899998753 3455667899999999999999999999986553 568
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 89999999986555444 44556899999999999999999999999999999999999999999999999999876433
Q ss_pred Cc---ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 279 NK---QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 253 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------- 253 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-------
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-------
Confidence 21 12344567889999999865 568999999999999999999 7788888777766666544321111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1247889999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=380.39 Aligned_cols=258 Identities=29% Similarity=0.404 Sum_probs=193.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+ .+.+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 345677889999999999875 45789999999987532 34578899999986 89999999999987 68899
Q ss_pred EEEeccchhcccccccCCC------CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC-------------C
Q 041720 202 LVFEYMEHDLAGLSSCHDI------KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE-------------G 262 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~------~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~-------------~ 262 (690)
||||||.+++...+..... ..++..++.++.||+.||.|||++|||||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 9999998765544433221 12445678899999999999999999999999999999754 4
Q ss_pred cEEEeecccceeccccCcc---cccccccccCCCCcccccC------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 041720 263 ILKLGDFGLANILTSKNKQ---KLTSRVVTLWYRPPELLMG------STNYNVSVDLWSVGCVFAELLI-GKPILKGRTE 332 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~~------~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~ 332 (690)
.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |.+||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876543221 2345689999999999965 2568999999999999999999 9999987654
Q ss_pred HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 333 ~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.+ ..+.......+... . .....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~~~~--------------------~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMK--------------------C--LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCCCT--------------------T--CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCccccc--------------------c--cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 43 23333221111000 0 001135678999999999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.18 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=204.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.+.||+|+||.||+|++ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 101 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 101 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCc
Confidence 34567899999999999999999974 57899999999765322 112358899999999999999999999987 678
Q ss_pred EEEEEeccchhcccccccC----CCCCChhHHHHHHHHHHHHHHHHHhC---CeEeccCCcccEEEccCCcEEEeecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCH----DIKFSEPQVKCYMRQLLHGVEHCHLR---GIMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~aL~yLH~~---givHrDLKp~NILld~~~~vKL~DFGla 272 (690)
.+|||||+.++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 8999999998766544432 23489999999999999999999999 9999999999999999999999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT----EVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~----~~e~l~~I~~~~g~~~~ 348 (690)
..+............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ....+....... ..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~- 257 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LK- 257 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TS-
T ss_pred cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hh-
Confidence 8876555555566779999999999865 458999999999999999999999996210 000000110000 00
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcc
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~ 409 (690)
...+. ..... ..........+..+.+||..||+.||.+|||+.++|+|-+
T Consensus 258 ----~~~~~--~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 ----EKKLE--ALVDV-----DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp ----SCCST--TSSCT-----TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ----chhhh--hhcCh-----hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00000 00000 0000111233467999999999999999999999998644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=396.19 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=206.8
Q ss_pred CCeeEE-eEEeecCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 124 ESFEKL-EKIGQGTYSSVFRARE--VATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 124 ~~y~~~-~~LG~G~fG~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..+.+. ++||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|++|+|||||++++++.+ +.+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCE
Confidence 334443 4799999999999954 4567899999998765555556789999999999999999999999965 468
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
+||||||.++.+..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999987777666667899999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 281 --QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 281 --~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.......+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+.......
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG----------- 592 (635)
T ss_dssp ----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 12233456788999999964 568999999999999999998 999999999888777765432111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||..||+.||.+|||++++++
T Consensus 593 -----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 -----------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01257899999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.21 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=192.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++.+.||+|+||.||+|++ .++.||||++... ...+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 4567899999999999999999986 4788999998643 245678999999999999999999998864 47
Q ss_pred EEEEeccchhcccccccCCC---CCChhHHHHHHHHHHHHHHHHHh---CCeEeccCCcccEEEccCCc-EEEeecccce
Q 041720 201 YLVFEYMEHDLAGLSSCHDI---KFSEPQVKCYMRQLLHGVEHCHL---RGIMHRDIKASNILVNNEGI-LKLGDFGLAN 273 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~aL~yLH~---~givHrDLKp~NILld~~~~-vKL~DFGla~ 273 (690)
+|||||+.++.+..+..... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 99999999876655544333 37889999999999999999999 89999999999999998886 7999999997
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTE--VEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~--~e~l~~I~~~~g~~~~~~w 351 (690)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.. +..+
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~---- 223 (307)
T 2eva_A 155 DIQT----HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP---- 223 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC----
T ss_pred cccc----ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC----
Confidence 6532 2234578999999999975 5689999999999999999999999985432 222222211 1110
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++.+.+||.+||+.||.+|||++++++
T Consensus 224 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 224 ----------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112367899999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=351.96 Aligned_cols=257 Identities=26% Similarity=0.322 Sum_probs=196.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhh--cCCCceeeeeceeecc--C
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR--LDHPNIIKLEGVITSR--L 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~--~ 196 (690)
+..++|++++.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.+. .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 3467899999999999999999986 7899999998643 22345566666666 7999999999986542 2
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHH--------hCCeEeccCCcccEEEccCCcEEEee
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH--------LRGIMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH--------~~givHrDLKp~NILld~~~~vKL~D 268 (690)
...++|||||+.++.+..+.. ...+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 456899999999876665553 347999999999999999999999 99999999999999999999999999
Q ss_pred cccceeccccCccc---ccccccccCCCCcccccCCC-----CCCcchhhHHHHHHHHHHHhC----------CCCCCCC
Q 041720 269 FGLANILTSKNKQK---LTSRVVTLWYRPPELLMGST-----NYNVSVDLWSVGCVFAELLIG----------KPILKGR 330 (690)
Q Consensus 269 FGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~-----~~~~~sDIWSlGviLyeLltG----------~~PF~~~ 330 (690)
||++.......... ....+||+.|+|||++.+.. .++.++|||||||++|+|++| .+||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765433221 23458999999999997643 345799999999999999999 8888653
Q ss_pred C----HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 331 T----EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 331 ~----~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
. ..+.+..+.......+. .+ . .......++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~--~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPN-----------------IP--N--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCC-----------------CC--G--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCC-----------------CC--h--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 22333333221111110 00 0 0001135578999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.27 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=204.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec--------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS-------- 194 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------- 194 (690)
..+|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 356999999999999999999999999999999997653 246789999999999999999998854
Q ss_pred ------cCcceEEEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEE
Q 041720 195 ------RLSNTIYLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKL 266 (690)
Q Consensus 195 ------~~~~~~~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL 266 (690)
.....++|||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 11456899999999865554442 2356999999999999999999999999999999999999999999999
Q ss_pred eecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 041720 267 GDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSP 346 (690)
Q Consensus 267 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~ 346 (690)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ......+... .
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~- 235 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I- 235 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C-
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c-
Confidence 9999998765432 3345678999999999975 56899999999999999999999887531 1111111110 0
Q ss_pred ChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 347 ~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
....++..+.+||.+||+.||.+|||+.|+++|.+.-.
T Consensus 236 ----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ----------------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01247889999999999999999999999999877654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=354.03 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=196.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++.+. .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCc
Confidence 45678899999999999999999976 58899999997543 345688999999999999999999987652 457
Q ss_pred EEEEEeccchhcccccccCCC--CCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDI--KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~--~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+++||||+.++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 899999999865554443322 389999999999999999999999999999999999999999999999999976543
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 233 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------- 233 (278)
T ss_dssp ----------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-----------
T ss_pred c----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence 2 233467889999999865 568999999999999999998 99999987766665554321100
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 234 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 -----------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 011357899999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=356.63 Aligned_cols=256 Identities=28% Similarity=0.405 Sum_probs=200.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA-TGK--MVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-~g~--~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
.+..++|++++.||+|+||.||+|++.. ++. .||||++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-
Confidence 3456789999999999999999998643 333 699999976543 34566789999999999999999999999986
Q ss_pred CcceEEEEEeccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 196 LSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
...++||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 3489999999976544 3434445799999999999999999999999999999999999999999999999999987
Q ss_pred ccccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 275 LTSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 275 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
+...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 245 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---- 245 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC----
T ss_pred ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC----
Confidence 6543322 2234567888999999865 567899999999999999999 9999999988887777654321111
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||.+||..||.+|||+.++++
T Consensus 246 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 -----------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11257899999999999999999999999995
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=367.11 Aligned_cols=256 Identities=17% Similarity=0.156 Sum_probs=198.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC--------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceee-------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT--------GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIK------- 187 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~------- 187 (690)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+|++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57899999999999999999999874 889999999754 24789999999999999998
Q ss_pred --------eeceeeccCcceEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE
Q 041720 188 --------LEGVITSRLSNTIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV 258 (690)
Q Consensus 188 --------l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl 258 (690)
+++++... ...+||||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 45555442 5789999999944444443332 3679999999999999999999999999999999999999
Q ss_pred ccCC--cEEEeecccceeccccCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 041720 259 NNEG--ILKLGDFGLANILTSKNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGR 330 (690)
Q Consensus 259 d~~~--~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~ 330 (690)
+.++ .+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 9999999999876543211 1244588999999999975 56899999999999999999999999876
Q ss_pred C-HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 331 T-EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 331 ~-~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
. ..+.+..........+..... .......+++++.+||..||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVG-------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEEC-------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhh-------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 333333222211111110000 00011357899999999999999999999999974
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.58 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=186.5
Q ss_pred cCCeeEE-eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-hhcCCCceeeeeceeec--cCcc
Q 041720 123 AESFEKL-EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMIL-RRLDHPNIIKLEGVITS--RLSN 198 (690)
Q Consensus 123 ~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~--~~~~ 198 (690)
.++|.++ +.||+|+||.||+|++..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4568888 7899999999999999999999999999642 3467888888 55699999999999865 2246
Q ss_pred eEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~ 273 (690)
.++|||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 78999999998655444332 236999999999999999999999999999999999999998 7899999999996
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
... ...++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~---------- 214 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------- 214 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS----------
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH----------
Confidence 532 1347889999999999999999999998755433211110000
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. .... .........+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 215 ---~-----~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 215 ---R-----MGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---C-----TTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ---h-----hccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0 0000 00011124689999999999999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=361.56 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=205.0
Q ss_pred cccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
..+..++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.+++.++||||+++++++.+ .+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 102 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PP 102 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SS
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CC
Confidence 34567889999999999999999998743 49999997654433334557789999999999999999999987 67
Q ss_pred eEEEEEeccchhcccccccC-CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCH-DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
.+++||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 89999999997665554443 44699999999999999999999999999999999999998 68999999999876432
Q ss_pred c----CcccccccccccCCCCcccccC--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Q 041720 278 K----NKQKLTSRVVTLWYRPPELLMG--------STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345 (690)
Q Consensus 278 ~----~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~ 345 (690)
. .........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 1122344568999999999864 245789999999999999999999999998887777666442111
Q ss_pred CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 346 ~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.. ....++.++.+||..||..||.+|||+.++++
T Consensus 262 ~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 NL---------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CC---------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CC---------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 01257889999999999999999999999995
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.28 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=196.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATG---KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
...|++.+.||+|+||.||+|++..++ ..||||.+.... .....+.+.+|+.+|++++||||+++++++... .+.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCC
Confidence 345889999999999999999875432 468999987532 345567899999999999999999999987552 467
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999986555444 44456899999999999999999999999999999999999999999999999999865432
Q ss_pred Ccc---cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 279 NKQ---KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 279 ~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
... ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+....+........
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~------- 317 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------- 317 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC-------
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 211 2234566889999999875 568999999999999999999 7899988776665555543211100
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 318 ---------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 318 ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12578899999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=378.40 Aligned_cols=254 Identities=15% Similarity=0.183 Sum_probs=197.2
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCC-Cceeee----------
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDH-PNIIKL---------- 188 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~l---------- 188 (690)
.....|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.+.| +|+..+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 344568899999999999999999999999999999874432 22335678999999999987 321111
Q ss_pred -----------eceeecc---CcceEEEEEeccchhcccccc------cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEe
Q 041720 189 -----------EGVITSR---LSNTIYLVFEYMEHDLAGLSS------CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248 (690)
Q Consensus 189 -----------~~~~~~~---~~~~~~LV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~aL~yLH~~givH 248 (690)
+.++... ....++++|+++.+++..++. .....+++..+..++.||+.||.|||++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111110 023578899988877665552 23446888899999999999999999999999
Q ss_pred ccCCcccEEEccCCcEEEeecccceeccccCcccccccccccCCCCccccc---------CCCCCCcchhhHHHHHHHHH
Q 041720 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM---------GSTNYNVSVDLWSVGCVFAE 319 (690)
Q Consensus 249 rDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---------~~~~~~~~sDIWSlGviLye 319 (690)
|||||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||+||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999875432 455677 9999999983 34568889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC
Q 041720 320 LLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG 399 (690)
Q Consensus 320 LltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp 399 (690)
|++|+.||.+.+..+....+ ......+++++.+||.+||+.||.+||
T Consensus 310 lltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHCCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCc
Confidence 99999999875432221111 111236889999999999999999999
Q ss_pred CHHHHHcCccccC
Q 041720 400 TASSLLMCEYFTT 412 (690)
Q Consensus 400 Ta~elL~hp~f~~ 412 (690)
|+.++|+||||+.
T Consensus 357 t~~~~l~~~~~~~ 369 (413)
T 3dzo_A 357 LPLQAMETPEYEQ 369 (413)
T ss_dssp CHHHHTTSHHHHH
T ss_pred CHHHHHhCHHHHH
Confidence 9999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=376.26 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=204.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCcee-eeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII-KLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~~ 200 (690)
..++|+++++||+|+||.||+|++..+++.||||++....... .+.+|+.+++.|.|++++ .+..++.+ .+..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE--GDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee--CCEE
Confidence 3578999999999999999999999999999999987654332 377899999999875544 44444444 6788
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE---ccCCcEEEeecccceeccc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV---NNEGILKLGDFGLANILTS 277 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl---d~~~~vKL~DFGla~~~~~ 277 (690)
+|||||+.+++..++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999999666666555556679999999999999999999999999999999999999 6889999999999987654
Q ss_pred cCcc------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCh
Q 041720 278 KNKQ------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPPE 348 (690)
Q Consensus 278 ~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~~ 348 (690)
.... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.. ..+.+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 3321 1235789999999999976 568999999999999999999999998754 34444444332211111
Q ss_pred hhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 349 EYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 349 ~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+..++.++.+||..||+.||.+||++.+|++
T Consensus 238 ------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 ------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1223478999999999999999999999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=387.69 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=204.2
Q ss_pred cCcCCeeEEe-EEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLE-KIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~-~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+..+.|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.|+|||||++++++.+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--- 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---
Confidence 4456677777 8999999999999875 356679999997653 23345678999999999999999999999975
Q ss_pred ceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||.++.+..++ .....+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 4699999999987665544 345569999999999999999999999999999999999999999999999999998764
Q ss_pred ccCcccc--cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNKQKL--TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
....... ....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..|......+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------- 559 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------- 559 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-------
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 3322211 22345688999999964 568999999999999999998 999999988888777765432111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
....+++++.+||..||..||.+|||+.+++
T Consensus 560 ---------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 560 ---------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred ---------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1125789999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.75 Aligned_cols=251 Identities=18% Similarity=0.217 Sum_probs=191.5
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHhhcC---------CCcee
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF------QPESIRFMAREIMILRRLD---------HPNII 186 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~iL~~L~---------HpnIv 186 (690)
..++|++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 356799999999999999999987 789999999987642 2233467889999999886 55555
Q ss_pred eeece-----------------eecc-----------CcceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHH
Q 041720 187 KLEGV-----------------ITSR-----------LSNTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHG 237 (690)
Q Consensus 187 ~l~~~-----------------~~~~-----------~~~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~a 237 (690)
+++++ +.+. ..+.+|||||||.++ ++..+.. ..+++..++.++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 55544 4320 157899999999876 4554433 468999999999999999
Q ss_pred HHHHH-hCCeEeccCCcccEEEccCC--------------------cEEEeecccceeccccCcccccccccccCCCCcc
Q 041720 238 VEHCH-LRGIMHRDIKASNILVNNEG--------------------ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296 (690)
Q Consensus 238 L~yLH-~~givHrDLKp~NILld~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE 296 (690)
|.||| ++|||||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChh
Confidence 99999 99999999999999999887 899999999987643 2458999999999
Q ss_pred cccCCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCcccccc
Q 041720 297 LLMGSTNYNVSVDLWSVGCV-FAELLIGKPILKGRTE-VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRE 374 (690)
Q Consensus 297 ~l~~~~~~~~~sDIWSlGvi-LyeLltG~~PF~~~~~-~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~ 374 (690)
++.+.. +.++|||||+++ ++++++|..||.+... ......+......... ....
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~ 303 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK----------------------CNTP 303 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC----------------------CCSH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc----------------------cchh
Confidence 997643 889999998777 7888999999954211 1122233221110000 0001
Q ss_pred ccCCCChhHHHHHHHhhccCCCCCCCHHHHH-cCcccc
Q 041720 375 RCKDFTPTAVDLIDTCLSIEPYKRGTASSLL-MCEYFT 411 (690)
Q Consensus 375 ~~~~is~~l~dLI~~~L~~DP~kRpTa~elL-~hp~f~ 411 (690)
....+++++++||.+||+.| |++|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 12257889999999999987 999999 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.63 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=201.3
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDN--FQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
|...+.||+|+||.||+|.+ +++.||||++.... ......+.+.+|+.+|+.++||||+++++++.+ .+.+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 45568899999999999974 68899999997542 234456779999999999999999999999987 6789999
Q ss_pred Eeccchhccccccc---CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 204 FEYMEHDLAGLSSC---HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~---~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99998765544332 234589999999999999999999999999999999999999999999999999987654322
Q ss_pred c-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh--hhhhccCCC
Q 041720 281 Q-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPE--EYWKKSKLP 357 (690)
Q Consensus 281 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~--~~w~~~~l~ 357 (690)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+......... ..|-..
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 263 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK--- 263 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS---
T ss_pred cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc---
Confidence 2 2334678999999999865 4789999999999999999999999876544333333222111110 001000
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.+.......+..+.+||..||+.||.+|||+.+++++
T Consensus 264 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 -------------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -------------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000112345678999999999999999999999853
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=362.18 Aligned_cols=247 Identities=17% Similarity=0.168 Sum_probs=194.9
Q ss_pred cccCcCCeeEEeEEeecCceEEEEE-----EEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC---CCceeeeec
Q 041720 119 VPMRAESFEKLEKIGQGTYSSVFRA-----REVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD---HPNIIKLEG 190 (690)
Q Consensus 119 ~~~~~~~y~~~~~LG~G~fG~Vy~a-----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~ 190 (690)
+.+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.++..++ |+||+++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3456788999999999999999999 467889999999997542 235677888888886 999999999
Q ss_pred eeeccCcceEEEEEeccchhccccccc-----CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-----
Q 041720 191 VITSRLSNTIYLVFEYMEHDLAGLSSC-----HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN----- 260 (690)
Q Consensus 191 ~~~~~~~~~~~LV~Ey~~g~ll~~~~~-----~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~----- 260 (690)
++.. .+..|||||||.++.+..+.. ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 135 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 135 AHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred eeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9987 688999999999876655443 3456999999999999999999999999999999999999998
Q ss_pred ------CCcEEEeecccceeccc-cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 041720 261 ------EGILKLGDFGLANILTS-KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEV 333 (690)
Q Consensus 261 ------~~~vKL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~ 333 (690)
++.+||+|||+++.+.. .........+||+.|+|||++.+ ..|+.++||||||||||+|++|++||......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976542 22334566789999999999976 45899999999999999999999999643210
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.|.... .... ...++.+.+||..||+.+|.+|++..+.|.
T Consensus 292 ----------------~~~~~~-----------~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 292 ----------------ECKPEG-----------LFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ----------------EEEECS-----------CCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ----------------ceeech-----------hccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 011000 0000 023567889999999999999966544443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=355.42 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAR----EVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 456779999999999999999998 4568999999999754 3455678999999999999999999999987644
Q ss_pred cceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...++|||||+.++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 4578999999988655444 344456999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ... ...+......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~---~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM---RMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHH---HHHCTTCCTHHHH
T ss_pred cccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHH---HhhccccchhhhH
Confidence 543221 1233456788999999875 4578999999999999999999999864211 111 1111111000000
Q ss_pred ----cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 354 ----SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 354 ----~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+.... .......+++++.+||.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNG-----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCC-----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000000 00012357899999999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=359.09 Aligned_cols=281 Identities=22% Similarity=0.293 Sum_probs=192.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHH--HHHHHHhhcCCCceeeeeceeec---
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA--REIMILRRLDHPNIIKLEGVITS--- 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~--~Ei~iL~~L~HpnIv~l~~~~~~--- 194 (690)
.+..++|++++.||+|+||.||+|++ +++.||||++.... ...+. .|+..+..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 45678899999999999999999975 78999999997542 12333 34444556899999999975432
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC---------CeEeccCCcccEEEccCCcEE
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR---------GIMHRDIKASNILVNNEGILK 265 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~---------givHrDLKp~NILld~~~~vK 265 (690)
.....+|||||||+++.+..+.... .+++..++.++.||+.||.|||+. |||||||||+||||+.++.+|
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 2245789999999887665554333 468899999999999999999999 999999999999999999999
Q ss_pred EeecccceeccccC-------cccccccccccCCCCcccccCC------CCCCcchhhHHHHHHHHHHHhCCCCC-CCCC
Q 041720 266 LGDFGLANILTSKN-------KQKLTSRVVTLWYRPPELLMGS------TNYNVSVDLWSVGCVFAELLIGKPIL-KGRT 331 (690)
Q Consensus 266 L~DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~------~~~~~~sDIWSlGviLyeLltG~~PF-~~~~ 331 (690)
|+|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||+||+|++|..|| .+..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765321 1223356799999999999752 34667899999999999999996554 4332
Q ss_pred HHHHHHHHHHHcCC-CChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH-----
Q 041720 332 EVEQLHKIFKLCGS-PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL----- 405 (690)
Q Consensus 332 ~~e~l~~I~~~~g~-~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL----- 405 (690)
..+....+....+. +....+...... ....+..+ .. ......+++++.+||.+||+.||.+|||+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFP--EA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCC--TT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcc--cccCCCCC--cc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 11111111111111 111110000000 00000000 00 000112445799999999999999999999995
Q ss_pred -cCccccCC
Q 041720 406 -MCEYFTTQ 413 (690)
Q Consensus 406 -~hp~f~~~ 413 (690)
.++|-++.
T Consensus 316 ll~~~~~~~ 324 (336)
T 3g2f_A 316 LMMIWERNK 324 (336)
T ss_dssp HHHCCCC--
T ss_pred HHHHHHhcc
Confidence 45666553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.09 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=190.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc--CCCceeeeeceeeccCc--c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL--DHPNIIKLEGVITSRLS--N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~~--~ 198 (690)
.++|++++.||+|+||.||+|++ +++.||||++.... ...+.+|.+++..+ +||||+++++++.+... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 46799999999999999999986 48999999996432 23344555665554 99999999999887322 6
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC--------CeEeccCCcccEEEccCCcEEEeecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR--------GIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~--------givHrDLKp~NILld~~~~vKL~DFG 270 (690)
.+||||||+.++.+..+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 89999999998666555433 3699999999999999999999999 99999999999999999999999999
Q ss_pred cceeccccCccc---ccccccccCCCCcccccCCCCCCc------chhhHHHHHHHHHHHhC----------CCCCCCCC
Q 041720 271 LANILTSKNKQK---LTSRVVTLWYRPPELLMGSTNYNV------SVDLWSVGCVFAELLIG----------KPILKGRT 331 (690)
Q Consensus 271 la~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~------~sDIWSlGviLyeLltG----------~~PF~~~~ 331 (690)
++..+....... ....+||+.|+|||++.+.. +.. ++|||||||++|+|++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 997765432221 23568999999999997643 333 49999999999999999 66665421
Q ss_pred ----HHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 332 ----EVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 332 ----~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..+.+..+.......+ ..+ . ......+++++.+||.+||+.||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~-----------------~~~--~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRP-----------------SFP--N--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCC-----------------CCC--G--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCc-----------------ccc--c--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221111000 000 0 00012356779999999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=385.05 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=208.7
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
.+..++|++.+.||+|+||.||+|++..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 45567899999999999999999998643 4679999987542 45556789999999999999999999999854
Q ss_pred cceEEEEEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.+||||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 56899999999876654443 4446899999999999999999999999999999999999999999999999999876
Q ss_pred cccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
............+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......+.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 613 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------- 613 (656)
T ss_dssp CC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC-------
T ss_pred CCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 5443333344566889999999865 578999999999999999997 9999999998888877755321110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 614 ---------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 ---------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1257899999999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=390.79 Aligned_cols=281 Identities=24% Similarity=0.292 Sum_probs=208.4
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec----cCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS----RLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~ 198 (690)
.++|++.+.||+|+||.||+|++..+|+.||||++... ......+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46799999999999999999999999999999998754 355667789999999999999999999998754 1256
Q ss_pred eEEEEEeccchhcccccccCC---CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCc---EEEeecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHD---IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGI---LKLGDFGLA 272 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~---vKL~DFGla 272 (690)
..|||||||.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 789999999887665544332 25999999999999999999999999999999999999997764 999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
..+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................. ....
T Consensus 172 ~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~--~~~~ 246 (676)
T 3qa8_A 172 KELDQG--ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE--HIVV 246 (676)
T ss_dssp CBTTSC--CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCS
T ss_pred cccccc--cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch--hhhh
Confidence 876533 23455789999999999865 578999999999999999999999998765443221111000000 0000
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.........+....+. .......+++.+.+||..||.+||.+|||+.++|+||||..
T Consensus 247 ~~~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000000000010 11122346788999999999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.59 Aligned_cols=254 Identities=26% Similarity=0.303 Sum_probs=196.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhh--cCCCceeeeeceeeccCc--c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRR--LDHPNIIKLEGVITSRLS--N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~~--~ 198 (690)
.++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++..... .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 35699999999999999999987 5899999998643 23557788888887 799999999999887322 2
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHH--------hCCeEeccCCcccEEEccCCcEEEeecc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH--------LRGIMHRDIKASNILVNNEGILKLGDFG 270 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH--------~~givHrDLKp~NILld~~~~vKL~DFG 270 (690)
.+||||||+.++.+..+... ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 79999999998666555433 36999999999999999999999 8999999999999999999999999999
Q ss_pred cceeccccCcc---cccccccccCCCCcccccCCCC-----CCcchhhHHHHHHHHHHHhC----------CCCCCCCC-
Q 041720 271 LANILTSKNKQ---KLTSRVVTLWYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIG----------KPILKGRT- 331 (690)
Q Consensus 271 la~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~-----~~~~sDIWSlGviLyeLltG----------~~PF~~~~- 331 (690)
++......... ......||+.|+|||++.+... ++.++|||||||+||+|++| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99876543321 2345678999999999976422 33689999999999999999 77887542
Q ss_pred ---HHHHHHHHHHHcC-CCC-hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 332 ---EVEQLHKIFKLCG-SPP-EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 332 ---~~e~l~~I~~~~g-~~~-~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
..+.+........ .+. ...| .....+..+.+||.+||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRW-----------------------QSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG-----------------------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccc-----------------------cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1222222211110 000 0000 01134467899999999999999999999996
Q ss_pred C
Q 041720 407 C 407 (690)
Q Consensus 407 h 407 (690)
|
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.07 Aligned_cols=229 Identities=17% Similarity=0.099 Sum_probs=185.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.++..++||||+++++++.+ .+.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcE
Confidence 346799999999999999999999999999999999876443 5566789999999999999999999999988 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||+.++.+..+.... ..+.++..++.||+.||.|||++||+||||||+||||+.++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999987666555432 4666789999999999999999999999999999999999999998543
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
|++| ++.++|||||||+||+|++|+.||.+.+..+.+.......
T Consensus 175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~----------------- 218 (286)
T 3uqc_A 175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT----------------- 218 (286)
T ss_dssp -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-----------------
T ss_pred -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-----------------
Confidence 3332 6889999999999999999999998754322110000000
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.............+++++.+||.+||+.||.+| |+.|+++
T Consensus 219 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 -----AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -----TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -----ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000001112335789999999999999999999 9999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=381.94 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=199.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc---c
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVA-TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS---N 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~ 198 (690)
.++|++++.||+|+||.||+|++.. +|+.||||++.... .......+.+|+.+|.+++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 78999999987543 45566778999999999999999999999987321 1
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++.+...... .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.+...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 27999999998877665443 79999999999999999999999999999999999999885 8999999999876432
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+.... ..+..
T Consensus 235 -----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~---------- 287 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED---------- 287 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT----------
T ss_pred -----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc----------
Confidence 45679999999999864 3588999999999999999999998752100 00000
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
.....+++.+.+||.+||+.||.+||+..++|.|+|+.
T Consensus 288 ---------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 288 ---------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00012467899999999999999999999999888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-33 Score=321.69 Aligned_cols=188 Identities=16% Similarity=0.065 Sum_probs=138.1
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeecCCC----C----hHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCcceEE
Q 041720 131 KIGQGTYSSVFRAREVATGKMVALKKVRFDNF----Q----PESIRFMAREIMILRRL-DHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 131 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++.|++|.+..++....|+.||+|++.+... . ....+.+.+|+++|+++ .|+||+++++++++ .+.+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 46778888888888888999999999986532 1 23456799999999999 79999999999998 78999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||+|+.|..++...+++++. .|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999999888888877778764 589999999999999999999999999999999999999999998765433 4
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI 326 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~P 326 (690)
...+.+||+.|||||++.+ .+..++|+|++|+++|+|+++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 4566899999999999975 467789999999999988766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=267.47 Aligned_cols=187 Identities=17% Similarity=0.133 Sum_probs=142.3
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPE------SIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..+.||+|+||.||+| ...+..+|+|++........ ..+.+.+|+.+|++++||||+++..++.+ .+..|
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~ 415 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKR 415 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccE
Confidence 3568999999999999 45678899998765433211 23458999999999999999944444444 45669
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||+++.+..+... +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++........
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999997766555443 5689999999999999999999999999999998 9999999999987543221
Q ss_pred c------ccccccccCCCCcccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 282 K------LTSRVVTLWYRPPELLMG-STNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 282 ~------~~~~~gt~~Y~APE~l~~-~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
. ....+||+.|||||++.+ ...|+..+|+|+..+-..+.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 246789999999999864 1347888999999999998888877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=225.33 Aligned_cols=146 Identities=19% Similarity=0.131 Sum_probs=118.4
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHhhcCCCceeee
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----------------ESIRFMAREIMILRRLDHPNIIKL 188 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIv~l 188 (690)
.|.+.+.||+|+||.||+|++ .+|+.||||+++...... .....+.+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 356679999999999999998 889999999997542211 23566889999999999 5 777
Q ss_pred eceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEee
Q 041720 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGD 268 (690)
Q Consensus 189 ~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~D 268 (690)
++++.. +..|||||||+++.+..+ .......++.||+.||.|||++|||||||||+||||+ ++.+||+|
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGGC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec---cceEEEEEecCCCcHHHc-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 776654 556999999998766542 1234568999999999999999999999999999999 99999999
Q ss_pred cccceeccccCcccccccccccCCCCccccc
Q 041720 269 FGLANILTSKNKQKLTSRVVTLWYRPPELLM 299 (690)
Q Consensus 269 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 299 (690)
||+++. +..|+|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999964 34478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=197.45 Aligned_cols=142 Identities=20% Similarity=0.224 Sum_probs=107.8
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCCC----------------------hHHHHHHHHHHHHHhhcC
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQ----------------------PESIRFMAREIMILRRLD 181 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~--vAvK~i~~~~~~----------------------~~~~~~~~~Ei~iL~~L~ 181 (690)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|..|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 999997644211 011235789999999998
Q ss_pred CCce--eeeeceeeccCcceEEEEEeccch-hc-ccccccCCCCCChhHHHHHHHHHHHHHHHHH-hCCeEeccCCcccE
Q 041720 182 HPNI--IKLEGVITSRLSNTIYLVFEYMEH-DL-AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH-LRGIMHRDIKASNI 256 (690)
Q Consensus 182 HpnI--v~l~~~~~~~~~~~~~LV~Ey~~g-~l-l~~~~~~~~~lse~~~~~i~~QIl~aL~yLH-~~givHrDLKp~NI 256 (690)
|++| +.++++ +..+|||||+++ +. ...+......+++..+..++.||+.||.||| +.|||||||||+||
T Consensus 129 ~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8764 333332 345899999953 21 1111111112346788999999999999999 99999999999999
Q ss_pred EEccCCcEEEeecccceec
Q 041720 257 LVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 257 Lld~~~~vKL~DFGla~~~ 275 (690)
|++. .++|+|||+|...
T Consensus 203 Ll~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EESS--SEEECCCTTCEET
T ss_pred EEcC--cEEEEECcccccC
Confidence 9998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=7.7e-18 Score=182.64 Aligned_cols=138 Identities=19% Similarity=0.212 Sum_probs=99.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC---------------ChHH-H----HHHHHHHHHHhhcCCCce
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---------------QPES-I----RFMAREIMILRRLDHPNI 185 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------------~~~~-~----~~~~~Ei~iL~~L~HpnI 185 (690)
|++...||.|+||.||+|.+ .+|+.||||+++.... .... . -...+|...|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999986 5799999999864210 0000 0 112356677777754443
Q ss_pred eeeeceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC---
Q 041720 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG--- 262 (690)
Q Consensus 186 v~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~--- 262 (690)
.-. ..+.. ...+|||||++|..+..+. ....+..++.||+.+|.|||+.|||||||||.||||++++
T Consensus 176 ~vp-~p~~~---~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVP-EPIAQ---SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCC-CEEEE---ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCC-eeeec---cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 211 11111 1227999999986654332 2345678899999999999999999999999999998876
Q ss_pred -------cEEEeeccccee
Q 041720 263 -------ILKLGDFGLANI 274 (690)
Q Consensus 263 -------~vKL~DFGla~~ 274 (690)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=126.52 Aligned_cols=140 Identities=14% Similarity=0.087 Sum_probs=108.9
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 202 (690)
..|++...++.|+++.||++.. .+..+++|+....... ....+.+|+.+|+.|. +..+.++++++.+ .+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 3588888999999999999963 4678999998752111 1124788999999984 6678888888876 578899
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh---------------------------------------
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL--------------------------------------- 243 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~--------------------------------------- 243 (690)
||||++|..+.... .+......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999997654331 1234456788999999999998
Q ss_pred --------------------CCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 244 --------------------RGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 244 --------------------~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
..++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998766677999998853
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-11 Score=121.39 Aligned_cols=135 Identities=16% Similarity=0.116 Sum_probs=98.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc--eeeeeceeeccCcceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN--IIKLEGVITSRLSNTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~~~ 201 (690)
..|.+....+.|..+.||++. ..+|..++||+..... ...+.+|+.+|+.+.+.+ +.+++++..+ .+..+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCE
Confidence 345554444466669999996 4567789999976431 134778999999985444 4568877765 46789
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG------------------------------------ 245 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g------------------------------------ 245 (690)
+||||++|..+. .. . .....++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~----~---~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SS----H---LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT-TS----C---CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC-cC----c---CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999987653 11 1 123467788888888888754
Q ss_pred ----------------------eEeccCCcccEEEccCCcEEEeeccccee
Q 041720 246 ----------------------IMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 246 ----------------------ivHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
++|+||+|.|||++.++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.1e-10 Score=120.77 Aligned_cols=143 Identities=14% Similarity=0.226 Sum_probs=105.1
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEee--cCCCChHHHHHHHHHHHHHhhcC--CCceeeeeceeeccC-cceEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVR--FDNFQPESIRFMAREIMILRRLD--HPNIIKLEGVITSRL-SNTIY 201 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~-~~~~~ 201 (690)
..++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+|+.|. +..+.+++.++.+.. .+..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3467899999999999864 34678888775 33211 12346888999999996 455778888776521 14579
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh--------------------------------------
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-------------------------------------- 243 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-------------------------------------- 243 (690)
+||||++|..+..... ..+++.+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999865533211 236788889999999999999997
Q ss_pred --------------------CCeEeccCCcccEEEccCCc--EEEeeccccee
Q 041720 244 --------------------RGIMHRDIKASNILVNNEGI--LKLGDFGLANI 274 (690)
Q Consensus 244 --------------------~givHrDLKp~NILld~~~~--vKL~DFGla~~ 274 (690)
..+||+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35999999999999997753 69999999975
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.6e-10 Score=121.14 Aligned_cols=184 Identities=16% Similarity=0.157 Sum_probs=120.3
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCc--eeeeeceeeccC-cceEEEEE
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPN--IIKLEGVITSRL-SNTIYLVF 204 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--Iv~l~~~~~~~~-~~~~~LV~ 204 (690)
++.|+.|.+..||++. ..+++|+... ......+.+|+.+|+.|. +.. +.+++....+.. ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3459999999999873 4588998642 244567899999998883 332 334443332210 12348899
Q ss_pred eccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 041720 205 EYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL----------------------------------------- 243 (690)
Q Consensus 205 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~----------------------------------------- 243 (690)
|+++|..+..... ..++..+...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999876543211 246777788888888888888885
Q ss_pred -----------------CCeEeccCCcccEEEcc--CCcEEEeecccceeccccCccccccc---------------ccc
Q 041720 244 -----------------RGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKNKQKLTSR---------------VVT 289 (690)
Q Consensus 244 -----------------~givHrDLKp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~---------------~gt 289 (690)
..++|+|++|.|||++. ...+.|+||+.+...+.. ..+... ...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHHH
Confidence 13799999999999998 456899999998764321 000000 001
Q ss_pred cCCCC-cccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041720 290 LWYRP-PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILK 328 (690)
Q Consensus 290 ~~Y~A-PE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~ 328 (690)
..+.. |+.+.. ...-.+.|+++.++|.+.+|.++|.
T Consensus 252 Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11122 222211 1223589999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.5e-06 Score=91.25 Aligned_cols=135 Identities=16% Similarity=0.163 Sum_probs=92.0
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC---ceeeeeceeeccCcceEEEEEe
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP---NIIKLEGVITSRLSNTIYLVFE 205 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~~~~~~~LV~E 205 (690)
++.|+.|....||+. |..++||+-. .......+.+|+.+|+.|.+. .|.+++.+.... .+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEe
Confidence 456899999999988 5668888853 234556789999999999653 244555555422 456789999
Q ss_pred ccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 041720 206 YMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR----------------------------------------- 244 (690)
Q Consensus 206 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~----------------------------------------- 244 (690)
|++|..+..... ..++..+...++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999865543111 1234444555555555555555532
Q ss_pred -------------------CeEeccCCcccEEEcc---CCc-EEEeecccceec
Q 041720 245 -------------------GIMHRDIKASNILVNN---EGI-LKLGDFGLANIL 275 (690)
Q Consensus 245 -------------------givHrDLKp~NILld~---~~~-vKL~DFGla~~~ 275 (690)
.++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3699999999999987 455 589999998653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.1e-06 Score=87.54 Aligned_cols=133 Identities=14% Similarity=0.107 Sum_probs=91.7
Q ss_pred EEeecCce-EEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEEEEeccc
Q 041720 131 KIGQGTYS-SVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYLVFEYME 208 (690)
Q Consensus 131 ~LG~G~fG-~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 208 (690)
.+..|..+ .||+......+..++||+-.. .....+.+|..+|+.|. +--|.+++.++.+ .+..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 45556555 699987667778899998653 23456889999999884 3235677777776 578899999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 041720 209 HDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLR-------------------------------------------- 244 (690)
Q Consensus 209 g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~-------------------------------------------- 244 (690)
|..+..... ........+..++...|..||..
T Consensus 104 G~~~~~~~~----~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLE----EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHH----HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred Ccccccccc----CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 854332211 11223334555555555555531
Q ss_pred --------------CeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 245 --------------GIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 245 --------------givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 169999999999999877778999999854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=5.1e-06 Score=90.06 Aligned_cols=78 Identities=18% Similarity=0.192 Sum_probs=48.8
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC--Ch---HHHHHHHHHHHHHhhcCC--Cc-eeeeeceeeccCcce
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QP---ESIRFMAREIMILRRLDH--PN-IIKLEGVITSRLSNT 199 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~---~~~~~~~~Ei~iL~~L~H--pn-Iv~l~~~~~~~~~~~ 199 (690)
.++.||.|.++.||++....+++.|+||....... .+ .....+..|+.+|+.+.. +. +.+++.+ + ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCc
Confidence 45689999999999997655678899998653211 00 112346778899888732 33 4455543 2 234
Q ss_pred EEEEEeccch
Q 041720 200 IYLVFEYMEH 209 (690)
Q Consensus 200 ~~LV~Ey~~g 209 (690)
.+|||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5899999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.8e-05 Score=84.20 Aligned_cols=86 Identities=8% Similarity=0.057 Sum_probs=54.2
Q ss_pred eEEeEE-eecCceEEEEEEEc--C----CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcC-C--Cceeeeeceeecc
Q 041720 127 EKLEKI-GQGTYSSVFRAREV--A----TGKMVALKKVRFDNF-QPESIRFMAREIMILRRLD-H--PNIIKLEGVITSR 195 (690)
Q Consensus 127 ~~~~~L-G~G~fG~Vy~a~~~--~----~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~~ 195 (690)
..++.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456778 88999999998642 1 266789998653220 0000124678888888874 2 3466777766542
Q ss_pred C-cceEEEEEeccchhcc
Q 041720 196 L-SNTIYLVFEYMEHDLA 212 (690)
Q Consensus 196 ~-~~~~~LV~Ey~~g~ll 212 (690)
. .+..|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 1 1356899999998543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.8e-05 Score=80.60 Aligned_cols=30 Identities=17% Similarity=0.273 Sum_probs=27.5
Q ss_pred CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 244 RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00064 Score=71.46 Aligned_cols=75 Identities=17% Similarity=0.184 Sum_probs=57.8
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC---CCceeeeeceeeccCcceEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD---HPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~LV 203 (690)
..++.|+.|.+..+|+... ++..++||+.... ....+..|+..|+.|. ...+.+++.+... .+..++|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEE
Confidence 4567899999999999863 5678899987643 2456889999998883 3567778777665 4678999
Q ss_pred Eeccchh
Q 041720 204 FEYMEHD 210 (690)
Q Consensus 204 ~Ey~~g~ 210 (690)
|||+++.
T Consensus 110 me~l~G~ 116 (312)
T 3jr1_A 110 LEALNKS 116 (312)
T ss_dssp EECCCCC
T ss_pred EEeccCC
Confidence 9999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0003 Score=76.81 Aligned_cols=78 Identities=8% Similarity=0.011 Sum_probs=45.9
Q ss_pred HhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccccccccc--ccCCCCcccccCCC--CCCcchhhHHHHHHH
Q 041720 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGST--NYNVSVDLWSVGCVF 317 (690)
Q Consensus 242 H~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~--~~~~~sDIWSlGviL 317 (690)
+...++|+||+|.|||++.++ ++|+||+.+..-... ..+..... ...|++|+...... .-....++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 456799999999999998877 999999998653211 11111111 13355555442100 011223445677777
Q ss_pred HHHHh
Q 041720 318 AELLI 322 (690)
Q Consensus 318 yeLlt 322 (690)
|.+++
T Consensus 307 ~~~y~ 311 (420)
T 2pyw_A 307 WNLFN 311 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00077 Score=69.42 Aligned_cols=76 Identities=16% Similarity=0.201 Sum_probs=52.9
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC---ceeeeeceeeccCcceEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP---NIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~~~~~~~ 201 (690)
...-++.+|.|..+.||+.+ ..+|+.|.||+....... ....+..|+..|+.|.-- -+.+++.+. .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc------Cce
Confidence 35667889999999999997 578999999986543221 123578899999988422 234444432 127
Q ss_pred EEEeccch
Q 041720 202 LVFEYMEH 209 (690)
Q Consensus 202 LV~Ey~~g 209 (690)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00065 Score=70.83 Aligned_cols=143 Identities=15% Similarity=0.105 Sum_probs=78.0
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc--eeeeeceeec----cCcce
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN--IIKLEGVITS----RLSNT 199 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~----~~~~~ 199 (690)
...++.|+.|....||++.. .+| .+++|+..... . ...+..|+.++..|.... +.+++..... ...+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567788899999999864 344 58899886521 1 123566788877773212 2333321100 01356
Q ss_pred EEEEEeccchhcccc---------------ccc--CC--CC----CChhHHHH---------------HHHHHHHHHHHH
Q 041720 200 IYLVFEYMEHDLAGL---------------SSC--HD--IK----FSEPQVKC---------------YMRQLLHGVEHC 241 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~---------------~~~--~~--~~----lse~~~~~---------------i~~QIl~aL~yL 241 (690)
.++||+|++|..+.. +.. .. .. ........ +...+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999998743211 000 00 00 00000000 001133444555
Q ss_pred Hh-------CCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 242 HL-------RGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 242 H~-------~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
+. .++||+|+++.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 42 3699999999999998876668999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.002 Score=70.70 Aligned_cols=73 Identities=19% Similarity=0.244 Sum_probs=49.1
Q ss_pred EEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcce
Q 041720 128 KLEKIGQGTYSSVFRAREVA-------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNT 199 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~ 199 (690)
.++.|+.|....||++.... ++..+++|+..... . ...+.+|+.+++.|...++ .++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 45678889999999997542 25789999884321 1 1235579999988843333 566665532
Q ss_pred EEEEEeccchh
Q 041720 200 IYLVFEYMEHD 210 (690)
Q Consensus 200 ~~LV~Ey~~g~ 210 (690)
.+||||++|.
T Consensus 148 -g~v~e~l~G~ 157 (429)
T 1nw1_A 148 -GRLEEYIPSR 157 (429)
T ss_dssp -EEEECCCCEE
T ss_pred -CEEEEEeCCc
Confidence 2899999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00044 Score=71.78 Aligned_cols=69 Identities=20% Similarity=0.103 Sum_probs=42.4
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceEEEEEecc
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
++.|+.|....+|++ ..+++|+..... ...-...+|+.+++.+....+ .+++.+.. ..-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDP----ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEEEeec
Confidence 678999999999998 458888875431 111113468877777742222 35554432 2236899999
Q ss_pred -chh
Q 041720 208 -EHD 210 (690)
Q Consensus 208 -~g~ 210 (690)
+|.
T Consensus 90 ~~g~ 93 (301)
T 3dxq_A 90 AGAQ 93 (301)
T ss_dssp TTCE
T ss_pred CCCc
Confidence 653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0012 Score=71.18 Aligned_cols=137 Identities=18% Similarity=0.165 Sum_probs=80.3
Q ss_pred EeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceE
Q 041720 129 LEKIGQGTYSSVFRAREVA-------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 200 (690)
++.|..|-...+|++.... ++..|++|+.-... .....+.+|..+++.|. +.-..++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE------ 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------
Confidence 3567778888999987532 35789999853211 12344668999998884 3223566665533
Q ss_pred EEEEeccchhcccccc------------------cCCCC----C--ChhHHHHHHHHHHH-------------------H
Q 041720 201 YLVFEYMEHDLAGLSS------------------CHDIK----F--SEPQVKCYMRQLLH-------------------G 237 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~------------------~~~~~----l--se~~~~~i~~QIl~-------------------a 237 (690)
.+||||++|..+.... ..... . -..++..|+.++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999974332110 00001 1 13455556554422 1
Q ss_pred HHHHH----h----CCeEeccCCcccEEEccC----CcEEEeeccccee
Q 041720 238 VEHCH----L----RGIMHRDIKASNILVNNE----GILKLGDFGLANI 274 (690)
Q Consensus 238 L~yLH----~----~givHrDLKp~NILld~~----~~vKL~DFGla~~ 274 (690)
+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 23332 2 249999999999999876 7899999998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0012 Score=70.65 Aligned_cols=74 Identities=11% Similarity=0.112 Sum_probs=42.9
Q ss_pred EEeEEeecCceEEEEEEEcC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCc-eeeeeceeeccCcc
Q 041720 128 KLEKIGQGTYSSVFRAREVA--------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN-IIKLEGVITSRLSN 198 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~ 198 (690)
.+..|+.|....+|++.... .+..+++|+..... ........|..+|+.|...+ +.++++... +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 34678888889999997532 13678898865321 11112357888888874333 345654431 2
Q ss_pred eEEEEEeccchh
Q 041720 199 TIYLVFEYMEHD 210 (690)
Q Consensus 199 ~~~LV~Ey~~g~ 210 (690)
++||||++|.
T Consensus 110 --~~v~e~i~G~ 119 (369)
T 3c5i_A 110 --GRIEEWLYGD 119 (369)
T ss_dssp --EEEEECCCSE
T ss_pred --cEEEEEecCC
Confidence 6899999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0042 Score=68.72 Aligned_cols=74 Identities=19% Similarity=0.153 Sum_probs=47.4
Q ss_pred EEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce-eeeeceeeccCcceEEEEEec
Q 041720 128 KLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI-IKLEGVITSRLSNTIYLVFEY 206 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey 206 (690)
.++.|+.|-...+|++.....+..+++|+..... . .. -...+|+.+|+.|...++ .++++++. + .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EI-INREREKKISCILYNKNIAKKIYVFFT----N--GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SC-SCHHHHHHHHHHHTTSSSBCCEEEEET----T--EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEe
Confidence 4567888999999999764435789999874321 1 00 012579999999865444 46766653 2 259999
Q ss_pred cchh
Q 041720 207 MEHD 210 (690)
Q Consensus 207 ~~g~ 210 (690)
++|.
T Consensus 183 I~G~ 186 (458)
T 2qg7_A 183 MDGY 186 (458)
T ss_dssp CCSE
T ss_pred eCCc
Confidence 9874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0061 Score=63.53 Aligned_cols=137 Identities=12% Similarity=0.048 Sum_probs=78.5
Q ss_pred eEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCC--ceeeeeceeec----cCcceEEEE
Q 041720 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP--NIIKLEGVITS----RLSNTIYLV 203 (690)
Q Consensus 130 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~----~~~~~~~LV 203 (690)
..|+ |....||++. ..+|+.+++|+........ ..+..|+.++..|... .+++++.. .. ...+..++|
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 8888999875 3456679999987443332 3466788888877422 24444443 11 013566889
Q ss_pred Eeccchhcccc---------------c---ccC-----CCCCChhH----------------------HHHHHHHHHHHH
Q 041720 204 FEYMEHDLAGL---------------S---SCH-----DIKFSEPQ----------------------VKCYMRQLLHGV 238 (690)
Q Consensus 204 ~Ey~~g~ll~~---------------~---~~~-----~~~lse~~----------------------~~~i~~QIl~aL 238 (690)
|+|++|..+.. + ... ...+.... ....+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998743210 0 000 00111110 011122222223
Q ss_pred HHH----HhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 239 EHC----HLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 239 ~yL----H~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234589999999999999 4 899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0084 Score=63.38 Aligned_cols=31 Identities=32% Similarity=0.428 Sum_probs=27.8
Q ss_pred CCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 244 RGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 244 ~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999988865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0072 Score=59.77 Aligned_cols=94 Identities=16% Similarity=0.038 Sum_probs=61.3
Q ss_pred cccccCCCCCChhHHHHHHHHHHHHHHHH-HhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccccccccccC
Q 041720 213 GLSSCHDIKFSEPQVKCYMRQLLHGVEHC-HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLW 291 (690)
Q Consensus 213 ~~~~~~~~~lse~~~~~i~~QIl~aL~yL-H~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~gt~~ 291 (690)
..+...+.+++|+++|.++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|-+.+ ..+. .....
T Consensus 37 eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~ 102 (229)
T 2yle_A 37 EILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPP 102 (229)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------------------
T ss_pred HHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccccC
Confidence 34455677899999999999999998776 222212344457899999999987764 2110 11223
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHHHh
Q 041720 292 YRPPELLMGSTNYNVSVDLWSVGCVFAELLI 322 (690)
Q Consensus 292 Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt 322 (690)
+.|||.+. ...+.+.=|||||++||..+-
T Consensus 103 ~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 103 PVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred CCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 56888763 345678889999999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0037 Score=65.54 Aligned_cols=31 Identities=32% Similarity=0.364 Sum_probs=27.3
Q ss_pred CCeEeccCCcccEEEccC----CcEEEeeccccee
Q 041720 244 RGIMHRDIKASNILVNNE----GILKLGDFGLANI 274 (690)
Q Consensus 244 ~givHrDLKp~NILld~~----~~vKL~DFGla~~ 274 (690)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6899999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.025 Score=61.84 Aligned_cols=75 Identities=11% Similarity=0.060 Sum_probs=46.9
Q ss_pred EEeEEeecCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcce
Q 041720 128 KLEKIGQGTYSSVFRAREVAT-------GKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 128 ~~~~LG~G~fG~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 199 (690)
.++.|..|-...+|++..... +..|++++..... ...-...+|..+++.|. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----E- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C-
Confidence 456677788889999975421 5789999864321 11112357888888884 322345554332 2
Q ss_pred EEEEEeccchhc
Q 041720 200 IYLVFEYMEHDL 211 (690)
Q Consensus 200 ~~LV~Ey~~g~l 211 (690)
++||||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.10 E-value=0.21 Score=53.80 Aligned_cols=29 Identities=31% Similarity=0.457 Sum_probs=25.0
Q ss_pred eEeccCCcccEEE------ccCCcEEEeeccccee
Q 041720 246 IMHRDIKASNILV------NNEGILKLGDFGLANI 274 (690)
Q Consensus 246 ivHrDLKp~NILl------d~~~~vKL~DFGla~~ 274 (690)
++|+|+.+.|||+ +.+..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999999864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.54 E-value=0.049 Score=60.19 Aligned_cols=65 Identities=14% Similarity=0.178 Sum_probs=18.4
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEE------EEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVAL------KKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAv------K~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+.+.|| ||.||++.......+||+ |.+.......+....+.+|..+++.++|||+++.+.+...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3344566 999999987655567888 7766544445555678889999999999999999887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 690 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-84 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-83 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-74 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-74 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-74 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-73 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-73 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-69 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-68 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-65 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-58 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-28 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 7e-84
Identities = 122/306 (39%), Positives = 178/306 (58%), Gaps = 12/306 (3%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+EKL KIGQGT+ VF+AR TG+ VALKKV +N + REI IL+ L H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 186 IKLEGVITSRLS------NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
+ L + ++ S +IYLVF++ EHDLAGL S +KF+ ++K M+ LL+G+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK---QKLTSRVVTLWYRPPE 296
+ H I+HRD+KA+N+L+ +G+LKL DFGLA + + T+RVVTLWYRPPE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SK 355
LL+G +Y +DLW GC+ AE+ PI++G TE QL I +LCGS E W
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFT--PTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413
+ + + +++R K + P A+DLID L ++P +R + L ++F +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
Query: 414 PYACDP 419
P D
Sbjct: 312 PMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (672), Expect = 3e-83
Identities = 112/302 (37%), Positives = 168/302 (55%), Gaps = 9/302 (2%)
Query: 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF---QPESIRFMAREIMILRRLDHP 183
EKL+ +G+G +++V++AR+ T ++VA+KK++ + + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
NII L + + I LVF++ME DL + + + + +K YM L G+E+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
I+HRD+K +N+L++ G+LKL DFGLA S N+ T +VVT WYR PELL G+
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK-SKLPHGDMF 362
Y V VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P EE W LP F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSL 422
K L +DLI P R TA+ L +YF+ +P L
Sbjct: 238 KSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 423 PK 424
P+
Sbjct: 296 PR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 4e-77
Identities = 101/332 (30%), Positives = 151/332 (45%), Gaps = 13/332 (3%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ L IG+G Y V A + VA+KK+ Q R + REI IL R H NI
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENI 68
Query: 186 IKLEGVI---TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
I + +I T +YLV M DL L S + ++ Q+L G+++ H
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ--KLTSRVVTLWYRPPELLMG 300
++HRD+K SN+L+N LK+ DFGLA + + LT V T WYR PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
S Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP +E
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 361 MFKPQNPYEGC--LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACD 418
+ P++ + A+DL+D L+ P+KR L Y D
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY---D 303
Query: 419 PSSLPKYPPKKEIDAKQRDEARRRKVRARMRE 450
PS P + D + D + + E
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 3e-74
Identities = 99/322 (30%), Positives = 152/322 (47%), Gaps = 18/322 (5%)
Query: 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
S+ + IG G++ V++A+ +G++VA+KKV D RF RE+ I+R+LDH N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 185 IIKLEGVITS----RLSNTIYLVFEYMEHDLAGLS---SCHDIKFSEPQVKCYMRQLLHG 237
I++L S + + LV +Y+ + ++ S VK YM QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 238 VEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPE 296
+ + H GI HRDIK N+L++ + +LKL DFG A L S + + +YR PE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPE 192
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
L+ G+T+Y S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P E ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416
+ + PQ + P A+ L L P R T +F
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310
Query: 417 CDPSSLPKYPPKKEIDAKQRDE 438
LP + E
Sbjct: 311 DPNVKLPNGRDTPALFNFTTQE 332
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 5e-74
Identities = 100/324 (30%), Positives = 161/324 (49%), Gaps = 12/324 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L+ +G G Y +V A + TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 184 NIIKLEGVITSR----LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
N+I L V T YLV +M DL L K E +++ + Q+L G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQMLKGLR 135
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ H GI+HRD+K N+ VN + LK+ DFGLA S ++T VVT WYR PE+++
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL 191
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y +VD+WSVGC+ AE++ GK + KG ++QL +I K+ G+PP E+ ++ +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 360 DMFKPQNPY--EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417
+ P + + +P AV+L++ L ++ +R TA L YF +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 418 DPSSLPKYPPKKEIDAKQRDEARR 441
D + KY + + DE +R
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKR 335
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 240 bits (613), Expect = 7e-74
Identities = 79/351 (22%), Positives = 128/351 (36%), Gaps = 36/351 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ ++ E++G G + V R E ATG A K V + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
++ L N + +++E+M +L + K SE + YMRQ+ G+ H H
Sbjct: 84 TLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 243 LRGIMHRDIKASNILVNNE--GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
+H D+K NI+ + LKL DFGL L KQ + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG 199
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
D+WSVG + LL G G + E L + + + +
Sbjct: 200 K-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+ D I L +P R T L + T S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 421 SLPKYPPKKEIDA-KQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPN 470
+P K D+ K + +A + R S ++ Q +++
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 344
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-73
Identities = 108/288 (37%), Positives = 160/288 (55%), Gaps = 4/288 (1%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E+F+K+EKIG+GTY V++AR TG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+KL VI + N +YLVFE++ DL + + P +K Y+ QLL G+ CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
++HRD+K N+L+N EG +KL DFGLA + T VVTLWYR PE+L+G
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
Y+ +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ L+ L +P KR +A + L +F
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 3e-73
Identities = 104/324 (32%), Positives = 153/324 (47%), Gaps = 12/324 (3%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E ++ L +G G Y SV A + TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 184 NIIKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
N+I L V T S N +YLV M DL + C K ++ V+ + Q+L G++
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ H I+HRD+K SN+ VN + LK+ DFGLA + T V T WYR PE+++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
+YN +VD+WSVGC+ AELL G+ + G ++QL I +L G+P E KK
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 360 DMFKPQNPY--EGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417
+ + P AVDL++ L ++ KR TA+ L YF
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 418 DPSSLPKYPPKKEIDAKQRDEARR 441
D Y E DE +
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (601), Expect = 5e-73
Identities = 111/297 (37%), Positives = 158/297 (53%), Gaps = 7/297 (2%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ +EKLEKIG+GTY +VF+A+ T ++VALK+VR D+ REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
NI++L V+ S + LVFE+ + DL + VK ++ QLL G+ CH
Sbjct: 62 NIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
R ++HRD+K N+L+N G LKL +FGLA + ++ VVTLWYRPP++L G+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 304 YNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
Y+ S+D+WS GC+FAEL P+ G +QL +IF+L G+P EE W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDP 419
P P L T DL+ L P +R +A L YF+ C P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD---FCPP 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 236 bits (603), Expect = 5e-73
Identities = 84/332 (25%), Positives = 149/332 (44%), Gaps = 40/332 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH 182
+ F L +IG G++ +V+ AR+V ++VA+KK+ + Q E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PN I+ G +T +LV EY + L H E ++ L G+ + H
Sbjct: 75 PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
++HRD+KA NIL++ G++KLGDFG A+I+ N S V T ++ PE+++
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFVGTPYWMAPEVILAMD 187
Query: 303 N--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
Y+ VD+WS+G EL KP L + L+ I + P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQS--------- 236
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
++ + +D+CL P R T+ LL + + P+
Sbjct: 237 ----------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER---PPT 277
Query: 421 SLPKYPPKKEIDAKQRDEARRRKVRARMREPA 452
+ + + ++ D + RK++ + + A
Sbjct: 278 VIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 309
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 235 bits (601), Expect = 5e-73
Identities = 106/287 (36%), Positives = 159/287 (55%), Gaps = 4/287 (1%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + LEKIG+GTY V++A+ G+ ALKK+R + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
NI+KL VI ++ + LVFE+++ DL L + K ++ QLL+G+ +CH
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
R ++HRD+K N+L+N EG LK+ DFGLA +K T +VTLWYR P++LMGS
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363
Y+ ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
K + +DL+ L ++P +R TA L YF
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-72
Identities = 72/307 (23%), Positives = 127/307 (41%), Gaps = 23/307 (7%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
++ + FEK+ ++G G VF+ +G ++A K + + + + RE+ +L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHEC 61
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEH 240
+ P I+ G S I + E+M+ + E + ++ G+ +
Sbjct: 62 NSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 241 CHLR-GIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ IMHRD+K SNILVN+ G +KL DFG++ L S V T Y PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQ 176
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVE-QLHKIFKLCG----SPPEEYWKKS 354
G+ +Y+V D+WS+G E+ +G+ + E +L ++ G +PP
Sbjct: 177 GT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 355 KLPHGDMFKPQNPYEGCLRERCKD----------FTPTAVDLIDTCLSIEPYKRGTASSL 404
L M L + + F+ D ++ CL P +R L
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 405 LMCEYFT 411
++ +
Sbjct: 296 MVHAFIK 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-72
Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 30/289 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E ++ ++ +G+G Y V A T + VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
N++K G R N YL EY DI EP + + QL+ GV + H
Sbjct: 64 NVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGST 302
GI HRDIK N+L++ LK+ DFGLA + N+++L +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
+ VD+WS G V +L G+ ++ Q + +K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW------------ 229
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
K + L+ L P R T + ++
Sbjct: 230 --------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 232 bits (592), Expect = 7e-71
Identities = 86/363 (23%), Positives = 143/363 (39%), Gaps = 51/363 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ ++ LE++G G + V R E ATG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+I L + + L+ E++ +L + D K SE +V YMRQ G++H H
Sbjct: 87 KLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 243 LRGIMHRDIKASNILV--NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
I+H DIK NI+ +K+ DFGLA L + + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDR 202
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
D+W++G + LL G G ++E L + + E+ +
Sbjct: 203 E-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
+P A D I L EP KR T L + D S
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHS 291
Query: 421 SLPKYPP-------KKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEPNSYS 473
+L P +++I K D + R+ +S ++ R + Q +SY
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP----QEYQIYDSYF 347
Query: 474 SKE 476
++
Sbjct: 348 DRK 350
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-70
Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 39/293 (13%)
Query: 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD 181
RAE +E L IG G+Y + R + GK++ K++ + + + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGL---SSCHDIKFSEPQVKCYMRQLLHG 237
HPNI++ I R + T+Y+V EY E DLA + + E V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 238 VEHCHLRG-----IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWY 292
++ CH R ++HRD+K +N+ ++ + +KLGDFGLA IL + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYY 180
Query: 293 RPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352
PE + +YN D+WS+GC+ EL P ++ E KI
Sbjct: 181 MSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------ 227
Query: 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
EG R ++ ++I L+++ Y R + +L
Sbjct: 228 ----------------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 3e-69
Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ +E + ++G G + V++A+ T + A K + + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+KL N ++++ E+ + + + +E Q++ +Q L + + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
I+HRD+KA NIL +G +KL DFG++ T Q+ S + T ++ PE++M T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCET 186
Query: 303 N----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ Y+ D+WS+G E+ +P + L KI K P +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
++ D + CL R T S LL + T
Sbjct: 241 --------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 5e-69
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIR-FMAREIMILRRLDH 182
E FE +G+G + +V+ ARE + ++ALK + + + + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PNI++L G + +YL+ EY KF E + Y+ +L + + +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+ ++HRDIK N+L+ + G LK+ DFG + + T+ TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGR- 179
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
++ VDLWS+G + E L+GKP + T E +I ++ + P+
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411
T A DLI L P +R +L + T
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 9e-69
Identities = 76/307 (24%), Positives = 136/307 (44%), Gaps = 35/307 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + + EKIGQG +V+ A +VATG+ VA++++ + EI+++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNP 77
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL 243
NI+ + +++V EY+ + E Q+ R+ L +E H
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 244 RGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTN 303
++HRDIK+ NIL+ +G +KL DFG +T + K ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKA- 192
Query: 304 YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363
Y VD+WS+G + E++ G+P + L+ I G+P + +K
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK---------- 241
Query: 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLP 423
+ D ++ CL ++ KRG+A LL ++ + S P
Sbjct: 242 ---------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTP 284
Query: 424 KYPPKKE 430
KE
Sbjct: 285 LIAAAKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-68
Identities = 78/297 (26%), Positives = 135/297 (45%), Gaps = 34/297 (11%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRR 179
R E F+ + +G+G++S+V ARE+AT + A+K + + + + ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
LDHP +KL +Y Y ++ F E + Y +++ +E
Sbjct: 65 LDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELL 298
+ H +GI+HRD+K NIL+N + +++ DFG A +L+ ++KQ + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 299 MGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ S DLW++GC+ +L+ G P + E KI KL PE+++
Sbjct: 183 TEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF------- 234
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415
P A DL++ L ++ KR + P+
Sbjct: 235 ----------------------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 6e-68
Identities = 66/338 (19%), Positives = 122/338 (36%), Gaps = 36/338 (10%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E + E +G+G + V R E ++ K K V+ ++ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+ L S + ++FE++ D+ + + +E ++ Y+ Q+ ++ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 243 LRGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMG 300
I H DI+ NI+ +K+ +FG A L K Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 301 STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
+ + D+WS+G + LL G T + + I + EE +
Sbjct: 178 DV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPS 420
K+ + A+D +D L E R TAS L + +
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 421 SLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQR 458
+ ++ + + AR+ + + Q+
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQK 309
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-66
Identities = 109/295 (36%), Positives = 161/295 (54%), Gaps = 13/295 (4%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVAT-GKMVALKKVRFDNFQPESIRFMAREIMILRRL-- 180
+ +E + +IG+G Y VF+AR++ G+ VALK+VR + RE+ +LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 181 -DHPNIIKLEGVITSRLS---NTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLL 235
+HPN+++L V T + + LVFE+++ D L + +K M QLL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 236 HGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
G++ H ++HRD+K NILV + G +KL DFGLA I + + TS VVTLWYR P
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAP 184
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E+L+ S +Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P EE W +
Sbjct: 185 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
F ++ + + D DL+ CL+ P KR +A S L YF
Sbjct: 244 ALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 217 bits (553), Expect = 2e-65
Identities = 87/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DH 182
+ ++ + K+G+G YS VF A + + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
PNII L ++ +S T LVFE++ + ++ ++ YM ++L +++CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 243 LRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
GIMHRD+K N+++++E L+L D+GLA Q+ RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 204
Query: 302 TNYNVSVDLWSVGCVFAELLIGK-PILKGRTEVEQLHKIFKLCGSP-PEEYWKKSKLPHG 359
Y+ S+D+WS+GC+ A ++ K P G +QL +I K+ G+ +Y K +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 360 DMFKPQNPYEGCLR-------ERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412
F R E +P A+D +D L + R TA + YF T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 5e-65
Identities = 92/335 (27%), Positives = 159/335 (47%), Gaps = 23/335 (6%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
++ L+ IG G V A + + VA+KK+ + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 186 IKLEGVITSRLS----NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I L V T + + +YLV E M+ L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H GI+HRD+K SNI+V ++ LK+ DFGLA + +T VVT +YR PE+++G
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P E+ KK + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 362 FKPQNPYEG-------------CLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCE 408
+ + Y G E K A DL+ L I+P KR + L
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 409 YFTTQPYACDPSSLPKYPPKKEIDAKQRDEARRRK 443
Y + + P K++D ++ ++
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 9e-65
Identities = 56/286 (19%), Positives = 120/286 (41%), Gaps = 33/286 (11%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+ G T+ + +V ++ E L + KF ++ RQ G+++ H
Sbjct: 65 NILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPELLMGS 301
+ I+HRD+K++NI ++ + +K+GDFGLA + + + ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 302 TN--YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y+ D+++ G V EL+ G+ +Q+ + P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------- 230
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
L + + L+ CL + +R +L
Sbjct: 231 ------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 210 bits (535), Expect = 1e-63
Identities = 83/301 (27%), Positives = 127/301 (42%), Gaps = 44/301 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA-------REIMI 176
E++E E +G+G S V R T K A+K + S + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 177 LRRL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQL 234
LR++ HPNII+L+ + +LVF+ M+ +L + + SE + + MR L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRAL 119
Query: 235 LHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
L + H I+HRD+K NIL++++ +KL DFG + L +KL T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLA 177
Query: 295 PELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349
PE++ S N Y VD+WS G + LL G P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEY 409
W D++ T DL+ L ++P KR TA L +
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 410 F 410
F
Sbjct: 273 F 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (535), Expect = 4e-63
Identities = 72/327 (22%), Positives = 135/327 (41%), Gaps = 42/327 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ ++ + +G G +S V A + T K+VA+K + + + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
NI+ L+ + S +YL+ + + +L ++E + Q+L V++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 243 LRGIMHRDIKASNILV---NNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
GI+HRD+K N+L + + + + DFGL+ + L++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLA 182
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y+ +VD WS+G + LL G P + + +I K YW
Sbjct: 183 QK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDP 419
D + +A D I + +P KR T L +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD------ 270
Query: 420 SSLPKYPPKKEIDAKQRDEARRRKVRA 446
++L K + + +++ A+ + +A
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-61
Identities = 71/313 (22%), Positives = 131/313 (41%), Gaps = 41/313 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVR----FDNFQPESIRFMAREIMILRR 179
+ ++ E++G G ++ V + RE +TG A K ++ + + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
+ HPN+I L V ++ + L+ E + +E + +++Q+L+GV
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 240 HCHLRGIMHRDIKASNILVNNEGI----LKLGDFGLANILTSKNKQKLTSRVVTLWYRPP 295
+ H I H D+K NI++ + + +K+ DFGLA+ + N + + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAP 185
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
E++ + D+WS+G + LL G G T+ E L + + +EY+
Sbjct: 186 EIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT---T 412
+ + A D I L +P KR T L + T
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 413 QPYACDPSSLPKY 425
Q S P++
Sbjct: 280 QQALSSAWSHPQF 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 37/291 (12%)
Query: 126 FEKLE-KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN 184
F K + +IG+G++ +V++ + T VA +++ + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 185 IIKLEGVI--TSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
I++ T + I LV E M ++ + RQ+L G++ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 243 LRG--IMHRDIKASNILVNNE-GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
R I+HRD+K NI + G +K+GD GLA + K + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYE 186
Query: 300 GSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359
Y+ SVD+++ G E+ + Q+++ G P +
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPASFD-------- 235
Query: 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
K P ++I+ C+ +R + LL +F
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 2e-58
Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 32/289 (11%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLD 181
++ +E E +G G S V AR++ + VA+K +R D + P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 182 HPNIIKLEGVITSR--LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
HP I+ + + Y+V EY++ + + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ--KLTSRVVTLWYRPPEL 297
H GI+HRD+K +NI+++ +K+ DFG+A + + + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
G + + D++S+GCV E+L G+P G + V ++ + PP
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-GTASSLL 405
+ + ++ L+ P R TA+ +
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-57
Identities = 68/355 (19%), Positives = 129/355 (36%), Gaps = 43/355 (12%)
Query: 124 ESFEKLEK-IGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-D 181
+ ++ + +G G V + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 182 HPNIIKLEGVITSRLS--NTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHG 237
P+I+++ V + + + +V E ++ +L + D F+E + M+ +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 238 VEHCHLRGIMHRDIKASNILVN---NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRP 294
+++ H I HRD+K N+L ILKL DFG A TS N + T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 295 PELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
PE+L Y+ S D+WS+G + LL G P + + E+
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---- 236
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQP 414
+ + LI L EP +R T + + +
Sbjct: 237 -----------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ-- 277
Query: 415 YACDPSSLPKYPPKKEIDAKQRDEARRRKVRARMREPASSKRQRRARQTLQLQEP 469
+ P + + + K+R E + ++ + + Q + ++ P
Sbjct: 278 -STKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNP 331
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 191 bits (487), Expect = 4e-56
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 42/293 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH 182
+ F+ L +G G++ V R G+ A+K ++ + + + E ++L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
P II++ G I+++ +Y+E +F P K Y ++ +E+ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+ I++RD+K NIL++ G +K+ DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK- 176
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
YN S+D WS G + E+L G ++ KI P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP-------------- 222
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYF 410
F DL+ ++ + +R + +F
Sbjct: 223 ---------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-56
Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
E+ + +E++G G + V+ VA+K ++ + P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHDLAG--LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V+T IY++ EYME+ L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
R +HRD++A+NILV++ K+ DFGLA ++ + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 302 TNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
T + + D+WS G + E++ G+ G T E + + +
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------- 225
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC--EYFT 411
G R + L+ C P R T L ++FT
Sbjct: 226 ---------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 192 bits (489), Expect = 8e-56
Identities = 64/294 (21%), Positives = 122/294 (41%), Gaps = 40/294 (13%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMA----REIMILRRLD 181
F IG+G + V+ R+ TGKM A+K + + + +A + ++ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
P I+ + + + + + + M FSE ++ Y +++ G+EH
Sbjct: 66 CPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H R +++RD+K +NIL++ G +++ D GLA + K+K + V T Y PE+L
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKG 180
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
Y+ S D +S+GC+ +LL G + ++ H+I ++ + E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP---------- 229
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYF 410
F+P L++ L + +R A + +F
Sbjct: 230 ---------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 49/313 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
ES K+GQG + V+ T + VA+K ++ PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEHD--LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
+++L V++ IY+V EYM L L PQ+ Q+ G+ +
Sbjct: 73 KLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
+HRD++A+NILV + K+ DFGLA ++ + + PE +
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 302 TNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
+ + D+WS G + EL G+ G E L ++ +
Sbjct: 190 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------- 229
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC--EYFTTQPYACD 418
G + + DL+ C EP +R T L +YFT
Sbjct: 230 ---------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT------- 273
Query: 419 PSSLPKYPPKKEI 431
S+ P+Y P + +
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-54
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLD 181
E F + +G+G++ VF A T + A+K ++ D + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 182 HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
HP + + ++ ++ V EY+ KF + Y +++ G++
Sbjct: 62 HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
H +GI++RD+K NIL++ +G +K+ DFG+ + + + T Y PE+L+G
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ 178
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
YN SVD WS G + E+LIG+ G+ E E H I P
Sbjct: 179 -KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR------------- 224
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
A DL+ EP KR +
Sbjct: 225 ----------------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 39/290 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNF-QPESIRFMAREIMILRR 179
+ LEK+G G++ V R A VA+K ++ D QPE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGV 238
LDH N+I+L GV+ + + +V E L H F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL--TSRVVTLWYRPPE 296
+ + +HRD+ A N+L+ ++K+GDFGL L + + R V + PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
L T ++ + D W G E+ G+ G + LHKI K P
Sbjct: 185 SLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-------- 235
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
R +D +++ C + +P R T +L
Sbjct: 236 -------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-54
Identities = 57/284 (20%), Positives = 114/284 (40%), Gaps = 37/284 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ L+++G G + V + VA+K ++ + + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+++L GV T I+++ EYM + L +F Q+ + + +E+
Sbjct: 60 KLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+ +HRD+ A N LVN++G++K+ DFGL+ + + + PPE+LM S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS- 176
Query: 303 NYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
++ D+W+ G + E+ +GK + T E I + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----------------GLRL 220
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
++P + ++ +C + +R T LL
Sbjct: 221 YRPHL------------ASEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 62/293 (21%), Positives = 110/293 (37%), Gaps = 48/293 (16%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRRLD 181
++ +G G + SV+ V+ VA+K V D + + + E+++L+++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 182 --HPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHD-IKFSEPQVKCYMRQLLHGV 238
+I+L ++ L+ E E + E + + Q+L V
Sbjct: 66 SGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 239 EHCHLRGIMHRDIKASNILVN-NEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
HCH G++HRDIK NIL++ N G LKL DFG +L T T Y PPE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 298 LMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357
+ + S +WS+G + +++ G + E+ + F+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------- 224
Query: 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410
+ + LI CL++ P R T + +
Sbjct: 225 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-53
Identities = 57/285 (20%), Positives = 108/285 (37%), Gaps = 43/285 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+ + L+ IG+G + V G VA+K ++ D F+ E ++ +L H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFL-AEASVMTQLRHS 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GVI +Y+V EYM L L S + + + +E+
Sbjct: 61 NLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
+HRD+ A N+LV+ + + K+ DFGL +S + + + + PE L
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREK 175
Query: 302 TNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360
++ D+WS G + E+ G+ + + ++ K
Sbjct: 176 -KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------- 215
Query: 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+K P P +++ C ++ R + L
Sbjct: 216 GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDH 182
F+ L+ +G+GT+ V RE ATG+ A+K +R + + + E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
P + L+ + + + V EY + F+E + + Y +++ +E+ H
Sbjct: 65 PFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
R +++RDIK N++++ +G +K+ DFGL S + + T Y PE+L +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDND 181
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
Y +VD W +G V E++ G+ + I ++ + P
Sbjct: 182 -YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EEIRFP----- 225
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYF 410
+ +P A L+ L +P +R A ++ +F
Sbjct: 226 --------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 2e-53
Identities = 56/304 (18%), Positives = 105/304 (34%), Gaps = 38/304 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI 185
+ KIG G++ ++ ++A G+ VA+K P+ + E I + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVG 64
Query: 186 IKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
I + + +V E + L L + KFS V Q++ +E+ H +
Sbjct: 65 IPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 246 IMHRDIKASNILVNNEG---ILKLGDFGLANILTSKN------KQKLTSRVVTLWYRPPE 296
+HRD+K N L+ ++ + DFGLA ++ + T Y
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
+G + DL S+G V +G +G + K ++
Sbjct: 184 THLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------- 229
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL--LMCEYFTTQP 414
+ + CK + ++ C S+ + S L L F Q
Sbjct: 230 --------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 415 YACD 418
++ D
Sbjct: 282 FSYD 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-53
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 37/284 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
+++IG G + V + VA+K +R E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
+++L GV I LVFE+MEH L+ F+ + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
++HRD+ A N LV ++K+ DFG+ + T + + PE+ S
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS- 177
Query: 303 NYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
Y+ D+WS G + E+ GK + R+ E + I
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STG 218
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
F+ P + + +++ C P R S LL
Sbjct: 219 FRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-53
Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRL 180
E E IG+G + V + ++ VA+K + +F+ +E + +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHP+I+KL GVIT N ++++ E +L + Y QL +
Sbjct: 66 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLM 299
+ + +HRDI A N+LV++ +KLGDFGL+ + K + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 300 GSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358
+ + D+W G E+L+ G +G + + +I
Sbjct: 183 FR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------- 224
Query: 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G + PT L+ C + +P +R + L
Sbjct: 225 -----------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 5e-52
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 41/291 (14%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRL 180
+ + IG G + V GK VA+K ++ + + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVE 239
DHPN+I LEGV+T S + ++ E+ME+ L +D +F+ Q+ +R + G++
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 240 HCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV----TLWYRPP 295
+ +HRD+ A NILVN+ + K+ DFGL+ L + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 296 ELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354
E + + + D+WS G V E++ G+ T + ++ I + PP
Sbjct: 203 EAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM----- 256
Query: 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
D L+ C + R ++
Sbjct: 257 -----------------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (455), Expect = 6e-52
Identities = 54/284 (19%), Positives = 111/284 (39%), Gaps = 35/284 (12%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHP 183
K+G G Y V+ VA+K ++ D + E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 184 NIIKLEGVITSRLSNTIYLVFEYMEH--DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
N+++L GV T Y++ E+M + L L C+ + S + Q+ +E+
Sbjct: 74 NLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 242 HLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGS 301
+ +HRD+ A N LV ++K+ DFGL+ ++T + + PE L +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 302 TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
+++ D+W+ G + E+ ++ Q++++ +
Sbjct: 192 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------------------- 230
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+ ER + +L+ C P R + + +
Sbjct: 231 -------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 48/281 (17%), Positives = 104/281 (37%), Gaps = 37/281 (13%)
Query: 131 KIGQGTYSSVFRA--REVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + +V + + K VA+K ++ + P + E ++++LD+P I+++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 189 EGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMH 248
G+ + + LV E E + + + + Q+ G+++ +H
Sbjct: 74 IGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 249 RDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYNV 306
RD+ A N+L+ + K+ DFGL+ L + + + PE + ++
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSS 189
Query: 307 SVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQ 365
D+WS G + E G+ +G E + K
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------------------ 225
Query: 366 NPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406
G DL++ C + + R +++ +
Sbjct: 226 ----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 7e-51
Identities = 62/327 (18%), Positives = 128/327 (39%), Gaps = 50/327 (15%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDH 182
+ F++++ +G G++ V + +G A+K + + + I E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 183 PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCH 242
P ++KLE + + + + + L +FSEP + Y Q++ E+ H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 243 LRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGST 302
+++RD+K N+L++ +G +++ DFG A + K + + T PE+++
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFA----KRVKGRTWTLCGTPEALAPEIILSK- 213
Query: 303 NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362
YN +VD W++G + E+ G P ++ KI P +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS----------- 262
Query: 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYFTTQPY-- 415
DL+ L ++ KR + + ++F T +
Sbjct: 263 ------------------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 416 ----ACDPSSLPKYPPKKEIDAKQRDE 438
+ +PK+ K D D+
Sbjct: 305 IYQRKVEAPFIPKF--KGPGDTSNFDD 329
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-51
Identities = 69/299 (23%), Positives = 129/299 (43%), Gaps = 39/299 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVA---TGKMVALKKVRFDNF--QPESIRFMAREIMILR 178
E+FE L+ +G G Y VF R+++ TGK+ A+K ++ + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 179 RLDH-PNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
+ P ++ L + ++L+ +Y+ +F+E +V+ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPEL 297
+EH H GI++RDIK NIL+++ G + L DFGL+ + ++ T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 298 LMGS-TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
+ G + ++ +VD WS+G + ELL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKR-----GTASSLLMCEYF 410
++ + A DLI L +P KR A + +F
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (446), Expect = 1e-50
Identities = 50/294 (17%), Positives = 93/294 (31%), Gaps = 40/294 (13%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
++ +IG+G++ +F + + VA+K + P+ + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 183 PNII-KLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHC 241
I + LV + + L L KFS V +Q+L V+
Sbjct: 60 CTGIPNVYYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 242 HLRGIMHRDIKASNILVNN-----EGILKLGDFGLANILTSK------NKQKLTSRVVTL 290
H + +++RDIK N L+ ++ + DFG+ ++ + T
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 291 WYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEY 350
Y +G + DL ++G VF L G +G K ++
Sbjct: 178 RYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------- 229
Query: 351 WKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL 404
+ LRE C F + ++ L
Sbjct: 230 --------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 39/281 (13%)
Query: 131 KIGQGTYSSVFRAREVATGK--MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKL 188
++G G + SV + K VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 189 EGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIM 247
GV + + LV E L + V + Q+ G+++ + +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 248 HRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV--TLWYRPPELLMGSTNYN 305
HRD+ A N+L+ N K+ DFGL+ L + + L + PE + ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFS 190
Query: 306 VSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKP 364
D+WS G E L G+ K E + I +
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------------------- 227
Query: 365 QNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G E + P L+ C + R ++
Sbjct: 228 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 70/313 (22%), Positives = 120/313 (38%), Gaps = 62/313 (19%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
E+ E + +G G + V A + VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 179 RL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEP----------- 225
+L H NI+ L G T S IYL+FEY + DL KFSE
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 226 -----------QVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274
+ C+ Q+ G+E + +HRD+ A N+LV + ++K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 275 LTSKNKQKL-TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTE 332
+ S + + + + + + PE L Y + D+WS G + E+ +G G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLS 392
+K+ + + FK P T ++ +C +
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 393 IEPYKRGTASSLL 405
+ KR + +L
Sbjct: 306 FDSRKRPSFPNLT 318
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 6e-50
Identities = 73/321 (22%), Positives = 118/321 (36%), Gaps = 68/321 (21%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ E + IG+G + VF+AR MVA+K ++ + F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMA 71
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGL----------------------- 214
D+PNI+KL GV + L+FEYM + DL
Sbjct: 72 EFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 215 SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274
SS S + C RQ+ G+ + R +HRD+ N LV ++K+ DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 275 LTSKNKQKLTSRVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTE 332
+ S + K + + PPE + Y D+W+ G V E+ G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 333 VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLS 392
E ++ + +G + ++ +L+ C S
Sbjct: 249 EEVIYYVR----------------------------DGNILACPENCPLELYNLMRLCWS 280
Query: 393 IEPYKRGTASSLL-----MCE 408
P R + S+ MCE
Sbjct: 281 KLPADRPSFCSIHRILQRMCE 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-50
Identities = 53/290 (18%), Positives = 108/290 (37%), Gaps = 36/290 (12%)
Query: 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALK---KVRFDNFQPESIRFMAREIMIL 177
++ F+K++ +G G + +V++ + G+ V + K + P++ + + E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 178 RRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHG 237
+D+P++ +L G+ + S + L H + + Q+ G
Sbjct: 66 ASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 238 VEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV-TLWYRPPE 296
+ + R ++HRD+ A N+LV +K+ DFGLA +L ++ K+ + + E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355
++ Y D+WS G EL+ G G E + K
Sbjct: 184 SILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
G + T ++ C I+ R L+
Sbjct: 229 --------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 71/300 (23%), Positives = 103/300 (34%), Gaps = 29/300 (9%)
Query: 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH 182
A + E IG+G + V+R + G+ VA+K E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRH 56
Query: 183 PNIIKLEGVITSR--LSNTIYLVFEYMEH-DLA------GLSSCHDIKFSEPQVKCYMRQ 233
NI+ ++LV +Y EH L ++ IK +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ---KLTSRVVTL 290
+ V I HRD+K+ NILV G + D GLA S RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 291 WYRPPELLMGSTN-----YNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGS 345
Y PE+L S N D++++G VF E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 346 PPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
P E +K N ++ C + ++ C R TA +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSC------EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (434), Expect = 3e-48
Identities = 74/337 (21%), Positives = 135/337 (40%), Gaps = 41/337 (12%)
Query: 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPN- 184
+ + K+G G +S+V+ A+++ VA+K VR D E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 185 ----------IIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIK---FSEPQVKCYM 231
I+KL + N +++V + L+ + VK
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 232 RQLLHGVEHCHLR-GIMHRDIKASNILVNNEGI-LKLGDFGLANILTSKNKQKLTSRVVT 289
+QLL G+++ H R GI+H DIK N+L+ L +A++ + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 290 -LWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT------EVEQLHKIFKL 342
YR PE+L+G+ + D+WS C+ EL+ G + + + + + +I +L
Sbjct: 192 TREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 343 CGSPPEEYWKKSK----------LPHGDMFKPQNPYEGCLRER---CKDFTPTAVDLIDT 389
G P + K L P E L E+ KD D +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 390 CLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426
L ++P KR A L+ + + +P
Sbjct: 311 MLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 58/308 (18%), Positives = 106/308 (34%), Gaps = 57/308 (18%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ +G G + V A + VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 179 RL-DHPNIIKLEGVITSRLSNTIYLVFEYMEH------------------DLAGLSSCHD 219
L +H NI+ L G T ++ EY + + +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 220 IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279
+ + + Q+ G+ + +HRD+ A NIL+ + I K+ DFGLA + + +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 280 KQKLTSRVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLH 337
+ + + PE + Y D+WS G EL +G G + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 338 KIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYK 397
K+ K + F+ +P + D++ TC +P K
Sbjct: 259 KMIK------------------EGFRMLSP---------EHAPAEMYDIMKTCWDADPLK 291
Query: 398 RGTASSLL 405
R T ++
Sbjct: 292 RPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-46
Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 38/289 (13%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREIMILRR 179
+ + IG G + V++ + VA+K ++ + + + F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 180 LDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGV 238
H NII+LEGVI+ + ++ EYME+ D +FS Q+ +R + G+
Sbjct: 66 FSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 239 EHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTS--RVVTLWYRPPE 296
++ +HRD+ A NILVN+ + K+ DFGL+ +L + T+ + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 297 LLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356
+ + + D+WS G V E++ ++ K
Sbjct: 184 AISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
D F+ P D L+ C E +R + ++
Sbjct: 228 ---DGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 52/284 (18%), Positives = 105/284 (36%), Gaps = 39/284 (13%)
Query: 130 EKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNII 186
E IG+G + V+ + A+K + E +F+ E +I++ HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 187 KLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG 245
L G+ + +V YM+H DL + + + Q+ G++ +
Sbjct: 92 SLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 246 IMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL---TSRVVTLWYRPPELLMGST 302
+HRD+ A N +++ + +K+ DFGLA + K + T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ- 209
Query: 303 NYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361
+ D+WS G + EL+ G P + + + +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----------------GRRL 253
Query: 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
+P+ +++ C + R + S L+
Sbjct: 254 LQPEY------------CPDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 59/305 (19%), Positives = 106/305 (34%), Gaps = 52/305 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
+ + + +G+G + V A + AT + VA+K ++ E M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDL----------------AGLSSCHDIKF 222
H N++ L G T + ++ E+ + +
Sbjct: 73 IGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 223 SEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282
+ + CY Q+ G+E R +HRD+ A NIL++ + ++K+ DFGLA +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 283 LTSRVV-TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIF 340
L + PE + Y + D+WS G + E+ G E+ +
Sbjct: 192 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT 400
K EG TP + C EP +R T
Sbjct: 251 K---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 401 ASSLL 405
S L+
Sbjct: 284 FSELV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-43
Identities = 51/299 (17%), Positives = 108/299 (36%), Gaps = 49/299 (16%)
Query: 124 ESFEKLEKIGQGTYSSVFRAR-----EVATGKMVALKKVRFDNFQPESIRFMAREIMILR 178
E ++GQG++ V+ + VA+K V E I F+ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMK 78
Query: 179 RLDHPNIIKLEGVITSRLSNTIYLVFEYMEH-DLAGLSSCHD---------IKFSEPQVK 228
+ ++++L GV++ ++ E M DL S ++
Sbjct: 79 EFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 229 CYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSRVV 288
++ G+ + + +HRD+ A N +V + +K+GDFG+ + + + + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 289 -TLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLCGSP 346
+ + PE L + D+WS G V E+ + +G + + L +
Sbjct: 197 LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249
Query: 347 PEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405
EG L ++ + +L+ C P R + ++
Sbjct: 250 ----------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 54/302 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRL- 180
+ + IG+G + V +AR G A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 181 DHPNIIKLEGVITSRLSNTIYLVFEYMEH----------------DLAGLSSCHDIKFSE 224
HPNII L G R +YL EY H +++ S
Sbjct: 69 HHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 225 PQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLT 284
Q+ + + G+++ + +HRD+ A NILV + K+ DFGL+ K+ T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 285 SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELL-IGKPILKGRTEVEQLHKIFKLC 343
+ + + E L S Y + D+WS G + E++ +G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 344 GSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403
G E+ + DL+ C +PY+R + +
Sbjct: 242 --------------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 404 LL 405
+L
Sbjct: 276 IL 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 54/306 (17%)
Query: 124 ESFEKLEKIGQGTYSSVFRAREVATGKM-------VALKKVRFDNFQPESIRFMAREIMI 176
+ + +G+G + V A + K VA+K ++ D + + ++ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 177 LRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEH----------------DLAGLSSCHDI 220
H NII L G T +Y++ EY S +
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 221 KFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280
+ S + Q+ G+E+ + +HRD+ A N+LV + ++K+ DFGLA + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 281 QKLT-SRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKI 339
K T + + + + PE L Y D+WS G + E+ VE+L K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 340 FKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG 399
K EG ++ + T ++ C P +R
Sbjct: 250 LK---------------------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 400 TASSLL 405
T L+
Sbjct: 283 TFKQLV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 109 bits (274), Expect = 3e-28
Identities = 33/204 (16%), Positives = 68/204 (33%), Gaps = 42/204 (20%)
Query: 130 EKIGQGTYSSVFRAREVATGKMVALKKVRFDN----------------FQPESIRFMARE 173
+ +G+G S+VF +K + + F +IR E
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 174 IMILRRLDHPNIIKLEGVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQ 233
L++L + K+ ++ E ++ + +
Sbjct: 65 FRALQKLQGLAVPKVYAW------EGNAVLMELIDAK-------ELYRVRVENPDEVLDM 111
Query: 234 LLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKLTSR---VVTL 290
+L V + RGI+H D+ N+LV+ EGI + DF + + + +++ R +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 291 WYRPPELLMGSTNYNVSVDLWSVG 314
++ Y D+ S
Sbjct: 171 YFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.09 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-59 Score=488.78 Aligned_cols=294 Identities=37% Similarity=0.624 Sum_probs=246.5
Q ss_pred eEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP---ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.+++||+|+||+||+|++..+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeeh
Confidence 35789999999999999999999999999997654321 223568899999999999999999999988 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||||.++++..+......+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 9999998888777777789999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
...+||+.|+|||++.+...|+.++|||||||+||||++|.+||.+.++.+++.+|.+.++.+..+.|............
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 55789999999999987777999999999999999999999999999999999999999999988877653221111111
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPK 424 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~ 424 (690)
.. .....+...+..+++++++||.+||+.||.+||||+|+|+||||++.|.++++..+|.
T Consensus 238 ~~-~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 KS-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CC-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred cc-CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 11 1112233445678999999999999999999999999999999999998888877764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=478.41 Aligned_cols=261 Identities=28% Similarity=0.387 Sum_probs=220.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .+..+.+.+|+.+|++|+|||||++++++.+ .+.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 4679999999999999999999999999999999986543 2334568899999999999999999999998 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc-c
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK-Q 281 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~-~ 281 (690)
|||||.++.+..++.....+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999987777777777899999999999999999999999999999999999999999999999999988654332 3
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
..+..+||+.|||||++.+...++.++||||||||||+|++|++||.+.+.......+........ ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-~~----------- 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NP----------- 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-TT-----------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-Cc-----------
Confidence 345678999999999998766567899999999999999999999987665544443333211111 11
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 229 --------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 229 --------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1258899999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=475.07 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=225.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.+ .+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 46799999999999999999999999999999999754321 2234568899999999999999999999998 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||+++.+...+.....+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---S 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---C
Confidence 9999999987776666667899999999999999999999999999999999999999999999999999987543 2
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.......+
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 224 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-------------- 224 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 3456789999999999976 5689999999999999999999999999999888888765432221
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
..+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 225 ---------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 ---------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 257899999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=471.93 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=214.2
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
+.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+...+.+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999988877777778899999999999999999999999775567899
Q ss_pred EEEeccchhccccccc----CCCCCChhHHHHHHHHHHHHHHHHHhCC-----eEeccCCcccEEEccCCcEEEeecccc
Q 041720 202 LVFEYMEHDLAGLSSC----HDIKFSEPQVKCYMRQLLHGVEHCHLRG-----IMHRDIKASNILVNNEGILKLGDFGLA 272 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~aL~yLH~~g-----ivHrDLKp~NILld~~~~vKL~DFGla 272 (690)
||||||+++.+..+.. ....+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999876655443 3457999999999999999999999976 999999999999999999999999999
Q ss_pred eeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 273 NILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 273 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
+.+... .......+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+.+|........
T Consensus 162 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~----- 234 (269)
T d2java1 162 RILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI----- 234 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----
T ss_pred eecccC-CCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 876543 234456789999999999965 5789999999999999999999999999999888888765321111
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYF 410 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f 410 (690)
...+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 235 -----------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 -----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 12588999999999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=472.45 Aligned_cols=289 Identities=37% Similarity=0.666 Sum_probs=241.4
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+++++||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 68999999999999999999999999999999997665444445678899999999999999999999998 7899999
Q ss_pred Eeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 204 FEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 204 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||.++++.... .....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-ccc
Confidence 9999988666543 34556999999999999999999999999999999999999999999999999999876533 344
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++.++....+.+.+..|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 55678999999999988777789999999999999999999999999999999999999999988877765222111111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
................+++++++||.+||+.||.+|||++|+|+||||++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 11111122233445678999999999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=476.24 Aligned_cols=263 Identities=30% Similarity=0.488 Sum_probs=225.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+|||||++++++.+ .+.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEE
Confidence 45789999999999999999999999999999999975432 12234678999999999999999999999988 6899
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
|||||||.++.+..+....+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999887766666667899999999999999999999999999999999999999999999999999988754322
Q ss_pred -ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 -QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 -~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------ 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP------------ 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC------------
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC------------
Confidence 33456789999999999976 5689999999999999999999999999999999988875432222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHH------HHcCccccCCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS------LLMCEYFTTQPYA 416 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~e------lL~hp~f~~~p~~ 416 (690)
..+++++++||.+||+.||.+|||++| +++||||++..|.
T Consensus 231 -----------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 231 -----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp -----------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -----------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 258899999999999999999999988 5778888876653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-57 Score=471.68 Aligned_cols=257 Identities=27% Similarity=0.484 Sum_probs=225.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEE
Confidence 35799999999999999999999999999999999865433 23568999999999999999999999998 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||.++.+..+... ..+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 9999999877665544 469999999999999999999999999999999999999999999999999998875432 34
Q ss_pred ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 283 LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+........ ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~------------ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QN------------ 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SS------------
T ss_pred ccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CC------------
Confidence 566789999999999976 5789999999999999999999999999998888887766432111 11
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 239 -------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 -------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1258899999999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-56 Score=479.27 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=234.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ .+.+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997543 3455778999999999999999999999998 689999
Q ss_pred EEeccchhcccc-cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc--CCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGL-SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN--EGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~--~~~vKL~DFGla~~~~~~~ 279 (690)
|||||.++.+.. +....+.+++.+++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+++.+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 999999876644 4455667999999999999999999999999999999999999964 578999999999887543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|......++...+.
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 250 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------- 250 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG-------
T ss_pred -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc-------
Confidence 34456789999999999976 568999999999999999999999999999999999998766555544332
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLP 423 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp 423 (690)
.+++++++||.+||+.||.+|||++|+|+||||+...++..+..+|
T Consensus 251 ------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 251 ------------------GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp ------------------GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred ------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 5899999999999999999999999999999999876655554444
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-56 Score=473.05 Aligned_cols=255 Identities=30% Similarity=0.518 Sum_probs=226.1
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-PESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
.|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++|+|||||++++++.+ .+.+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 499999999999999999999999999999999876544 4556779999999999999999999999988 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||||.++++..+......+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence 99999998877777777899999999999999999999999999999999999999999999999999986532 3
Q ss_pred cccccccCCCCcccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMG--STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~--~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
...+||+.|||||++.+ ...|+.++|||||||+||||++|.+||.+.+..+.+.++......+..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 235 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------------- 235 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------------
Confidence 45789999999999865 345899999999999999999999999999998888887664222111
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
...+|+++++||.+||+.||.+|||++|+|+||||...
T Consensus 236 --------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 236 --------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 12578999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=469.41 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=223.3
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
+.|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ .+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 45999999999999999999999999999999997653 3345678899999999999999999999988 6899999
Q ss_pred Eeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 204 FEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 204 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
||||.++.+..+. .....+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|..+... ...
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 9999998776554 34557999999999999999999999999999999999999999999999999999765432 233
Q ss_pred ccccccccCCCCcccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 283 LTSRVVTLWYRPPELLMG----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 283 ~~~~~gt~~Y~APE~l~~----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
..+.+||+.|||||++.. ...|+.++|||||||+||+|++|++||.+.+..+.+.++........
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----------- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----------- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 456789999999999853 35689999999999999999999999999998888888765321111
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
.....+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 236 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 ---------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011258899999999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-56 Score=473.74 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=211.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 456999999999999999999999999999999998665432 23568899999999999999999999988 689999
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc---cCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN---NEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld---~~~~vKL~DFGla~~~~~~~ 279 (690)
|||||+|+.+..++.....+++.++..++.||+.||.|||++|||||||||+|||+. .++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999877766666677899999999999999999999999999999999999995 4789999999999876432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....|......++...|
T Consensus 164 -~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 233 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT--------
T ss_pred -CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc--------
Confidence 34456789999999999976 57899999999999999999999999999999988888775544443322
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
..+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 234 -----------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------------cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 2689999999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=477.21 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=230.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
+..++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 79 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDR 79 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccc
Confidence 346789999999999999999999999999999999976432 12234668899999999999999999999998 689
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||||.++.+..+......++|..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 9999999999988777777778999999999999999999999999999999999999999999999999999876533
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+......+|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p------------ 225 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------ 225 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred CcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC------------
Confidence 234566899999999999976 5789999999999999999999999999999988888866432222
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+|+++++||.+||++||.+|+ +++|+|+||||.+..|
T Consensus 226 -----------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 226 -----------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -----------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 25899999999999999999999 4999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-57 Score=478.61 Aligned_cols=287 Identities=26% Similarity=0.381 Sum_probs=219.6
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|+++++||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|+.|+|||||+++++|.+ .+.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 78 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 78 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 456789999999999999999999999999999999998653 34455778999999999999999999999998 688
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+|||||||.++.+..++...+.+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999998877777666789999999999999999999997 5999999999999999999999999999987643
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhh----hhc
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQ-LHKIFKLCGSPPEEY----WKK 353 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~-l~~I~~~~g~~~~~~----w~~ 353 (690)
...++.+||++|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+. ...+....+.+.... +..
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred --CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 23456799999999999986 5799999999999999999999999987654432 222222222221110 000
Q ss_pred cCCC-CCCCCCCCCCCcccc---------ccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 354 SKLP-HGDMFKPQNPYEGCL---------RERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 354 ~~l~-~~~~~~~~~~~~~~l---------~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.... ......+.......+ ......+|.+++|||.+||++||.+|||++|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 000000000000000 00012468899999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=466.07 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=231.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcCCCceeeeeceeeccCcc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLDHPNIIKLEGVITSRLSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 198 (690)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++|+|||||++++++.+ .+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence 356999999999999999999999999999999997654321 235678999999999999999999999998 68
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC----cEEEeeccccee
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG----ILKLGDFGLANI 274 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~----~vKL~DFGla~~ 274 (690)
.+|||||||.++.+..++.....+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999887776666667899999999999999999999999999999999999998776 599999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
+... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......++...+.
T Consensus 167 ~~~~--~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 241 (293)
T d1jksa_ 167 IDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-- 241 (293)
T ss_dssp CTTS--CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT--
T ss_pred cCCC--ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC--
Confidence 6543 33456789999999999975 578999999999999999999999999999999999998776666555443
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
.+|+++++||.+||+.||.+|||++|+|+||||+...+
T Consensus 242 -----------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 242 -----------------------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp -----------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred -----------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 68999999999999999999999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=458.90 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=217.4
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc--CcceEEEE
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR--LSNTIYLV 203 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~LV 203 (690)
|++.++||+|+||+||+|++..++..||||++..........+.+.+|+++|++|+|||||++++++.+. ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4777889999999999999999999999999987766667778899999999999999999999998652 24678999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCC--eEeccCCcccEEEc-cCCcEEEeecccceeccccCc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRG--IMHRDIKASNILVN-NEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~g--ivHrDLKp~NILld-~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||+++.+..++.....+++..++.++.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 999999888777666678999999999999999999999999 99999999999996 478999999999976433
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
......+||+.|||||++.+ .|+.++|||||||+||+|++|++||.+....+.+.+.+.. +..+...+
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~~~--------- 235 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFD--------- 235 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGG---------
T ss_pred CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcccC---------
Confidence 23456789999999999864 5899999999999999999999999876655544333221 11222211
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCcccc
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFT 411 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~ 411 (690)
..+++++.+||.+||+.||.+|||++|+|+||||+
T Consensus 236 ----------------~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 ----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 25788999999999999999999999999999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-56 Score=462.79 Aligned_cols=285 Identities=37% Similarity=0.646 Sum_probs=240.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+++++||+|+||+||+|++. +|+.||||++..........+.+.+|+.+|++++|||||++++++.+ .+.+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 68999999999999999999984 88999999997765444445678999999999999999999999998 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
|||+.++++..+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 9999999888888888889999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFK 363 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~ 363 (690)
...++++.|+|||.+.+...++.++|||||||+||||++|++||.+.+..+++.++....+.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 55678999999999988778899999999999999999999999999999999999999999988877653221111111
Q ss_pred CCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccC
Q 041720 364 PQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTT 412 (690)
Q Consensus 364 ~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~ 412 (690)
...............+++.+.|||++||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111122233445678999999999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-56 Score=476.11 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=229.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.+.|++++.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|++|+|||||++++++.+ .+.+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 357999999999999999999999999999999997653 3445678899999999999999999999998 789999
Q ss_pred EEeccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEc--cCCcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVN--NEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld--~~~~vKL~DFGla~~~~~~~ 279 (690)
|||||+++.+. .+.....++++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999987664 4445556799999999999999999999999999999999999998 5689999999999887543
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|......++...|.
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 253 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS------- 253 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT-------
T ss_pred -CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc-------
Confidence 34456789999999999975 678999999999999999999999999999999999998866655544332
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 254 ------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 254 ------------------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 689999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-55 Score=467.73 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=228.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ .+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 4679999999999999999999999999999999975422 12234678899999999999999999999988 78999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||.|+.+.........+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999998887777778899999999999999999999999999999999999999999999999999987643
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
.....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.......+
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 221 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-------------- 221 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--------------
Confidence 2346789999999999975 5689999999999999999999999999999999998876432222
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||.+||..||.+|+ |++++|+||||++..|
T Consensus 222 ---------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 222 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 25789999999999999999996 9999999999988543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-54 Score=452.57 Aligned_cols=262 Identities=31% Similarity=0.430 Sum_probs=229.3
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHhhcC-CCceeeeeceeec
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ-------PESIRFMAREIMILRRLD-HPNIIKLEGVITS 194 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 194 (690)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999876432 123346889999999997 9999999999998
Q ss_pred cCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
.+.+|||||||+++.+..++...+.+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 789999999999877766666677899999999999999999999999999999999999999999999999999988
Q ss_pred ccccCcccccccccccCCCCcccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMG-----STNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEE 349 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~ 349 (690)
+... ...+..+||+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+.+..+.+..|......++..
T Consensus 160 ~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 160 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 7543 23456789999999999853 3457899999999999999999999999999999998888754443332
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+ ..+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 238 ~~-------------------------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TG-------------------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cc-------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 22 2689999999999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-55 Score=470.80 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=227.9
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccc
Confidence 35789999999999999999999999999999999975422 12234568899999999999999999999988 6889
Q ss_pred EEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 201 YLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
++||||+.++.+...+...+.+++.+++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999988777766667899999999999999999999999999999999999999999999999999988653
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGD 360 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~ 360 (690)
.....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|......++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------- 258 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------- 258 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred -ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC-------------
Confidence 2345789999999999976 5789999999999999999999999999999999988876433222
Q ss_pred CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCCC
Q 041720 361 MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQPY 415 (690)
Q Consensus 361 ~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p~ 415 (690)
..+++++.+||++||+.||.+|+ |++++|+||||+...|
T Consensus 259 ----------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 25899999999999999999995 9999999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=461.60 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=229.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997653 233568899999999999999999999998 689999
Q ss_pred EEeccchhccccccc-CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC--CcEEEeecccceeccccC
Q 041720 203 VFEYMEHDLAGLSSC-HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE--GILKLGDFGLANILTSKN 279 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~--~~vKL~DFGla~~~~~~~ 279 (690)
|||||.|+.+...+. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.+ ..+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999876655554 44479999999999999999999999999999999999999854 48999999999876432
Q ss_pred cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 280 KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 280 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
......++|+.|+|||.+.+ ..|+.++||||||||||+|++|.+||.+.+..+.+.+|......++...|.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 228 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK------- 228 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT-------
T ss_pred -CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc-------
Confidence 33455788999999999865 578999999999999999999999999999999999999887777776665
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+|+++++||.+||..||.+|||++|+|+||||+..
T Consensus 229 ------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 229 ------------------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 689999999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=459.43 Aligned_cols=295 Identities=40% Similarity=0.675 Sum_probs=238.2
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC------
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL------ 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 196 (690)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999999999999999999776555555567889999999999999999999986521
Q ss_pred cceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 197 SNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
.+.+|+|||||.++++.........+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 35689999999998888777777789999999999999999999999999999999999999999999999999998765
Q ss_pred ccC---cccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKN---KQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
... .......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+....+.++.+.|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 12334568999999999998877899999999999999999999999999999999999999999988776654
Q ss_pred cCCCCC-CCCCCCCCCcccccccc--CCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCC
Q 041720 354 SKLPHG-DMFKPQNPYEGCLRERC--KDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYAC 417 (690)
Q Consensus 354 ~~l~~~-~~~~~~~~~~~~l~~~~--~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~ 417 (690)
...... ..+.............+ ...+++++|||.+||++||.+|||++|+|+||||+..|.++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 222111 11100011111111111 23477899999999999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=454.86 Aligned_cols=286 Identities=38% Similarity=0.654 Sum_probs=234.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHhhc---CCCceeeeeceeecc---
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVAT-GKMVALKKVRFDNFQPESIRFMAREIMILRRL---DHPNIIKLEGVITSR--- 195 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~--- 195 (690)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 67899999976543332233466788877766 799999999998631
Q ss_pred CcceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 196 LSNTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
....++||||||.++++.+. ......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 24678999999998866543 34455699999999999999999999999999999999999999999999999999986
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|+...+.+....|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 34567889999999999976 67899999999999999999999999999999999999999999988877653
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.......+. .............+++.+++||.+||++||.+|||++|+|+||||++.
T Consensus 243 ~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSC--CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhc--cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 222111111 111122333456789999999999999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=444.92 Aligned_cols=287 Identities=38% Similarity=0.652 Sum_probs=246.1
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++|||||++++++.+ ...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 57999999999999999999999999999999998776666677889999999999999999999999998 6899999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcccc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQKL 283 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 283 (690)
||++.++.+..+......+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||+++...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999998888777778889999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCCC
Q 041720 284 TSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPI-LKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMF 362 (690)
Q Consensus 284 ~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~P-F~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~ 362 (690)
....+++.|+|||++.+...++.++|||||||++|+|++|+.| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4566789999999998777789999999999999999998866 677888899999999999988777754222111111
Q ss_pred CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 363 KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 363 ~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.+..............+++.+.+||.+||++||.+||||+|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 122222233444556789999999999999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=462.25 Aligned_cols=298 Identities=32% Similarity=0.544 Sum_probs=237.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC----cc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL----SN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 198 (690)
.++|+++++||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 56899999999999999999999999999999999876666677788999999999999999999999997632 23
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||+..+.... ....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHH--HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 67999999965444333 234799999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
..+..+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+....+.++.++|.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 34567899999999999877778999999999999999999999999999999999999999999988776432110
Q ss_pred CCCC--CCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCCCCCCCCCCCC
Q 041720 359 GDMF--KPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYACDPSSLPKYP 426 (690)
Q Consensus 359 ~~~~--~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~~~~~~lp~~~ 426 (690)
...+ .........+......+++++++||.+||..||.+|||++|+|+||||+......+....+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~ 320 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 320 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCC
Confidence 0000 0000011122334467899999999999999999999999999999999865544444444433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-54 Score=466.84 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=219.1
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF----QPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..++|++++.||+|+||.||+|++..+|+.||||++.+... .........+|+.+|+.++|||||++++++.+ .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--C
Confidence 45789999999999999999999999999999999975422 12222233455778888899999999999988 6
Q ss_pred ceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 198 NTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+.+|||||||.++.+..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 89999999999888777766677899999999999999999999999999999999999999999999999999987653
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. .....+||+.|+|||++.+...|+.++|||||||+||+|++|++||.+.+..+... +.......+...
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~------- 228 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVEL------- 228 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCC-------
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCC-------
Confidence 2 34557899999999999766779999999999999999999999998765443332 222221111111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCC-----HHHHHcCccccCCCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGT-----ASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpT-----a~elL~hp~f~~~p~ 415 (690)
...+++++++||.+||+.||.+||| |+|+|+||||++..|
T Consensus 229 ------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 229 ------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ------------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ------------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1268999999999999999999999 899999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=460.65 Aligned_cols=281 Identities=33% Similarity=0.524 Sum_probs=235.0
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----CcceE
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSNTI 200 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~~ 200 (690)
+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+.+|++|+|||||+++++|... ....+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 599999999999999999999999999999999865422 34799999999999999999998542 23468
Q ss_pred EEEEeccchhccccc---ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceecc
Q 041720 201 YLVFEYMEHDLAGLS---SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILT 276 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~---~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~ 276 (690)
|||||||++++...+ ......+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998765443 33456799999999999999999999999999999999999999775 89999999998765
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
.. ....+.+||+.|+|||.+.+...|+.++|||||||++|||++|++||.+.+..+++..|++.++.+..+.|.....
T Consensus 175 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 43 3445678999999999998777899999999999999999999999999999999999999999999888876433
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
.......+..............+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222222222222222223345789999999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=456.70 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=223.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHh-hcCCCceeeeeceeeccCcceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILR-RLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+..|+.++. .++|||||++++++.+ .+.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 679999999999999999999999999999999975421 1122345666777665 6899999999999998 68999
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ 281 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 281 (690)
||||||.++.+..++.....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cc
Confidence 99999999888777777778999999999999999999999999999999999999999999999999999875543 24
Q ss_pred cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCCCC
Q 041720 282 KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDM 361 (690)
Q Consensus 282 ~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~ 361 (690)
..+..+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p-------------- 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-------------- 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 4456789999999999976 5789999999999999999999999999999998888865321111
Q ss_pred CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHH-HHHcCccccCCC
Q 041720 362 FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTAS-SLLMCEYFTTQP 414 (690)
Q Consensus 362 ~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~-elL~hp~f~~~p 414 (690)
+.+|+++.+||.+||+.||.+|||+. ++++||||++..
T Consensus 224 ---------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 224 ---------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp ---------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 25899999999999999999999995 899999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=442.11 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=211.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHhhcC--CCceeeeeceeeccC
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQP----ESIRFMAREIMILRRLD--HPNIIKLEGVITSRL 196 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~ 196 (690)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 357999999999999999999999999999999997653321 11234678999999996 8999999999988
Q ss_pred cceEEEEEeccch-hcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-CCcEEEeeccccee
Q 041720 197 SNTIYLVFEYMEH-DLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-EGILKLGDFGLANI 274 (690)
Q Consensus 197 ~~~~~LV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-~~~vKL~DFGla~~ 274 (690)
.+.+|+||||+.+ +++.........+++.+++.++.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 6899999999976 455555555668999999999999999999999999999999999999985 47999999999987
Q ss_pred ccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 275 LTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 275 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
... ...++.+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+ .+......
T Consensus 161 ~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~--------- 222 (273)
T d1xwsa_ 161 LKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF--------- 222 (273)
T ss_dssp CCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC---------
T ss_pred ccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC---------
Confidence 543 344567899999999999876667888999999999999999999998632 22221111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 223 --------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 223 --------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 012589999999999999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=436.04 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=212.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.++||+|+||+||+|+. +..||||+++.........+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~ 77 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQ 77 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cE
Confidence 35577899999999999999999974 3359999998776666777889999999999999999999998754 56
Q ss_pred EEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 200 IYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
++||||||+++.+..++ .....+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999987665544 45567999999999999999999999999999999999999999999999999999876533
Q ss_pred C-cccccccccccCCCCcccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 279 N-KQKLTSRVVTLWYRPPELLMGS--TNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 279 ~-~~~~~~~~gt~~Y~APE~l~~~--~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
. ........||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+..+.+..+......++.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~------- 230 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD------- 230 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-------
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-------
Confidence 2 2344567899999999998642 35899999999999999999999999998877766666554332221
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
+......+++++.+||.+||+.||.+|||++|++++
T Consensus 231 ----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ----------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011123688999999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=448.98 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=208.0
Q ss_pred cCCeeEEe-EEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec--cCcc
Q 041720 123 AESFEKLE-KIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS--RLSN 198 (690)
Q Consensus 123 ~~~y~~~~-~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~ 198 (690)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46799886 599999999999999999999999999742 3467899987655 89999999999875 2246
Q ss_pred eEEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccce
Q 041720 199 TIYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLAN 273 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~ 273 (690)
.+|||||||+|+.|..++.. ...|++.+++.|+.||+.||.|||++|||||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 79999999998766554433 346999999999999999999999999999999999999985 4679999999998
Q ss_pred eccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC----CCChh
Q 041720 274 ILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCG----SPPEE 349 (690)
Q Consensus 274 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g----~~~~~ 349 (690)
..... ......+||+.|||||++.+ ..|+.++||||||||||+|+||++||.+.+..+....+..... .++..
T Consensus 163 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 163 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp ECCCC--CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eccCC--CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 76543 34456789999999999865 6799999999999999999999999988766555544433211 11111
Q ss_pred hhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCC
Q 041720 350 YWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQ 413 (690)
Q Consensus 350 ~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~ 413 (690)
. ...+|+++++||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 240 E-------------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp H-------------------------HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred c-------------------------cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 1 12589999999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-52 Score=433.66 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=216.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC--cce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRL--SNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~ 199 (690)
.++|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999987644 3556678999999999999999999999987632 245
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+|||||||+|+.+.......+.+++.+++.++.||+.||.|||++|||||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999998877777667789999999999999999999999999999999999999999999999999987654322
Q ss_pred c--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 280 K--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ......+||+.|||||++.+ ..|+.++||||||||||+|+||++||.+.+..+.+.++......++...+
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------ 238 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc------
Confidence 2 23456789999999999975 56899999999999999999999999999999988888765444433322
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-CHHHHHcCcccc
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-TASSLLMCEYFT 411 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-Ta~elL~hp~f~ 411 (690)
..+|+++.+||.+||+.||.+|| |+++++ |+|++
T Consensus 239 -------------------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~r 273 (277)
T d1o6ya_ 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLVR 273 (277)
T ss_dssp -------------------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred -------------------cCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHHH
Confidence 36899999999999999999999 555554 66653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=444.54 Aligned_cols=287 Identities=33% Similarity=0.486 Sum_probs=230.6
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 198 (690)
.++|+++++||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.|+|||||++++++... ..+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4679999999999999999999999999999999987766666777899999999999999999999998642 123
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+++++ |+.++.+..+.. ..++++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~i~~-~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVT-HLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEE-ECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eEEEEE-eecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 345554 555554444443 3479999999999999999999999999999999999999999999999999997653
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
....+..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|....+.++.+.+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 334567899999999998877778999999999999999999999999999999999999999988876654321110
Q ss_pred CCC--CCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 359 GDM--FKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~--~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
... ..........+......++++++|||.+||+.||.+|||+.|+|+||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000 000000111222334578999999999999999999999999999999997643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=440.77 Aligned_cols=291 Identities=31% Similarity=0.494 Sum_probs=230.9
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC---cce
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL---SNT 199 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 199 (690)
.++|+++++||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356999999999999999999999999999999997654 3455677899999999999999999999987521 235
Q ss_pred EEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccC
Q 041720 200 IYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKN 279 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 279 (690)
+||||+++.+++...+. . ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~-~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLK-T-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHHHHHH-H-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchhhhhh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 67777766555554443 2 369999999999999999999999999999999999999999999999999998765432
Q ss_pred c--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 280 K--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 280 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
. ......+||+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...+..+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 23456789999999999977778899999999999999999999999999999999999888888775543321110
Q ss_pred CCC--CCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCCC
Q 041720 358 HGD--MFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPYA 416 (690)
Q Consensus 358 ~~~--~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~~ 416 (690)
... ..................+++++++||.+||++||.+|||++|+|+||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000 00000111112233456789999999999999999999999999999999976543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=438.14 Aligned_cols=283 Identities=29% Similarity=0.495 Sum_probs=226.8
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 201 (690)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.+. ||||+++++++.......++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 467999999999999999999999999999999997532 356889999999995 99999999999865567899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCC-cEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEG-ILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~~ 280 (690)
+|||||.++.+.... ..+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-- 183 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 183 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--
Confidence 999999988765543 3699999999999999999999999999999999999998755 6999999999876543
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhh-ccCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWK-KSKLPH 358 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~-~~~l~~ 358 (690)
......++|+.|+|||.+.+...|+.++|||||||++|+|++|..||.. .+..++...+...++.+....|. ......
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3446678999999999998877789999999999999999999999875 45667777777777654333222 111111
Q ss_pred CCCC------CCCCCCccc-cccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 359 GDMF------KPQNPYEGC-LRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 359 ~~~~------~~~~~~~~~-l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
...+ ......... .......++++++|||++||++||.+|||++|+|+||||++..|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0000 000111111 11122457899999999999999999999999999999997543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=432.17 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=217.0
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|+++++||+|+||.||+|++ .++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~ 81 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CC
Confidence 35567899999999999999999996 46788999999765443 3468999999999999999999998865 56
Q ss_pred EEEEEeccchhcccccccC--CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCH--DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+|||||||+++.+...... ...+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 7999999998877553332 23599999999999999999999999999999999999999999999999999998765
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........||+.|||||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+......+.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~--------- 231 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--------- 231 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---------
T ss_pred CccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------
Confidence 54445566788999999999875 568999999999999999999 5777888888887777654321111
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc--CccccC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM--CEYFTT 412 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~--hp~f~~ 412 (690)
...+++++.+||.+||+.||.+|||++++++ |+||+.
T Consensus 232 -------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 -------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1257899999999999999999999999998 788863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=449.47 Aligned_cols=287 Identities=30% Similarity=0.490 Sum_probs=228.0
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc----Ccc
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR----LSN 198 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 198 (690)
.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3679999999999999999999999999999999988776777777899999999999999999999998653 247
Q ss_pred eEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 199 TIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
.+|||||||.++++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~- 171 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc-
Confidence 899999999998776553 3689999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC-
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP- 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~- 357 (690)
....+..++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++.+++...+.+..++|......
T Consensus 172 -~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred -ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 234456789999999999976 57899999999999999999999999999999999999999999888887642110
Q ss_pred ----CCCCCCCCCCCc--------cccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcCccccCCCC
Q 041720 358 ----HGDMFKPQNPYE--------GCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMCEYFTTQPY 415 (690)
Q Consensus 358 ----~~~~~~~~~~~~--------~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~hp~f~~~p~ 415 (690)
............ .........+++++++||++||.+||.+||||+|||+||||+...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 000000000000 0001112235678999999999999999999999999999997543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=426.42 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=203.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|++++.||+|+||.||+|++. ++..||||+++...... +.+.+|+.+|++++|||||++++++.+ .+.++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~ 76 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPIC 76 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceecc--CCceE
Confidence 4678999999999999999999875 67789999998655443 468899999999999999999999987 67899
Q ss_pred EEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
||||||.++.+..+ ......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999998876554 44556789999999999999999999999999999999999999999999999999988765544
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+......+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------ 223 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------ 223 (263)
T ss_dssp --------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC------------
T ss_pred eeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence 44556788999999999975 568999999999999999999 6888888888888887765322111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....++++.+||.+||+.||.+|||++|+|+|
T Consensus 224 ----------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ----------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12468899999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=430.75 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=208.4
Q ss_pred eeEE-eEEeecCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEE
Q 041720 126 FEKL-EKIGQGTYSSVFRAREV--ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 126 y~~~-~~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 202 (690)
+.+. ++||+|+||+||+|.+. .+++.||||+++.....+...+.+.+|+.+|++|+|||||++++++.+ +.++|
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~l 84 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWML 84 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEE
Confidence 3443 46999999999999864 456789999998665556667789999999999999999999999865 45789
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCccc
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQK 282 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 282 (690)
|||||+++.+..+......+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+.......
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998887777777789999999999999999999999999999999999999999999999999998765433222
Q ss_pred --ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 283 --LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 283 --~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.....||+.|||||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....|......+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------- 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 234578999999999975 568999999999999999998 899999998888777665421110
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHH---HcCcccc
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL---LMCEYFT 411 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~el---L~hp~f~ 411 (690)
....+|+++.+||.+||+.||.+|||++++ |+|+|+.
T Consensus 231 ---------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 231 ---------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 012578999999999999999999999998 4566553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-52 Score=432.97 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=211.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++.++||+|+||+||+|++..+|+.||||+++.+... .+.+.+|+.+|++|+|||||++++++.+ .+.
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPP 87 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCe
Confidence 45677899999999999999999999999999999999765433 3568899999999999999999999987 688
Q ss_pred EEEEEeccchhcccccc--cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 200 IYLVFEYMEHDLAGLSS--CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~--~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+|||||||+++.+...+ .....+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999987665443 2345789999999999999999999999999999999999999999999999999988765
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKP-ILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~-PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
..........||+.|+|||++.+ ..|+.++|||||||+||||++|.. ||.+.+..+....+... ..++
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~--------- 236 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME--------- 236 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC---------
T ss_pred CCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCC---------
Confidence 54445555678999999999875 568999999999999999999655 45555554444433221 1111
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
....+++++.+||.+||+.||.+|||++|+++
T Consensus 237 ------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 ------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11258899999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=423.42 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=218.3
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEE
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 201 (690)
..++|+++++||+|+||+||+|++ .++..||||+++...... +.+.+|+.++++++|||||++++++.+ .+.++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~ 75 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceE
Confidence 467899999999999999999997 578899999998766543 468899999999999999999999987 68899
Q ss_pred EEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCc
Q 041720 202 LVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 202 LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 280 (690)
+||||+.++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999998765444 45556799999999999999999999999999999999999999999999999999987765554
Q ss_pred ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCCCC
Q 041720 281 QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLPHG 359 (690)
Q Consensus 281 ~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~ 359 (690)
.......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+...+|......+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 222 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------ 222 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred eeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 55556788999999999975 568999999999999999998 8999999999888888765322111
Q ss_pred CCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 360 DMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 360 ~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....++++.+||.+||+.||.+|||++++|+|
T Consensus 223 ----------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 ----------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12578899999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-51 Score=430.23 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=203.7
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK---MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+..++|++.++||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|++|+|||||++++++.+ .
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~ 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--S 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 345679999999999999999999877664 58999886543 45566789999999999999999999999987 6
Q ss_pred ceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||+++.+..+. .....+++.++..++.||+.||.|||+++||||||||+||||+.++++||+|||+++.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 8899999999998776544 445579999999999999999999999999999999999999999999999999998765
Q ss_pred ccCccc----ccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhh
Q 041720 277 SKNKQK----LTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYW 351 (690)
Q Consensus 277 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w 351 (690)
...... .....||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+......+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 254 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---- 254 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 432221 223467899999999875 578999999999999999998 8999999999888877754322111
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++++.+||.+||+.||.+|||+.|++++
T Consensus 255 ------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12578999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=427.14 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=216.1
Q ss_pred cCcCCeeEEeE-EeecCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEK-IGQGTYSSVFRAREVA--TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~-LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+..++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|++|+|||||++++++.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---
Confidence 45677899885 9999999999998754 45589999997553 45567789999999999999999999999875
Q ss_pred ceEEEEEeccchhccccc-ccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGLS-SCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||+++.+..+ ......+++.++..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 468999999998776654 4455679999999999999999999999999999999999999999999999999998875
Q ss_pred ccCc--ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhc
Q 041720 277 SKNK--QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKK 353 (690)
Q Consensus 277 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~ 353 (690)
.... .......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..|......+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~------- 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------- 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC-------
T ss_pred ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 4332 22234578999999999865 568999999999999999998 999999988888777765422111
Q ss_pred cCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHH---HcCcccc
Q 041720 354 SKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSL---LMCEYFT 411 (690)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~el---L~hp~f~ 411 (690)
....+++++.+||.+||+.||.+|||+.++ |+|+|+.
T Consensus 233 ---------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 ---------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 113688999999999999999999999888 6677774
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=434.87 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=210.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGK-----MVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|++.++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 456789999999999999999999876553 69999986543 233456788999999998 89999999999988
Q ss_pred cCcceEEEEEeccchhcccccccCC-----------------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccC
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCHD-----------------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDI 251 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~~-----------------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDL 251 (690)
.+.+|||||||+++.+..++... ..+++..++.|+.||+.||.|||+++||||||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 68899999999987665544321 34899999999999999999999999999999
Q ss_pred CcccEEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 041720 252 KASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKG 329 (690)
Q Consensus 252 Kp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~ 329 (690)
||+|||++.++++||+|||+|+........ ...+.+||+.|||||++.+ ..|+.++|||||||+||||++ |.+||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544332 2345678999999999875 578999999999999999997 8999998
Q ss_pred CCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 330 ~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.+..+.+.+++.....++ ....+++++.+||.+||+.||.+|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 877777777665322221 112578999999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=421.55 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=203.3
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVAT---GKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
+..++|++.+.||+|+||+||+|++..+ +..||||+++.. ......+.+.+|+.+|++++|||||++++++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 4567899999999999999999998654 356899988643 345556779999999999999999999999864
Q ss_pred ceEEEEEeccchhcccc-cccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHDLAGL-SSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+.+|||||||.++.+.. .......+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 67899999999876654 34556679999999999999999999999999999999999999999999999999998876
Q ss_pred ccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccC
Q 041720 277 SKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSK 355 (690)
Q Consensus 277 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~ 355 (690)
.......+...||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~--------- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 544444556778999999999975 578999999999999999998 899999999888888775432111
Q ss_pred CCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 356 LPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 356 l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 230 -------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 -------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 113688999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=421.13 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=208.6
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceE
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 200 (690)
+..++|++.+.||+|+||+||+|++..+ ..||||++....... +.+.+|+.+|++++|||||++++++.+ +.+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec---CCe
Confidence 4567899999999999999999997654 579999997665432 568899999999999999999999864 567
Q ss_pred EEEEeccchhccccccc--CCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecccc
Q 041720 201 YLVFEYMEHDLAGLSSC--HDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSK 278 (690)
Q Consensus 201 ~LV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 278 (690)
+||||||.++.+..... ....+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999886554332 2346999999999999999999999999999999999999999999999999999877554
Q ss_pred CcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCCC
Q 041720 279 NKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKLP 357 (690)
Q Consensus 279 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l~ 357 (690)
.........||+.|+|||++.. ..++.++|||||||+||||++ |.+||.+....+.+..+......+.
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~---------- 235 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---------- 235 (285)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------
T ss_pred CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------
Confidence 4445556788999999999975 578999999999999999999 5677788888888877765322111
Q ss_pred CCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc--CccccCC
Q 041720 358 HGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM--CEYFTTQ 413 (690)
Q Consensus 358 ~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~--hp~f~~~ 413 (690)
...+++++++||.+||+.||.+|||+++++. ++||+..
T Consensus 236 ------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 ------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1257899999999999999999999999987 8888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=435.89 Aligned_cols=266 Identities=26% Similarity=0.424 Sum_probs=221.8
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHhhcCC-Cceeeeeceeecc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREV---ATGKMVALKKVRFDNF--QPESIRFMAREIMILRRLDH-PNIIKLEGVITSR 195 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~ 195 (690)
..++|+++++||+|+||+||+|++. .+|+.||||++++... .....+.+.+|+.+|++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 3578999999999999999999874 4789999999865422 11223557899999999966 899999999988
Q ss_pred CcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
...+++|||||.++.+.........+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 6899999999999887777767778999999999999999999999999999999999999999999999999999887
Q ss_pred cccCcccccccccccCCCCcccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 276 TSKNKQKLTSRVVTLWYRPPELLMGST-NYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 276 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
............|++.|+|||.+.+.. .++.++|||||||+||+|++|.+||.+.+..+....+......+...
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~----- 254 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----- 254 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-----
Confidence 655555566788999999999997643 57889999999999999999999998876655555554432111110
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCC-----CHHHHHcCccccCCC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRG-----TASSLLMCEYFTTQP 414 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRp-----Ta~elL~hp~f~~~p 414 (690)
....+++++.+||.+||++||.+|| |++|+|+||||+...
T Consensus 255 --------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 255 --------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 1125899999999999999999999 589999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=415.08 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=203.1
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATG----KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..+.|++.++||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|++|+|||||++++++.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-- 80 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 80 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--
Confidence 45678999999999999999999877654 479999997543 44556678999999999999999999999987
Q ss_pred cceEEEEEeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
.+.+++|||||.++++.... .....+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 68899999999988665543 44567999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
...... ......||+.|||||++.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..+......+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----- 234 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT----- 234 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-----
Confidence 543222 2234568999999999975 5789999999999999999995 666777777776666543221111
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+++.+.+||.+||+.||.+|||+.|+++
T Consensus 235 -----------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 235 -----------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1257889999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=420.95 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=204.4
Q ss_pred CcCCeeEEeEEeecCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc
Q 041720 122 RAESFEKLEKIGQGTYSSVFRAREVATGK----MVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS 197 (690)
Q Consensus 122 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 197 (690)
..++|+++++||+|+||+||+|++..+|+ .||+|+++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 45679999999999999999999988876 58888876432 33345678999999999999999999999986
Q ss_pred ceEEEEEeccchh-cccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceecc
Q 041720 198 NTIYLVFEYMEHD-LAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILT 276 (690)
Q Consensus 198 ~~~~LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~ 276 (690)
+..++||||+.++ ++..+......+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 4567777887765 555555566789999999999999999999999999999999999999999999999999998765
Q ss_pred ccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhcc
Q 041720 277 SKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKS 354 (690)
Q Consensus 277 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~ 354 (690)
..... ......||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+......+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~------- 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------- 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 43322 2334568999999999976 578999999999999999998 8999998887776666654321111
Q ss_pred CCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 355 KLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 355 ~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
...+++++.+||.+||+.||.+|||+.|++.|
T Consensus 235 ---------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 ---------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ---------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 12578899999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=408.81 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC-CC--cEEEEEEeecCCC-ChHHHHHHHHHHHHHhhcCCCceeeeeceeeccC
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA-TG--KMVALKKVRFDNF-QPESIRFMAREIMILRRLDHPNIIKLEGVITSRL 196 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-~g--~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 196 (690)
+..++|++++.||+|+||.||+|+... ++ ..||||++..... ..+..+.+.+|+.+|++++|||||++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--
Confidence 446789999999999999999998643 33 3689999976543 34556789999999999999999999999975
Q ss_pred cceEEEEEeccchhccc-ccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceec
Q 041720 197 SNTIYLVFEYMEHDLAG-LSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANIL 275 (690)
Q Consensus 197 ~~~~~LV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~ 275 (690)
+.++||||||.++.+. ......+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 4678999999976554 44445567999999999999999999999999999999999999999999999999999986
Q ss_pred cccCcc--cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Q 041720 276 TSKNKQ--KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWK 352 (690)
Q Consensus 276 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~ 352 (690)
...... ......|++.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+.+|......++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP----- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-----
Confidence 543222 2234567889999999975 678999999999999999998 8999999999999888865322221
Q ss_pred ccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 353 KSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
....+++++.+||.+||+.||.+|||+.|++
T Consensus 236 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 236 ----------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1136889999999999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=410.83 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=200.8
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeec
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITS 194 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 194 (690)
+..++|+++++||+|+||.||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 456789999999999999999999754 45789999997543 344556777888888777 68999999998766
Q ss_pred cCcceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEE
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILV 258 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILl 258 (690)
. ...+++|||||+++.+..++.. ...+++.++..++.||+.||.|||++|||||||||+||||
T Consensus 89 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 89 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp T-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred C-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 3 5678999999998766554422 2348999999999999999999999999999999999999
Q ss_pred ccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 041720 259 NNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQL 336 (690)
Q Consensus 259 d~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l 336 (690)
+.++++||+|||+|+........ ..+..+||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876543322 3345689999999999975 6789999999999999999986 5789887666655
Q ss_pred HHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 337 HKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 337 ~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
..++.....++ ....+++++.+||.+||+.||.+|||++|+|+|
T Consensus 247 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544322111 112578999999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-48 Score=410.08 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=212.0
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeecc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSR 195 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 195 (690)
+..++|++++.||+|+||+||+|++. .+++.||||+++... .....+.+.+|+.+|++++||||+++++++.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~- 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV- 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc-
Confidence 34678999999999999999999875 356789999997543 45566789999999999999999999999987
Q ss_pred CcceEEEEEeccchhcccccccC------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccC
Q 041720 196 LSNTIYLVFEYMEHDLAGLSSCH------------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDI 251 (690)
Q Consensus 196 ~~~~~~LV~Ey~~g~ll~~~~~~------------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDL 251 (690)
.+.+++||||+.++.+..++.. ...+++..+..++.||+.||.|||+++||||||
T Consensus 88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 6889999999998765543321 124889999999999999999999999999999
Q ss_pred CcccEEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCC
Q 041720 252 KASNILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKG 329 (690)
Q Consensus 252 Kp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~ 329 (690)
||+||||+.++++||+|||+++.+...... ..+...||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999999876543322 3345678999999999975 5789999999999999999998 589999
Q ss_pred CCHHHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 330 RTEVEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 330 ~~~~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+..+.+..+......+ ....+++++.+||.+||+.||.+|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~~~~----------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILA----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999888875432111 11268899999999999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=401.22 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=200.9
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcce
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNT 199 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 199 (690)
.+..++|++++.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.+|++++|||||++++++.+. .+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCc
Confidence 35677899999999999999999987 57899999997543 335688999999999999999999988652 466
Q ss_pred EEEEEeccchhcccccccCC--CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccc
Q 041720 200 IYLVFEYMEHDLAGLSSCHD--IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTS 277 (690)
Q Consensus 200 ~~LV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~ 277 (690)
+||||||++++.+..++... ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999998776554332 3489999999999999999999999999999999999999999999999999986543
Q ss_pred cCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhhhccCC
Q 041720 278 KNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEVEQLHKIFKLCGSPPEEYWKKSKL 356 (690)
Q Consensus 278 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~e~l~~I~~~~g~~~~~~w~~~~l 356 (690)
. .....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+..|......
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~----------- 219 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------- 219 (262)
T ss_dssp ----------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-----------
T ss_pred C----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2 234567899999999975 568999999999999999998 79999988887777776432110
Q ss_pred CCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 357 PHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 357 ~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....+++++.+||.+||+.||.+|||+.+++++
T Consensus 220 -----------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 -----------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1112578999999999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=407.36 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=207.9
Q ss_pred cCcCCeeEEeEEeecCceEEEEEEEcCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceeeccCc
Q 041720 121 MRAESFEKLEKIGQGTYSSVFRAREVATGKM--VALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVITSRLS 197 (690)
Q Consensus 121 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 197 (690)
+..++|++.++||+|+||+||+|++..+|.. ||||++.... ..+..+.+.+|+.+|.++ +|||||++++++.+ .
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--C
Confidence 4567899999999999999999999888874 6778776433 234456789999999999 79999999999998 6
Q ss_pred ceEEEEEeccchhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccC
Q 041720 198 NTIYLVFEYMEHDLAGLSSCH----------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNE 261 (690)
Q Consensus 198 ~~~~LV~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~ 261 (690)
+.++||||||+++.+..++.. ...+++.++..++.||+.||.|||+++||||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 899999999998776655432 3569999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 041720 262 GILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIF 340 (690)
Q Consensus 262 ~~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~ 340 (690)
+.+||+|||+++...... ......||..|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999998654322 2234578999999999975 5689999999999999999996 57899988888877764
Q ss_pred HHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 341 KLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 341 ~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
.....+ ....+++++.+||.+||+.||++|||+.|||+|
T Consensus 241 ~~~~~~----------------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE----------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 421110 112578999999999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=402.68 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=208.3
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeece
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVATG-------KMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGV 191 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 191 (690)
.+..++|++.+.||+|+||.||+|++..++ ..||||+++.+. .......+.+|+.++.++ +|||||+++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 456788999999999999999999876554 479999997654 445567788999999888 89999999999
Q ss_pred eeccCcceEEEEEeccchhcccccccCC----------------CCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 192 ITSRLSNTIYLVFEYMEHDLAGLSSCHD----------------IKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 192 ~~~~~~~~~~LV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
|.+ .+.+++|||||.++.+..++... ..+++.++..++.||+.||.|||+++||||||||+|
T Consensus 88 ~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 88 CTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp ECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 987 67899999999988766554322 358999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
||++.++.+||+|||+++........ .....++|+.|+|||.+.+ ..|+.++||||||||||||++ |.+||.+.+..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999877543322 2344678999999999975 679999999999999999998 79999988887
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+....+.... .++ ....+++++.+||.+||+.||.+|||+.|||+
T Consensus 245 ~~~~~i~~~~-~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 245 ELFKLLKEGH-RMD---------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHTTC-CCC---------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCC-CCC---------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666554321 111 01258899999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=402.14 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=214.4
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhc-CCCceeeeeceee
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREV-----ATGKMVALKKVRFDNFQPESIRFMAREIMILRRL-DHPNIIKLEGVIT 193 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 193 (690)
.+..++|++.++||+|+||.||+|++. .+++.||||+++... .......+.+|+.++..+ +|||||++++++.
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 355678999999999999999999863 466789999998654 345566789999999999 6999999999998
Q ss_pred ccCcceEEEEEeccchhcccccccC------------------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCccc
Q 041720 194 SRLSNTIYLVFEYMEHDLAGLSSCH------------------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASN 255 (690)
Q Consensus 194 ~~~~~~~~LV~Ey~~g~ll~~~~~~------------------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~N 255 (690)
+ .+.+|||||||+++.+..++.. ...+++..+..++.||+.||.|||+++||||||||+|
T Consensus 98 ~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 98 I--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp S--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred e--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 7 6789999999998766544322 2358999999999999999999999999999999999
Q ss_pred EEEccCCcEEEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 041720 256 ILVNNEGILKLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLI-GKPILKGRTEV 333 (690)
Q Consensus 256 ILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLlt-G~~PF~~~~~~ 333 (690)
||++.++.+||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+..
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999877644332 3345688999999999975 678999999999999999998 78888888877
Q ss_pred HHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 334 EQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 334 e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
+.+.++......+.. ...+++.+.+||.+||+.||.+|||+++||+
T Consensus 255 ~~~~~~i~~~~~~~~---------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLS---------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTCCCCC---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCC---------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 777776654322211 1257889999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=402.42 Aligned_cols=255 Identities=17% Similarity=0.258 Sum_probs=214.1
Q ss_pred ccCcCCeeEEeEEeecCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeec
Q 041720 120 PMRAESFEKLEKIGQGTYSSVFRAREVA-----TGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITS 194 (690)
Q Consensus 120 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 194 (690)
.+..++|++.++||+|+||+||+|.+.. ++..||||+++... .......+.+|+.+|++++|||||++++++..
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4567899999999999999999998752 45789999997543 44556678999999999999999999999987
Q ss_pred cCcceEEEEEeccchhcccccccC----------CCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcE
Q 041720 195 RLSNTIYLVFEYMEHDLAGLSSCH----------DIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGIL 264 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~v 264 (690)
.+.++||||||.++.+..+... ...+++..+..++.||+.||.|||+++||||||||+||||+.++++
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 6789999999998766543321 1246888999999999999999999999999999999999999999
Q ss_pred EEeecccceeccccCcc-cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHH
Q 041720 265 KLGDFGLANILTSKNKQ-KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIG-KPILKGRTEVEQLHKIFKL 342 (690)
Q Consensus 265 KL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG-~~PF~~~~~~e~l~~I~~~ 342 (690)
||+|||+++.+...... .....+||+.|+|||.+.+ ..++.++|||||||+||||+|| .+||.+.+..+.+..+...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 99999999876543322 2344578999999999975 5689999999999999999998 5999999999888887653
Q ss_pred cCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 343 CGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 343 ~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
...+. ...+++.+.+||.+||+.||.+|||+.++|+
T Consensus 252 ~~~~~----------------------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 GLLDK----------------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC----------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21111 1257889999999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=393.83 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=205.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|+|+|.++..+... .+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 4699999999999999999999999999999998765433 2367899999999877766555444332 6889999
Q ss_pred EeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc---CCcEEEeecccceeccccCc
Q 041720 204 FEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN---EGILKLGDFGLANILTSKNK 280 (690)
Q Consensus 204 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~---~~~vKL~DFGla~~~~~~~~ 280 (690)
||||++++..........+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999998887777777778999999999999999999999999999999999999864 45799999999998754322
Q ss_pred c------cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc---CCCChhhh
Q 041720 281 Q------KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRTEVEQLHKIFKLC---GSPPEEYW 351 (690)
Q Consensus 281 ~------~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~~~e~l~~I~~~~---g~~~~~~w 351 (690)
. .....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.........+.... ..++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 237 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 237 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH---
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh---
Confidence 1 2345689999999999976 568999999999999999999999998866555443332211 11111
Q ss_pred hccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHH---HHcCccccC
Q 041720 352 KKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASS---LLMCEYFTT 412 (690)
Q Consensus 352 ~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~e---lL~hp~f~~ 412 (690)
......+|+++.+||..||+.||.+||++++ +|+|+|.+.
T Consensus 238 ---------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 ---------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1123478999999999999999999999875 467776643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=392.18 Aligned_cols=250 Identities=18% Similarity=0.237 Sum_probs=198.9
Q ss_pred eEEeEEeecCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCcceEEEE
Q 041720 127 EKLEKIGQGTYSSVFRAREVATG---KMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLSNTIYLV 203 (690)
Q Consensus 127 ~~~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 203 (690)
...++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+.+|++|+|||||++++++.+. .+.+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 34678999999999999986543 36999999743 3566678899999999999999999999998653 5689999
Q ss_pred Eeccchhcccccc-cCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeecccceeccccCcc-
Q 041720 204 FEYMEHDLAGLSS-CHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDFGLANILTSKNKQ- 281 (690)
Q Consensus 204 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~- 281 (690)
||||.++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999988766544 44556788899999999999999999999999999999999999999999999999876543222
Q ss_pred --cccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhccCCCC
Q 041720 282 --KLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKG-RTEVEQLHKIFKLCGSPPEEYWKKSKLPH 358 (690)
Q Consensus 282 --~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~-~~~~e~l~~I~~~~g~~~~~~w~~~~l~~ 358 (690)
......||+.|+|||.+.. ..++.++|||||||+||||+||..||.. .+..+....+......+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~------------ 254 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------------ 254 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC------------
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2234578999999999875 5689999999999999999997666554 44444444443321110
Q ss_pred CCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHcC
Q 041720 359 GDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLMC 407 (690)
Q Consensus 359 ~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~h 407 (690)
....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 255 ----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 ----------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012578899999999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.5e-45 Score=380.00 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=207.5
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC-CceeeeeceeeccCcceEE
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-PNIIKLEGVITSRLSNTIY 201 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~~ 201 (690)
.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|.| +||+.+++++.. ....+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccE
Confidence 46799999999999999999999999999999998765432 236789999999965 899999999887 68899
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEcc-----CCcEEEeecccceecc
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNN-----EGILKLGDFGLANILT 276 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~-----~~~vKL~DFGla~~~~ 276 (690)
+||||+++++...+......+++..+..++.|++.||.|||++|||||||||+||||+. ++.+||+|||+|+.+.
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999988777766666668999999999999999999999999999999999999964 5789999999998865
Q ss_pred ccCc------ccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCC
Q 041720 277 SKNK------QKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT---EVEQLHKIFKLCGSPP 347 (690)
Q Consensus 277 ~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~---~~e~l~~I~~~~g~~~ 347 (690)
.... ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.. ..+...++......++
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3322 12345689999999999976 578999999999999999999999998643 3344444433221111
Q ss_pred hhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHH
Q 041720 348 EEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLL 405 (690)
Q Consensus 348 ~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL 405 (690)
..+.++.+|+++.+||..|+..+|.+||+.+.+.
T Consensus 237 ------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 237 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1122347899999999999999999999987764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-45 Score=391.30 Aligned_cols=283 Identities=26% Similarity=0.392 Sum_probs=217.5
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-----------CCceeeeecee
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-----------HPNIIKLEGVI 192 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~~~~ 192 (690)
.+|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.+. |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999754 333456788999988875 57899999998
Q ss_pred eccCcceEEEEEeccchhc---ccccccCCCCCChhHHHHHHHHHHHHHHHHHh-CCeEeccCCcccEEEccCC------
Q 041720 193 TSRLSNTIYLVFEYMEHDL---AGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL-RGIMHRDIKASNILVNNEG------ 262 (690)
Q Consensus 193 ~~~~~~~~~LV~Ey~~g~l---l~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~-~givHrDLKp~NILld~~~------ 262 (690)
........++||+++.... ..........+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7655567777777765432 22334455679999999999999999999998 8999999999999998665
Q ss_pred cEEEeecccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHH
Q 041720 263 ILKLGDFGLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCVFAELLIGKPILKGRT------EVEQL 336 (690)
Q Consensus 263 ~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGviLyeLltG~~PF~~~~------~~e~l 336 (690)
.+||+|||.+..... .....+||+.|+|||++.+ ..|+.++|||||||++++|++|++||.+.. ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986542 3355789999999999975 568999999999999999999999997543 45677
Q ss_pred HHHHHHcCCCChhhhhccCCCC----------CCCCCCCCCCccccc---cccCCCChhHHHHHHHhhccCCCCCCCHHH
Q 041720 337 HKIFKLCGSPPEEYWKKSKLPH----------GDMFKPQNPYEGCLR---ERCKDFTPTAVDLIDTCLSIEPYKRGTASS 403 (690)
Q Consensus 337 ~~I~~~~g~~~~~~w~~~~l~~----------~~~~~~~~~~~~~l~---~~~~~is~~l~dLI~~~L~~DP~kRpTa~e 403 (690)
..++..++.++...+....... ........+...... ......+++++|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 7888888988877665422110 000000001111111 112345678999999999999999999999
Q ss_pred HHcCccccCCC
Q 041720 404 LLMCEYFTTQP 414 (690)
Q Consensus 404 lL~hp~f~~~p 414 (690)
||+||||++.+
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 99999999654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=379.91 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=190.7
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCceeeeeceeeccCc--ceEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNIIKLEGVITSRLS--NTIY 201 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~~~ 201 (690)
++|.+.++||+|+||.||+|++ +|+.||||+++... ........|+..+..++|||||++++++.+... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5689999999999999999975 78999999996442 222223456666678899999999999986422 3689
Q ss_pred EEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh--------CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 202 LVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL--------RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 202 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~--------~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
||||||.++.+..++... .+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999998776666543 68999999999999999999996 599999999999999999999999999998
Q ss_pred eccccCcc---cccccccccCCCCcccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------------
Q 041720 274 ILTSKNKQ---KLTSRVVTLWYRPPELLMGST-----NYNVSVDLWSVGCVFAELLIGKPILKGRTE------------- 332 (690)
Q Consensus 274 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~-----~~~~~sDIWSlGviLyeLltG~~PF~~~~~------------- 332 (690)
.+...... .....+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77543322 234578999999999986532 257789999999999999999988753221
Q ss_pred -HHHHHHHHHHcCCCChhhhhccCCCCCCCCCCCCCCccccccccCCCChhHHHHHHHhhccCCCCCCCHHHHHc
Q 041720 333 -VEQLHKIFKLCGSPPEEYWKKSKLPHGDMFKPQNPYEGCLRERCKDFTPTAVDLIDTCLSIEPYKRGTASSLLM 406 (690)
Q Consensus 333 -~e~l~~I~~~~g~~~~~~w~~~~l~~~~~~~~~~~~~~~l~~~~~~is~~l~dLI~~~L~~DP~kRpTa~elL~ 406 (690)
.+.+.......+ ..|..+ .. .........+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-----------------~~p~~~--~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 237 SVEEMRKVVCEQK-----------------LRPNIP--NR--WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSC-----------------CCCCCC--GG--GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccc-----------------cCCCCC--cc--cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111111000 000000 00 000122345889999999999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=6.1e-25 Score=214.03 Aligned_cols=171 Identities=19% Similarity=0.154 Sum_probs=123.5
Q ss_pred eeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHhhcCCCceeeee
Q 041720 126 FEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQ----------------PESIRFMAREIMILRRLDHPNIIKLE 189 (690)
Q Consensus 126 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIv~l~ 189 (690)
+.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|+.+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46789999999999999987 57899999987642110 11223456789999999999999887
Q ss_pred ceeeccCcceEEEEEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHhCCeEeccCCcccEEEccCCcEEEeec
Q 041720 190 GVITSRLSNTIYLVFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHLRGIMHRDIKASNILVNNEGILKLGDF 269 (690)
Q Consensus 190 ~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~~givHrDLKp~NILld~~~~vKL~DF 269 (690)
++.. .+|||||+++.... .+++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6532 27999999986443 25566778999999999999999999999999999999865 5899999
Q ss_pred ccceeccccCcccccccccccCCCCcccccCCCCCCcchhhHHHHHH
Q 041720 270 GLANILTSKNKQKLTSRVVTLWYRPPELLMGSTNYNVSVDLWSVGCV 316 (690)
Q Consensus 270 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~sDIWSlGvi 316 (690)
|+|..............-.+ .-.+.+ .+.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~~~~l~rd~~---~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWREILERDVR---NIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHHHHHHHHHH---HHHHHH--HHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHHH---HHHHHH--cCCCCCcccHHHHHHH
Confidence 99977543322111000000 001222 1457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=2.5e-06 Score=84.10 Aligned_cols=140 Identities=14% Similarity=0.092 Sum_probs=88.6
Q ss_pred CCeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeeccCcceEEE
Q 041720 124 ESFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITSRLSNTIYL 202 (690)
Q Consensus 124 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 202 (690)
+.|+..+..+-++.+.||+.. .++..++||+....... ....+.+|..+|..|. +--+.+++.+..+ .+..++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 356766665556667999884 46667888887643211 1123677888888774 3234566666665 578899
Q ss_pred EEeccchhcccccccCCCCCChhHHHHHHHHHHHHHHHHHh---------------------------------------
Q 041720 203 VFEYMEHDLAGLSSCHDIKFSEPQVKCYMRQLLHGVEHCHL--------------------------------------- 243 (690)
Q Consensus 203 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~aL~yLH~--------------------------------------- 243 (690)
||++++|..+..... +......++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 999998864432111 111222233334444444442
Q ss_pred --------------------CCeEeccCCcccEEEccCCcEEEeeccccee
Q 041720 244 --------------------RGIMHRDIKASNILVNNEGILKLGDFGLANI 274 (690)
Q Consensus 244 --------------------~givHrDLKp~NILld~~~~vKL~DFGla~~ 274 (690)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999776677999998854
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=3.4e-05 Score=75.30 Aligned_cols=73 Identities=15% Similarity=0.111 Sum_probs=49.5
Q ss_pred EEeecCc-eEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC--CceeeeeceeeccCcceEEEEEecc
Q 041720 131 KIGQGTY-SSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH--PNIIKLEGVITSRLSNTIYLVFEYM 207 (690)
Q Consensus 131 ~LG~G~f-G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~LV~Ey~ 207 (690)
.+..|.. +.||+.. ..++..+++|....... ..+..|+.+|+.|.. -.+.+++.+..+ .+..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 4555554 6789886 45677789998764432 236778888887743 235567766665 57889999999
Q ss_pred chhc
Q 041720 208 EHDL 211 (690)
Q Consensus 208 ~g~l 211 (690)
+|..
T Consensus 89 ~G~~ 92 (255)
T d1nd4a_ 89 PGQD 92 (255)
T ss_dssp SSEE
T ss_pred eccc
Confidence 8754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=1.8e-05 Score=83.34 Aligned_cols=77 Identities=19% Similarity=0.179 Sum_probs=47.4
Q ss_pred EeEEeecCceEEEEEEEcCCCcEEEEEEeecC-----CCChHHHHHHHHHHHHHhhcC-C--CceeeeeceeeccCcceE
Q 041720 129 LEKIGQGTYSSVFRAREVATGKMVALKKVRFD-----NFQPESIRFMAREIMILRRLD-H--PNIIKLEGVITSRLSNTI 200 (690)
Q Consensus 129 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~-----~~~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~~~~~~~ 200 (690)
.+.||.|....||++.+..+++.|+||.-... ...+....+...|..+|+.+. + ..+.+++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCC
Confidence 55789999999999987777889999975421 001112234556888887762 2 3455665443 2345
Q ss_pred EEEEeccch
Q 041720 201 YLVFEYMEH 209 (690)
Q Consensus 201 ~LV~Ey~~g 209 (690)
++|||++.+
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0014 Score=66.37 Aligned_cols=70 Identities=10% Similarity=0.069 Sum_probs=43.6
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCCCce--eeeece---eeccCcceEEEEEeccchh
Q 041720 137 YSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDHPNI--IKLEGV---ITSRLSNTIYLVFEYMEHD 210 (690)
Q Consensus 137 fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~---~~~~~~~~~~LV~Ey~~g~ 210 (690)
--.||++. ..+|..|++|+.+..... .+.+..|+..|..|....| +..+.. ......+..+.|++++.|.
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35899997 478888999998765433 2457778888888742222 111111 0001246678899998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.98 E-value=0.0025 Score=66.25 Aligned_cols=78 Identities=19% Similarity=0.158 Sum_probs=51.1
Q ss_pred cCCeeEEeEEeecCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcC-CCceeeeeceeec
Q 041720 123 AESFEKLEKIGQGTYSSVFRAREVA-------TGKMVALKKVRFDNFQPESIRFMAREIMILRRLD-HPNIIKLEGVITS 194 (690)
Q Consensus 123 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 194 (690)
.+.+++ +.|+.|-.-.+|++.... ..+.|.+++.- .... .-...+|..+++.+. +.-..++++++.+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 334444 678888889999997543 23567777764 2211 124568999999885 4334477777643
Q ss_pred cCcceEEEEEeccchhc
Q 041720 195 RLSNTIYLVFEYMEHDL 211 (690)
Q Consensus 195 ~~~~~~~LV~Ey~~g~l 211 (690)
.+||||+.|..
T Consensus 117 ------g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ------GRLEEYIPSRP 127 (395)
T ss_dssp ------EEEECCCCEEE
T ss_pred ------ceEEEEecccc
Confidence 58999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.09 E-value=0.012 Score=58.49 Aligned_cols=143 Identities=15% Similarity=0.144 Sum_probs=73.6
Q ss_pred CeeEEeEEeecCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHhhcCC-----Cceeeee-ceeeccCcc
Q 041720 125 SFEKLEKIGQGTYSSVFRAREVATGKMVALKKVRFDNFQPESIRFMAREIMILRRLDH-----PNIIKLE-GVITSRLSN 198 (690)
Q Consensus 125 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-----pnIv~l~-~~~~~~~~~ 198 (690)
.....+.|..|---+.|+... .+| .+++|+..... . ...+..|+.+|..|.. |..+... |........
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC-C---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence 345566677888889999863 444 48999986432 1 1345567777777632 2222211 111001123
Q ss_pred eEEEEEeccchhcccccc-----------------------cCCCC------------------CChhHHHHHHHHHHHH
Q 041720 199 TIYLVFEYMEHDLAGLSS-----------------------CHDIK------------------FSEPQVKCYMRQLLHG 237 (690)
Q Consensus 199 ~~~LV~Ey~~g~ll~~~~-----------------------~~~~~------------------lse~~~~~i~~QIl~a 237 (690)
....++.++.+....... ..... .........+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence 445566655542111000 00000 0111222233333333
Q ss_pred HHHHHh----CCeEeccCCcccEEEccCCcEEEeecccce
Q 041720 238 VEHCHL----RGIMHRDIKASNILVNNEGILKLGDFGLAN 273 (690)
Q Consensus 238 L~yLH~----~givHrDLKp~NILld~~~~vKL~DFGla~ 273 (690)
+.-.+. .|+||+|+.+.|||++.+...-|+||+.+.
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 333332 379999999999999988777899999984
|